data_2kxc_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kxc _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 15.9 m . . . . . 0 C--O 1.237 0.434 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 19.0 ttmt -118.2 131.34 56.39 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.991 0.916 . . . . 0.0 109.728 177.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 27.8 p -73.47 156.93 37.71 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.265 0.626 . . . . 0.0 111.315 -177.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 2.1 pp -127.32 -5.84 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 N-CA-C 114.722 1.378 . . . . 0.0 114.722 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -156.58 158.58 31.46 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 125.852 1.661 . . . . 0.0 110.415 171.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.21 156.68 64.04 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.216 2.611 . . . . 0.0 112.918 176.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 52.1 t-80 . . . . . 0 N--CA 1.474 0.735 0 C-N-CA 125.093 1.357 . . . . 0.0 111.735 179.164 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 53.7 p . . . . . 0 N--CA 1.48 1.029 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 67.7 mt -104.39 124.52 49.36 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.763 1.225 . . . . 0.0 111.45 -177.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 23.7 tp -77.26 124.47 27.89 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.637 0.775 . . . . 0.0 110.828 176.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 58.5 p -94.97 153.38 17.68 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.876 1.27 . . . . 0.0 112.632 174.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -167.42 178.85 5.26 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.759 1.624 . . . . 0.0 112.132 -175.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -117.28 178.51 4.34 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.663 1.985 . . . . 0.0 110.93 173.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -66.96 141.3 57.66 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.304 -0.873 . . . . 0.0 111.47 170.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 79.29 5.44 89.14 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 124.232 0.92 . . . . 0.0 115.345 174.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -74.34 166.62 23.17 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.757 1.223 . . . . 0.0 112.822 176.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 90.8 t -119.36 126.33 75.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 125.666 1.586 . . . . 0.0 108.884 -174.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 26.4 mt -133.62 135.46 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.56 1.144 . . . . 0.0 109.059 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 59.3 m -102.72 136.73 42.01 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.757 1.223 . . . . 0.0 110.058 -177.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 19.5 mt -75.34 148.0 39.64 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -175.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 49.5 mt -121.25 0.93 10.2 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 124.782 1.233 . . . . 0.0 112.908 178.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 371' ' ' ILE . . . . . 0.42 ' CG2' ' HD2' ' A' ' 372' ' ' PRO . 2.2 mt -137.13 142.67 38.96 Favored Pre-proline 0 N--CA 1.48 1.05 0 C-N-CA 126.716 2.006 . . . . 0.0 109.794 177.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 372' ' ' PRO . . . . . 0.42 ' HD2' ' CG2' ' A' ' 371' ' ' ILE . 55.6 Cg_endo -72.27 -8.87 23.5 Favored 'Trans proline' 0 CA--C 1.546 1.085 0 C-N-CA 123.423 2.749 . . . . 0.0 113.959 176.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -153.63 152.82 31.29 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.855 1.662 . . . . 0.0 112.139 174.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -72.88 169.68 16.31 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.23 1.012 . . . . 0.0 113.63 174.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 18.2 tppt? -126.39 102.36 7.12 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.776 2.03 . . . . 0.0 109.801 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 52.67 30.36 8.64 Favored 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 178.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 102.09 -18.44 51.93 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.803 1.668 . . . . 0.0 114.199 -178.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 82.0 m95 -84.4 129.47 34.86 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.524 1.13 . . . . 0.0 111.119 175.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 11.4 mt -99.23 158.56 15.61 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.925 0.89 . . . . 0.0 110.285 165.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -118.57 123.78 45.87 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.867 1.267 . . . . 0.0 107.721 171.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -148.62 172.43 28.81 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-N 115.854 -0.612 . . . . 0.0 113.602 -173.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -123.83 119.32 29.34 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.547 1.539 . . . . 0.0 109.402 176.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 25.0 t-80 -62.92 147.86 49.11 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.905 1.282 . . . . 0.0 111.546 177.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -80.39 -50.4 10.17 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 120.91 -1.119 . . . . 0.0 113.46 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 68.0 t -69.38 -49.0 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 O-C-N 121.37 -0.831 . . . . 0.0 113.111 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 20.3 t -86.11 -23.26 26.71 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.406 0.682 . . . . 0.0 112.646 -175.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 34.7 mmtm 53.46 20.51 2.06 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 126.187 1.795 . . . . 0.0 114.265 -169.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -76.41 152.78 36.12 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.458 0.703 . . . . 0.0 111.799 171.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 74.4 mtm180 -122.15 157.14 32.18 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.443 1.897 . . . . 0.0 111.195 177.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 161.02 170.57 25.81 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.529 1.061 . . . . 0.0 112.505 174.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -66.74 147.36 53.37 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.133 0.492 . . . . 0.0 110.313 166.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -154.73 155.73 30.76 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 124.304 1.042 . . . . 0.0 110.427 172.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -64.6 119.42 6.46 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.347 2.032 . . . . 0.0 110.822 176.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 28.9 t -55.79 -38.79 70.4 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.56 -0.712 . . . . 0.0 111.936 177.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 1.6 p -61.15 -17.39 52.61 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.306 1.842 . . . . 0.0 115.859 177.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -76.55 -0.34 22.85 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 119.705 1.139 . . . . 0.0 113.086 169.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 32.4 p . . . . . 0 N--CA 1.466 0.37 0 C-N-CA 126.081 1.752 . . . . 0.0 111.008 179.646 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 62.8 mt . . . . . 0 N--CA 1.478 0.935 0 CA-C-O 119.106 -0.473 . . . . 0.0 109.829 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -69.44 159.75 52.42 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 123.601 2.867 . . . . 0.0 112.264 178.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.23 144.95 87.98 Favored 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 122.374 2.05 . . . . 0.0 112.241 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -73.58 156.11 88.85 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 123.265 0.626 . . . . 0.0 112.224 173.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -69.14 174.73 8.55 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.48 2.787 . . . . 0.0 113.155 177.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -88.6 4.77 45.78 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.797 1.239 . . . . 0.0 112.62 -178.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 36.3 p90 -136.32 154.62 77.23 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 124.677 1.191 . . . . 0.0 112.829 -176.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.95 153.17 58.1 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 123.753 2.969 . . . . 0.0 112.779 178.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -68.7 143.15 94.67 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 123.732 0.813 . . . . 0.0 113.028 -177.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.73 176.86 8.82 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.992 3.128 . . . . 0.0 113.023 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 27.8 p -130.32 153.0 81.18 Favored Pre-proline 0 N--CA 1.478 0.959 0 C-N-CA 124.983 1.313 . . . . 0.0 112.82 -173.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -67.07 163.26 34.7 Favored 'Trans proline' 0 CA--C 1.548 1.183 0 C-N-CA 123.485 2.79 . . . . 0.0 111.338 176.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo . . . . . 0 CA--C 1.54 0.803 0 C-N-CA 123.007 2.471 . . . . 0.0 112.516 178.787 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 16.2 m . . . . . 0 C--O 1.236 0.387 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -113.45 133.4 55.22 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.675 0.79 . . . . 0.0 110.092 174.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 68.3 p -72.84 154.75 40.47 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.279 1.032 . . . . 0.0 111.175 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.9 pp -125.59 -6.41 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 -179.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -155.92 159.76 31.31 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 126.273 1.829 . . . . 0.0 109.889 169.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -68.75 155.96 67.02 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.041 2.494 . . . . 0.0 113.203 177.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 . . . . . 0 CA--C 1.541 0.605 0 C-N-CA 125.466 1.507 . . . . 0.0 111.409 178.711 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 75.8 p . . . . . 0 N--CA 1.483 1.177 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 69.0 mt -112.17 133.41 54.32 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.818 1.247 . . . . 0.0 111.762 -176.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 27.9 tp -87.72 121.27 29.94 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.096 0.958 . . . . 0.0 111.01 177.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 59.8 p -86.7 153.48 21.7 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.454 1.102 . . . . 0.0 112.866 172.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -167.53 178.34 5.47 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.901 1.68 . . . . 0.0 112.147 -178.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -118.54 175.96 5.48 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.877 2.071 . . . . 0.0 111.067 173.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -64.06 141.19 58.86 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.817 0.847 . . . . 0.0 111.404 169.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 75.47 11.49 84.28 Favored Glycine 0 CA--C 1.539 1.556 0 N-CA-C 114.975 0.75 . . . . 0.0 114.975 175.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -81.98 162.9 22.49 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.989 1.316 . . . . 0.0 112.036 173.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 86.9 t -117.35 129.2 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.96 1.304 . . . . 0.0 109.41 -172.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 30.5 mt -134.72 136.13 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.383 1.073 . . . . 0.0 109.474 -177.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 33.6 m -99.97 138.81 36.53 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.149 1.379 . . . . 0.0 110.31 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 20.8 mt -76.62 146.7 38.05 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 122.853 0.461 . . . . 0.0 112.219 -177.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 39.5 mt -120.07 -3.31 10.12 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 124.799 1.24 . . . . 0.0 112.773 177.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 6.2 mt -135.87 142.0 38.85 Favored Pre-proline 0 N--CA 1.481 1.101 0 C-N-CA 127.186 2.194 . . . . 0.0 109.917 177.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.13 -7.05 20.3 Favored 'Trans proline' 0 CA--C 1.546 1.121 0 C-N-CA 124.446 3.431 . . . . 0.0 115.248 175.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -151.48 167.34 28.33 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 126.091 1.756 . . . . 0.0 112.228 176.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -92.11 170.08 10.12 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.542 1.137 . . . . 0.0 113.036 175.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 10.5 tptp -133.51 111.09 10.41 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 126.366 1.866 . . . . 0.0 110.272 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 52.35 27.52 4.92 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 124.87 1.268 . . . . 0.0 114.257 -177.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 98.12 -14.31 62.63 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 125.727 1.632 . . . . 0.0 114.595 -176.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 75.7 m95 -87.04 133.31 33.61 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.412 1.106 . . . . 0.0 111.518 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 18.1 mt -102.01 162.59 12.79 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 124.342 1.057 . . . . 0.0 110.198 164.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -125.08 121.79 35.34 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.957 1.303 . . . . 0.0 107.733 175.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -145.44 174.12 25.57 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 115.542 -0.754 . . . . 0.0 114.139 -173.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -124.55 120.57 32.33 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.773 1.629 . . . . 0.0 109.798 177.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 15.8 t-80 -65.6 144.62 56.85 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.792 1.237 . . . . 0.0 111.952 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -77.71 -48.61 16.29 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 120.877 -1.139 . . . . 0.0 113.538 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 83.3 t -69.96 -48.99 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 124.03 0.932 . . . . 0.0 113.296 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 7.2 t -93.59 -16.05 24.77 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -171.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp 53.36 18.82 1.4 Allowed 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 127.024 2.13 . . . . 0.0 114.986 -173.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -78.01 156.11 30.33 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.411 0.684 . . . . 0.0 111.581 174.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -123.78 157.98 32.79 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.112 1.765 . . . . 0.0 110.652 177.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 159.68 168.86 22.26 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 124.252 0.93 . . . . 0.0 112.67 175.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -67.2 148.44 51.77 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.313 0.578 . . . . 0.0 110.258 168.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -154.36 154.39 29.5 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 124.526 1.13 . . . . 0.0 110.463 173.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -65.46 121.65 9.12 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.558 2.172 . . . . 0.0 110.883 177.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 30.4 t -56.44 -38.01 71.02 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.464 -0.772 . . . . 0.0 112.397 178.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 75.3 m -63.27 -19.6 64.71 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -73.08 -1.88 19.1 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.271 1.029 . . . . 0.0 113.192 171.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 53.8 p . . . . . 0 N--CA 1.467 0.412 0 C-N-CA 125.962 1.705 . . . . 0.0 111.441 178.071 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 64.1 mt . . . . . 0 CA--C 1.549 0.923 0 CA-C-O 119.009 -0.52 . . . . 0.0 109.759 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -69.76 158.73 55.95 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 123.459 2.772 . . . . 0.0 111.862 177.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.0 144.8 88.7 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 122.245 1.964 . . . . 0.0 112.256 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -69.74 154.77 94.47 Favored Pre-proline 0 CA--C 1.55 0.981 0 C-N-CA 122.962 0.505 . . . . 0.0 111.905 171.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -68.52 174.09 8.87 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.283 2.655 . . . . 0.0 113.009 177.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -86.65 1.95 50.13 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.463 1.105 . . . . 0.0 113.044 -178.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -132.74 153.57 81.12 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 124.736 1.215 . . . . 0.0 112.943 -176.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.4 152.97 61.16 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 123.694 2.929 . . . . 0.0 112.757 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -68.63 143.89 95.58 Favored Pre-proline 0 CA--C 1.551 1.013 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -73.54 -179.28 4.34 Favored 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 124.028 3.152 . . . . 0.0 112.791 176.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 22.2 p -134.28 155.07 80.21 Favored Pre-proline 0 N--CA 1.479 1.024 0 C-N-CA 125.247 1.419 . . . . 0.0 112.632 -175.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.59 163.13 36.22 Favored 'Trans proline' 0 CA--C 1.548 1.189 0 C-N-CA 123.512 2.808 . . . . 0.0 111.742 176.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo . . . . . 0 CA--C 1.54 0.786 0 C-N-CA 122.935 2.423 . . . . 0.0 112.576 177.764 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 15.7 m . . . . . 0 C--O 1.235 0.335 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -121.02 128.17 52.43 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.227 1.011 . . . . 0.0 109.901 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 59.0 p -71.79 154.04 41.56 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.01 0.924 . . . . 0.0 111.415 -177.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.8 pp -124.65 -8.36 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -156.01 159.54 31.45 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 126.731 2.012 . . . . 0.0 110.116 169.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.63 158.35 58.09 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.208 2.605 . . . . 0.0 113.331 177.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 . . . . . 0 N--CA 1.474 0.748 0 C-N-CA 124.98 1.312 . . . . 0.0 111.866 179.043 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 74.3 p . . . . . 0 N--CA 1.485 1.287 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 47.7 mt -97.37 120.43 37.71 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.714 1.206 . . . . 0.0 110.473 175.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 25.4 tp -73.18 131.95 42.63 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.494 0.718 . . . . 0.0 110.502 175.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 31.9 p -110.75 149.58 30.31 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.072 1.749 . . . . 0.0 112.395 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -167.11 179.08 5.33 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.149 1.379 . . . . 0.0 112.667 -169.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -116.49 177.0 4.85 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.712 2.005 . . . . 0.0 111.155 173.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -67.04 142.83 57.05 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.177 0.991 . . . . 0.0 111.888 170.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 75.61 5.39 78.32 Favored Glycine 0 CA--C 1.538 1.502 0 C-N-CA 124.376 0.988 . . . . 0.0 115.248 174.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -73.75 161.48 30.19 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.704 1.202 . . . . 0.0 111.723 171.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 59.3 t -112.51 138.32 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.485 1.114 . . . . 0.0 109.407 178.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 36.5 mt -136.26 140.77 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 124.717 1.207 . . . . 0.0 108.835 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 23.5 m -98.27 140.18 32.95 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.765 1.226 . . . . 0.0 110.853 178.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 22.7 mt -79.11 141.16 37.55 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 122.804 0.442 . . . . 0.0 111.554 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 63.1 mt -113.03 -4.45 13.86 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 124.673 1.189 . . . . 0.0 112.744 178.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 7.9 mt -132.92 141.76 42.21 Favored Pre-proline 0 N--CA 1.478 0.928 0 C-N-CA 127.001 2.12 . . . . 0.0 109.851 177.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.35 -7.98 22.42 Favored 'Trans proline' 0 CA--C 1.547 1.133 0 C-N-CA 123.974 3.116 . . . . 0.0 114.575 175.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -153.5 151.96 30.42 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.05 1.74 . . . . 0.0 112.062 175.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -74.62 171.33 14.05 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.417 1.087 . . . . 0.0 113.731 175.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -132.95 107.14 8.1 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.205 1.802 . . . . 0.0 110.249 -178.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 51.28 30.91 6.33 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 125.004 1.322 . . . . 0.0 114.343 -179.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 98.95 -16.75 59.1 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.772 1.653 . . . . 0.0 114.3 -177.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -85.75 132.06 34.21 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.308 1.043 . . . . 0.0 111.146 177.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 13.2 mt -100.7 159.94 14.76 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.939 0.896 . . . . 0.0 110.114 164.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -121.66 123.25 41.45 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 173.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -146.0 172.89 26.51 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-N 115.743 -0.662 . . . . 0.0 114.376 -172.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -124.68 116.46 22.41 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.88 1.672 . . . . 0.0 109.126 176.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 21.5 t-80 -61.88 144.29 55.14 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.818 1.247 . . . . 0.0 111.982 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -80.29 -45.32 18.07 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 121.217 -0.927 . . . . 0.0 112.705 -178.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 97.2 t -70.87 -52.73 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 124.256 1.022 . . . . 0.0 113.469 175.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 7.6 t -91.56 -15.61 28.41 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -171.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt 54.41 19.08 2.15 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 126.767 2.027 . . . . 0.0 114.777 -174.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -77.87 157.51 29.82 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.522 0.729 . . . . 0.0 111.822 174.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 54.1 mtt85 -128.52 155.9 44.14 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.007 1.723 . . . . 0.0 110.801 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 160.15 169.67 23.75 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 124.69 1.138 . . . . 0.0 112.03 176.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -66.8 147.17 53.6 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.114 0.566 . . . . 0.0 110.234 166.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -154.47 155.4 30.67 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 124.32 1.048 . . . . 0.0 110.17 172.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -65.64 120.1 7.23 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.167 1.911 . . . . 0.0 110.749 176.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 29.8 t -54.46 -38.45 66.37 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 121.897 -0.502 . . . . 0.0 111.958 176.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 17.9 m -58.58 -21.37 52.9 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.836 1.654 . . . . 0.0 115.255 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -77.41 0.27 23.17 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.606 1.163 . . . . 0.0 113.468 173.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 68.9 p . . . . . 0 N--CA 1.466 0.371 0 C-N-CA 125.945 1.698 . . . . 0.0 111.328 176.34 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 58.9 mt . . . . . 0 CA--C 1.55 0.946 0 CA-C-O 118.954 -0.546 . . . . 0.0 109.821 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.36 160.37 49.75 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 123.532 2.821 . . . . 0.0 112.079 178.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.99 144.16 86.99 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.331 2.02 . . . . 0.0 112.357 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -72.41 156.14 90.63 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 123.361 0.664 . . . . 0.0 112.138 172.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -68.75 175.02 7.76 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.443 2.762 . . . . 0.0 113.219 176.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -91.8 8.93 34.86 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.856 1.262 . . . . 0.0 112.35 -178.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 36.3 p90 -137.73 154.56 74.86 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 124.617 1.167 . . . . 0.0 112.786 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -72.07 153.54 57.46 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 123.763 2.975 . . . . 0.0 112.74 178.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -69.26 142.42 92.52 Favored Pre-proline 0 CA--C 1.551 1.008 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -175.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -73.86 179.75 5.38 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 124.173 3.249 . . . . 0.0 113.266 178.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 28.1 p -132.59 155.45 81.21 Favored Pre-proline 0 N--CA 1.479 0.988 0 C-N-CA 125.392 1.477 . . . . 0.0 113.024 -172.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.13 163.0 39.43 Favored 'Trans proline' 0 CA--C 1.548 1.197 0 C-N-CA 123.545 2.83 . . . . 0.0 111.936 175.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo . . . . . 0 CA--C 1.54 0.818 0 C-N-CA 123.376 2.717 . . . . 0.0 112.925 178.016 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 16.3 m . . . . . 0 C--O 1.237 0.409 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -115.95 132.13 56.74 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 124.396 1.079 . . . . 0.0 109.885 177.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 72.3 p -75.04 153.94 38.2 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.526 0.73 . . . . 0.0 111.366 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.9 pp -123.97 -7.92 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -156.38 158.77 31.62 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 126.102 1.761 . . . . 0.0 110.117 170.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.02 155.78 68.34 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 122.947 2.431 . . . . 0.0 112.968 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 . . . . . 0 N--CA 1.471 0.616 0 C-N-CA 124.931 1.292 . . . . 0.0 111.621 178.772 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 36.7 p . . . . . 0 N--CA 1.482 1.168 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 81.8 mt -106.23 126.22 51.96 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.961 1.305 . . . . 0.0 110.963 -176.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 31.5 tp -73.86 141.8 46.09 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 122.987 0.515 . . . . 0.0 110.205 171.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 58.0 p -121.65 148.86 44.02 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.192 1.397 . . . . 0.0 111.721 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -165.54 178.5 6.68 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.97 1.308 . . . . 0.0 112.447 -167.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -117.7 177.63 4.69 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 127.117 2.167 . . . . 0.0 110.802 174.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -67.54 141.5 56.84 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 121.215 -0.928 . . . . 0.0 111.595 170.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 77.48 6.7 86.84 Favored Glycine 0 CA--C 1.538 1.485 0 N-CA-C 115.274 0.87 . . . . 0.0 115.274 176.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -74.02 164.67 26.32 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 118.437 1.119 . . . . 0.0 112.02 170.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 77.2 t -120.61 128.07 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.337 1.455 . . . . 0.0 109.125 -174.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 31.0 mt -132.55 137.06 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 123.399 0.68 . . . . 0.0 109.506 -175.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 20.5 m -98.02 140.27 32.61 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.334 1.054 . . . . 0.0 110.649 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 23.8 mt -81.17 142.94 32.74 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 122.975 0.51 . . . . 0.0 111.718 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 39.2 mt -116.04 -4.54 12.0 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.42 1.088 . . . . 0.0 113.003 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 6.9 mt -134.13 141.53 39.83 Favored Pre-proline 0 N--CA 1.477 0.88 0 C-N-CA 127.007 2.123 . . . . 0.0 109.57 177.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.81 -7.36 20.98 Favored 'Trans proline' 0 CA--C 1.549 1.255 0 C-N-CA 123.98 3.12 . . . . 0.0 114.561 176.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -150.3 154.49 37.96 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.073 1.749 . . . . 0.0 111.478 173.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -78.47 168.82 19.22 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 121.006 -1.059 . . . . 0.0 113.156 173.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -121.89 103.01 8.54 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 126.253 1.821 . . . . 0.0 110.253 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 52.14 31.47 9.05 Favored 'General case' 0 CA--C 1.555 1.136 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 177.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 99.84 -4.33 57.67 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 125.317 1.437 . . . . 0.0 114.675 -178.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -101.69 118.47 37.01 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.199 1.4 . . . . 0.0 110.67 176.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 12.6 mt -82.93 161.49 21.81 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.393 0.616 . . . . 0.0 110.546 162.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -126.04 123.5 38.56 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.152 1.381 . . . . 0.0 107.975 171.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -150.67 173.88 30.13 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-N 115.933 -0.576 . . . . 0.0 114.509 -169.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -126.21 120.29 29.67 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.653 1.581 . . . . 0.0 110.11 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 25.0 t-80 -66.4 156.07 35.66 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.256 1.422 . . . . 0.0 112.554 178.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -83.05 -48.18 10.88 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 178.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 71.2 t -75.66 -49.07 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 125.206 1.402 . . . . 0.0 113.393 -178.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 23.2 t -87.77 -23.34 24.12 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 118.786 0.721 . . . . 0.0 112.561 -176.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 7.0 mmmm 54.91 19.49 2.67 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 126.529 1.932 . . . . 0.0 114.006 -171.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -75.09 155.26 37.33 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.896 0.878 . . . . 0.0 111.817 172.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 -121.49 156.37 32.93 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 126.111 1.764 . . . . 0.0 111.429 176.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 165.57 169.63 29.44 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.898 1.237 . . . . 0.0 112.042 175.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -66.99 149.92 49.96 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.06 0.457 . . . . 0.0 110.126 166.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -155.87 154.37 27.66 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 124.263 1.025 . . . . 0.0 110.162 171.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -63.78 119.84 7.03 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.181 1.921 . . . . 0.0 110.406 177.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.1 -36.41 70.59 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 121.391 -0.818 . . . . 0.0 111.564 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 18.2 m -59.43 -22.11 60.99 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 126.748 2.019 . . . . 0.0 114.944 178.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -74.88 0.72 14.66 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.763 1.225 . . . . 0.0 113.217 172.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 36.6 p . . . . . 0 N--CA 1.468 0.461 0 C-N-CA 125.735 1.614 . . . . 0.0 111.803 179.859 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 57.9 mt . . . . . 0 N--CA 1.479 0.997 0 CA-C-O 119.033 -0.508 . . . . 0.0 109.663 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -69.93 160.49 49.48 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 123.574 2.849 . . . . 0.0 112.138 177.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.07 144.49 87.52 Favored 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 122.294 1.996 . . . . 0.0 112.136 178.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -73.14 155.49 90.12 Favored Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 123.118 0.567 . . . . 0.0 112.027 173.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -69.07 174.7 8.52 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 123.537 2.824 . . . . 0.0 113.128 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -92.34 9.02 35.82 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.913 1.285 . . . . 0.0 112.472 -178.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 34.9 p90 -137.85 153.86 74.11 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 124.621 1.168 . . . . 0.0 112.842 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -71.92 151.91 57.08 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.579 2.853 . . . . 0.0 112.364 177.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -69.91 146.3 95.16 Favored Pre-proline 0 CA--C 1.549 0.923 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -175.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.95 178.12 6.87 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 123.979 3.119 . . . . 0.0 112.833 176.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 25.3 p -132.36 154.02 81.43 Favored Pre-proline 0 N--CA 1.478 0.941 0 C-N-CA 125.316 1.447 . . . . 0.0 112.449 -175.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -66.5 162.24 37.6 Favored 'Trans proline' 0 CA--C 1.548 1.186 0 C-N-CA 123.353 2.702 . . . . 0.0 111.48 175.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 CA--C 1.541 0.827 0 C-N-CA 123.167 2.578 . . . . 0.0 112.713 179.085 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 17.4 m . . . . . 0 C--O 1.234 0.288 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -118.19 134.99 54.52 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.292 1.037 . . . . 0.0 110.362 176.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 81.3 p -77.44 154.21 32.83 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.065 1.346 . . . . 0.0 111.674 -176.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.9 pp -119.7 -9.62 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -178.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -154.69 159.04 32.25 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 126.427 1.891 . . . . 0.0 110.538 170.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -69.88 158.01 58.25 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.225 2.617 . . . . 0.0 112.987 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 35.9 t-80 . . . . . 0 CA--C 1.539 0.539 0 C-N-CA 125.835 1.654 . . . . 0.0 111.193 -179.242 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 41.2 p . . . . . 0 N--CA 1.479 1.006 0 N-CA-C 114.004 1.112 . . . . 0.0 114.004 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -102.68 118.52 37.02 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.096 1.358 . . . . 0.0 110.773 -171.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 28.5 tp -72.25 120.64 18.14 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 122.999 0.52 . . . . 0.0 110.736 176.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 50.1 m -95.54 147.97 23.0 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.315 1.046 . . . . 0.0 111.982 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -164.5 178.02 7.71 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.131 1.372 . . . . 0.0 113.215 -171.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -116.71 175.12 5.72 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.373 1.869 . . . . 0.0 111.681 174.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -64.31 140.72 58.9 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.01 0.924 . . . . 0.0 111.563 170.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 75.12 6.31 79.06 Favored Glycine 0 CA--C 1.539 1.532 0 C-N-CA 123.985 0.803 . . . . 0.0 115.076 176.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -77.02 161.62 28.18 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.731 1.212 . . . . 0.0 111.983 174.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 91.9 t -114.64 131.53 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 124.952 1.301 . . . . 0.0 109.841 -172.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 23.8 mt -135.23 139.73 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.204 1.402 . . . . 0.0 108.839 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 25.0 m -100.88 138.66 37.62 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.16 1.384 . . . . 0.0 110.302 -178.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 23.0 mt -79.15 136.37 37.09 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 118.138 0.426 . . . . 0.0 111.768 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 24.9 mt -114.36 -10.13 12.69 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.308 1.043 . . . . 0.0 113.089 -179.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 10.0 mt -126.69 141.16 39.47 Favored Pre-proline 0 N--CA 1.475 0.822 0 C-N-CA 126.565 1.946 . . . . 0.0 109.588 175.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.12 -7.71 21.51 Favored 'Trans proline' 0 CA--C 1.548 1.203 0 C-N-CA 123.8 3.0 . . . . 0.0 114.615 176.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -152.52 153.27 33.12 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.686 1.595 . . . . 0.0 112.368 176.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 19.2 pm0 -75.56 169.06 18.83 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.652 1.181 . . . . 0.0 113.619 173.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -130.63 106.67 8.65 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 126.75 2.02 . . . . 0.0 109.992 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 51.12 30.48 5.62 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 124.926 1.29 . . . . 0.0 114.41 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 100.94 -14.06 58.81 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 125.807 1.67 . . . . 0.0 114.475 -178.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 82.0 m95 -89.42 135.47 33.57 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.281 1.032 . . . . 0.0 111.633 178.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 18.9 mt -107.17 161.02 15.14 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.833 1.253 . . . . 0.0 109.973 166.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -123.16 120.05 32.05 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.671 1.188 . . . . 0.0 107.884 175.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -143.7 170.96 25.52 Favored Glycine 0 CA--C 1.527 0.844 0 CA-C-N 115.611 -0.722 . . . . 0.0 114.199 -173.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -120.37 118.43 30.34 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.424 1.489 . . . . 0.0 110.114 178.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 19.8 t-80 -63.4 147.43 51.24 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.903 1.281 . . . . 0.0 112.059 178.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -79.87 -49.46 11.9 Favored 'General case' 0 CA--C 1.547 0.865 0 O-C-N 120.868 -1.145 . . . . 0.0 113.411 177.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 63.7 t -68.8 -50.78 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.993 0.917 . . . . 0.0 113.234 178.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 23.0 t -86.15 -23.56 26.53 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.439 0.695 . . . . 0.0 112.868 -173.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp 54.71 16.42 1.38 Allowed 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 126.655 1.982 . . . . 0.0 114.66 -168.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -75.17 153.35 38.21 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.387 0.675 . . . . 0.0 111.794 172.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 82.4 mtm180 -124.06 151.1 44.22 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 126.42 1.888 . . . . 0.0 110.76 177.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 170.26 168.31 31.92 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 124.521 1.057 . . . . 0.0 112.146 175.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -65.5 145.68 55.81 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.136 0.493 . . . . 0.0 110.237 167.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -153.33 155.23 31.59 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 124.432 1.093 . . . . 0.0 111.037 175.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -65.65 121.7 9.15 Favored 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 122.496 2.131 . . . . 0.0 111.715 178.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 41.0 t -59.55 -27.75 66.49 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 121.644 -0.66 . . . . 0.0 112.649 174.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 17.8 m -66.96 -17.94 65.15 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 174.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -83.38 -2.24 55.3 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.717 1.207 . . . . 0.0 113.543 178.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 67.1 p . . . . . 0 N--CA 1.472 0.635 0 C-N-CA 126.29 1.836 . . . . 0.0 109.897 172.017 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 45.2 mt . . . . . 0 N--CA 1.476 0.862 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -69.16 160.64 49.09 Favored 'Trans proline' 0 CA--C 1.545 1.047 0 C-N-CA 123.321 2.681 . . . . 0.0 111.963 177.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -64.52 145.86 88.26 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 122.286 1.99 . . . . 0.0 112.321 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -68.63 153.24 96.06 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 122.975 0.51 . . . . 0.0 111.85 171.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -69.56 174.48 9.27 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 123.487 2.791 . . . . 0.0 113.165 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -87.94 2.9 50.5 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.608 1.163 . . . . 0.0 112.957 -178.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 37.5 p90 -133.86 154.48 80.44 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 124.744 1.217 . . . . 0.0 112.778 -176.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.47 152.62 60.4 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 123.625 2.883 . . . . 0.0 112.688 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -66.96 142.0 97.07 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 123.703 0.801 . . . . 0.0 113.033 -177.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.19 176.94 8.46 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 123.852 3.035 . . . . 0.0 112.836 177.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 31.9 p -131.56 154.5 81.87 Favored Pre-proline 0 N--CA 1.478 0.951 0 C-N-CA 125.254 1.422 . . . . 0.0 112.659 -173.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.28 162.89 40.03 Favored 'Trans proline' 0 CA--C 1.548 1.18 0 C-N-CA 123.562 2.842 . . . . 0.0 111.94 176.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo . . . . . 0 CA--C 1.54 0.8 0 C-N-CA 123.236 2.624 . . . . 0.0 112.562 178.733 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 15.3 m . . . . . 0 C--O 1.234 0.281 0 CA-C-O 121.292 0.568 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -122.78 132.55 54.27 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.45 1.1 . . . . 0.0 109.699 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 74.2 p -78.67 152.42 31.66 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.502 1.121 . . . . 0.0 111.172 -177.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.8 pp -120.95 -9.33 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 -178.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -153.38 158.62 32.72 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 126.286 1.834 . . . . 0.0 110.308 168.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -69.09 156.93 63.59 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.407 2.738 . . . . 0.0 113.271 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 44.0 t-80 . . . . . 0 N--CA 1.473 0.676 0 C-N-CA 125.516 1.526 . . . . 0.0 111.4 178.602 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 56.3 p . . . . . 0 N--CA 1.479 1.017 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 56.2 mt -102.08 132.32 48.01 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.606 1.162 . . . . 0.0 111.13 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 28.2 tp -83.66 120.11 25.58 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.06 0.544 . . . . 0.0 110.872 175.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 54.7 p -88.54 152.46 21.84 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.566 1.147 . . . . 0.0 112.637 172.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -167.88 177.57 5.63 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.532 1.533 . . . . 0.0 112.304 -176.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -117.07 174.46 6.09 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.452 1.901 . . . . 0.0 111.452 174.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -64.27 140.49 58.87 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.442 -0.786 . . . . 0.0 111.608 170.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 77.57 3.76 83.63 Favored Glycine 0 CA--C 1.537 1.406 0 C-N-CA 124.349 0.976 . . . . 0.0 115.117 175.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -72.1 168.36 18.3 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.527 1.131 . . . . 0.0 112.344 173.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 91.2 t -118.91 130.42 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.603 1.561 . . . . 0.0 108.935 -174.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 17.2 mt -134.35 138.32 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.401 1.08 . . . . 0.0 109.57 -178.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 11.8 m -104.31 139.22 39.61 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.144 1.378 . . . . 0.0 110.72 -176.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 25.9 mt -79.17 142.81 36.0 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -173.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 29.8 mt -119.18 -8.8 10.09 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.514 1.125 . . . . 0.0 113.07 178.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 5.7 mt -134.73 141.25 37.94 Favored Pre-proline 0 N--CA 1.478 0.957 0 C-N-CA 126.833 2.053 . . . . 0.0 109.397 176.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.64 -0.6 10.01 Favored 'Trans proline' 0 CA--C 1.548 1.219 0 C-N-CA 124.62 3.546 . . . . 0.0 114.601 175.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -151.05 175.84 11.71 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.779 2.032 . . . . 0.0 111.535 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -116.16 164.96 13.71 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.148 1.379 . . . . 0.0 112.928 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -123.21 106.52 10.81 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 126.121 1.768 . . . . 0.0 110.323 -176.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 49.96 33.1 6.25 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.314 1.446 . . . . 0.0 114.789 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 96.82 -2.49 62.07 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.113 1.34 . . . . 0.0 114.628 -178.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 78.8 m95 -101.47 121.89 42.79 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.158 1.383 . . . . 0.0 110.763 177.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 13.1 mt -88.42 164.45 15.49 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.424 0.689 . . . . 0.0 110.151 162.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -127.29 121.03 30.01 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 124.953 1.301 . . . . 0.0 108.088 173.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -147.84 177.22 26.24 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.137 0.875 . . . . 0.0 113.865 -170.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -129.63 124.16 33.03 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.541 1.536 . . . . 0.0 110.555 -177.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -66.63 140.88 57.95 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.33 1.052 . . . . 0.0 112.164 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -73.05 -36.75 66.95 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 120.939 -1.1 . . . . 0.0 113.511 177.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 59.1 t -77.31 -34.43 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -173.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 8.5 t -124.62 -12.29 7.19 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.704 1.201 . . . . 0.0 113.442 -168.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? 56.37 16.91 2.62 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 125.995 1.718 . . . . 0.0 114.739 -175.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -66.99 147.24 53.48 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.204 1.002 . . . . 0.0 111.186 170.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -121.76 156.52 32.98 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.845 1.658 . . . . 0.0 111.516 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 164.52 170.17 29.09 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 124.162 0.886 . . . . 0.0 113.027 173.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -65.85 145.18 56.26 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.184 0.594 . . . . 0.0 110.346 168.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -153.48 153.46 29.18 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 124.125 0.97 . . . . 0.0 111.314 174.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -63.49 121.46 9.25 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.546 2.164 . . . . 0.0 111.345 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.66 -17.38 64.0 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 121.296 -0.877 . . . . 0.0 113.036 178.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 77.6 p -73.98 -22.19 59.71 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.777 2.031 . . . . 0.0 114.159 174.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -79.8 -1.11 37.36 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.254 1.421 . . . . 0.0 113.425 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 69.9 p . . . . . 0 N--CA 1.471 0.599 0 C-N-CA 126.584 1.954 . . . . 0.0 110.873 174.658 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 69.3 mt . . . . . 0 N--CA 1.477 0.923 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.28 160.34 49.91 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 123.57 2.847 . . . . 0.0 112.16 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.07 144.87 88.55 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.378 2.052 . . . . 0.0 112.238 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -73.42 157.13 88.35 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 123.387 0.675 . . . . 0.0 112.192 173.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -68.34 174.13 8.64 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.289 2.659 . . . . 0.0 113.157 176.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -86.26 0.28 54.17 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.651 1.18 . . . . 0.0 113.02 -178.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 38.4 p90 -133.28 153.57 80.69 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 124.792 1.237 . . . . 0.0 113.003 -174.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -71.45 152.54 60.46 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.542 2.828 . . . . 0.0 112.317 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -68.12 149.03 98.3 Favored Pre-proline 0 CA--C 1.55 0.952 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -176.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -72.27 -176.83 2.35 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 124.122 3.215 . . . . 0.0 112.801 176.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 24.3 p -137.04 153.89 75.58 Favored Pre-proline 0 N--CA 1.476 0.855 0 C-N-CA 125.341 1.457 . . . . 0.0 112.649 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -67.61 165.24 28.11 Favored 'Trans proline' 0 CA--C 1.548 1.176 0 C-N-CA 123.504 2.803 . . . . 0.0 111.948 175.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo . . . . . 0 CA--C 1.541 0.86 0 C-N-CA 123.453 2.769 . . . . 0.0 113.351 177.194 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 16.0 m . . . . . 0 C--O 1.236 0.343 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -119.26 132.01 55.85 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.954 0.901 . . . . 0.0 109.904 178.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 66.8 p -74.74 149.89 39.63 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 124.852 1.261 . . . . 0.0 111.483 -178.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.7 pp -124.63 -7.82 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -176.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -154.95 157.19 31.89 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 126.67 1.988 . . . . 0.0 109.652 169.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -69.05 158.34 58.28 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.883 2.388 . . . . 0.0 112.439 177.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 36.3 t-80 . . . . . 0 N--CA 1.475 0.794 0 C-N-CA 125.048 1.339 . . . . 0.0 112.018 -179.166 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 32.6 p . . . . . 0 N--CA 1.485 1.3 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 49.3 mt -110.49 134.68 52.13 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.308 1.443 . . . . 0.0 110.921 -177.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 31.8 tp -83.21 126.05 32.22 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.871 0.868 . . . . 0.0 110.953 177.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 69.8 m -91.38 147.49 22.99 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.405 1.082 . . . . 0.0 111.957 173.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -163.21 177.56 8.94 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.708 1.603 . . . . 0.0 112.19 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -131.98 154.03 49.74 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.743 2.017 . . . . 0.0 111.5 178.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -50.89 130.59 25.51 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.716 0.806 . . . . 0.0 112.748 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 94.93 -14.27 65.63 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 124.342 0.973 . . . . 0.0 114.362 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -68.75 155.44 40.12 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.378 1.089 . . . . 0.0 112.165 174.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 69.3 t -111.74 142.52 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 125.823 1.649 . . . . 0.0 109.893 -175.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 16.9 mt -136.59 138.61 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.107 1.363 . . . . 0.0 109.024 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 18.5 m -102.55 137.24 41.04 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.705 1.202 . . . . 0.0 110.2 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 27.0 mt -77.04 143.51 39.26 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 122.935 0.494 . . . . 0.0 111.966 -175.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 42.5 mt -116.77 -7.18 11.52 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 124.73 1.212 . . . . 0.0 113.084 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 7.1 mt -130.83 140.41 38.59 Favored Pre-proline 0 N--CA 1.477 0.892 0 C-N-CA 126.617 1.967 . . . . 0.0 109.391 176.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.01 -7.29 20.77 Favored 'Trans proline' 0 CA--C 1.547 1.14 0 C-N-CA 123.582 2.854 . . . . 0.0 114.849 176.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -152.67 152.24 31.51 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.85 1.66 . . . . 0.0 111.937 174.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -76.45 170.45 16.36 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.626 1.17 . . . . 0.0 113.68 176.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -129.7 106.25 8.58 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.337 1.855 . . . . 0.0 110.142 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 49.92 32.51 5.61 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 125.328 1.451 . . . . 0.0 114.559 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 99.65 -14.37 60.56 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 125.506 1.527 . . . . 0.0 114.388 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -89.01 134.03 34.13 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.662 1.231 . . . . 0.0 111.457 176.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 13.1 mt -102.1 162.09 13.18 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.533 1.133 . . . . 0.0 110.277 165.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -124.07 123.04 39.46 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.981 1.312 . . . . 0.0 107.924 172.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -149.27 175.01 28.68 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 115.644 -0.707 . . . . 0.0 113.704 -170.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -126.47 122.72 36.02 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.272 1.429 . . . . 0.0 110.73 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -63.13 149.0 46.35 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.834 1.254 . . . . 0.0 112.353 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -88.34 -24.98 22.99 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 120.859 -1.151 . . . . 0.0 113.903 178.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 59.1 t -80.33 -35.01 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 O-C-N 121.352 -0.843 . . . . 0.0 112.658 -179.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 6.6 t -128.62 -10.79 5.02 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.59 1.156 . . . . 0.0 113.707 -169.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 4.8 mptt 53.82 24.65 4.6 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 125.432 1.493 . . . . 0.0 113.512 -175.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -68.79 147.45 51.75 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.6 1.16 . . . . 0.0 110.92 168.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 74.0 mtm-85 -120.2 157.28 29.4 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.556 1.542 . . . . 0.0 111.821 178.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 164.86 169.42 28.45 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.643 1.116 . . . . 0.0 112.584 175.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -69.61 148.01 49.94 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 122.802 0.441 . . . . 0.0 110.54 169.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -155.47 155.97 30.36 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 123.98 0.912 . . . . 0.0 111.685 175.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -65.02 121.1 8.48 Favored 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 122.81 2.34 . . . . 0.0 111.883 177.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 89.8 p -60.23 -22.4 62.98 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 176.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 18.1 m -74.59 -18.37 60.58 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 175.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -80.65 -0.86 39.97 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.712 1.205 . . . . 0.0 113.133 178.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 62.2 p . . . . . 0 N--CA 1.467 0.382 0 C-N-CA 125.871 1.668 . . . . 0.0 111.516 175.52 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 63.6 mt . . . . . 0 CA--C 1.55 0.943 0 CA-C-O 119.004 -0.522 . . . . 0.0 109.682 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.92 161.33 46.36 Favored 'Trans proline' 0 CA--C 1.545 1.05 0 C-N-CA 123.573 2.849 . . . . 0.0 112.091 177.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.16 144.46 86.92 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.271 1.981 . . . . 0.0 112.707 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -72.15 156.5 90.62 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 123.47 0.708 . . . . 0.0 112.194 171.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.42 174.37 9.32 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.435 2.757 . . . . 0.0 113.222 176.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -89.24 3.16 52.92 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.886 1.274 . . . . 0.0 113.016 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 40.8 p90 -134.15 154.42 80.09 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 124.764 1.226 . . . . 0.0 112.91 -175.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -71.54 153.37 60.31 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 123.689 2.926 . . . . 0.0 112.721 178.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -68.21 142.64 95.07 Favored Pre-proline 0 CA--C 1.553 1.081 0 C-N-CA 124.078 0.951 . . . . 0.0 113.215 -176.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.38 177.2 8.21 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 124.125 3.217 . . . . 0.0 113.002 176.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 35.6 p -132.43 153.35 81.17 Favored Pre-proline 0 N--CA 1.479 0.986 0 C-N-CA 125.289 1.436 . . . . 0.0 112.848 -175.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -69.17 162.94 39.73 Favored 'Trans proline' 0 CA--C 1.549 1.271 0 C-N-CA 123.699 2.933 . . . . 0.0 112.103 177.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo . . . . . 0 CA--C 1.541 0.83 0 C-N-CA 123.409 2.74 . . . . 0.0 113.223 179.159 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 16.8 m . . . . . 0 N--CA 1.467 0.376 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -115.07 132.96 56.43 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.752 0.821 . . . . 0.0 110.61 174.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 81.7 p -72.06 152.29 42.51 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.411 1.084 . . . . 0.0 111.185 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.8 pp -121.97 -8.86 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -178.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -155.06 158.18 32.02 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 127.04 2.136 . . . . 0.0 109.897 169.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -68.85 158.01 59.57 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.116 2.544 . . . . 0.0 112.691 177.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 . . . . . 0 CA--C 1.542 0.648 0 C-N-CA 125.117 1.367 . . . . 0.0 111.696 -179.533 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 39.8 p . . . . . 0 N--CA 1.482 1.132 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 66.6 mt -101.66 128.15 48.09 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.968 1.307 . . . . 0.0 110.86 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 33.1 tp -78.32 121.35 24.33 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.208 0.603 . . . . 0.0 110.171 173.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 71.0 m -94.97 146.72 24.05 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.384 1.074 . . . . 0.0 111.438 175.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -162.58 178.14 8.82 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.252 1.421 . . . . 0.0 112.455 -175.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -116.47 173.52 6.56 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.145 1.778 . . . . 0.0 111.456 174.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -65.33 142.03 58.38 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.041 0.936 . . . . 0.0 111.565 171.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 75.41 9.36 84.45 Favored Glycine 0 CA--C 1.538 1.517 0 N-CA-C 114.808 0.683 . . . . 0.0 114.808 177.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -81.6 161.93 23.31 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.597 1.159 . . . . 0.0 111.705 172.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 31.2 t -115.42 135.35 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.735 1.214 . . . . 0.0 109.35 -174.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 18.4 mt -138.16 135.82 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.496 1.118 . . . . 0.0 109.342 -176.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 12.5 m -92.64 141.85 28.02 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.246 1.018 . . . . 0.0 110.476 174.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 23.0 mt -82.25 143.2 31.51 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 122.968 0.507 . . . . 0.0 111.64 178.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 47.2 mt -114.37 -4.65 12.95 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 124.591 1.156 . . . . 0.0 112.841 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 6.9 mt -134.65 141.71 39.8 Favored Pre-proline 0 N--CA 1.48 1.045 0 C-N-CA 127.048 2.139 . . . . 0.0 109.66 177.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.2 -8.07 22.11 Favored 'Trans proline' 0 CA--C 1.547 1.171 0 C-N-CA 124.025 3.15 . . . . 0.0 114.706 176.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 26.2 pt-20 -151.26 160.21 43.94 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.823 1.649 . . . . 0.0 111.94 173.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -85.42 169.9 13.22 Favored 'General case' 0 CA--C 1.55 0.96 0 O-C-N 121.048 -1.032 . . . . 0.0 113.026 177.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -126.63 105.82 8.97 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.731 2.012 . . . . 0.0 109.826 -177.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 50.85 31.42 6.07 Favored 'General case' 0 CA--C 1.555 1.145 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 100.79 -11.09 59.16 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 125.482 1.515 . . . . 0.0 114.408 -178.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -95.22 126.9 40.86 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.543 1.137 . . . . 0.0 111.248 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 13.0 mt -95.59 161.5 14.02 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.523 0.678 . . . . 0.0 110.495 163.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -124.01 122.16 37.17 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 125.159 1.383 . . . . 0.0 107.779 175.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -146.97 176.51 25.81 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-N 115.632 -0.713 . . . . 0.0 114.201 -171.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -129.55 120.82 25.96 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.493 1.517 . . . . 0.0 110.464 -178.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -65.51 141.15 58.57 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.643 1.177 . . . . 0.0 112.219 -177.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -75.69 -29.83 59.14 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 120.619 -1.301 . . . . 0.0 113.526 -178.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 51.2 t -81.49 -37.33 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 124.207 1.003 . . . . 0.0 113.419 -175.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 6.9 t -124.81 -8.84 7.27 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.484 1.113 . . . . 0.0 113.699 -171.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.58 23.76 3.74 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 126.181 1.792 . . . . 0.0 113.822 -177.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -68.97 150.83 47.26 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.436 1.094 . . . . 0.0 110.938 169.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -125.63 157.35 37.44 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.632 1.573 . . . . 0.0 110.757 -177.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 161.04 169.58 24.49 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 124.496 1.046 . . . . 0.0 112.237 174.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -66.77 148.38 52.0 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.151 0.501 . . . . 0.0 110.399 168.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -155.04 154.87 29.52 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 124.321 1.048 . . . . 0.0 110.223 171.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -63.72 122.2 10.2 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.434 2.089 . . . . 0.0 110.774 177.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 95.8 p -55.13 -40.24 70.32 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.8 -0.562 . . . . 0.0 112.135 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 5.3 t -62.15 -23.05 66.35 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.244 1.818 . . . . 0.0 114.464 -178.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -72.16 -3.43 23.3 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.615 1.166 . . . . 0.0 113.58 172.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 68.2 p . . . . . 0 N--CA 1.465 0.292 0 C-N-CA 125.5 1.52 . . . . 0.0 111.083 176.404 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 61.2 mt . . . . . 0 CA--C 1.549 0.941 0 CA-C-O 119.035 -0.507 . . . . 0.0 109.806 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.76 160.25 50.39 Favored 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 123.571 2.848 . . . . 0.0 112.003 177.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.97 142.91 83.56 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.455 2.103 . . . . 0.0 112.36 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -72.19 154.4 92.19 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 123.282 0.633 . . . . 0.0 111.883 172.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -69.24 174.4 9.11 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.463 2.775 . . . . 0.0 113.039 178.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -87.64 1.76 52.81 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.636 1.174 . . . . 0.0 112.843 -178.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 34.7 p90 -133.54 154.35 80.73 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.712 1.205 . . . . 0.0 112.873 -175.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.95 152.72 57.77 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.667 2.912 . . . . 0.0 112.684 178.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -69.94 144.67 93.37 Favored Pre-proline 0 CA--C 1.55 0.98 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -176.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -73.8 179.32 5.77 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 124.103 3.202 . . . . 0.0 113.069 176.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 29.0 p -133.48 154.77 81.0 Favored Pre-proline 0 N--CA 1.479 1.015 0 C-N-CA 125.424 1.49 . . . . 0.0 112.64 -174.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.59 162.19 42.0 Favored 'Trans proline' 0 CA--C 1.548 1.222 0 C-N-CA 123.863 3.042 . . . . 0.0 111.995 176.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo . . . . . 0 CA--C 1.54 0.785 0 C-N-CA 123.447 2.765 . . . . 0.0 112.772 178.326 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 15.5 m . . . . . 0 C--O 1.235 0.319 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.89 125.98 44.81 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.264 1.026 . . . . 0.0 109.383 -175.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 73.1 p -72.31 153.23 41.63 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.585 0.754 . . . . 0.0 110.793 -175.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.9 pp -122.91 -6.94 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -177.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -158.73 160.3 29.34 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 126.684 1.993 . . . . 0.0 110.158 170.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -69.75 157.5 60.2 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 123.286 2.657 . . . . 0.0 113.263 176.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 . . . . . 0 N--CA 1.473 0.709 0 C-N-CA 125.218 1.407 . . . . 0.0 111.957 -179.973 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 44.8 p . . . . . 0 N--CA 1.483 1.194 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 55.9 mt -102.35 127.68 49.24 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.706 1.203 . . . . 0.0 111.121 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 23.3 tp -77.68 129.54 35.67 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.498 0.719 . . . . 0.0 110.955 177.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 43.9 t -101.81 146.52 27.68 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.884 1.273 . . . . 0.0 111.827 176.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -163.9 178.32 7.87 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.919 1.688 . . . . 0.0 112.246 -174.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -117.3 177.13 4.84 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.898 2.079 . . . . 0.0 111.15 174.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -64.65 140.43 58.87 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.966 0.906 . . . . 0.0 111.597 169.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 75.34 5.62 77.77 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 124.594 1.093 . . . . 0.0 115.707 175.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -71.87 169.3 16.1 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.674 1.19 . . . . 0.0 112.12 171.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 95.7 t -126.42 127.52 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 125.519 1.528 . . . . 0.0 108.84 -169.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 35.3 mt -133.62 138.26 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 124.352 1.061 . . . . 0.0 108.969 -176.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 52.2 m -102.88 136.65 42.31 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.972 1.309 . . . . 0.0 110.045 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 15.9 mt -73.37 147.09 44.67 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -175.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 58.3 mt -120.78 -8.52 9.44 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.582 1.153 . . . . 0.0 113.396 177.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 6.5 mt -133.73 140.99 38.35 Favored Pre-proline 0 N--CA 1.48 1.047 0 C-N-CA 126.311 1.844 . . . . 0.0 109.666 176.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.73 -7.68 21.63 Favored 'Trans proline' 0 CA--C 1.546 1.104 0 C-N-CA 124.047 3.165 . . . . 0.0 114.722 176.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -152.22 153.8 34.5 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.76 1.624 . . . . 0.0 112.146 174.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -77.44 170.83 15.87 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 124.46 1.104 . . . . 0.0 113.894 175.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -129.26 105.62 8.26 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.563 1.945 . . . . 0.0 109.897 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 50.68 32.62 7.15 Favored 'General case' 0 CA--C 1.553 1.09 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 98.37 -12.63 63.33 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 125.411 1.481 . . . . 0.0 114.411 -178.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 77.6 m95 -89.38 123.19 33.31 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.315 1.058 . . . . 0.0 110.807 176.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 13.5 mt -90.23 161.37 15.73 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.367 0.667 . . . . 0.0 110.225 161.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -124.43 124.84 43.19 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.123 1.369 . . . . 0.0 107.934 171.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -148.8 172.09 29.01 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 124.154 0.883 . . . . 0.0 113.287 -171.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -124.88 121.05 33.42 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.233 1.413 . . . . 0.0 109.699 177.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -64.05 147.45 52.09 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.523 1.129 . . . . 0.0 111.93 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -81.15 -46.71 14.5 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 120.876 -1.14 . . . . 0.0 113.175 178.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 57.8 t -70.98 -51.78 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 98.9 p -91.51 -17.12 26.19 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -174.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp 55.96 17.57 2.65 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 126.809 2.044 . . . . 0.0 114.725 -172.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -72.06 151.72 42.91 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 121.455 0.645 . . . . 0.0 111.732 171.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 72.5 mtm180 -120.67 157.0 30.54 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.347 1.859 . . . . 0.0 110.551 176.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 163.21 169.38 26.57 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 124.095 0.855 . . . . 0.0 112.368 173.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -65.71 148.35 51.91 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.074 0.464 . . . . 0.0 110.077 166.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -154.96 153.95 28.17 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 124.111 0.964 . . . . 0.0 110.457 172.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -63.98 122.11 10.02 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.492 2.128 . . . . 0.0 110.752 176.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 95.2 p -55.16 -38.06 67.8 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 74.7 m -64.88 -19.44 65.91 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -74.13 -2.51 24.89 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.36 1.064 . . . . 0.0 113.125 171.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 64.2 p . . . . . 0 N--CA 1.466 0.372 0 C-N-CA 125.703 1.601 . . . . 0.0 110.823 173.849 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 71.9 mt . . . . . 0 N--CA 1.477 0.906 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.11 159.56 52.72 Favored 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 123.636 2.891 . . . . 0.0 112.29 178.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.57 146.07 88.44 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 122.473 2.115 . . . . 0.0 112.445 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -74.24 157.21 86.92 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 123.616 0.766 . . . . 0.0 112.3 173.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -68.84 174.84 8.12 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.453 2.769 . . . . 0.0 113.19 175.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -86.2 0.6 53.31 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.735 1.214 . . . . 0.0 112.965 -178.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 36.6 p90 -134.73 155.18 79.65 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 124.796 1.239 . . . . 0.0 112.96 -174.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.86 152.72 58.29 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.726 2.951 . . . . 0.0 112.821 178.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -68.06 144.34 96.91 Favored Pre-proline 0 CA--C 1.552 1.032 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -175.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.4 -179.59 4.59 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 124.141 3.228 . . . . 0.0 112.857 176.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 22.8 p -135.17 155.29 79.03 Favored Pre-proline 0 N--CA 1.481 1.08 0 C-N-CA 125.051 1.341 . . . . 0.0 112.814 -175.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.87 163.47 35.41 Favored 'Trans proline' 0 CA--C 1.548 1.21 0 C-N-CA 123.628 2.885 . . . . 0.0 111.88 175.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo . . . . . 0 CA--C 1.541 0.847 0 C-N-CA 123.312 2.675 . . . . 0.0 113.092 178.043 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 17.7 m . . . . . 0 N--CA 1.467 0.403 0 CA-C-O 121.206 0.527 . . . . 0.0 110.62 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -123.27 126.95 47.85 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.081 1.352 . . . . 0.0 110.599 -178.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 81.6 p -71.7 152.09 43.09 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.586 0.754 . . . . 0.0 111.427 -178.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.9 pp -122.93 -8.98 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 -177.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -155.08 158.91 32.15 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 126.705 2.002 . . . . 0.0 109.842 169.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.05 156.13 66.14 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.129 2.553 . . . . 0.0 113.117 177.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 . . . . . 0 N--CA 1.474 0.731 0 C-N-CA 125.199 1.4 . . . . 0.0 111.103 177.753 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 32.8 p . . . . . 0 N--CA 1.481 1.082 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 66.8 mt -112.21 127.04 55.84 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.318 1.447 . . . . 0.0 111.312 -176.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 28.8 tp -78.74 124.79 28.56 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.936 0.894 . . . . 0.0 110.668 176.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 54.2 p -99.61 152.16 20.36 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.237 1.415 . . . . 0.0 112.434 177.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -167.45 177.32 6.06 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.052 1.341 . . . . 0.0 112.992 -172.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -115.32 177.13 4.77 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.857 2.063 . . . . 0.0 111.161 173.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -67.22 140.46 57.42 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.093 0.957 . . . . 0.0 111.818 170.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 74.66 4.68 71.37 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 125.007 1.289 . . . . 0.0 115.797 177.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -68.42 164.23 21.48 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 118.115 0.958 . . . . 0.0 111.461 167.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 95.7 t -118.16 136.17 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.642 1.177 . . . . 0.0 109.251 -177.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 29.7 mt -133.45 141.18 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.349 1.06 . . . . 0.0 108.795 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 23.5 m -102.21 136.34 42.21 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.817 1.247 . . . . 0.0 109.528 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 21.0 mt -79.18 138.71 37.97 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 118.544 0.611 . . . . 0.0 111.446 -177.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 44.7 mt -112.83 -10.15 13.6 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.993 0.917 . . . . 0.0 113.277 -177.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 9.0 mt -124.58 140.1 34.64 Favored Pre-proline 0 N--CA 1.478 0.938 0 C-N-CA 126.363 1.865 . . . . 0.0 109.682 176.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.83 -8.36 23.45 Favored 'Trans proline' 0 CA--C 1.547 1.156 0 C-N-CA 123.834 3.022 . . . . 0.0 114.322 176.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -152.18 149.1 28.38 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.922 1.689 . . . . 0.0 111.893 173.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -74.08 171.35 13.68 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.443 1.097 . . . . 0.0 113.744 175.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -128.24 103.42 7.17 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.217 1.807 . . . . 0.0 110.448 -179.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 52.05 30.55 7.6 Favored 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 99.69 -15.57 59.59 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 125.654 1.597 . . . . 0.0 114.287 -178.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -85.07 128.8 34.79 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.221 1.011 . . . . 0.0 110.955 175.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 12.1 mt -99.4 161.41 13.63 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.212 1.005 . . . . 0.0 110.213 165.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -123.82 122.21 37.44 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 125.157 1.383 . . . . 0.0 107.519 173.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -145.5 167.24 27.56 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-N 115.82 -0.627 . . . . 0.0 113.927 -172.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -113.45 118.47 34.6 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.006 1.322 . . . . 0.0 109.019 173.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 33.9 t-80 -63.69 141.66 58.69 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.321 1.049 . . . . 0.0 111.789 178.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -75.2 -46.19 35.55 Favored 'General case' 0 CA--C 1.547 0.827 0 O-C-N 120.573 -1.329 . . . . 0.0 113.037 -178.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 57.4 t -70.31 -54.26 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 178.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 93.4 p -90.25 -17.27 27.76 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 119.583 1.083 . . . . 0.0 113.785 -173.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm 56.41 20.0 4.45 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 126.651 1.98 . . . . 0.0 114.023 -175.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -76.38 158.81 31.07 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.276 0.63 . . . . 0.0 112.051 171.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 82.2 mtt85 -125.18 158.91 32.81 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.148 1.779 . . . . 0.0 110.645 176.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 159.38 169.72 23.05 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.951 1.262 . . . . 0.0 112.278 176.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -68.36 148.73 50.29 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.994 0.426 . . . . 0.0 110.627 169.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -155.82 156.32 30.46 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 124.084 0.954 . . . . 0.0 110.747 172.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -66.72 120.61 7.73 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 122.433 2.088 . . . . 0.0 111.724 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 36.2 t -59.92 -25.38 65.1 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 175.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 75.2 m -69.44 -18.81 63.76 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 174.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -81.1 -0.34 39.58 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.635 1.174 . . . . 0.0 113.987 177.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 81.3 p . . . . . 0 N--CA 1.467 0.424 0 C-N-CA 125.055 1.342 . . . . 0.0 111.599 174.332 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 52.7 mt . . . . . 0 CA--C 1.549 0.905 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -69.03 160.95 47.86 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 123.42 2.747 . . . . 0.0 112.124 178.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.59 144.68 85.38 Favored 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 122.267 1.978 . . . . 0.0 112.352 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -70.59 153.66 94.84 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 123.095 0.558 . . . . 0.0 111.872 171.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -69.7 174.67 9.12 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 123.509 2.806 . . . . 0.0 113.2 179.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -86.05 1.33 50.73 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.353 1.061 . . . . 0.0 113.037 -178.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 38.1 p90 -133.46 154.37 80.83 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 124.823 1.249 . . . . 0.0 113.033 -174.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.56 153.11 60.24 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 123.66 2.907 . . . . 0.0 112.875 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -68.48 141.13 92.93 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 123.914 0.885 . . . . 0.0 113.096 -177.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.59 177.54 7.87 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 124.059 3.173 . . . . 0.0 113.239 177.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 32.8 p -134.25 153.94 79.72 Favored Pre-proline 0 N--CA 1.478 0.963 0 C-N-CA 125.401 1.48 . . . . 0.0 112.998 -172.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -68.29 163.22 37.18 Favored 'Trans proline' 0 CA--C 1.548 1.202 0 C-N-CA 123.772 2.981 . . . . 0.0 111.854 176.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo . . . . . 0 CA--C 1.541 0.833 0 C-N-CA 123.242 2.628 . . . . 0.0 112.885 178.945 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 16.7 m . . . . . 0 C--O 1.234 0.283 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.45 134.27 54.75 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.385 1.074 . . . . 0.0 110.343 175.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 62.1 p -76.63 158.64 30.93 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.186 1.394 . . . . 0.0 111.774 179.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 2.0 pp -122.91 -9.79 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -155.35 159.22 31.9 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 125.836 1.654 . . . . 0.0 111.26 170.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.91 155.61 65.0 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.534 2.823 . . . . 0.0 113.443 177.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 . . . . . 0 N--CA 1.474 0.741 0 C-N-CA 125.411 1.485 . . . . 0.0 111.899 -179.384 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 48.3 p . . . . . 0 N--CA 1.479 0.995 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 62.0 mt -107.84 131.01 54.94 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.841 1.256 . . . . 0.0 111.487 -178.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 24.0 tp -82.86 132.97 35.14 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.682 0.793 . . . . 0.0 110.534 174.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 45.3 m -114.86 147.73 39.5 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.226 1.411 . . . . 0.0 112.379 -178.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -166.42 178.95 5.83 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.412 1.485 . . . . 0.0 112.397 -166.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -118.18 174.79 6.01 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.974 2.11 . . . . 0.0 111.724 176.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 66.3 tt0 -64.25 140.94 58.92 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.317 -0.864 . . . . 0.0 111.002 168.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 70.36 19.48 76.06 Favored Glycine 0 CA--C 1.537 1.433 0 N-CA-C 114.37 0.508 . . . . 0.0 114.37 177.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -86.23 170.09 12.43 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.732 1.213 . . . . 0.0 111.522 169.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 89.7 t -125.82 128.09 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 125.658 1.583 . . . . 0.0 109.038 -168.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 22.7 mt -133.18 143.13 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 124.358 1.063 . . . . 0.0 110.056 -176.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 2.6 m -100.77 144.03 30.22 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.641 1.576 . . . . 0.0 110.398 -177.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 23.5 mt -84.67 141.11 30.83 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 118.333 0.515 . . . . 0.0 112.085 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 43.8 mt -120.05 -11.69 9.23 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.758 1.223 . . . . 0.0 113.298 179.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 7.1 mt -130.25 141.1 40.71 Favored Pre-proline 0 N--CA 1.476 0.853 0 C-N-CA 126.703 2.001 . . . . 0.0 109.224 175.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.69 -6.02 18.28 Favored 'Trans proline' 0 CA--C 1.548 1.208 0 C-N-CA 124.113 3.209 . . . . 0.0 114.835 175.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -151.67 162.78 40.42 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.162 1.785 . . . . 0.0 112.169 175.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.57 170.91 9.78 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.485 1.114 . . . . 0.0 113.202 176.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -128.63 106.39 8.92 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.403 1.881 . . . . 0.0 110.54 -178.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 51.32 31.09 6.62 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 124.943 1.297 . . . . 0.0 114.468 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 98.32 -8.32 62.45 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 125.293 1.425 . . . . 0.0 114.515 -177.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -95.42 122.46 38.17 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.729 1.265 . . . . 0.0 110.979 177.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 14.2 mt -88.39 160.49 17.56 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.751 0.82 . . . . 0.0 110.625 162.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 79.4 t80 -123.28 124.46 43.02 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.169 1.388 . . . . 0.0 107.924 170.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -149.95 173.84 29.56 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 123.864 0.745 . . . . 0.0 113.289 -170.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -126.29 115.18 19.3 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.959 1.304 . . . . 0.0 110.271 178.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 23.4 t-80 -61.59 144.72 53.95 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.43 1.092 . . . . 0.0 112.151 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -79.2 -48.26 14.53 Favored 'General case' 0 CA--C 1.548 0.882 0 O-C-N 120.926 -1.109 . . . . 0.0 112.565 178.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 58.5 t -68.3 -53.6 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 124.325 1.05 . . . . 0.0 113.73 176.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 40.2 m -89.77 -16.51 30.11 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 119.277 0.944 . . . . 0.0 113.188 -171.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 11.1 mmmm 54.49 19.92 2.58 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 127.358 2.263 . . . . 0.0 114.647 -176.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -82.14 152.7 26.39 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.938 0.895 . . . . 0.0 111.496 174.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 56.4 mtm-85 -117.58 158.97 23.66 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 126.172 1.789 . . . . 0.0 110.931 173.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 159.8 171.76 26.09 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.512 1.053 . . . . 0.0 112.453 175.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -68.46 145.22 54.27 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 120.961 0.41 . . . . 0.0 110.456 168.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -153.91 154.55 30.21 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 124.246 1.019 . . . . 0.0 111.015 173.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -63.4 122.94 11.28 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.529 2.153 . . . . 0.0 112.046 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 82.6 p -61.27 -25.98 67.46 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 176.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.83 -13.34 61.65 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.969 2.107 . . . . 0.0 114.86 174.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -85.01 -0.57 54.85 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.5 1.12 . . . . 0.0 113.133 174.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 71.3 p . . . . . 0 N--CA 1.475 0.802 0 C-N-CA 126.653 1.981 . . . . 0.0 110.475 173.873 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 55.1 mt . . . . . 0 N--CA 1.477 0.899 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -68.82 160.07 51.2 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 123.483 2.789 . . . . 0.0 112.007 178.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -63.77 144.47 89.03 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.428 2.086 . . . . 0.0 112.271 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -70.01 153.34 95.47 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 122.99 0.516 . . . . 0.0 111.629 171.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -69.28 174.75 8.64 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.459 2.773 . . . . 0.0 113.151 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -85.62 1.39 49.42 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.318 1.047 . . . . 0.0 112.976 -178.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 33.8 p90 -134.55 154.33 79.6 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 124.775 1.23 . . . . 0.0 112.94 -175.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.34 151.97 60.49 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.645 2.897 . . . . 0.0 112.681 178.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -66.83 145.23 98.89 Favored Pre-proline 0 CA--C 1.549 0.913 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -177.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.32 175.22 10.89 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.752 2.968 . . . . 0.0 112.781 178.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 23.0 p -129.73 153.96 80.91 Favored Pre-proline 0 N--CA 1.477 0.922 0 C-N-CA 124.732 1.213 . . . . 0.0 112.363 -173.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -66.56 163.08 34.08 Favored 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 122.999 2.466 . . . . 0.0 111.651 175.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo . . . . . 0 CA--C 1.539 0.736 0 C-N-CA 123.102 2.534 . . . . 0.0 112.257 174.955 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 16.0 m . . . . . 0 C--O 1.236 0.355 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -121.02 131.71 54.45 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.197 0.999 . . . . 0.0 109.664 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 74.8 p -74.9 152.6 38.86 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.962 0.905 . . . . 0.0 111.177 -177.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.8 pp -123.49 -6.71 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -178.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -154.04 158.23 32.47 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 126.249 1.82 . . . . 0.0 110.121 169.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -68.96 154.5 70.72 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.792 2.328 . . . . 0.0 112.413 176.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 . . . . . 0 CA--C 1.537 0.466 0 C-N-CA 125.499 1.52 . . . . 0.0 110.7 179.846 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 38.0 p . . . . . 0 N--CA 1.485 1.277 0 N-CA-C 114.336 1.235 . . . . 0.0 114.336 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 56.8 mt -98.15 128.8 44.84 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.87 1.268 . . . . 0.0 110.485 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 31.4 tp -80.22 114.12 18.89 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.377 0.671 . . . . 0.0 110.844 175.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 50.3 m -83.88 150.03 25.98 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.043 0.937 . . . . 0.0 112.559 175.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -164.8 178.17 7.4 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.598 1.559 . . . . 0.0 113.217 -177.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -117.15 173.96 6.38 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.431 1.892 . . . . 0.0 111.258 173.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -64.98 142.32 58.48 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 121.301 -0.874 . . . . 0.0 111.648 170.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 77.05 5.79 85.34 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 124.071 0.843 . . . . 0.0 114.98 175.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -77.83 166.33 23.05 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.97 1.308 . . . . 0.0 111.96 172.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 67.9 t -121.07 131.24 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.105 1.362 . . . . 0.0 109.325 -172.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 25.2 mt -134.76 137.6 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.527 1.131 . . . . 0.0 109.245 -177.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 12.0 m -98.09 140.22 32.73 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.931 1.292 . . . . 0.0 110.236 -178.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 23.7 mt -80.03 137.94 36.91 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 118.235 0.47 . . . . 0.0 111.928 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 37.1 mt -114.62 -9.8 12.57 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.527 1.131 . . . . 0.0 113.122 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 9.4 mt -127.75 141.17 40.22 Favored Pre-proline 0 N--CA 1.479 1.01 0 C-N-CA 126.893 2.077 . . . . 0.0 109.632 176.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.28 -7.1 20.35 Favored 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 124.088 3.192 . . . . 0.0 114.817 177.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -151.24 160.22 43.94 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.288 1.835 . . . . 0.0 111.428 174.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.34 168.0 17.99 Favored 'General case' 0 CA--C 1.547 0.86 0 O-C-N 120.993 -1.067 . . . . 0.0 113.027 173.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -122.89 103.49 8.66 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 126.954 2.101 . . . . 0.0 109.105 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 51.96 30.54 7.41 Favored 'General case' 0 CA--C 1.555 1.17 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 102.45 -17.95 52.2 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 125.894 1.711 . . . . 0.0 114.276 -178.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -84.86 128.31 34.56 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.511 1.124 . . . . 0.0 111.463 178.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 16.9 mt -98.17 161.32 13.77 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.121 0.968 . . . . 0.0 110.51 164.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -125.9 121.72 33.98 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 125.37 1.468 . . . . 0.0 107.552 174.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -145.38 171.72 26.36 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-N 115.555 -0.748 . . . . 0.0 113.872 -172.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -119.63 117.26 27.84 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.006 1.323 . . . . 0.0 109.872 176.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 24.4 t-80 -63.77 145.16 56.29 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.854 1.262 . . . . 0.0 112.035 178.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -80.23 -44.66 19.34 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 120.914 -1.116 . . . . 0.0 113.706 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 57.7 t -69.18 -51.05 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 123.926 0.891 . . . . 0.0 113.306 176.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 13.2 t -91.03 -21.32 21.31 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -171.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt 56.32 16.71 2.5 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 126.446 1.898 . . . . 0.0 114.597 -171.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -74.11 156.16 37.69 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.362 0.665 . . . . 0.0 111.852 172.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -124.79 155.27 39.66 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.203 1.801 . . . . 0.0 110.08 176.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 162.62 168.76 25.01 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 124.911 1.243 . . . . 0.0 112.021 177.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -68.86 147.74 51.26 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.111 0.565 . . . . 0.0 110.721 171.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -155.21 155.27 29.83 Favored Pre-proline 0 CA--C 1.541 0.597 0 C-N-CA 124.315 1.046 . . . . 0.0 110.676 172.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -66.11 121.42 8.74 Favored 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 122.353 2.036 . . . . 0.0 110.975 177.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 29.7 t -55.01 -39.13 68.75 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.687 -0.633 . . . . 0.0 112.364 178.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 15.5 m -59.47 -21.85 60.68 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -74.24 -0.27 16.4 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.552 1.141 . . . . 0.0 113.514 172.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 48.1 p . . . . . 0 N--CA 1.468 0.468 0 C-N-CA 125.86 1.664 . . . . 0.0 111.792 179.11 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 35.7 mt . . . . . 0 CA--C 1.548 0.901 0 CA-C-O 119.295 -0.383 . . . . 0.0 110.329 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.19 159.13 52.97 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 123.498 2.799 . . . . 0.0 112.063 178.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.82 147.08 89.36 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.402 2.068 . . . . 0.0 112.561 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -73.98 157.11 87.46 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 123.692 0.797 . . . . 0.0 112.465 174.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.19 174.77 8.53 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.449 2.766 . . . . 0.0 113.381 176.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -88.39 3.06 51.27 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.997 1.319 . . . . 0.0 112.623 -178.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 32.6 p90 -134.85 154.62 79.43 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 124.557 1.143 . . . . 0.0 112.823 -175.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.51 152.49 60.07 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 123.788 2.992 . . . . 0.0 112.868 179.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -68.17 142.97 95.48 Favored Pre-proline 0 CA--C 1.551 0.981 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -176.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.32 179.94 5.01 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 124.114 3.209 . . . . 0.0 112.709 176.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 26.6 p -135.21 154.3 78.74 Favored Pre-proline 0 N--CA 1.479 0.983 0 C-N-CA 125.036 1.334 . . . . 0.0 112.657 -173.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -66.56 161.92 39.21 Favored 'Trans proline' 0 CA--C 1.547 1.165 0 C-N-CA 123.336 2.691 . . . . 0.0 111.484 175.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo . . . . . 0 CA--C 1.541 0.856 0 C-N-CA 123.052 2.501 . . . . 0.0 112.417 176.68 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 17.3 m . . . . . 0 N--CA 1.466 0.34 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 15.5 ttpt -119.53 136.39 54.36 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.138 0.975 . . . . 0.0 110.667 175.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 77.8 p -78.7 155.95 29.17 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.765 1.626 . . . . 0.0 111.783 -176.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.8 pp -122.24 -9.16 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 -176.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -155.29 159.22 31.91 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 126.346 1.858 . . . . 0.0 110.472 169.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.91 155.94 64.2 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.315 2.677 . . . . 0.0 113.348 178.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 44.7 t-80 . . . . . 0 N--CA 1.473 0.715 0 C-N-CA 125.583 1.553 . . . . 0.0 111.98 -178.838 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 58.0 p . . . . . 0 N--CA 1.482 1.16 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 58.4 mt -108.31 130.34 55.19 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.759 1.224 . . . . 0.0 111.358 -178.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 36.4 tp -82.49 120.1 25.05 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.877 0.871 . . . . 0.0 110.862 176.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 55.6 p -89.76 152.7 21.18 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.665 1.186 . . . . 0.0 112.523 173.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -167.75 178.93 5.02 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.434 1.494 . . . . 0.0 112.483 -175.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -117.94 174.06 6.41 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.405 1.882 . . . . 0.0 111.525 174.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -64.92 141.97 58.6 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.747 0.819 . . . . 0.0 111.368 170.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 73.66 10.67 80.11 Favored Glycine 0 CA--C 1.537 1.452 0 N-CA-C 114.525 0.57 . . . . 0.0 114.525 177.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -82.79 164.01 20.87 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.415 1.086 . . . . 0.0 111.342 171.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 93.6 t -119.46 136.99 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.559 1.144 . . . . 0.0 109.881 -171.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 17.1 mt -137.35 137.94 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.997 1.319 . . . . 0.0 109.272 -176.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 10.2 m -95.52 140.56 30.19 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.869 1.268 . . . . 0.0 110.56 176.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 23.3 mt -79.23 139.08 38.01 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.347 0.659 . . . . 0.0 111.803 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 32.4 mt -116.44 -6.78 11.72 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 124.253 1.021 . . . . 0.0 113.347 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 4.9 mt -134.49 140.52 35.92 Favored Pre-proline 0 N--CA 1.48 1.073 0 C-N-CA 126.517 1.927 . . . . 0.0 109.344 176.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.6 -8.53 23.81 Favored 'Trans proline' 0 CA--C 1.546 1.109 0 C-N-CA 123.963 3.109 . . . . 0.0 114.74 178.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -152.05 157.31 41.48 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.882 1.673 . . . . 0.0 111.92 175.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -80.35 168.73 18.66 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.481 1.112 . . . . 0.0 113.841 177.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -125.65 105.18 8.81 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.685 1.994 . . . . 0.0 110.287 178.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 50.96 32.14 7.09 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 125.084 1.354 . . . . 0.0 114.535 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 99.04 -16.67 59.11 Favored Glycine 0 CA--C 1.536 1.393 0 C-N-CA 125.743 1.64 . . . . 0.0 114.305 -178.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 83.0 m95 -85.33 129.74 34.74 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.479 1.112 . . . . 0.0 111.12 175.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 12.6 mt -99.15 162.99 12.75 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.227 1.011 . . . . 0.0 110.316 164.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -127.22 119.06 25.52 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.962 1.305 . . . . 0.0 107.935 176.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -146.63 175.47 26.04 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.064 0.84 . . . . 0.0 113.871 -170.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -127.42 121.63 31.41 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.376 1.47 . . . . 0.0 110.524 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 -66.84 133.58 50.37 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.317 1.047 . . . . 0.0 112.135 -176.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -70.25 -31.04 68.24 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 120.304 -1.497 . . . . 0.0 113.349 -178.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 58.1 t -81.42 -33.97 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 124.408 1.083 . . . . 0.0 113.522 -176.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 13.2 t -125.31 -15.2 6.28 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.887 1.275 . . . . 0.0 113.37 -167.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 54.84 20.8 3.25 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 126.78 2.032 . . . . 0.0 114.202 -177.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -69.22 147.99 50.48 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.573 1.149 . . . . 0.0 111.147 166.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 81.7 mtm180 -122.43 156.78 33.32 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.95 1.7 . . . . 0.0 111.473 179.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 162.83 171.45 29.07 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 124.817 1.198 . . . . 0.0 112.296 174.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -67.66 147.78 52.23 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.148 0.499 . . . . 0.0 110.347 169.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -154.42 155.75 31.04 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 124.321 1.048 . . . . 0.0 110.863 173.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -65.71 121.63 9.06 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.158 1.905 . . . . 0.0 111.627 178.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 33.8 t -61.86 -16.91 54.21 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 121.417 -0.802 . . . . 0.0 113.053 172.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 16.6 m -73.23 -17.65 61.32 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.888 1.275 . . . . 0.0 113.785 173.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -88.56 1.62 54.59 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.286 1.434 . . . . 0.0 113.072 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 58.3 p . . . . . 0 N--CA 1.472 0.661 0 C-N-CA 127.084 2.154 . . . . 0.0 109.826 172.098 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 60.7 mt . . . . . 0 CA--C 1.547 0.861 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.88 159.37 53.56 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 123.433 2.755 . . . . 0.0 112.147 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.44 146.14 89.05 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 122.42 2.08 . . . . 0.0 112.438 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -72.28 156.44 90.52 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 123.48 0.712 . . . . 0.0 112.14 172.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -68.96 174.77 8.34 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.43 2.754 . . . . 0.0 113.054 175.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -86.9 2.02 50.63 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.556 1.142 . . . . 0.0 112.844 -178.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 37.3 p90 -133.94 154.62 80.42 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 124.666 1.187 . . . . 0.0 112.79 -174.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.43 153.17 60.97 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 123.652 2.901 . . . . 0.0 112.758 178.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -65.92 143.22 98.4 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 123.821 0.848 . . . . 0.0 113.084 -177.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.8 177.81 7.17 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 124.001 3.134 . . . . 0.0 112.945 178.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 25.5 p -130.48 154.76 81.68 Favored Pre-proline 0 N--CA 1.478 0.944 0 C-N-CA 125.288 1.435 . . . . 0.0 112.775 -175.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.79 165.44 29.69 Favored 'Trans proline' 0 CA--C 1.547 1.15 0 C-N-CA 123.439 2.76 . . . . 0.0 111.885 174.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo . . . . . 0 CA--C 1.541 0.867 0 C-N-CA 123.406 2.737 . . . . 0.0 112.821 174.594 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 15.6 m . . . . . 0 N--CA 1.467 0.384 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -120.48 136.42 54.76 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.143 0.977 . . . . 0.0 109.946 177.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 45.9 p -80.44 148.57 30.47 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.383 1.473 . . . . 0.0 110.877 -175.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.7 pp -112.87 -10.25 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -176.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -155.55 159.31 31.75 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 126.666 1.987 . . . . 0.0 110.528 170.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.86 156.06 61.15 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 123.536 2.824 . . . . 0.0 113.129 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 32.0 t-80 . . . . . 0 N--CA 1.474 0.727 0 C-N-CA 125.385 1.474 . . . . 0.0 111.79 -179.78 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 35.8 p . . . . . 0 N--CA 1.479 0.984 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 68.7 mt -103.57 130.75 51.04 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.935 1.294 . . . . 0.0 110.97 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 30.2 tp -82.8 128.97 34.9 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.247 0.619 . . . . 0.0 110.401 174.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 34.4 t -107.87 147.32 31.11 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.591 1.556 . . . . 0.0 111.474 -179.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -164.58 177.94 7.72 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.626 1.57 . . . . 0.0 112.354 -170.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -121.82 168.83 11.4 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.944 2.098 . . . . 0.0 111.069 175.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -61.94 136.58 58.03 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.175 -0.953 . . . . 0.0 111.312 173.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 83.71 -1.92 88.09 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 123.749 0.69 . . . . 0.0 114.793 178.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -70.88 167.02 19.89 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.382 1.091 . . . . 0.0 112.203 170.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 84.6 t -125.86 133.41 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 125.018 1.327 . . . . 0.0 109.545 -169.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 24.9 mt -136.48 141.35 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.733 1.213 . . . . 0.0 109.462 -176.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 3.3 m -100.78 140.34 35.2 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.319 1.448 . . . . 0.0 110.599 -177.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 21.7 mt -80.21 136.98 36.59 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 118.423 0.556 . . . . 0.0 111.963 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 38.3 mt -117.52 -11.77 10.45 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.589 1.156 . . . . 0.0 113.341 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 371' ' ' ILE . . . . . 0.411 ' CG2' ' HD2' ' A' ' 372' ' ' PRO . 5.6 mt -128.09 140.04 37.13 Favored Pre-proline 0 N--CA 1.474 0.746 0 C-N-CA 126.154 1.782 . . . . 0.0 109.68 176.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 372' ' ' PRO . . . . . 0.411 ' HD2' ' CG2' ' A' ' 371' ' ' ILE . 60.6 Cg_endo -72.97 -7.22 20.35 Favored 'Trans proline' 0 CA--C 1.546 1.076 0 C-N-CA 123.434 2.756 . . . . 0.0 114.001 177.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -150.62 157.41 42.95 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.799 1.639 . . . . 0.0 112.088 173.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -84.91 171.54 12.09 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.222 1.009 . . . . 0.0 112.786 175.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -133.36 110.21 9.88 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.97 1.708 . . . . 0.0 110.819 -176.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 50.74 31.02 5.46 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 125.336 1.454 . . . . 0.0 114.448 -179.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 99.18 -8.41 60.78 Favored Glycine 0 CA--C 1.536 1.396 0 C-N-CA 125.379 1.466 . . . . 0.0 114.467 -177.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 75.3 m95 -99.44 128.43 45.56 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 118.438 1.119 . . . . 0.0 111.55 -178.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 14.1 mt -96.07 161.21 14.07 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.915 0.886 . . . . 0.0 110.544 165.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -124.92 122.36 37.12 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 125.167 1.387 . . . . 0.0 107.646 173.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -145.84 169.67 27.23 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 115.627 -0.715 . . . . 0.0 113.159 -173.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -117.55 114.67 23.78 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.811 1.244 . . . . 0.0 109.516 177.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 26.7 t-80 -60.69 146.35 46.02 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.861 1.264 . . . . 0.0 111.87 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -81.25 -46.2 15.14 Favored 'General case' 0 CA--C 1.548 0.866 0 O-C-N 120.768 -1.208 . . . . 0.0 112.866 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 60.1 t -68.92 -53.85 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 124.051 0.94 . . . . 0.0 113.31 175.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 16.3 t -86.11 -22.43 27.11 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -171.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm 54.93 17.2 1.73 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 126.575 1.95 . . . . 0.0 114.579 -168.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -74.33 156.03 37.55 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.476 0.655 . . . . 0.0 111.986 172.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 54.5 mtp180 -127.31 148.43 50.24 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.636 1.974 . . . . 0.0 109.758 177.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 167.98 168.79 30.61 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 124.501 1.048 . . . . 0.0 111.859 178.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -68.05 145.85 54.06 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.098 0.475 . . . . 0.0 110.556 170.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -152.76 154.45 31.42 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 124.103 0.961 . . . . 0.0 110.776 173.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.57 122.29 10.36 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.333 2.022 . . . . 0.0 110.864 178.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 98.1 p -56.4 -37.31 69.98 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.687 -0.633 . . . . 0.0 112.079 176.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 17.2 m -58.2 -20.95 45.47 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 127.273 2.229 . . . . 0.0 115.003 177.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -79.91 1.32 27.69 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.788 1.235 . . . . 0.0 112.961 175.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 60.3 p . . . . . 0 N--CA 1.472 0.671 0 C-N-CA 126.574 1.95 . . . . 0.0 110.673 174.516 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 52.4 mt . . . . . 0 N--CA 1.479 1.019 0 CA-C-O 119.117 -0.468 . . . . 0.0 109.878 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -69.39 160.31 50.3 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 123.702 2.935 . . . . 0.0 112.163 178.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.96 144.22 87.31 Favored 'Trans proline' 0 CA--C 1.534 0.522 0 C-N-CA 122.376 2.051 . . . . 0.0 112.191 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -69.6 153.56 95.58 Favored Pre-proline 0 CA--C 1.551 1.01 0 C-N-CA 122.972 0.509 . . . . 0.0 111.733 171.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -69.23 174.26 9.31 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.322 2.681 . . . . 0.0 113.19 178.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -86.67 2.48 48.34 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.523 1.129 . . . . 0.0 112.948 -178.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 34.0 p90 -133.52 153.39 80.31 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 124.748 1.219 . . . . 0.0 113.104 -176.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -71.62 152.12 59.05 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 123.623 2.882 . . . . 0.0 112.607 178.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -68.56 146.33 97.64 Favored Pre-proline 0 CA--C 1.55 0.971 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -176.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.7 178.72 5.97 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 124.034 3.156 . . . . 0.0 113.086 177.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 19.3 p -133.12 155.0 81.48 Favored Pre-proline 0 N--CA 1.48 1.027 0 C-N-CA 125.18 1.392 . . . . 0.0 112.658 -175.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.02 161.0 47.65 Favored 'Trans proline' 0 CA--C 1.547 1.151 0 C-N-CA 123.375 2.717 . . . . 0.0 111.986 176.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo . . . . . 0 CA--C 1.54 0.817 0 C-N-CA 123.232 2.621 . . . . 0.0 112.74 178.451 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 15.9 m . . . . . 0 C--O 1.236 0.377 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 5.7 tptt -119.37 130.53 55.38 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 124.183 0.993 . . . . 0.0 109.372 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 76.3 p -74.46 151.57 39.56 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.457 0.703 . . . . 0.0 111.127 -176.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.9 pp -122.69 -8.36 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -178.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -155.63 159.35 31.71 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 126.919 2.088 . . . . 0.0 110.024 169.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.1 159.62 53.17 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.275 2.65 . . . . 0.0 112.97 176.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 . . . . . 0 N--CA 1.474 0.771 0 C-N-CA 125.051 1.34 . . . . 0.0 111.993 179.494 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 52.2 p . . . . . 0 N--CA 1.481 1.119 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 47.1 mt -106.71 116.72 32.42 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.045 1.338 . . . . 0.0 110.972 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 25.5 tp -72.05 124.31 24.67 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.644 0.778 . . . . 0.0 110.669 176.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 58.0 p -97.76 152.65 18.92 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.988 1.315 . . . . 0.0 112.401 175.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -167.4 178.43 5.5 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.513 1.525 . . . . 0.0 112.195 -173.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -118.83 173.74 6.7 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.787 2.035 . . . . 0.0 110.941 173.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -65.19 141.16 58.76 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.746 0.818 . . . . 0.0 111.624 171.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 80.29 3.21 89.76 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 124.173 0.892 . . . . 0.0 115.213 175.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -76.2 168.79 19.41 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.231 1.412 . . . . 0.0 112.238 173.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 80.5 t -123.49 130.01 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 125.642 1.577 . . . . 0.0 109.153 -171.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 30.8 mt -134.72 137.29 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.136 0.974 . . . . 0.0 109.525 -178.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 20.0 m -97.76 139.31 33.83 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.033 1.333 . . . . 0.0 110.491 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 20.3 mt -79.34 144.33 34.3 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.235 0.47 . . . . 0.0 111.972 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 47.4 mt -118.58 -1.15 11.22 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.731 1.212 . . . . 0.0 112.93 -178.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 371' ' ' ILE . . . . . 0.449 ' CG2' ' HD2' ' A' ' 372' ' ' PRO . 3.8 mt -134.36 142.57 43.42 Favored Pre-proline 0 N--CA 1.478 0.937 0 C-N-CA 126.848 2.059 . . . . 0.0 109.947 177.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 372' ' ' PRO . . . . . 0.449 ' HD2' ' CG2' ' A' ' 371' ' ' ILE . 57.0 Cg_endo -71.87 -9.08 24.21 Favored 'Trans proline' 0 CA--C 1.547 1.151 0 C-N-CA 123.463 2.775 . . . . 0.0 114.021 176.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -152.65 150.22 29.25 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.027 1.731 . . . . 0.0 111.857 173.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -71.49 168.69 16.99 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.202 1.001 . . . . 0.0 113.554 173.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -123.72 103.4 8.36 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 126.324 1.85 . . . . 0.0 109.911 178.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 51.65 32.73 9.65 Favored 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 177.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 99.29 -12.72 61.83 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 125.415 1.484 . . . . 0.0 114.298 -178.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -89.18 121.41 31.45 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.451 1.1 . . . . 0.0 110.709 175.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 13.1 mt -88.8 158.86 18.0 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.366 0.667 . . . . 0.0 110.372 162.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -120.65 125.18 47.06 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 125.001 1.32 . . . . 0.0 107.789 170.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -149.41 171.64 29.54 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 115.873 -0.603 . . . . 0.0 113.871 -172.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -123.08 120.93 34.73 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.452 1.501 . . . . 0.0 109.623 177.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 29.4 t-80 -65.68 150.68 48.08 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.717 1.207 . . . . 0.0 112.159 178.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -81.15 -49.31 10.99 Favored 'General case' 0 CA--C 1.548 0.883 0 O-C-N 120.941 -1.099 . . . . 0.0 113.649 178.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 82.8 t -71.05 -52.15 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 178.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 23.2 t -83.96 -23.33 31.12 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.595 0.758 . . . . 0.0 112.852 -174.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp 55.72 15.83 1.75 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 126.681 1.992 . . . . 0.0 114.532 -168.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -73.14 153.72 40.64 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.409 0.623 . . . . 0.0 111.944 173.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -123.68 153.61 40.58 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 126.553 1.941 . . . . 0.0 110.682 178.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 165.45 169.59 29.27 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 124.344 0.973 . . . . 0.0 112.24 175.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -66.92 148.09 52.4 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.066 0.46 . . . . 0.0 110.148 166.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -155.67 154.39 27.95 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 124.3 1.04 . . . . 0.0 110.359 172.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -63.82 123.19 11.56 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.525 2.15 . . . . 0.0 110.926 177.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 99.2 p -56.75 -38.55 72.58 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.655 -0.653 . . . . 0.0 112.136 178.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 14.7 m -61.32 -22.4 64.87 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.044 1.738 . . . . 0.0 114.825 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -73.66 -1.89 20.82 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.829 1.251 . . . . 0.0 113.215 172.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 62.3 p . . . . . 0 N--CA 1.465 0.315 0 C-N-CA 125.675 1.59 . . . . 0.0 110.987 175.244 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 53.8 mt . . . . . 0 N--CA 1.477 0.891 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -69.31 158.87 55.92 Favored 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 123.569 2.846 . . . . 0.0 112.049 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -64.46 145.56 87.99 Favored 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 122.37 2.047 . . . . 0.0 112.17 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -73.07 156.41 89.56 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 123.193 0.597 . . . . 0.0 112.215 173.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -68.78 174.32 8.8 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 123.42 2.747 . . . . 0.0 113.023 175.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -89.5 3.98 50.67 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.509 1.124 . . . . 0.0 113.087 -178.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 34.7 p90 -134.09 154.38 80.14 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 124.722 1.209 . . . . 0.0 112.701 -177.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.49 152.6 60.25 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 123.687 2.924 . . . . 0.0 112.641 179.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -67.87 143.9 96.82 Favored Pre-proline 0 CA--C 1.55 0.969 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -177.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.13 179.08 5.76 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 123.858 3.039 . . . . 0.0 112.716 177.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 24.7 p -131.31 154.91 82.07 Favored Pre-proline 0 N--CA 1.479 0.997 0 C-N-CA 125.194 1.398 . . . . 0.0 112.458 -174.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -67.03 164.57 29.49 Favored 'Trans proline' 0 CA--C 1.546 1.123 0 C-N-CA 123.397 2.732 . . . . 0.0 111.17 174.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo . . . . . 0 CA--C 1.54 0.791 0 C-N-CA 122.835 2.357 . . . . 0.0 112.352 175.662 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 17.9 m . . . . . 0 N--CA 1.468 0.468 0 CA-C-O 120.983 0.421 . . . . 0.0 110.052 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt -121.76 134.3 54.93 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.249 1.02 . . . . 0.0 110.221 175.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 82.7 p -76.4 156.34 33.27 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.622 1.569 . . . . 0.0 111.75 -179.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.9 pp -123.24 -6.91 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -153.73 157.69 32.62 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 125.758 1.623 . . . . 0.0 110.577 169.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.67 155.54 62.73 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.194 2.596 . . . . 0.0 112.994 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 32.6 t-80 . . . . . 0 CA--C 1.539 0.525 0 C-N-CA 125.934 1.694 . . . . 0.0 110.43 -178.219 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 17.5 p . . . . . 0 N--CA 1.483 1.19 0 N-CA-C 115.949 1.833 . . . . 0.0 115.949 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 15.3 mt -99.51 137.65 37.7 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.664 1.186 . . . . 0.0 110.653 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 30.6 tp -82.91 124.81 30.7 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 122.995 0.518 . . . . 0.0 110.818 175.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 47.4 m -91.74 147.55 22.91 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.775 1.23 . . . . 0.0 111.985 175.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -166.2 177.99 6.56 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.676 1.59 . . . . 0.0 112.755 -175.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -115.53 175.01 5.71 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.318 1.847 . . . . 0.0 111.617 173.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -62.46 141.1 58.55 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 121.349 -0.845 . . . . 0.0 111.106 168.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 71.53 18.63 77.23 Favored Glycine 0 CA--C 1.537 1.45 0 N-CA-C 114.651 0.62 . . . . 0.0 114.651 176.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -88.25 159.52 18.08 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.688 1.195 . . . . 0.0 111.645 173.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 88.0 t -111.28 130.33 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.011 1.324 . . . . 0.0 109.765 -173.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 23.1 mt -136.01 136.53 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.865 1.266 . . . . 0.0 109.035 -177.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 9.9 m -97.89 139.45 33.73 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.87 1.268 . . . . 0.0 110.004 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 20.6 mt -78.99 140.79 37.91 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 118.864 0.756 . . . . 0.0 111.953 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 37.4 mt -119.53 -5.38 10.29 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.891 1.276 . . . . 0.0 113.569 -177.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 371' ' ' ILE . . . . . 0.449 ' CG2' ' HD2' ' A' ' 372' ' ' PRO . 0.2 OUTLIER -127.9 146.76 60.26 Favored Pre-proline 0 N--CA 1.477 0.888 0 C-N-CA 126.722 2.009 . . . . 0.0 108.213 173.73 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 372' ' ' PRO . . . . . 0.449 ' HD2' ' CG2' ' A' ' 371' ' ' ILE . 82.9 Cg_endo -75.01 -17.09 19.81 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.461 2.774 . . . . 0.0 112.402 177.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -148.25 142.48 26.13 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.172 1.789 . . . . 0.0 111.202 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -72.29 172.95 9.36 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 125.658 1.583 . . . . 0.0 113.592 176.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -132.97 108.43 8.9 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.377 1.871 . . . . 0.0 110.833 -177.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 50.18 32.44 6.02 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 125.323 1.449 . . . . 0.0 114.707 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 98.94 -7.44 60.69 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 125.236 1.398 . . . . 0.0 114.462 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 78.8 m95 -99.77 128.97 45.84 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.485 1.143 . . . . 0.0 111.505 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 16.2 mt -98.42 161.36 13.73 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.622 1.169 . . . . 0.0 110.92 167.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 380' ' ' TYR . . . . . 0.432 ' HB3' ' CG1' ' A' ' 371' ' ' ILE . 60.2 t80 -121.33 122.2 39.33 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 173.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -145.58 170.75 26.8 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 115.749 -0.66 . . . . 0.0 114.46 -174.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -120.62 119.05 31.74 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.385 1.474 . . . . 0.0 109.717 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 -61.93 146.53 49.66 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.068 1.347 . . . . 0.0 111.68 177.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -80.55 -47.82 13.64 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 120.801 -1.187 . . . . 0.0 113.512 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 89.7 t -69.93 -51.93 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 124.287 1.035 . . . . 0.0 113.241 177.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 13.5 t -86.93 -21.69 26.1 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -173.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp 54.62 19.45 2.45 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 126.439 1.896 . . . . 0.0 114.303 -169.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -75.98 153.8 36.3 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.376 0.67 . . . . 0.0 111.896 172.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 70.9 mtm180 -127.93 148.04 50.49 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.463 1.905 . . . . 0.0 110.458 -179.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 169.86 170.93 34.87 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.83 1.205 . . . . 0.0 111.881 177.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -67.69 145.56 54.65 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.61 0.764 . . . . 0.0 110.902 171.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -152.78 153.2 29.8 Favored Pre-proline 0 CA--C 1.541 0.631 0 O-C-N 120.826 -1.171 . . . . 0.0 111.849 174.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -63.76 124.26 13.35 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 122.902 2.401 . . . . 0.0 112.14 178.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 97.5 p -62.97 -21.0 65.79 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 174.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 19.3 m -74.23 -17.54 60.87 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.826 1.25 . . . . 0.0 114.23 174.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -81.84 -2.72 52.0 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.567 1.147 . . . . 0.0 113.439 177.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 72.2 p . . . . . 0 N--CA 1.47 0.563 0 C-N-CA 126.563 1.945 . . . . 0.0 110.061 173.994 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 36.0 mt . . . . . 0 N--CA 1.477 0.902 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -68.7 162.48 40.98 Favored 'Trans proline' 0 CA--C 1.545 1.049 0 C-N-CA 123.492 2.794 . . . . 0.0 111.776 177.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.26 143.32 83.04 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.09 1.86 . . . . 0.0 112.365 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -70.0 152.91 95.75 Favored Pre-proline 0 CA--C 1.553 1.065 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.528 170.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -69.77 174.86 8.89 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.402 2.735 . . . . 0.0 113.309 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -90.69 8.35 34.86 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.756 1.222 . . . . 0.0 112.568 -178.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 37.0 p90 -135.82 153.01 76.93 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 124.828 1.251 . . . . 0.0 112.874 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.07 152.09 62.18 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.662 2.908 . . . . 0.0 112.276 178.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -67.53 144.13 97.52 Favored Pre-proline 0 CA--C 1.551 0.99 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -175.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.36 177.07 8.37 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 124.03 3.153 . . . . 0.0 113.106 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 27.3 p -132.23 153.66 81.36 Favored Pre-proline 0 N--CA 1.478 0.968 0 C-N-CA 125.076 1.35 . . . . 0.0 112.827 -172.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -67.84 165.07 29.13 Favored 'Trans proline' 0 CA--C 1.55 1.284 0 C-N-CA 123.55 2.833 . . . . 0.0 112.054 175.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo . . . . . 0 CA--C 1.543 0.939 0 C-N-CA 123.664 2.909 . . . . 0.0 113.173 176.468 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 16.7 m . . . . . 0 C--O 1.234 0.253 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -111.28 131.82 54.85 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.771 0.796 . . . . 0.0 109.944 175.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 70.6 p -76.34 151.67 36.6 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.955 1.702 . . . . 0.0 111.61 -175.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.7 pp -122.56 -6.1 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 N-CA-C 114.684 1.364 . . . . 0.0 114.684 -175.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -154.58 158.96 32.32 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 126.446 1.898 . . . . 0.0 110.199 169.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -69.46 159.3 54.16 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 123.085 2.523 . . . . 0.0 112.923 177.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 . . . . . 0 N--CA 1.473 0.723 0 C-N-CA 124.918 1.287 . . . . 0.0 112.039 179.601 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 39.6 p . . . . . 0 N--CA 1.483 1.185 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 63.0 mt -106.83 125.46 51.04 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.028 1.331 . . . . 0.0 110.653 179.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 26.0 tp -77.3 127.58 32.84 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.338 0.655 . . . . 0.0 110.596 176.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 37.3 p -100.96 147.08 26.58 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.136 1.374 . . . . 0.0 112.217 177.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -163.48 178.99 7.59 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.556 1.542 . . . . 0.0 112.054 -174.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -130.27 157.32 42.83 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 127.282 2.233 . . . . 0.0 111.358 177.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -50.98 129.51 23.81 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.494 0.717 . . . . 0.0 112.311 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 91.45 -9.01 78.33 Favored Glycine 0 CA--C 1.538 1.476 0 C-N-CA 124.261 0.934 . . . . 0.0 114.633 -179.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -68.05 153.02 44.6 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 118.903 1.351 . . . . 0.0 111.891 172.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 74.3 t -115.51 140.26 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 125.389 1.476 . . . . 0.0 109.989 -173.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 36.2 mt -136.07 136.57 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 125.668 1.587 . . . . 0.0 108.559 -177.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 31.8 m -99.46 137.23 38.25 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.649 1.18 . . . . 0.0 109.7 177.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 15.7 mt -69.45 147.34 51.06 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -177.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 77.4 mt -120.87 -2.21 9.81 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 125.079 1.351 . . . . 0.0 113.435 178.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 371' ' ' ILE . . . . . 0.436 ' CG2' ' HD2' ' A' ' 372' ' ' PRO . 2.0 mt -137.04 142.7 39.29 Favored Pre-proline 0 N--CA 1.477 0.906 0 C-N-CA 126.623 1.969 . . . . 0.0 109.14 177.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 372' ' ' PRO . . . . . 0.436 ' HD2' ' CG2' ' A' ' 371' ' ' ILE . 42.3 Cg_endo -70.42 -15.83 34.67 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 123.056 2.504 . . . . 0.0 113.308 177.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -145.15 150.13 36.23 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.492 1.917 . . . . 0.0 111.028 177.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -75.23 172.28 12.69 Favored 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 176.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -124.7 101.87 7.31 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.255 1.822 . . . . 0.0 110.293 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 51.95 31.78 9.07 Favored 'General case' 0 CA--C 1.554 1.135 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 175.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 100.01 -4.36 57.43 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 125.099 1.333 . . . . 0.0 114.64 -178.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 82.5 m95 -103.28 121.29 42.41 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.639 1.576 . . . . 0.0 110.521 176.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 12.1 mt -85.07 160.42 19.99 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.364 0.666 . . . . 0.0 110.578 163.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -122.98 126.49 47.27 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.208 1.403 . . . . 0.0 107.56 170.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -150.48 170.38 30.38 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-N 115.857 -0.611 . . . . 0.0 113.643 -173.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -118.83 119.64 34.99 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.226 1.41 . . . . 0.0 109.325 176.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -61.59 146.32 49.25 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.361 1.464 . . . . 0.0 111.745 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -79.55 -47.67 15.13 Favored 'General case' 0 CA--C 1.548 0.897 0 O-C-N 120.774 -1.203 . . . . 0.0 113.734 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 81.9 t -73.93 -49.47 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.988 0.915 . . . . 0.0 112.968 178.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 15.5 t -86.91 -21.74 26.12 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -173.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp 54.27 17.47 1.52 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 126.712 2.005 . . . . 0.0 114.771 -169.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -75.21 159.58 31.41 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.506 0.723 . . . . 0.0 112.16 173.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -126.58 159.0 34.78 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.336 1.854 . . . . 0.0 110.468 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 157.72 169.67 21.67 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 124.454 1.025 . . . . 0.0 112.538 175.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -67.85 145.58 54.49 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.002 0.521 . . . . 0.0 110.416 169.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -153.2 153.63 29.74 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 124.003 0.921 . . . . 0.0 111.162 173.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -62.86 121.06 8.81 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.748 2.299 . . . . 0.0 111.381 178.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.0 -17.53 63.4 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 121.303 -0.873 . . . . 0.0 113.096 177.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 79.6 p -73.43 -22.12 60.29 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.712 2.005 . . . . 0.0 114.282 174.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -79.09 2.89 19.15 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.507 1.523 . . . . 0.0 113.325 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 30.8 p . . . . . 0 CA--C 1.539 0.521 0 C-N-CA 126.966 2.106 . . . . 0.0 109.93 175.557 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 61.9 mt . . . . . 0 CA--C 1.549 0.919 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -69.37 160.57 49.28 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 123.611 2.874 . . . . 0.0 112.357 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.37 145.47 88.24 Favored 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 122.579 2.186 . . . . 0.0 112.368 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -77.24 158.2 79.84 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 123.691 0.796 . . . . 0.0 112.448 174.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -68.56 174.97 7.63 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 123.527 2.818 . . . . 0.0 113.176 176.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -93.56 9.87 34.96 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.908 1.283 . . . . 0.0 112.408 -178.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 38.6 p90 -138.46 153.93 73.07 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 124.67 1.188 . . . . 0.0 112.622 -178.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -71.18 152.28 61.76 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.444 2.763 . . . . 0.0 112.069 176.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -66.81 148.86 98.68 Favored Pre-proline 0 CA--C 1.549 0.926 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -176.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.78 -175.9 1.83 Allowed 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 124.069 3.179 . . . . 0.0 112.638 176.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 23.4 p -135.41 153.4 77.85 Favored Pre-proline 0 N--CA 1.475 0.8 0 C-N-CA 125.196 1.399 . . . . 0.0 112.465 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -65.42 164.38 26.18 Favored 'Trans proline' 0 CA--C 1.549 1.241 0 C-N-CA 123.225 2.617 . . . . 0.0 111.273 173.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo . . . . . 0 CA--C 1.542 0.915 0 C-N-CA 123.379 2.719 . . . . 0.0 113.248 177.761 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 12.9 m . . . . . 0 C--O 1.236 0.385 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -118.92 130.82 55.92 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.709 0.804 . . . . 0.0 110.203 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 76.5 p -73.61 151.17 40.94 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.792 0.837 . . . . 0.0 111.138 -178.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.8 pp -123.45 -7.93 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 -177.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -154.35 156.78 32.04 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 126.255 1.822 . . . . 0.0 110.233 169.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -69.78 156.74 62.52 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 123.316 2.677 . . . . 0.0 112.856 178.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 . . . . . 0 CA--C 1.543 0.687 0 C-N-CA 125.024 1.329 . . . . 0.0 111.855 179.356 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . 0.26 24.9 p . . . . . 0 N--CA 1.488 1.461 0 N-CA-C 116.334 1.976 . . . . 0.0 116.334 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -77.71 141.99 39.01 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.084 1.354 . . . . 0.0 110.554 172.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 22.9 tp -85.41 136.83 33.29 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 161.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 65.8 m -117.23 143.81 45.47 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.443 1.497 . . . . 0.0 111.428 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -162.55 178.98 8.09 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.091 1.357 . . . . 0.0 112.892 -167.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -116.93 173.53 6.6 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.226 1.811 . . . . 0.0 111.443 174.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -65.63 142.74 57.96 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.16 0.984 . . . . 0.0 111.559 171.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 75.67 8.28 84.13 Favored Glycine 0 CA--C 1.534 1.258 0 CA-C-O 119.298 -0.723 . . . . 0.0 114.819 176.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -79.07 163.41 25.15 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.556 1.142 . . . . 0.0 111.733 171.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 99.8 t -114.84 134.65 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.124 1.37 . . . . 0.0 109.163 -176.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 35.9 mt -132.45 141.48 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.275 1.03 . . . . 0.0 109.043 178.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 16.9 m -105.34 137.27 43.41 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.074 1.35 . . . . 0.0 109.467 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 9.9 mt -73.44 145.1 46.0 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -176.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 72.2 mt -119.53 -12.65 9.29 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 124.83 1.252 . . . . 0.0 113.311 178.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 9.8 mt -127.79 141.22 40.41 Favored Pre-proline 0 N--CA 1.478 0.932 0 C-N-CA 126.096 1.759 . . . . 0.0 110.255 175.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.7 -7.58 21.45 Favored 'Trans proline' 0 CA--C 1.547 1.144 0 C-N-CA 123.948 3.098 . . . . 0.0 114.48 176.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -152.55 153.71 33.96 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.663 1.585 . . . . 0.0 112.262 172.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -75.32 169.78 17.39 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.491 1.116 . . . . 0.0 113.647 174.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -128.6 105.92 8.61 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 126.669 1.988 . . . . 0.0 109.957 179.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 50.37 32.17 6.1 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 124.954 1.302 . . . . 0.0 114.373 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 99.55 -17.38 57.7 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 125.863 1.697 . . . . 0.0 114.377 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -82.59 125.29 31.0 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.542 1.137 . . . . 0.0 111.138 176.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 14.4 mt -94.42 162.94 13.62 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.636 0.774 . . . . 0.0 110.364 162.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -126.45 125.38 42.03 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 170.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -147.53 169.96 28.35 Favored Glycine 0 CA--C 1.527 0.781 0 C-N-CA 124.085 0.85 . . . . 0.0 112.671 -173.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -117.24 121.2 40.54 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 124.492 1.117 . . . . 0.0 109.275 175.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -63.54 152.35 38.87 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.762 1.225 . . . . 0.0 112.382 178.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -86.85 -45.89 10.44 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 120.991 -1.068 . . . . 0.0 113.45 177.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 53.1 t -67.32 -54.49 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 123.799 0.84 . . . . 0.0 113.008 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 22.2 m -96.07 -12.86 24.21 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -172.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt 55.47 19.82 3.36 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 126.674 1.99 . . . . 0.0 114.77 -174.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -75.35 158.31 32.97 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.54 0.736 . . . . 0.0 112.153 175.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 53.7 mtt180 -128.83 153.13 47.73 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 127.022 2.129 . . . . 0.0 109.579 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 162.68 166.09 20.86 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 125.198 1.38 . . . . 0.0 111.421 176.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -65.82 144.5 56.8 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.388 0.675 . . . . 0.0 110.177 170.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -153.31 155.1 31.51 Favored Pre-proline 0 CA--C 1.539 0.527 0 O-C-N 120.507 -1.371 . . . . 0.0 110.978 175.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -65.38 118.63 5.62 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.23 1.953 . . . . 0.0 110.831 177.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 29.4 t -54.15 -38.77 65.85 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.75 -0.593 . . . . 0.0 112.109 177.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 14.7 m -60.08 -21.66 61.75 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 178.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -75.43 -3.47 34.0 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.561 1.145 . . . . 0.0 113.157 173.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 80.8 p . . . . . 0 N--CA 1.465 0.324 0 C-N-CA 125.712 1.605 . . . . 0.0 110.747 172.167 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 49.8 mt . . . . . 0 N--CA 1.479 1.001 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -68.69 160.93 47.44 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 123.624 2.883 . . . . 0.0 112.036 177.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.77 144.85 89.98 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.31 2.006 . . . . 0.0 112.493 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -68.29 152.54 96.47 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 123.041 0.536 . . . . 0.0 111.875 172.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -70.07 174.41 9.81 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.608 2.872 . . . . 0.0 113.543 -178.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -89.37 5.27 45.89 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.208 1.403 . . . . 0.0 112.378 -178.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 29.3 p90 -137.08 155.06 76.29 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 124.353 1.061 . . . . 0.0 112.642 -177.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.75 153.13 53.65 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 123.806 3.004 . . . . 0.0 112.965 178.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -67.81 140.03 93.84 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 123.788 0.835 . . . . 0.0 112.968 -177.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -73.45 179.05 5.9 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 123.979 3.119 . . . . 0.0 112.789 176.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 25.8 p -132.79 154.79 81.58 Favored Pre-proline 0 N--CA 1.48 1.058 0 C-N-CA 125.122 1.369 . . . . 0.0 112.479 -175.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -66.94 165.15 27.1 Favored 'Trans proline' 0 CA--C 1.549 1.243 0 C-N-CA 123.437 2.758 . . . . 0.0 111.621 175.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo . . . . . 0 CA--C 1.539 0.764 0 C-N-CA 123.337 2.692 . . . . 0.0 113.147 178.564 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 16.7 m . . . . . 0 C--O 1.235 0.342 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -122.99 132.23 54.05 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 124.268 1.027 . . . . 0.0 109.352 -177.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 74.4 p -78.35 152.47 32.32 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.416 0.686 . . . . 0.0 110.824 -177.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.8 pp -125.7 -5.68 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 N-CA-C 114.441 1.275 . . . . 0.0 114.441 -178.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -153.86 160.67 30.68 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 126.117 1.767 . . . . 0.0 110.431 168.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -69.77 156.59 62.91 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 123.117 2.545 . . . . 0.0 113.139 174.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 . . . . . 0 N--CA 1.473 0.694 0 C-N-CA 125.224 1.41 . . . . 0.0 111.451 179.127 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 65.7 p . . . . . 0 N--CA 1.483 1.211 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 45.3 mt -101.49 116.09 31.99 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.728 1.211 . . . . 0.0 111.027 -176.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 27.6 tp -74.04 118.25 16.78 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.502 0.721 . . . . 0.0 110.962 178.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 59.9 p -87.91 154.34 20.6 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.282 1.033 . . . . 0.0 112.978 174.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -167.39 179.41 5.01 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.917 1.687 . . . . 0.0 112.014 -177.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -119.49 176.7 5.23 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.577 1.951 . . . . 0.0 110.942 172.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 66.5 tt0 -65.92 139.47 58.26 Favored 'General case' 0 CA--C 1.546 0.814 0 O-C-N 121.349 -0.844 . . . . 0.0 111.548 171.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 82.19 4.29 90.27 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.298 0.951 . . . . 0.0 115.376 175.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -77.07 170.25 16.86 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.946 1.298 . . . . 0.0 112.616 173.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 94.6 t -125.24 129.35 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.786 1.634 . . . . 0.0 109.09 -169.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 29.6 mt -134.81 137.8 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.94 0.896 . . . . 0.0 109.968 -177.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 10.1 m -96.9 140.06 32.01 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.993 1.317 . . . . 0.0 110.834 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 20.7 mt -78.91 136.67 37.34 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 122.943 0.497 . . . . 0.0 111.55 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 50.1 mt -114.63 -2.0 13.2 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.7 1.2 . . . . 0.0 113.045 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 371' ' ' ILE . . . . . 0.437 ' CG2' ' HD2' ' A' ' 372' ' ' PRO . 2.1 mt -134.82 143.28 45.64 Favored Pre-proline 0 N--CA 1.478 0.972 0 C-N-CA 126.623 1.969 . . . . 0.0 109.568 178.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 372' ' ' PRO . . . . . 0.437 ' HD2' ' CG2' ' A' ' 371' ' ' ILE . 56.1 Cg_endo -72.46 -9.73 24.5 Favored 'Trans proline' 0 CA--C 1.548 1.18 0 C-N-CA 123.203 2.602 . . . . 0.0 113.639 176.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -153.32 152.43 31.11 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.862 1.665 . . . . 0.0 112.302 174.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -71.83 169.91 14.76 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.769 1.228 . . . . 0.0 113.855 173.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -129.36 106.96 9.14 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.466 1.907 . . . . 0.0 110.047 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 51.05 31.69 6.73 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.097 1.359 . . . . 0.0 114.567 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 97.35 -11.79 65.19 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 125.465 1.507 . . . . 0.0 114.439 -178.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 77.8 m95 -89.28 123.94 33.95 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.49 1.116 . . . . 0.0 110.809 175.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 15.1 mt -90.14 156.76 18.12 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.536 0.735 . . . . 0.0 110.228 162.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -116.77 124.55 49.88 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.904 1.282 . . . . 0.0 107.616 169.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -148.74 171.95 28.99 Favored Glycine 0 CA--C 1.524 0.594 0 CA-C-N 115.659 -0.701 . . . . 0.0 113.376 -173.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -122.81 120.42 33.49 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.774 1.23 . . . . 0.0 109.859 177.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 25.2 t-80 -64.86 145.61 56.04 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.429 1.092 . . . . 0.0 111.66 178.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -80.19 -45.37 18.19 Favored 'General case' 0 CA--C 1.547 0.861 0 O-C-N 120.927 -1.108 . . . . 0.0 113.448 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 87.7 t -72.53 -53.78 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 177.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 35.2 m -86.41 -17.32 34.64 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.288 0.949 . . . . 0.0 113.142 -172.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp 53.96 21.31 2.8 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 126.69 1.996 . . . . 0.0 114.505 -173.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -80.55 152.46 28.62 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.189 0.596 . . . . 0.0 111.527 173.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 46.7 mtm-85 -119.44 155.6 31.73 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.252 1.821 . . . . 0.0 110.65 175.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 164.01 169.68 27.87 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.372 0.987 . . . . 0.0 112.217 174.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -66.53 145.75 55.28 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.351 0.661 . . . . 0.0 110.485 166.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -155.23 154.43 28.57 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 124.482 1.113 . . . . 0.0 110.391 172.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -65.37 124.14 12.48 Favored 'Trans proline' 0 CA--C 1.532 0.4 0 C-N-CA 122.581 2.188 . . . . 0.0 111.497 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 96.3 p -56.88 -37.21 71.06 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 8.7 p -67.66 -14.24 62.78 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.094 1.758 . . . . 0.0 115.503 179.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -79.86 -2.08 41.92 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 119.524 1.056 . . . . 0.0 113.106 168.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 77.0 p . . . . . 0 C--O 1.234 0.287 0 C-N-CA 125.446 1.498 . . . . 0.0 111.186 172.285 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 63.6 mt . . . . . 0 N--CA 1.477 0.885 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -69.41 159.85 52.07 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 123.561 2.841 . . . . 0.0 112.238 178.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.13 144.74 87.9 Favored 'Trans proline' 0 CA--C 1.535 0.529 0 C-N-CA 122.424 2.083 . . . . 0.0 112.148 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -73.89 156.7 87.93 Favored Pre-proline 0 CA--C 1.551 0.994 0 C-N-CA 123.243 0.617 . . . . 0.0 112.207 173.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -68.87 175.21 7.65 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.346 2.697 . . . . 0.0 113.128 176.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -92.2 9.03 35.42 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.853 1.261 . . . . 0.0 112.514 -178.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 34.9 p90 -138.31 154.16 73.53 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 124.846 1.259 . . . . 0.0 112.759 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.6 153.04 60.05 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 123.621 2.881 . . . . 0.0 112.547 178.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -67.52 144.16 97.56 Favored Pre-proline 0 CA--C 1.55 0.964 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -176.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.86 176.26 9.24 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.949 3.099 . . . . 0.0 112.555 178.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 22.5 p -129.39 154.24 80.67 Favored Pre-proline 0 N--CA 1.479 0.993 0 C-N-CA 124.759 1.224 . . . . 0.0 112.779 -171.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -67.85 162.09 41.13 Favored 'Trans proline' 0 CA--C 1.546 1.118 0 C-N-CA 123.28 2.653 . . . . 0.0 111.352 176.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo . . . . . 0 CA--C 1.54 0.811 0 C-N-CA 122.982 2.454 . . . . 0.0 112.482 177.146 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 16.2 m . . . . . 0 C--O 1.237 0.413 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -120.53 131.24 54.6 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.914 0.886 . . . . 0.0 110.364 178.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 71.3 p -73.49 151.75 40.94 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.06 0.944 . . . . 0.0 111.379 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.7 pp -124.3 -8.28 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -177.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -154.35 157.23 32.26 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 126.474 1.91 . . . . 0.0 109.906 169.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.3 157.4 61.97 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.093 2.529 . . . . 0.0 113.025 177.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 . . . . . 0 N--CA 1.472 0.666 0 C-N-CA 125.064 1.345 . . . . 0.0 111.259 178.231 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 29.6 p . . . . . 0 N--CA 1.479 1.014 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 70.7 mt -108.0 128.97 55.13 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.997 1.319 . . . . 0.0 111.195 -177.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 31.1 tp -80.68 121.11 25.46 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.477 0.711 . . . . 0.0 110.642 176.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 47.4 p -90.19 152.62 21.01 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.564 1.145 . . . . 0.0 112.487 173.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -165.94 179.21 5.98 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.581 1.553 . . . . 0.0 112.34 -177.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -119.08 174.51 6.28 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.338 1.855 . . . . 0.0 111.205 174.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -68.62 137.99 54.68 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.044 0.938 . . . . 0.0 111.693 172.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 84.21 12.96 75.17 Favored Glycine 0 CA--C 1.536 1.39 0 N-CA-C 114.881 0.712 . . . . 0.0 114.881 174.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -95.48 160.91 14.29 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.96 1.704 . . . . 0.0 111.669 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 72.7 t -108.91 133.73 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.632 1.173 . . . . 0.0 109.74 -171.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 16.5 mt -133.88 139.23 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.446 1.098 . . . . 0.0 109.349 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 6.8 m -101.2 141.84 33.49 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.593 1.157 . . . . 0.0 110.134 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 23.7 mt -79.36 141.72 36.68 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.008 0.523 . . . . 0.0 111.943 -177.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 61.6 mt -116.46 -7.78 11.64 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.596 1.158 . . . . 0.0 113.003 178.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 7.5 mt -132.77 142.01 43.18 Favored Pre-proline 0 N--CA 1.478 0.969 0 C-N-CA 126.857 2.063 . . . . 0.0 109.807 175.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.08 -8.81 24.35 Favored 'Trans proline' 0 CA--C 1.548 1.177 0 C-N-CA 123.828 3.019 . . . . 0.0 114.788 175.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 26.8 pt-20 -152.69 155.4 37.18 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.811 1.645 . . . . 0.0 112.404 174.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -75.87 170.72 15.69 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.613 1.165 . . . . 0.0 113.853 174.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -132.51 107.86 8.74 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.533 1.933 . . . . 0.0 110.268 -178.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 50.65 30.53 4.96 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 124.993 1.317 . . . . 0.0 114.331 -178.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 100.14 -16.42 58.24 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 125.674 1.606 . . . . 0.0 114.425 -178.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -87.07 129.61 34.84 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.55 1.175 . . . . 0.0 111.198 178.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 12.5 mt -96.62 161.68 13.78 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.955 0.902 . . . . 0.0 110.311 163.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -124.83 123.75 40.62 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.201 1.4 . . . . 0.0 107.771 173.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -148.65 175.16 28.05 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-N 115.731 -0.668 . . . . 0.0 113.682 -172.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -126.07 120.62 30.7 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.254 1.422 . . . . 0.0 110.027 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -61.85 155.93 22.01 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.716 1.206 . . . . 0.0 111.887 179.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -98.46 -21.96 16.28 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 120.661 -1.274 . . . . 0.0 114.363 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 58.5 t -82.63 -33.81 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 C-N-CA 123.466 0.706 . . . . 0.0 112.718 178.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 5.5 t -127.33 -11.49 5.74 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.683 1.193 . . . . 0.0 113.694 -170.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? 54.68 23.02 4.42 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 125.753 1.621 . . . . 0.0 113.762 -177.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -69.25 154.47 41.99 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.688 1.195 . . . . 0.0 111.355 169.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 80.3 mtt180 -127.05 161.19 28.99 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.922 1.689 . . . . 0.0 110.947 -177.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 156.87 169.39 20.74 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 124.521 1.058 . . . . 0.0 112.449 174.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -67.1 147.87 52.6 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.144 0.497 . . . . 0.0 110.361 168.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -154.36 155.71 31.05 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 124.112 0.965 . . . . 0.0 110.75 172.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -65.15 120.39 7.6 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.314 2.009 . . . . 0.0 111.707 178.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 81.7 p -57.99 -22.77 51.04 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 114.225 1.195 . . . . 0.0 114.225 177.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 16.3 m -77.09 -17.69 58.52 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 176.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -79.36 -2.49 41.81 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.476 1.11 . . . . 0.0 113.687 177.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 67.2 p . . . . . 0 C--O 1.236 0.383 0 C-N-CA 125.623 1.569 . . . . 0.0 110.771 171.343 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 61.0 mt . . . . . 0 N--CA 1.478 0.93 0 CA-C-O 119.067 -0.492 . . . . 0.0 109.773 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -69.31 160.57 49.3 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 123.568 2.845 . . . . 0.0 112.074 178.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -63.99 143.45 85.03 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 122.281 1.987 . . . . 0.0 112.103 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -71.94 155.05 92.39 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 123.083 0.553 . . . . 0.0 112.053 172.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -68.8 174.87 8.02 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.419 2.746 . . . . 0.0 113.095 176.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -91.14 8.95 33.08 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.913 1.285 . . . . 0.0 112.407 -178.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 38.2 p90 -138.02 154.36 74.22 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 124.9 1.28 . . . . 0.0 112.827 -178.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -72.03 153.82 57.69 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.726 2.951 . . . . 0.0 112.58 178.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -68.97 142.9 93.88 Favored Pre-proline 0 CA--C 1.552 1.043 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -176.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -73.92 179.65 5.49 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 124.173 3.249 . . . . 0.0 113.071 176.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 26.9 p -132.89 155.29 81.32 Favored Pre-proline 0 N--CA 1.48 1.058 0 C-N-CA 125.25 1.42 . . . . 0.0 112.842 -174.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -67.46 164.64 30.04 Favored 'Trans proline' 0 CA--C 1.549 1.266 0 C-N-CA 123.504 2.803 . . . . 0.0 111.57 174.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo . . . . . 0 CA--C 1.542 0.88 0 C-N-CA 123.46 2.773 . . . . 0.0 113.085 176.574 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.688 0 N-CA-C 111.281 -0.727 . . . . 0.0 111.281 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 15.4 t -139.09 -30.3 0.74 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.338 1.055 . . . . 0.0 113.712 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' HIS . . . . . . . . . . . . . 14.2 p-80 -119.14 14.34 13.06 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.753 1.621 . . . . 0.0 112.531 173.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' MET . . . . . . . . . . . . . 14.7 ptm -148.01 154.17 39.93 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.204 1.802 . . . . 0.0 111.882 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.6 37.25 1.2 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 125.173 1.389 . . . . 0.0 114.044 -171.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.75 121.59 43.79 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.7 1.6 . . . . 0.0 110.751 178.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -70.39 142.54 52.07 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.369 0.667 . . . . 0.0 111.029 171.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 4.7 mptt -136.19 169.01 18.33 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.144 1.377 . . . . 0.0 112.313 174.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 15.9 m -132.44 154.52 40.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 126.704 2.002 . . . . 0.0 109.033 165.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 19.0 ttmt -118.2 131.34 56.39 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.991 0.916 . . . . 0.0 109.728 177.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 27.8 p -73.47 156.93 37.71 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.265 0.626 . . . . 0.0 111.315 -177.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 2.1 pp -127.32 -5.84 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 N-CA-C 114.722 1.378 . . . . 0.0 114.722 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -156.58 158.58 31.46 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 125.852 1.661 . . . . 0.0 110.415 171.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.21 156.68 64.04 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.216 2.611 . . . . 0.0 112.918 176.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 52.1 t-80 -140.28 151.03 44.77 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.093 1.357 . . . . 0.0 111.735 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 15.2 t -147.62 150.69 34.9 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.545 1.538 . . . . 0.0 112.005 -176.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -77.45 -35.22 54.15 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -177.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 67.86 -62.58 0.34 Allowed Glycine 0 CA--C 1.54 1.647 0 C-N-CA 126.738 2.113 . . . . 0.0 115.753 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 50.1 m -143.2 27.84 1.56 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 126.541 1.936 . . . . 0.0 112.118 -173.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -138.21 173.63 11.41 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.875 1.67 . . . . 0.0 111.445 -174.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 2.6 tmmm? -120.53 -31.88 4.2 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.207 1.403 . . . . 0.0 113.143 177.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 53.7 p -86.05 13.34 7.84 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.111 1.364 . . . . 0.0 114.601 -174.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 67.7 mt -104.39 124.52 49.36 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.763 1.225 . . . . 0.0 111.45 -177.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 23.7 tp -77.26 124.47 27.89 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.637 0.775 . . . . 0.0 110.828 176.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 58.5 p -94.97 153.38 17.68 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.876 1.27 . . . . 0.0 112.632 174.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -167.42 178.85 5.26 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.759 1.624 . . . . 0.0 112.132 -175.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -117.28 178.51 4.34 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.663 1.985 . . . . 0.0 110.93 173.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -66.96 141.3 57.66 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.304 -0.873 . . . . 0.0 111.47 170.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 79.29 5.44 89.14 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 124.232 0.92 . . . . 0.0 115.345 174.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -74.34 166.62 23.17 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.757 1.223 . . . . 0.0 112.822 176.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 90.8 t -119.36 126.33 75.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 125.666 1.586 . . . . 0.0 108.884 -174.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 26.4 mt -133.62 135.46 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.56 1.144 . . . . 0.0 109.059 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 59.3 m -102.72 136.73 42.01 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.757 1.223 . . . . 0.0 110.058 -177.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 19.5 mt -75.34 148.0 39.64 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -175.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 49.5 mt -121.25 0.93 10.2 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 124.782 1.233 . . . . 0.0 112.908 178.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 371' ' ' ILE . . . . . 0.42 ' CG2' ' HD2' ' A' ' 372' ' ' PRO . 2.2 mt -137.13 142.67 38.96 Favored Pre-proline 0 N--CA 1.48 1.05 0 C-N-CA 126.716 2.006 . . . . 0.0 109.794 177.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 372' ' ' PRO . . . . . 0.42 ' HD2' ' CG2' ' A' ' 371' ' ' ILE . 55.6 Cg_endo -72.27 -8.87 23.5 Favored 'Trans proline' 0 CA--C 1.546 1.085 0 C-N-CA 123.423 2.749 . . . . 0.0 113.959 176.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -153.63 152.82 31.29 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.855 1.662 . . . . 0.0 112.139 174.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -72.88 169.68 16.31 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.23 1.012 . . . . 0.0 113.63 174.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 18.2 tppt? -126.39 102.36 7.12 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.776 2.03 . . . . 0.0 109.801 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 52.67 30.36 8.64 Favored 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 178.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 102.09 -18.44 51.93 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.803 1.668 . . . . 0.0 114.199 -178.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 82.0 m95 -84.4 129.47 34.86 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.524 1.13 . . . . 0.0 111.119 175.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 11.4 mt -99.23 158.56 15.61 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.925 0.89 . . . . 0.0 110.285 165.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -118.57 123.78 45.87 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.867 1.267 . . . . 0.0 107.721 171.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -148.62 172.43 28.81 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-N 115.854 -0.612 . . . . 0.0 113.602 -173.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -123.83 119.32 29.34 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.547 1.539 . . . . 0.0 109.402 176.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 25.0 t-80 -62.92 147.86 49.11 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.905 1.282 . . . . 0.0 111.546 177.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -80.39 -50.4 10.17 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 120.91 -1.119 . . . . 0.0 113.46 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 68.0 t -69.38 -49.0 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 O-C-N 121.37 -0.831 . . . . 0.0 113.111 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 20.3 t -86.11 -23.26 26.71 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.406 0.682 . . . . 0.0 112.646 -175.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 34.7 mmtm 53.46 20.51 2.06 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 126.187 1.795 . . . . 0.0 114.265 -169.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -76.41 152.78 36.12 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.458 0.703 . . . . 0.0 111.799 171.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 74.4 mtm180 -122.15 157.14 32.18 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.443 1.897 . . . . 0.0 111.195 177.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 161.02 170.57 25.81 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.529 1.061 . . . . 0.0 112.505 174.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -66.74 147.36 53.37 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.133 0.492 . . . . 0.0 110.313 166.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -154.73 155.73 30.76 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 124.304 1.042 . . . . 0.0 110.427 172.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -64.6 119.42 6.46 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.347 2.032 . . . . 0.0 110.822 176.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 28.9 t -55.79 -38.79 70.4 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.56 -0.712 . . . . 0.0 111.936 177.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 1.6 p -61.15 -17.39 52.61 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.306 1.842 . . . . 0.0 115.859 177.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -76.55 -0.34 22.85 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 119.705 1.139 . . . . 0.0 113.086 169.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 32.4 p -134.1 161.88 33.64 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 126.081 1.752 . . . . 0.0 111.008 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 51.6 mttm -134.62 155.41 50.53 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.12 1.368 . . . . 0.0 109.814 175.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.45 124.78 21.16 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 175.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 3.6 tp -52.36 -46.22 66.08 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 123.347 1.546 . . . . 0.0 114.962 -173.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -98.46 63.59 1.51 Allowed 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 127.063 2.145 . . . . 0.0 112.499 -178.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 . . . . . 0 C--O 1.255 1.373 0 N-CA-C 114.973 1.472 . . . . 0.0 114.973 171.95 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 526' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.82 0.343 . . . . 0.0 110.985 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 62.8 mt -66.89 132.99 93.9 Favored Pre-proline 0 N--CA 1.478 0.935 0 C-N-CA 125.01 1.324 . . . . 0.0 109.829 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -69.44 159.75 52.42 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 123.601 2.867 . . . . 0.0 112.264 178.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.23 144.95 87.98 Favored 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 122.374 2.05 . . . . 0.0 112.241 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -73.58 156.11 88.85 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 123.265 0.626 . . . . 0.0 112.224 173.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -69.14 174.73 8.55 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.48 2.787 . . . . 0.0 113.155 177.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -88.6 4.77 45.78 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.797 1.239 . . . . 0.0 112.62 -178.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 36.3 p90 -136.32 154.62 77.23 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 124.677 1.191 . . . . 0.0 112.829 -176.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.95 153.17 58.1 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 123.753 2.969 . . . . 0.0 112.779 178.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -68.7 143.15 94.67 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 123.732 0.813 . . . . 0.0 113.028 -177.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.73 176.86 8.82 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.992 3.128 . . . . 0.0 113.023 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 27.8 p -130.32 153.0 81.18 Favored Pre-proline 0 N--CA 1.478 0.959 0 C-N-CA 124.983 1.313 . . . . 0.0 112.82 -173.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -67.07 163.26 34.7 Favored 'Trans proline' 0 CA--C 1.548 1.183 0 C-N-CA 123.485 2.79 . . . . 0.0 111.338 176.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -63.76 150.74 87.74 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.007 2.471 . . . . 0.0 112.516 178.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 540' ' ' VAL . . . . . . . . . . . . . 40.9 t -97.65 103.96 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.181 1.392 . . . . 0.0 108.514 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 541' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -139.11 158.14 44.72 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.748 2.019 . . . . 0.0 111.463 -173.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 542' ' ' ASN . . . . . . . . . . . . . 50.9 t30 . . . . . 0 C--O 1.254 1.315 0 C-N-CA 125.267 1.427 . . . . 0.0 113.258 177.72 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.566 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 22.4 t -62.23 117.27 5.84 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.011 0.924 . . . . 0.0 111.486 176.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -153.44 137.73 16.61 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.232 1.413 . . . . 0.0 110.535 -177.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -153.46 167.3 29.93 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.407 1.483 . . . . 0.0 112.384 -177.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -139.75 129.5 24.6 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.963 1.705 . . . . 0.0 109.568 176.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -151.47 80.24 1.29 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.769 1.228 . . . . 0.0 112.325 -166.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -59.32 136.77 58.07 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.692 0.758 . . . . 0.0 112.037 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 10.5 mptt -131.6 167.8 18.8 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 126.028 1.731 . . . . 0.0 111.506 176.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 16.2 m -133.55 152.89 35.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 126.454 1.901 . . . . 0.0 109.161 166.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -113.45 133.4 55.22 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.675 0.79 . . . . 0.0 110.092 174.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 68.3 p -72.84 154.75 40.47 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.279 1.032 . . . . 0.0 111.175 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.9 pp -125.59 -6.41 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 -179.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -155.92 159.76 31.31 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 126.273 1.829 . . . . 0.0 109.889 169.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -68.75 155.96 67.02 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.041 2.494 . . . . 0.0 113.203 177.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -140.47 152.4 45.61 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.466 1.507 . . . . 0.0 111.409 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 14.5 t -146.85 152.48 38.8 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.389 1.475 . . . . 0.0 111.749 -177.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -73.05 100.59 3.04 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.387 1.075 . . . . 0.0 111.353 176.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . -74.21 80.19 0.86 Allowed Glycine 0 CA--C 1.534 1.219 0 C-N-CA 125.465 1.507 . . . . 0.0 113.083 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 4.3 t 54.77 52.1 12.65 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.831 1.652 . . . . 0.0 112.849 -175.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -143.75 171.36 14.31 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 125.274 1.43 . . . . 0.0 112.214 -174.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 43.0 mtmt -121.74 -9.71 8.83 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 125.647 1.579 . . . . 0.0 114.817 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 75.8 p -115.26 20.47 14.87 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.938 1.295 . . . . 0.0 112.973 -172.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 69.0 mt -112.17 133.41 54.32 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.818 1.247 . . . . 0.0 111.762 -176.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 27.9 tp -87.72 121.27 29.94 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.096 0.958 . . . . 0.0 111.01 177.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 59.8 p -86.7 153.48 21.7 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.454 1.102 . . . . 0.0 112.866 172.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -167.53 178.34 5.47 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.901 1.68 . . . . 0.0 112.147 -178.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -118.54 175.96 5.48 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.877 2.071 . . . . 0.0 111.067 173.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -64.06 141.19 58.86 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.817 0.847 . . . . 0.0 111.404 169.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 75.47 11.49 84.28 Favored Glycine 0 CA--C 1.539 1.556 0 N-CA-C 114.975 0.75 . . . . 0.0 114.975 175.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -81.98 162.9 22.49 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.989 1.316 . . . . 0.0 112.036 173.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 86.9 t -117.35 129.2 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.96 1.304 . . . . 0.0 109.41 -172.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 30.5 mt -134.72 136.13 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.383 1.073 . . . . 0.0 109.474 -177.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 33.6 m -99.97 138.81 36.53 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.149 1.379 . . . . 0.0 110.31 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 20.8 mt -76.62 146.7 38.05 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 122.853 0.461 . . . . 0.0 112.219 -177.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 39.5 mt -120.07 -3.31 10.12 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 124.799 1.24 . . . . 0.0 112.773 177.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 6.2 mt -135.87 142.0 38.85 Favored Pre-proline 0 N--CA 1.481 1.101 0 C-N-CA 127.186 2.194 . . . . 0.0 109.917 177.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.13 -7.05 20.3 Favored 'Trans proline' 0 CA--C 1.546 1.121 0 C-N-CA 124.446 3.431 . . . . 0.0 115.248 175.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -151.48 167.34 28.33 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 126.091 1.756 . . . . 0.0 112.228 176.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -92.11 170.08 10.12 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.542 1.137 . . . . 0.0 113.036 175.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 10.5 tptp -133.51 111.09 10.41 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 126.366 1.866 . . . . 0.0 110.272 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 52.35 27.52 4.92 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 124.87 1.268 . . . . 0.0 114.257 -177.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 98.12 -14.31 62.63 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 125.727 1.632 . . . . 0.0 114.595 -176.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 75.7 m95 -87.04 133.31 33.61 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.412 1.106 . . . . 0.0 111.518 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 18.1 mt -102.01 162.59 12.79 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 124.342 1.057 . . . . 0.0 110.198 164.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -125.08 121.79 35.34 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.957 1.303 . . . . 0.0 107.733 175.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -145.44 174.12 25.57 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 115.542 -0.754 . . . . 0.0 114.139 -173.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -124.55 120.57 32.33 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.773 1.629 . . . . 0.0 109.798 177.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 15.8 t-80 -65.6 144.62 56.85 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.792 1.237 . . . . 0.0 111.952 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -77.71 -48.61 16.29 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 120.877 -1.139 . . . . 0.0 113.538 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 83.3 t -69.96 -48.99 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 124.03 0.932 . . . . 0.0 113.296 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 7.2 t -93.59 -16.05 24.77 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -171.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp 53.36 18.82 1.4 Allowed 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 127.024 2.13 . . . . 0.0 114.986 -173.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -78.01 156.11 30.33 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.411 0.684 . . . . 0.0 111.581 174.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -123.78 157.98 32.79 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.112 1.765 . . . . 0.0 110.652 177.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 159.68 168.86 22.26 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 124.252 0.93 . . . . 0.0 112.67 175.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -67.2 148.44 51.77 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.313 0.578 . . . . 0.0 110.258 168.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -154.36 154.39 29.5 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 124.526 1.13 . . . . 0.0 110.463 173.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -65.46 121.65 9.12 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.558 2.172 . . . . 0.0 110.883 177.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 30.4 t -56.44 -38.01 71.02 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.464 -0.772 . . . . 0.0 112.397 178.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 75.3 m -63.27 -19.6 64.71 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -73.08 -1.88 19.1 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.271 1.029 . . . . 0.0 113.192 171.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 53.8 p -131.77 164.06 26.84 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.962 1.705 . . . . 0.0 111.441 178.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -134.88 158.23 44.8 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.508 1.523 . . . . 0.0 109.27 174.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.5 127.26 30.32 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 171.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.77 -53.59 24.17 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 123.56 1.647 . . . . 0.0 114.132 -175.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -80.6 31.85 0.3 Allowed 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 128.301 2.64 . . . . 0.0 113.809 -176.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 . . . . . 0 C--O 1.255 1.388 0 C-N-CA 126.852 2.061 . . . . 0.0 113.975 174.261 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 526' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.832 0.348 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 64.1 mt -68.69 132.7 90.8 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 125.173 1.389 . . . . 0.0 109.759 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -69.76 158.73 55.95 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 123.459 2.772 . . . . 0.0 111.862 177.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.0 144.8 88.7 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 122.245 1.964 . . . . 0.0 112.256 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -69.74 154.77 94.47 Favored Pre-proline 0 CA--C 1.55 0.981 0 C-N-CA 122.962 0.505 . . . . 0.0 111.905 171.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -68.52 174.09 8.87 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.283 2.655 . . . . 0.0 113.009 177.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -86.65 1.95 50.13 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.463 1.105 . . . . 0.0 113.044 -178.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -132.74 153.57 81.12 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 124.736 1.215 . . . . 0.0 112.943 -176.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.4 152.97 61.16 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 123.694 2.929 . . . . 0.0 112.757 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -68.63 143.89 95.58 Favored Pre-proline 0 CA--C 1.551 1.013 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -73.54 -179.28 4.34 Favored 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 124.028 3.152 . . . . 0.0 112.791 176.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 22.2 p -134.28 155.07 80.21 Favored Pre-proline 0 N--CA 1.479 1.024 0 C-N-CA 125.247 1.419 . . . . 0.0 112.632 -175.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.59 163.13 36.22 Favored 'Trans proline' 0 CA--C 1.548 1.189 0 C-N-CA 123.512 2.808 . . . . 0.0 111.742 176.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -64.52 149.79 89.34 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 122.935 2.423 . . . . 0.0 112.576 177.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 540' ' ' VAL . . . . . . . . . . . . . 9.8 p -146.45 148.31 17.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 127.29 2.236 . . . . 0.0 109.347 -177.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 541' ' ' GLN . . . . . . . . . . . . . 41.0 mm-40 -136.97 144.53 43.4 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 126.27 1.828 . . . . 0.0 110.612 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 542' ' ' ASN . . . . . . . . . . . . . 55.8 t-20 . . . . . 0 C--O 1.255 1.358 0 C-N-CA 125.361 1.464 . . . . 0.0 111.433 -176.943 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.591 0 N-CA-C 111.759 -0.536 . . . . 0.0 111.759 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 82.0 p 42.92 39.04 1.59 Allowed 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 127.345 2.258 . . . . 0.0 116.116 177.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' HIS . . . . . . . . . . . . . 32.1 t60 -142.2 114.12 8.07 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.1 1.36 . . . . 0.0 110.721 -175.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' MET . . . . . . . . . . . . . 20.2 ptm -63.01 154.82 29.44 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.47 1.108 . . . . 0.0 113.233 178.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -118.81 -46.71 2.54 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.54 1.136 . . . . 0.0 112.747 -177.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -142.78 136.83 29.25 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 126.578 1.951 . . . . 0.0 110.323 -176.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' GLN . . . . . . . . . . . . . 72.6 tp60 -77.35 140.61 39.99 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.68 0.752 . . . . 0.0 111.804 177.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 3.1 mptm? -121.35 163.41 18.7 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.801 1.64 . . . . 0.0 111.3 173.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 15.7 m -134.6 157.72 41.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 126.643 1.977 . . . . 0.0 109.362 171.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -121.02 128.17 52.43 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.227 1.011 . . . . 0.0 109.901 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 59.0 p -71.79 154.04 41.56 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.01 0.924 . . . . 0.0 111.415 -177.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.8 pp -124.65 -8.36 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -156.01 159.54 31.45 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 126.731 2.012 . . . . 0.0 110.116 169.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.63 158.35 58.09 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.208 2.605 . . . . 0.0 113.331 177.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -142.62 154.99 44.89 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.98 1.312 . . . . 0.0 111.866 179.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 9.6 t -148.59 166.71 27.47 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.368 1.467 . . . . 0.0 113.065 -172.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -107.06 82.87 1.74 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.5 1.92 . . . . 0.0 110.546 -176.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . -62.91 -39.9 98.61 Favored Glycine 0 CA--C 1.537 1.43 0 N-CA-C 115.76 1.064 . . . . 0.0 115.76 -169.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 21.8 m -147.77 28.23 0.96 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.93 1.292 . . . . 0.0 112.417 -177.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 355' ' ' ASN . . . . . 0.583 HD21 ' HG ' ' A' ' 358' ' ' LEU . 54.4 t30 -142.49 172.07 13.19 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.524 1.13 . . . . 0.0 113.268 -169.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -127.7 8.52 6.36 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 125.982 1.713 . . . . 0.0 114.979 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 74.3 p -127.22 16.83 7.19 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 125.606 1.563 . . . . 0.0 113.409 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 358' ' ' LEU . . . . . 0.583 ' HG ' HD21 ' A' ' 355' ' ' ASN . 47.7 mt -97.37 120.43 37.71 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.714 1.206 . . . . 0.0 110.473 175.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 25.4 tp -73.18 131.95 42.63 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.494 0.718 . . . . 0.0 110.502 175.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 31.9 p -110.75 149.58 30.31 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.072 1.749 . . . . 0.0 112.395 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -167.11 179.08 5.33 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.149 1.379 . . . . 0.0 112.667 -169.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -116.49 177.0 4.85 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.712 2.005 . . . . 0.0 111.155 173.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -67.04 142.83 57.05 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.177 0.991 . . . . 0.0 111.888 170.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 75.61 5.39 78.32 Favored Glycine 0 CA--C 1.538 1.502 0 C-N-CA 124.376 0.988 . . . . 0.0 115.248 174.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -73.75 161.48 30.19 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.704 1.202 . . . . 0.0 111.723 171.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 59.3 t -112.51 138.32 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.485 1.114 . . . . 0.0 109.407 178.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 36.5 mt -136.26 140.77 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 124.717 1.207 . . . . 0.0 108.835 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 23.5 m -98.27 140.18 32.95 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.765 1.226 . . . . 0.0 110.853 178.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 22.7 mt -79.11 141.16 37.55 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 122.804 0.442 . . . . 0.0 111.554 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 63.1 mt -113.03 -4.45 13.86 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 124.673 1.189 . . . . 0.0 112.744 178.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 7.9 mt -132.92 141.76 42.21 Favored Pre-proline 0 N--CA 1.478 0.928 0 C-N-CA 127.001 2.12 . . . . 0.0 109.851 177.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.35 -7.98 22.42 Favored 'Trans proline' 0 CA--C 1.547 1.133 0 C-N-CA 123.974 3.116 . . . . 0.0 114.575 175.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -153.5 151.96 30.42 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.05 1.74 . . . . 0.0 112.062 175.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -74.62 171.33 14.05 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.417 1.087 . . . . 0.0 113.731 175.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -132.95 107.14 8.1 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.205 1.802 . . . . 0.0 110.249 -178.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 51.28 30.91 6.33 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 125.004 1.322 . . . . 0.0 114.343 -179.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 98.95 -16.75 59.1 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.772 1.653 . . . . 0.0 114.3 -177.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -85.75 132.06 34.21 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.308 1.043 . . . . 0.0 111.146 177.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 13.2 mt -100.7 159.94 14.76 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.939 0.896 . . . . 0.0 110.114 164.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -121.66 123.25 41.45 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 173.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -146.0 172.89 26.51 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-N 115.743 -0.662 . . . . 0.0 114.376 -172.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -124.68 116.46 22.41 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.88 1.672 . . . . 0.0 109.126 176.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 21.5 t-80 -61.88 144.29 55.14 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.818 1.247 . . . . 0.0 111.982 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -80.29 -45.32 18.07 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 121.217 -0.927 . . . . 0.0 112.705 -178.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 97.2 t -70.87 -52.73 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 124.256 1.022 . . . . 0.0 113.469 175.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 7.6 t -91.56 -15.61 28.41 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -171.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt 54.41 19.08 2.15 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 126.767 2.027 . . . . 0.0 114.777 -174.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -77.87 157.51 29.82 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.522 0.729 . . . . 0.0 111.822 174.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 54.1 mtt85 -128.52 155.9 44.14 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.007 1.723 . . . . 0.0 110.801 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 160.15 169.67 23.75 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 124.69 1.138 . . . . 0.0 112.03 176.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -66.8 147.17 53.6 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.114 0.566 . . . . 0.0 110.234 166.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -154.47 155.4 30.67 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 124.32 1.048 . . . . 0.0 110.17 172.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -65.64 120.1 7.23 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.167 1.911 . . . . 0.0 110.749 176.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 29.8 t -54.46 -38.45 66.37 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 121.897 -0.502 . . . . 0.0 111.958 176.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 17.9 m -58.58 -21.37 52.9 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.836 1.654 . . . . 0.0 115.255 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -77.41 0.27 23.17 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.606 1.163 . . . . 0.0 113.468 173.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 68.9 p -130.9 159.72 36.6 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.945 1.698 . . . . 0.0 111.328 176.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -124.73 164.28 20.29 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 125.307 1.443 . . . . 0.0 109.738 171.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.11 126.52 27.99 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.078 -0.964 . . . . 0.0 108.726 173.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.35 -50.74 64.4 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 123.877 1.799 . . . . 0.0 114.459 -174.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -66.52 100.8 0.7 Allowed 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 128.303 2.641 . . . . 0.0 111.393 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 . . . . . 0 C--O 1.254 1.313 0 C-N-CA 126.329 1.851 . . . . 0.0 114.52 -173.998 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 526' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 . . . . . 0 N--CA 1.486 1.348 0 N-CA-C 110.578 -0.156 . . . . 0.0 110.578 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 58.9 mt -69.68 130.98 89.9 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 124.202 1.001 . . . . 0.0 109.821 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.36 160.37 49.75 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 123.532 2.821 . . . . 0.0 112.079 178.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.99 144.16 86.99 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.331 2.02 . . . . 0.0 112.357 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -72.41 156.14 90.63 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 123.361 0.664 . . . . 0.0 112.138 172.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -68.75 175.02 7.76 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.443 2.762 . . . . 0.0 113.219 176.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -91.8 8.93 34.86 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.856 1.262 . . . . 0.0 112.35 -178.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 36.3 p90 -137.73 154.56 74.86 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 124.617 1.167 . . . . 0.0 112.786 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -72.07 153.54 57.46 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 123.763 2.975 . . . . 0.0 112.74 178.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -69.26 142.42 92.52 Favored Pre-proline 0 CA--C 1.551 1.008 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -175.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -73.86 179.75 5.38 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 124.173 3.249 . . . . 0.0 113.266 178.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 28.1 p -132.59 155.45 81.21 Favored Pre-proline 0 N--CA 1.479 0.988 0 C-N-CA 125.392 1.477 . . . . 0.0 113.024 -172.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.13 163.0 39.43 Favored 'Trans proline' 0 CA--C 1.548 1.197 0 C-N-CA 123.545 2.83 . . . . 0.0 111.936 175.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -66.22 152.06 82.04 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.376 2.717 . . . . 0.0 112.925 178.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 540' ' ' VAL . . . . . . . . . . . . . 46.1 t -90.21 -27.89 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 124.627 1.171 . . . . 0.0 111.998 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 541' ' ' GLN . . . . . . . . . . . . . 23.0 mm100 -66.46 164.03 17.21 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.702 1.201 . . . . 0.0 113.086 175.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 542' ' ' ASN . . . . . . . . . . . . . 38.6 p30 . . . . . 0 C--O 1.255 1.343 0 C-N-CA 126.479 1.912 . . . . 0.0 113.398 -177.362 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.485 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 78.3 p -148.36 163.46 37.03 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.466 1.506 . . . . 0.0 112.098 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -84.2 -28.08 27.57 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -177.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' MET . . . . . . . . . . . . . 75.7 mtp -141.45 152.88 44.61 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.931 1.292 . . . . 0.0 112.87 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -77.26 -46.75 22.11 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.1 1.36 . . . . 0.0 113.373 -174.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -74.52 124.63 26.97 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.944 1.298 . . . . 0.0 110.388 176.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' GLN . . . . . . . . . . . . . 71.6 tp60 -67.98 136.83 54.53 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.868 0.842 . . . . 0.0 111.062 174.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -124.78 165.41 18.04 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.964 1.706 . . . . 0.0 111.002 177.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 16.3 m -134.45 156.2 40.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 126.717 2.007 . . . . 0.0 109.233 169.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -115.95 132.13 56.74 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 124.396 1.079 . . . . 0.0 109.885 177.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 72.3 p -75.04 153.94 38.2 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.526 0.73 . . . . 0.0 111.366 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.9 pp -123.97 -7.92 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -156.38 158.77 31.62 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 126.102 1.761 . . . . 0.0 110.117 170.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.02 155.78 68.34 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 122.947 2.431 . . . . 0.0 112.968 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -138.25 149.79 46.08 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.931 1.292 . . . . 0.0 111.621 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 10.4 m -142.9 131.72 22.76 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.098 1.359 . . . . 0.0 110.894 -167.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -73.06 -22.96 60.52 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 -178.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 57.81 -120.78 23.22 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.3 0.952 . . . . 0.0 112.118 -176.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 66.1 p -80.05 -10.67 59.79 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 176.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -84.46 170.35 13.6 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.253 1.021 . . . . 0.0 112.993 -176.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 20.8 ttpp -125.73 -16.92 5.59 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -178.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 36.7 p -99.94 13.15 34.9 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.315 1.446 . . . . 0.0 113.549 -176.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 81.8 mt -106.23 126.22 51.96 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.961 1.305 . . . . 0.0 110.963 -176.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 31.5 tp -73.86 141.8 46.09 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 122.987 0.515 . . . . 0.0 110.205 171.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 58.0 p -121.65 148.86 44.02 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.192 1.397 . . . . 0.0 111.721 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -165.54 178.5 6.68 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.97 1.308 . . . . 0.0 112.447 -167.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -117.7 177.63 4.69 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 127.117 2.167 . . . . 0.0 110.802 174.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -67.54 141.5 56.84 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 121.215 -0.928 . . . . 0.0 111.595 170.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 77.48 6.7 86.84 Favored Glycine 0 CA--C 1.538 1.485 0 N-CA-C 115.274 0.87 . . . . 0.0 115.274 176.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -74.02 164.67 26.32 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 118.437 1.119 . . . . 0.0 112.02 170.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 77.2 t -120.61 128.07 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.337 1.455 . . . . 0.0 109.125 -174.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 31.0 mt -132.55 137.06 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 123.399 0.68 . . . . 0.0 109.506 -175.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 20.5 m -98.02 140.27 32.61 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.334 1.054 . . . . 0.0 110.649 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 23.8 mt -81.17 142.94 32.74 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 122.975 0.51 . . . . 0.0 111.718 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 39.2 mt -116.04 -4.54 12.0 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.42 1.088 . . . . 0.0 113.003 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 6.9 mt -134.13 141.53 39.83 Favored Pre-proline 0 N--CA 1.477 0.88 0 C-N-CA 127.007 2.123 . . . . 0.0 109.57 177.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.81 -7.36 20.98 Favored 'Trans proline' 0 CA--C 1.549 1.255 0 C-N-CA 123.98 3.12 . . . . 0.0 114.561 176.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -150.3 154.49 37.96 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.073 1.749 . . . . 0.0 111.478 173.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -78.47 168.82 19.22 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 121.006 -1.059 . . . . 0.0 113.156 173.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -121.89 103.01 8.54 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 126.253 1.821 . . . . 0.0 110.253 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 52.14 31.47 9.05 Favored 'General case' 0 CA--C 1.555 1.136 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 177.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 99.84 -4.33 57.67 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 125.317 1.437 . . . . 0.0 114.675 -178.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -101.69 118.47 37.01 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.199 1.4 . . . . 0.0 110.67 176.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 12.6 mt -82.93 161.49 21.81 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.393 0.616 . . . . 0.0 110.546 162.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -126.04 123.5 38.56 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.152 1.381 . . . . 0.0 107.975 171.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -150.67 173.88 30.13 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-N 115.933 -0.576 . . . . 0.0 114.509 -169.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -126.21 120.29 29.67 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.653 1.581 . . . . 0.0 110.11 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 25.0 t-80 -66.4 156.07 35.66 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.256 1.422 . . . . 0.0 112.554 178.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -83.05 -48.18 10.88 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 178.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 71.2 t -75.66 -49.07 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 125.206 1.402 . . . . 0.0 113.393 -178.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 23.2 t -87.77 -23.34 24.12 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 118.786 0.721 . . . . 0.0 112.561 -176.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 7.0 mmmm 54.91 19.49 2.67 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 126.529 1.932 . . . . 0.0 114.006 -171.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -75.09 155.26 37.33 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.896 0.878 . . . . 0.0 111.817 172.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 -121.49 156.37 32.93 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 126.111 1.764 . . . . 0.0 111.429 176.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 165.57 169.63 29.44 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.898 1.237 . . . . 0.0 112.042 175.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -66.99 149.92 49.96 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.06 0.457 . . . . 0.0 110.126 166.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -155.87 154.37 27.66 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 124.263 1.025 . . . . 0.0 110.162 171.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -63.78 119.84 7.03 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.181 1.921 . . . . 0.0 110.406 177.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.1 -36.41 70.59 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 121.391 -0.818 . . . . 0.0 111.564 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 18.2 m -59.43 -22.11 60.99 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 126.748 2.019 . . . . 0.0 114.944 178.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -74.88 0.72 14.66 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.763 1.225 . . . . 0.0 113.217 172.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 36.6 p -134.81 162.79 31.39 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.735 1.614 . . . . 0.0 111.803 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -134.28 156.42 48.46 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.499 1.52 . . . . 0.0 109.988 176.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.1 124.28 20.07 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.41 1.084 . . . . 0.0 110.337 -177.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 23.9 tp -61.37 -44.62 96.86 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 123.216 1.484 . . . . 0.0 114.838 -175.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -93.61 56.65 2.42 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 127.932 2.493 . . . . 0.0 111.881 -176.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? . . . . . 0 C--O 1.253 1.286 0 C-N-CA 126.792 2.037 . . . . 0.0 115.884 178.855 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 526' ' ' HIS . . . . . . . . . . . . . 32.4 m80 . . . . . 0 N--CA 1.485 1.306 0 CA-C-O 120.462 0.172 . . . . 0.0 110.629 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 57.9 mt -72.28 131.79 84.71 Favored Pre-proline 0 N--CA 1.479 0.997 0 C-N-CA 124.455 1.102 . . . . 0.0 109.663 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -69.93 160.49 49.48 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 123.574 2.849 . . . . 0.0 112.138 177.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.07 144.49 87.52 Favored 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 122.294 1.996 . . . . 0.0 112.136 178.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -73.14 155.49 90.12 Favored Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 123.118 0.567 . . . . 0.0 112.027 173.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -69.07 174.7 8.52 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 123.537 2.824 . . . . 0.0 113.128 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -92.34 9.02 35.82 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.913 1.285 . . . . 0.0 112.472 -178.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 34.9 p90 -137.85 153.86 74.11 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 124.621 1.168 . . . . 0.0 112.842 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -71.92 151.91 57.08 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.579 2.853 . . . . 0.0 112.364 177.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -69.91 146.3 95.16 Favored Pre-proline 0 CA--C 1.549 0.923 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -175.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.95 178.12 6.87 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 123.979 3.119 . . . . 0.0 112.833 176.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 25.3 p -132.36 154.02 81.43 Favored Pre-proline 0 N--CA 1.478 0.941 0 C-N-CA 125.316 1.447 . . . . 0.0 112.449 -175.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -66.5 162.24 37.6 Favored 'Trans proline' 0 CA--C 1.548 1.186 0 C-N-CA 123.353 2.702 . . . . 0.0 111.48 175.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -64.11 154.02 72.92 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.167 2.578 . . . . 0.0 112.713 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 540' ' ' VAL . . . . . . . . . . . . . 38.3 t -100.93 106.38 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.348 1.459 . . . . 0.0 108.219 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 541' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -138.46 175.42 9.58 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 127.337 2.255 . . . . 0.0 111.315 -173.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 542' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 . . . . . 0 C--O 1.253 1.273 0 C-N-CA 126.096 1.758 . . . . 0.0 111.865 -176.17 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.62 0 N-CA-C 112.424 -0.27 . . . . 0.0 112.424 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 11.7 t -145.82 71.98 1.29 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.982 1.313 . . . . 0.0 111.477 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -66.31 -9.7 35.53 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 176.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' MET . . . . . . . . . . . . . 3.1 tpt -85.62 -25.88 26.38 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -175.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 25.5 tptp -61.98 -33.15 73.78 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.37 1.068 . . . . 0.0 113.465 -175.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -108.16 109.21 20.55 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 126.157 1.783 . . . . 0.0 108.316 174.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' GLN . . . . . . . . . . . . . 71.0 tp60 -62.22 136.32 57.88 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.736 0.779 . . . . 0.0 111.081 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -119.67 160.76 21.9 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.363 1.465 . . . . 0.0 111.498 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 17.4 m -136.07 154.06 32.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 126.312 1.845 . . . . 0.0 109.543 171.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -118.19 134.99 54.52 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.292 1.037 . . . . 0.0 110.362 176.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 81.3 p -77.44 154.21 32.83 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.065 1.346 . . . . 0.0 111.674 -176.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.9 pp -119.7 -9.62 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -178.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -154.69 159.04 32.25 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 126.427 1.891 . . . . 0.0 110.538 170.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -69.88 158.01 58.25 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.225 2.617 . . . . 0.0 112.987 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 35.9 t-80 -142.42 144.35 33.06 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.835 1.654 . . . . 0.0 111.193 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 62.2 m -147.58 124.67 11.4 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.619 1.168 . . . . 0.0 111.055 -171.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -65.09 123.29 19.11 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.768 0.827 . . . . 0.0 110.764 167.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . -122.46 -30.23 1.2 Allowed Glycine 0 N--CA 1.478 1.474 0 C-N-CA 124.256 0.932 . . . . 0.0 115.288 -171.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 5.7 t -144.72 39.1 1.24 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.809 1.644 . . . . 0.0 109.796 173.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -141.05 176.13 9.07 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.802 1.641 . . . . 0.0 111.603 -162.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -138.5 -41.25 0.5 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.682 1.193 . . . . 0.0 114.037 177.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 41.2 p -88.05 14.85 8.25 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.143 1.377 . . . . 0.0 114.004 -174.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -102.68 118.52 37.02 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.096 1.358 . . . . 0.0 110.773 -171.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 28.5 tp -72.25 120.64 18.14 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 122.999 0.52 . . . . 0.0 110.736 176.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 50.1 m -95.54 147.97 23.0 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.315 1.046 . . . . 0.0 111.982 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -164.5 178.02 7.71 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.131 1.372 . . . . 0.0 113.215 -171.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -116.71 175.12 5.72 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.373 1.869 . . . . 0.0 111.681 174.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -64.31 140.72 58.9 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.01 0.924 . . . . 0.0 111.563 170.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 75.12 6.31 79.06 Favored Glycine 0 CA--C 1.539 1.532 0 C-N-CA 123.985 0.803 . . . . 0.0 115.076 176.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -77.02 161.62 28.18 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.731 1.212 . . . . 0.0 111.983 174.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 91.9 t -114.64 131.53 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 124.952 1.301 . . . . 0.0 109.841 -172.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 23.8 mt -135.23 139.73 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.204 1.402 . . . . 0.0 108.839 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 25.0 m -100.88 138.66 37.62 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.16 1.384 . . . . 0.0 110.302 -178.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 23.0 mt -79.15 136.37 37.09 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 118.138 0.426 . . . . 0.0 111.768 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 24.9 mt -114.36 -10.13 12.69 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.308 1.043 . . . . 0.0 113.089 -179.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 10.0 mt -126.69 141.16 39.47 Favored Pre-proline 0 N--CA 1.475 0.822 0 C-N-CA 126.565 1.946 . . . . 0.0 109.588 175.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.12 -7.71 21.51 Favored 'Trans proline' 0 CA--C 1.548 1.203 0 C-N-CA 123.8 3.0 . . . . 0.0 114.615 176.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -152.52 153.27 33.12 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.686 1.595 . . . . 0.0 112.368 176.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 19.2 pm0 -75.56 169.06 18.83 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.652 1.181 . . . . 0.0 113.619 173.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -130.63 106.67 8.65 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 126.75 2.02 . . . . 0.0 109.992 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 51.12 30.48 5.62 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 124.926 1.29 . . . . 0.0 114.41 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 100.94 -14.06 58.81 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 125.807 1.67 . . . . 0.0 114.475 -178.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 82.0 m95 -89.42 135.47 33.57 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.281 1.032 . . . . 0.0 111.633 178.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 18.9 mt -107.17 161.02 15.14 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.833 1.253 . . . . 0.0 109.973 166.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -123.16 120.05 32.05 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.671 1.188 . . . . 0.0 107.884 175.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -143.7 170.96 25.52 Favored Glycine 0 CA--C 1.527 0.844 0 CA-C-N 115.611 -0.722 . . . . 0.0 114.199 -173.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -120.37 118.43 30.34 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.424 1.489 . . . . 0.0 110.114 178.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 19.8 t-80 -63.4 147.43 51.24 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.903 1.281 . . . . 0.0 112.059 178.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -79.87 -49.46 11.9 Favored 'General case' 0 CA--C 1.547 0.865 0 O-C-N 120.868 -1.145 . . . . 0.0 113.411 177.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 63.7 t -68.8 -50.78 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.993 0.917 . . . . 0.0 113.234 178.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 23.0 t -86.15 -23.56 26.53 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.439 0.695 . . . . 0.0 112.868 -173.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp 54.71 16.42 1.38 Allowed 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 126.655 1.982 . . . . 0.0 114.66 -168.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -75.17 153.35 38.21 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.387 0.675 . . . . 0.0 111.794 172.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 82.4 mtm180 -124.06 151.1 44.22 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 126.42 1.888 . . . . 0.0 110.76 177.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 170.26 168.31 31.92 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 124.521 1.057 . . . . 0.0 112.146 175.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -65.5 145.68 55.81 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.136 0.493 . . . . 0.0 110.237 167.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -153.33 155.23 31.59 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 124.432 1.093 . . . . 0.0 111.037 175.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -65.65 121.7 9.15 Favored 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 122.496 2.131 . . . . 0.0 111.715 178.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 41.0 t -59.55 -27.75 66.49 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 121.644 -0.66 . . . . 0.0 112.649 174.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 17.8 m -66.96 -17.94 65.15 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 174.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -83.38 -2.24 55.3 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.717 1.207 . . . . 0.0 113.543 178.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 67.1 p -127.38 168.06 15.35 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.29 1.836 . . . . 0.0 109.897 172.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? -126.49 -75.11 0.58 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.769 0.828 . . . . 0.0 109.717 175.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -166.84 151.45 7.34 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 127.252 2.221 . . . . 0.0 107.49 171.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.96 -69.2 0.26 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 124.106 1.907 . . . . 0.0 111.825 172.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -60.66 155.51 18.8 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 110.449 -3.069 . . . . 0.0 112.87 -175.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 . . . . . 0 C--O 1.253 1.282 0 C-N-CA 125.988 1.715 . . . . 0.0 112.72 -172.557 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 526' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.923 0.392 . . . . 0.0 110.987 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 45.2 mt -70.0 133.27 88.05 Favored Pre-proline 0 N--CA 1.476 0.862 0 C-N-CA 125.012 1.325 . . . . 0.0 109.625 178.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -69.16 160.64 49.09 Favored 'Trans proline' 0 CA--C 1.545 1.047 0 C-N-CA 123.321 2.681 . . . . 0.0 111.963 177.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -64.52 145.86 88.26 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 122.286 1.99 . . . . 0.0 112.321 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -68.63 153.24 96.06 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 122.975 0.51 . . . . 0.0 111.85 171.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -69.56 174.48 9.27 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 123.487 2.791 . . . . 0.0 113.165 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -87.94 2.9 50.5 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.608 1.163 . . . . 0.0 112.957 -178.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 37.5 p90 -133.86 154.48 80.44 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 124.744 1.217 . . . . 0.0 112.778 -176.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.47 152.62 60.4 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 123.625 2.883 . . . . 0.0 112.688 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -66.96 142.0 97.07 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 123.703 0.801 . . . . 0.0 113.033 -177.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.19 176.94 8.46 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 123.852 3.035 . . . . 0.0 112.836 177.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 31.9 p -131.56 154.5 81.87 Favored Pre-proline 0 N--CA 1.478 0.951 0 C-N-CA 125.254 1.422 . . . . 0.0 112.659 -173.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.28 162.89 40.03 Favored 'Trans proline' 0 CA--C 1.548 1.18 0 C-N-CA 123.562 2.842 . . . . 0.0 111.94 176.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -64.42 144.89 86.89 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 123.236 2.624 . . . . 0.0 112.562 178.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 540' ' ' VAL . . . . . . . . . . . . . 48.9 t -75.95 -37.39 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 124.209 1.004 . . . . 0.0 111.389 178.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 541' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -68.13 151.77 46.5 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.715 1.206 . . . . 0.0 113.13 176.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 542' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 . . . . . 0 C--O 1.252 1.22 0 C-N-CA 124.778 1.231 . . . . 0.0 112.223 173.405 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.443 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.4 p -152.65 165.98 33.57 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.828 1.251 . . . . 0.0 112.698 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 338' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -138.16 162.49 34.09 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.022 1.729 . . . . 0.0 111.245 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 339' ' ' MET . . . . . . . . . . . . . 45.2 mtm 53.74 34.28 18.68 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.877 1.671 . . . . 0.0 113.753 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 17.3 ttpt -112.48 25.87 11.09 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.849 1.66 . . . . 0.0 113.465 -170.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 341' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.66 102.04 10.38 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.427 1.491 . . . . 0.0 109.418 178.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 342' ' ' GLN . . . . . . . . . . . . . 71.3 tp60 -65.35 136.03 56.04 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.599 0.714 . . . . 0.0 111.214 176.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -132.36 167.8 19.24 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.984 1.314 . . . . 0.0 111.326 175.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 15.3 m -130.58 160.27 41.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 126.636 1.975 . . . . 0.0 109.576 171.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -122.78 132.55 54.27 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.45 1.1 . . . . 0.0 109.699 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 74.2 p -78.67 152.42 31.66 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.502 1.121 . . . . 0.0 111.172 -177.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.8 pp -120.95 -9.33 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 -178.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -153.38 158.62 32.72 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 126.286 1.834 . . . . 0.0 110.308 168.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -69.09 156.93 63.59 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.407 2.738 . . . . 0.0 113.271 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 44.0 t-80 -138.97 144.02 38.78 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.516 1.526 . . . . 0.0 111.4 178.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 86.1 m -140.87 137.76 33.45 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 126.018 1.727 . . . . 0.0 110.352 -174.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -67.06 -33.08 74.73 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -173.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 52.47 62.35 5.86 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 124.748 1.166 . . . . 0.0 115.115 170.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 2.8 t 74.93 47.43 0.11 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 126.045 1.738 . . . . 0.0 112.611 -174.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -144.41 170.3 16.29 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 125.359 1.463 . . . . 0.0 111.232 173.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -128.01 -21.41 3.65 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.728 1.611 . . . . 0.0 113.84 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 56.3 p -96.37 8.24 44.47 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.831 1.252 . . . . 0.0 113.757 -178.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 56.2 mt -102.08 132.32 48.01 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.606 1.162 . . . . 0.0 111.13 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 28.2 tp -83.66 120.11 25.58 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.06 0.544 . . . . 0.0 110.872 175.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 54.7 p -88.54 152.46 21.84 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.566 1.147 . . . . 0.0 112.637 172.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -167.88 177.57 5.63 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.532 1.533 . . . . 0.0 112.304 -176.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -117.07 174.46 6.09 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.452 1.901 . . . . 0.0 111.452 174.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -64.27 140.49 58.87 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.442 -0.786 . . . . 0.0 111.608 170.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 77.57 3.76 83.63 Favored Glycine 0 CA--C 1.537 1.406 0 C-N-CA 124.349 0.976 . . . . 0.0 115.117 175.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -72.1 168.36 18.3 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.527 1.131 . . . . 0.0 112.344 173.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 91.2 t -118.91 130.42 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.603 1.561 . . . . 0.0 108.935 -174.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 17.2 mt -134.35 138.32 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.401 1.08 . . . . 0.0 109.57 -178.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 11.8 m -104.31 139.22 39.61 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.144 1.378 . . . . 0.0 110.72 -176.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 25.9 mt -79.17 142.81 36.0 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -173.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 29.8 mt -119.18 -8.8 10.09 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.514 1.125 . . . . 0.0 113.07 178.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 5.7 mt -134.73 141.25 37.94 Favored Pre-proline 0 N--CA 1.478 0.957 0 C-N-CA 126.833 2.053 . . . . 0.0 109.397 176.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.64 -0.6 10.01 Favored 'Trans proline' 0 CA--C 1.548 1.219 0 C-N-CA 124.62 3.546 . . . . 0.0 114.601 175.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -151.05 175.84 11.71 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.779 2.032 . . . . 0.0 111.535 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -116.16 164.96 13.71 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.148 1.379 . . . . 0.0 112.928 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -123.21 106.52 10.81 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 126.121 1.768 . . . . 0.0 110.323 -176.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 49.96 33.1 6.25 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.314 1.446 . . . . 0.0 114.789 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 96.82 -2.49 62.07 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.113 1.34 . . . . 0.0 114.628 -178.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 78.8 m95 -101.47 121.89 42.79 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.158 1.383 . . . . 0.0 110.763 177.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 13.1 mt -88.42 164.45 15.49 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.424 0.689 . . . . 0.0 110.151 162.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -127.29 121.03 30.01 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 124.953 1.301 . . . . 0.0 108.088 173.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -147.84 177.22 26.24 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.137 0.875 . . . . 0.0 113.865 -170.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -129.63 124.16 33.03 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.541 1.536 . . . . 0.0 110.555 -177.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -66.63 140.88 57.95 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.33 1.052 . . . . 0.0 112.164 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -73.05 -36.75 66.95 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 120.939 -1.1 . . . . 0.0 113.511 177.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 59.1 t -77.31 -34.43 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -173.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 8.5 t -124.62 -12.29 7.19 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.704 1.201 . . . . 0.0 113.442 -168.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? 56.37 16.91 2.62 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 125.995 1.718 . . . . 0.0 114.739 -175.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -66.99 147.24 53.48 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.204 1.002 . . . . 0.0 111.186 170.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -121.76 156.52 32.98 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.845 1.658 . . . . 0.0 111.516 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 164.52 170.17 29.09 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 124.162 0.886 . . . . 0.0 113.027 173.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -65.85 145.18 56.26 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.184 0.594 . . . . 0.0 110.346 168.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -153.48 153.46 29.18 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 124.125 0.97 . . . . 0.0 111.314 174.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -63.49 121.46 9.25 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.546 2.164 . . . . 0.0 111.345 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.66 -17.38 64.0 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 121.296 -0.877 . . . . 0.0 113.036 178.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 77.6 p -73.98 -22.19 59.71 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.777 2.031 . . . . 0.0 114.159 174.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -79.8 -1.11 37.36 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.254 1.421 . . . . 0.0 113.425 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 69.9 p -129.98 166.67 19.6 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.584 1.954 . . . . 0.0 110.873 174.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -127.06 -90.91 0.52 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.963 0.905 . . . . 0.0 110.2 176.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -162.04 135.16 6.12 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.688 1.595 . . . . 0.0 109.131 173.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 17.6 tp -65.6 -53.37 42.62 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -177.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -149.3 111.84 4.75 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 125.738 1.615 . . . . 0.0 112.965 -174.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 . . . . . 0 C--O 1.253 1.258 0 C-N-CA 125.566 1.546 . . . . 0.0 113.794 179.529 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 526' ' ' HIS . . . . . . . . . . . . . 52.2 m80 . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.659 0.266 . . . . 0.0 110.577 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 69.3 mt -68.65 131.47 91.35 Favored Pre-proline 0 N--CA 1.477 0.923 0 C-N-CA 124.513 1.125 . . . . 0.0 109.517 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.28 160.34 49.91 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 123.57 2.847 . . . . 0.0 112.16 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.07 144.87 88.55 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.378 2.052 . . . . 0.0 112.238 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -73.42 157.13 88.35 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 123.387 0.675 . . . . 0.0 112.192 173.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -68.34 174.13 8.64 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.289 2.659 . . . . 0.0 113.157 176.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -86.26 0.28 54.17 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.651 1.18 . . . . 0.0 113.02 -178.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 38.4 p90 -133.28 153.57 80.69 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 124.792 1.237 . . . . 0.0 113.003 -174.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -71.45 152.54 60.46 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.542 2.828 . . . . 0.0 112.317 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -68.12 149.03 98.3 Favored Pre-proline 0 CA--C 1.55 0.952 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -176.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -72.27 -176.83 2.35 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 124.122 3.215 . . . . 0.0 112.801 176.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 24.3 p -137.04 153.89 75.58 Favored Pre-proline 0 N--CA 1.476 0.855 0 C-N-CA 125.341 1.457 . . . . 0.0 112.649 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -67.61 165.24 28.11 Favored 'Trans proline' 0 CA--C 1.548 1.176 0 C-N-CA 123.504 2.803 . . . . 0.0 111.948 175.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -62.41 159.27 36.57 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.453 2.769 . . . . 0.0 113.351 177.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 540' ' ' VAL . . . . . . . . . . . . . 3.6 t -137.23 49.79 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 126.554 1.942 . . . . 0.0 109.61 -171.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 541' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -126.45 169.82 12.61 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.921 2.088 . . . . 0.0 111.316 -178.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 542' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 . . . . . 0 C--O 1.254 1.306 0 C-N-CA 126.384 1.874 . . . . 0.0 113.053 -175.256 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.49 0 N-CA-C 111.054 -0.819 . . . . 0.0 111.054 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 23.0 t -145.66 129.27 17.07 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.035 1.334 . . . . 0.0 110.599 175.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 338' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -71.82 -38.1 70.25 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.531 0.938 . . . . 0.0 113.531 -173.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 339' ' ' MET . . . . . . . . . . . . . 84.9 mtp -98.23 143.26 28.92 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.088 0.955 . . . . 0.0 111.618 -177.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -74.44 95.77 2.78 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.645 1.178 . . . . 0.0 110.957 173.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 341' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.38 165.06 33.18 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.984 2.114 . . . . 0.0 109.693 172.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 342' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -138.76 140.16 38.54 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.039 0.935 . . . . 0.0 110.788 172.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -120.4 162.23 19.86 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.031 1.333 . . . . 0.0 111.717 174.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 16.0 m -134.77 156.23 39.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 126.909 2.084 . . . . 0.0 108.973 172.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -119.26 132.01 55.85 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.954 0.901 . . . . 0.0 109.904 178.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 66.8 p -74.74 149.89 39.63 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 124.852 1.261 . . . . 0.0 111.483 -178.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.7 pp -124.63 -7.82 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -176.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -154.95 157.19 31.89 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 126.67 1.988 . . . . 0.0 109.652 169.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -69.05 158.34 58.28 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.883 2.388 . . . . 0.0 112.439 177.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 36.3 t-80 -128.52 161.38 29.68 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.048 1.339 . . . . 0.0 112.018 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 86.9 m -132.14 141.28 49.07 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.581 1.552 . . . . 0.0 111.291 -166.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -140.0 31.23 2.0 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 125.512 1.525 . . . . 0.0 111.993 -176.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . -75.34 -29.71 59.7 Favored Glycine 0 CA--C 1.537 1.43 0 O-C-N 120.875 -1.141 . . . . 0.0 115.135 -173.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 46.3 m -102.09 5.68 40.58 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.078 1.351 . . . . 0.0 113.415 -178.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -142.56 173.14 11.8 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.143 1.777 . . . . 0.0 111.799 -173.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 2.4 mmmm -134.14 8.88 3.76 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 -171.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 32.6 p -134.3 18.42 3.69 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 125.767 1.627 . . . . 0.0 113.047 -177.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 49.3 mt -110.49 134.68 52.13 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.308 1.443 . . . . 0.0 110.921 -177.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 31.8 tp -83.21 126.05 32.22 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.871 0.868 . . . . 0.0 110.953 177.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 69.8 m -91.38 147.49 22.99 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.405 1.082 . . . . 0.0 111.957 173.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -163.21 177.56 8.94 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.708 1.603 . . . . 0.0 112.19 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -131.98 154.03 49.74 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.743 2.017 . . . . 0.0 111.5 178.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -50.89 130.59 25.51 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.716 0.806 . . . . 0.0 112.748 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 94.93 -14.27 65.63 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 124.342 0.973 . . . . 0.0 114.362 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -68.75 155.44 40.12 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.378 1.089 . . . . 0.0 112.165 174.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 69.3 t -111.74 142.52 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 125.823 1.649 . . . . 0.0 109.893 -175.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 16.9 mt -136.59 138.61 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.107 1.363 . . . . 0.0 109.024 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 18.5 m -102.55 137.24 41.04 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.705 1.202 . . . . 0.0 110.2 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 27.0 mt -77.04 143.51 39.26 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 122.935 0.494 . . . . 0.0 111.966 -175.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 42.5 mt -116.77 -7.18 11.52 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 124.73 1.212 . . . . 0.0 113.084 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 7.1 mt -130.83 140.41 38.59 Favored Pre-proline 0 N--CA 1.477 0.892 0 C-N-CA 126.617 1.967 . . . . 0.0 109.391 176.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.01 -7.29 20.77 Favored 'Trans proline' 0 CA--C 1.547 1.14 0 C-N-CA 123.582 2.854 . . . . 0.0 114.849 176.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -152.67 152.24 31.51 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.85 1.66 . . . . 0.0 111.937 174.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -76.45 170.45 16.36 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.626 1.17 . . . . 0.0 113.68 176.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -129.7 106.25 8.58 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.337 1.855 . . . . 0.0 110.142 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 49.92 32.51 5.61 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 125.328 1.451 . . . . 0.0 114.559 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 99.65 -14.37 60.56 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 125.506 1.527 . . . . 0.0 114.388 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -89.01 134.03 34.13 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.662 1.231 . . . . 0.0 111.457 176.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 13.1 mt -102.1 162.09 13.18 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.533 1.133 . . . . 0.0 110.277 165.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -124.07 123.04 39.46 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.981 1.312 . . . . 0.0 107.924 172.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -149.27 175.01 28.68 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 115.644 -0.707 . . . . 0.0 113.704 -170.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -126.47 122.72 36.02 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.272 1.429 . . . . 0.0 110.73 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -63.13 149.0 46.35 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.834 1.254 . . . . 0.0 112.353 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -88.34 -24.98 22.99 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 120.859 -1.151 . . . . 0.0 113.903 178.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 59.1 t -80.33 -35.01 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 O-C-N 121.352 -0.843 . . . . 0.0 112.658 -179.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 6.6 t -128.62 -10.79 5.02 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.59 1.156 . . . . 0.0 113.707 -169.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 4.8 mptt 53.82 24.65 4.6 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 125.432 1.493 . . . . 0.0 113.512 -175.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -68.79 147.45 51.75 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.6 1.16 . . . . 0.0 110.92 168.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 74.0 mtm-85 -120.2 157.28 29.4 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.556 1.542 . . . . 0.0 111.821 178.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 164.86 169.42 28.45 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.643 1.116 . . . . 0.0 112.584 175.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -69.61 148.01 49.94 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 122.802 0.441 . . . . 0.0 110.54 169.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -155.47 155.97 30.36 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 123.98 0.912 . . . . 0.0 111.685 175.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -65.02 121.1 8.48 Favored 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 122.81 2.34 . . . . 0.0 111.883 177.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 89.8 p -60.23 -22.4 62.98 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 176.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 18.1 m -74.59 -18.37 60.58 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 175.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -80.65 -0.86 39.97 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.712 1.205 . . . . 0.0 113.133 178.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 62.2 p -131.07 165.61 22.86 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.871 1.668 . . . . 0.0 111.516 175.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -135.49 159.87 40.24 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.863 1.665 . . . . 0.0 109.674 174.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.74 124.68 20.59 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.381 0.672 . . . . 0.0 109.49 174.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.5 tp -54.87 -45.16 74.57 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 123.692 1.71 . . . . 0.0 114.9 -172.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -73.83 99.89 3.32 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 127.165 2.186 . . . . 0.0 111.798 -177.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 . . . . . 0 C--O 1.253 1.239 0 C-N-CA 125.557 1.543 . . . . 0.0 113.719 177.803 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 526' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.809 0.338 . . . . 0.0 110.807 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 63.6 mt -69.14 132.16 90.24 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 124.838 1.255 . . . . 0.0 109.682 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.92 161.33 46.36 Favored 'Trans proline' 0 CA--C 1.545 1.05 0 C-N-CA 123.573 2.849 . . . . 0.0 112.091 177.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.16 144.46 86.92 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.271 1.981 . . . . 0.0 112.707 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -72.15 156.5 90.62 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 123.47 0.708 . . . . 0.0 112.194 171.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.42 174.37 9.32 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.435 2.757 . . . . 0.0 113.222 176.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -89.24 3.16 52.92 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.886 1.274 . . . . 0.0 113.016 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 40.8 p90 -134.15 154.42 80.09 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 124.764 1.226 . . . . 0.0 112.91 -175.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -71.54 153.37 60.31 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 123.689 2.926 . . . . 0.0 112.721 178.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -68.21 142.64 95.07 Favored Pre-proline 0 CA--C 1.553 1.081 0 C-N-CA 124.078 0.951 . . . . 0.0 113.215 -176.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.38 177.2 8.21 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 124.125 3.217 . . . . 0.0 113.002 176.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 35.6 p -132.43 153.35 81.17 Favored Pre-proline 0 N--CA 1.479 0.986 0 C-N-CA 125.289 1.436 . . . . 0.0 112.848 -175.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -69.17 162.94 39.73 Favored 'Trans proline' 0 CA--C 1.549 1.271 0 C-N-CA 123.699 2.933 . . . . 0.0 112.103 177.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -65.87 153.46 78.02 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.409 2.74 . . . . 0.0 113.223 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 540' ' ' VAL . . . . . . . . . . . . . 46.8 t -89.92 -16.99 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 125.241 1.417 . . . . 0.0 112.23 -178.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 541' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -61.79 162.07 9.3 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.275 1.43 . . . . 0.0 113.265 177.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 542' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 . . . . . 0 C--O 1.248 1.001 0 C-N-CA 126.027 1.731 . . . . 0.0 112.095 -174.36 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.6 0 CA-C-O 121.298 0.388 . . . . 0.0 112.212 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 36.6 p -66.02 147.0 54.02 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.276 1.03 . . . . 0.0 112.625 173.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 338' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -157.0 170.83 21.63 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.204 1.402 . . . . 0.0 112.165 176.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 339' ' ' MET . . . . . . . . . . . . . 22.7 mmt 55.94 23.12 6.31 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 126.36 1.864 . . . . 0.0 115.035 178.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm -69.93 -24.4 63.36 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -173.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 341' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -132.75 138.38 47.17 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.919 1.688 . . . . 0.0 109.868 176.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 342' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -75.42 137.84 41.27 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.856 0.836 . . . . 0.0 110.877 172.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -122.46 162.61 21.37 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 126.076 1.75 . . . . 0.0 110.681 175.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 16.8 m -136.67 154.12 31.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 125.93 1.692 . . . . 0.0 109.618 171.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -115.07 132.96 56.43 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.752 0.821 . . . . 0.0 110.61 174.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 81.7 p -72.06 152.29 42.51 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.411 1.084 . . . . 0.0 111.185 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.8 pp -121.97 -8.86 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -178.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -155.06 158.18 32.02 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 127.04 2.136 . . . . 0.0 109.897 169.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -68.85 158.01 59.57 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.116 2.544 . . . . 0.0 112.691 177.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 -139.18 146.13 40.19 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.117 1.367 . . . . 0.0 111.696 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 86.9 m -142.58 123.7 14.54 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.384 1.473 . . . . 0.0 111.436 -172.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -59.38 114.56 2.73 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 125.464 1.506 . . . . 0.0 111.179 165.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . -111.34 -41.07 1.18 Allowed Glycine 0 CA--C 1.54 1.6 0 N-CA-C 115.668 1.027 . . . . 0.0 115.668 -168.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 16.1 t -137.38 33.65 2.53 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.569 1.548 . . . . 0.0 110.746 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -149.89 -179.48 7.17 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.722 1.609 . . . . 0.0 112.045 -165.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 46.8 tptt -132.25 -30.45 1.52 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.291 1.436 . . . . 0.0 113.763 172.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 39.8 p -89.29 23.51 2.48 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.618 1.167 . . . . 0.0 113.918 -174.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 66.6 mt -101.66 128.15 48.09 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.968 1.307 . . . . 0.0 110.86 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 33.1 tp -78.32 121.35 24.33 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.208 0.603 . . . . 0.0 110.171 173.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 71.0 m -94.97 146.72 24.05 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.384 1.074 . . . . 0.0 111.438 175.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -162.58 178.14 8.82 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.252 1.421 . . . . 0.0 112.455 -175.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -116.47 173.52 6.56 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.145 1.778 . . . . 0.0 111.456 174.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -65.33 142.03 58.38 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.041 0.936 . . . . 0.0 111.565 171.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 75.41 9.36 84.45 Favored Glycine 0 CA--C 1.538 1.517 0 N-CA-C 114.808 0.683 . . . . 0.0 114.808 177.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -81.6 161.93 23.31 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.597 1.159 . . . . 0.0 111.705 172.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 31.2 t -115.42 135.35 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.735 1.214 . . . . 0.0 109.35 -174.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 18.4 mt -138.16 135.82 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.496 1.118 . . . . 0.0 109.342 -176.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 12.5 m -92.64 141.85 28.02 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.246 1.018 . . . . 0.0 110.476 174.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 23.0 mt -82.25 143.2 31.51 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 122.968 0.507 . . . . 0.0 111.64 178.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 47.2 mt -114.37 -4.65 12.95 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 124.591 1.156 . . . . 0.0 112.841 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 6.9 mt -134.65 141.71 39.8 Favored Pre-proline 0 N--CA 1.48 1.045 0 C-N-CA 127.048 2.139 . . . . 0.0 109.66 177.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.2 -8.07 22.11 Favored 'Trans proline' 0 CA--C 1.547 1.171 0 C-N-CA 124.025 3.15 . . . . 0.0 114.706 176.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 26.2 pt-20 -151.26 160.21 43.94 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.823 1.649 . . . . 0.0 111.94 173.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -85.42 169.9 13.22 Favored 'General case' 0 CA--C 1.55 0.96 0 O-C-N 121.048 -1.032 . . . . 0.0 113.026 177.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -126.63 105.82 8.97 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.731 2.012 . . . . 0.0 109.826 -177.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 50.85 31.42 6.07 Favored 'General case' 0 CA--C 1.555 1.145 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 100.79 -11.09 59.16 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 125.482 1.515 . . . . 0.0 114.408 -178.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -95.22 126.9 40.86 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.543 1.137 . . . . 0.0 111.248 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 13.0 mt -95.59 161.5 14.02 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.523 0.678 . . . . 0.0 110.495 163.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -124.01 122.16 37.17 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 125.159 1.383 . . . . 0.0 107.779 175.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -146.97 176.51 25.81 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-N 115.632 -0.713 . . . . 0.0 114.201 -171.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -129.55 120.82 25.96 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.493 1.517 . . . . 0.0 110.464 -178.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -65.51 141.15 58.57 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.643 1.177 . . . . 0.0 112.219 -177.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -75.69 -29.83 59.14 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 120.619 -1.301 . . . . 0.0 113.526 -178.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 51.2 t -81.49 -37.33 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 124.207 1.003 . . . . 0.0 113.419 -175.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 6.9 t -124.81 -8.84 7.27 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.484 1.113 . . . . 0.0 113.699 -171.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.58 23.76 3.74 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 126.181 1.792 . . . . 0.0 113.822 -177.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -68.97 150.83 47.26 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.436 1.094 . . . . 0.0 110.938 169.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -125.63 157.35 37.44 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.632 1.573 . . . . 0.0 110.757 -177.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 161.04 169.58 24.49 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 124.496 1.046 . . . . 0.0 112.237 174.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -66.77 148.38 52.0 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.151 0.501 . . . . 0.0 110.399 168.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -155.04 154.87 29.52 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 124.321 1.048 . . . . 0.0 110.223 171.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -63.72 122.2 10.2 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.434 2.089 . . . . 0.0 110.774 177.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 95.8 p -55.13 -40.24 70.32 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.8 -0.562 . . . . 0.0 112.135 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 5.3 t -62.15 -23.05 66.35 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.244 1.818 . . . . 0.0 114.464 -178.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -72.16 -3.43 23.3 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.615 1.166 . . . . 0.0 113.58 172.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 68.2 p -130.47 158.21 40.54 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.5 1.52 . . . . 0.0 111.083 176.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -128.36 161.55 29.17 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.772 1.229 . . . . 0.0 110.055 174.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.32 124.12 20.04 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 114.784 -1.098 . . . . 0.0 108.514 174.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -49.1 -58.46 4.92 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 123.929 1.823 . . . . 0.0 113.427 -176.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -70.3 76.97 0.54 Allowed 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 129.1 2.96 . . . . 0.0 112.871 -177.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 . . . . . 0 N--CA 1.486 1.33 0 C-N-CA 129.046 2.938 . . . . 0.0 115.308 -175.677 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 526' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.942 0.401 . . . . 0.0 111.23 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 61.2 mt -67.32 132.41 93.26 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 125.126 1.37 . . . . 0.0 109.806 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.76 160.25 50.39 Favored 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 123.571 2.848 . . . . 0.0 112.003 177.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.97 142.91 83.56 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.455 2.103 . . . . 0.0 112.36 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -72.19 154.4 92.19 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 123.282 0.633 . . . . 0.0 111.883 172.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -69.24 174.4 9.11 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.463 2.775 . . . . 0.0 113.039 178.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -87.64 1.76 52.81 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.636 1.174 . . . . 0.0 112.843 -178.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 34.7 p90 -133.54 154.35 80.73 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.712 1.205 . . . . 0.0 112.873 -175.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.95 152.72 57.77 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.667 2.912 . . . . 0.0 112.684 178.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -69.94 144.67 93.37 Favored Pre-proline 0 CA--C 1.55 0.98 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -176.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -73.8 179.32 5.77 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 124.103 3.202 . . . . 0.0 113.069 176.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 29.0 p -133.48 154.77 81.0 Favored Pre-proline 0 N--CA 1.479 1.015 0 C-N-CA 125.424 1.49 . . . . 0.0 112.64 -174.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.59 162.19 42.0 Favored 'Trans proline' 0 CA--C 1.548 1.222 0 C-N-CA 123.863 3.042 . . . . 0.0 111.995 176.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.49 149.87 84.33 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.447 2.765 . . . . 0.0 112.772 178.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 540' ' ' VAL . . . . . . . . . . . . . 47.3 t -76.19 -34.35 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 124.461 1.105 . . . . 0.0 111.805 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 541' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.55 169.8 22.33 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.831 1.652 . . . . 0.0 112.155 -177.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 542' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 . . . . . 0 C--O 1.254 1.299 0 C-N-CA 125.425 1.49 . . . . 0.0 113.601 -176.286 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.641 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 87.4 p -151.62 170.16 20.37 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.757 1.223 . . . . 0.0 112.434 176.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 338' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -98.19 -1.13 42.83 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.386 1.474 . . . . 0.0 114.031 -178.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 339' ' ' MET . . . . . . . . . . . . . 93.8 mtp -72.15 -42.47 65.93 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -174.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -74.44 -33.12 62.85 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.129 0.972 . . . . 0.0 113.113 -178.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 341' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.1 76.3 1.37 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 126.011 1.724 . . . . 0.0 111.678 -173.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 342' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -42.82 145.79 0.43 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 127.811 2.444 . . . . 0.0 113.548 171.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.36 163.98 20.59 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.738 1.615 . . . . 0.0 111.336 166.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 15.5 m -128.4 158.61 40.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 126.43 1.892 . . . . 0.0 109.032 168.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.89 125.98 44.81 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.264 1.026 . . . . 0.0 109.383 -175.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 73.1 p -72.31 153.23 41.63 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.585 0.754 . . . . 0.0 110.793 -175.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.9 pp -122.91 -6.94 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -177.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -158.73 160.3 29.34 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 126.684 1.993 . . . . 0.0 110.158 170.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -69.75 157.5 60.2 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 123.286 2.657 . . . . 0.0 113.263 176.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -144.63 152.66 40.81 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.218 1.407 . . . . 0.0 111.957 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 13.7 t -151.71 156.43 40.31 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.75 1.22 . . . . 0.0 112.972 -178.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -84.65 69.5 10.65 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.532 1.933 . . . . 0.0 111.89 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . -53.75 -31.06 45.36 Favored Glycine 0 CA--C 1.54 1.651 0 C-N-CA 125.35 1.452 . . . . 0.0 116.57 -171.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 5.1 t -154.0 42.74 0.54 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.844 1.257 . . . . 0.0 111.643 178.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -147.36 175.88 10.44 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -165.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.16 -9.27 4.28 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 127.306 2.243 . . . . 0.0 115.217 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 44.8 p -126.28 17.98 7.67 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 125.269 1.427 . . . . 0.0 113.155 -172.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 55.9 mt -102.35 127.68 49.24 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.706 1.203 . . . . 0.0 111.121 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 23.3 tp -77.68 129.54 35.67 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.498 0.719 . . . . 0.0 110.955 177.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 43.9 t -101.81 146.52 27.68 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.884 1.273 . . . . 0.0 111.827 176.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -163.9 178.32 7.87 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.919 1.688 . . . . 0.0 112.246 -174.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -117.3 177.13 4.84 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.898 2.079 . . . . 0.0 111.15 174.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -64.65 140.43 58.87 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.966 0.906 . . . . 0.0 111.597 169.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 75.34 5.62 77.77 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 124.594 1.093 . . . . 0.0 115.707 175.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -71.87 169.3 16.1 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.674 1.19 . . . . 0.0 112.12 171.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 95.7 t -126.42 127.52 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 125.519 1.528 . . . . 0.0 108.84 -169.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 35.3 mt -133.62 138.26 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 124.352 1.061 . . . . 0.0 108.969 -176.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 52.2 m -102.88 136.65 42.31 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.972 1.309 . . . . 0.0 110.045 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 15.9 mt -73.37 147.09 44.67 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -175.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 58.3 mt -120.78 -8.52 9.44 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.582 1.153 . . . . 0.0 113.396 177.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 6.5 mt -133.73 140.99 38.35 Favored Pre-proline 0 N--CA 1.48 1.047 0 C-N-CA 126.311 1.844 . . . . 0.0 109.666 176.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.73 -7.68 21.63 Favored 'Trans proline' 0 CA--C 1.546 1.104 0 C-N-CA 124.047 3.165 . . . . 0.0 114.722 176.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -152.22 153.8 34.5 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.76 1.624 . . . . 0.0 112.146 174.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -77.44 170.83 15.87 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 124.46 1.104 . . . . 0.0 113.894 175.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -129.26 105.62 8.26 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.563 1.945 . . . . 0.0 109.897 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 50.68 32.62 7.15 Favored 'General case' 0 CA--C 1.553 1.09 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 98.37 -12.63 63.33 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 125.411 1.481 . . . . 0.0 114.411 -178.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 77.6 m95 -89.38 123.19 33.31 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.315 1.058 . . . . 0.0 110.807 176.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 13.5 mt -90.23 161.37 15.73 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.367 0.667 . . . . 0.0 110.225 161.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -124.43 124.84 43.19 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.123 1.369 . . . . 0.0 107.934 171.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -148.8 172.09 29.01 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 124.154 0.883 . . . . 0.0 113.287 -171.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -124.88 121.05 33.42 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.233 1.413 . . . . 0.0 109.699 177.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -64.05 147.45 52.09 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.523 1.129 . . . . 0.0 111.93 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -81.15 -46.71 14.5 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 120.876 -1.14 . . . . 0.0 113.175 178.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 57.8 t -70.98 -51.78 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 98.9 p -91.51 -17.12 26.19 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -174.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp 55.96 17.57 2.65 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 126.809 2.044 . . . . 0.0 114.725 -172.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -72.06 151.72 42.91 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 121.455 0.645 . . . . 0.0 111.732 171.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 72.5 mtm180 -120.67 157.0 30.54 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.347 1.859 . . . . 0.0 110.551 176.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 163.21 169.38 26.57 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 124.095 0.855 . . . . 0.0 112.368 173.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -65.71 148.35 51.91 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.074 0.464 . . . . 0.0 110.077 166.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -154.96 153.95 28.17 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 124.111 0.964 . . . . 0.0 110.457 172.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -63.98 122.11 10.02 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.492 2.128 . . . . 0.0 110.752 176.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 95.2 p -55.16 -38.06 67.8 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 74.7 m -64.88 -19.44 65.91 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -74.13 -2.51 24.89 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.36 1.064 . . . . 0.0 113.125 171.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 64.2 p -128.22 156.73 42.5 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.703 1.601 . . . . 0.0 110.823 173.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 32.1 mmtm -120.86 165.02 15.76 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.386 1.074 . . . . 0.0 109.249 167.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.29 126.35 27.32 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 169.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.1 tt -54.48 -59.17 5.06 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 124.858 2.266 . . . . 0.0 113.847 -168.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -80.33 143.6 33.45 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 109.403 -3.544 . . . . 0.0 112.047 -173.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 . . . . . 0 C--O 1.252 1.232 0 C-N-CA 125.065 1.346 . . . . 0.0 113.565 -177.365 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 526' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.851 0.358 . . . . 0.0 110.654 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 71.9 mt -72.16 132.87 83.97 Favored Pre-proline 0 N--CA 1.477 0.906 0 C-N-CA 124.611 1.164 . . . . 0.0 109.429 178.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.11 159.56 52.72 Favored 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 123.636 2.891 . . . . 0.0 112.29 178.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.57 146.07 88.44 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 122.473 2.115 . . . . 0.0 112.445 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -74.24 157.21 86.92 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 123.616 0.766 . . . . 0.0 112.3 173.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -68.84 174.84 8.12 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.453 2.769 . . . . 0.0 113.19 175.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -86.2 0.6 53.31 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.735 1.214 . . . . 0.0 112.965 -178.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 36.6 p90 -134.73 155.18 79.65 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 124.796 1.239 . . . . 0.0 112.96 -174.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.86 152.72 58.29 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.726 2.951 . . . . 0.0 112.821 178.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -68.06 144.34 96.91 Favored Pre-proline 0 CA--C 1.552 1.032 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -175.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.4 -179.59 4.59 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 124.141 3.228 . . . . 0.0 112.857 176.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 22.8 p -135.17 155.29 79.03 Favored Pre-proline 0 N--CA 1.481 1.08 0 C-N-CA 125.051 1.341 . . . . 0.0 112.814 -175.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.87 163.47 35.41 Favored 'Trans proline' 0 CA--C 1.548 1.21 0 C-N-CA 123.628 2.885 . . . . 0.0 111.88 175.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -65.48 156.91 60.99 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.312 2.675 . . . . 0.0 113.092 178.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 540' ' ' VAL . . . . . . . . . . . . . 8.3 p -145.14 140.43 22.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 127.116 2.166 . . . . 0.0 109.75 -176.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 541' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -131.36 7.59 4.57 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.477 1.511 . . . . 0.0 113.784 -171.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 542' ' ' ASN . . . . . . . . . . . . . 26.9 m120 . . . . . 0 C--O 1.252 1.236 0 C-N-CA 125.28 1.432 . . . . 0.0 112.983 173.74 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.973 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 33.5 p -144.02 135.73 26.1 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.124 1.37 . . . . 0.0 111.962 -177.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 338' ' ' HIS . . . . . . . . . . . . . 15.0 p-80 -83.64 -2.26 55.74 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 339' ' ' MET . . . . . . . . . . . . . 15.0 ttp 48.79 64.98 1.49 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 126.67 1.988 . . . . 0.0 113.929 177.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -52.56 -31.3 35.29 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 126.04 1.736 . . . . 0.0 115.001 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 341' ' ' LYS . . . . . . . . . . . . . 1.2 tpmt? -157.47 149.75 22.67 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.334 1.854 . . . . 0.0 110.806 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 342' ' ' GLN . . . . . . . . . . . . . 71.2 tp60 -67.2 147.84 52.54 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.01 0.924 . . . . 0.0 112.425 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 9.3 tptt -121.76 159.6 26.33 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.712 1.605 . . . . 0.0 111.637 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 17.7 m -139.38 158.95 28.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 126.166 1.787 . . . . 0.0 110.62 174.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -123.27 126.95 47.85 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.081 1.352 . . . . 0.0 110.599 -178.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 81.6 p -71.7 152.09 43.09 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.586 0.754 . . . . 0.0 111.427 -178.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.9 pp -122.93 -8.98 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 -177.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -155.08 158.91 32.15 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 126.705 2.002 . . . . 0.0 109.842 169.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.05 156.13 66.14 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.129 2.553 . . . . 0.0 113.117 177.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -138.03 142.61 40.35 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.199 1.4 . . . . 0.0 111.103 177.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 88.5 m -138.73 137.2 36.54 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 126.148 1.779 . . . . 0.0 109.814 -175.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -64.99 -44.66 88.55 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -171.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 59.88 85.38 0.04 OUTLIER Glycine 0 CA--C 1.538 1.479 0 C-N-CA 124.565 1.079 . . . . 0.0 114.224 177.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 17.8 m 61.25 32.69 19.33 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 125.207 1.403 . . . . 0.0 114.024 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 51.9 m-80 -137.39 160.88 37.83 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.913 1.685 . . . . 0.0 111.767 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 36.1 mtmm -125.88 -4.77 6.93 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 125.49 1.516 . . . . 0.0 114.632 -177.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 32.8 p -110.14 11.57 23.7 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.886 1.675 . . . . 0.0 112.836 -176.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 66.8 mt -112.21 127.04 55.84 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.318 1.447 . . . . 0.0 111.312 -176.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 28.8 tp -78.74 124.79 28.56 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.936 0.894 . . . . 0.0 110.668 176.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 54.2 p -99.61 152.16 20.36 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.237 1.415 . . . . 0.0 112.434 177.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -167.45 177.32 6.06 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.052 1.341 . . . . 0.0 112.992 -172.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -115.32 177.13 4.77 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.857 2.063 . . . . 0.0 111.161 173.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -67.22 140.46 57.42 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.093 0.957 . . . . 0.0 111.818 170.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 74.66 4.68 71.37 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 125.007 1.289 . . . . 0.0 115.797 177.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -68.42 164.23 21.48 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 118.115 0.958 . . . . 0.0 111.461 167.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 95.7 t -118.16 136.17 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.642 1.177 . . . . 0.0 109.251 -177.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 29.7 mt -133.45 141.18 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.349 1.06 . . . . 0.0 108.795 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 23.5 m -102.21 136.34 42.21 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.817 1.247 . . . . 0.0 109.528 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 21.0 mt -79.18 138.71 37.97 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 118.544 0.611 . . . . 0.0 111.446 -177.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 44.7 mt -112.83 -10.15 13.6 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.993 0.917 . . . . 0.0 113.277 -177.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 9.0 mt -124.58 140.1 34.64 Favored Pre-proline 0 N--CA 1.478 0.938 0 C-N-CA 126.363 1.865 . . . . 0.0 109.682 176.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.83 -8.36 23.45 Favored 'Trans proline' 0 CA--C 1.547 1.156 0 C-N-CA 123.834 3.022 . . . . 0.0 114.322 176.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -152.18 149.1 28.38 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.922 1.689 . . . . 0.0 111.893 173.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -74.08 171.35 13.68 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.443 1.097 . . . . 0.0 113.744 175.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -128.24 103.42 7.17 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.217 1.807 . . . . 0.0 110.448 -179.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 52.05 30.55 7.6 Favored 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 99.69 -15.57 59.59 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 125.654 1.597 . . . . 0.0 114.287 -178.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -85.07 128.8 34.79 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.221 1.011 . . . . 0.0 110.955 175.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 12.1 mt -99.4 161.41 13.63 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.212 1.005 . . . . 0.0 110.213 165.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -123.82 122.21 37.44 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 125.157 1.383 . . . . 0.0 107.519 173.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -145.5 167.24 27.56 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-N 115.82 -0.627 . . . . 0.0 113.927 -172.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -113.45 118.47 34.6 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.006 1.322 . . . . 0.0 109.019 173.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 33.9 t-80 -63.69 141.66 58.69 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.321 1.049 . . . . 0.0 111.789 178.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -75.2 -46.19 35.55 Favored 'General case' 0 CA--C 1.547 0.827 0 O-C-N 120.573 -1.329 . . . . 0.0 113.037 -178.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 57.4 t -70.31 -54.26 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 178.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 93.4 p -90.25 -17.27 27.76 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 119.583 1.083 . . . . 0.0 113.785 -173.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm 56.41 20.0 4.45 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 126.651 1.98 . . . . 0.0 114.023 -175.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -76.38 158.81 31.07 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.276 0.63 . . . . 0.0 112.051 171.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 82.2 mtt85 -125.18 158.91 32.81 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.148 1.779 . . . . 0.0 110.645 176.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 159.38 169.72 23.05 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.951 1.262 . . . . 0.0 112.278 176.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -68.36 148.73 50.29 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.994 0.426 . . . . 0.0 110.627 169.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -155.82 156.32 30.46 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 124.084 0.954 . . . . 0.0 110.747 172.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -66.72 120.61 7.73 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 122.433 2.088 . . . . 0.0 111.724 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 36.2 t -59.92 -25.38 65.1 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 175.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 75.2 m -69.44 -18.81 63.76 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 174.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -81.1 -0.34 39.58 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.635 1.174 . . . . 0.0 113.987 177.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 81.3 p -127.44 161.01 29.72 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.055 1.342 . . . . 0.0 111.599 174.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 32.3 mmtm -124.6 169.04 12.32 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.514 1.926 . . . . 0.0 109.248 170.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.72 128.23 35.53 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 171.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.54 -62.09 1.84 Allowed 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 123.94 1.829 . . . . 0.0 113.354 -177.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -60.2 119.76 8.49 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 128.945 2.898 . . . . 0.0 112.109 -178.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 . . . . . 0 C--O 1.259 1.576 0 C-N-CA 124.982 1.313 . . . . 0.0 113.865 -179.788 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 526' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.991 0.424 . . . . 0.0 111.013 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 52.7 mt -72.23 133.27 83.54 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 125.034 1.334 . . . . 0.0 109.438 176.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -69.03 160.95 47.86 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 123.42 2.747 . . . . 0.0 112.124 178.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.59 144.68 85.38 Favored 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 122.267 1.978 . . . . 0.0 112.352 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -70.59 153.66 94.84 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 123.095 0.558 . . . . 0.0 111.872 171.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -69.7 174.67 9.12 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 123.509 2.806 . . . . 0.0 113.2 179.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -86.05 1.33 50.73 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.353 1.061 . . . . 0.0 113.037 -178.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 38.1 p90 -133.46 154.37 80.83 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 124.823 1.249 . . . . 0.0 113.033 -174.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.56 153.11 60.24 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 123.66 2.907 . . . . 0.0 112.875 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -68.48 141.13 92.93 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 123.914 0.885 . . . . 0.0 113.096 -177.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.59 177.54 7.87 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 124.059 3.173 . . . . 0.0 113.239 177.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 32.8 p -134.25 153.94 79.72 Favored Pre-proline 0 N--CA 1.478 0.963 0 C-N-CA 125.401 1.48 . . . . 0.0 112.998 -172.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -68.29 163.22 37.18 Favored 'Trans proline' 0 CA--C 1.548 1.202 0 C-N-CA 123.772 2.981 . . . . 0.0 111.854 176.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -65.1 148.41 89.23 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.242 2.628 . . . . 0.0 112.885 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 540' ' ' VAL . . . . . . . . . . . . . 7.5 p -82.77 -10.45 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 125.05 1.34 . . . . 0.0 113.367 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 541' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -114.06 176.09 5.19 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.155 1.782 . . . . 0.0 112.081 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 542' ' ' ASN . . . . . . . . . . . . . 14.0 m120 . . . . . 0 C--O 1.253 1.259 0 C-N-CA 126.468 1.907 . . . . 0.0 111.639 -177.185 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.529 0 CA-C-O 121.241 0.356 . . . . 0.0 112.287 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 52.1 m -141.83 110.22 6.0 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.612 1.565 . . . . 0.0 109.899 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 338' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -67.71 -53.72 25.26 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.407 0.683 . . . . 0.0 111.872 -174.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 339' ' ' MET . . . . . . . . . . . . . 15.6 ptp -170.51 150.03 3.37 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.59 1.956 . . . . 0.0 111.348 174.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -88.72 -15.6 34.37 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.647 1.179 . . . . 0.0 114.087 178.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 341' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -137.39 134.72 36.25 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 126.894 2.078 . . . . 0.0 109.097 -178.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 342' ' ' GLN . . . . . . . . . . . . . 71.3 tp60 -65.08 137.12 57.47 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 118.837 0.744 . . . . 0.0 111.155 177.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 3.2 mptm? -123.74 164.4 19.22 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 125.708 1.603 . . . . 0.0 111.349 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 16.7 m -133.88 155.36 39.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 126.937 2.095 . . . . 0.0 109.54 171.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.45 134.27 54.75 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.385 1.074 . . . . 0.0 110.343 175.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 62.1 p -76.63 158.64 30.93 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.186 1.394 . . . . 0.0 111.774 179.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 2.0 pp -122.91 -9.79 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -155.35 159.22 31.9 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 125.836 1.654 . . . . 0.0 111.26 170.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.91 155.61 65.0 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.534 2.823 . . . . 0.0 113.443 177.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 -139.37 140.73 37.54 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.411 1.485 . . . . 0.0 111.899 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 28.3 m -136.91 128.72 29.03 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.673 1.589 . . . . 0.0 110.774 -172.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -67.42 -37.38 82.96 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -177.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 74.95 -55.06 2.64 Favored Glycine 0 CA--C 1.539 1.532 0 C-N-CA 126.538 2.018 . . . . 0.0 116.095 170.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 3.0 t -148.44 23.1 1.03 Allowed 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.75 1.62 . . . . 0.0 112.104 -176.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -131.5 165.5 23.44 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.087 1.755 . . . . 0.0 110.802 -166.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -121.32 -29.08 4.55 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 178.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 48.3 p -88.88 12.81 14.2 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.117 1.367 . . . . 0.0 113.987 -175.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 62.0 mt -107.84 131.01 54.94 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.841 1.256 . . . . 0.0 111.487 -178.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 24.0 tp -82.86 132.97 35.14 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.682 0.793 . . . . 0.0 110.534 174.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 45.3 m -114.86 147.73 39.5 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.226 1.411 . . . . 0.0 112.379 -178.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -166.42 178.95 5.83 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.412 1.485 . . . . 0.0 112.397 -166.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -118.18 174.79 6.01 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.974 2.11 . . . . 0.0 111.724 176.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 66.3 tt0 -64.25 140.94 58.92 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.317 -0.864 . . . . 0.0 111.002 168.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 70.36 19.48 76.06 Favored Glycine 0 CA--C 1.537 1.433 0 N-CA-C 114.37 0.508 . . . . 0.0 114.37 177.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -86.23 170.09 12.43 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.732 1.213 . . . . 0.0 111.522 169.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 89.7 t -125.82 128.09 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 125.658 1.583 . . . . 0.0 109.038 -168.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 22.7 mt -133.18 143.13 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 124.358 1.063 . . . . 0.0 110.056 -176.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 2.6 m -100.77 144.03 30.22 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.641 1.576 . . . . 0.0 110.398 -177.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 23.5 mt -84.67 141.11 30.83 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 118.333 0.515 . . . . 0.0 112.085 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 43.8 mt -120.05 -11.69 9.23 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.758 1.223 . . . . 0.0 113.298 179.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 7.1 mt -130.25 141.1 40.71 Favored Pre-proline 0 N--CA 1.476 0.853 0 C-N-CA 126.703 2.001 . . . . 0.0 109.224 175.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.69 -6.02 18.28 Favored 'Trans proline' 0 CA--C 1.548 1.208 0 C-N-CA 124.113 3.209 . . . . 0.0 114.835 175.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -151.67 162.78 40.42 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.162 1.785 . . . . 0.0 112.169 175.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.57 170.91 9.78 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.485 1.114 . . . . 0.0 113.202 176.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -128.63 106.39 8.92 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.403 1.881 . . . . 0.0 110.54 -178.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 51.32 31.09 6.62 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 124.943 1.297 . . . . 0.0 114.468 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 98.32 -8.32 62.45 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 125.293 1.425 . . . . 0.0 114.515 -177.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -95.42 122.46 38.17 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.729 1.265 . . . . 0.0 110.979 177.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 14.2 mt -88.39 160.49 17.56 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.751 0.82 . . . . 0.0 110.625 162.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 79.4 t80 -123.28 124.46 43.02 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.169 1.388 . . . . 0.0 107.924 170.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -149.95 173.84 29.56 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 123.864 0.745 . . . . 0.0 113.289 -170.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -126.29 115.18 19.3 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.959 1.304 . . . . 0.0 110.271 178.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 23.4 t-80 -61.59 144.72 53.95 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.43 1.092 . . . . 0.0 112.151 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -79.2 -48.26 14.53 Favored 'General case' 0 CA--C 1.548 0.882 0 O-C-N 120.926 -1.109 . . . . 0.0 112.565 178.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 58.5 t -68.3 -53.6 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 124.325 1.05 . . . . 0.0 113.73 176.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 40.2 m -89.77 -16.51 30.11 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 119.277 0.944 . . . . 0.0 113.188 -171.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 11.1 mmmm 54.49 19.92 2.58 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 127.358 2.263 . . . . 0.0 114.647 -176.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -82.14 152.7 26.39 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.938 0.895 . . . . 0.0 111.496 174.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 56.4 mtm-85 -117.58 158.97 23.66 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 126.172 1.789 . . . . 0.0 110.931 173.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 159.8 171.76 26.09 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.512 1.053 . . . . 0.0 112.453 175.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -68.46 145.22 54.27 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 120.961 0.41 . . . . 0.0 110.456 168.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -153.91 154.55 30.21 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 124.246 1.019 . . . . 0.0 111.015 173.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -63.4 122.94 11.28 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.529 2.153 . . . . 0.0 112.046 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 82.6 p -61.27 -25.98 67.46 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 176.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.83 -13.34 61.65 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.969 2.107 . . . . 0.0 114.86 174.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -85.01 -0.57 54.85 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.5 1.12 . . . . 0.0 113.133 174.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 71.3 p -131.69 169.76 15.73 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.653 1.981 . . . . 0.0 110.475 173.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -133.32 -73.49 0.49 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.322 1.049 . . . . 0.0 110.114 178.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 399' ' ' LEU . . . . . 0.408 HD11 ' H ' ' A' ' 400' ' ' LEU . 0.2 OUTLIER -165.78 158.39 15.12 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.92 2.488 . . . . 0.0 106.91 170.637 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . 0.408 ' H ' HD11 ' A' ' 399' ' ' LEU . 0.2 OUTLIER -59.79 -71.59 0.12 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 123.482 1.61 . . . . 0.0 111.806 172.512 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -108.15 129.99 55.15 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 111.168 -2.742 . . . . 0.0 110.355 -170.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 . . . . . 0 C--O 1.254 1.29 0 C-N-CA 124.712 1.205 . . . . 0.0 112.735 -177.062 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 526' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 121.127 0.489 . . . . 0.0 109.976 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 55.1 mt -75.69 133.15 73.8 Favored Pre-proline 0 N--CA 1.477 0.899 0 C-N-CA 124.847 1.259 . . . . 0.0 109.371 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -68.82 160.07 51.2 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 123.483 2.789 . . . . 0.0 112.007 178.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -63.77 144.47 89.03 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.428 2.086 . . . . 0.0 112.271 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -70.01 153.34 95.47 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 122.99 0.516 . . . . 0.0 111.629 171.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -69.28 174.75 8.64 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.459 2.773 . . . . 0.0 113.151 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -85.62 1.39 49.42 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.318 1.047 . . . . 0.0 112.976 -178.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 33.8 p90 -134.55 154.33 79.6 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 124.775 1.23 . . . . 0.0 112.94 -175.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.34 151.97 60.49 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.645 2.897 . . . . 0.0 112.681 178.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -66.83 145.23 98.89 Favored Pre-proline 0 CA--C 1.549 0.913 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -177.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.32 175.22 10.89 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.752 2.968 . . . . 0.0 112.781 178.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 23.0 p -129.73 153.96 80.91 Favored Pre-proline 0 N--CA 1.477 0.922 0 C-N-CA 124.732 1.213 . . . . 0.0 112.363 -173.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -66.56 163.08 34.08 Favored 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 122.999 2.466 . . . . 0.0 111.651 175.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -64.57 163.31 27.69 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 123.102 2.534 . . . . 0.0 112.257 174.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 540' ' ' VAL . . . . . . . . . . . . . 23.2 t -122.22 107.31 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.05 1.34 . . . . 0.0 108.275 -178.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 541' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -139.68 143.96 37.36 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.47 1.908 . . . . 0.0 110.417 -176.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 542' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 . . . . . 0 C--O 1.255 1.367 0 C-N-CA 124.791 1.236 . . . . 0.0 112.56 -179.346 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.532 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 1.6 t 56.45 27.75 12.64 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 126.04 1.736 . . . . 0.0 114.803 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 338' ' ' HIS . . . . . . . . . . . . . 42.0 t60 -82.86 64.76 7.65 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.503 1.521 . . . . 0.0 112.234 -176.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 339' ' ' MET . . . . . . . . . . . . . 14.7 mmt -139.28 165.12 28.02 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.934 1.694 . . . . 0.0 112.615 -176.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 34.9 tttm -131.69 33.18 4.03 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.338 1.855 . . . . 0.0 111.977 -179.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 341' ' ' LYS . . . . . . . . . . . . . 64.6 mtpt -133.62 157.22 46.28 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 126.964 2.106 . . . . 0.0 109.786 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 342' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -118.65 138.72 52.41 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.929 0.871 . . . . 0.0 111.395 -178.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -123.7 163.53 20.93 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 126.047 1.739 . . . . 0.0 111.952 -178.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 16.0 m -137.5 157.59 34.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 127.028 2.131 . . . . 0.0 109.159 169.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -121.02 131.71 54.45 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.197 0.999 . . . . 0.0 109.664 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 74.8 p -74.9 152.6 38.86 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.962 0.905 . . . . 0.0 111.177 -177.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.8 pp -123.49 -6.71 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -178.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -154.04 158.23 32.47 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 126.249 1.82 . . . . 0.0 110.121 169.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -68.96 154.5 70.72 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.792 2.328 . . . . 0.0 112.413 176.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 -140.32 145.06 36.72 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.499 1.52 . . . . 0.0 110.7 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 95.8 m -142.35 126.53 17.48 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.022 1.329 . . . . 0.0 110.192 -171.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -58.05 116.45 3.53 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.791 0.836 . . . . 0.0 111.413 168.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . -136.33 136.35 8.34 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 125.011 1.291 . . . . 0.0 110.986 177.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 83.5 p 52.06 20.03 1.17 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 126.02 1.728 . . . . 0.0 115.366 -166.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -149.38 174.81 12.05 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.811 1.244 . . . . 0.0 113.599 -172.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -126.75 -31.57 2.67 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 126.161 1.784 . . . . 0.0 114.318 177.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 38.0 p -90.85 19.16 5.76 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 126.009 1.724 . . . . 0.0 114.336 -174.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 56.8 mt -98.15 128.8 44.84 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.87 1.268 . . . . 0.0 110.485 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 31.4 tp -80.22 114.12 18.89 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.377 0.671 . . . . 0.0 110.844 175.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 50.3 m -83.88 150.03 25.98 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.043 0.937 . . . . 0.0 112.559 175.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -164.8 178.17 7.4 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.598 1.559 . . . . 0.0 113.217 -177.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -117.15 173.96 6.38 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.431 1.892 . . . . 0.0 111.258 173.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -64.98 142.32 58.48 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 121.301 -0.874 . . . . 0.0 111.648 170.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 77.05 5.79 85.34 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 124.071 0.843 . . . . 0.0 114.98 175.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -77.83 166.33 23.05 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.97 1.308 . . . . 0.0 111.96 172.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 67.9 t -121.07 131.24 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.105 1.362 . . . . 0.0 109.325 -172.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 25.2 mt -134.76 137.6 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.527 1.131 . . . . 0.0 109.245 -177.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 12.0 m -98.09 140.22 32.73 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.931 1.292 . . . . 0.0 110.236 -178.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 23.7 mt -80.03 137.94 36.91 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 118.235 0.47 . . . . 0.0 111.928 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 37.1 mt -114.62 -9.8 12.57 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.527 1.131 . . . . 0.0 113.122 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 9.4 mt -127.75 141.17 40.22 Favored Pre-proline 0 N--CA 1.479 1.01 0 C-N-CA 126.893 2.077 . . . . 0.0 109.632 176.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.28 -7.1 20.35 Favored 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 124.088 3.192 . . . . 0.0 114.817 177.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -151.24 160.22 43.94 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.288 1.835 . . . . 0.0 111.428 174.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.34 168.0 17.99 Favored 'General case' 0 CA--C 1.547 0.86 0 O-C-N 120.993 -1.067 . . . . 0.0 113.027 173.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -122.89 103.49 8.66 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 126.954 2.101 . . . . 0.0 109.105 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 51.96 30.54 7.41 Favored 'General case' 0 CA--C 1.555 1.17 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 102.45 -17.95 52.2 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 125.894 1.711 . . . . 0.0 114.276 -178.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -84.86 128.31 34.56 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.511 1.124 . . . . 0.0 111.463 178.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 16.9 mt -98.17 161.32 13.77 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.121 0.968 . . . . 0.0 110.51 164.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -125.9 121.72 33.98 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 125.37 1.468 . . . . 0.0 107.552 174.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -145.38 171.72 26.36 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-N 115.555 -0.748 . . . . 0.0 113.872 -172.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -119.63 117.26 27.84 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.006 1.323 . . . . 0.0 109.872 176.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 24.4 t-80 -63.77 145.16 56.29 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.854 1.262 . . . . 0.0 112.035 178.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -80.23 -44.66 19.34 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 120.914 -1.116 . . . . 0.0 113.706 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 57.7 t -69.18 -51.05 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 123.926 0.891 . . . . 0.0 113.306 176.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 13.2 t -91.03 -21.32 21.31 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -171.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt 56.32 16.71 2.5 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 126.446 1.898 . . . . 0.0 114.597 -171.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -74.11 156.16 37.69 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.362 0.665 . . . . 0.0 111.852 172.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -124.79 155.27 39.66 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.203 1.801 . . . . 0.0 110.08 176.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 162.62 168.76 25.01 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 124.911 1.243 . . . . 0.0 112.021 177.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -68.86 147.74 51.26 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.111 0.565 . . . . 0.0 110.721 171.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -155.21 155.27 29.83 Favored Pre-proline 0 CA--C 1.541 0.597 0 C-N-CA 124.315 1.046 . . . . 0.0 110.676 172.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -66.11 121.42 8.74 Favored 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 122.353 2.036 . . . . 0.0 110.975 177.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 29.7 t -55.01 -39.13 68.75 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.687 -0.633 . . . . 0.0 112.364 178.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 15.5 m -59.47 -21.85 60.68 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -74.24 -0.27 16.4 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.552 1.141 . . . . 0.0 113.514 172.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 48.1 p -133.27 162.81 30.8 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.86 1.664 . . . . 0.0 111.792 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -135.16 155.52 50.55 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.311 1.444 . . . . 0.0 110.036 176.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.31 124.34 20.32 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.742 0.817 . . . . 0.0 109.575 175.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 14.1 tp -60.12 -42.65 95.2 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 115.389 1.625 . . . . 0.0 115.389 -171.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -111.09 72.6 0.78 Allowed 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 126.824 2.05 . . . . 0.0 111.907 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 . . . . . 0 C--O 1.252 1.22 0 C-N-CA 126.665 1.986 . . . . 0.0 114.412 176.751 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 526' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.444 0.164 . . . . 0.0 110.835 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 35.7 mt -68.66 131.74 91.24 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 124.399 1.08 . . . . 0.0 110.329 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.19 159.13 52.97 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 123.498 2.799 . . . . 0.0 112.063 178.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.82 147.08 89.36 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.402 2.068 . . . . 0.0 112.561 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -73.98 157.11 87.46 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 123.692 0.797 . . . . 0.0 112.465 174.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.19 174.77 8.53 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.449 2.766 . . . . 0.0 113.381 176.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -88.39 3.06 51.27 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.997 1.319 . . . . 0.0 112.623 -178.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 32.6 p90 -134.85 154.62 79.43 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 124.557 1.143 . . . . 0.0 112.823 -175.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.51 152.49 60.07 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 123.788 2.992 . . . . 0.0 112.868 179.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -68.17 142.97 95.48 Favored Pre-proline 0 CA--C 1.551 0.981 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -176.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.32 179.94 5.01 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 124.114 3.209 . . . . 0.0 112.709 176.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 26.6 p -135.21 154.3 78.74 Favored Pre-proline 0 N--CA 1.479 0.983 0 C-N-CA 125.036 1.334 . . . . 0.0 112.657 -173.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -66.56 161.92 39.21 Favored 'Trans proline' 0 CA--C 1.547 1.165 0 C-N-CA 123.336 2.691 . . . . 0.0 111.484 175.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -64.94 154.61 72.33 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 123.052 2.501 . . . . 0.0 112.417 176.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 540' ' ' VAL . . . . . . . . . . . . . 6.9 m -70.33 -13.5 17.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 126.933 2.093 . . . . 0.0 114.695 -177.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 541' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.69 170.61 18.78 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 125.892 1.677 . . . . 0.0 111.716 174.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 542' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 . . . . . 0 C--O 1.253 1.262 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 -175.215 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.493 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 21.1 t -149.76 155.17 39.68 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.132 1.373 . . . . 0.0 111.595 177.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 338' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -135.92 9.99 3.32 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.261 1.424 . . . . 0.0 113.57 -172.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 339' ' ' MET . . . . . . . . . . . . . 79.8 mtp -131.34 158.29 41.1 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.996 1.318 . . . . 0.0 111.654 -176.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -109.94 47.47 0.95 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.853 1.661 . . . . 0.0 111.412 -173.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 341' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -66.47 75.48 0.1 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 126.926 2.09 . . . . 0.0 112.6 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 342' ' ' GLN . . . . . . . . . . . . . 70.7 tp60 -61.25 136.21 57.98 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.742 0.782 . . . . 0.0 111.057 175.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 3.4 mptm? -124.47 164.16 20.32 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.615 1.566 . . . . 0.0 110.747 177.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 17.3 m -133.26 154.91 40.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 126.471 1.909 . . . . 0.0 109.555 169.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 15.5 ttpt -119.53 136.39 54.36 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.138 0.975 . . . . 0.0 110.667 175.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 77.8 p -78.7 155.95 29.17 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.765 1.626 . . . . 0.0 111.783 -176.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.8 pp -122.24 -9.16 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 -176.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -155.29 159.22 31.91 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 126.346 1.858 . . . . 0.0 110.472 169.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.91 155.94 64.2 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.315 2.677 . . . . 0.0 113.348 178.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 44.7 t-80 -139.36 150.33 45.2 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.583 1.553 . . . . 0.0 111.98 -178.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 11.3 t -147.34 150.29 34.44 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.452 1.501 . . . . 0.0 112.12 -178.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -78.59 -26.46 45.44 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -178.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 66.75 -57.66 0.21 Allowed Glycine 0 CA--C 1.54 1.646 0 C-N-CA 127.378 2.418 . . . . 0.0 115.969 178.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 9.7 t -143.61 -13.26 0.67 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 126.868 2.067 . . . . 0.0 112.811 178.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -77.0 175.93 9.12 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 125.362 1.465 . . . . 0.0 112.592 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -125.13 -30.73 3.17 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.899 1.68 . . . . 0.0 113.229 176.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 58.0 p -91.07 17.17 8.37 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 125.136 1.374 . . . . 0.0 114.193 -175.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 58.4 mt -108.31 130.34 55.19 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.759 1.224 . . . . 0.0 111.358 -178.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 36.4 tp -82.49 120.1 25.05 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.877 0.871 . . . . 0.0 110.862 176.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 55.6 p -89.76 152.7 21.18 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.665 1.186 . . . . 0.0 112.523 173.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -167.75 178.93 5.02 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.434 1.494 . . . . 0.0 112.483 -175.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -117.94 174.06 6.41 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.405 1.882 . . . . 0.0 111.525 174.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -64.92 141.97 58.6 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.747 0.819 . . . . 0.0 111.368 170.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 73.66 10.67 80.11 Favored Glycine 0 CA--C 1.537 1.452 0 N-CA-C 114.525 0.57 . . . . 0.0 114.525 177.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -82.79 164.01 20.87 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.415 1.086 . . . . 0.0 111.342 171.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 93.6 t -119.46 136.99 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.559 1.144 . . . . 0.0 109.881 -171.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 17.1 mt -137.35 137.94 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.997 1.319 . . . . 0.0 109.272 -176.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 10.2 m -95.52 140.56 30.19 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.869 1.268 . . . . 0.0 110.56 176.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 23.3 mt -79.23 139.08 38.01 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.347 0.659 . . . . 0.0 111.803 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 32.4 mt -116.44 -6.78 11.72 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 124.253 1.021 . . . . 0.0 113.347 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 4.9 mt -134.49 140.52 35.92 Favored Pre-proline 0 N--CA 1.48 1.073 0 C-N-CA 126.517 1.927 . . . . 0.0 109.344 176.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.6 -8.53 23.81 Favored 'Trans proline' 0 CA--C 1.546 1.109 0 C-N-CA 123.963 3.109 . . . . 0.0 114.74 178.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -152.05 157.31 41.48 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.882 1.673 . . . . 0.0 111.92 175.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -80.35 168.73 18.66 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.481 1.112 . . . . 0.0 113.841 177.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -125.65 105.18 8.81 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.685 1.994 . . . . 0.0 110.287 178.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 50.96 32.14 7.09 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 125.084 1.354 . . . . 0.0 114.535 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 99.04 -16.67 59.11 Favored Glycine 0 CA--C 1.536 1.393 0 C-N-CA 125.743 1.64 . . . . 0.0 114.305 -178.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 83.0 m95 -85.33 129.74 34.74 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.479 1.112 . . . . 0.0 111.12 175.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 12.6 mt -99.15 162.99 12.75 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.227 1.011 . . . . 0.0 110.316 164.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -127.22 119.06 25.52 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.962 1.305 . . . . 0.0 107.935 176.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -146.63 175.47 26.04 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.064 0.84 . . . . 0.0 113.871 -170.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -127.42 121.63 31.41 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.376 1.47 . . . . 0.0 110.524 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 -66.84 133.58 50.37 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.317 1.047 . . . . 0.0 112.135 -176.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -70.25 -31.04 68.24 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 120.304 -1.497 . . . . 0.0 113.349 -178.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 58.1 t -81.42 -33.97 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 124.408 1.083 . . . . 0.0 113.522 -176.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 13.2 t -125.31 -15.2 6.28 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.887 1.275 . . . . 0.0 113.37 -167.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 54.84 20.8 3.25 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 126.78 2.032 . . . . 0.0 114.202 -177.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -69.22 147.99 50.48 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.573 1.149 . . . . 0.0 111.147 166.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 81.7 mtm180 -122.43 156.78 33.32 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.95 1.7 . . . . 0.0 111.473 179.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 162.83 171.45 29.07 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 124.817 1.198 . . . . 0.0 112.296 174.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -67.66 147.78 52.23 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.148 0.499 . . . . 0.0 110.347 169.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -154.42 155.75 31.04 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 124.321 1.048 . . . . 0.0 110.863 173.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -65.71 121.63 9.06 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.158 1.905 . . . . 0.0 111.627 178.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 33.8 t -61.86 -16.91 54.21 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 121.417 -0.802 . . . . 0.0 113.053 172.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 16.6 m -73.23 -17.65 61.32 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.888 1.275 . . . . 0.0 113.785 173.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -88.56 1.62 54.59 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.286 1.434 . . . . 0.0 113.072 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 58.3 p -128.42 167.38 17.1 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 127.084 2.154 . . . . 0.0 109.826 172.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -128.99 -71.27 0.64 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.997 0.919 . . . . 0.0 109.6 175.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -167.51 158.34 11.34 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.508 2.323 . . . . 0.0 107.656 170.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.81 -68.4 0.31 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 124.064 1.888 . . . . 0.0 111.32 170.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -63.07 155.3 28.2 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 110.197 -3.183 . . . . 0.0 112.957 -171.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 . . . . . 0 C--O 1.253 1.287 0 C-N-CA 125.907 1.683 . . . . 0.0 112.401 -177.815 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 526' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.883 0.373 . . . . 0.0 110.512 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 60.7 mt -73.85 131.54 81.55 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 124.884 1.273 . . . . 0.0 109.488 -178.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.88 159.37 53.56 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 123.433 2.755 . . . . 0.0 112.147 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.44 146.14 89.05 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 122.42 2.08 . . . . 0.0 112.438 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -72.28 156.44 90.52 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 123.48 0.712 . . . . 0.0 112.14 172.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -68.96 174.77 8.34 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.43 2.754 . . . . 0.0 113.054 175.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -86.9 2.02 50.63 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.556 1.142 . . . . 0.0 112.844 -178.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 37.3 p90 -133.94 154.62 80.42 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 124.666 1.187 . . . . 0.0 112.79 -174.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.43 153.17 60.97 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 123.652 2.901 . . . . 0.0 112.758 178.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -65.92 143.22 98.4 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 123.821 0.848 . . . . 0.0 113.084 -177.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.8 177.81 7.17 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 124.001 3.134 . . . . 0.0 112.945 178.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 25.5 p -130.48 154.76 81.68 Favored Pre-proline 0 N--CA 1.478 0.944 0 C-N-CA 125.288 1.435 . . . . 0.0 112.775 -175.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.79 165.44 29.69 Favored 'Trans proline' 0 CA--C 1.547 1.15 0 C-N-CA 123.439 2.76 . . . . 0.0 111.885 174.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -65.92 165.96 22.06 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.406 2.737 . . . . 0.0 112.821 174.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 540' ' ' VAL . . . . . . . . . . . . . 17.6 t -120.26 76.42 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-O 123.29 1.519 . . . . 0.0 109.556 -173.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 541' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -146.8 160.7 41.94 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.919 2.088 . . . . 0.0 111.78 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 542' ' ' ASN . . . . . . . . . . . . . 8.9 t30 . . . . . 0 C--O 1.252 1.218 0 C-N-CA 125.19 1.396 . . . . 0.0 112.182 179.234 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.434 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 61.1 m -140.27 160.28 40.32 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.7 1.6 . . . . 0.0 111.362 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 338' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -135.18 24.74 3.54 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.833 1.253 . . . . 0.0 113.647 -171.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 339' ' ' MET . . . . . . . . . . . . . 28.1 ptm -95.44 -6.39 40.9 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -176.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -79.38 -44.51 21.34 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.139 0.976 . . . . 0.0 113.598 -173.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 341' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -81.65 71.18 8.66 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.843 1.257 . . . . 0.0 110.455 169.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 342' ' ' GLN . . . . . . . . . . . . . 71.1 tp60 -61.38 136.51 58.06 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.392 0.615 . . . . 0.0 110.172 170.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 3.3 mptm? -124.14 163.99 20.38 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.235 1.414 . . . . 0.0 110.834 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 15.6 m -132.89 157.13 42.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 126.73 2.012 . . . . 0.0 109.436 171.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -120.48 136.42 54.76 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.143 0.977 . . . . 0.0 109.946 177.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 45.9 p -80.44 148.57 30.47 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.383 1.473 . . . . 0.0 110.877 -175.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.7 pp -112.87 -10.25 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -176.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -155.55 159.31 31.75 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 126.666 1.987 . . . . 0.0 110.528 170.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.86 156.06 61.15 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 123.536 2.824 . . . . 0.0 113.129 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 32.0 t-80 -136.71 141.01 43.05 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.385 1.474 . . . . 0.0 111.79 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 92.8 m -128.97 122.56 30.4 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.55 1.54 . . . . 0.0 110.387 -172.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -71.73 -30.35 65.52 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -176.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 60.82 -134.77 49.41 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 123.818 0.723 . . . . 0.0 112.985 -177.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 12.6 t -66.8 -26.68 67.07 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 74.4 m-80 -69.25 156.05 39.39 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.825 0.85 . . . . 0.0 112.63 178.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 14.3 tptt -113.28 -24.58 9.29 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.877 1.271 . . . . 0.0 113.935 -177.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 35.8 p -91.59 12.14 21.95 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.004 1.322 . . . . 0.0 113.891 -175.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 68.7 mt -103.57 130.75 51.04 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.935 1.294 . . . . 0.0 110.97 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 30.2 tp -82.8 128.97 34.9 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.247 0.619 . . . . 0.0 110.401 174.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 34.4 t -107.87 147.32 31.11 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.591 1.556 . . . . 0.0 111.474 -179.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -164.58 177.94 7.72 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.626 1.57 . . . . 0.0 112.354 -170.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -121.82 168.83 11.4 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.944 2.098 . . . . 0.0 111.069 175.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -61.94 136.58 58.03 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.175 -0.953 . . . . 0.0 111.312 173.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 83.71 -1.92 88.09 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 123.749 0.69 . . . . 0.0 114.793 178.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -70.88 167.02 19.89 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.382 1.091 . . . . 0.0 112.203 170.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 84.6 t -125.86 133.41 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 125.018 1.327 . . . . 0.0 109.545 -169.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 24.9 mt -136.48 141.35 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.733 1.213 . . . . 0.0 109.462 -176.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 3.3 m -100.78 140.34 35.2 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.319 1.448 . . . . 0.0 110.599 -177.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 21.7 mt -80.21 136.98 36.59 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 118.423 0.556 . . . . 0.0 111.963 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 38.3 mt -117.52 -11.77 10.45 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.589 1.156 . . . . 0.0 113.341 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 371' ' ' ILE . . . . . 0.411 ' CG2' ' HD2' ' A' ' 372' ' ' PRO . 5.6 mt -128.09 140.04 37.13 Favored Pre-proline 0 N--CA 1.474 0.746 0 C-N-CA 126.154 1.782 . . . . 0.0 109.68 176.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 372' ' ' PRO . . . . . 0.411 ' HD2' ' CG2' ' A' ' 371' ' ' ILE . 60.6 Cg_endo -72.97 -7.22 20.35 Favored 'Trans proline' 0 CA--C 1.546 1.076 0 C-N-CA 123.434 2.756 . . . . 0.0 114.001 177.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -150.62 157.41 42.95 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.799 1.639 . . . . 0.0 112.088 173.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -84.91 171.54 12.09 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.222 1.009 . . . . 0.0 112.786 175.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -133.36 110.21 9.88 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.97 1.708 . . . . 0.0 110.819 -176.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 50.74 31.02 5.46 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 125.336 1.454 . . . . 0.0 114.448 -179.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 99.18 -8.41 60.78 Favored Glycine 0 CA--C 1.536 1.396 0 C-N-CA 125.379 1.466 . . . . 0.0 114.467 -177.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 75.3 m95 -99.44 128.43 45.56 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 118.438 1.119 . . . . 0.0 111.55 -178.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 14.1 mt -96.07 161.21 14.07 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.915 0.886 . . . . 0.0 110.544 165.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -124.92 122.36 37.12 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 125.167 1.387 . . . . 0.0 107.646 173.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -145.84 169.67 27.23 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 115.627 -0.715 . . . . 0.0 113.159 -173.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -117.55 114.67 23.78 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.811 1.244 . . . . 0.0 109.516 177.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 26.7 t-80 -60.69 146.35 46.02 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.861 1.264 . . . . 0.0 111.87 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -81.25 -46.2 15.14 Favored 'General case' 0 CA--C 1.548 0.866 0 O-C-N 120.768 -1.208 . . . . 0.0 112.866 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 60.1 t -68.92 -53.85 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 124.051 0.94 . . . . 0.0 113.31 175.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 16.3 t -86.11 -22.43 27.11 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -171.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm 54.93 17.2 1.73 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 126.575 1.95 . . . . 0.0 114.579 -168.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -74.33 156.03 37.55 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.476 0.655 . . . . 0.0 111.986 172.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 54.5 mtp180 -127.31 148.43 50.24 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.636 1.974 . . . . 0.0 109.758 177.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 167.98 168.79 30.61 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 124.501 1.048 . . . . 0.0 111.859 178.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -68.05 145.85 54.06 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.098 0.475 . . . . 0.0 110.556 170.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -152.76 154.45 31.42 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 124.103 0.961 . . . . 0.0 110.776 173.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.57 122.29 10.36 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.333 2.022 . . . . 0.0 110.864 178.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 98.1 p -56.4 -37.31 69.98 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.687 -0.633 . . . . 0.0 112.079 176.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 17.2 m -58.2 -20.95 45.47 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 127.273 2.229 . . . . 0.0 115.003 177.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -79.91 1.32 27.69 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.788 1.235 . . . . 0.0 112.961 175.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 60.3 p -131.15 164.43 25.51 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 126.574 1.95 . . . . 0.0 110.673 174.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 12.1 mmmm -128.26 -74.71 0.57 Allowed 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.161 0.984 . . . . 0.0 109.519 177.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -169.73 155.84 6.1 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 128.079 2.552 . . . . 0.0 107.729 169.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.27 -59.71 4.37 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 123.474 1.607 . . . . 0.0 112.711 173.103 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -135.25 146.18 48.33 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 112.216 -2.265 . . . . 0.0 111.915 -172.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 . . . . . 0 C--O 1.255 1.369 0 C-N-CA 125.477 1.511 . . . . 0.0 112.353 -165.613 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 526' ' ' HIS . . . . . . . . . . . . . 32.4 m170 . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 121.004 0.43 . . . . 0.0 111.268 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 52.4 mt -65.34 133.02 95.34 Favored Pre-proline 0 N--CA 1.479 1.019 0 C-N-CA 124.982 1.313 . . . . 0.0 109.878 177.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -69.39 160.31 50.3 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 123.702 2.935 . . . . 0.0 112.163 178.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.96 144.22 87.31 Favored 'Trans proline' 0 CA--C 1.534 0.522 0 C-N-CA 122.376 2.051 . . . . 0.0 112.191 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -69.6 153.56 95.58 Favored Pre-proline 0 CA--C 1.551 1.01 0 C-N-CA 122.972 0.509 . . . . 0.0 111.733 171.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -69.23 174.26 9.31 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.322 2.681 . . . . 0.0 113.19 178.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -86.67 2.48 48.34 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.523 1.129 . . . . 0.0 112.948 -178.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 34.0 p90 -133.52 153.39 80.31 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 124.748 1.219 . . . . 0.0 113.104 -176.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -71.62 152.12 59.05 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 123.623 2.882 . . . . 0.0 112.607 178.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -68.56 146.33 97.64 Favored Pre-proline 0 CA--C 1.55 0.971 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -176.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.7 178.72 5.97 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 124.034 3.156 . . . . 0.0 113.086 177.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 19.3 p -133.12 155.0 81.48 Favored Pre-proline 0 N--CA 1.48 1.027 0 C-N-CA 125.18 1.392 . . . . 0.0 112.658 -175.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.02 161.0 47.65 Favored 'Trans proline' 0 CA--C 1.547 1.151 0 C-N-CA 123.375 2.717 . . . . 0.0 111.986 176.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -66.85 150.82 83.16 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.232 2.621 . . . . 0.0 112.74 178.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 540' ' ' VAL . . . . . . . . . . . . . 49.9 t -71.96 -28.94 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 124.722 1.209 . . . . 0.0 112.241 -178.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 541' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -149.65 168.13 24.44 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.553 1.541 . . . . 0.0 112.501 -177.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 542' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 . . . . . 0 C--O 1.252 1.211 0 C-N-CA 125.351 1.461 . . . . 0.0 113.832 174.384 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.462 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 36.9 m -61.98 160.51 12.27 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.157 1.383 . . . . 0.0 113.323 176.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 338' ' ' HIS . . . . . . . . . . . . . 31.5 p80 -128.21 -23.81 3.22 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 -176.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 339' ' ' MET . . . . . . . . . . . . . 81.7 mtp -71.1 135.44 47.68 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 119.132 0.878 . . . . 0.0 110.84 175.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.11 -26.8 64.13 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.182 0.993 . . . . 0.0 113.598 -175.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 341' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -119.83 165.43 14.6 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.639 1.976 . . . . 0.0 110.012 176.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 342' ' ' GLN . . . . . . . . . . . . . 72.3 tp60 -124.25 138.15 54.43 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.856 0.836 . . . . 0.0 110.625 175.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 3.1 mptm? -120.93 163.9 17.53 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 125.642 1.577 . . . . 0.0 111.091 177.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 15.9 m -133.91 155.57 39.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 C-N-CA 126.569 1.948 . . . . 0.0 108.926 168.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 5.7 tptt -119.37 130.53 55.38 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 124.183 0.993 . . . . 0.0 109.372 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 76.3 p -74.46 151.57 39.56 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.457 0.703 . . . . 0.0 111.127 -176.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.9 pp -122.69 -8.36 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -178.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -155.63 159.35 31.71 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 126.919 2.088 . . . . 0.0 110.024 169.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.1 159.62 53.17 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.275 2.65 . . . . 0.0 112.97 176.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -140.35 152.0 45.45 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.051 1.34 . . . . 0.0 111.993 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 15.2 t -146.31 154.65 41.93 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.598 1.559 . . . . 0.0 112.183 -174.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -92.06 -34.43 14.39 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -176.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 69.48 -61.87 0.63 Allowed Glycine 0 CA--C 1.54 1.645 0 C-N-CA 126.58 2.038 . . . . 0.0 115.995 177.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 49.2 m -142.27 19.98 2.08 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 126.351 1.86 . . . . 0.0 112.415 -172.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -128.66 164.52 22.73 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.984 1.714 . . . . 0.0 111.281 -165.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.44 -11.68 9.46 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -178.046 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 52.2 p -116.57 15.82 15.55 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.363 1.465 . . . . 0.0 112.727 -171.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 47.1 mt -106.71 116.72 32.42 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.045 1.338 . . . . 0.0 110.972 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 25.5 tp -72.05 124.31 24.67 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.644 0.778 . . . . 0.0 110.669 176.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 58.0 p -97.76 152.65 18.92 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.988 1.315 . . . . 0.0 112.401 175.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -167.4 178.43 5.5 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.513 1.525 . . . . 0.0 112.195 -173.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -118.83 173.74 6.7 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.787 2.035 . . . . 0.0 110.941 173.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -65.19 141.16 58.76 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.746 0.818 . . . . 0.0 111.624 171.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 80.29 3.21 89.76 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 124.173 0.892 . . . . 0.0 115.213 175.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -76.2 168.79 19.41 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.231 1.412 . . . . 0.0 112.238 173.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 80.5 t -123.49 130.01 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 125.642 1.577 . . . . 0.0 109.153 -171.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 30.8 mt -134.72 137.29 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.136 0.974 . . . . 0.0 109.525 -178.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 20.0 m -97.76 139.31 33.83 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.033 1.333 . . . . 0.0 110.491 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 20.3 mt -79.34 144.33 34.3 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.235 0.47 . . . . 0.0 111.972 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 47.4 mt -118.58 -1.15 11.22 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.731 1.212 . . . . 0.0 112.93 -178.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 371' ' ' ILE . . . . . 0.449 ' CG2' ' HD2' ' A' ' 372' ' ' PRO . 3.8 mt -134.36 142.57 43.42 Favored Pre-proline 0 N--CA 1.478 0.937 0 C-N-CA 126.848 2.059 . . . . 0.0 109.947 177.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 372' ' ' PRO . . . . . 0.449 ' HD2' ' CG2' ' A' ' 371' ' ' ILE . 57.0 Cg_endo -71.87 -9.08 24.21 Favored 'Trans proline' 0 CA--C 1.547 1.151 0 C-N-CA 123.463 2.775 . . . . 0.0 114.021 176.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -152.65 150.22 29.25 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.027 1.731 . . . . 0.0 111.857 173.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -71.49 168.69 16.99 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.202 1.001 . . . . 0.0 113.554 173.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -123.72 103.4 8.36 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 126.324 1.85 . . . . 0.0 109.911 178.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 51.65 32.73 9.65 Favored 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 177.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 99.29 -12.72 61.83 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 125.415 1.484 . . . . 0.0 114.298 -178.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -89.18 121.41 31.45 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.451 1.1 . . . . 0.0 110.709 175.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 13.1 mt -88.8 158.86 18.0 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.366 0.667 . . . . 0.0 110.372 162.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -120.65 125.18 47.06 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 125.001 1.32 . . . . 0.0 107.789 170.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -149.41 171.64 29.54 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 115.873 -0.603 . . . . 0.0 113.871 -172.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -123.08 120.93 34.73 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.452 1.501 . . . . 0.0 109.623 177.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 29.4 t-80 -65.68 150.68 48.08 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.717 1.207 . . . . 0.0 112.159 178.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -81.15 -49.31 10.99 Favored 'General case' 0 CA--C 1.548 0.883 0 O-C-N 120.941 -1.099 . . . . 0.0 113.649 178.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 82.8 t -71.05 -52.15 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 178.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 23.2 t -83.96 -23.33 31.12 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.595 0.758 . . . . 0.0 112.852 -174.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp 55.72 15.83 1.75 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 126.681 1.992 . . . . 0.0 114.532 -168.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -73.14 153.72 40.64 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.409 0.623 . . . . 0.0 111.944 173.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -123.68 153.61 40.58 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 126.553 1.941 . . . . 0.0 110.682 178.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 165.45 169.59 29.27 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 124.344 0.973 . . . . 0.0 112.24 175.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -66.92 148.09 52.4 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.066 0.46 . . . . 0.0 110.148 166.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -155.67 154.39 27.95 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 124.3 1.04 . . . . 0.0 110.359 172.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -63.82 123.19 11.56 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.525 2.15 . . . . 0.0 110.926 177.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 99.2 p -56.75 -38.55 72.58 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.655 -0.653 . . . . 0.0 112.136 178.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 14.7 m -61.32 -22.4 64.87 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.044 1.738 . . . . 0.0 114.825 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -73.66 -1.89 20.82 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.829 1.251 . . . . 0.0 113.215 172.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 62.3 p -129.14 160.54 32.53 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.675 1.59 . . . . 0.0 110.987 175.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 30.5 mmtm -123.34 161.5 24.56 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 125.349 1.46 . . . . 0.0 109.563 171.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.3 124.63 23.23 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 174.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.51 -53.15 55.62 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 124.159 1.933 . . . . 0.0 113.911 -175.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -78.69 77.25 5.17 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 128.381 2.672 . . . . 0.0 112.547 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 . . . . . 0 C--O 1.254 1.314 0 C-N-CA 127.06 2.144 . . . . 0.0 114.315 176.624 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 526' ' ' HIS . . . . . . . . . . . . . 37.2 p-80 . . . . . 0 N--CA 1.485 1.289 0 CA-C-O 120.909 0.385 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 53.8 mt -69.78 133.22 88.5 Favored Pre-proline 0 N--CA 1.477 0.891 0 C-N-CA 124.546 1.138 . . . . 0.0 109.552 177.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -69.31 158.87 55.92 Favored 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 123.569 2.846 . . . . 0.0 112.049 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -64.46 145.56 87.99 Favored 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 122.37 2.047 . . . . 0.0 112.17 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -73.07 156.41 89.56 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 123.193 0.597 . . . . 0.0 112.215 173.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -68.78 174.32 8.8 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 123.42 2.747 . . . . 0.0 113.023 175.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -89.5 3.98 50.67 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.509 1.124 . . . . 0.0 113.087 -178.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 34.7 p90 -134.09 154.38 80.14 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 124.722 1.209 . . . . 0.0 112.701 -177.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.49 152.6 60.25 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 123.687 2.924 . . . . 0.0 112.641 179.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -67.87 143.9 96.82 Favored Pre-proline 0 CA--C 1.55 0.969 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -177.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.13 179.08 5.76 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 123.858 3.039 . . . . 0.0 112.716 177.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 24.7 p -131.31 154.91 82.07 Favored Pre-proline 0 N--CA 1.479 0.997 0 C-N-CA 125.194 1.398 . . . . 0.0 112.458 -174.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -67.03 164.57 29.49 Favored 'Trans proline' 0 CA--C 1.546 1.123 0 C-N-CA 123.397 2.732 . . . . 0.0 111.17 174.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -64.12 159.18 44.17 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.835 2.357 . . . . 0.0 112.352 175.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 540' ' ' VAL . . . . . . . . . . . . . 32.7 m -66.11 -13.41 15.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 126.821 2.048 . . . . 0.0 114.697 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 541' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -97.46 126.26 42.62 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.777 1.631 . . . . 0.0 110.579 177.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 542' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 . . . . . 0 C--O 1.253 1.254 0 C-N-CA 124.663 1.185 . . . . 0.0 112.975 174.495 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.454 0 N-CA-C 111.574 -0.61 . . . . 0.0 111.574 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 44.6 m -127.21 -44.05 1.61 Allowed 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.022 0.929 . . . . 0.0 113.227 -174.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 338' ' ' HIS . . . . . . . . . . . . . 24.4 p-80 -90.06 -9.04 49.98 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.236 1.014 . . . . 0.0 113.261 170.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 339' ' ' MET . . . . . . . . . . . . . 8.7 tpt -123.26 85.45 2.42 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.194 1.798 . . . . 0.0 109.486 -175.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -119.84 0.14 10.8 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.519 1.528 . . . . 0.0 114.478 -173.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 341' ' ' LYS . . . . . . . . . . . . . 2.3 tmmm? -89.71 57.52 3.92 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 127.154 2.182 . . . . 0.0 110.139 176.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 342' ' ' GLN . . . . . . . . . . . . . 70.1 tp60 -68.2 148.4 50.9 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.706 0.765 . . . . 0.0 110.775 174.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 9.7 tptt -124.5 155.62 38.66 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 125.211 1.405 . . . . 0.0 111.347 -175.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 17.9 m -138.03 157.2 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 125.609 1.564 . . . . 0.0 110.052 175.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt -121.76 134.3 54.93 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.249 1.02 . . . . 0.0 110.221 175.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 82.7 p -76.4 156.34 33.27 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.622 1.569 . . . . 0.0 111.75 -179.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.9 pp -123.24 -6.91 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -153.73 157.69 32.62 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 125.758 1.623 . . . . 0.0 110.577 169.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.67 155.54 62.73 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.194 2.596 . . . . 0.0 112.994 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 32.6 t-80 -143.9 137.75 28.08 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.934 1.694 . . . . 0.0 110.43 -178.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 48.7 m -142.0 125.24 16.44 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.508 1.123 . . . . 0.0 110.292 -177.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -61.4 -50.89 71.03 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.101 0.96 . . . . 0.0 112.887 177.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 50.44 -109.71 0.75 Allowed Glycine 0 CA--C 1.54 1.642 0 O-C-N 121.143 -0.973 . . . . 0.0 113.365 -176.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 27.8 m -70.8 -15.81 62.69 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 176.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -70.98 176.73 4.13 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.503 1.121 . . . . 0.0 112.414 174.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? -133.83 154.7 50.84 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.864 1.666 . . . . 0.0 110.275 171.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 17.5 p 57.27 17.97 3.99 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 127.22 2.208 . . . . 0.0 115.949 175.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 15.3 mt -99.51 137.65 37.7 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.664 1.186 . . . . 0.0 110.653 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 30.6 tp -82.91 124.81 30.7 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 122.995 0.518 . . . . 0.0 110.818 175.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 47.4 m -91.74 147.55 22.91 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.775 1.23 . . . . 0.0 111.985 175.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -166.2 177.99 6.56 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.676 1.59 . . . . 0.0 112.755 -175.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -115.53 175.01 5.71 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.318 1.847 . . . . 0.0 111.617 173.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -62.46 141.1 58.55 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 121.349 -0.845 . . . . 0.0 111.106 168.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 71.53 18.63 77.23 Favored Glycine 0 CA--C 1.537 1.45 0 N-CA-C 114.651 0.62 . . . . 0.0 114.651 176.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -88.25 159.52 18.08 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.688 1.195 . . . . 0.0 111.645 173.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 88.0 t -111.28 130.33 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.011 1.324 . . . . 0.0 109.765 -173.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 23.1 mt -136.01 136.53 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.865 1.266 . . . . 0.0 109.035 -177.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 9.9 m -97.89 139.45 33.73 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.87 1.268 . . . . 0.0 110.004 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 20.6 mt -78.99 140.79 37.91 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 118.864 0.756 . . . . 0.0 111.953 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 37.4 mt -119.53 -5.38 10.29 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.891 1.276 . . . . 0.0 113.569 -177.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 371' ' ' ILE . . . . . 0.449 ' CG2' ' HD2' ' A' ' 372' ' ' PRO . 0.2 OUTLIER -127.9 146.76 60.26 Favored Pre-proline 0 N--CA 1.477 0.888 0 C-N-CA 126.722 2.009 . . . . 0.0 108.213 173.73 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 372' ' ' PRO . . . . . 0.449 ' HD2' ' CG2' ' A' ' 371' ' ' ILE . 82.9 Cg_endo -75.01 -17.09 19.81 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.461 2.774 . . . . 0.0 112.402 177.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -148.25 142.48 26.13 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.172 1.789 . . . . 0.0 111.202 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -72.29 172.95 9.36 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 125.658 1.583 . . . . 0.0 113.592 176.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -132.97 108.43 8.9 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.377 1.871 . . . . 0.0 110.833 -177.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 50.18 32.44 6.02 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 125.323 1.449 . . . . 0.0 114.707 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 98.94 -7.44 60.69 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 125.236 1.398 . . . . 0.0 114.462 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 78.8 m95 -99.77 128.97 45.84 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.485 1.143 . . . . 0.0 111.505 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 16.2 mt -98.42 161.36 13.73 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.622 1.169 . . . . 0.0 110.92 167.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 380' ' ' TYR . . . . . 0.432 ' HB3' ' CG1' ' A' ' 371' ' ' ILE . 60.2 t80 -121.33 122.2 39.33 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 173.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -145.58 170.75 26.8 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 115.749 -0.66 . . . . 0.0 114.46 -174.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -120.62 119.05 31.74 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.385 1.474 . . . . 0.0 109.717 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 -61.93 146.53 49.66 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.068 1.347 . . . . 0.0 111.68 177.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -80.55 -47.82 13.64 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 120.801 -1.187 . . . . 0.0 113.512 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 89.7 t -69.93 -51.93 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 124.287 1.035 . . . . 0.0 113.241 177.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 13.5 t -86.93 -21.69 26.1 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -173.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp 54.62 19.45 2.45 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 126.439 1.896 . . . . 0.0 114.303 -169.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -75.98 153.8 36.3 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.376 0.67 . . . . 0.0 111.896 172.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 70.9 mtm180 -127.93 148.04 50.49 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.463 1.905 . . . . 0.0 110.458 -179.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 169.86 170.93 34.87 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.83 1.205 . . . . 0.0 111.881 177.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -67.69 145.56 54.65 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.61 0.764 . . . . 0.0 110.902 171.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -152.78 153.2 29.8 Favored Pre-proline 0 CA--C 1.541 0.631 0 O-C-N 120.826 -1.171 . . . . 0.0 111.849 174.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -63.76 124.26 13.35 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 122.902 2.401 . . . . 0.0 112.14 178.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 97.5 p -62.97 -21.0 65.79 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 174.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 19.3 m -74.23 -17.54 60.87 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.826 1.25 . . . . 0.0 114.23 174.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -81.84 -2.72 52.0 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.567 1.147 . . . . 0.0 113.439 177.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 72.2 p -128.18 169.66 13.88 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.563 1.945 . . . . 0.0 110.061 173.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -130.12 -77.79 0.54 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.786 0.834 . . . . 0.0 109.984 177.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -166.86 145.79 5.31 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.378 2.271 . . . . 0.0 107.41 172.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.79 -68.44 0.36 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 123.115 1.436 . . . . 0.0 112.79 176.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -129.61 126.96 39.65 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 112.553 -2.112 . . . . 0.0 112.019 -169.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 . . . . . 0 C--O 1.254 1.33 0 C-N-CA 125.567 1.547 . . . . 0.0 112.355 -171.934 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 526' ' ' HIS . . . . . . . . . . . . . 40.3 m80 . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.49 0.186 . . . . 0.0 110.726 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 36.0 mt -70.05 130.89 89.33 Favored Pre-proline 0 N--CA 1.477 0.902 0 C-N-CA 124.02 0.928 . . . . 0.0 109.272 176.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -68.7 162.48 40.98 Favored 'Trans proline' 0 CA--C 1.545 1.049 0 C-N-CA 123.492 2.794 . . . . 0.0 111.776 177.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.26 143.32 83.04 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.09 1.86 . . . . 0.0 112.365 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -70.0 152.91 95.75 Favored Pre-proline 0 CA--C 1.553 1.065 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.528 170.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -69.77 174.86 8.89 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.402 2.735 . . . . 0.0 113.309 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -90.69 8.35 34.86 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.756 1.222 . . . . 0.0 112.568 -178.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 37.0 p90 -135.82 153.01 76.93 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 124.828 1.251 . . . . 0.0 112.874 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.07 152.09 62.18 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.662 2.908 . . . . 0.0 112.276 178.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -67.53 144.13 97.52 Favored Pre-proline 0 CA--C 1.551 0.99 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -175.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.36 177.07 8.37 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 124.03 3.153 . . . . 0.0 113.106 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 27.3 p -132.23 153.66 81.36 Favored Pre-proline 0 N--CA 1.478 0.968 0 C-N-CA 125.076 1.35 . . . . 0.0 112.827 -172.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -67.84 165.07 29.13 Favored 'Trans proline' 0 CA--C 1.55 1.284 0 C-N-CA 123.55 2.833 . . . . 0.0 112.054 175.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -65.49 163.73 28.78 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 123.664 2.909 . . . . 0.0 113.173 176.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 540' ' ' VAL . . . . . . . . . . . . . 4.7 t -133.88 53.06 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 125.635 1.574 . . . . 0.0 110.065 -169.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 541' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -70.25 59.72 0.19 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 127.139 2.176 . . . . 0.0 113.428 178.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 542' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 . . . . . 0 C--O 1.254 1.323 0 C-N-CA 125.396 1.478 . . . . 0.0 112.385 173.65 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.693 0 N-CA-C 111.518 -0.633 . . . . 0.0 111.518 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 81.4 p -152.14 140.75 20.78 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.256 1.022 . . . . 0.0 112.524 174.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 338' ' ' HIS . . . . . . . . . . . . . 25.4 p-80 -73.48 -24.02 60.14 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -178.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 339' ' ' MET . . . . . . . . . . . . . 5.4 ppp? -75.72 -21.19 57.75 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -178.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -101.6 -37.2 8.48 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.627 1.171 . . . . 0.0 112.817 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 341' ' ' LYS . . . . . . . . . . . . . 34.9 tptt -112.39 44.04 1.51 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 126.288 1.835 . . . . 0.0 110.107 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 342' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -50.39 131.52 24.5 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.398 1.079 . . . . 0.0 110.238 -179.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -120.72 146.97 45.91 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.93 1.292 . . . . 0.0 111.726 178.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 16.7 m -127.67 143.26 41.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 113.998 -1.455 . . . . 0.0 108.729 173.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -111.28 131.82 54.85 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.771 0.796 . . . . 0.0 109.944 175.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 70.6 p -76.34 151.67 36.6 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.955 1.702 . . . . 0.0 111.61 -175.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.7 pp -122.56 -6.1 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 N-CA-C 114.684 1.364 . . . . 0.0 114.684 -175.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -154.58 158.96 32.32 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 126.446 1.898 . . . . 0.0 110.199 169.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -69.46 159.3 54.16 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 123.085 2.523 . . . . 0.0 112.923 177.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -136.85 150.21 48.16 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.918 1.287 . . . . 0.0 112.039 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 35.5 m -140.85 144.07 35.12 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.429 1.492 . . . . 0.0 111.004 -162.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -110.81 -28.86 8.21 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -175.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 55.21 -116.72 7.23 Favored Glycine 0 CA--C 1.538 1.524 0 CA-C-N 119.159 0.89 . . . . 0.0 112.73 -175.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 80.6 p -75.24 -15.42 60.53 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 177.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -72.8 159.76 33.26 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.4 1.08 . . . . 0.0 112.325 -178.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 34.1 mtmm -127.98 -1.71 5.88 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 -179.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 39.6 p -117.89 11.67 13.56 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 125.44 1.496 . . . . 0.0 113.015 -176.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 63.0 mt -106.83 125.46 51.04 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.028 1.331 . . . . 0.0 110.653 179.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 26.0 tp -77.3 127.58 32.84 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.338 0.655 . . . . 0.0 110.596 176.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 37.3 p -100.96 147.08 26.58 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.136 1.374 . . . . 0.0 112.217 177.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -163.48 178.99 7.59 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.556 1.542 . . . . 0.0 112.054 -174.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -130.27 157.32 42.83 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 127.282 2.233 . . . . 0.0 111.358 177.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -50.98 129.51 23.81 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.494 0.717 . . . . 0.0 112.311 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 91.45 -9.01 78.33 Favored Glycine 0 CA--C 1.538 1.476 0 C-N-CA 124.261 0.934 . . . . 0.0 114.633 -179.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -68.05 153.02 44.6 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 118.903 1.351 . . . . 0.0 111.891 172.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 74.3 t -115.51 140.26 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 125.389 1.476 . . . . 0.0 109.989 -173.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 36.2 mt -136.07 136.57 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 125.668 1.587 . . . . 0.0 108.559 -177.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 31.8 m -99.46 137.23 38.25 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.649 1.18 . . . . 0.0 109.7 177.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 15.7 mt -69.45 147.34 51.06 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -177.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 77.4 mt -120.87 -2.21 9.81 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 125.079 1.351 . . . . 0.0 113.435 178.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 371' ' ' ILE . . . . . 0.436 ' CG2' ' HD2' ' A' ' 372' ' ' PRO . 2.0 mt -137.04 142.7 39.29 Favored Pre-proline 0 N--CA 1.477 0.906 0 C-N-CA 126.623 1.969 . . . . 0.0 109.14 177.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 372' ' ' PRO . . . . . 0.436 ' HD2' ' CG2' ' A' ' 371' ' ' ILE . 42.3 Cg_endo -70.42 -15.83 34.67 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 123.056 2.504 . . . . 0.0 113.308 177.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -145.15 150.13 36.23 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.492 1.917 . . . . 0.0 111.028 177.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -75.23 172.28 12.69 Favored 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 176.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -124.7 101.87 7.31 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.255 1.822 . . . . 0.0 110.293 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 51.95 31.78 9.07 Favored 'General case' 0 CA--C 1.554 1.135 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 175.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 100.01 -4.36 57.43 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 125.099 1.333 . . . . 0.0 114.64 -178.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 82.5 m95 -103.28 121.29 42.41 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.639 1.576 . . . . 0.0 110.521 176.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 12.1 mt -85.07 160.42 19.99 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.364 0.666 . . . . 0.0 110.578 163.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -122.98 126.49 47.27 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.208 1.403 . . . . 0.0 107.56 170.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -150.48 170.38 30.38 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-N 115.857 -0.611 . . . . 0.0 113.643 -173.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -118.83 119.64 34.99 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.226 1.41 . . . . 0.0 109.325 176.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -61.59 146.32 49.25 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.361 1.464 . . . . 0.0 111.745 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -79.55 -47.67 15.13 Favored 'General case' 0 CA--C 1.548 0.897 0 O-C-N 120.774 -1.203 . . . . 0.0 113.734 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 81.9 t -73.93 -49.47 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.988 0.915 . . . . 0.0 112.968 178.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 15.5 t -86.91 -21.74 26.12 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -173.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp 54.27 17.47 1.52 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 126.712 2.005 . . . . 0.0 114.771 -169.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -75.21 159.58 31.41 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.506 0.723 . . . . 0.0 112.16 173.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -126.58 159.0 34.78 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.336 1.854 . . . . 0.0 110.468 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 157.72 169.67 21.67 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 124.454 1.025 . . . . 0.0 112.538 175.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -67.85 145.58 54.49 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.002 0.521 . . . . 0.0 110.416 169.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -153.2 153.63 29.74 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 124.003 0.921 . . . . 0.0 111.162 173.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -62.86 121.06 8.81 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.748 2.299 . . . . 0.0 111.381 178.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.0 -17.53 63.4 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 121.303 -0.873 . . . . 0.0 113.096 177.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 79.6 p -73.43 -22.12 60.29 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.712 2.005 . . . . 0.0 114.282 174.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -79.09 2.89 19.15 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.507 1.523 . . . . 0.0 113.325 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 30.8 p -133.97 171.01 14.78 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.966 2.106 . . . . 0.0 109.93 175.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -125.43 -80.81 0.62 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.717 0.807 . . . . 0.0 109.521 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -165.25 150.48 9.28 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 127.629 2.372 . . . . 0.0 106.77 167.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.96 -70.4 0.15 Allowed 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 123.836 1.779 . . . . 0.0 112.443 176.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -61.14 122.0 13.92 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 110.799 -2.909 . . . . 0.0 111.655 -170.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 . . . . . 0 C--O 1.252 1.234 0 C-N-CA 125.024 1.329 . . . . 0.0 114.032 -177.121 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 526' ' ' HIS . . . . . . . . . . . . . 47.3 p-80 . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 121.095 0.474 . . . . 0.0 111.289 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 61.9 mt -68.4 131.32 91.79 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 124.478 1.111 . . . . 0.0 109.491 176.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -69.37 160.57 49.28 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 123.611 2.874 . . . . 0.0 112.357 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.37 145.47 88.24 Favored 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 122.579 2.186 . . . . 0.0 112.368 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -77.24 158.2 79.84 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 123.691 0.796 . . . . 0.0 112.448 174.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -68.56 174.97 7.63 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 123.527 2.818 . . . . 0.0 113.176 176.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -93.56 9.87 34.96 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.908 1.283 . . . . 0.0 112.408 -178.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 38.6 p90 -138.46 153.93 73.07 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 124.67 1.188 . . . . 0.0 112.622 -178.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -71.18 152.28 61.76 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.444 2.763 . . . . 0.0 112.069 176.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -66.81 148.86 98.68 Favored Pre-proline 0 CA--C 1.549 0.926 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -176.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.78 -175.9 1.83 Allowed 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 124.069 3.179 . . . . 0.0 112.638 176.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 23.4 p -135.41 153.4 77.85 Favored Pre-proline 0 N--CA 1.475 0.8 0 C-N-CA 125.196 1.399 . . . . 0.0 112.465 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -65.42 164.38 26.18 Favored 'Trans proline' 0 CA--C 1.549 1.241 0 C-N-CA 123.225 2.617 . . . . 0.0 111.273 173.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -65.65 169.97 12.0 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 123.379 2.719 . . . . 0.0 113.248 177.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 540' ' ' VAL . . . . . . . . . . . . . 22.6 m -67.64 2.15 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 128.428 2.691 . . . . 0.0 115.713 177.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 541' ' ' GLN . . . . . . . . . . . . . 28.9 pt20 -129.86 166.66 19.52 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.899 2.079 . . . . 0.0 111.763 179.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 542' ' ' ASN . . . . . . . . . . . . . 1.5 t30 . . . . . 0 C--O 1.254 1.304 0 C-N-CA 125.339 1.456 . . . . 0.0 111.454 -177.953 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.61 0 N-CA-C 111.694 -0.562 . . . . 0.0 111.694 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 28.5 m -71.42 75.1 0.76 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 126.436 1.895 . . . . 0.0 113.954 -174.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 338' ' ' HIS . . . . . . . . . . . . . 13.7 t-160 -61.38 -39.6 91.27 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.068 1.347 . . . . 0.0 113.536 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 339' ' ' MET . . . . . . . . . . . . . 20.7 ptp -159.32 173.7 15.89 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.126 1.77 . . . . 0.0 112.126 177.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 11.7 mmmm -115.81 -64.15 1.35 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.772 1.229 . . . . 0.0 112.666 -173.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 341' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -73.72 144.87 45.55 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 118.936 0.789 . . . . 0.0 111.032 170.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 342' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.67 152.26 41.81 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.784 1.234 . . . . 0.0 112.155 177.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -120.08 163.12 18.15 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 114.132 -1.394 . . . . 0.0 112.847 166.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 12.9 m -134.32 153.54 35.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 127.573 2.349 . . . . 0.0 108.5 171.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -118.92 130.82 55.92 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.709 0.804 . . . . 0.0 110.203 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 76.5 p -73.61 151.17 40.94 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.792 0.837 . . . . 0.0 111.138 -178.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.8 pp -123.45 -7.93 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 -177.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -154.35 156.78 32.04 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 126.255 1.822 . . . . 0.0 110.233 169.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -69.78 156.74 62.52 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 123.316 2.677 . . . . 0.0 112.856 178.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -138.26 145.38 41.25 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.024 1.329 . . . . 0.0 111.855 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 28.7 m -145.37 135.04 23.41 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.396 1.478 . . . . 0.0 110.962 -174.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -75.63 33.58 0.11 Allowed 'General case' 0 CA--C 1.56 1.344 0 C-N-CA 126.929 2.092 . . . . 0.0 114.595 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . -48.28 -24.48 3.6 Favored Glycine 0 CA--C 1.54 1.608 0 C-N-CA 127.407 2.432 . . . . 0.0 118.847 -163.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 5.7 t -150.31 39.09 0.73 Allowed 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 118.951 1.375 . . . . 0.0 111.172 175.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -139.85 179.01 6.84 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.626 1.17 . . . . 0.0 112.668 -162.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 15.2 ttmt -142.82 147.16 34.98 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.859 1.664 . . . . 0.0 111.346 176.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . 0.26 24.9 p 59.62 19.92 8.51 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 128.005 2.522 . . . . 0.0 116.334 -177.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -77.71 141.99 39.01 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.084 1.354 . . . . 0.0 110.554 172.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 22.9 tp -85.41 136.83 33.29 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 161.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 65.8 m -117.23 143.81 45.47 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.443 1.497 . . . . 0.0 111.428 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -162.55 178.98 8.09 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.091 1.357 . . . . 0.0 112.892 -167.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -116.93 173.53 6.6 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.226 1.811 . . . . 0.0 111.443 174.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -65.63 142.74 57.96 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.16 0.984 . . . . 0.0 111.559 171.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 75.67 8.28 84.13 Favored Glycine 0 CA--C 1.534 1.258 0 CA-C-O 119.298 -0.723 . . . . 0.0 114.819 176.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -79.07 163.41 25.15 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.556 1.142 . . . . 0.0 111.733 171.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 99.8 t -114.84 134.65 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.124 1.37 . . . . 0.0 109.163 -176.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 35.9 mt -132.45 141.48 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.275 1.03 . . . . 0.0 109.043 178.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 16.9 m -105.34 137.27 43.41 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.074 1.35 . . . . 0.0 109.467 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 9.9 mt -73.44 145.1 46.0 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -176.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 72.2 mt -119.53 -12.65 9.29 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 124.83 1.252 . . . . 0.0 113.311 178.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 9.8 mt -127.79 141.22 40.41 Favored Pre-proline 0 N--CA 1.478 0.932 0 C-N-CA 126.096 1.759 . . . . 0.0 110.255 175.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.7 -7.58 21.45 Favored 'Trans proline' 0 CA--C 1.547 1.144 0 C-N-CA 123.948 3.098 . . . . 0.0 114.48 176.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -152.55 153.71 33.96 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.663 1.585 . . . . 0.0 112.262 172.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -75.32 169.78 17.39 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.491 1.116 . . . . 0.0 113.647 174.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -128.6 105.92 8.61 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 126.669 1.988 . . . . 0.0 109.957 179.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 50.37 32.17 6.1 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 124.954 1.302 . . . . 0.0 114.373 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 99.55 -17.38 57.7 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 125.863 1.697 . . . . 0.0 114.377 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -82.59 125.29 31.0 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.542 1.137 . . . . 0.0 111.138 176.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 14.4 mt -94.42 162.94 13.62 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.636 0.774 . . . . 0.0 110.364 162.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -126.45 125.38 42.03 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 170.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -147.53 169.96 28.35 Favored Glycine 0 CA--C 1.527 0.781 0 C-N-CA 124.085 0.85 . . . . 0.0 112.671 -173.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -117.24 121.2 40.54 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 124.492 1.117 . . . . 0.0 109.275 175.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -63.54 152.35 38.87 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.762 1.225 . . . . 0.0 112.382 178.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -86.85 -45.89 10.44 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 120.991 -1.068 . . . . 0.0 113.45 177.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 53.1 t -67.32 -54.49 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 123.799 0.84 . . . . 0.0 113.008 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 22.2 m -96.07 -12.86 24.21 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -172.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt 55.47 19.82 3.36 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 126.674 1.99 . . . . 0.0 114.77 -174.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -75.35 158.31 32.97 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.54 0.736 . . . . 0.0 112.153 175.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 53.7 mtt180 -128.83 153.13 47.73 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 127.022 2.129 . . . . 0.0 109.579 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 162.68 166.09 20.86 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 125.198 1.38 . . . . 0.0 111.421 176.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -65.82 144.5 56.8 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.388 0.675 . . . . 0.0 110.177 170.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -153.31 155.1 31.51 Favored Pre-proline 0 CA--C 1.539 0.527 0 O-C-N 120.507 -1.371 . . . . 0.0 110.978 175.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -65.38 118.63 5.62 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.23 1.953 . . . . 0.0 110.831 177.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 29.4 t -54.15 -38.77 65.85 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.75 -0.593 . . . . 0.0 112.109 177.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 14.7 m -60.08 -21.66 61.75 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 178.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -75.43 -3.47 34.0 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.561 1.145 . . . . 0.0 113.157 173.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 80.8 p -123.05 160.17 26.92 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.712 1.605 . . . . 0.0 110.747 172.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 10.1 mmpt? -121.5 163.95 17.98 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.708 1.203 . . . . 0.0 108.61 167.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.2 129.86 42.72 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.142 169.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -50.98 -62.23 1.74 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 123.96 1.838 . . . . 0.0 112.315 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -66.7 146.66 54.23 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 111.35 -2.659 . . . . 0.0 112.06 177.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 . . . . . 0 N--CA 1.487 1.404 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -175.737 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 526' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 120.76 0.314 . . . . 0.0 110.768 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 49.8 mt -66.65 132.75 94.12 Favored Pre-proline 0 N--CA 1.479 1.001 0 C-N-CA 124.652 1.181 . . . . 0.0 109.8 178.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -68.69 160.93 47.44 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 123.624 2.883 . . . . 0.0 112.036 177.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.77 144.85 89.98 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.31 2.006 . . . . 0.0 112.493 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -68.29 152.54 96.47 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 123.041 0.536 . . . . 0.0 111.875 172.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -70.07 174.41 9.81 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.608 2.872 . . . . 0.0 113.543 -178.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -89.37 5.27 45.89 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.208 1.403 . . . . 0.0 112.378 -178.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 29.3 p90 -137.08 155.06 76.29 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 124.353 1.061 . . . . 0.0 112.642 -177.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.75 153.13 53.65 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 123.806 3.004 . . . . 0.0 112.965 178.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -67.81 140.03 93.84 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 123.788 0.835 . . . . 0.0 112.968 -177.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -73.45 179.05 5.9 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 123.979 3.119 . . . . 0.0 112.789 176.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 25.8 p -132.79 154.79 81.58 Favored Pre-proline 0 N--CA 1.48 1.058 0 C-N-CA 125.122 1.369 . . . . 0.0 112.479 -175.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -66.94 165.15 27.1 Favored 'Trans proline' 0 CA--C 1.549 1.243 0 C-N-CA 123.437 2.758 . . . . 0.0 111.621 175.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -64.54 160.72 38.4 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.337 2.692 . . . . 0.0 113.147 178.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 540' ' ' VAL . . . . . . . . . . . . . 18.8 t -129.76 83.42 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 125.471 1.508 . . . . 0.0 109.235 -174.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 541' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -135.38 4.63 3.17 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.372 1.869 . . . . 0.0 113.955 -174.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 542' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 . . . . . 0 C--O 1.254 1.313 0 C-N-CA 125.426 1.491 . . . . 0.0 112.958 177.117 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.557 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 85.5 p -149.26 167.19 26.7 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.257 1.423 . . . . 0.0 112.172 178.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 338' ' ' HIS . . . . . . . . . . . . . 16.5 t60 -68.53 172.38 6.24 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.876 0.87 . . . . 0.0 112.143 171.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 339' ' ' MET . . . . . . . . . . . . . 25.1 ptp -139.75 160.29 40.24 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.782 1.233 . . . . 0.0 112.899 177.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -101.18 -1.14 34.64 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 125.088 1.355 . . . . 0.0 113.929 -175.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 341' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -76.33 111.86 12.22 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.509 1.524 . . . . 0.0 111.381 178.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 342' ' ' GLN . . . . . . . . . . . . . 72.6 tp60 -64.85 138.45 58.38 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.579 0.704 . . . . 0.0 111.107 172.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 3.2 mptm? -124.59 164.31 20.1 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 125.858 1.663 . . . . 0.0 111.179 176.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 16.7 m -131.82 159.53 43.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 126.219 1.808 . . . . 0.0 109.212 168.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -122.99 132.23 54.05 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 124.268 1.027 . . . . 0.0 109.352 -177.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 74.4 p -78.35 152.47 32.32 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.416 0.686 . . . . 0.0 110.824 -177.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.8 pp -125.7 -5.68 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 N-CA-C 114.441 1.275 . . . . 0.0 114.441 -178.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -153.86 160.67 30.68 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 126.117 1.767 . . . . 0.0 110.431 168.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -69.77 156.59 62.91 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 123.117 2.545 . . . . 0.0 113.139 174.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -141.51 152.05 43.82 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.224 1.41 . . . . 0.0 111.451 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 7.7 t -148.27 157.92 43.78 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.954 1.301 . . . . 0.0 113.018 -174.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -87.31 82.75 7.5 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.809 1.643 . . . . 0.0 112.866 -175.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . -66.07 105.31 1.23 Allowed Glycine 0 CA--C 1.537 1.424 0 C-N-CA 124.24 0.924 . . . . 0.0 112.704 174.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 33.5 m 52.13 44.07 29.96 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 126.04 1.736 . . . . 0.0 114.44 179.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -147.15 174.13 11.87 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -169.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.64 -16.12 3.86 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 126.135 1.774 . . . . 0.0 115.082 174.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 65.7 p -102.96 13.61 33.92 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 125.098 1.359 . . . . 0.0 113.511 -176.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 45.3 mt -101.49 116.09 31.99 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.728 1.211 . . . . 0.0 111.027 -176.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 27.6 tp -74.04 118.25 16.78 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.502 0.721 . . . . 0.0 110.962 178.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 59.9 p -87.91 154.34 20.6 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.282 1.033 . . . . 0.0 112.978 174.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -167.39 179.41 5.01 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.917 1.687 . . . . 0.0 112.014 -177.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -119.49 176.7 5.23 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.577 1.951 . . . . 0.0 110.942 172.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 66.5 tt0 -65.92 139.47 58.26 Favored 'General case' 0 CA--C 1.546 0.814 0 O-C-N 121.349 -0.844 . . . . 0.0 111.548 171.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 82.19 4.29 90.27 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.298 0.951 . . . . 0.0 115.376 175.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -77.07 170.25 16.86 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.946 1.298 . . . . 0.0 112.616 173.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 94.6 t -125.24 129.35 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.786 1.634 . . . . 0.0 109.09 -169.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 29.6 mt -134.81 137.8 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.94 0.896 . . . . 0.0 109.968 -177.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 10.1 m -96.9 140.06 32.01 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.993 1.317 . . . . 0.0 110.834 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 20.7 mt -78.91 136.67 37.34 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 122.943 0.497 . . . . 0.0 111.55 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 50.1 mt -114.63 -2.0 13.2 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.7 1.2 . . . . 0.0 113.045 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 371' ' ' ILE . . . . . 0.437 ' CG2' ' HD2' ' A' ' 372' ' ' PRO . 2.1 mt -134.82 143.28 45.64 Favored Pre-proline 0 N--CA 1.478 0.972 0 C-N-CA 126.623 1.969 . . . . 0.0 109.568 178.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 372' ' ' PRO . . . . . 0.437 ' HD2' ' CG2' ' A' ' 371' ' ' ILE . 56.1 Cg_endo -72.46 -9.73 24.5 Favored 'Trans proline' 0 CA--C 1.548 1.18 0 C-N-CA 123.203 2.602 . . . . 0.0 113.639 176.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -153.32 152.43 31.11 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.862 1.665 . . . . 0.0 112.302 174.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -71.83 169.91 14.76 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.769 1.228 . . . . 0.0 113.855 173.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -129.36 106.96 9.14 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.466 1.907 . . . . 0.0 110.047 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 51.05 31.69 6.73 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.097 1.359 . . . . 0.0 114.567 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 97.35 -11.79 65.19 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 125.465 1.507 . . . . 0.0 114.439 -178.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 77.8 m95 -89.28 123.94 33.95 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.49 1.116 . . . . 0.0 110.809 175.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 15.1 mt -90.14 156.76 18.12 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.536 0.735 . . . . 0.0 110.228 162.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -116.77 124.55 49.88 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.904 1.282 . . . . 0.0 107.616 169.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -148.74 171.95 28.99 Favored Glycine 0 CA--C 1.524 0.594 0 CA-C-N 115.659 -0.701 . . . . 0.0 113.376 -173.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -122.81 120.42 33.49 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.774 1.23 . . . . 0.0 109.859 177.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 25.2 t-80 -64.86 145.61 56.04 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.429 1.092 . . . . 0.0 111.66 178.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -80.19 -45.37 18.19 Favored 'General case' 0 CA--C 1.547 0.861 0 O-C-N 120.927 -1.108 . . . . 0.0 113.448 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 87.7 t -72.53 -53.78 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 177.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 35.2 m -86.41 -17.32 34.64 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.288 0.949 . . . . 0.0 113.142 -172.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp 53.96 21.31 2.8 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 126.69 1.996 . . . . 0.0 114.505 -173.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -80.55 152.46 28.62 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.189 0.596 . . . . 0.0 111.527 173.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 46.7 mtm-85 -119.44 155.6 31.73 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.252 1.821 . . . . 0.0 110.65 175.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 164.01 169.68 27.87 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.372 0.987 . . . . 0.0 112.217 174.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -66.53 145.75 55.28 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.351 0.661 . . . . 0.0 110.485 166.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -155.23 154.43 28.57 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 124.482 1.113 . . . . 0.0 110.391 172.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -65.37 124.14 12.48 Favored 'Trans proline' 0 CA--C 1.532 0.4 0 C-N-CA 122.581 2.188 . . . . 0.0 111.497 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 96.3 p -56.88 -37.21 71.06 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 8.7 p -67.66 -14.24 62.78 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.094 1.758 . . . . 0.0 115.503 179.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -79.86 -2.08 41.92 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 119.524 1.056 . . . . 0.0 113.106 168.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 77.0 p -126.86 166.07 18.15 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.446 1.498 . . . . 0.0 111.186 172.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -144.51 163.49 33.7 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.975 1.31 . . . . 0.0 110.346 171.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.52 124.58 19.5 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.809 0.844 . . . . 0.0 109.433 178.364 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 3.6 tp -49.74 -43.31 47.84 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 -172.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -77.67 -19.93 54.56 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 113.058 -1.883 . . . . 0.0 115.116 -175.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 . . . . . 0 N--CA 1.485 1.311 0 C-N-CA 125.939 1.696 . . . . 0.0 112.988 -171.518 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 526' ' ' HIS . . . . . . . . . . . . . 64.6 m80 . . . . . 0 N--CA 1.485 1.32 0 CA-C-O 120.869 0.366 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 63.6 mt -71.38 133.29 85.29 Favored Pre-proline 0 N--CA 1.477 0.885 0 C-N-CA 124.857 1.263 . . . . 0.0 109.429 176.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -69.41 159.85 52.07 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 123.561 2.841 . . . . 0.0 112.238 178.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.13 144.74 87.9 Favored 'Trans proline' 0 CA--C 1.535 0.529 0 C-N-CA 122.424 2.083 . . . . 0.0 112.148 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -73.89 156.7 87.93 Favored Pre-proline 0 CA--C 1.551 0.994 0 C-N-CA 123.243 0.617 . . . . 0.0 112.207 173.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -68.87 175.21 7.65 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.346 2.697 . . . . 0.0 113.128 176.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -92.2 9.03 35.42 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.853 1.261 . . . . 0.0 112.514 -178.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 34.9 p90 -138.31 154.16 73.53 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 124.846 1.259 . . . . 0.0 112.759 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.6 153.04 60.05 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 123.621 2.881 . . . . 0.0 112.547 178.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -67.52 144.16 97.56 Favored Pre-proline 0 CA--C 1.55 0.964 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -176.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.86 176.26 9.24 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.949 3.099 . . . . 0.0 112.555 178.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 22.5 p -129.39 154.24 80.67 Favored Pre-proline 0 N--CA 1.479 0.993 0 C-N-CA 124.759 1.224 . . . . 0.0 112.779 -171.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -67.85 162.09 41.13 Favored 'Trans proline' 0 CA--C 1.546 1.118 0 C-N-CA 123.28 2.653 . . . . 0.0 111.352 176.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -65.5 154.18 74.86 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.982 2.454 . . . . 0.0 112.482 177.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 540' ' ' VAL . . . . . . . . . . . . . 12.6 m -68.42 -10.91 13.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 127.316 2.246 . . . . 0.0 114.897 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 541' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -150.45 165.39 33.32 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.043 1.737 . . . . 0.0 111.963 177.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 542' ' ' ASN . . . . . . . . . . . . . 9.5 p30 . . . . . 0 C--O 1.253 1.249 0 C-N-CA 124.671 1.188 . . . . 0.0 113.684 174.797 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.495 0 N-CA-C 111.727 -0.549 . . . . 0.0 111.727 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 18.6 m -87.97 12.36 13.52 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.426 1.49 . . . . 0.0 114.902 -172.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 338' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 -142.71 144.13 32.57 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.283 1.433 . . . . 0.0 111.582 -174.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 339' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -152.26 174.84 13.29 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 126.131 1.773 . . . . 0.0 112.358 -177.008 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -131.25 48.22 2.45 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.409 1.483 . . . . 0.0 112.679 -172.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 341' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -123.78 99.55 6.34 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 126.248 1.819 . . . . 0.0 110.389 175.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 342' ' ' GLN . . . . . . . . . . . . . 70.5 tp60 -66.35 137.13 56.68 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.353 0.597 . . . . 0.0 111.352 174.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 3.1 mptm? -127.57 165.82 19.19 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.825 1.65 . . . . 0.0 111.868 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 16.2 m -135.25 157.15 39.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 126.725 2.01 . . . . 0.0 109.399 169.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -120.53 131.24 54.6 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.914 0.886 . . . . 0.0 110.364 178.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 71.3 p -73.49 151.75 40.94 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.06 0.944 . . . . 0.0 111.379 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.7 pp -124.3 -8.28 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -177.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -154.35 157.23 32.26 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 126.474 1.91 . . . . 0.0 109.906 169.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.3 157.4 61.97 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.093 2.529 . . . . 0.0 113.025 177.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -139.17 144.45 38.59 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.064 1.345 . . . . 0.0 111.259 178.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 55.0 m -142.26 134.21 27.25 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.803 1.641 . . . . 0.0 109.869 -171.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -67.01 -46.05 75.68 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -170.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 57.07 89.9 0.01 OUTLIER Glycine 0 CA--C 1.538 1.517 0 C-N-CA 125.153 1.358 . . . . 0.0 114.925 176.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 77.8 p 60.95 29.01 18.75 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 126.271 1.828 . . . . 0.0 115.127 -176.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -135.97 160.34 38.9 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.915 1.686 . . . . 0.0 111.895 -179.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 33.7 mtmm -125.13 -7.65 7.11 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -178.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 29.6 p -106.76 9.77 31.0 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.584 1.554 . . . . 0.0 113.096 -176.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 70.7 mt -108.0 128.97 55.13 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.997 1.319 . . . . 0.0 111.195 -177.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 31.1 tp -80.68 121.11 25.46 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.477 0.711 . . . . 0.0 110.642 176.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 47.4 p -90.19 152.62 21.01 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.564 1.145 . . . . 0.0 112.487 173.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -165.94 179.21 5.98 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.581 1.553 . . . . 0.0 112.34 -177.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -119.08 174.51 6.28 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.338 1.855 . . . . 0.0 111.205 174.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -68.62 137.99 54.68 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.044 0.938 . . . . 0.0 111.693 172.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 84.21 12.96 75.17 Favored Glycine 0 CA--C 1.536 1.39 0 N-CA-C 114.881 0.712 . . . . 0.0 114.881 174.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -95.48 160.91 14.29 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.96 1.704 . . . . 0.0 111.669 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 72.7 t -108.91 133.73 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.632 1.173 . . . . 0.0 109.74 -171.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 16.5 mt -133.88 139.23 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.446 1.098 . . . . 0.0 109.349 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 6.8 m -101.2 141.84 33.49 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.593 1.157 . . . . 0.0 110.134 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 23.7 mt -79.36 141.72 36.68 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.008 0.523 . . . . 0.0 111.943 -177.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 61.6 mt -116.46 -7.78 11.64 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.596 1.158 . . . . 0.0 113.003 178.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 7.5 mt -132.77 142.01 43.18 Favored Pre-proline 0 N--CA 1.478 0.969 0 C-N-CA 126.857 2.063 . . . . 0.0 109.807 175.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.08 -8.81 24.35 Favored 'Trans proline' 0 CA--C 1.548 1.177 0 C-N-CA 123.828 3.019 . . . . 0.0 114.788 175.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 26.8 pt-20 -152.69 155.4 37.18 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.811 1.645 . . . . 0.0 112.404 174.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -75.87 170.72 15.69 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.613 1.165 . . . . 0.0 113.853 174.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -132.51 107.86 8.74 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.533 1.933 . . . . 0.0 110.268 -178.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 50.65 30.53 4.96 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 124.993 1.317 . . . . 0.0 114.331 -178.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 100.14 -16.42 58.24 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 125.674 1.606 . . . . 0.0 114.425 -178.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -87.07 129.61 34.84 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.55 1.175 . . . . 0.0 111.198 178.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 12.5 mt -96.62 161.68 13.78 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.955 0.902 . . . . 0.0 110.311 163.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -124.83 123.75 40.62 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.201 1.4 . . . . 0.0 107.771 173.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -148.65 175.16 28.05 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-N 115.731 -0.668 . . . . 0.0 113.682 -172.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -126.07 120.62 30.7 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.254 1.422 . . . . 0.0 110.027 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -61.85 155.93 22.01 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.716 1.206 . . . . 0.0 111.887 179.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -98.46 -21.96 16.28 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 120.661 -1.274 . . . . 0.0 114.363 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 58.5 t -82.63 -33.81 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 C-N-CA 123.466 0.706 . . . . 0.0 112.718 178.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 5.5 t -127.33 -11.49 5.74 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.683 1.193 . . . . 0.0 113.694 -170.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? 54.68 23.02 4.42 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 125.753 1.621 . . . . 0.0 113.762 -177.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -69.25 154.47 41.99 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.688 1.195 . . . . 0.0 111.355 169.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 80.3 mtt180 -127.05 161.19 28.99 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.922 1.689 . . . . 0.0 110.947 -177.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 156.87 169.39 20.74 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 124.521 1.058 . . . . 0.0 112.449 174.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -67.1 147.87 52.6 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.144 0.497 . . . . 0.0 110.361 168.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -154.36 155.71 31.05 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 124.112 0.965 . . . . 0.0 110.75 172.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -65.15 120.39 7.6 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.314 2.009 . . . . 0.0 111.707 178.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 81.7 p -57.99 -22.77 51.04 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 114.225 1.195 . . . . 0.0 114.225 177.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 16.3 m -77.09 -17.69 58.52 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 176.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -79.36 -2.49 41.81 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.476 1.11 . . . . 0.0 113.687 177.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 67.2 p -123.36 163.68 20.31 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.623 1.569 . . . . 0.0 110.771 171.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -126.74 151.91 47.55 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 125.193 1.397 . . . . 0.0 108.886 169.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.69 128.2 35.41 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 176.263 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 60.0 tp -56.05 -36.52 68.12 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 115.699 1.74 . . . . 0.0 115.699 -169.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -149.97 125.04 9.99 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 127.627 2.371 . . . . 0.0 113.009 176.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 . . . . . 0 C--O 1.254 1.328 0 C-N-CA 125.209 1.404 . . . . 0.0 113.639 176.38 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 526' ' ' HIS . . . . . . . . . . . . . 53.6 m80 . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.65 0.262 . . . . 0.0 110.817 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 61.0 mt -65.56 132.01 94.93 Favored Pre-proline 0 N--CA 1.478 0.93 0 C-N-CA 124.785 1.234 . . . . 0.0 109.773 179.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -69.31 160.57 49.3 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 123.568 2.845 . . . . 0.0 112.074 178.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -63.99 143.45 85.03 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 122.281 1.987 . . . . 0.0 112.103 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -71.94 155.05 92.39 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 123.083 0.553 . . . . 0.0 112.053 172.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -68.8 174.87 8.02 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.419 2.746 . . . . 0.0 113.095 176.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -91.14 8.95 33.08 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.913 1.285 . . . . 0.0 112.407 -178.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 38.2 p90 -138.02 154.36 74.22 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 124.9 1.28 . . . . 0.0 112.827 -178.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -72.03 153.82 57.69 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.726 2.951 . . . . 0.0 112.58 178.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -68.97 142.9 93.88 Favored Pre-proline 0 CA--C 1.552 1.043 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -176.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -73.92 179.65 5.49 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 124.173 3.249 . . . . 0.0 113.071 176.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 26.9 p -132.89 155.29 81.32 Favored Pre-proline 0 N--CA 1.48 1.058 0 C-N-CA 125.25 1.42 . . . . 0.0 112.842 -174.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -67.46 164.64 30.04 Favored 'Trans proline' 0 CA--C 1.549 1.266 0 C-N-CA 123.504 2.803 . . . . 0.0 111.57 174.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -66.21 162.53 35.52 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 123.46 2.773 . . . . 0.0 113.085 176.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 540' ' ' VAL . . . . . . . . . . . . . 35.2 t -115.98 -7.47 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 125.752 1.621 . . . . 0.0 111.583 -177.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 541' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.58 84.98 2.11 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.679 1.992 . . . . 0.0 110.791 -175.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 542' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 . . . . . 0 C--O 1.254 1.294 0 C-N-CA 125.622 1.569 . . . . 0.0 113.426 -179.431 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 15.9 m . . . . . 0 C--O 1.237 0.434 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 19.0 ttmt -118.2 131.34 56.39 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.991 0.916 . . . . 0.0 109.728 177.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 27.8 p -73.47 156.93 37.71 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.265 0.626 . . . . 0.0 111.315 -177.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 2.1 pp -127.32 -5.84 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 N-CA-C 114.722 1.378 . . . . 0.0 114.722 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -156.58 158.58 31.46 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 125.852 1.661 . . . . 0.0 110.415 171.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.21 156.68 64.04 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.216 2.611 . . . . 0.0 112.918 176.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 52.1 t-80 . . . . . 0 N--CA 1.474 0.735 0 C-N-CA 125.093 1.357 . . . . 0.0 111.735 179.164 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 53.7 p . . . . . 0 N--CA 1.48 1.029 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 67.7 mt -104.39 124.52 49.36 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.763 1.225 . . . . 0.0 111.45 -177.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 23.7 tp -77.26 124.47 27.89 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.637 0.775 . . . . 0.0 110.828 176.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 58.5 p -94.97 153.38 17.68 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.876 1.27 . . . . 0.0 112.632 174.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -167.42 178.85 5.26 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.759 1.624 . . . . 0.0 112.132 -175.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -117.28 178.51 4.34 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.663 1.985 . . . . 0.0 110.93 173.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -66.96 141.3 57.66 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.304 -0.873 . . . . 0.0 111.47 170.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 79.29 5.44 89.14 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 124.232 0.92 . . . . 0.0 115.345 174.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -74.34 166.62 23.17 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.757 1.223 . . . . 0.0 112.822 176.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 90.8 t -119.36 126.33 75.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 125.666 1.586 . . . . 0.0 108.884 -174.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 26.4 mt -133.62 135.46 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.56 1.144 . . . . 0.0 109.059 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 59.3 m -102.72 136.73 42.01 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.757 1.223 . . . . 0.0 110.058 -177.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 19.5 mt -75.34 148.0 39.64 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -175.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 49.5 mt -121.25 0.93 10.2 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 124.782 1.233 . . . . 0.0 112.908 178.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 371' ' ' ILE . . . . . 0.531 HG22 ' HD2' ' A' ' 372' ' ' PRO . 2.2 mt -137.13 142.67 38.96 Favored Pre-proline 0 N--CA 1.48 1.05 0 C-N-CA 126.716 2.006 . . . . 0.0 109.794 177.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 372' ' ' PRO . . . . . 0.531 ' HD2' HG22 ' A' ' 371' ' ' ILE . 55.6 Cg_endo -72.27 -8.87 23.5 Favored 'Trans proline' 0 CA--C 1.546 1.085 0 C-N-CA 123.423 2.749 . . . . 0.0 113.959 176.036 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -153.63 152.82 31.29 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.855 1.662 . . . . 0.0 112.139 174.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -72.88 169.68 16.31 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.23 1.012 . . . . 0.0 113.63 174.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 18.2 tppt? -126.39 102.36 7.12 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.776 2.03 . . . . 0.0 109.801 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 52.67 30.36 8.64 Favored 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 178.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 102.09 -18.44 51.93 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.803 1.668 . . . . 0.0 114.199 -178.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 82.0 m95 -84.4 129.47 34.86 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.524 1.13 . . . . 0.0 111.119 175.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 11.4 mt -99.23 158.56 15.61 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.925 0.89 . . . . 0.0 110.285 165.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 380' ' ' TYR . . . . . 0.416 ' HB3' HD11 ' A' ' 371' ' ' ILE . 50.2 t80 -118.57 123.78 45.87 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.867 1.267 . . . . 0.0 107.721 171.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -148.62 172.43 28.81 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-N 115.854 -0.612 . . . . 0.0 113.602 -173.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -123.83 119.32 29.34 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.547 1.539 . . . . 0.0 109.402 176.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 25.0 t-80 -62.92 147.86 49.11 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.905 1.282 . . . . 0.0 111.546 177.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -80.39 -50.4 10.17 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 120.91 -1.119 . . . . 0.0 113.46 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 68.0 t -69.38 -49.0 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 O-C-N 121.37 -0.831 . . . . 0.0 113.111 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 20.3 t -86.11 -23.26 26.71 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.406 0.682 . . . . 0.0 112.646 -175.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 34.7 mmtm 53.46 20.51 2.06 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 126.187 1.795 . . . . 0.0 114.265 -169.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -76.41 152.78 36.12 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.458 0.703 . . . . 0.0 111.799 171.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 74.4 mtm180 -122.15 157.14 32.18 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.443 1.897 . . . . 0.0 111.195 177.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 161.02 170.57 25.81 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.529 1.061 . . . . 0.0 112.505 174.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -66.74 147.36 53.37 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.133 0.492 . . . . 0.0 110.313 166.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -154.73 155.73 30.76 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 124.304 1.042 . . . . 0.0 110.427 172.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -64.6 119.42 6.46 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.347 2.032 . . . . 0.0 110.822 176.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 28.9 t -55.79 -38.79 70.4 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.56 -0.712 . . . . 0.0 111.936 177.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 1.6 p -61.15 -17.39 52.61 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.306 1.842 . . . . 0.0 115.859 177.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -76.55 -0.34 22.85 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 119.705 1.139 . . . . 0.0 113.086 169.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 32.4 p . . . . . 0 N--CA 1.466 0.37 0 C-N-CA 126.081 1.752 . . . . 0.0 111.008 179.646 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 62.8 mt . . . . . 0 N--CA 1.478 0.935 0 CA-C-O 119.106 -0.473 . . . . 0.0 109.829 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -69.44 159.75 52.42 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 123.601 2.867 . . . . 0.0 112.264 178.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.23 144.95 87.98 Favored 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 122.374 2.05 . . . . 0.0 112.241 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -73.58 156.11 88.85 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 123.265 0.626 . . . . 0.0 112.224 173.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -69.14 174.73 8.55 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.48 2.787 . . . . 0.0 113.155 177.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -88.6 4.77 45.78 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.797 1.239 . . . . 0.0 112.62 -178.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 36.3 p90 -136.32 154.62 77.23 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 124.677 1.191 . . . . 0.0 112.829 -176.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.95 153.17 58.1 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 123.753 2.969 . . . . 0.0 112.779 178.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -68.7 143.15 94.67 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 123.732 0.813 . . . . 0.0 113.028 -177.033 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.73 176.86 8.82 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.992 3.128 . . . . 0.0 113.023 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 27.8 p -130.32 153.0 81.18 Favored Pre-proline 0 N--CA 1.478 0.959 0 C-N-CA 124.983 1.313 . . . . 0.0 112.82 -173.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -67.07 163.26 34.7 Favored 'Trans proline' 0 CA--C 1.548 1.183 0 C-N-CA 123.485 2.79 . . . . 0.0 111.338 176.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo . . . . . 0 CA--C 1.54 0.803 0 C-N-CA 123.007 2.471 . . . . 0.0 112.516 178.787 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 16.2 m . . . . . 0 C--O 1.236 0.387 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -113.45 133.4 55.22 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.675 0.79 . . . . 0.0 110.092 174.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 68.3 p -72.84 154.75 40.47 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.279 1.032 . . . . 0.0 111.175 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.9 pp -125.59 -6.41 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 -179.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -155.92 159.76 31.31 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 126.273 1.829 . . . . 0.0 109.889 169.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -68.75 155.96 67.02 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.041 2.494 . . . . 0.0 113.203 177.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 . . . . . 0 CA--C 1.541 0.605 0 C-N-CA 125.466 1.507 . . . . 0.0 111.409 178.711 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 75.8 p . . . . . 0 N--CA 1.483 1.177 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 69.0 mt -112.17 133.41 54.32 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.818 1.247 . . . . 0.0 111.762 -176.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 27.9 tp -87.72 121.27 29.94 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.096 0.958 . . . . 0.0 111.01 177.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 59.8 p -86.7 153.48 21.7 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.454 1.102 . . . . 0.0 112.866 172.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -167.53 178.34 5.47 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.901 1.68 . . . . 0.0 112.147 -178.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -118.54 175.96 5.48 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.877 2.071 . . . . 0.0 111.067 173.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -64.06 141.19 58.86 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.817 0.847 . . . . 0.0 111.404 169.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 75.47 11.49 84.28 Favored Glycine 0 CA--C 1.539 1.556 0 N-CA-C 114.975 0.75 . . . . 0.0 114.975 175.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -81.98 162.9 22.49 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.989 1.316 . . . . 0.0 112.036 173.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 86.9 t -117.35 129.2 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.96 1.304 . . . . 0.0 109.41 -172.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 30.5 mt -134.72 136.13 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.383 1.073 . . . . 0.0 109.474 -177.067 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 33.6 m -99.97 138.81 36.53 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.149 1.379 . . . . 0.0 110.31 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 20.8 mt -76.62 146.7 38.05 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 122.853 0.461 . . . . 0.0 112.219 -177.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 39.5 mt -120.07 -3.31 10.12 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 124.799 1.24 . . . . 0.0 112.773 177.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 371' ' ' ILE . . . . . 0.45 HG22 ' H ' ' A' ' 373' ' ' GLU . 6.2 mt -135.87 142.0 38.85 Favored Pre-proline 0 N--CA 1.481 1.101 0 C-N-CA 127.186 2.194 . . . . 0.0 109.917 177.371 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.13 -7.05 20.3 Favored 'Trans proline' 0 CA--C 1.546 1.121 0 C-N-CA 124.446 3.431 . . . . 0.0 115.248 175.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 373' ' ' GLU . . . . . 0.45 ' H ' HG22 ' A' ' 371' ' ' ILE . 18.1 pt-20 -151.48 167.34 28.33 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 126.091 1.756 . . . . 0.0 112.228 176.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -92.11 170.08 10.12 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.542 1.137 . . . . 0.0 113.036 175.003 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 10.5 tptp -133.51 111.09 10.41 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 126.366 1.866 . . . . 0.0 110.272 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 52.35 27.52 4.92 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 124.87 1.268 . . . . 0.0 114.257 -177.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 98.12 -14.31 62.63 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 125.727 1.632 . . . . 0.0 114.595 -176.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 75.7 m95 -87.04 133.31 33.61 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.412 1.106 . . . . 0.0 111.518 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 18.1 mt -102.01 162.59 12.79 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 124.342 1.057 . . . . 0.0 110.198 164.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -125.08 121.79 35.34 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.957 1.303 . . . . 0.0 107.733 175.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -145.44 174.12 25.57 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 115.542 -0.754 . . . . 0.0 114.139 -173.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -124.55 120.57 32.33 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.773 1.629 . . . . 0.0 109.798 177.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 15.8 t-80 -65.6 144.62 56.85 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.792 1.237 . . . . 0.0 111.952 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -77.71 -48.61 16.29 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 120.877 -1.139 . . . . 0.0 113.538 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 83.3 t -69.96 -48.99 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 124.03 0.932 . . . . 0.0 113.296 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 7.2 t -93.59 -16.05 24.77 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -171.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp 53.36 18.82 1.4 Allowed 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 127.024 2.13 . . . . 0.0 114.986 -173.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -78.01 156.11 30.33 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.411 0.684 . . . . 0.0 111.581 174.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -123.78 157.98 32.79 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.112 1.765 . . . . 0.0 110.652 177.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 159.68 168.86 22.26 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 124.252 0.93 . . . . 0.0 112.67 175.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -67.2 148.44 51.77 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.313 0.578 . . . . 0.0 110.258 168.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -154.36 154.39 29.5 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 124.526 1.13 . . . . 0.0 110.463 173.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -65.46 121.65 9.12 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.558 2.172 . . . . 0.0 110.883 177.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 30.4 t -56.44 -38.01 71.02 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.464 -0.772 . . . . 0.0 112.397 178.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 75.3 m -63.27 -19.6 64.71 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -73.08 -1.88 19.1 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.271 1.029 . . . . 0.0 113.192 171.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 53.8 p . . . . . 0 N--CA 1.467 0.412 0 C-N-CA 125.962 1.705 . . . . 0.0 111.441 178.071 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 64.1 mt . . . . . 0 CA--C 1.549 0.923 0 CA-C-O 119.009 -0.52 . . . . 0.0 109.759 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -69.76 158.73 55.95 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 123.459 2.772 . . . . 0.0 111.862 177.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.0 144.8 88.7 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 122.245 1.964 . . . . 0.0 112.256 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -69.74 154.77 94.47 Favored Pre-proline 0 CA--C 1.55 0.981 0 C-N-CA 122.962 0.505 . . . . 0.0 111.905 171.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -68.52 174.09 8.87 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.283 2.655 . . . . 0.0 113.009 177.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -86.65 1.95 50.13 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.463 1.105 . . . . 0.0 113.044 -178.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -132.74 153.57 81.12 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 124.736 1.215 . . . . 0.0 112.943 -176.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.4 152.97 61.16 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 123.694 2.929 . . . . 0.0 112.757 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -68.63 143.89 95.58 Favored Pre-proline 0 CA--C 1.551 1.013 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -73.54 -179.28 4.34 Favored 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 124.028 3.152 . . . . 0.0 112.791 176.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 22.2 p -134.28 155.07 80.21 Favored Pre-proline 0 N--CA 1.479 1.024 0 C-N-CA 125.247 1.419 . . . . 0.0 112.632 -175.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.59 163.13 36.22 Favored 'Trans proline' 0 CA--C 1.548 1.189 0 C-N-CA 123.512 2.808 . . . . 0.0 111.742 176.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo . . . . . 0 CA--C 1.54 0.786 0 C-N-CA 122.935 2.423 . . . . 0.0 112.576 177.764 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 15.7 m . . . . . 0 C--O 1.235 0.335 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -121.02 128.17 52.43 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.227 1.011 . . . . 0.0 109.901 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 59.0 p -71.79 154.04 41.56 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.01 0.924 . . . . 0.0 111.415 -177.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.8 pp -124.65 -8.36 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -156.01 159.54 31.45 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 126.731 2.012 . . . . 0.0 110.116 169.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.63 158.35 58.09 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.208 2.605 . . . . 0.0 113.331 177.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 . . . . . 0 N--CA 1.474 0.748 0 C-N-CA 124.98 1.312 . . . . 0.0 111.866 179.043 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 74.3 p . . . . . 0 N--CA 1.485 1.287 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 47.7 mt -97.37 120.43 37.71 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.714 1.206 . . . . 0.0 110.473 175.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 25.4 tp -73.18 131.95 42.63 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.494 0.718 . . . . 0.0 110.502 175.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 31.9 p -110.75 149.58 30.31 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.072 1.749 . . . . 0.0 112.395 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -167.11 179.08 5.33 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.149 1.379 . . . . 0.0 112.667 -169.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -116.49 177.0 4.85 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.712 2.005 . . . . 0.0 111.155 173.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -67.04 142.83 57.05 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.177 0.991 . . . . 0.0 111.888 170.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 75.61 5.39 78.32 Favored Glycine 0 CA--C 1.538 1.502 0 C-N-CA 124.376 0.988 . . . . 0.0 115.248 174.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -73.75 161.48 30.19 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.704 1.202 . . . . 0.0 111.723 171.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 59.3 t -112.51 138.32 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.485 1.114 . . . . 0.0 109.407 178.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 36.5 mt -136.26 140.77 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 124.717 1.207 . . . . 0.0 108.835 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 23.5 m -98.27 140.18 32.95 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.765 1.226 . . . . 0.0 110.853 178.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 22.7 mt -79.11 141.16 37.55 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 122.804 0.442 . . . . 0.0 111.554 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 63.1 mt -113.03 -4.45 13.86 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 124.673 1.189 . . . . 0.0 112.744 178.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 7.9 mt -132.92 141.76 42.21 Favored Pre-proline 0 N--CA 1.478 0.928 0 C-N-CA 127.001 2.12 . . . . 0.0 109.851 177.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.35 -7.98 22.42 Favored 'Trans proline' 0 CA--C 1.547 1.133 0 C-N-CA 123.974 3.116 . . . . 0.0 114.575 175.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -153.5 151.96 30.42 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.05 1.74 . . . . 0.0 112.062 175.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -74.62 171.33 14.05 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.417 1.087 . . . . 0.0 113.731 175.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -132.95 107.14 8.1 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.205 1.802 . . . . 0.0 110.249 -178.275 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 51.28 30.91 6.33 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 125.004 1.322 . . . . 0.0 114.343 -179.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 98.95 -16.75 59.1 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.772 1.653 . . . . 0.0 114.3 -177.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -85.75 132.06 34.21 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.308 1.043 . . . . 0.0 111.146 177.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 13.2 mt -100.7 159.94 14.76 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.939 0.896 . . . . 0.0 110.114 164.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -121.66 123.25 41.45 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 173.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -146.0 172.89 26.51 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-N 115.743 -0.662 . . . . 0.0 114.376 -172.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -124.68 116.46 22.41 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.88 1.672 . . . . 0.0 109.126 176.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 21.5 t-80 -61.88 144.29 55.14 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.818 1.247 . . . . 0.0 111.982 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -80.29 -45.32 18.07 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 121.217 -0.927 . . . . 0.0 112.705 -178.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 97.2 t -70.87 -52.73 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 124.256 1.022 . . . . 0.0 113.469 175.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 7.6 t -91.56 -15.61 28.41 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -171.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt 54.41 19.08 2.15 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 126.767 2.027 . . . . 0.0 114.777 -174.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -77.87 157.51 29.82 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.522 0.729 . . . . 0.0 111.822 174.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 54.1 mtt85 -128.52 155.9 44.14 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.007 1.723 . . . . 0.0 110.801 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 160.15 169.67 23.75 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 124.69 1.138 . . . . 0.0 112.03 176.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -66.8 147.17 53.6 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.114 0.566 . . . . 0.0 110.234 166.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -154.47 155.4 30.67 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 124.32 1.048 . . . . 0.0 110.17 172.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -65.64 120.1 7.23 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.167 1.911 . . . . 0.0 110.749 176.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 29.8 t -54.46 -38.45 66.37 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 121.897 -0.502 . . . . 0.0 111.958 176.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 17.9 m -58.58 -21.37 52.9 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.836 1.654 . . . . 0.0 115.255 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -77.41 0.27 23.17 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.606 1.163 . . . . 0.0 113.468 173.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 68.9 p . . . . . 0 N--CA 1.466 0.371 0 C-N-CA 125.945 1.698 . . . . 0.0 111.328 176.34 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 58.9 mt . . . . . 0 CA--C 1.55 0.946 0 CA-C-O 118.954 -0.546 . . . . 0.0 109.821 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.36 160.37 49.75 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 123.532 2.821 . . . . 0.0 112.079 178.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.99 144.16 86.99 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.331 2.02 . . . . 0.0 112.357 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -72.41 156.14 90.63 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 123.361 0.664 . . . . 0.0 112.138 172.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -68.75 175.02 7.76 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.443 2.762 . . . . 0.0 113.219 176.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -91.8 8.93 34.86 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.856 1.262 . . . . 0.0 112.35 -178.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 36.3 p90 -137.73 154.56 74.86 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 124.617 1.167 . . . . 0.0 112.786 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -72.07 153.54 57.46 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 123.763 2.975 . . . . 0.0 112.74 178.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -69.26 142.42 92.52 Favored Pre-proline 0 CA--C 1.551 1.008 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -175.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -73.86 179.75 5.38 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 124.173 3.249 . . . . 0.0 113.266 178.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 28.1 p -132.59 155.45 81.21 Favored Pre-proline 0 N--CA 1.479 0.988 0 C-N-CA 125.392 1.477 . . . . 0.0 113.024 -172.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.13 163.0 39.43 Favored 'Trans proline' 0 CA--C 1.548 1.197 0 C-N-CA 123.545 2.83 . . . . 0.0 111.936 175.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo . . . . . 0 CA--C 1.54 0.818 0 C-N-CA 123.376 2.717 . . . . 0.0 112.925 178.016 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 16.3 m . . . . . 0 C--O 1.237 0.409 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -115.95 132.13 56.74 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 124.396 1.079 . . . . 0.0 109.885 177.267 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 72.3 p -75.04 153.94 38.2 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.526 0.73 . . . . 0.0 111.366 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.9 pp -123.97 -7.92 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -156.38 158.77 31.62 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 126.102 1.761 . . . . 0.0 110.117 170.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.02 155.78 68.34 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 122.947 2.431 . . . . 0.0 112.968 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 . . . . . 0 N--CA 1.471 0.616 0 C-N-CA 124.931 1.292 . . . . 0.0 111.621 178.772 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 36.7 p . . . . . 0 N--CA 1.482 1.168 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 81.8 mt -106.23 126.22 51.96 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.961 1.305 . . . . 0.0 110.963 -176.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 31.5 tp -73.86 141.8 46.09 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 122.987 0.515 . . . . 0.0 110.205 171.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 58.0 p -121.65 148.86 44.02 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.192 1.397 . . . . 0.0 111.721 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -165.54 178.5 6.68 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.97 1.308 . . . . 0.0 112.447 -167.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -117.7 177.63 4.69 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 127.117 2.167 . . . . 0.0 110.802 174.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -67.54 141.5 56.84 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 121.215 -0.928 . . . . 0.0 111.595 170.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 77.48 6.7 86.84 Favored Glycine 0 CA--C 1.538 1.485 0 N-CA-C 115.274 0.87 . . . . 0.0 115.274 176.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -74.02 164.67 26.32 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 118.437 1.119 . . . . 0.0 112.02 170.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 77.2 t -120.61 128.07 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.337 1.455 . . . . 0.0 109.125 -174.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 31.0 mt -132.55 137.06 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 123.399 0.68 . . . . 0.0 109.506 -175.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 20.5 m -98.02 140.27 32.61 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.334 1.054 . . . . 0.0 110.649 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 23.8 mt -81.17 142.94 32.74 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 122.975 0.51 . . . . 0.0 111.718 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 39.2 mt -116.04 -4.54 12.0 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.42 1.088 . . . . 0.0 113.003 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 6.9 mt -134.13 141.53 39.83 Favored Pre-proline 0 N--CA 1.477 0.88 0 C-N-CA 127.007 2.123 . . . . 0.0 109.57 177.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.81 -7.36 20.98 Favored 'Trans proline' 0 CA--C 1.549 1.255 0 C-N-CA 123.98 3.12 . . . . 0.0 114.561 176.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -150.3 154.49 37.96 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.073 1.749 . . . . 0.0 111.478 173.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -78.47 168.82 19.22 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 121.006 -1.059 . . . . 0.0 113.156 173.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -121.89 103.01 8.54 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 126.253 1.821 . . . . 0.0 110.253 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 52.14 31.47 9.05 Favored 'General case' 0 CA--C 1.555 1.136 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 177.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 99.84 -4.33 57.67 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 125.317 1.437 . . . . 0.0 114.675 -178.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -101.69 118.47 37.01 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.199 1.4 . . . . 0.0 110.67 176.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 12.6 mt -82.93 161.49 21.81 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.393 0.616 . . . . 0.0 110.546 162.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -126.04 123.5 38.56 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.152 1.381 . . . . 0.0 107.975 171.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -150.67 173.88 30.13 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-N 115.933 -0.576 . . . . 0.0 114.509 -169.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -126.21 120.29 29.67 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.653 1.581 . . . . 0.0 110.11 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 25.0 t-80 -66.4 156.07 35.66 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.256 1.422 . . . . 0.0 112.554 178.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -83.05 -48.18 10.88 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 178.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 71.2 t -75.66 -49.07 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 125.206 1.402 . . . . 0.0 113.393 -178.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 23.2 t -87.77 -23.34 24.12 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 118.786 0.721 . . . . 0.0 112.561 -176.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 7.0 mmmm 54.91 19.49 2.67 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 126.529 1.932 . . . . 0.0 114.006 -171.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -75.09 155.26 37.33 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.896 0.878 . . . . 0.0 111.817 172.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 -121.49 156.37 32.93 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 126.111 1.764 . . . . 0.0 111.429 176.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 165.57 169.63 29.44 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.898 1.237 . . . . 0.0 112.042 175.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -66.99 149.92 49.96 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.06 0.457 . . . . 0.0 110.126 166.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -155.87 154.37 27.66 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 124.263 1.025 . . . . 0.0 110.162 171.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 393' ' ' PRO . . . . . 0.4 ' HB3' ' HB1' ' B' ' 535' ' ' ALA . 20.4 Cg_endo -63.78 119.84 7.03 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.181 1.921 . . . . 0.0 110.406 177.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.1 -36.41 70.59 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 121.391 -0.818 . . . . 0.0 111.564 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 18.2 m -59.43 -22.11 60.99 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 126.748 2.019 . . . . 0.0 114.944 178.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -74.88 0.72 14.66 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.763 1.225 . . . . 0.0 113.217 172.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 36.6 p . . . . . 0 N--CA 1.468 0.461 0 C-N-CA 125.735 1.614 . . . . 0.0 111.803 179.859 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 57.9 mt . . . . . 0 N--CA 1.479 0.997 0 CA-C-O 119.033 -0.508 . . . . 0.0 109.663 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -69.93 160.49 49.48 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 123.574 2.849 . . . . 0.0 112.138 177.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.07 144.49 87.52 Favored 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 122.294 1.996 . . . . 0.0 112.136 178.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -73.14 155.49 90.12 Favored Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 123.118 0.567 . . . . 0.0 112.027 173.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -69.07 174.7 8.52 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 123.537 2.824 . . . . 0.0 113.128 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -92.34 9.02 35.82 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.913 1.285 . . . . 0.0 112.472 -178.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 34.9 p90 -137.85 153.86 74.11 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 124.621 1.168 . . . . 0.0 112.842 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -71.92 151.91 57.08 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.579 2.853 . . . . 0.0 112.364 177.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 535' ' ' ALA . . . . . 0.4 ' HB1' ' HB3' ' A' ' 393' ' ' PRO . . . -69.91 146.3 95.16 Favored Pre-proline 0 CA--C 1.549 0.923 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -175.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.95 178.12 6.87 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 123.979 3.119 . . . . 0.0 112.833 176.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 25.3 p -132.36 154.02 81.43 Favored Pre-proline 0 N--CA 1.478 0.941 0 C-N-CA 125.316 1.447 . . . . 0.0 112.449 -175.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -66.5 162.24 37.6 Favored 'Trans proline' 0 CA--C 1.548 1.186 0 C-N-CA 123.353 2.702 . . . . 0.0 111.48 175.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 CA--C 1.541 0.827 0 C-N-CA 123.167 2.578 . . . . 0.0 112.713 179.085 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 17.4 m . . . . . 0 C--O 1.234 0.288 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -118.19 134.99 54.52 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.292 1.037 . . . . 0.0 110.362 176.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 81.3 p -77.44 154.21 32.83 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.065 1.346 . . . . 0.0 111.674 -176.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.9 pp -119.7 -9.62 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -178.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -154.69 159.04 32.25 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 126.427 1.891 . . . . 0.0 110.538 170.044 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -69.88 158.01 58.25 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.225 2.617 . . . . 0.0 112.987 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 35.9 t-80 . . . . . 0 CA--C 1.539 0.539 0 C-N-CA 125.835 1.654 . . . . 0.0 111.193 -179.242 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 41.2 p . . . . . 0 N--CA 1.479 1.006 0 N-CA-C 114.004 1.112 . . . . 0.0 114.004 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -102.68 118.52 37.02 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.096 1.358 . . . . 0.0 110.773 -171.223 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 28.5 tp -72.25 120.64 18.14 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 122.999 0.52 . . . . 0.0 110.736 176.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 50.1 m -95.54 147.97 23.0 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.315 1.046 . . . . 0.0 111.982 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -164.5 178.02 7.71 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.131 1.372 . . . . 0.0 113.215 -171.315 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -116.71 175.12 5.72 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.373 1.869 . . . . 0.0 111.681 174.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -64.31 140.72 58.9 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.01 0.924 . . . . 0.0 111.563 170.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 75.12 6.31 79.06 Favored Glycine 0 CA--C 1.539 1.532 0 C-N-CA 123.985 0.803 . . . . 0.0 115.076 176.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -77.02 161.62 28.18 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.731 1.212 . . . . 0.0 111.983 174.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 91.9 t -114.64 131.53 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 124.952 1.301 . . . . 0.0 109.841 -172.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 23.8 mt -135.23 139.73 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.204 1.402 . . . . 0.0 108.839 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 25.0 m -100.88 138.66 37.62 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.16 1.384 . . . . 0.0 110.302 -178.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 23.0 mt -79.15 136.37 37.09 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 118.138 0.426 . . . . 0.0 111.768 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 24.9 mt -114.36 -10.13 12.69 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.308 1.043 . . . . 0.0 113.089 -179.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 10.0 mt -126.69 141.16 39.47 Favored Pre-proline 0 N--CA 1.475 0.822 0 C-N-CA 126.565 1.946 . . . . 0.0 109.588 175.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.12 -7.71 21.51 Favored 'Trans proline' 0 CA--C 1.548 1.203 0 C-N-CA 123.8 3.0 . . . . 0.0 114.615 176.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -152.52 153.27 33.12 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.686 1.595 . . . . 0.0 112.368 176.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 19.2 pm0 -75.56 169.06 18.83 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.652 1.181 . . . . 0.0 113.619 173.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -130.63 106.67 8.65 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 126.75 2.02 . . . . 0.0 109.992 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 51.12 30.48 5.62 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 124.926 1.29 . . . . 0.0 114.41 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 100.94 -14.06 58.81 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 125.807 1.67 . . . . 0.0 114.475 -178.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 82.0 m95 -89.42 135.47 33.57 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.281 1.032 . . . . 0.0 111.633 178.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 18.9 mt -107.17 161.02 15.14 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.833 1.253 . . . . 0.0 109.973 166.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -123.16 120.05 32.05 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.671 1.188 . . . . 0.0 107.884 175.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -143.7 170.96 25.52 Favored Glycine 0 CA--C 1.527 0.844 0 CA-C-N 115.611 -0.722 . . . . 0.0 114.199 -173.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -120.37 118.43 30.34 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.424 1.489 . . . . 0.0 110.114 178.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 19.8 t-80 -63.4 147.43 51.24 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.903 1.281 . . . . 0.0 112.059 178.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -79.87 -49.46 11.9 Favored 'General case' 0 CA--C 1.547 0.865 0 O-C-N 120.868 -1.145 . . . . 0.0 113.411 177.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 63.7 t -68.8 -50.78 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.993 0.917 . . . . 0.0 113.234 178.213 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 23.0 t -86.15 -23.56 26.53 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.439 0.695 . . . . 0.0 112.868 -173.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp 54.71 16.42 1.38 Allowed 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 126.655 1.982 . . . . 0.0 114.66 -168.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -75.17 153.35 38.21 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.387 0.675 . . . . 0.0 111.794 172.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 82.4 mtm180 -124.06 151.1 44.22 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 126.42 1.888 . . . . 0.0 110.76 177.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 170.26 168.31 31.92 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 124.521 1.057 . . . . 0.0 112.146 175.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -65.5 145.68 55.81 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.136 0.493 . . . . 0.0 110.237 167.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -153.33 155.23 31.59 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 124.432 1.093 . . . . 0.0 111.037 175.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -65.65 121.7 9.15 Favored 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 122.496 2.131 . . . . 0.0 111.715 178.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 41.0 t -59.55 -27.75 66.49 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 121.644 -0.66 . . . . 0.0 112.649 174.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 17.8 m -66.96 -17.94 65.15 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 174.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -83.38 -2.24 55.3 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.717 1.207 . . . . 0.0 113.543 178.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 67.1 p . . . . . 0 N--CA 1.472 0.635 0 C-N-CA 126.29 1.836 . . . . 0.0 109.897 172.017 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 45.2 mt . . . . . 0 N--CA 1.476 0.862 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -69.16 160.64 49.09 Favored 'Trans proline' 0 CA--C 1.545 1.047 0 C-N-CA 123.321 2.681 . . . . 0.0 111.963 177.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -64.52 145.86 88.26 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 122.286 1.99 . . . . 0.0 112.321 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -68.63 153.24 96.06 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 122.975 0.51 . . . . 0.0 111.85 171.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -69.56 174.48 9.27 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 123.487 2.791 . . . . 0.0 113.165 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -87.94 2.9 50.5 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.608 1.163 . . . . 0.0 112.957 -178.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 37.5 p90 -133.86 154.48 80.44 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 124.744 1.217 . . . . 0.0 112.778 -176.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.47 152.62 60.4 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 123.625 2.883 . . . . 0.0 112.688 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -66.96 142.0 97.07 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 123.703 0.801 . . . . 0.0 113.033 -177.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.19 176.94 8.46 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 123.852 3.035 . . . . 0.0 112.836 177.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 31.9 p -131.56 154.5 81.87 Favored Pre-proline 0 N--CA 1.478 0.951 0 C-N-CA 125.254 1.422 . . . . 0.0 112.659 -173.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.28 162.89 40.03 Favored 'Trans proline' 0 CA--C 1.548 1.18 0 C-N-CA 123.562 2.842 . . . . 0.0 111.94 176.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo . . . . . 0 CA--C 1.54 0.8 0 C-N-CA 123.236 2.624 . . . . 0.0 112.562 178.733 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 15.3 m . . . . . 0 C--O 1.234 0.281 0 CA-C-O 121.292 0.568 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -122.78 132.55 54.27 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.45 1.1 . . . . 0.0 109.699 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 74.2 p -78.67 152.42 31.66 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.502 1.121 . . . . 0.0 111.172 -177.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.8 pp -120.95 -9.33 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 -178.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -153.38 158.62 32.72 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 126.286 1.834 . . . . 0.0 110.308 168.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -69.09 156.93 63.59 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.407 2.738 . . . . 0.0 113.271 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 44.0 t-80 . . . . . 0 N--CA 1.473 0.676 0 C-N-CA 125.516 1.526 . . . . 0.0 111.4 178.602 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 56.3 p . . . . . 0 N--CA 1.479 1.017 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 56.2 mt -102.08 132.32 48.01 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.606 1.162 . . . . 0.0 111.13 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 28.2 tp -83.66 120.11 25.58 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.06 0.544 . . . . 0.0 110.872 175.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 54.7 p -88.54 152.46 21.84 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.566 1.147 . . . . 0.0 112.637 172.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -167.88 177.57 5.63 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.532 1.533 . . . . 0.0 112.304 -176.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -117.07 174.46 6.09 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.452 1.901 . . . . 0.0 111.452 174.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -64.27 140.49 58.87 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.442 -0.786 . . . . 0.0 111.608 170.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 77.57 3.76 83.63 Favored Glycine 0 CA--C 1.537 1.406 0 C-N-CA 124.349 0.976 . . . . 0.0 115.117 175.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -72.1 168.36 18.3 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.527 1.131 . . . . 0.0 112.344 173.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 91.2 t -118.91 130.42 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.603 1.561 . . . . 0.0 108.935 -174.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 17.2 mt -134.35 138.32 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.401 1.08 . . . . 0.0 109.57 -178.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 11.8 m -104.31 139.22 39.61 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.144 1.378 . . . . 0.0 110.72 -176.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 25.9 mt -79.17 142.81 36.0 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -173.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 29.8 mt -119.18 -8.8 10.09 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.514 1.125 . . . . 0.0 113.07 178.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 371' ' ' ILE . . . . . 0.441 HG22 ' H ' ' A' ' 373' ' ' GLU . 5.7 mt -134.73 141.25 37.94 Favored Pre-proline 0 N--CA 1.478 0.957 0 C-N-CA 126.833 2.053 . . . . 0.0 109.397 176.581 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.64 -0.6 10.01 Favored 'Trans proline' 0 CA--C 1.548 1.219 0 C-N-CA 124.62 3.546 . . . . 0.0 114.601 175.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 373' ' ' GLU . . . . . 0.441 ' H ' HG22 ' A' ' 371' ' ' ILE . 12.6 pt-20 -151.05 175.84 11.71 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.779 2.032 . . . . 0.0 111.535 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -116.16 164.96 13.71 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.148 1.379 . . . . 0.0 112.928 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -123.21 106.52 10.81 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 126.121 1.768 . . . . 0.0 110.323 -176.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 49.96 33.1 6.25 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.314 1.446 . . . . 0.0 114.789 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 96.82 -2.49 62.07 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.113 1.34 . . . . 0.0 114.628 -178.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 78.8 m95 -101.47 121.89 42.79 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.158 1.383 . . . . 0.0 110.763 177.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 13.1 mt -88.42 164.45 15.49 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.424 0.689 . . . . 0.0 110.151 162.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -127.29 121.03 30.01 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 124.953 1.301 . . . . 0.0 108.088 173.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -147.84 177.22 26.24 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.137 0.875 . . . . 0.0 113.865 -170.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -129.63 124.16 33.03 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.541 1.536 . . . . 0.0 110.555 -177.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -66.63 140.88 57.95 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.33 1.052 . . . . 0.0 112.164 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -73.05 -36.75 66.95 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 120.939 -1.1 . . . . 0.0 113.511 177.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 59.1 t -77.31 -34.43 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -173.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 8.5 t -124.62 -12.29 7.19 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.704 1.201 . . . . 0.0 113.442 -168.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? 56.37 16.91 2.62 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 125.995 1.718 . . . . 0.0 114.739 -175.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -66.99 147.24 53.48 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.204 1.002 . . . . 0.0 111.186 170.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -121.76 156.52 32.98 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.845 1.658 . . . . 0.0 111.516 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 164.52 170.17 29.09 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 124.162 0.886 . . . . 0.0 113.027 173.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -65.85 145.18 56.26 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.184 0.594 . . . . 0.0 110.346 168.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -153.48 153.46 29.18 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 124.125 0.97 . . . . 0.0 111.314 174.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -63.49 121.46 9.25 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.546 2.164 . . . . 0.0 111.345 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.66 -17.38 64.0 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 121.296 -0.877 . . . . 0.0 113.036 178.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 77.6 p -73.98 -22.19 59.71 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.777 2.031 . . . . 0.0 114.159 174.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -79.8 -1.11 37.36 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.254 1.421 . . . . 0.0 113.425 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 69.9 p . . . . . 0 N--CA 1.471 0.599 0 C-N-CA 126.584 1.954 . . . . 0.0 110.873 174.658 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 69.3 mt . . . . . 0 N--CA 1.477 0.923 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.28 160.34 49.91 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 123.57 2.847 . . . . 0.0 112.16 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.07 144.87 88.55 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.378 2.052 . . . . 0.0 112.238 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -73.42 157.13 88.35 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 123.387 0.675 . . . . 0.0 112.192 173.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -68.34 174.13 8.64 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.289 2.659 . . . . 0.0 113.157 176.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -86.26 0.28 54.17 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.651 1.18 . . . . 0.0 113.02 -178.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 38.4 p90 -133.28 153.57 80.69 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 124.792 1.237 . . . . 0.0 113.003 -174.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -71.45 152.54 60.46 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.542 2.828 . . . . 0.0 112.317 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -68.12 149.03 98.3 Favored Pre-proline 0 CA--C 1.55 0.952 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -176.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -72.27 -176.83 2.35 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 124.122 3.215 . . . . 0.0 112.801 176.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 24.3 p -137.04 153.89 75.58 Favored Pre-proline 0 N--CA 1.476 0.855 0 C-N-CA 125.341 1.457 . . . . 0.0 112.649 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -67.61 165.24 28.11 Favored 'Trans proline' 0 CA--C 1.548 1.176 0 C-N-CA 123.504 2.803 . . . . 0.0 111.948 175.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo . . . . . 0 CA--C 1.541 0.86 0 C-N-CA 123.453 2.769 . . . . 0.0 113.351 177.194 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 16.0 m . . . . . 0 C--O 1.236 0.343 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -119.26 132.01 55.85 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.954 0.901 . . . . 0.0 109.904 178.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 66.8 p -74.74 149.89 39.63 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 124.852 1.261 . . . . 0.0 111.483 -178.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.7 pp -124.63 -7.82 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -176.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -154.95 157.19 31.89 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 126.67 1.988 . . . . 0.0 109.652 169.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -69.05 158.34 58.28 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.883 2.388 . . . . 0.0 112.439 177.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 36.3 t-80 . . . . . 0 N--CA 1.475 0.794 0 C-N-CA 125.048 1.339 . . . . 0.0 112.018 -179.166 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 32.6 p . . . . . 0 N--CA 1.485 1.3 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 49.3 mt -110.49 134.68 52.13 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.308 1.443 . . . . 0.0 110.921 -177.042 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 31.8 tp -83.21 126.05 32.22 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.871 0.868 . . . . 0.0 110.953 177.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 69.8 m -91.38 147.49 22.99 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.405 1.082 . . . . 0.0 111.957 173.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -163.21 177.56 8.94 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.708 1.603 . . . . 0.0 112.19 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -131.98 154.03 49.74 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.743 2.017 . . . . 0.0 111.5 178.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -50.89 130.59 25.51 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.716 0.806 . . . . 0.0 112.748 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 94.93 -14.27 65.63 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 124.342 0.973 . . . . 0.0 114.362 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -68.75 155.44 40.12 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.378 1.089 . . . . 0.0 112.165 174.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 69.3 t -111.74 142.52 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 125.823 1.649 . . . . 0.0 109.893 -175.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 16.9 mt -136.59 138.61 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.107 1.363 . . . . 0.0 109.024 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 18.5 m -102.55 137.24 41.04 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.705 1.202 . . . . 0.0 110.2 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 27.0 mt -77.04 143.51 39.26 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 122.935 0.494 . . . . 0.0 111.966 -175.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 42.5 mt -116.77 -7.18 11.52 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 124.73 1.212 . . . . 0.0 113.084 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 7.1 mt -130.83 140.41 38.59 Favored Pre-proline 0 N--CA 1.477 0.892 0 C-N-CA 126.617 1.967 . . . . 0.0 109.391 176.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.01 -7.29 20.77 Favored 'Trans proline' 0 CA--C 1.547 1.14 0 C-N-CA 123.582 2.854 . . . . 0.0 114.849 176.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -152.67 152.24 31.51 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.85 1.66 . . . . 0.0 111.937 174.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -76.45 170.45 16.36 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.626 1.17 . . . . 0.0 113.68 176.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -129.7 106.25 8.58 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.337 1.855 . . . . 0.0 110.142 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 49.92 32.51 5.61 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 125.328 1.451 . . . . 0.0 114.559 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 99.65 -14.37 60.56 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 125.506 1.527 . . . . 0.0 114.388 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -89.01 134.03 34.13 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.662 1.231 . . . . 0.0 111.457 176.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 13.1 mt -102.1 162.09 13.18 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.533 1.133 . . . . 0.0 110.277 165.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -124.07 123.04 39.46 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.981 1.312 . . . . 0.0 107.924 172.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -149.27 175.01 28.68 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 115.644 -0.707 . . . . 0.0 113.704 -170.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -126.47 122.72 36.02 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.272 1.429 . . . . 0.0 110.73 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -63.13 149.0 46.35 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.834 1.254 . . . . 0.0 112.353 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -88.34 -24.98 22.99 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 120.859 -1.151 . . . . 0.0 113.903 178.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 59.1 t -80.33 -35.01 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 O-C-N 121.352 -0.843 . . . . 0.0 112.658 -179.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 6.6 t -128.62 -10.79 5.02 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.59 1.156 . . . . 0.0 113.707 -169.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 4.8 mptt 53.82 24.65 4.6 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 125.432 1.493 . . . . 0.0 113.512 -175.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -68.79 147.45 51.75 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.6 1.16 . . . . 0.0 110.92 168.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 74.0 mtm-85 -120.2 157.28 29.4 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.556 1.542 . . . . 0.0 111.821 178.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 164.86 169.42 28.45 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.643 1.116 . . . . 0.0 112.584 175.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -69.61 148.01 49.94 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 122.802 0.441 . . . . 0.0 110.54 169.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -155.47 155.97 30.36 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 123.98 0.912 . . . . 0.0 111.685 175.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -65.02 121.1 8.48 Favored 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 122.81 2.34 . . . . 0.0 111.883 177.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 89.8 p -60.23 -22.4 62.98 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 176.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 18.1 m -74.59 -18.37 60.58 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 175.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -80.65 -0.86 39.97 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.712 1.205 . . . . 0.0 113.133 178.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 62.2 p . . . . . 0 N--CA 1.467 0.382 0 C-N-CA 125.871 1.668 . . . . 0.0 111.516 175.52 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 63.6 mt . . . . . 0 CA--C 1.55 0.943 0 CA-C-O 119.004 -0.522 . . . . 0.0 109.682 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.92 161.33 46.36 Favored 'Trans proline' 0 CA--C 1.545 1.05 0 C-N-CA 123.573 2.849 . . . . 0.0 112.091 177.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.16 144.46 86.92 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.271 1.981 . . . . 0.0 112.707 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -72.15 156.5 90.62 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 123.47 0.708 . . . . 0.0 112.194 171.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.42 174.37 9.32 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.435 2.757 . . . . 0.0 113.222 176.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -89.24 3.16 52.92 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.886 1.274 . . . . 0.0 113.016 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 40.8 p90 -134.15 154.42 80.09 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 124.764 1.226 . . . . 0.0 112.91 -175.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -71.54 153.37 60.31 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 123.689 2.926 . . . . 0.0 112.721 178.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -68.21 142.64 95.07 Favored Pre-proline 0 CA--C 1.553 1.081 0 C-N-CA 124.078 0.951 . . . . 0.0 113.215 -176.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.38 177.2 8.21 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 124.125 3.217 . . . . 0.0 113.002 176.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 35.6 p -132.43 153.35 81.17 Favored Pre-proline 0 N--CA 1.479 0.986 0 C-N-CA 125.289 1.436 . . . . 0.0 112.848 -175.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -69.17 162.94 39.73 Favored 'Trans proline' 0 CA--C 1.549 1.271 0 C-N-CA 123.699 2.933 . . . . 0.0 112.103 177.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo . . . . . 0 CA--C 1.541 0.83 0 C-N-CA 123.409 2.74 . . . . 0.0 113.223 179.159 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 16.8 m . . . . . 0 N--CA 1.467 0.376 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -115.07 132.96 56.43 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.752 0.821 . . . . 0.0 110.61 174.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 81.7 p -72.06 152.29 42.51 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.411 1.084 . . . . 0.0 111.185 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.8 pp -121.97 -8.86 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -178.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -155.06 158.18 32.02 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 127.04 2.136 . . . . 0.0 109.897 169.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -68.85 158.01 59.57 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.116 2.544 . . . . 0.0 112.691 177.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 . . . . . 0 CA--C 1.542 0.648 0 C-N-CA 125.117 1.367 . . . . 0.0 111.696 -179.533 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 39.8 p . . . . . 0 N--CA 1.482 1.132 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 66.6 mt -101.66 128.15 48.09 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.968 1.307 . . . . 0.0 110.86 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 33.1 tp -78.32 121.35 24.33 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.208 0.603 . . . . 0.0 110.171 173.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 71.0 m -94.97 146.72 24.05 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.384 1.074 . . . . 0.0 111.438 175.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -162.58 178.14 8.82 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.252 1.421 . . . . 0.0 112.455 -175.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -116.47 173.52 6.56 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.145 1.778 . . . . 0.0 111.456 174.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -65.33 142.03 58.38 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.041 0.936 . . . . 0.0 111.565 171.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 75.41 9.36 84.45 Favored Glycine 0 CA--C 1.538 1.517 0 N-CA-C 114.808 0.683 . . . . 0.0 114.808 177.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -81.6 161.93 23.31 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.597 1.159 . . . . 0.0 111.705 172.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 31.2 t -115.42 135.35 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.735 1.214 . . . . 0.0 109.35 -174.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 18.4 mt -138.16 135.82 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.496 1.118 . . . . 0.0 109.342 -176.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 12.5 m -92.64 141.85 28.02 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.246 1.018 . . . . 0.0 110.476 174.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 23.0 mt -82.25 143.2 31.51 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 122.968 0.507 . . . . 0.0 111.64 178.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 47.2 mt -114.37 -4.65 12.95 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 124.591 1.156 . . . . 0.0 112.841 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 371' ' ' ILE . . . . . 0.4 HG22 ' H ' ' A' ' 373' ' ' GLU . 6.9 mt -134.65 141.71 39.8 Favored Pre-proline 0 N--CA 1.48 1.045 0 C-N-CA 127.048 2.139 . . . . 0.0 109.66 177.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.2 -8.07 22.11 Favored 'Trans proline' 0 CA--C 1.547 1.171 0 C-N-CA 124.025 3.15 . . . . 0.0 114.706 176.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 373' ' ' GLU . . . . . 0.4 ' H ' HG22 ' A' ' 371' ' ' ILE . 26.2 pt-20 -151.26 160.21 43.94 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.823 1.649 . . . . 0.0 111.94 173.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -85.42 169.9 13.22 Favored 'General case' 0 CA--C 1.55 0.96 0 O-C-N 121.048 -1.032 . . . . 0.0 113.026 177.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -126.63 105.82 8.97 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.731 2.012 . . . . 0.0 109.826 -177.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 50.85 31.42 6.07 Favored 'General case' 0 CA--C 1.555 1.145 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 100.79 -11.09 59.16 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 125.482 1.515 . . . . 0.0 114.408 -178.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -95.22 126.9 40.86 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.543 1.137 . . . . 0.0 111.248 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 13.0 mt -95.59 161.5 14.02 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.523 0.678 . . . . 0.0 110.495 163.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -124.01 122.16 37.17 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 125.159 1.383 . . . . 0.0 107.779 175.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -146.97 176.51 25.81 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-N 115.632 -0.713 . . . . 0.0 114.201 -171.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -129.55 120.82 25.96 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.493 1.517 . . . . 0.0 110.464 -178.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -65.51 141.15 58.57 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.643 1.177 . . . . 0.0 112.219 -177.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -75.69 -29.83 59.14 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 120.619 -1.301 . . . . 0.0 113.526 -178.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 51.2 t -81.49 -37.33 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 124.207 1.003 . . . . 0.0 113.419 -175.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 6.9 t -124.81 -8.84 7.27 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.484 1.113 . . . . 0.0 113.699 -171.138 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.58 23.76 3.74 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 126.181 1.792 . . . . 0.0 113.822 -177.226 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -68.97 150.83 47.26 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.436 1.094 . . . . 0.0 110.938 169.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -125.63 157.35 37.44 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.632 1.573 . . . . 0.0 110.757 -177.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 161.04 169.58 24.49 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 124.496 1.046 . . . . 0.0 112.237 174.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -66.77 148.38 52.0 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.151 0.501 . . . . 0.0 110.399 168.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -155.04 154.87 29.52 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 124.321 1.048 . . . . 0.0 110.223 171.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -63.72 122.2 10.2 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.434 2.089 . . . . 0.0 110.774 177.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 95.8 p -55.13 -40.24 70.32 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.8 -0.562 . . . . 0.0 112.135 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 5.3 t -62.15 -23.05 66.35 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.244 1.818 . . . . 0.0 114.464 -178.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -72.16 -3.43 23.3 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.615 1.166 . . . . 0.0 113.58 172.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 68.2 p . . . . . 0 N--CA 1.465 0.292 0 C-N-CA 125.5 1.52 . . . . 0.0 111.083 176.404 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 61.2 mt . . . . . 0 CA--C 1.549 0.941 0 CA-C-O 119.035 -0.507 . . . . 0.0 109.806 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.76 160.25 50.39 Favored 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 123.571 2.848 . . . . 0.0 112.003 177.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.97 142.91 83.56 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.455 2.103 . . . . 0.0 112.36 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -72.19 154.4 92.19 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 123.282 0.633 . . . . 0.0 111.883 172.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -69.24 174.4 9.11 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.463 2.775 . . . . 0.0 113.039 178.006 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -87.64 1.76 52.81 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.636 1.174 . . . . 0.0 112.843 -178.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 34.7 p90 -133.54 154.35 80.73 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.712 1.205 . . . . 0.0 112.873 -175.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.95 152.72 57.77 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.667 2.912 . . . . 0.0 112.684 178.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -69.94 144.67 93.37 Favored Pre-proline 0 CA--C 1.55 0.98 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -176.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -73.8 179.32 5.77 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 124.103 3.202 . . . . 0.0 113.069 176.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 29.0 p -133.48 154.77 81.0 Favored Pre-proline 0 N--CA 1.479 1.015 0 C-N-CA 125.424 1.49 . . . . 0.0 112.64 -174.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.59 162.19 42.0 Favored 'Trans proline' 0 CA--C 1.548 1.222 0 C-N-CA 123.863 3.042 . . . . 0.0 111.995 176.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo . . . . . 0 CA--C 1.54 0.785 0 C-N-CA 123.447 2.765 . . . . 0.0 112.772 178.326 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 15.5 m . . . . . 0 C--O 1.235 0.319 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.89 125.98 44.81 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.264 1.026 . . . . 0.0 109.383 -175.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 73.1 p -72.31 153.23 41.63 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.585 0.754 . . . . 0.0 110.793 -175.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.9 pp -122.91 -6.94 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -177.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -158.73 160.3 29.34 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 126.684 1.993 . . . . 0.0 110.158 170.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -69.75 157.5 60.2 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 123.286 2.657 . . . . 0.0 113.263 176.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 . . . . . 0 N--CA 1.473 0.709 0 C-N-CA 125.218 1.407 . . . . 0.0 111.957 -179.973 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 44.8 p . . . . . 0 N--CA 1.483 1.194 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 55.9 mt -102.35 127.68 49.24 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.706 1.203 . . . . 0.0 111.121 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 23.3 tp -77.68 129.54 35.67 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.498 0.719 . . . . 0.0 110.955 177.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 43.9 t -101.81 146.52 27.68 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.884 1.273 . . . . 0.0 111.827 176.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -163.9 178.32 7.87 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.919 1.688 . . . . 0.0 112.246 -174.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -117.3 177.13 4.84 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.898 2.079 . . . . 0.0 111.15 174.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -64.65 140.43 58.87 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.966 0.906 . . . . 0.0 111.597 169.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 75.34 5.62 77.77 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 124.594 1.093 . . . . 0.0 115.707 175.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -71.87 169.3 16.1 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.674 1.19 . . . . 0.0 112.12 171.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 95.7 t -126.42 127.52 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 125.519 1.528 . . . . 0.0 108.84 -169.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 35.3 mt -133.62 138.26 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 124.352 1.061 . . . . 0.0 108.969 -176.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 52.2 m -102.88 136.65 42.31 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.972 1.309 . . . . 0.0 110.045 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 15.9 mt -73.37 147.09 44.67 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -175.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 58.3 mt -120.78 -8.52 9.44 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.582 1.153 . . . . 0.0 113.396 177.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 6.5 mt -133.73 140.99 38.35 Favored Pre-proline 0 N--CA 1.48 1.047 0 C-N-CA 126.311 1.844 . . . . 0.0 109.666 176.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.73 -7.68 21.63 Favored 'Trans proline' 0 CA--C 1.546 1.104 0 C-N-CA 124.047 3.165 . . . . 0.0 114.722 176.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -152.22 153.8 34.5 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.76 1.624 . . . . 0.0 112.146 174.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -77.44 170.83 15.87 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 124.46 1.104 . . . . 0.0 113.894 175.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -129.26 105.62 8.26 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.563 1.945 . . . . 0.0 109.897 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 50.68 32.62 7.15 Favored 'General case' 0 CA--C 1.553 1.09 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 98.37 -12.63 63.33 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 125.411 1.481 . . . . 0.0 114.411 -178.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 77.6 m95 -89.38 123.19 33.31 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.315 1.058 . . . . 0.0 110.807 176.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 13.5 mt -90.23 161.37 15.73 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.367 0.667 . . . . 0.0 110.225 161.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -124.43 124.84 43.19 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.123 1.369 . . . . 0.0 107.934 171.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -148.8 172.09 29.01 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 124.154 0.883 . . . . 0.0 113.287 -171.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -124.88 121.05 33.42 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.233 1.413 . . . . 0.0 109.699 177.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -64.05 147.45 52.09 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.523 1.129 . . . . 0.0 111.93 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -81.15 -46.71 14.5 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 120.876 -1.14 . . . . 0.0 113.175 178.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 57.8 t -70.98 -51.78 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 98.9 p -91.51 -17.12 26.19 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -174.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp 55.96 17.57 2.65 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 126.809 2.044 . . . . 0.0 114.725 -172.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -72.06 151.72 42.91 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 121.455 0.645 . . . . 0.0 111.732 171.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 72.5 mtm180 -120.67 157.0 30.54 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.347 1.859 . . . . 0.0 110.551 176.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 163.21 169.38 26.57 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 124.095 0.855 . . . . 0.0 112.368 173.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -65.71 148.35 51.91 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.074 0.464 . . . . 0.0 110.077 166.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -154.96 153.95 28.17 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 124.111 0.964 . . . . 0.0 110.457 172.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -63.98 122.11 10.02 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.492 2.128 . . . . 0.0 110.752 176.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 95.2 p -55.16 -38.06 67.8 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 74.7 m -64.88 -19.44 65.91 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -74.13 -2.51 24.89 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.36 1.064 . . . . 0.0 113.125 171.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 64.2 p . . . . . 0 N--CA 1.466 0.372 0 C-N-CA 125.703 1.601 . . . . 0.0 110.823 173.849 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 71.9 mt . . . . . 0 N--CA 1.477 0.906 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.11 159.56 52.72 Favored 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 123.636 2.891 . . . . 0.0 112.29 178.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.57 146.07 88.44 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 122.473 2.115 . . . . 0.0 112.445 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -74.24 157.21 86.92 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 123.616 0.766 . . . . 0.0 112.3 173.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -68.84 174.84 8.12 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.453 2.769 . . . . 0.0 113.19 175.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -86.2 0.6 53.31 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.735 1.214 . . . . 0.0 112.965 -178.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 36.6 p90 -134.73 155.18 79.65 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 124.796 1.239 . . . . 0.0 112.96 -174.029 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.86 152.72 58.29 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.726 2.951 . . . . 0.0 112.821 178.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -68.06 144.34 96.91 Favored Pre-proline 0 CA--C 1.552 1.032 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -175.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.4 -179.59 4.59 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 124.141 3.228 . . . . 0.0 112.857 176.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 22.8 p -135.17 155.29 79.03 Favored Pre-proline 0 N--CA 1.481 1.08 0 C-N-CA 125.051 1.341 . . . . 0.0 112.814 -175.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.87 163.47 35.41 Favored 'Trans proline' 0 CA--C 1.548 1.21 0 C-N-CA 123.628 2.885 . . . . 0.0 111.88 175.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo . . . . . 0 CA--C 1.541 0.847 0 C-N-CA 123.312 2.675 . . . . 0.0 113.092 178.043 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 17.7 m . . . . . 0 N--CA 1.467 0.403 0 CA-C-O 121.206 0.527 . . . . 0.0 110.62 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -123.27 126.95 47.85 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.081 1.352 . . . . 0.0 110.599 -178.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 81.6 p -71.7 152.09 43.09 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.586 0.754 . . . . 0.0 111.427 -178.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.9 pp -122.93 -8.98 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 -177.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -155.08 158.91 32.15 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 126.705 2.002 . . . . 0.0 109.842 169.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.05 156.13 66.14 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.129 2.553 . . . . 0.0 113.117 177.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 . . . . . 0 N--CA 1.474 0.731 0 C-N-CA 125.199 1.4 . . . . 0.0 111.103 177.753 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 32.8 p . . . . . 0 N--CA 1.481 1.082 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 66.8 mt -112.21 127.04 55.84 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.318 1.447 . . . . 0.0 111.312 -176.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 28.8 tp -78.74 124.79 28.56 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.936 0.894 . . . . 0.0 110.668 176.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 54.2 p -99.61 152.16 20.36 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.237 1.415 . . . . 0.0 112.434 177.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -167.45 177.32 6.06 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.052 1.341 . . . . 0.0 112.992 -172.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -115.32 177.13 4.77 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.857 2.063 . . . . 0.0 111.161 173.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -67.22 140.46 57.42 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.093 0.957 . . . . 0.0 111.818 170.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 74.66 4.68 71.37 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 125.007 1.289 . . . . 0.0 115.797 177.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -68.42 164.23 21.48 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 118.115 0.958 . . . . 0.0 111.461 167.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 95.7 t -118.16 136.17 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.642 1.177 . . . . 0.0 109.251 -177.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 29.7 mt -133.45 141.18 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.349 1.06 . . . . 0.0 108.795 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 23.5 m -102.21 136.34 42.21 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.817 1.247 . . . . 0.0 109.528 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 21.0 mt -79.18 138.71 37.97 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 118.544 0.611 . . . . 0.0 111.446 -177.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 44.7 mt -112.83 -10.15 13.6 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.993 0.917 . . . . 0.0 113.277 -177.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 371' ' ' ILE . . . . . 0.408 ' CG2' ' HD2' ' A' ' 372' ' ' PRO . 9.0 mt -124.58 140.1 34.64 Favored Pre-proline 0 N--CA 1.478 0.938 0 C-N-CA 126.363 1.865 . . . . 0.0 109.682 176.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 372' ' ' PRO . . . . . 0.408 ' HD2' ' CG2' ' A' ' 371' ' ' ILE . 58.1 Cg_endo -70.83 -8.36 23.45 Favored 'Trans proline' 0 CA--C 1.547 1.156 0 C-N-CA 123.834 3.022 . . . . 0.0 114.322 176.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -152.18 149.1 28.38 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.922 1.689 . . . . 0.0 111.893 173.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -74.08 171.35 13.68 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.443 1.097 . . . . 0.0 113.744 175.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -128.24 103.42 7.17 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.217 1.807 . . . . 0.0 110.448 -179.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 52.05 30.55 7.6 Favored 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 99.69 -15.57 59.59 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 125.654 1.597 . . . . 0.0 114.287 -178.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -85.07 128.8 34.79 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.221 1.011 . . . . 0.0 110.955 175.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 12.1 mt -99.4 161.41 13.63 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.212 1.005 . . . . 0.0 110.213 165.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -123.82 122.21 37.44 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 125.157 1.383 . . . . 0.0 107.519 173.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -145.5 167.24 27.56 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-N 115.82 -0.627 . . . . 0.0 113.927 -172.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -113.45 118.47 34.6 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.006 1.322 . . . . 0.0 109.019 173.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 33.9 t-80 -63.69 141.66 58.69 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.321 1.049 . . . . 0.0 111.789 178.015 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -75.2 -46.19 35.55 Favored 'General case' 0 CA--C 1.547 0.827 0 O-C-N 120.573 -1.329 . . . . 0.0 113.037 -178.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 57.4 t -70.31 -54.26 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 178.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 93.4 p -90.25 -17.27 27.76 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 119.583 1.083 . . . . 0.0 113.785 -173.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm 56.41 20.0 4.45 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 126.651 1.98 . . . . 0.0 114.023 -175.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -76.38 158.81 31.07 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.276 0.63 . . . . 0.0 112.051 171.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 82.2 mtt85 -125.18 158.91 32.81 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.148 1.779 . . . . 0.0 110.645 176.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 159.38 169.72 23.05 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.951 1.262 . . . . 0.0 112.278 176.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -68.36 148.73 50.29 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.994 0.426 . . . . 0.0 110.627 169.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -155.82 156.32 30.46 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 124.084 0.954 . . . . 0.0 110.747 172.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -66.72 120.61 7.73 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 122.433 2.088 . . . . 0.0 111.724 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 36.2 t -59.92 -25.38 65.1 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 175.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 75.2 m -69.44 -18.81 63.76 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 174.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -81.1 -0.34 39.58 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.635 1.174 . . . . 0.0 113.987 177.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 81.3 p . . . . . 0 N--CA 1.467 0.424 0 C-N-CA 125.055 1.342 . . . . 0.0 111.599 174.332 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 52.7 mt . . . . . 0 CA--C 1.549 0.905 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -69.03 160.95 47.86 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 123.42 2.747 . . . . 0.0 112.124 178.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.59 144.68 85.38 Favored 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 122.267 1.978 . . . . 0.0 112.352 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -70.59 153.66 94.84 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 123.095 0.558 . . . . 0.0 111.872 171.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -69.7 174.67 9.12 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 123.509 2.806 . . . . 0.0 113.2 179.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -86.05 1.33 50.73 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.353 1.061 . . . . 0.0 113.037 -178.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 38.1 p90 -133.46 154.37 80.83 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 124.823 1.249 . . . . 0.0 113.033 -174.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.56 153.11 60.24 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 123.66 2.907 . . . . 0.0 112.875 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -68.48 141.13 92.93 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 123.914 0.885 . . . . 0.0 113.096 -177.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.59 177.54 7.87 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 124.059 3.173 . . . . 0.0 113.239 177.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 32.8 p -134.25 153.94 79.72 Favored Pre-proline 0 N--CA 1.478 0.963 0 C-N-CA 125.401 1.48 . . . . 0.0 112.998 -172.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -68.29 163.22 37.18 Favored 'Trans proline' 0 CA--C 1.548 1.202 0 C-N-CA 123.772 2.981 . . . . 0.0 111.854 176.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo . . . . . 0 CA--C 1.541 0.833 0 C-N-CA 123.242 2.628 . . . . 0.0 112.885 178.945 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 16.7 m . . . . . 0 C--O 1.234 0.283 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.45 134.27 54.75 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.385 1.074 . . . . 0.0 110.343 175.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 62.1 p -76.63 158.64 30.93 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.186 1.394 . . . . 0.0 111.774 179.086 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 2.0 pp -122.91 -9.79 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -155.35 159.22 31.9 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 125.836 1.654 . . . . 0.0 111.26 170.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.91 155.61 65.0 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.534 2.823 . . . . 0.0 113.443 177.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 . . . . . 0 N--CA 1.474 0.741 0 C-N-CA 125.411 1.485 . . . . 0.0 111.899 -179.384 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 48.3 p . . . . . 0 N--CA 1.479 0.995 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 62.0 mt -107.84 131.01 54.94 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.841 1.256 . . . . 0.0 111.487 -178.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 24.0 tp -82.86 132.97 35.14 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.682 0.793 . . . . 0.0 110.534 174.14 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 45.3 m -114.86 147.73 39.5 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.226 1.411 . . . . 0.0 112.379 -178.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -166.42 178.95 5.83 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.412 1.485 . . . . 0.0 112.397 -166.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -118.18 174.79 6.01 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.974 2.11 . . . . 0.0 111.724 176.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 66.3 tt0 -64.25 140.94 58.92 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.317 -0.864 . . . . 0.0 111.002 168.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 70.36 19.48 76.06 Favored Glycine 0 CA--C 1.537 1.433 0 N-CA-C 114.37 0.508 . . . . 0.0 114.37 177.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -86.23 170.09 12.43 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.732 1.213 . . . . 0.0 111.522 169.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 89.7 t -125.82 128.09 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 125.658 1.583 . . . . 0.0 109.038 -168.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 22.7 mt -133.18 143.13 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 124.358 1.063 . . . . 0.0 110.056 -176.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 2.6 m -100.77 144.03 30.22 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.641 1.576 . . . . 0.0 110.398 -177.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 23.5 mt -84.67 141.11 30.83 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 118.333 0.515 . . . . 0.0 112.085 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 43.8 mt -120.05 -11.69 9.23 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.758 1.223 . . . . 0.0 113.298 179.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 371' ' ' ILE . . . . . 0.413 HG22 ' H ' ' A' ' 373' ' ' GLU . 7.1 mt -130.25 141.1 40.71 Favored Pre-proline 0 N--CA 1.476 0.853 0 C-N-CA 126.703 2.001 . . . . 0.0 109.224 175.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.69 -6.02 18.28 Favored 'Trans proline' 0 CA--C 1.548 1.208 0 C-N-CA 124.113 3.209 . . . . 0.0 114.835 175.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 373' ' ' GLU . . . . . 0.413 ' H ' HG22 ' A' ' 371' ' ' ILE . 12.6 pt-20 -151.67 162.78 40.42 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.162 1.785 . . . . 0.0 112.169 175.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.57 170.91 9.78 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.485 1.114 . . . . 0.0 113.202 176.007 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -128.63 106.39 8.92 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.403 1.881 . . . . 0.0 110.54 -178.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 51.32 31.09 6.62 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 124.943 1.297 . . . . 0.0 114.468 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 98.32 -8.32 62.45 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 125.293 1.425 . . . . 0.0 114.515 -177.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -95.42 122.46 38.17 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.729 1.265 . . . . 0.0 110.979 177.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 14.2 mt -88.39 160.49 17.56 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.751 0.82 . . . . 0.0 110.625 162.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 79.4 t80 -123.28 124.46 43.02 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.169 1.388 . . . . 0.0 107.924 170.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -149.95 173.84 29.56 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 123.864 0.745 . . . . 0.0 113.289 -170.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -126.29 115.18 19.3 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.959 1.304 . . . . 0.0 110.271 178.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 23.4 t-80 -61.59 144.72 53.95 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.43 1.092 . . . . 0.0 112.151 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -79.2 -48.26 14.53 Favored 'General case' 0 CA--C 1.548 0.882 0 O-C-N 120.926 -1.109 . . . . 0.0 112.565 178.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 58.5 t -68.3 -53.6 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 124.325 1.05 . . . . 0.0 113.73 176.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 40.2 m -89.77 -16.51 30.11 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 119.277 0.944 . . . . 0.0 113.188 -171.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 11.1 mmmm 54.49 19.92 2.58 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 127.358 2.263 . . . . 0.0 114.647 -176.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -82.14 152.7 26.39 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.938 0.895 . . . . 0.0 111.496 174.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 56.4 mtm-85 -117.58 158.97 23.66 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 126.172 1.789 . . . . 0.0 110.931 173.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 159.8 171.76 26.09 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.512 1.053 . . . . 0.0 112.453 175.268 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -68.46 145.22 54.27 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 120.961 0.41 . . . . 0.0 110.456 168.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -153.91 154.55 30.21 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 124.246 1.019 . . . . 0.0 111.015 173.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -63.4 122.94 11.28 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.529 2.153 . . . . 0.0 112.046 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 82.6 p -61.27 -25.98 67.46 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 176.084 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.83 -13.34 61.65 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.969 2.107 . . . . 0.0 114.86 174.355 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -85.01 -0.57 54.85 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.5 1.12 . . . . 0.0 113.133 174.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 71.3 p . . . . . 0 N--CA 1.475 0.802 0 C-N-CA 126.653 1.981 . . . . 0.0 110.475 173.873 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 55.1 mt . . . . . 0 N--CA 1.477 0.899 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -68.82 160.07 51.2 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 123.483 2.789 . . . . 0.0 112.007 178.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -63.77 144.47 89.03 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.428 2.086 . . . . 0.0 112.271 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -70.01 153.34 95.47 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 122.99 0.516 . . . . 0.0 111.629 171.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -69.28 174.75 8.64 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.459 2.773 . . . . 0.0 113.151 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -85.62 1.39 49.42 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.318 1.047 . . . . 0.0 112.976 -178.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 33.8 p90 -134.55 154.33 79.6 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 124.775 1.23 . . . . 0.0 112.94 -175.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.34 151.97 60.49 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.645 2.897 . . . . 0.0 112.681 178.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -66.83 145.23 98.89 Favored Pre-proline 0 CA--C 1.549 0.913 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -177.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.32 175.22 10.89 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.752 2.968 . . . . 0.0 112.781 178.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 23.0 p -129.73 153.96 80.91 Favored Pre-proline 0 N--CA 1.477 0.922 0 C-N-CA 124.732 1.213 . . . . 0.0 112.363 -173.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -66.56 163.08 34.08 Favored 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 122.999 2.466 . . . . 0.0 111.651 175.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo . . . . . 0 CA--C 1.539 0.736 0 C-N-CA 123.102 2.534 . . . . 0.0 112.257 174.955 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 16.0 m . . . . . 0 C--O 1.236 0.355 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -121.02 131.71 54.45 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.197 0.999 . . . . 0.0 109.664 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 74.8 p -74.9 152.6 38.86 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.962 0.905 . . . . 0.0 111.177 -177.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.8 pp -123.49 -6.71 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -178.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -154.04 158.23 32.47 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 126.249 1.82 . . . . 0.0 110.121 169.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -68.96 154.5 70.72 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.792 2.328 . . . . 0.0 112.413 176.121 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 . . . . . 0 CA--C 1.537 0.466 0 C-N-CA 125.499 1.52 . . . . 0.0 110.7 179.846 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 38.0 p . . . . . 0 N--CA 1.485 1.277 0 N-CA-C 114.336 1.235 . . . . 0.0 114.336 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 56.8 mt -98.15 128.8 44.84 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.87 1.268 . . . . 0.0 110.485 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 31.4 tp -80.22 114.12 18.89 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.377 0.671 . . . . 0.0 110.844 175.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 50.3 m -83.88 150.03 25.98 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.043 0.937 . . . . 0.0 112.559 175.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -164.8 178.17 7.4 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.598 1.559 . . . . 0.0 113.217 -177.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -117.15 173.96 6.38 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.431 1.892 . . . . 0.0 111.258 173.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -64.98 142.32 58.48 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 121.301 -0.874 . . . . 0.0 111.648 170.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 77.05 5.79 85.34 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 124.071 0.843 . . . . 0.0 114.98 175.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -77.83 166.33 23.05 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.97 1.308 . . . . 0.0 111.96 172.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 67.9 t -121.07 131.24 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.105 1.362 . . . . 0.0 109.325 -172.304 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 25.2 mt -134.76 137.6 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.527 1.131 . . . . 0.0 109.245 -177.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 12.0 m -98.09 140.22 32.73 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.931 1.292 . . . . 0.0 110.236 -178.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 23.7 mt -80.03 137.94 36.91 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 118.235 0.47 . . . . 0.0 111.928 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 37.1 mt -114.62 -9.8 12.57 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.527 1.131 . . . . 0.0 113.122 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 9.4 mt -127.75 141.17 40.22 Favored Pre-proline 0 N--CA 1.479 1.01 0 C-N-CA 126.893 2.077 . . . . 0.0 109.632 176.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.28 -7.1 20.35 Favored 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 124.088 3.192 . . . . 0.0 114.817 177.036 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -151.24 160.22 43.94 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.288 1.835 . . . . 0.0 111.428 174.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.34 168.0 17.99 Favored 'General case' 0 CA--C 1.547 0.86 0 O-C-N 120.993 -1.067 . . . . 0.0 113.027 173.032 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -122.89 103.49 8.66 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 126.954 2.101 . . . . 0.0 109.105 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 51.96 30.54 7.41 Favored 'General case' 0 CA--C 1.555 1.17 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 102.45 -17.95 52.2 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 125.894 1.711 . . . . 0.0 114.276 -178.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -84.86 128.31 34.56 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.511 1.124 . . . . 0.0 111.463 178.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 16.9 mt -98.17 161.32 13.77 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.121 0.968 . . . . 0.0 110.51 164.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -125.9 121.72 33.98 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 125.37 1.468 . . . . 0.0 107.552 174.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -145.38 171.72 26.36 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-N 115.555 -0.748 . . . . 0.0 113.872 -172.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -119.63 117.26 27.84 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.006 1.323 . . . . 0.0 109.872 176.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 24.4 t-80 -63.77 145.16 56.29 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.854 1.262 . . . . 0.0 112.035 178.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -80.23 -44.66 19.34 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 120.914 -1.116 . . . . 0.0 113.706 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 57.7 t -69.18 -51.05 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 123.926 0.891 . . . . 0.0 113.306 176.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 13.2 t -91.03 -21.32 21.31 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -171.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt 56.32 16.71 2.5 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 126.446 1.898 . . . . 0.0 114.597 -171.271 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -74.11 156.16 37.69 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.362 0.665 . . . . 0.0 111.852 172.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -124.79 155.27 39.66 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.203 1.801 . . . . 0.0 110.08 176.062 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 162.62 168.76 25.01 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 124.911 1.243 . . . . 0.0 112.021 177.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -68.86 147.74 51.26 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.111 0.565 . . . . 0.0 110.721 171.207 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -155.21 155.27 29.83 Favored Pre-proline 0 CA--C 1.541 0.597 0 C-N-CA 124.315 1.046 . . . . 0.0 110.676 172.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -66.11 121.42 8.74 Favored 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 122.353 2.036 . . . . 0.0 110.975 177.202 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 29.7 t -55.01 -39.13 68.75 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.687 -0.633 . . . . 0.0 112.364 178.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 15.5 m -59.47 -21.85 60.68 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -74.24 -0.27 16.4 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.552 1.141 . . . . 0.0 113.514 172.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 48.1 p . . . . . 0 N--CA 1.468 0.468 0 C-N-CA 125.86 1.664 . . . . 0.0 111.792 179.11 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 35.7 mt . . . . . 0 CA--C 1.548 0.901 0 CA-C-O 119.295 -0.383 . . . . 0.0 110.329 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.19 159.13 52.97 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 123.498 2.799 . . . . 0.0 112.063 178.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.82 147.08 89.36 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.402 2.068 . . . . 0.0 112.561 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -73.98 157.11 87.46 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 123.692 0.797 . . . . 0.0 112.465 174.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.19 174.77 8.53 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.449 2.766 . . . . 0.0 113.381 176.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -88.39 3.06 51.27 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.997 1.319 . . . . 0.0 112.623 -178.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 32.6 p90 -134.85 154.62 79.43 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 124.557 1.143 . . . . 0.0 112.823 -175.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.51 152.49 60.07 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 123.788 2.992 . . . . 0.0 112.868 179.087 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -68.17 142.97 95.48 Favored Pre-proline 0 CA--C 1.551 0.981 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -176.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.32 179.94 5.01 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 124.114 3.209 . . . . 0.0 112.709 176.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 26.6 p -135.21 154.3 78.74 Favored Pre-proline 0 N--CA 1.479 0.983 0 C-N-CA 125.036 1.334 . . . . 0.0 112.657 -173.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -66.56 161.92 39.21 Favored 'Trans proline' 0 CA--C 1.547 1.165 0 C-N-CA 123.336 2.691 . . . . 0.0 111.484 175.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo . . . . . 0 CA--C 1.541 0.856 0 C-N-CA 123.052 2.501 . . . . 0.0 112.417 176.68 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 17.3 m . . . . . 0 N--CA 1.466 0.34 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 15.5 ttpt -119.53 136.39 54.36 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.138 0.975 . . . . 0.0 110.667 175.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 77.8 p -78.7 155.95 29.17 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.765 1.626 . . . . 0.0 111.783 -176.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.8 pp -122.24 -9.16 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 -176.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -155.29 159.22 31.91 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 126.346 1.858 . . . . 0.0 110.472 169.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.91 155.94 64.2 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.315 2.677 . . . . 0.0 113.348 178.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 44.7 t-80 . . . . . 0 N--CA 1.473 0.715 0 C-N-CA 125.583 1.553 . . . . 0.0 111.98 -178.838 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 58.0 p . . . . . 0 N--CA 1.482 1.16 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 58.4 mt -108.31 130.34 55.19 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.759 1.224 . . . . 0.0 111.358 -178.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 36.4 tp -82.49 120.1 25.05 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.877 0.871 . . . . 0.0 110.862 176.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 55.6 p -89.76 152.7 21.18 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.665 1.186 . . . . 0.0 112.523 173.522 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -167.75 178.93 5.02 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.434 1.494 . . . . 0.0 112.483 -175.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -117.94 174.06 6.41 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.405 1.882 . . . . 0.0 111.525 174.094 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -64.92 141.97 58.6 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.747 0.819 . . . . 0.0 111.368 170.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 73.66 10.67 80.11 Favored Glycine 0 CA--C 1.537 1.452 0 N-CA-C 114.525 0.57 . . . . 0.0 114.525 177.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -82.79 164.01 20.87 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.415 1.086 . . . . 0.0 111.342 171.457 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 93.6 t -119.46 136.99 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.559 1.144 . . . . 0.0 109.881 -171.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 17.1 mt -137.35 137.94 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.997 1.319 . . . . 0.0 109.272 -176.323 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 10.2 m -95.52 140.56 30.19 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.869 1.268 . . . . 0.0 110.56 176.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 23.3 mt -79.23 139.08 38.01 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.347 0.659 . . . . 0.0 111.803 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 32.4 mt -116.44 -6.78 11.72 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 124.253 1.021 . . . . 0.0 113.347 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 4.9 mt -134.49 140.52 35.92 Favored Pre-proline 0 N--CA 1.48 1.073 0 C-N-CA 126.517 1.927 . . . . 0.0 109.344 176.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.6 -8.53 23.81 Favored 'Trans proline' 0 CA--C 1.546 1.109 0 C-N-CA 123.963 3.109 . . . . 0.0 114.74 178.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -152.05 157.31 41.48 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.882 1.673 . . . . 0.0 111.92 175.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -80.35 168.73 18.66 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.481 1.112 . . . . 0.0 113.841 177.085 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -125.65 105.18 8.81 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.685 1.994 . . . . 0.0 110.287 178.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 50.96 32.14 7.09 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 125.084 1.354 . . . . 0.0 114.535 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 99.04 -16.67 59.11 Favored Glycine 0 CA--C 1.536 1.393 0 C-N-CA 125.743 1.64 . . . . 0.0 114.305 -178.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 83.0 m95 -85.33 129.74 34.74 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.479 1.112 . . . . 0.0 111.12 175.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 12.6 mt -99.15 162.99 12.75 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.227 1.011 . . . . 0.0 110.316 164.277 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -127.22 119.06 25.52 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.962 1.305 . . . . 0.0 107.935 176.165 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -146.63 175.47 26.04 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.064 0.84 . . . . 0.0 113.871 -170.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -127.42 121.63 31.41 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.376 1.47 . . . . 0.0 110.524 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 -66.84 133.58 50.37 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.317 1.047 . . . . 0.0 112.135 -176.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -70.25 -31.04 68.24 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 120.304 -1.497 . . . . 0.0 113.349 -178.172 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 58.1 t -81.42 -33.97 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 124.408 1.083 . . . . 0.0 113.522 -176.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 13.2 t -125.31 -15.2 6.28 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.887 1.275 . . . . 0.0 113.37 -167.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 54.84 20.8 3.25 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 126.78 2.032 . . . . 0.0 114.202 -177.236 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -69.22 147.99 50.48 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.573 1.149 . . . . 0.0 111.147 166.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 81.7 mtm180 -122.43 156.78 33.32 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.95 1.7 . . . . 0.0 111.473 179.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 162.83 171.45 29.07 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 124.817 1.198 . . . . 0.0 112.296 174.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -67.66 147.78 52.23 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.148 0.499 . . . . 0.0 110.347 169.135 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -154.42 155.75 31.04 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 124.321 1.048 . . . . 0.0 110.863 173.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -65.71 121.63 9.06 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.158 1.905 . . . . 0.0 111.627 178.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 33.8 t -61.86 -16.91 54.21 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 121.417 -0.802 . . . . 0.0 113.053 172.07 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 16.6 m -73.23 -17.65 61.32 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.888 1.275 . . . . 0.0 113.785 173.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -88.56 1.62 54.59 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.286 1.434 . . . . 0.0 113.072 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 58.3 p . . . . . 0 N--CA 1.472 0.661 0 C-N-CA 127.084 2.154 . . . . 0.0 109.826 172.098 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 60.7 mt . . . . . 0 CA--C 1.547 0.861 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.88 159.37 53.56 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 123.433 2.755 . . . . 0.0 112.147 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.44 146.14 89.05 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 122.42 2.08 . . . . 0.0 112.438 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -72.28 156.44 90.52 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 123.48 0.712 . . . . 0.0 112.14 172.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -68.96 174.77 8.34 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.43 2.754 . . . . 0.0 113.054 175.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -86.9 2.02 50.63 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.556 1.142 . . . . 0.0 112.844 -178.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 37.3 p90 -133.94 154.62 80.42 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 124.666 1.187 . . . . 0.0 112.79 -174.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.43 153.17 60.97 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 123.652 2.901 . . . . 0.0 112.758 178.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -65.92 143.22 98.4 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 123.821 0.848 . . . . 0.0 113.084 -177.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.8 177.81 7.17 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 124.001 3.134 . . . . 0.0 112.945 178.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 25.5 p -130.48 154.76 81.68 Favored Pre-proline 0 N--CA 1.478 0.944 0 C-N-CA 125.288 1.435 . . . . 0.0 112.775 -175.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.79 165.44 29.69 Favored 'Trans proline' 0 CA--C 1.547 1.15 0 C-N-CA 123.439 2.76 . . . . 0.0 111.885 174.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo . . . . . 0 CA--C 1.541 0.867 0 C-N-CA 123.406 2.737 . . . . 0.0 112.821 174.594 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 15.6 m . . . . . 0 N--CA 1.467 0.384 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -120.48 136.42 54.76 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.143 0.977 . . . . 0.0 109.946 177.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 45.9 p -80.44 148.57 30.47 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.383 1.473 . . . . 0.0 110.877 -175.253 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.7 pp -112.87 -10.25 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -176.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -155.55 159.31 31.75 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 126.666 1.987 . . . . 0.0 110.528 170.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.86 156.06 61.15 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 123.536 2.824 . . . . 0.0 113.129 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 32.0 t-80 . . . . . 0 N--CA 1.474 0.727 0 C-N-CA 125.385 1.474 . . . . 0.0 111.79 -179.78 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 35.8 p . . . . . 0 N--CA 1.479 0.984 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 68.7 mt -103.57 130.75 51.04 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.935 1.294 . . . . 0.0 110.97 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 30.2 tp -82.8 128.97 34.9 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.247 0.619 . . . . 0.0 110.401 174.033 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 34.4 t -107.87 147.32 31.11 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.591 1.556 . . . . 0.0 111.474 -179.105 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -164.58 177.94 7.72 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.626 1.57 . . . . 0.0 112.354 -170.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -121.82 168.83 11.4 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.944 2.098 . . . . 0.0 111.069 175.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -61.94 136.58 58.03 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.175 -0.953 . . . . 0.0 111.312 173.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 83.71 -1.92 88.09 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 123.749 0.69 . . . . 0.0 114.793 178.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -70.88 167.02 19.89 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.382 1.091 . . . . 0.0 112.203 170.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 84.6 t -125.86 133.41 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 125.018 1.327 . . . . 0.0 109.545 -169.043 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 24.9 mt -136.48 141.35 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.733 1.213 . . . . 0.0 109.462 -176.045 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 3.3 m -100.78 140.34 35.2 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.319 1.448 . . . . 0.0 110.599 -177.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 21.7 mt -80.21 136.98 36.59 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 118.423 0.556 . . . . 0.0 111.963 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 38.3 mt -117.52 -11.77 10.45 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.589 1.156 . . . . 0.0 113.341 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 371' ' ' ILE . . . . . 0.439 ' CG2' ' HD2' ' A' ' 372' ' ' PRO . 5.6 mt -128.09 140.04 37.13 Favored Pre-proline 0 N--CA 1.474 0.746 0 C-N-CA 126.154 1.782 . . . . 0.0 109.68 176.292 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 372' ' ' PRO . . . . . 0.439 ' HD2' ' CG2' ' A' ' 371' ' ' ILE . 60.6 Cg_endo -72.97 -7.22 20.35 Favored 'Trans proline' 0 CA--C 1.546 1.076 0 C-N-CA 123.434 2.756 . . . . 0.0 114.001 177.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -150.62 157.41 42.95 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.799 1.639 . . . . 0.0 112.088 173.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -84.91 171.54 12.09 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.222 1.009 . . . . 0.0 112.786 175.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -133.36 110.21 9.88 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.97 1.708 . . . . 0.0 110.819 -176.138 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 50.74 31.02 5.46 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 125.336 1.454 . . . . 0.0 114.448 -179.258 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 99.18 -8.41 60.78 Favored Glycine 0 CA--C 1.536 1.396 0 C-N-CA 125.379 1.466 . . . . 0.0 114.467 -177.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 75.3 m95 -99.44 128.43 45.56 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 118.438 1.119 . . . . 0.0 111.55 -178.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 14.1 mt -96.07 161.21 14.07 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.915 0.886 . . . . 0.0 110.544 165.227 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -124.92 122.36 37.12 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 125.167 1.387 . . . . 0.0 107.646 173.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -145.84 169.67 27.23 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 115.627 -0.715 . . . . 0.0 113.159 -173.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -117.55 114.67 23.78 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.811 1.244 . . . . 0.0 109.516 177.187 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 26.7 t-80 -60.69 146.35 46.02 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.861 1.264 . . . . 0.0 111.87 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -81.25 -46.2 15.14 Favored 'General case' 0 CA--C 1.548 0.866 0 O-C-N 120.768 -1.208 . . . . 0.0 112.866 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 60.1 t -68.92 -53.85 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 124.051 0.94 . . . . 0.0 113.31 175.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 16.3 t -86.11 -22.43 27.11 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -171.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm 54.93 17.2 1.73 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 126.575 1.95 . . . . 0.0 114.579 -168.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -74.33 156.03 37.55 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.476 0.655 . . . . 0.0 111.986 172.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 54.5 mtp180 -127.31 148.43 50.24 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.636 1.974 . . . . 0.0 109.758 177.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 167.98 168.79 30.61 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 124.501 1.048 . . . . 0.0 111.859 178.566 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -68.05 145.85 54.06 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.098 0.475 . . . . 0.0 110.556 170.211 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -152.76 154.45 31.42 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 124.103 0.961 . . . . 0.0 110.776 173.166 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.57 122.29 10.36 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.333 2.022 . . . . 0.0 110.864 178.579 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 98.1 p -56.4 -37.31 69.98 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.687 -0.633 . . . . 0.0 112.079 176.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 17.2 m -58.2 -20.95 45.47 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 127.273 2.229 . . . . 0.0 115.003 177.29 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -79.91 1.32 27.69 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.788 1.235 . . . . 0.0 112.961 175.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 60.3 p . . . . . 0 N--CA 1.472 0.671 0 C-N-CA 126.574 1.95 . . . . 0.0 110.673 174.516 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 52.4 mt . . . . . 0 N--CA 1.479 1.019 0 CA-C-O 119.117 -0.468 . . . . 0.0 109.878 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -69.39 160.31 50.3 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 123.702 2.935 . . . . 0.0 112.163 178.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.96 144.22 87.31 Favored 'Trans proline' 0 CA--C 1.534 0.522 0 C-N-CA 122.376 2.051 . . . . 0.0 112.191 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -69.6 153.56 95.58 Favored Pre-proline 0 CA--C 1.551 1.01 0 C-N-CA 122.972 0.509 . . . . 0.0 111.733 171.097 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -69.23 174.26 9.31 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.322 2.681 . . . . 0.0 113.19 178.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -86.67 2.48 48.34 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.523 1.129 . . . . 0.0 112.948 -178.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 34.0 p90 -133.52 153.39 80.31 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 124.748 1.219 . . . . 0.0 113.104 -176.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -71.62 152.12 59.05 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 123.623 2.882 . . . . 0.0 112.607 178.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -68.56 146.33 97.64 Favored Pre-proline 0 CA--C 1.55 0.971 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -176.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.7 178.72 5.97 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 124.034 3.156 . . . . 0.0 113.086 177.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 19.3 p -133.12 155.0 81.48 Favored Pre-proline 0 N--CA 1.48 1.027 0 C-N-CA 125.18 1.392 . . . . 0.0 112.658 -175.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.02 161.0 47.65 Favored 'Trans proline' 0 CA--C 1.547 1.151 0 C-N-CA 123.375 2.717 . . . . 0.0 111.986 176.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo . . . . . 0 CA--C 1.54 0.817 0 C-N-CA 123.232 2.621 . . . . 0.0 112.74 178.451 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 15.9 m . . . . . 0 C--O 1.236 0.377 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 5.7 tptt -119.37 130.53 55.38 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 124.183 0.993 . . . . 0.0 109.372 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 76.3 p -74.46 151.57 39.56 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.457 0.703 . . . . 0.0 111.127 -176.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.9 pp -122.69 -8.36 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -178.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -155.63 159.35 31.71 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 126.919 2.088 . . . . 0.0 110.024 169.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.1 159.62 53.17 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.275 2.65 . . . . 0.0 112.97 176.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 . . . . . 0 N--CA 1.474 0.771 0 C-N-CA 125.051 1.34 . . . . 0.0 111.993 179.494 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 52.2 p . . . . . 0 N--CA 1.481 1.119 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 47.1 mt -106.71 116.72 32.42 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.045 1.338 . . . . 0.0 110.972 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 25.5 tp -72.05 124.31 24.67 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.644 0.778 . . . . 0.0 110.669 176.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 58.0 p -97.76 152.65 18.92 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.988 1.315 . . . . 0.0 112.401 175.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -167.4 178.43 5.5 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.513 1.525 . . . . 0.0 112.195 -173.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -118.83 173.74 6.7 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.787 2.035 . . . . 0.0 110.941 173.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -65.19 141.16 58.76 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.746 0.818 . . . . 0.0 111.624 171.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 80.29 3.21 89.76 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 124.173 0.892 . . . . 0.0 115.213 175.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -76.2 168.79 19.41 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.231 1.412 . . . . 0.0 112.238 173.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 80.5 t -123.49 130.01 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 125.642 1.577 . . . . 0.0 109.153 -171.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 30.8 mt -134.72 137.29 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.136 0.974 . . . . 0.0 109.525 -178.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 20.0 m -97.76 139.31 33.83 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.033 1.333 . . . . 0.0 110.491 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 20.3 mt -79.34 144.33 34.3 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.235 0.47 . . . . 0.0 111.972 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 47.4 mt -118.58 -1.15 11.22 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.731 1.212 . . . . 0.0 112.93 -178.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 371' ' ' ILE . . . . . 0.488 ' CG2' ' HD2' ' A' ' 372' ' ' PRO . 3.8 mt -134.36 142.57 43.42 Favored Pre-proline 0 N--CA 1.478 0.937 0 C-N-CA 126.848 2.059 . . . . 0.0 109.947 177.409 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 372' ' ' PRO . . . . . 0.488 ' HD2' ' CG2' ' A' ' 371' ' ' ILE . 57.0 Cg_endo -71.87 -9.08 24.21 Favored 'Trans proline' 0 CA--C 1.547 1.151 0 C-N-CA 123.463 2.775 . . . . 0.0 114.021 176.07 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -152.65 150.22 29.25 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.027 1.731 . . . . 0.0 111.857 173.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -71.49 168.69 16.99 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.202 1.001 . . . . 0.0 113.554 173.253 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -123.72 103.4 8.36 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 126.324 1.85 . . . . 0.0 109.911 178.262 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 51.65 32.73 9.65 Favored 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 177.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 99.29 -12.72 61.83 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 125.415 1.484 . . . . 0.0 114.298 -178.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -89.18 121.41 31.45 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.451 1.1 . . . . 0.0 110.709 175.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 13.1 mt -88.8 158.86 18.0 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.366 0.667 . . . . 0.0 110.372 162.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 380' ' ' TYR . . . . . 0.417 ' HB3' HD11 ' A' ' 371' ' ' ILE . 58.7 t80 -120.65 125.18 47.06 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 125.001 1.32 . . . . 0.0 107.789 170.338 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -149.41 171.64 29.54 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 115.873 -0.603 . . . . 0.0 113.871 -172.456 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -123.08 120.93 34.73 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.452 1.501 . . . . 0.0 109.623 177.195 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 29.4 t-80 -65.68 150.68 48.08 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.717 1.207 . . . . 0.0 112.159 178.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -81.15 -49.31 10.99 Favored 'General case' 0 CA--C 1.548 0.883 0 O-C-N 120.941 -1.099 . . . . 0.0 113.649 178.029 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 82.8 t -71.05 -52.15 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 178.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 23.2 t -83.96 -23.33 31.12 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.595 0.758 . . . . 0.0 112.852 -174.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp 55.72 15.83 1.75 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 126.681 1.992 . . . . 0.0 114.532 -168.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -73.14 153.72 40.64 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.409 0.623 . . . . 0.0 111.944 173.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -123.68 153.61 40.58 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 126.553 1.941 . . . . 0.0 110.682 178.261 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 165.45 169.59 29.27 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 124.344 0.973 . . . . 0.0 112.24 175.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -66.92 148.09 52.4 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.066 0.46 . . . . 0.0 110.148 166.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -155.67 154.39 27.95 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 124.3 1.04 . . . . 0.0 110.359 172.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -63.82 123.19 11.56 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.525 2.15 . . . . 0.0 110.926 177.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 99.2 p -56.75 -38.55 72.58 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.655 -0.653 . . . . 0.0 112.136 178.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 14.7 m -61.32 -22.4 64.87 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.044 1.738 . . . . 0.0 114.825 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -73.66 -1.89 20.82 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.829 1.251 . . . . 0.0 113.215 172.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 62.3 p . . . . . 0 N--CA 1.465 0.315 0 C-N-CA 125.675 1.59 . . . . 0.0 110.987 175.244 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 53.8 mt . . . . . 0 N--CA 1.477 0.891 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -69.31 158.87 55.92 Favored 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 123.569 2.846 . . . . 0.0 112.049 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -64.46 145.56 87.99 Favored 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 122.37 2.047 . . . . 0.0 112.17 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -73.07 156.41 89.56 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 123.193 0.597 . . . . 0.0 112.215 173.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -68.78 174.32 8.8 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 123.42 2.747 . . . . 0.0 113.023 175.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -89.5 3.98 50.67 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.509 1.124 . . . . 0.0 113.087 -178.408 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 34.7 p90 -134.09 154.38 80.14 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 124.722 1.209 . . . . 0.0 112.701 -177.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.49 152.6 60.25 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 123.687 2.924 . . . . 0.0 112.641 179.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -67.87 143.9 96.82 Favored Pre-proline 0 CA--C 1.55 0.969 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -177.054 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.13 179.08 5.76 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 123.858 3.039 . . . . 0.0 112.716 177.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 24.7 p -131.31 154.91 82.07 Favored Pre-proline 0 N--CA 1.479 0.997 0 C-N-CA 125.194 1.398 . . . . 0.0 112.458 -174.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -67.03 164.57 29.49 Favored 'Trans proline' 0 CA--C 1.546 1.123 0 C-N-CA 123.397 2.732 . . . . 0.0 111.17 174.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo . . . . . 0 CA--C 1.54 0.791 0 C-N-CA 122.835 2.357 . . . . 0.0 112.352 175.662 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 17.9 m . . . . . 0 N--CA 1.468 0.468 0 CA-C-O 120.983 0.421 . . . . 0.0 110.052 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt -121.76 134.3 54.93 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.249 1.02 . . . . 0.0 110.221 175.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 82.7 p -76.4 156.34 33.27 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.622 1.569 . . . . 0.0 111.75 -179.085 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.9 pp -123.24 -6.91 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -153.73 157.69 32.62 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 125.758 1.623 . . . . 0.0 110.577 169.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.67 155.54 62.73 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.194 2.596 . . . . 0.0 112.994 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 32.6 t-80 . . . . . 0 CA--C 1.539 0.525 0 C-N-CA 125.934 1.694 . . . . 0.0 110.43 -178.219 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 17.5 p . . . . . 0 N--CA 1.483 1.19 0 N-CA-C 115.949 1.833 . . . . 0.0 115.949 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 15.3 mt -99.51 137.65 37.7 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.664 1.186 . . . . 0.0 110.653 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 30.6 tp -82.91 124.81 30.7 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 122.995 0.518 . . . . 0.0 110.818 175.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 47.4 m -91.74 147.55 22.91 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.775 1.23 . . . . 0.0 111.985 175.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -166.2 177.99 6.56 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.676 1.59 . . . . 0.0 112.755 -175.601 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -115.53 175.01 5.71 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.318 1.847 . . . . 0.0 111.617 173.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -62.46 141.1 58.55 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 121.349 -0.845 . . . . 0.0 111.106 168.191 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 71.53 18.63 77.23 Favored Glycine 0 CA--C 1.537 1.45 0 N-CA-C 114.651 0.62 . . . . 0.0 114.651 176.178 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -88.25 159.52 18.08 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.688 1.195 . . . . 0.0 111.645 173.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 88.0 t -111.28 130.33 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.011 1.324 . . . . 0.0 109.765 -173.045 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 23.1 mt -136.01 136.53 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.865 1.266 . . . . 0.0 109.035 -177.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 9.9 m -97.89 139.45 33.73 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.87 1.268 . . . . 0.0 110.004 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 20.6 mt -78.99 140.79 37.91 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 118.864 0.756 . . . . 0.0 111.953 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 37.4 mt -119.53 -5.38 10.29 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.891 1.276 . . . . 0.0 113.569 -177.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 371' ' ' ILE . . . . . 0.872 HG22 ' HD2' ' A' ' 372' ' ' PRO . 0.2 OUTLIER -127.9 146.76 60.26 Favored Pre-proline 0 N--CA 1.477 0.888 0 C-N-CA 126.722 2.009 . . . . 0.0 108.213 173.73 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 372' ' ' PRO . . . . . 0.872 ' HD2' HG22 ' A' ' 371' ' ' ILE . 82.9 Cg_endo -75.01 -17.09 19.81 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.461 2.774 . . . . 0.0 112.402 177.439 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -148.25 142.48 26.13 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.172 1.789 . . . . 0.0 111.202 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -72.29 172.95 9.36 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 125.658 1.583 . . . . 0.0 113.592 176.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -132.97 108.43 8.9 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.377 1.871 . . . . 0.0 110.833 -177.192 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 50.18 32.44 6.02 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 125.323 1.449 . . . . 0.0 114.707 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 98.94 -7.44 60.69 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 125.236 1.398 . . . . 0.0 114.462 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 78.8 m95 -99.77 128.97 45.84 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.485 1.143 . . . . 0.0 111.505 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 16.2 mt -98.42 161.36 13.73 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.622 1.169 . . . . 0.0 110.92 167.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 380' ' ' TYR . . . . . 0.453 ' HB3' ' CG1' ' A' ' 371' ' ' ILE . 60.2 t80 -121.33 122.2 39.33 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 173.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -145.58 170.75 26.8 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 115.749 -0.66 . . . . 0.0 114.46 -174.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -120.62 119.05 31.74 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.385 1.474 . . . . 0.0 109.717 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 -61.93 146.53 49.66 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.068 1.347 . . . . 0.0 111.68 177.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -80.55 -47.82 13.64 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 120.801 -1.187 . . . . 0.0 113.512 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 89.7 t -69.93 -51.93 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 124.287 1.035 . . . . 0.0 113.241 177.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 13.5 t -86.93 -21.69 26.1 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -173.22 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp 54.62 19.45 2.45 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 126.439 1.896 . . . . 0.0 114.303 -169.367 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -75.98 153.8 36.3 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.376 0.67 . . . . 0.0 111.896 172.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 70.9 mtm180 -127.93 148.04 50.49 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.463 1.905 . . . . 0.0 110.458 -179.133 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 169.86 170.93 34.87 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.83 1.205 . . . . 0.0 111.881 177.158 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -67.69 145.56 54.65 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.61 0.764 . . . . 0.0 110.902 171.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -152.78 153.2 29.8 Favored Pre-proline 0 CA--C 1.541 0.631 0 O-C-N 120.826 -1.171 . . . . 0.0 111.849 174.111 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -63.76 124.26 13.35 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 122.902 2.401 . . . . 0.0 112.14 178.726 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 97.5 p -62.97 -21.0 65.79 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 174.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 19.3 m -74.23 -17.54 60.87 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.826 1.25 . . . . 0.0 114.23 174.117 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -81.84 -2.72 52.0 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.567 1.147 . . . . 0.0 113.439 177.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 72.2 p . . . . . 0 N--CA 1.47 0.563 0 C-N-CA 126.563 1.945 . . . . 0.0 110.061 173.994 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 36.0 mt . . . . . 0 N--CA 1.477 0.902 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -68.7 162.48 40.98 Favored 'Trans proline' 0 CA--C 1.545 1.049 0 C-N-CA 123.492 2.794 . . . . 0.0 111.776 177.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.26 143.32 83.04 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.09 1.86 . . . . 0.0 112.365 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -70.0 152.91 95.75 Favored Pre-proline 0 CA--C 1.553 1.065 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.528 170.205 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -69.77 174.86 8.89 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.402 2.735 . . . . 0.0 113.309 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -90.69 8.35 34.86 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.756 1.222 . . . . 0.0 112.568 -178.381 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 37.0 p90 -135.82 153.01 76.93 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 124.828 1.251 . . . . 0.0 112.874 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.07 152.09 62.18 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.662 2.908 . . . . 0.0 112.276 178.107 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -67.53 144.13 97.52 Favored Pre-proline 0 CA--C 1.551 0.99 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -175.189 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.36 177.07 8.37 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 124.03 3.153 . . . . 0.0 113.106 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 27.3 p -132.23 153.66 81.36 Favored Pre-proline 0 N--CA 1.478 0.968 0 C-N-CA 125.076 1.35 . . . . 0.0 112.827 -172.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -67.84 165.07 29.13 Favored 'Trans proline' 0 CA--C 1.55 1.284 0 C-N-CA 123.55 2.833 . . . . 0.0 112.054 175.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo . . . . . 0 CA--C 1.543 0.939 0 C-N-CA 123.664 2.909 . . . . 0.0 113.173 176.468 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 16.7 m . . . . . 0 C--O 1.234 0.253 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -111.28 131.82 54.85 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.771 0.796 . . . . 0.0 109.944 175.06 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 70.6 p -76.34 151.67 36.6 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.955 1.702 . . . . 0.0 111.61 -175.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.7 pp -122.56 -6.1 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 N-CA-C 114.684 1.364 . . . . 0.0 114.684 -175.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -154.58 158.96 32.32 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 126.446 1.898 . . . . 0.0 110.199 169.347 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -69.46 159.3 54.16 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 123.085 2.523 . . . . 0.0 112.923 177.362 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 . . . . . 0 N--CA 1.473 0.723 0 C-N-CA 124.918 1.287 . . . . 0.0 112.039 179.601 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 39.6 p . . . . . 0 N--CA 1.483 1.185 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 63.0 mt -106.83 125.46 51.04 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.028 1.331 . . . . 0.0 110.653 179.536 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 26.0 tp -77.3 127.58 32.84 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.338 0.655 . . . . 0.0 110.596 176.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 37.3 p -100.96 147.08 26.58 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.136 1.374 . . . . 0.0 112.217 177.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -163.48 178.99 7.59 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.556 1.542 . . . . 0.0 112.054 -174.276 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -130.27 157.32 42.83 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 127.282 2.233 . . . . 0.0 111.358 177.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -50.98 129.51 23.81 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.494 0.717 . . . . 0.0 112.311 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 91.45 -9.01 78.33 Favored Glycine 0 CA--C 1.538 1.476 0 C-N-CA 124.261 0.934 . . . . 0.0 114.633 -179.324 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -68.05 153.02 44.6 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 118.903 1.351 . . . . 0.0 111.891 172.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 74.3 t -115.51 140.26 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 125.389 1.476 . . . . 0.0 109.989 -173.601 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 36.2 mt -136.07 136.57 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 125.668 1.587 . . . . 0.0 108.559 -177.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 31.8 m -99.46 137.23 38.25 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.649 1.18 . . . . 0.0 109.7 177.215 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 15.7 mt -69.45 147.34 51.06 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -177.315 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 77.4 mt -120.87 -2.21 9.81 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 125.079 1.351 . . . . 0.0 113.435 178.079 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 371' ' ' ILE . . . . . 0.62 HG22 ' HD2' ' A' ' 372' ' ' PRO . 2.0 mt -137.04 142.7 39.29 Favored Pre-proline 0 N--CA 1.477 0.906 0 C-N-CA 126.623 1.969 . . . . 0.0 109.14 177.343 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 372' ' ' PRO . . . . . 0.62 ' HD2' HG22 ' A' ' 371' ' ' ILE . 42.3 Cg_endo -70.42 -15.83 34.67 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 123.056 2.504 . . . . 0.0 113.308 177.5 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -145.15 150.13 36.23 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.492 1.917 . . . . 0.0 111.028 177.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -75.23 172.28 12.69 Favored 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 176.026 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -124.7 101.87 7.31 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.255 1.822 . . . . 0.0 110.293 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 51.95 31.78 9.07 Favored 'General case' 0 CA--C 1.554 1.135 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 175.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 100.01 -4.36 57.43 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 125.099 1.333 . . . . 0.0 114.64 -178.433 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 82.5 m95 -103.28 121.29 42.41 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.639 1.576 . . . . 0.0 110.521 176.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 12.1 mt -85.07 160.42 19.99 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.364 0.666 . . . . 0.0 110.578 163.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 380' ' ' TYR . . . . . 0.429 ' HB3' HD11 ' A' ' 371' ' ' ILE . 57.5 t80 -122.98 126.49 47.27 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.208 1.403 . . . . 0.0 107.56 170.246 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -150.48 170.38 30.38 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-N 115.857 -0.611 . . . . 0.0 113.643 -173.035 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -118.83 119.64 34.99 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.226 1.41 . . . . 0.0 109.325 176.042 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -61.59 146.32 49.25 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.361 1.464 . . . . 0.0 111.745 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -79.55 -47.67 15.13 Favored 'General case' 0 CA--C 1.548 0.897 0 O-C-N 120.774 -1.203 . . . . 0.0 113.734 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 81.9 t -73.93 -49.47 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.988 0.915 . . . . 0.0 112.968 178.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 15.5 t -86.91 -21.74 26.12 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -173.07 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp 54.27 17.47 1.52 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 126.712 2.005 . . . . 0.0 114.771 -169.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -75.21 159.58 31.41 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.506 0.723 . . . . 0.0 112.16 173.289 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -126.58 159.0 34.78 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.336 1.854 . . . . 0.0 110.468 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 157.72 169.67 21.67 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 124.454 1.025 . . . . 0.0 112.538 175.133 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -67.85 145.58 54.49 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.002 0.521 . . . . 0.0 110.416 169.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -153.2 153.63 29.74 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 124.003 0.921 . . . . 0.0 111.162 173.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -62.86 121.06 8.81 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.748 2.299 . . . . 0.0 111.381 178.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.0 -17.53 63.4 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 121.303 -0.873 . . . . 0.0 113.096 177.31 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 79.6 p -73.43 -22.12 60.29 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.712 2.005 . . . . 0.0 114.282 174.191 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -79.09 2.89 19.15 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.507 1.523 . . . . 0.0 113.325 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 30.8 p . . . . . 0 CA--C 1.539 0.521 0 C-N-CA 126.966 2.106 . . . . 0.0 109.93 175.557 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 61.9 mt . . . . . 0 CA--C 1.549 0.919 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -69.37 160.57 49.28 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 123.611 2.874 . . . . 0.0 112.357 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.37 145.47 88.24 Favored 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 122.579 2.186 . . . . 0.0 112.368 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -77.24 158.2 79.84 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 123.691 0.796 . . . . 0.0 112.448 174.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -68.56 174.97 7.63 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 123.527 2.818 . . . . 0.0 113.176 176.09 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -93.56 9.87 34.96 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.908 1.283 . . . . 0.0 112.408 -178.241 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 38.6 p90 -138.46 153.93 73.07 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 124.67 1.188 . . . . 0.0 112.622 -178.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -71.18 152.28 61.76 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.444 2.763 . . . . 0.0 112.069 176.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -66.81 148.86 98.68 Favored Pre-proline 0 CA--C 1.549 0.926 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -176.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.78 -175.9 1.83 Allowed 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 124.069 3.179 . . . . 0.0 112.638 176.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 23.4 p -135.41 153.4 77.85 Favored Pre-proline 0 N--CA 1.475 0.8 0 C-N-CA 125.196 1.399 . . . . 0.0 112.465 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -65.42 164.38 26.18 Favored 'Trans proline' 0 CA--C 1.549 1.241 0 C-N-CA 123.225 2.617 . . . . 0.0 111.273 173.149 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo . . . . . 0 CA--C 1.542 0.915 0 C-N-CA 123.379 2.719 . . . . 0.0 113.248 177.761 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 12.9 m . . . . . 0 C--O 1.236 0.385 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -118.92 130.82 55.92 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.709 0.804 . . . . 0.0 110.203 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 76.5 p -73.61 151.17 40.94 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.792 0.837 . . . . 0.0 111.138 -178.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.8 pp -123.45 -7.93 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 -177.08 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -154.35 156.78 32.04 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 126.255 1.822 . . . . 0.0 110.233 169.106 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -69.78 156.74 62.52 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 123.316 2.677 . . . . 0.0 112.856 178.342 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 350' ' ' HIS . . . . . 0.416 ' HE1' HD12 ' A' ' 358' ' ' LEU . 55.5 t-80 . . . . . 0 CA--C 1.543 0.687 0 C-N-CA 125.024 1.329 . . . . 0.0 111.855 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . 0.26 24.9 p . . . . . 0 N--CA 1.488 1.461 0 N-CA-C 116.334 1.976 . . . . 0.0 116.334 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 358' ' ' LEU . . . . . 0.416 HD12 ' HE1' ' A' ' 350' ' ' HIS . 4.4 mm? -77.71 141.99 39.01 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.084 1.354 . . . . 0.0 110.554 172.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 22.9 tp -85.41 136.83 33.29 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 161.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 65.8 m -117.23 143.81 45.47 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.443 1.497 . . . . 0.0 111.428 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -162.55 178.98 8.09 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.091 1.357 . . . . 0.0 112.892 -167.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -116.93 173.53 6.6 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.226 1.811 . . . . 0.0 111.443 174.418 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -65.63 142.74 57.96 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.16 0.984 . . . . 0.0 111.559 171.025 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 75.67 8.28 84.13 Favored Glycine 0 CA--C 1.534 1.258 0 CA-C-O 119.298 -0.723 . . . . 0.0 114.819 176.49 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -79.07 163.41 25.15 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.556 1.142 . . . . 0.0 111.733 171.143 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 99.8 t -114.84 134.65 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.124 1.37 . . . . 0.0 109.163 -176.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 35.9 mt -132.45 141.48 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.275 1.03 . . . . 0.0 109.043 178.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 16.9 m -105.34 137.27 43.41 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.074 1.35 . . . . 0.0 109.467 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 9.9 mt -73.44 145.1 46.0 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -176.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 72.2 mt -119.53 -12.65 9.29 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 124.83 1.252 . . . . 0.0 113.311 178.085 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 371' ' ' ILE . . . . . 0.415 ' CG2' ' HD2' ' A' ' 372' ' ' PRO . 9.8 mt -127.79 141.22 40.41 Favored Pre-proline 0 N--CA 1.478 0.932 0 C-N-CA 126.096 1.759 . . . . 0.0 110.255 175.098 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 372' ' ' PRO . . . . . 0.415 ' HD2' ' CG2' ' A' ' 371' ' ' ILE . 56.5 Cg_endo -71.7 -7.58 21.45 Favored 'Trans proline' 0 CA--C 1.547 1.144 0 C-N-CA 123.948 3.098 . . . . 0.0 114.48 176.163 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -152.55 153.71 33.96 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.663 1.585 . . . . 0.0 112.262 172.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -75.32 169.78 17.39 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.491 1.116 . . . . 0.0 113.647 174.001 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -128.6 105.92 8.61 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 126.669 1.988 . . . . 0.0 109.957 179.198 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 50.37 32.17 6.1 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 124.954 1.302 . . . . 0.0 114.373 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 99.55 -17.38 57.7 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 125.863 1.697 . . . . 0.0 114.377 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -82.59 125.29 31.0 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.542 1.137 . . . . 0.0 111.138 176.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 14.4 mt -94.42 162.94 13.62 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.636 0.774 . . . . 0.0 110.364 162.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -126.45 125.38 42.03 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 170.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -147.53 169.96 28.35 Favored Glycine 0 CA--C 1.527 0.781 0 C-N-CA 124.085 0.85 . . . . 0.0 112.671 -173.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -117.24 121.2 40.54 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 124.492 1.117 . . . . 0.0 109.275 175.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -63.54 152.35 38.87 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.762 1.225 . . . . 0.0 112.382 178.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -86.85 -45.89 10.44 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 120.991 -1.068 . . . . 0.0 113.45 177.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 53.1 t -67.32 -54.49 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 123.799 0.84 . . . . 0.0 113.008 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 22.2 m -96.07 -12.86 24.21 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -172.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt 55.47 19.82 3.36 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 126.674 1.99 . . . . 0.0 114.77 -174.259 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -75.35 158.31 32.97 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.54 0.736 . . . . 0.0 112.153 175.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 53.7 mtt180 -128.83 153.13 47.73 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 127.022 2.129 . . . . 0.0 109.579 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 162.68 166.09 20.86 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 125.198 1.38 . . . . 0.0 111.421 176.324 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -65.82 144.5 56.8 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.388 0.675 . . . . 0.0 110.177 170.085 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -153.31 155.1 31.51 Favored Pre-proline 0 CA--C 1.539 0.527 0 O-C-N 120.507 -1.371 . . . . 0.0 110.978 175.329 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -65.38 118.63 5.62 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.23 1.953 . . . . 0.0 110.831 177.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 29.4 t -54.15 -38.77 65.85 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.75 -0.593 . . . . 0.0 112.109 177.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 14.7 m -60.08 -21.66 61.75 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 178.224 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -75.43 -3.47 34.0 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.561 1.145 . . . . 0.0 113.157 173.047 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 80.8 p . . . . . 0 N--CA 1.465 0.324 0 C-N-CA 125.712 1.605 . . . . 0.0 110.747 172.167 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 49.8 mt . . . . . 0 N--CA 1.479 1.001 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -68.69 160.93 47.44 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 123.624 2.883 . . . . 0.0 112.036 177.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.77 144.85 89.98 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.31 2.006 . . . . 0.0 112.493 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -68.29 152.54 96.47 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 123.041 0.536 . . . . 0.0 111.875 172.047 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -70.07 174.41 9.81 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.608 2.872 . . . . 0.0 113.543 -178.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -89.37 5.27 45.89 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.208 1.403 . . . . 0.0 112.378 -178.58 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 29.3 p90 -137.08 155.06 76.29 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 124.353 1.061 . . . . 0.0 112.642 -177.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.75 153.13 53.65 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 123.806 3.004 . . . . 0.0 112.965 178.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -67.81 140.03 93.84 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 123.788 0.835 . . . . 0.0 112.968 -177.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -73.45 179.05 5.9 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 123.979 3.119 . . . . 0.0 112.789 176.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 25.8 p -132.79 154.79 81.58 Favored Pre-proline 0 N--CA 1.48 1.058 0 C-N-CA 125.122 1.369 . . . . 0.0 112.479 -175.148 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -66.94 165.15 27.1 Favored 'Trans proline' 0 CA--C 1.549 1.243 0 C-N-CA 123.437 2.758 . . . . 0.0 111.621 175.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo . . . . . 0 CA--C 1.539 0.764 0 C-N-CA 123.337 2.692 . . . . 0.0 113.147 178.564 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 16.7 m . . . . . 0 C--O 1.235 0.342 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -122.99 132.23 54.05 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 124.268 1.027 . . . . 0.0 109.352 -177.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 74.4 p -78.35 152.47 32.32 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.416 0.686 . . . . 0.0 110.824 -177.354 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.8 pp -125.7 -5.68 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 N-CA-C 114.441 1.275 . . . . 0.0 114.441 -178.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -153.86 160.67 30.68 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 126.117 1.767 . . . . 0.0 110.431 168.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -69.77 156.59 62.91 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 123.117 2.545 . . . . 0.0 113.139 174.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 . . . . . 0 N--CA 1.473 0.694 0 C-N-CA 125.224 1.41 . . . . 0.0 111.451 179.127 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 65.7 p . . . . . 0 N--CA 1.483 1.211 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 45.3 mt -101.49 116.09 31.99 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.728 1.211 . . . . 0.0 111.027 -176.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 27.6 tp -74.04 118.25 16.78 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.502 0.721 . . . . 0.0 110.962 178.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 59.9 p -87.91 154.34 20.6 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.282 1.033 . . . . 0.0 112.978 174.217 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -167.39 179.41 5.01 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.917 1.687 . . . . 0.0 112.014 -177.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -119.49 176.7 5.23 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.577 1.951 . . . . 0.0 110.942 172.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 66.5 tt0 -65.92 139.47 58.26 Favored 'General case' 0 CA--C 1.546 0.814 0 O-C-N 121.349 -0.844 . . . . 0.0 111.548 171.253 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 82.19 4.29 90.27 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.298 0.951 . . . . 0.0 115.376 175.121 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -77.07 170.25 16.86 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.946 1.298 . . . . 0.0 112.616 173.197 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 94.6 t -125.24 129.35 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.786 1.634 . . . . 0.0 109.09 -169.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 29.6 mt -134.81 137.8 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.94 0.896 . . . . 0.0 109.968 -177.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 10.1 m -96.9 140.06 32.01 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.993 1.317 . . . . 0.0 110.834 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 20.7 mt -78.91 136.67 37.34 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 122.943 0.497 . . . . 0.0 111.55 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 50.1 mt -114.63 -2.0 13.2 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.7 1.2 . . . . 0.0 113.045 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 371' ' ' ILE . . . . . 0.584 HG22 ' HD2' ' A' ' 372' ' ' PRO . 2.1 mt -134.82 143.28 45.64 Favored Pre-proline 0 N--CA 1.478 0.972 0 C-N-CA 126.623 1.969 . . . . 0.0 109.568 178.118 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 372' ' ' PRO . . . . . 0.584 ' HD2' HG22 ' A' ' 371' ' ' ILE . 56.1 Cg_endo -72.46 -9.73 24.5 Favored 'Trans proline' 0 CA--C 1.548 1.18 0 C-N-CA 123.203 2.602 . . . . 0.0 113.639 176.532 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -153.32 152.43 31.11 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.862 1.665 . . . . 0.0 112.302 174.093 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -71.83 169.91 14.76 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.769 1.228 . . . . 0.0 113.855 173.192 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -129.36 106.96 9.14 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.466 1.907 . . . . 0.0 110.047 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 51.05 31.69 6.73 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.097 1.359 . . . . 0.0 114.567 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 97.35 -11.79 65.19 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 125.465 1.507 . . . . 0.0 114.439 -178.177 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 77.8 m95 -89.28 123.94 33.95 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.49 1.116 . . . . 0.0 110.809 175.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 15.1 mt -90.14 156.76 18.12 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.536 0.735 . . . . 0.0 110.228 162.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 380' ' ' TYR . . . . . 0.482 ' HB3' HD11 ' A' ' 371' ' ' ILE . 58.7 t80 -116.77 124.55 49.88 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.904 1.282 . . . . 0.0 107.616 169.433 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -148.74 171.95 28.99 Favored Glycine 0 CA--C 1.524 0.594 0 CA-C-N 115.659 -0.701 . . . . 0.0 113.376 -173.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -122.81 120.42 33.49 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.774 1.23 . . . . 0.0 109.859 177.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 25.2 t-80 -64.86 145.61 56.04 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.429 1.092 . . . . 0.0 111.66 178.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -80.19 -45.37 18.19 Favored 'General case' 0 CA--C 1.547 0.861 0 O-C-N 120.927 -1.108 . . . . 0.0 113.448 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 87.7 t -72.53 -53.78 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 177.184 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 35.2 m -86.41 -17.32 34.64 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.288 0.949 . . . . 0.0 113.142 -172.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp 53.96 21.31 2.8 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 126.69 1.996 . . . . 0.0 114.505 -173.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -80.55 152.46 28.62 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.189 0.596 . . . . 0.0 111.527 173.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 46.7 mtm-85 -119.44 155.6 31.73 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.252 1.821 . . . . 0.0 110.65 175.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 164.01 169.68 27.87 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.372 0.987 . . . . 0.0 112.217 174.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -66.53 145.75 55.28 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.351 0.661 . . . . 0.0 110.485 166.606 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -155.23 154.43 28.57 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 124.482 1.113 . . . . 0.0 110.391 172.236 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 393' ' ' PRO . . . . . 0.438 ' HB3' ' HB1' ' B' ' 535' ' ' ALA . 24.3 Cg_endo -65.37 124.14 12.48 Favored 'Trans proline' 0 CA--C 1.532 0.4 0 C-N-CA 122.581 2.188 . . . . 0.0 111.497 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 96.3 p -56.88 -37.21 71.06 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 8.7 p -67.66 -14.24 62.78 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.094 1.758 . . . . 0.0 115.503 179.214 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -79.86 -2.08 41.92 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 119.524 1.056 . . . . 0.0 113.106 168.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 77.0 p . . . . . 0 C--O 1.234 0.287 0 C-N-CA 125.446 1.498 . . . . 0.0 111.186 172.285 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 63.6 mt . . . . . 0 N--CA 1.477 0.885 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -69.41 159.85 52.07 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 123.561 2.841 . . . . 0.0 112.238 178.468 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.13 144.74 87.9 Favored 'Trans proline' 0 CA--C 1.535 0.529 0 C-N-CA 122.424 2.083 . . . . 0.0 112.148 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -73.89 156.7 87.93 Favored Pre-proline 0 CA--C 1.551 0.994 0 C-N-CA 123.243 0.617 . . . . 0.0 112.207 173.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -68.87 175.21 7.65 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.346 2.697 . . . . 0.0 113.128 176.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -92.2 9.03 35.42 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.853 1.261 . . . . 0.0 112.514 -178.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 34.9 p90 -138.31 154.16 73.53 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 124.846 1.259 . . . . 0.0 112.759 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.6 153.04 60.05 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 123.621 2.881 . . . . 0.0 112.547 178.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 535' ' ' ALA . . . . . 0.438 ' HB1' ' HB3' ' A' ' 393' ' ' PRO . . . -67.52 144.16 97.56 Favored Pre-proline 0 CA--C 1.55 0.964 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -176.467 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.86 176.26 9.24 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.949 3.099 . . . . 0.0 112.555 178.292 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 22.5 p -129.39 154.24 80.67 Favored Pre-proline 0 N--CA 1.479 0.993 0 C-N-CA 124.759 1.224 . . . . 0.0 112.779 -171.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -67.85 162.09 41.13 Favored 'Trans proline' 0 CA--C 1.546 1.118 0 C-N-CA 123.28 2.653 . . . . 0.0 111.352 176.468 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo . . . . . 0 CA--C 1.54 0.811 0 C-N-CA 122.982 2.454 . . . . 0.0 112.482 177.146 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 16.2 m . . . . . 0 C--O 1.237 0.413 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -120.53 131.24 54.6 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.914 0.886 . . . . 0.0 110.364 178.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 71.3 p -73.49 151.75 40.94 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.06 0.944 . . . . 0.0 111.379 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.7 pp -124.3 -8.28 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -177.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -154.35 157.23 32.26 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 126.474 1.91 . . . . 0.0 109.906 169.103 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.3 157.4 61.97 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.093 2.529 . . . . 0.0 113.025 177.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 . . . . . 0 N--CA 1.472 0.666 0 C-N-CA 125.064 1.345 . . . . 0.0 111.259 178.231 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 29.6 p . . . . . 0 N--CA 1.479 1.014 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 70.7 mt -108.0 128.97 55.13 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.997 1.319 . . . . 0.0 111.195 -177.245 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 31.1 tp -80.68 121.11 25.46 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.477 0.711 . . . . 0.0 110.642 176.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 47.4 p -90.19 152.62 21.01 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.564 1.145 . . . . 0.0 112.487 173.096 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -165.94 179.21 5.98 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.581 1.553 . . . . 0.0 112.34 -177.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -119.08 174.51 6.28 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.338 1.855 . . . . 0.0 111.205 174.309 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -68.62 137.99 54.68 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.044 0.938 . . . . 0.0 111.693 172.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 84.21 12.96 75.17 Favored Glycine 0 CA--C 1.536 1.39 0 N-CA-C 114.881 0.712 . . . . 0.0 114.881 174.105 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -95.48 160.91 14.29 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.96 1.704 . . . . 0.0 111.669 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 72.7 t -108.91 133.73 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.632 1.173 . . . . 0.0 109.74 -171.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 16.5 mt -133.88 139.23 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.446 1.098 . . . . 0.0 109.349 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 6.8 m -101.2 141.84 33.49 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.593 1.157 . . . . 0.0 110.134 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 23.7 mt -79.36 141.72 36.68 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.008 0.523 . . . . 0.0 111.943 -177.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 61.6 mt -116.46 -7.78 11.64 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.596 1.158 . . . . 0.0 113.003 178.096 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 7.5 mt -132.77 142.01 43.18 Favored Pre-proline 0 N--CA 1.478 0.969 0 C-N-CA 126.857 2.063 . . . . 0.0 109.807 175.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.08 -8.81 24.35 Favored 'Trans proline' 0 CA--C 1.548 1.177 0 C-N-CA 123.828 3.019 . . . . 0.0 114.788 175.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 26.8 pt-20 -152.69 155.4 37.18 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.811 1.645 . . . . 0.0 112.404 174.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -75.87 170.72 15.69 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.613 1.165 . . . . 0.0 113.853 174.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -132.51 107.86 8.74 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.533 1.933 . . . . 0.0 110.268 -178.164 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 50.65 30.53 4.96 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 124.993 1.317 . . . . 0.0 114.331 -178.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 100.14 -16.42 58.24 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 125.674 1.606 . . . . 0.0 114.425 -178.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -87.07 129.61 34.84 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.55 1.175 . . . . 0.0 111.198 178.207 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 12.5 mt -96.62 161.68 13.78 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.955 0.902 . . . . 0.0 110.311 163.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -124.83 123.75 40.62 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.201 1.4 . . . . 0.0 107.771 173.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -148.65 175.16 28.05 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-N 115.731 -0.668 . . . . 0.0 113.682 -172.101 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -126.07 120.62 30.7 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.254 1.422 . . . . 0.0 110.027 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -61.85 155.93 22.01 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.716 1.206 . . . . 0.0 111.887 179.068 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -98.46 -21.96 16.28 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 120.661 -1.274 . . . . 0.0 114.363 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 58.5 t -82.63 -33.81 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 C-N-CA 123.466 0.706 . . . . 0.0 112.718 178.253 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 5.5 t -127.33 -11.49 5.74 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.683 1.193 . . . . 0.0 113.694 -170.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? 54.68 23.02 4.42 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 125.753 1.621 . . . . 0.0 113.762 -177.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -69.25 154.47 41.99 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.688 1.195 . . . . 0.0 111.355 169.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 80.3 mtt180 -127.05 161.19 28.99 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.922 1.689 . . . . 0.0 110.947 -177.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 156.87 169.39 20.74 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 124.521 1.058 . . . . 0.0 112.449 174.296 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -67.1 147.87 52.6 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.144 0.497 . . . . 0.0 110.361 168.101 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -154.36 155.71 31.05 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 124.112 0.965 . . . . 0.0 110.75 172.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -65.15 120.39 7.6 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.314 2.009 . . . . 0.0 111.707 178.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 81.7 p -57.99 -22.77 51.04 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 114.225 1.195 . . . . 0.0 114.225 177.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 16.3 m -77.09 -17.69 58.52 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 176.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -79.36 -2.49 41.81 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.476 1.11 . . . . 0.0 113.687 177.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 67.2 p . . . . . 0 C--O 1.236 0.383 0 C-N-CA 125.623 1.569 . . . . 0.0 110.771 171.343 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 61.0 mt . . . . . 0 N--CA 1.478 0.93 0 CA-C-O 119.067 -0.492 . . . . 0.0 109.773 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -69.31 160.57 49.3 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 123.568 2.845 . . . . 0.0 112.074 178.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -63.99 143.45 85.03 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 122.281 1.987 . . . . 0.0 112.103 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -71.94 155.05 92.39 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 123.083 0.553 . . . . 0.0 112.053 172.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -68.8 174.87 8.02 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.419 2.746 . . . . 0.0 113.095 176.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -91.14 8.95 33.08 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.913 1.285 . . . . 0.0 112.407 -178.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 38.2 p90 -138.02 154.36 74.22 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 124.9 1.28 . . . . 0.0 112.827 -178.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -72.03 153.82 57.69 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.726 2.951 . . . . 0.0 112.58 178.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -68.97 142.9 93.88 Favored Pre-proline 0 CA--C 1.552 1.043 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -176.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -73.92 179.65 5.49 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 124.173 3.249 . . . . 0.0 113.071 176.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 26.9 p -132.89 155.29 81.32 Favored Pre-proline 0 N--CA 1.48 1.058 0 C-N-CA 125.25 1.42 . . . . 0.0 112.842 -174.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -67.46 164.64 30.04 Favored 'Trans proline' 0 CA--C 1.549 1.266 0 C-N-CA 123.504 2.803 . . . . 0.0 111.57 174.244 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo . . . . . 0 CA--C 1.542 0.88 0 C-N-CA 123.46 2.773 . . . . 0.0 113.085 176.574 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.688 0 N-CA-C 111.281 -0.727 . . . . 0.0 111.281 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 15.4 t -139.09 -30.3 0.74 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.338 1.055 . . . . 0.0 113.712 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 338' ' ' HIS . . . . . . . . . . . . . 14.2 p-80 -119.14 14.34 13.06 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.753 1.621 . . . . 0.0 112.531 173.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 339' ' ' MET . . . . . . . . . . . . . 14.7 ptm -148.01 154.17 39.93 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.204 1.802 . . . . 0.0 111.882 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.6 37.25 1.2 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 125.173 1.389 . . . . 0.0 114.044 -171.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 341' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.75 121.59 43.79 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.7 1.6 . . . . 0.0 110.751 178.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 342' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -70.39 142.54 52.07 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.369 0.667 . . . . 0.0 111.029 171.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 4.7 mptt -136.19 169.01 18.33 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.144 1.377 . . . . 0.0 112.313 174.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 15.9 m -132.44 154.52 40.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 126.704 2.002 . . . . 0.0 109.033 165.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 19.0 ttmt -118.2 131.34 56.39 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.991 0.916 . . . . 0.0 109.728 177.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 27.8 p -73.47 156.93 37.71 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.265 0.626 . . . . 0.0 111.315 -177.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 2.1 pp -127.32 -5.84 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 N-CA-C 114.722 1.378 . . . . 0.0 114.722 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -156.58 158.58 31.46 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 125.852 1.661 . . . . 0.0 110.415 171.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.21 156.68 64.04 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.216 2.611 . . . . 0.0 112.918 176.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 52.1 t-80 -140.28 151.03 44.77 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.093 1.357 . . . . 0.0 111.735 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 15.2 t -147.62 150.69 34.9 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.545 1.538 . . . . 0.0 112.005 -176.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -77.45 -35.22 54.15 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -177.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 67.86 -62.58 0.34 Allowed Glycine 0 CA--C 1.54 1.647 0 C-N-CA 126.738 2.113 . . . . 0.0 115.753 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 50.1 m -143.2 27.84 1.56 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 126.541 1.936 . . . . 0.0 112.118 -173.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -138.21 173.63 11.41 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.875 1.67 . . . . 0.0 111.445 -174.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 2.6 tmmm? -120.53 -31.88 4.2 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.207 1.403 . . . . 0.0 113.143 177.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 53.7 p -86.05 13.34 7.84 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.111 1.364 . . . . 0.0 114.601 -174.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 67.7 mt -104.39 124.52 49.36 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.763 1.225 . . . . 0.0 111.45 -177.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 23.7 tp -77.26 124.47 27.89 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.637 0.775 . . . . 0.0 110.828 176.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 58.5 p -94.97 153.38 17.68 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.876 1.27 . . . . 0.0 112.632 174.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -167.42 178.85 5.26 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.759 1.624 . . . . 0.0 112.132 -175.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -117.28 178.51 4.34 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.663 1.985 . . . . 0.0 110.93 173.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -66.96 141.3 57.66 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.304 -0.873 . . . . 0.0 111.47 170.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 79.29 5.44 89.14 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 124.232 0.92 . . . . 0.0 115.345 174.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -74.34 166.62 23.17 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.757 1.223 . . . . 0.0 112.822 176.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 90.8 t -119.36 126.33 75.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 125.666 1.586 . . . . 0.0 108.884 -174.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 26.4 mt -133.62 135.46 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.56 1.144 . . . . 0.0 109.059 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 59.3 m -102.72 136.73 42.01 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.757 1.223 . . . . 0.0 110.058 -177.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 19.5 mt -75.34 148.0 39.64 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -175.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 49.5 mt -121.25 0.93 10.2 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 124.782 1.233 . . . . 0.0 112.908 178.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 371' ' ' ILE . . . . . 0.531 HG22 ' HD2' ' A' ' 372' ' ' PRO . 2.2 mt -137.13 142.67 38.96 Favored Pre-proline 0 N--CA 1.48 1.05 0 C-N-CA 126.716 2.006 . . . . 0.0 109.794 177.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 372' ' ' PRO . . . . . 0.531 ' HD2' HG22 ' A' ' 371' ' ' ILE . 55.6 Cg_endo -72.27 -8.87 23.5 Favored 'Trans proline' 0 CA--C 1.546 1.085 0 C-N-CA 123.423 2.749 . . . . 0.0 113.959 176.036 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -153.63 152.82 31.29 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.855 1.662 . . . . 0.0 112.139 174.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -72.88 169.68 16.31 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.23 1.012 . . . . 0.0 113.63 174.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 18.2 tppt? -126.39 102.36 7.12 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.776 2.03 . . . . 0.0 109.801 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 52.67 30.36 8.64 Favored 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 178.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 102.09 -18.44 51.93 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.803 1.668 . . . . 0.0 114.199 -178.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 82.0 m95 -84.4 129.47 34.86 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.524 1.13 . . . . 0.0 111.119 175.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 11.4 mt -99.23 158.56 15.61 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.925 0.89 . . . . 0.0 110.285 165.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 380' ' ' TYR . . . . . 0.416 ' HB3' HD11 ' A' ' 371' ' ' ILE . 50.2 t80 -118.57 123.78 45.87 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.867 1.267 . . . . 0.0 107.721 171.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -148.62 172.43 28.81 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-N 115.854 -0.612 . . . . 0.0 113.602 -173.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -123.83 119.32 29.34 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.547 1.539 . . . . 0.0 109.402 176.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 25.0 t-80 -62.92 147.86 49.11 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.905 1.282 . . . . 0.0 111.546 177.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -80.39 -50.4 10.17 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 120.91 -1.119 . . . . 0.0 113.46 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 68.0 t -69.38 -49.0 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 O-C-N 121.37 -0.831 . . . . 0.0 113.111 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 20.3 t -86.11 -23.26 26.71 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.406 0.682 . . . . 0.0 112.646 -175.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 34.7 mmtm 53.46 20.51 2.06 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 126.187 1.795 . . . . 0.0 114.265 -169.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -76.41 152.78 36.12 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.458 0.703 . . . . 0.0 111.799 171.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 74.4 mtm180 -122.15 157.14 32.18 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.443 1.897 . . . . 0.0 111.195 177.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 161.02 170.57 25.81 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.529 1.061 . . . . 0.0 112.505 174.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -66.74 147.36 53.37 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.133 0.492 . . . . 0.0 110.313 166.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -154.73 155.73 30.76 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 124.304 1.042 . . . . 0.0 110.427 172.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -64.6 119.42 6.46 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.347 2.032 . . . . 0.0 110.822 176.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 28.9 t -55.79 -38.79 70.4 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.56 -0.712 . . . . 0.0 111.936 177.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 1.6 p -61.15 -17.39 52.61 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.306 1.842 . . . . 0.0 115.859 177.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -76.55 -0.34 22.85 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 119.705 1.139 . . . . 0.0 113.086 169.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 32.4 p -134.1 161.88 33.64 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 126.081 1.752 . . . . 0.0 111.008 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 51.6 mttm -134.62 155.41 50.53 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.12 1.368 . . . . 0.0 109.814 175.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.45 124.78 21.16 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 175.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 3.6 tp -52.36 -46.22 66.08 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 123.347 1.546 . . . . 0.0 114.962 -173.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -98.46 63.59 1.51 Allowed 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 127.063 2.145 . . . . 0.0 112.499 -178.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 . . . . . 0 C--O 1.255 1.373 0 N-CA-C 114.973 1.472 . . . . 0.0 114.973 171.95 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 526' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.82 0.343 . . . . 0.0 110.985 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 62.8 mt -66.89 132.99 93.9 Favored Pre-proline 0 N--CA 1.478 0.935 0 C-N-CA 125.01 1.324 . . . . 0.0 109.829 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -69.44 159.75 52.42 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 123.601 2.867 . . . . 0.0 112.264 178.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.23 144.95 87.98 Favored 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 122.374 2.05 . . . . 0.0 112.241 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -73.58 156.11 88.85 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 123.265 0.626 . . . . 0.0 112.224 173.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -69.14 174.73 8.55 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.48 2.787 . . . . 0.0 113.155 177.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -88.6 4.77 45.78 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.797 1.239 . . . . 0.0 112.62 -178.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 36.3 p90 -136.32 154.62 77.23 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 124.677 1.191 . . . . 0.0 112.829 -176.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.95 153.17 58.1 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 123.753 2.969 . . . . 0.0 112.779 178.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -68.7 143.15 94.67 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 123.732 0.813 . . . . 0.0 113.028 -177.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.73 176.86 8.82 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.992 3.128 . . . . 0.0 113.023 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 27.8 p -130.32 153.0 81.18 Favored Pre-proline 0 N--CA 1.478 0.959 0 C-N-CA 124.983 1.313 . . . . 0.0 112.82 -173.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -67.07 163.26 34.7 Favored 'Trans proline' 0 CA--C 1.548 1.183 0 C-N-CA 123.485 2.79 . . . . 0.0 111.338 176.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -63.76 150.74 87.74 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.007 2.471 . . . . 0.0 112.516 178.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 540' ' ' VAL . . . . . . . . . . . . . 40.9 t -97.65 103.96 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.181 1.392 . . . . 0.0 108.514 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 541' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -139.11 158.14 44.72 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.748 2.019 . . . . 0.0 111.463 -173.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 542' ' ' ASN . . . . . . . . . . . . . 50.9 t30 . . . . . 0 C--O 1.254 1.315 0 C-N-CA 125.267 1.427 . . . . 0.0 113.258 177.72 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.566 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 22.4 t -62.23 117.27 5.84 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.011 0.924 . . . . 0.0 111.486 176.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 338' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -153.44 137.73 16.61 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.232 1.413 . . . . 0.0 110.535 -177.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 339' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -153.46 167.3 29.93 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.407 1.483 . . . . 0.0 112.384 -177.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -139.75 129.5 24.6 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.963 1.705 . . . . 0.0 109.568 176.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 341' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -151.47 80.24 1.29 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.769 1.228 . . . . 0.0 112.325 -166.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 342' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -59.32 136.77 58.07 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.692 0.758 . . . . 0.0 112.037 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 10.5 mptt -131.6 167.8 18.8 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 126.028 1.731 . . . . 0.0 111.506 176.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 16.2 m -133.55 152.89 35.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 126.454 1.901 . . . . 0.0 109.161 166.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -113.45 133.4 55.22 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.675 0.79 . . . . 0.0 110.092 174.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 68.3 p -72.84 154.75 40.47 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.279 1.032 . . . . 0.0 111.175 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.9 pp -125.59 -6.41 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 -179.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -155.92 159.76 31.31 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 126.273 1.829 . . . . 0.0 109.889 169.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -68.75 155.96 67.02 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.041 2.494 . . . . 0.0 113.203 177.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -140.47 152.4 45.61 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.466 1.507 . . . . 0.0 111.409 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 14.5 t -146.85 152.48 38.8 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.389 1.475 . . . . 0.0 111.749 -177.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -73.05 100.59 3.04 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.387 1.075 . . . . 0.0 111.353 176.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . -74.21 80.19 0.86 Allowed Glycine 0 CA--C 1.534 1.219 0 C-N-CA 125.465 1.507 . . . . 0.0 113.083 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 4.3 t 54.77 52.1 12.65 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.831 1.652 . . . . 0.0 112.849 -175.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -143.75 171.36 14.31 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 125.274 1.43 . . . . 0.0 112.214 -174.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 43.0 mtmt -121.74 -9.71 8.83 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 125.647 1.579 . . . . 0.0 114.817 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 75.8 p -115.26 20.47 14.87 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.938 1.295 . . . . 0.0 112.973 -172.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 69.0 mt -112.17 133.41 54.32 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.818 1.247 . . . . 0.0 111.762 -176.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 27.9 tp -87.72 121.27 29.94 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.096 0.958 . . . . 0.0 111.01 177.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 59.8 p -86.7 153.48 21.7 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.454 1.102 . . . . 0.0 112.866 172.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -167.53 178.34 5.47 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.901 1.68 . . . . 0.0 112.147 -178.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -118.54 175.96 5.48 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.877 2.071 . . . . 0.0 111.067 173.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -64.06 141.19 58.86 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.817 0.847 . . . . 0.0 111.404 169.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 75.47 11.49 84.28 Favored Glycine 0 CA--C 1.539 1.556 0 N-CA-C 114.975 0.75 . . . . 0.0 114.975 175.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -81.98 162.9 22.49 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.989 1.316 . . . . 0.0 112.036 173.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 86.9 t -117.35 129.2 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.96 1.304 . . . . 0.0 109.41 -172.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 30.5 mt -134.72 136.13 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.383 1.073 . . . . 0.0 109.474 -177.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 33.6 m -99.97 138.81 36.53 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.149 1.379 . . . . 0.0 110.31 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 20.8 mt -76.62 146.7 38.05 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 122.853 0.461 . . . . 0.0 112.219 -177.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 39.5 mt -120.07 -3.31 10.12 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 124.799 1.24 . . . . 0.0 112.773 177.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 371' ' ' ILE . . . . . 0.45 HG22 ' H ' ' A' ' 373' ' ' GLU . 6.2 mt -135.87 142.0 38.85 Favored Pre-proline 0 N--CA 1.481 1.101 0 C-N-CA 127.186 2.194 . . . . 0.0 109.917 177.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.13 -7.05 20.3 Favored 'Trans proline' 0 CA--C 1.546 1.121 0 C-N-CA 124.446 3.431 . . . . 0.0 115.248 175.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 373' ' ' GLU . . . . . 0.45 ' H ' HG22 ' A' ' 371' ' ' ILE . 18.1 pt-20 -151.48 167.34 28.33 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 126.091 1.756 . . . . 0.0 112.228 176.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -92.11 170.08 10.12 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.542 1.137 . . . . 0.0 113.036 175.003 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 10.5 tptp -133.51 111.09 10.41 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 126.366 1.866 . . . . 0.0 110.272 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 52.35 27.52 4.92 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 124.87 1.268 . . . . 0.0 114.257 -177.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 98.12 -14.31 62.63 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 125.727 1.632 . . . . 0.0 114.595 -176.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 75.7 m95 -87.04 133.31 33.61 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.412 1.106 . . . . 0.0 111.518 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 18.1 mt -102.01 162.59 12.79 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 124.342 1.057 . . . . 0.0 110.198 164.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -125.08 121.79 35.34 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.957 1.303 . . . . 0.0 107.733 175.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -145.44 174.12 25.57 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 115.542 -0.754 . . . . 0.0 114.139 -173.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -124.55 120.57 32.33 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.773 1.629 . . . . 0.0 109.798 177.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 15.8 t-80 -65.6 144.62 56.85 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.792 1.237 . . . . 0.0 111.952 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -77.71 -48.61 16.29 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 120.877 -1.139 . . . . 0.0 113.538 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 83.3 t -69.96 -48.99 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 124.03 0.932 . . . . 0.0 113.296 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 7.2 t -93.59 -16.05 24.77 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -171.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp 53.36 18.82 1.4 Allowed 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 127.024 2.13 . . . . 0.0 114.986 -173.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -78.01 156.11 30.33 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.411 0.684 . . . . 0.0 111.581 174.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -123.78 157.98 32.79 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.112 1.765 . . . . 0.0 110.652 177.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 159.68 168.86 22.26 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 124.252 0.93 . . . . 0.0 112.67 175.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -67.2 148.44 51.77 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.313 0.578 . . . . 0.0 110.258 168.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -154.36 154.39 29.5 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 124.526 1.13 . . . . 0.0 110.463 173.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -65.46 121.65 9.12 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.558 2.172 . . . . 0.0 110.883 177.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 30.4 t -56.44 -38.01 71.02 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.464 -0.772 . . . . 0.0 112.397 178.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 75.3 m -63.27 -19.6 64.71 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -73.08 -1.88 19.1 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.271 1.029 . . . . 0.0 113.192 171.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 53.8 p -131.77 164.06 26.84 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.962 1.705 . . . . 0.0 111.441 178.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -134.88 158.23 44.8 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.508 1.523 . . . . 0.0 109.27 174.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.5 127.26 30.32 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 171.196 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.77 -53.59 24.17 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 123.56 1.647 . . . . 0.0 114.132 -175.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -80.6 31.85 0.3 Allowed 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 128.301 2.64 . . . . 0.0 113.809 -176.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 . . . . . 0 C--O 1.255 1.388 0 C-N-CA 126.852 2.061 . . . . 0.0 113.975 174.261 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 526' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.832 0.348 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 64.1 mt -68.69 132.7 90.8 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 125.173 1.389 . . . . 0.0 109.759 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -69.76 158.73 55.95 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 123.459 2.772 . . . . 0.0 111.862 177.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.0 144.8 88.7 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 122.245 1.964 . . . . 0.0 112.256 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -69.74 154.77 94.47 Favored Pre-proline 0 CA--C 1.55 0.981 0 C-N-CA 122.962 0.505 . . . . 0.0 111.905 171.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -68.52 174.09 8.87 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.283 2.655 . . . . 0.0 113.009 177.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -86.65 1.95 50.13 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.463 1.105 . . . . 0.0 113.044 -178.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -132.74 153.57 81.12 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 124.736 1.215 . . . . 0.0 112.943 -176.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.4 152.97 61.16 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 123.694 2.929 . . . . 0.0 112.757 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -68.63 143.89 95.58 Favored Pre-proline 0 CA--C 1.551 1.013 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -73.54 -179.28 4.34 Favored 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 124.028 3.152 . . . . 0.0 112.791 176.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 22.2 p -134.28 155.07 80.21 Favored Pre-proline 0 N--CA 1.479 1.024 0 C-N-CA 125.247 1.419 . . . . 0.0 112.632 -175.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.59 163.13 36.22 Favored 'Trans proline' 0 CA--C 1.548 1.189 0 C-N-CA 123.512 2.808 . . . . 0.0 111.742 176.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -64.52 149.79 89.34 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 122.935 2.423 . . . . 0.0 112.576 177.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 540' ' ' VAL . . . . . . . . . . . . . 9.8 p -146.45 148.31 17.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 127.29 2.236 . . . . 0.0 109.347 -177.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 541' ' ' GLN . . . . . . . . . . . . . 41.0 mm-40 -136.97 144.53 43.4 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 126.27 1.828 . . . . 0.0 110.612 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 542' ' ' ASN . . . . . . . . . . . . . 55.8 t-20 . . . . . 0 C--O 1.255 1.358 0 C-N-CA 125.361 1.464 . . . . 0.0 111.433 -176.943 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.591 0 N-CA-C 111.759 -0.536 . . . . 0.0 111.759 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 82.0 p 42.92 39.04 1.59 Allowed 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 127.345 2.258 . . . . 0.0 116.116 177.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 338' ' ' HIS . . . . . . . . . . . . . 32.1 t60 -142.2 114.12 8.07 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.1 1.36 . . . . 0.0 110.721 -175.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 339' ' ' MET . . . . . . . . . . . . . 20.2 ptm -63.01 154.82 29.44 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.47 1.108 . . . . 0.0 113.233 178.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -118.81 -46.71 2.54 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.54 1.136 . . . . 0.0 112.747 -177.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 341' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -142.78 136.83 29.25 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 126.578 1.951 . . . . 0.0 110.323 -176.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 342' ' ' GLN . . . . . . . . . . . . . 72.6 tp60 -77.35 140.61 39.99 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.68 0.752 . . . . 0.0 111.804 177.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 3.1 mptm? -121.35 163.41 18.7 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.801 1.64 . . . . 0.0 111.3 173.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 15.7 m -134.6 157.72 41.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 126.643 1.977 . . . . 0.0 109.362 171.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -121.02 128.17 52.43 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.227 1.011 . . . . 0.0 109.901 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 59.0 p -71.79 154.04 41.56 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.01 0.924 . . . . 0.0 111.415 -177.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.8 pp -124.65 -8.36 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -156.01 159.54 31.45 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 126.731 2.012 . . . . 0.0 110.116 169.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.63 158.35 58.09 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.208 2.605 . . . . 0.0 113.331 177.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -142.62 154.99 44.89 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.98 1.312 . . . . 0.0 111.866 179.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 9.6 t -148.59 166.71 27.47 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.368 1.467 . . . . 0.0 113.065 -172.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -107.06 82.87 1.74 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.5 1.92 . . . . 0.0 110.546 -176.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . -62.91 -39.9 98.61 Favored Glycine 0 CA--C 1.537 1.43 0 N-CA-C 115.76 1.064 . . . . 0.0 115.76 -169.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 21.8 m -147.77 28.23 0.96 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.93 1.292 . . . . 0.0 112.417 -177.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -142.49 172.07 13.19 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.524 1.13 . . . . 0.0 113.268 -169.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -127.7 8.52 6.36 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 125.982 1.713 . . . . 0.0 114.979 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 74.3 p -127.22 16.83 7.19 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 125.606 1.563 . . . . 0.0 113.409 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 47.7 mt -97.37 120.43 37.71 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.714 1.206 . . . . 0.0 110.473 175.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 25.4 tp -73.18 131.95 42.63 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.494 0.718 . . . . 0.0 110.502 175.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 31.9 p -110.75 149.58 30.31 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.072 1.749 . . . . 0.0 112.395 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -167.11 179.08 5.33 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.149 1.379 . . . . 0.0 112.667 -169.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -116.49 177.0 4.85 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.712 2.005 . . . . 0.0 111.155 173.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -67.04 142.83 57.05 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.177 0.991 . . . . 0.0 111.888 170.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 75.61 5.39 78.32 Favored Glycine 0 CA--C 1.538 1.502 0 C-N-CA 124.376 0.988 . . . . 0.0 115.248 174.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -73.75 161.48 30.19 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.704 1.202 . . . . 0.0 111.723 171.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 59.3 t -112.51 138.32 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.485 1.114 . . . . 0.0 109.407 178.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 36.5 mt -136.26 140.77 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 124.717 1.207 . . . . 0.0 108.835 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 23.5 m -98.27 140.18 32.95 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.765 1.226 . . . . 0.0 110.853 178.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 22.7 mt -79.11 141.16 37.55 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 122.804 0.442 . . . . 0.0 111.554 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 63.1 mt -113.03 -4.45 13.86 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 124.673 1.189 . . . . 0.0 112.744 178.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 7.9 mt -132.92 141.76 42.21 Favored Pre-proline 0 N--CA 1.478 0.928 0 C-N-CA 127.001 2.12 . . . . 0.0 109.851 177.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.35 -7.98 22.42 Favored 'Trans proline' 0 CA--C 1.547 1.133 0 C-N-CA 123.974 3.116 . . . . 0.0 114.575 175.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -153.5 151.96 30.42 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.05 1.74 . . . . 0.0 112.062 175.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -74.62 171.33 14.05 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.417 1.087 . . . . 0.0 113.731 175.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -132.95 107.14 8.1 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.205 1.802 . . . . 0.0 110.249 -178.275 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 51.28 30.91 6.33 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 125.004 1.322 . . . . 0.0 114.343 -179.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 98.95 -16.75 59.1 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.772 1.653 . . . . 0.0 114.3 -177.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -85.75 132.06 34.21 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.308 1.043 . . . . 0.0 111.146 177.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 13.2 mt -100.7 159.94 14.76 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.939 0.896 . . . . 0.0 110.114 164.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -121.66 123.25 41.45 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 173.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -146.0 172.89 26.51 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-N 115.743 -0.662 . . . . 0.0 114.376 -172.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -124.68 116.46 22.41 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.88 1.672 . . . . 0.0 109.126 176.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 21.5 t-80 -61.88 144.29 55.14 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.818 1.247 . . . . 0.0 111.982 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -80.29 -45.32 18.07 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 121.217 -0.927 . . . . 0.0 112.705 -178.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 97.2 t -70.87 -52.73 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 124.256 1.022 . . . . 0.0 113.469 175.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 7.6 t -91.56 -15.61 28.41 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -171.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt 54.41 19.08 2.15 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 126.767 2.027 . . . . 0.0 114.777 -174.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -77.87 157.51 29.82 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.522 0.729 . . . . 0.0 111.822 174.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 54.1 mtt85 -128.52 155.9 44.14 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.007 1.723 . . . . 0.0 110.801 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 160.15 169.67 23.75 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 124.69 1.138 . . . . 0.0 112.03 176.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -66.8 147.17 53.6 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.114 0.566 . . . . 0.0 110.234 166.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -154.47 155.4 30.67 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 124.32 1.048 . . . . 0.0 110.17 172.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -65.64 120.1 7.23 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.167 1.911 . . . . 0.0 110.749 176.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 29.8 t -54.46 -38.45 66.37 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 121.897 -0.502 . . . . 0.0 111.958 176.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 17.9 m -58.58 -21.37 52.9 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.836 1.654 . . . . 0.0 115.255 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -77.41 0.27 23.17 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.606 1.163 . . . . 0.0 113.468 173.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 68.9 p -130.9 159.72 36.6 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.945 1.698 . . . . 0.0 111.328 176.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -124.73 164.28 20.29 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 125.307 1.443 . . . . 0.0 109.738 171.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.11 126.52 27.99 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.078 -0.964 . . . . 0.0 108.726 173.118 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 400' ' ' LEU . . . . . 0.4 HD12 ' O ' ' A' ' 400' ' ' LEU . 0.7 OUTLIER -53.35 -50.74 64.4 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 123.877 1.799 . . . . 0.0 114.459 -174.305 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -66.52 100.8 0.7 Allowed 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 128.303 2.641 . . . . 0.0 111.393 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 . . . . . 0 C--O 1.254 1.313 0 C-N-CA 126.329 1.851 . . . . 0.0 114.52 -173.998 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 526' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 . . . . . 0 N--CA 1.486 1.348 0 N-CA-C 110.578 -0.156 . . . . 0.0 110.578 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 58.9 mt -69.68 130.98 89.9 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 124.202 1.001 . . . . 0.0 109.821 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.36 160.37 49.75 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 123.532 2.821 . . . . 0.0 112.079 178.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.99 144.16 86.99 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.331 2.02 . . . . 0.0 112.357 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -72.41 156.14 90.63 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 123.361 0.664 . . . . 0.0 112.138 172.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -68.75 175.02 7.76 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.443 2.762 . . . . 0.0 113.219 176.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -91.8 8.93 34.86 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.856 1.262 . . . . 0.0 112.35 -178.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 36.3 p90 -137.73 154.56 74.86 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 124.617 1.167 . . . . 0.0 112.786 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -72.07 153.54 57.46 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 123.763 2.975 . . . . 0.0 112.74 178.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -69.26 142.42 92.52 Favored Pre-proline 0 CA--C 1.551 1.008 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -175.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -73.86 179.75 5.38 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 124.173 3.249 . . . . 0.0 113.266 178.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 28.1 p -132.59 155.45 81.21 Favored Pre-proline 0 N--CA 1.479 0.988 0 C-N-CA 125.392 1.477 . . . . 0.0 113.024 -172.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.13 163.0 39.43 Favored 'Trans proline' 0 CA--C 1.548 1.197 0 C-N-CA 123.545 2.83 . . . . 0.0 111.936 175.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -66.22 152.06 82.04 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.376 2.717 . . . . 0.0 112.925 178.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 540' ' ' VAL . . . . . . . . . . . . . 46.1 t -90.21 -27.89 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 124.627 1.171 . . . . 0.0 111.998 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 541' ' ' GLN . . . . . . . . . . . . . 23.0 mm100 -66.46 164.03 17.21 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.702 1.201 . . . . 0.0 113.086 175.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 542' ' ' ASN . . . . . . . . . . . . . 38.6 p30 . . . . . 0 C--O 1.255 1.343 0 C-N-CA 126.479 1.912 . . . . 0.0 113.398 -177.362 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.485 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 78.3 p -148.36 163.46 37.03 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.466 1.506 . . . . 0.0 112.098 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 338' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -84.2 -28.08 27.57 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -177.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 339' ' ' MET . . . . . . . . . . . . . 75.7 mtp -141.45 152.88 44.61 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.931 1.292 . . . . 0.0 112.87 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -77.26 -46.75 22.11 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.1 1.36 . . . . 0.0 113.373 -174.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 341' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -74.52 124.63 26.97 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.944 1.298 . . . . 0.0 110.388 176.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 342' ' ' GLN . . . . . . . . . . . . . 71.6 tp60 -67.98 136.83 54.53 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.868 0.842 . . . . 0.0 111.062 174.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -124.78 165.41 18.04 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.964 1.706 . . . . 0.0 111.002 177.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 16.3 m -134.45 156.2 40.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 126.717 2.007 . . . . 0.0 109.233 169.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -115.95 132.13 56.74 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 124.396 1.079 . . . . 0.0 109.885 177.267 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 72.3 p -75.04 153.94 38.2 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.526 0.73 . . . . 0.0 111.366 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.9 pp -123.97 -7.92 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -156.38 158.77 31.62 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 126.102 1.761 . . . . 0.0 110.117 170.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.02 155.78 68.34 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 122.947 2.431 . . . . 0.0 112.968 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -138.25 149.79 46.08 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.931 1.292 . . . . 0.0 111.621 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 10.4 m -142.9 131.72 22.76 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.098 1.359 . . . . 0.0 110.894 -167.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -73.06 -22.96 60.52 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 -178.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 57.81 -120.78 23.22 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.3 0.952 . . . . 0.0 112.118 -176.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 66.1 p -80.05 -10.67 59.79 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 176.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -84.46 170.35 13.6 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.253 1.021 . . . . 0.0 112.993 -176.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 20.8 ttpp -125.73 -16.92 5.59 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -178.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 36.7 p -99.94 13.15 34.9 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.315 1.446 . . . . 0.0 113.549 -176.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 81.8 mt -106.23 126.22 51.96 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.961 1.305 . . . . 0.0 110.963 -176.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 31.5 tp -73.86 141.8 46.09 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 122.987 0.515 . . . . 0.0 110.205 171.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 58.0 p -121.65 148.86 44.02 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.192 1.397 . . . . 0.0 111.721 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -165.54 178.5 6.68 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.97 1.308 . . . . 0.0 112.447 -167.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -117.7 177.63 4.69 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 127.117 2.167 . . . . 0.0 110.802 174.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -67.54 141.5 56.84 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 121.215 -0.928 . . . . 0.0 111.595 170.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 77.48 6.7 86.84 Favored Glycine 0 CA--C 1.538 1.485 0 N-CA-C 115.274 0.87 . . . . 0.0 115.274 176.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -74.02 164.67 26.32 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 118.437 1.119 . . . . 0.0 112.02 170.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 77.2 t -120.61 128.07 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.337 1.455 . . . . 0.0 109.125 -174.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 31.0 mt -132.55 137.06 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 123.399 0.68 . . . . 0.0 109.506 -175.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 20.5 m -98.02 140.27 32.61 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.334 1.054 . . . . 0.0 110.649 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 23.8 mt -81.17 142.94 32.74 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 122.975 0.51 . . . . 0.0 111.718 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 39.2 mt -116.04 -4.54 12.0 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.42 1.088 . . . . 0.0 113.003 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 6.9 mt -134.13 141.53 39.83 Favored Pre-proline 0 N--CA 1.477 0.88 0 C-N-CA 127.007 2.123 . . . . 0.0 109.57 177.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.81 -7.36 20.98 Favored 'Trans proline' 0 CA--C 1.549 1.255 0 C-N-CA 123.98 3.12 . . . . 0.0 114.561 176.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -150.3 154.49 37.96 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.073 1.749 . . . . 0.0 111.478 173.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -78.47 168.82 19.22 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 121.006 -1.059 . . . . 0.0 113.156 173.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -121.89 103.01 8.54 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 126.253 1.821 . . . . 0.0 110.253 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 52.14 31.47 9.05 Favored 'General case' 0 CA--C 1.555 1.136 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 177.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 99.84 -4.33 57.67 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 125.317 1.437 . . . . 0.0 114.675 -178.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -101.69 118.47 37.01 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.199 1.4 . . . . 0.0 110.67 176.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 12.6 mt -82.93 161.49 21.81 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.393 0.616 . . . . 0.0 110.546 162.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -126.04 123.5 38.56 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.152 1.381 . . . . 0.0 107.975 171.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -150.67 173.88 30.13 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-N 115.933 -0.576 . . . . 0.0 114.509 -169.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -126.21 120.29 29.67 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.653 1.581 . . . . 0.0 110.11 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 25.0 t-80 -66.4 156.07 35.66 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.256 1.422 . . . . 0.0 112.554 178.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -83.05 -48.18 10.88 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 178.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 71.2 t -75.66 -49.07 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 125.206 1.402 . . . . 0.0 113.393 -178.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 23.2 t -87.77 -23.34 24.12 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 118.786 0.721 . . . . 0.0 112.561 -176.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 7.0 mmmm 54.91 19.49 2.67 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 126.529 1.932 . . . . 0.0 114.006 -171.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -75.09 155.26 37.33 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.896 0.878 . . . . 0.0 111.817 172.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 -121.49 156.37 32.93 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 126.111 1.764 . . . . 0.0 111.429 176.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 165.57 169.63 29.44 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.898 1.237 . . . . 0.0 112.042 175.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -66.99 149.92 49.96 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.06 0.457 . . . . 0.0 110.126 166.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -155.87 154.37 27.66 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 124.263 1.025 . . . . 0.0 110.162 171.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 393' ' ' PRO . . . . . 0.4 ' HB3' ' HB1' ' B' ' 535' ' ' ALA . 20.4 Cg_endo -63.78 119.84 7.03 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.181 1.921 . . . . 0.0 110.406 177.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.1 -36.41 70.59 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 121.391 -0.818 . . . . 0.0 111.564 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 18.2 m -59.43 -22.11 60.99 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 126.748 2.019 . . . . 0.0 114.944 178.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -74.88 0.72 14.66 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.763 1.225 . . . . 0.0 113.217 172.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 36.6 p -134.81 162.79 31.39 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.735 1.614 . . . . 0.0 111.803 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -134.28 156.42 48.46 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.499 1.52 . . . . 0.0 109.988 176.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.1 124.28 20.07 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.41 1.084 . . . . 0.0 110.337 -177.326 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 23.9 tp -61.37 -44.62 96.86 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 123.216 1.484 . . . . 0.0 114.838 -175.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -93.61 56.65 2.42 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 127.932 2.493 . . . . 0.0 111.881 -176.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? . . . . . 0 C--O 1.253 1.286 0 C-N-CA 126.792 2.037 . . . . 0.0 115.884 178.855 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 526' ' ' HIS . . . . . . . . . . . . . 32.4 m80 . . . . . 0 N--CA 1.485 1.306 0 CA-C-O 120.462 0.172 . . . . 0.0 110.629 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 57.9 mt -72.28 131.79 84.71 Favored Pre-proline 0 N--CA 1.479 0.997 0 C-N-CA 124.455 1.102 . . . . 0.0 109.663 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -69.93 160.49 49.48 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 123.574 2.849 . . . . 0.0 112.138 177.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.07 144.49 87.52 Favored 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 122.294 1.996 . . . . 0.0 112.136 178.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -73.14 155.49 90.12 Favored Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 123.118 0.567 . . . . 0.0 112.027 173.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -69.07 174.7 8.52 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 123.537 2.824 . . . . 0.0 113.128 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -92.34 9.02 35.82 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.913 1.285 . . . . 0.0 112.472 -178.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 34.9 p90 -137.85 153.86 74.11 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 124.621 1.168 . . . . 0.0 112.842 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -71.92 151.91 57.08 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.579 2.853 . . . . 0.0 112.364 177.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 535' ' ' ALA . . . . . 0.4 ' HB1' ' HB3' ' A' ' 393' ' ' PRO . . . -69.91 146.3 95.16 Favored Pre-proline 0 CA--C 1.549 0.923 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -175.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.95 178.12 6.87 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 123.979 3.119 . . . . 0.0 112.833 176.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 25.3 p -132.36 154.02 81.43 Favored Pre-proline 0 N--CA 1.478 0.941 0 C-N-CA 125.316 1.447 . . . . 0.0 112.449 -175.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -66.5 162.24 37.6 Favored 'Trans proline' 0 CA--C 1.548 1.186 0 C-N-CA 123.353 2.702 . . . . 0.0 111.48 175.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -64.11 154.02 72.92 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.167 2.578 . . . . 0.0 112.713 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 540' ' ' VAL . . . . . . . . . . . . . 38.3 t -100.93 106.38 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.348 1.459 . . . . 0.0 108.219 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 541' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -138.46 175.42 9.58 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 127.337 2.255 . . . . 0.0 111.315 -173.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 542' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 . . . . . 0 C--O 1.253 1.273 0 C-N-CA 126.096 1.758 . . . . 0.0 111.865 -176.17 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.62 0 N-CA-C 112.424 -0.27 . . . . 0.0 112.424 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 11.7 t -145.82 71.98 1.29 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.982 1.313 . . . . 0.0 111.477 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 338' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -66.31 -9.7 35.53 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 176.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 339' ' ' MET . . . . . . . . . . . . . 3.1 tpt -85.62 -25.88 26.38 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -175.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 25.5 tptp -61.98 -33.15 73.78 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.37 1.068 . . . . 0.0 113.465 -175.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 341' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -108.16 109.21 20.55 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 126.157 1.783 . . . . 0.0 108.316 174.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 342' ' ' GLN . . . . . . . . . . . . . 71.0 tp60 -62.22 136.32 57.88 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.736 0.779 . . . . 0.0 111.081 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -119.67 160.76 21.9 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.363 1.465 . . . . 0.0 111.498 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 17.4 m -136.07 154.06 32.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 126.312 1.845 . . . . 0.0 109.543 171.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -118.19 134.99 54.52 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.292 1.037 . . . . 0.0 110.362 176.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 81.3 p -77.44 154.21 32.83 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.065 1.346 . . . . 0.0 111.674 -176.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.9 pp -119.7 -9.62 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -178.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -154.69 159.04 32.25 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 126.427 1.891 . . . . 0.0 110.538 170.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -69.88 158.01 58.25 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.225 2.617 . . . . 0.0 112.987 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 35.9 t-80 -142.42 144.35 33.06 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.835 1.654 . . . . 0.0 111.193 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 62.2 m -147.58 124.67 11.4 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.619 1.168 . . . . 0.0 111.055 -171.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -65.09 123.29 19.11 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.768 0.827 . . . . 0.0 110.764 167.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . -122.46 -30.23 1.2 Allowed Glycine 0 N--CA 1.478 1.474 0 C-N-CA 124.256 0.932 . . . . 0.0 115.288 -171.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 5.7 t -144.72 39.1 1.24 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.809 1.644 . . . . 0.0 109.796 173.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -141.05 176.13 9.07 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.802 1.641 . . . . 0.0 111.603 -162.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -138.5 -41.25 0.5 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.682 1.193 . . . . 0.0 114.037 177.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 41.2 p -88.05 14.85 8.25 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.143 1.377 . . . . 0.0 114.004 -174.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -102.68 118.52 37.02 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.096 1.358 . . . . 0.0 110.773 -171.223 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 28.5 tp -72.25 120.64 18.14 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 122.999 0.52 . . . . 0.0 110.736 176.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 50.1 m -95.54 147.97 23.0 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.315 1.046 . . . . 0.0 111.982 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -164.5 178.02 7.71 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.131 1.372 . . . . 0.0 113.215 -171.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -116.71 175.12 5.72 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.373 1.869 . . . . 0.0 111.681 174.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -64.31 140.72 58.9 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.01 0.924 . . . . 0.0 111.563 170.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 75.12 6.31 79.06 Favored Glycine 0 CA--C 1.539 1.532 0 C-N-CA 123.985 0.803 . . . . 0.0 115.076 176.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -77.02 161.62 28.18 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.731 1.212 . . . . 0.0 111.983 174.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 91.9 t -114.64 131.53 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 124.952 1.301 . . . . 0.0 109.841 -172.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 23.8 mt -135.23 139.73 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.204 1.402 . . . . 0.0 108.839 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 25.0 m -100.88 138.66 37.62 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.16 1.384 . . . . 0.0 110.302 -178.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 23.0 mt -79.15 136.37 37.09 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 118.138 0.426 . . . . 0.0 111.768 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 24.9 mt -114.36 -10.13 12.69 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.308 1.043 . . . . 0.0 113.089 -179.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 10.0 mt -126.69 141.16 39.47 Favored Pre-proline 0 N--CA 1.475 0.822 0 C-N-CA 126.565 1.946 . . . . 0.0 109.588 175.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.12 -7.71 21.51 Favored 'Trans proline' 0 CA--C 1.548 1.203 0 C-N-CA 123.8 3.0 . . . . 0.0 114.615 176.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -152.52 153.27 33.12 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.686 1.595 . . . . 0.0 112.368 176.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 19.2 pm0 -75.56 169.06 18.83 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.652 1.181 . . . . 0.0 113.619 173.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -130.63 106.67 8.65 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 126.75 2.02 . . . . 0.0 109.992 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 51.12 30.48 5.62 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 124.926 1.29 . . . . 0.0 114.41 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 100.94 -14.06 58.81 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 125.807 1.67 . . . . 0.0 114.475 -178.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 82.0 m95 -89.42 135.47 33.57 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.281 1.032 . . . . 0.0 111.633 178.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 18.9 mt -107.17 161.02 15.14 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.833 1.253 . . . . 0.0 109.973 166.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -123.16 120.05 32.05 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.671 1.188 . . . . 0.0 107.884 175.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -143.7 170.96 25.52 Favored Glycine 0 CA--C 1.527 0.844 0 CA-C-N 115.611 -0.722 . . . . 0.0 114.199 -173.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -120.37 118.43 30.34 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.424 1.489 . . . . 0.0 110.114 178.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 19.8 t-80 -63.4 147.43 51.24 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.903 1.281 . . . . 0.0 112.059 178.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -79.87 -49.46 11.9 Favored 'General case' 0 CA--C 1.547 0.865 0 O-C-N 120.868 -1.145 . . . . 0.0 113.411 177.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 63.7 t -68.8 -50.78 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.993 0.917 . . . . 0.0 113.234 178.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 23.0 t -86.15 -23.56 26.53 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.439 0.695 . . . . 0.0 112.868 -173.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp 54.71 16.42 1.38 Allowed 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 126.655 1.982 . . . . 0.0 114.66 -168.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -75.17 153.35 38.21 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.387 0.675 . . . . 0.0 111.794 172.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 82.4 mtm180 -124.06 151.1 44.22 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 126.42 1.888 . . . . 0.0 110.76 177.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 170.26 168.31 31.92 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 124.521 1.057 . . . . 0.0 112.146 175.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -65.5 145.68 55.81 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.136 0.493 . . . . 0.0 110.237 167.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -153.33 155.23 31.59 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 124.432 1.093 . . . . 0.0 111.037 175.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -65.65 121.7 9.15 Favored 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 122.496 2.131 . . . . 0.0 111.715 178.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 41.0 t -59.55 -27.75 66.49 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 121.644 -0.66 . . . . 0.0 112.649 174.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 17.8 m -66.96 -17.94 65.15 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 174.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -83.38 -2.24 55.3 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.717 1.207 . . . . 0.0 113.543 178.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 67.1 p -127.38 168.06 15.35 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.29 1.836 . . . . 0.0 109.897 172.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? -126.49 -75.11 0.58 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.769 0.828 . . . . 0.0 109.717 175.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 399' ' ' LEU . . . . . 0.467 HD13 ' H ' ' A' ' 400' ' ' LEU . 0.2 OUTLIER -166.84 151.45 7.34 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 127.252 2.221 . . . . 0.0 107.49 171.762 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 400' ' ' LEU . . . . . 0.467 ' H ' HD13 ' A' ' 399' ' ' LEU . 0.2 OUTLIER -61.96 -69.2 0.26 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 124.106 1.907 . . . . 0.0 111.825 172.906 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -60.66 155.51 18.8 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 110.449 -3.069 . . . . 0.0 112.87 -175.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 . . . . . 0 C--O 1.253 1.282 0 C-N-CA 125.988 1.715 . . . . 0.0 112.72 -172.557 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 526' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.923 0.392 . . . . 0.0 110.987 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 45.2 mt -70.0 133.27 88.05 Favored Pre-proline 0 N--CA 1.476 0.862 0 C-N-CA 125.012 1.325 . . . . 0.0 109.625 178.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -69.16 160.64 49.09 Favored 'Trans proline' 0 CA--C 1.545 1.047 0 C-N-CA 123.321 2.681 . . . . 0.0 111.963 177.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -64.52 145.86 88.26 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 122.286 1.99 . . . . 0.0 112.321 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -68.63 153.24 96.06 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 122.975 0.51 . . . . 0.0 111.85 171.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -69.56 174.48 9.27 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 123.487 2.791 . . . . 0.0 113.165 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -87.94 2.9 50.5 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.608 1.163 . . . . 0.0 112.957 -178.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 37.5 p90 -133.86 154.48 80.44 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 124.744 1.217 . . . . 0.0 112.778 -176.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.47 152.62 60.4 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 123.625 2.883 . . . . 0.0 112.688 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -66.96 142.0 97.07 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 123.703 0.801 . . . . 0.0 113.033 -177.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.19 176.94 8.46 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 123.852 3.035 . . . . 0.0 112.836 177.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 31.9 p -131.56 154.5 81.87 Favored Pre-proline 0 N--CA 1.478 0.951 0 C-N-CA 125.254 1.422 . . . . 0.0 112.659 -173.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.28 162.89 40.03 Favored 'Trans proline' 0 CA--C 1.548 1.18 0 C-N-CA 123.562 2.842 . . . . 0.0 111.94 176.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -64.42 144.89 86.89 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 123.236 2.624 . . . . 0.0 112.562 178.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 540' ' ' VAL . . . . . . . . . . . . . 48.9 t -75.95 -37.39 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 124.209 1.004 . . . . 0.0 111.389 178.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 541' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -68.13 151.77 46.5 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.715 1.206 . . . . 0.0 113.13 176.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 542' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 . . . . . 0 C--O 1.252 1.22 0 C-N-CA 124.778 1.231 . . . . 0.0 112.223 173.405 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.443 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.4 p -152.65 165.98 33.57 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.828 1.251 . . . . 0.0 112.698 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 338' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -138.16 162.49 34.09 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.022 1.729 . . . . 0.0 111.245 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 339' ' ' MET . . . . . . . . . . . . . 45.2 mtm 53.74 34.28 18.68 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.877 1.671 . . . . 0.0 113.753 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 17.3 ttpt -112.48 25.87 11.09 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.849 1.66 . . . . 0.0 113.465 -170.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 341' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.66 102.04 10.38 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.427 1.491 . . . . 0.0 109.418 178.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 342' ' ' GLN . . . . . . . . . . . . . 71.3 tp60 -65.35 136.03 56.04 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.599 0.714 . . . . 0.0 111.214 176.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -132.36 167.8 19.24 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.984 1.314 . . . . 0.0 111.326 175.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 15.3 m -130.58 160.27 41.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 126.636 1.975 . . . . 0.0 109.576 171.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -122.78 132.55 54.27 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.45 1.1 . . . . 0.0 109.699 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 74.2 p -78.67 152.42 31.66 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.502 1.121 . . . . 0.0 111.172 -177.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.8 pp -120.95 -9.33 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 -178.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -153.38 158.62 32.72 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 126.286 1.834 . . . . 0.0 110.308 168.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -69.09 156.93 63.59 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.407 2.738 . . . . 0.0 113.271 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 44.0 t-80 -138.97 144.02 38.78 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.516 1.526 . . . . 0.0 111.4 178.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 86.1 m -140.87 137.76 33.45 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 126.018 1.727 . . . . 0.0 110.352 -174.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -67.06 -33.08 74.73 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -173.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 52.47 62.35 5.86 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 124.748 1.166 . . . . 0.0 115.115 170.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 2.8 t 74.93 47.43 0.11 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 126.045 1.738 . . . . 0.0 112.611 -174.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -144.41 170.3 16.29 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 125.359 1.463 . . . . 0.0 111.232 173.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -128.01 -21.41 3.65 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.728 1.611 . . . . 0.0 113.84 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 56.3 p -96.37 8.24 44.47 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.831 1.252 . . . . 0.0 113.757 -178.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 56.2 mt -102.08 132.32 48.01 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.606 1.162 . . . . 0.0 111.13 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 28.2 tp -83.66 120.11 25.58 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.06 0.544 . . . . 0.0 110.872 175.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 54.7 p -88.54 152.46 21.84 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.566 1.147 . . . . 0.0 112.637 172.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -167.88 177.57 5.63 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.532 1.533 . . . . 0.0 112.304 -176.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -117.07 174.46 6.09 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.452 1.901 . . . . 0.0 111.452 174.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -64.27 140.49 58.87 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.442 -0.786 . . . . 0.0 111.608 170.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 77.57 3.76 83.63 Favored Glycine 0 CA--C 1.537 1.406 0 C-N-CA 124.349 0.976 . . . . 0.0 115.117 175.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -72.1 168.36 18.3 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.527 1.131 . . . . 0.0 112.344 173.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 91.2 t -118.91 130.42 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.603 1.561 . . . . 0.0 108.935 -174.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 17.2 mt -134.35 138.32 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.401 1.08 . . . . 0.0 109.57 -178.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 11.8 m -104.31 139.22 39.61 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.144 1.378 . . . . 0.0 110.72 -176.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 25.9 mt -79.17 142.81 36.0 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -173.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 29.8 mt -119.18 -8.8 10.09 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.514 1.125 . . . . 0.0 113.07 178.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 371' ' ' ILE . . . . . 0.441 HG22 ' H ' ' A' ' 373' ' ' GLU . 5.7 mt -134.73 141.25 37.94 Favored Pre-proline 0 N--CA 1.478 0.957 0 C-N-CA 126.833 2.053 . . . . 0.0 109.397 176.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.64 -0.6 10.01 Favored 'Trans proline' 0 CA--C 1.548 1.219 0 C-N-CA 124.62 3.546 . . . . 0.0 114.601 175.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 373' ' ' GLU . . . . . 0.441 ' H ' HG22 ' A' ' 371' ' ' ILE . 12.6 pt-20 -151.05 175.84 11.71 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.779 2.032 . . . . 0.0 111.535 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -116.16 164.96 13.71 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.148 1.379 . . . . 0.0 112.928 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -123.21 106.52 10.81 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 126.121 1.768 . . . . 0.0 110.323 -176.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 49.96 33.1 6.25 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.314 1.446 . . . . 0.0 114.789 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 96.82 -2.49 62.07 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.113 1.34 . . . . 0.0 114.628 -178.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 78.8 m95 -101.47 121.89 42.79 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.158 1.383 . . . . 0.0 110.763 177.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 13.1 mt -88.42 164.45 15.49 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.424 0.689 . . . . 0.0 110.151 162.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -127.29 121.03 30.01 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 124.953 1.301 . . . . 0.0 108.088 173.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -147.84 177.22 26.24 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.137 0.875 . . . . 0.0 113.865 -170.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -129.63 124.16 33.03 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.541 1.536 . . . . 0.0 110.555 -177.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -66.63 140.88 57.95 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.33 1.052 . . . . 0.0 112.164 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -73.05 -36.75 66.95 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 120.939 -1.1 . . . . 0.0 113.511 177.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 59.1 t -77.31 -34.43 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -173.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 8.5 t -124.62 -12.29 7.19 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.704 1.201 . . . . 0.0 113.442 -168.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? 56.37 16.91 2.62 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 125.995 1.718 . . . . 0.0 114.739 -175.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -66.99 147.24 53.48 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.204 1.002 . . . . 0.0 111.186 170.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -121.76 156.52 32.98 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.845 1.658 . . . . 0.0 111.516 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 164.52 170.17 29.09 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 124.162 0.886 . . . . 0.0 113.027 173.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -65.85 145.18 56.26 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.184 0.594 . . . . 0.0 110.346 168.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -153.48 153.46 29.18 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 124.125 0.97 . . . . 0.0 111.314 174.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -63.49 121.46 9.25 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.546 2.164 . . . . 0.0 111.345 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.66 -17.38 64.0 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 121.296 -0.877 . . . . 0.0 113.036 178.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 77.6 p -73.98 -22.19 59.71 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.777 2.031 . . . . 0.0 114.159 174.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -79.8 -1.11 37.36 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.254 1.421 . . . . 0.0 113.425 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 69.9 p -129.98 166.67 19.6 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.584 1.954 . . . . 0.0 110.873 174.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -127.06 -90.91 0.52 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.963 0.905 . . . . 0.0 110.2 176.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 399' ' ' LEU . . . . . 0.415 HD13 ' N ' ' A' ' 400' ' ' LEU . 0.6 OUTLIER -162.04 135.16 6.12 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.688 1.595 . . . . 0.0 109.131 173.783 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 400' ' ' LEU . . . . . 0.415 ' N ' HD13 ' A' ' 399' ' ' LEU . 17.6 tp -65.6 -53.37 42.62 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -177.122 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -149.3 111.84 4.75 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 125.738 1.615 . . . . 0.0 112.965 -174.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 . . . . . 0 C--O 1.253 1.258 0 C-N-CA 125.566 1.546 . . . . 0.0 113.794 179.529 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 526' ' ' HIS . . . . . . . . . . . . . 52.2 m80 . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.659 0.266 . . . . 0.0 110.577 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 69.3 mt -68.65 131.47 91.35 Favored Pre-proline 0 N--CA 1.477 0.923 0 C-N-CA 124.513 1.125 . . . . 0.0 109.517 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.28 160.34 49.91 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 123.57 2.847 . . . . 0.0 112.16 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.07 144.87 88.55 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.378 2.052 . . . . 0.0 112.238 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -73.42 157.13 88.35 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 123.387 0.675 . . . . 0.0 112.192 173.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -68.34 174.13 8.64 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.289 2.659 . . . . 0.0 113.157 176.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -86.26 0.28 54.17 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.651 1.18 . . . . 0.0 113.02 -178.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 38.4 p90 -133.28 153.57 80.69 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 124.792 1.237 . . . . 0.0 113.003 -174.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -71.45 152.54 60.46 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.542 2.828 . . . . 0.0 112.317 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -68.12 149.03 98.3 Favored Pre-proline 0 CA--C 1.55 0.952 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -176.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -72.27 -176.83 2.35 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 124.122 3.215 . . . . 0.0 112.801 176.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 24.3 p -137.04 153.89 75.58 Favored Pre-proline 0 N--CA 1.476 0.855 0 C-N-CA 125.341 1.457 . . . . 0.0 112.649 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -67.61 165.24 28.11 Favored 'Trans proline' 0 CA--C 1.548 1.176 0 C-N-CA 123.504 2.803 . . . . 0.0 111.948 175.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -62.41 159.27 36.57 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.453 2.769 . . . . 0.0 113.351 177.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 540' ' ' VAL . . . . . . . . . . . . . 3.6 t -137.23 49.79 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 126.554 1.942 . . . . 0.0 109.61 -171.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 541' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -126.45 169.82 12.61 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.921 2.088 . . . . 0.0 111.316 -178.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 542' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 . . . . . 0 C--O 1.254 1.306 0 C-N-CA 126.384 1.874 . . . . 0.0 113.053 -175.256 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.49 0 N-CA-C 111.054 -0.819 . . . . 0.0 111.054 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 23.0 t -145.66 129.27 17.07 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.035 1.334 . . . . 0.0 110.599 175.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 338' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -71.82 -38.1 70.25 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.531 0.938 . . . . 0.0 113.531 -173.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 339' ' ' MET . . . . . . . . . . . . . 84.9 mtp -98.23 143.26 28.92 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.088 0.955 . . . . 0.0 111.618 -177.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -74.44 95.77 2.78 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.645 1.178 . . . . 0.0 110.957 173.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 341' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.38 165.06 33.18 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.984 2.114 . . . . 0.0 109.693 172.432 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 342' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -138.76 140.16 38.54 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.039 0.935 . . . . 0.0 110.788 172.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -120.4 162.23 19.86 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.031 1.333 . . . . 0.0 111.717 174.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 16.0 m -134.77 156.23 39.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 126.909 2.084 . . . . 0.0 108.973 172.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -119.26 132.01 55.85 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.954 0.901 . . . . 0.0 109.904 178.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 66.8 p -74.74 149.89 39.63 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 124.852 1.261 . . . . 0.0 111.483 -178.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.7 pp -124.63 -7.82 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -176.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -154.95 157.19 31.89 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 126.67 1.988 . . . . 0.0 109.652 169.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -69.05 158.34 58.28 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.883 2.388 . . . . 0.0 112.439 177.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 36.3 t-80 -128.52 161.38 29.68 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.048 1.339 . . . . 0.0 112.018 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 86.9 m -132.14 141.28 49.07 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.581 1.552 . . . . 0.0 111.291 -166.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -140.0 31.23 2.0 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 125.512 1.525 . . . . 0.0 111.993 -176.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . -75.34 -29.71 59.7 Favored Glycine 0 CA--C 1.537 1.43 0 O-C-N 120.875 -1.141 . . . . 0.0 115.135 -173.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 46.3 m -102.09 5.68 40.58 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.078 1.351 . . . . 0.0 113.415 -178.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -142.56 173.14 11.8 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.143 1.777 . . . . 0.0 111.799 -173.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 2.4 mmmm -134.14 8.88 3.76 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 -171.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 32.6 p -134.3 18.42 3.69 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 125.767 1.627 . . . . 0.0 113.047 -177.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 49.3 mt -110.49 134.68 52.13 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.308 1.443 . . . . 0.0 110.921 -177.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 31.8 tp -83.21 126.05 32.22 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.871 0.868 . . . . 0.0 110.953 177.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 69.8 m -91.38 147.49 22.99 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.405 1.082 . . . . 0.0 111.957 173.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -163.21 177.56 8.94 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.708 1.603 . . . . 0.0 112.19 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -131.98 154.03 49.74 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.743 2.017 . . . . 0.0 111.5 178.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -50.89 130.59 25.51 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.716 0.806 . . . . 0.0 112.748 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 94.93 -14.27 65.63 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 124.342 0.973 . . . . 0.0 114.362 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -68.75 155.44 40.12 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.378 1.089 . . . . 0.0 112.165 174.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 69.3 t -111.74 142.52 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 125.823 1.649 . . . . 0.0 109.893 -175.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 16.9 mt -136.59 138.61 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.107 1.363 . . . . 0.0 109.024 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 18.5 m -102.55 137.24 41.04 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.705 1.202 . . . . 0.0 110.2 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 27.0 mt -77.04 143.51 39.26 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 122.935 0.494 . . . . 0.0 111.966 -175.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 42.5 mt -116.77 -7.18 11.52 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 124.73 1.212 . . . . 0.0 113.084 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 7.1 mt -130.83 140.41 38.59 Favored Pre-proline 0 N--CA 1.477 0.892 0 C-N-CA 126.617 1.967 . . . . 0.0 109.391 176.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.01 -7.29 20.77 Favored 'Trans proline' 0 CA--C 1.547 1.14 0 C-N-CA 123.582 2.854 . . . . 0.0 114.849 176.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -152.67 152.24 31.51 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.85 1.66 . . . . 0.0 111.937 174.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -76.45 170.45 16.36 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.626 1.17 . . . . 0.0 113.68 176.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -129.7 106.25 8.58 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.337 1.855 . . . . 0.0 110.142 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 49.92 32.51 5.61 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 125.328 1.451 . . . . 0.0 114.559 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 99.65 -14.37 60.56 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 125.506 1.527 . . . . 0.0 114.388 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -89.01 134.03 34.13 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.662 1.231 . . . . 0.0 111.457 176.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 13.1 mt -102.1 162.09 13.18 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.533 1.133 . . . . 0.0 110.277 165.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -124.07 123.04 39.46 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.981 1.312 . . . . 0.0 107.924 172.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -149.27 175.01 28.68 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 115.644 -0.707 . . . . 0.0 113.704 -170.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -126.47 122.72 36.02 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.272 1.429 . . . . 0.0 110.73 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -63.13 149.0 46.35 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.834 1.254 . . . . 0.0 112.353 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -88.34 -24.98 22.99 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 120.859 -1.151 . . . . 0.0 113.903 178.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 59.1 t -80.33 -35.01 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 O-C-N 121.352 -0.843 . . . . 0.0 112.658 -179.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 6.6 t -128.62 -10.79 5.02 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.59 1.156 . . . . 0.0 113.707 -169.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 4.8 mptt 53.82 24.65 4.6 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 125.432 1.493 . . . . 0.0 113.512 -175.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -68.79 147.45 51.75 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.6 1.16 . . . . 0.0 110.92 168.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 74.0 mtm-85 -120.2 157.28 29.4 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.556 1.542 . . . . 0.0 111.821 178.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 164.86 169.42 28.45 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.643 1.116 . . . . 0.0 112.584 175.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -69.61 148.01 49.94 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 122.802 0.441 . . . . 0.0 110.54 169.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -155.47 155.97 30.36 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 123.98 0.912 . . . . 0.0 111.685 175.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -65.02 121.1 8.48 Favored 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 122.81 2.34 . . . . 0.0 111.883 177.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 89.8 p -60.23 -22.4 62.98 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 176.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 18.1 m -74.59 -18.37 60.58 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 175.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -80.65 -0.86 39.97 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.712 1.205 . . . . 0.0 113.133 178.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 62.2 p -131.07 165.61 22.86 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.871 1.668 . . . . 0.0 111.516 175.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -135.49 159.87 40.24 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.863 1.665 . . . . 0.0 109.674 174.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.74 124.68 20.59 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.381 0.672 . . . . 0.0 109.49 174.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.5 tp -54.87 -45.16 74.57 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 123.692 1.71 . . . . 0.0 114.9 -172.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -73.83 99.89 3.32 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 127.165 2.186 . . . . 0.0 111.798 -177.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 . . . . . 0 C--O 1.253 1.239 0 C-N-CA 125.557 1.543 . . . . 0.0 113.719 177.803 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 526' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.809 0.338 . . . . 0.0 110.807 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 63.6 mt -69.14 132.16 90.24 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 124.838 1.255 . . . . 0.0 109.682 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.92 161.33 46.36 Favored 'Trans proline' 0 CA--C 1.545 1.05 0 C-N-CA 123.573 2.849 . . . . 0.0 112.091 177.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.16 144.46 86.92 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.271 1.981 . . . . 0.0 112.707 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -72.15 156.5 90.62 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 123.47 0.708 . . . . 0.0 112.194 171.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.42 174.37 9.32 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.435 2.757 . . . . 0.0 113.222 176.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -89.24 3.16 52.92 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.886 1.274 . . . . 0.0 113.016 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 40.8 p90 -134.15 154.42 80.09 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 124.764 1.226 . . . . 0.0 112.91 -175.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -71.54 153.37 60.31 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 123.689 2.926 . . . . 0.0 112.721 178.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -68.21 142.64 95.07 Favored Pre-proline 0 CA--C 1.553 1.081 0 C-N-CA 124.078 0.951 . . . . 0.0 113.215 -176.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.38 177.2 8.21 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 124.125 3.217 . . . . 0.0 113.002 176.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 35.6 p -132.43 153.35 81.17 Favored Pre-proline 0 N--CA 1.479 0.986 0 C-N-CA 125.289 1.436 . . . . 0.0 112.848 -175.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -69.17 162.94 39.73 Favored 'Trans proline' 0 CA--C 1.549 1.271 0 C-N-CA 123.699 2.933 . . . . 0.0 112.103 177.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -65.87 153.46 78.02 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.409 2.74 . . . . 0.0 113.223 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 540' ' ' VAL . . . . . . . . . . . . . 46.8 t -89.92 -16.99 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 125.241 1.417 . . . . 0.0 112.23 -178.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 541' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -61.79 162.07 9.3 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.275 1.43 . . . . 0.0 113.265 177.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 542' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 . . . . . 0 C--O 1.248 1.001 0 C-N-CA 126.027 1.731 . . . . 0.0 112.095 -174.36 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.6 0 CA-C-O 121.298 0.388 . . . . 0.0 112.212 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 36.6 p -66.02 147.0 54.02 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.276 1.03 . . . . 0.0 112.625 173.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 338' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -157.0 170.83 21.63 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.204 1.402 . . . . 0.0 112.165 176.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 339' ' ' MET . . . . . . . . . . . . . 22.7 mmt 55.94 23.12 6.31 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 126.36 1.864 . . . . 0.0 115.035 178.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm -69.93 -24.4 63.36 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -173.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 341' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -132.75 138.38 47.17 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.919 1.688 . . . . 0.0 109.868 176.173 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 342' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -75.42 137.84 41.27 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.856 0.836 . . . . 0.0 110.877 172.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -122.46 162.61 21.37 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 126.076 1.75 . . . . 0.0 110.681 175.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 16.8 m -136.67 154.12 31.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 125.93 1.692 . . . . 0.0 109.618 171.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -115.07 132.96 56.43 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.752 0.821 . . . . 0.0 110.61 174.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 81.7 p -72.06 152.29 42.51 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.411 1.084 . . . . 0.0 111.185 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.8 pp -121.97 -8.86 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -178.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -155.06 158.18 32.02 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 127.04 2.136 . . . . 0.0 109.897 169.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -68.85 158.01 59.57 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.116 2.544 . . . . 0.0 112.691 177.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 -139.18 146.13 40.19 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.117 1.367 . . . . 0.0 111.696 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 86.9 m -142.58 123.7 14.54 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.384 1.473 . . . . 0.0 111.436 -172.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -59.38 114.56 2.73 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 125.464 1.506 . . . . 0.0 111.179 165.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . -111.34 -41.07 1.18 Allowed Glycine 0 CA--C 1.54 1.6 0 N-CA-C 115.668 1.027 . . . . 0.0 115.668 -168.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 16.1 t -137.38 33.65 2.53 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.569 1.548 . . . . 0.0 110.746 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -149.89 -179.48 7.17 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.722 1.609 . . . . 0.0 112.045 -165.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 46.8 tptt -132.25 -30.45 1.52 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.291 1.436 . . . . 0.0 113.763 172.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 39.8 p -89.29 23.51 2.48 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.618 1.167 . . . . 0.0 113.918 -174.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 66.6 mt -101.66 128.15 48.09 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.968 1.307 . . . . 0.0 110.86 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 33.1 tp -78.32 121.35 24.33 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.208 0.603 . . . . 0.0 110.171 173.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 71.0 m -94.97 146.72 24.05 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.384 1.074 . . . . 0.0 111.438 175.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -162.58 178.14 8.82 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.252 1.421 . . . . 0.0 112.455 -175.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -116.47 173.52 6.56 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.145 1.778 . . . . 0.0 111.456 174.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -65.33 142.03 58.38 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.041 0.936 . . . . 0.0 111.565 171.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 75.41 9.36 84.45 Favored Glycine 0 CA--C 1.538 1.517 0 N-CA-C 114.808 0.683 . . . . 0.0 114.808 177.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -81.6 161.93 23.31 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.597 1.159 . . . . 0.0 111.705 172.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 31.2 t -115.42 135.35 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.735 1.214 . . . . 0.0 109.35 -174.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 18.4 mt -138.16 135.82 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.496 1.118 . . . . 0.0 109.342 -176.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 12.5 m -92.64 141.85 28.02 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.246 1.018 . . . . 0.0 110.476 174.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 23.0 mt -82.25 143.2 31.51 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 122.968 0.507 . . . . 0.0 111.64 178.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 47.2 mt -114.37 -4.65 12.95 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 124.591 1.156 . . . . 0.0 112.841 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 371' ' ' ILE . . . . . 0.4 HG22 ' H ' ' A' ' 373' ' ' GLU . 6.9 mt -134.65 141.71 39.8 Favored Pre-proline 0 N--CA 1.48 1.045 0 C-N-CA 127.048 2.139 . . . . 0.0 109.66 177.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.2 -8.07 22.11 Favored 'Trans proline' 0 CA--C 1.547 1.171 0 C-N-CA 124.025 3.15 . . . . 0.0 114.706 176.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 373' ' ' GLU . . . . . 0.4 ' H ' HG22 ' A' ' 371' ' ' ILE . 26.2 pt-20 -151.26 160.21 43.94 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.823 1.649 . . . . 0.0 111.94 173.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -85.42 169.9 13.22 Favored 'General case' 0 CA--C 1.55 0.96 0 O-C-N 121.048 -1.032 . . . . 0.0 113.026 177.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -126.63 105.82 8.97 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.731 2.012 . . . . 0.0 109.826 -177.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 50.85 31.42 6.07 Favored 'General case' 0 CA--C 1.555 1.145 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 100.79 -11.09 59.16 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 125.482 1.515 . . . . 0.0 114.408 -178.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -95.22 126.9 40.86 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.543 1.137 . . . . 0.0 111.248 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 13.0 mt -95.59 161.5 14.02 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.523 0.678 . . . . 0.0 110.495 163.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -124.01 122.16 37.17 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 125.159 1.383 . . . . 0.0 107.779 175.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -146.97 176.51 25.81 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-N 115.632 -0.713 . . . . 0.0 114.201 -171.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -129.55 120.82 25.96 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.493 1.517 . . . . 0.0 110.464 -178.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -65.51 141.15 58.57 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.643 1.177 . . . . 0.0 112.219 -177.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -75.69 -29.83 59.14 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 120.619 -1.301 . . . . 0.0 113.526 -178.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 51.2 t -81.49 -37.33 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 124.207 1.003 . . . . 0.0 113.419 -175.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 6.9 t -124.81 -8.84 7.27 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.484 1.113 . . . . 0.0 113.699 -171.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.58 23.76 3.74 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 126.181 1.792 . . . . 0.0 113.822 -177.226 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -68.97 150.83 47.26 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.436 1.094 . . . . 0.0 110.938 169.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -125.63 157.35 37.44 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.632 1.573 . . . . 0.0 110.757 -177.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 161.04 169.58 24.49 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 124.496 1.046 . . . . 0.0 112.237 174.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -66.77 148.38 52.0 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.151 0.501 . . . . 0.0 110.399 168.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -155.04 154.87 29.52 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 124.321 1.048 . . . . 0.0 110.223 171.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -63.72 122.2 10.2 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.434 2.089 . . . . 0.0 110.774 177.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 95.8 p -55.13 -40.24 70.32 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.8 -0.562 . . . . 0.0 112.135 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 5.3 t -62.15 -23.05 66.35 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.244 1.818 . . . . 0.0 114.464 -178.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -72.16 -3.43 23.3 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.615 1.166 . . . . 0.0 113.58 172.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 68.2 p -130.47 158.21 40.54 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.5 1.52 . . . . 0.0 111.083 176.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -128.36 161.55 29.17 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.772 1.229 . . . . 0.0 110.055 174.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.32 124.12 20.04 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 114.784 -1.098 . . . . 0.0 108.514 174.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -49.1 -58.46 4.92 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 123.929 1.823 . . . . 0.0 113.427 -176.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -70.3 76.97 0.54 Allowed 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 129.1 2.96 . . . . 0.0 112.871 -177.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 . . . . . 0 N--CA 1.486 1.33 0 C-N-CA 129.046 2.938 . . . . 0.0 115.308 -175.677 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 526' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.942 0.401 . . . . 0.0 111.23 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 61.2 mt -67.32 132.41 93.26 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 125.126 1.37 . . . . 0.0 109.806 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.76 160.25 50.39 Favored 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 123.571 2.848 . . . . 0.0 112.003 177.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.97 142.91 83.56 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.455 2.103 . . . . 0.0 112.36 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -72.19 154.4 92.19 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 123.282 0.633 . . . . 0.0 111.883 172.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -69.24 174.4 9.11 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.463 2.775 . . . . 0.0 113.039 178.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -87.64 1.76 52.81 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.636 1.174 . . . . 0.0 112.843 -178.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 34.7 p90 -133.54 154.35 80.73 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.712 1.205 . . . . 0.0 112.873 -175.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.95 152.72 57.77 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.667 2.912 . . . . 0.0 112.684 178.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -69.94 144.67 93.37 Favored Pre-proline 0 CA--C 1.55 0.98 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -176.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -73.8 179.32 5.77 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 124.103 3.202 . . . . 0.0 113.069 176.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 29.0 p -133.48 154.77 81.0 Favored Pre-proline 0 N--CA 1.479 1.015 0 C-N-CA 125.424 1.49 . . . . 0.0 112.64 -174.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.59 162.19 42.0 Favored 'Trans proline' 0 CA--C 1.548 1.222 0 C-N-CA 123.863 3.042 . . . . 0.0 111.995 176.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.49 149.87 84.33 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.447 2.765 . . . . 0.0 112.772 178.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 540' ' ' VAL . . . . . . . . . . . . . 47.3 t -76.19 -34.35 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 124.461 1.105 . . . . 0.0 111.805 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 541' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.55 169.8 22.33 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.831 1.652 . . . . 0.0 112.155 -177.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 542' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 . . . . . 0 C--O 1.254 1.299 0 C-N-CA 125.425 1.49 . . . . 0.0 113.601 -176.286 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.641 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 87.4 p -151.62 170.16 20.37 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.757 1.223 . . . . 0.0 112.434 176.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 338' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -98.19 -1.13 42.83 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.386 1.474 . . . . 0.0 114.031 -178.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 339' ' ' MET . . . . . . . . . . . . . 93.8 mtp -72.15 -42.47 65.93 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -174.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -74.44 -33.12 62.85 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.129 0.972 . . . . 0.0 113.113 -178.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 341' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.1 76.3 1.37 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 126.011 1.724 . . . . 0.0 111.678 -173.114 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 342' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -42.82 145.79 0.43 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 127.811 2.444 . . . . 0.0 113.548 171.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.36 163.98 20.59 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.738 1.615 . . . . 0.0 111.336 166.072 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 15.5 m -128.4 158.61 40.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 126.43 1.892 . . . . 0.0 109.032 168.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.89 125.98 44.81 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.264 1.026 . . . . 0.0 109.383 -175.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 73.1 p -72.31 153.23 41.63 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.585 0.754 . . . . 0.0 110.793 -175.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.9 pp -122.91 -6.94 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -177.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -158.73 160.3 29.34 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 126.684 1.993 . . . . 0.0 110.158 170.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -69.75 157.5 60.2 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 123.286 2.657 . . . . 0.0 113.263 176.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -144.63 152.66 40.81 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.218 1.407 . . . . 0.0 111.957 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 13.7 t -151.71 156.43 40.31 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.75 1.22 . . . . 0.0 112.972 -178.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -84.65 69.5 10.65 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.532 1.933 . . . . 0.0 111.89 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . -53.75 -31.06 45.36 Favored Glycine 0 CA--C 1.54 1.651 0 C-N-CA 125.35 1.452 . . . . 0.0 116.57 -171.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 5.1 t -154.0 42.74 0.54 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.844 1.257 . . . . 0.0 111.643 178.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -147.36 175.88 10.44 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -165.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.16 -9.27 4.28 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 127.306 2.243 . . . . 0.0 115.217 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 44.8 p -126.28 17.98 7.67 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 125.269 1.427 . . . . 0.0 113.155 -172.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 55.9 mt -102.35 127.68 49.24 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.706 1.203 . . . . 0.0 111.121 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 23.3 tp -77.68 129.54 35.67 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.498 0.719 . . . . 0.0 110.955 177.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 43.9 t -101.81 146.52 27.68 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.884 1.273 . . . . 0.0 111.827 176.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -163.9 178.32 7.87 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.919 1.688 . . . . 0.0 112.246 -174.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -117.3 177.13 4.84 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.898 2.079 . . . . 0.0 111.15 174.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -64.65 140.43 58.87 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.966 0.906 . . . . 0.0 111.597 169.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 75.34 5.62 77.77 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 124.594 1.093 . . . . 0.0 115.707 175.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -71.87 169.3 16.1 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.674 1.19 . . . . 0.0 112.12 171.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 95.7 t -126.42 127.52 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 125.519 1.528 . . . . 0.0 108.84 -169.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 35.3 mt -133.62 138.26 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 124.352 1.061 . . . . 0.0 108.969 -176.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 52.2 m -102.88 136.65 42.31 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.972 1.309 . . . . 0.0 110.045 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 15.9 mt -73.37 147.09 44.67 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -175.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 58.3 mt -120.78 -8.52 9.44 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.582 1.153 . . . . 0.0 113.396 177.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 6.5 mt -133.73 140.99 38.35 Favored Pre-proline 0 N--CA 1.48 1.047 0 C-N-CA 126.311 1.844 . . . . 0.0 109.666 176.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.73 -7.68 21.63 Favored 'Trans proline' 0 CA--C 1.546 1.104 0 C-N-CA 124.047 3.165 . . . . 0.0 114.722 176.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -152.22 153.8 34.5 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.76 1.624 . . . . 0.0 112.146 174.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -77.44 170.83 15.87 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 124.46 1.104 . . . . 0.0 113.894 175.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -129.26 105.62 8.26 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.563 1.945 . . . . 0.0 109.897 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 50.68 32.62 7.15 Favored 'General case' 0 CA--C 1.553 1.09 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 98.37 -12.63 63.33 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 125.411 1.481 . . . . 0.0 114.411 -178.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 77.6 m95 -89.38 123.19 33.31 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.315 1.058 . . . . 0.0 110.807 176.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 13.5 mt -90.23 161.37 15.73 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.367 0.667 . . . . 0.0 110.225 161.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -124.43 124.84 43.19 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.123 1.369 . . . . 0.0 107.934 171.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -148.8 172.09 29.01 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 124.154 0.883 . . . . 0.0 113.287 -171.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -124.88 121.05 33.42 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.233 1.413 . . . . 0.0 109.699 177.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -64.05 147.45 52.09 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.523 1.129 . . . . 0.0 111.93 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -81.15 -46.71 14.5 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 120.876 -1.14 . . . . 0.0 113.175 178.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 57.8 t -70.98 -51.78 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 98.9 p -91.51 -17.12 26.19 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -174.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp 55.96 17.57 2.65 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 126.809 2.044 . . . . 0.0 114.725 -172.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -72.06 151.72 42.91 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 121.455 0.645 . . . . 0.0 111.732 171.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 72.5 mtm180 -120.67 157.0 30.54 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.347 1.859 . . . . 0.0 110.551 176.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 163.21 169.38 26.57 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 124.095 0.855 . . . . 0.0 112.368 173.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -65.71 148.35 51.91 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.074 0.464 . . . . 0.0 110.077 166.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -154.96 153.95 28.17 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 124.111 0.964 . . . . 0.0 110.457 172.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -63.98 122.11 10.02 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.492 2.128 . . . . 0.0 110.752 176.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 95.2 p -55.16 -38.06 67.8 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 74.7 m -64.88 -19.44 65.91 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -74.13 -2.51 24.89 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.36 1.064 . . . . 0.0 113.125 171.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 64.2 p -128.22 156.73 42.5 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.703 1.601 . . . . 0.0 110.823 173.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 32.1 mmtm -120.86 165.02 15.76 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.386 1.074 . . . . 0.0 109.249 167.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.29 126.35 27.32 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 169.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.1 tt -54.48 -59.17 5.06 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 124.858 2.266 . . . . 0.0 113.847 -168.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -80.33 143.6 33.45 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 109.403 -3.544 . . . . 0.0 112.047 -173.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 . . . . . 0 C--O 1.252 1.232 0 C-N-CA 125.065 1.346 . . . . 0.0 113.565 -177.365 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 526' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.851 0.358 . . . . 0.0 110.654 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 71.9 mt -72.16 132.87 83.97 Favored Pre-proline 0 N--CA 1.477 0.906 0 C-N-CA 124.611 1.164 . . . . 0.0 109.429 178.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.11 159.56 52.72 Favored 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 123.636 2.891 . . . . 0.0 112.29 178.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.57 146.07 88.44 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 122.473 2.115 . . . . 0.0 112.445 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -74.24 157.21 86.92 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 123.616 0.766 . . . . 0.0 112.3 173.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -68.84 174.84 8.12 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.453 2.769 . . . . 0.0 113.19 175.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -86.2 0.6 53.31 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.735 1.214 . . . . 0.0 112.965 -178.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 36.6 p90 -134.73 155.18 79.65 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 124.796 1.239 . . . . 0.0 112.96 -174.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.86 152.72 58.29 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.726 2.951 . . . . 0.0 112.821 178.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -68.06 144.34 96.91 Favored Pre-proline 0 CA--C 1.552 1.032 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -175.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.4 -179.59 4.59 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 124.141 3.228 . . . . 0.0 112.857 176.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 22.8 p -135.17 155.29 79.03 Favored Pre-proline 0 N--CA 1.481 1.08 0 C-N-CA 125.051 1.341 . . . . 0.0 112.814 -175.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.87 163.47 35.41 Favored 'Trans proline' 0 CA--C 1.548 1.21 0 C-N-CA 123.628 2.885 . . . . 0.0 111.88 175.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -65.48 156.91 60.99 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.312 2.675 . . . . 0.0 113.092 178.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 540' ' ' VAL . . . . . . . . . . . . . 8.3 p -145.14 140.43 22.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 127.116 2.166 . . . . 0.0 109.75 -176.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 541' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -131.36 7.59 4.57 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.477 1.511 . . . . 0.0 113.784 -171.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 542' ' ' ASN . . . . . . . . . . . . . 26.9 m120 . . . . . 0 C--O 1.252 1.236 0 C-N-CA 125.28 1.432 . . . . 0.0 112.983 173.74 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.973 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 33.5 p -144.02 135.73 26.1 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.124 1.37 . . . . 0.0 111.962 -177.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 338' ' ' HIS . . . . . . . . . . . . . 15.0 p-80 -83.64 -2.26 55.74 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 339' ' ' MET . . . . . . . . . . . . . 15.0 ttp 48.79 64.98 1.49 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 126.67 1.988 . . . . 0.0 113.929 177.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -52.56 -31.3 35.29 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 126.04 1.736 . . . . 0.0 115.001 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 341' ' ' LYS . . . . . . . . . . . . . 1.2 tpmt? -157.47 149.75 22.67 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.334 1.854 . . . . 0.0 110.806 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 342' ' ' GLN . . . . . . . . . . . . . 71.2 tp60 -67.2 147.84 52.54 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.01 0.924 . . . . 0.0 112.425 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 9.3 tptt -121.76 159.6 26.33 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.712 1.605 . . . . 0.0 111.637 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 17.7 m -139.38 158.95 28.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 126.166 1.787 . . . . 0.0 110.62 174.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -123.27 126.95 47.85 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.081 1.352 . . . . 0.0 110.599 -178.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 81.6 p -71.7 152.09 43.09 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.586 0.754 . . . . 0.0 111.427 -178.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.9 pp -122.93 -8.98 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 -177.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -155.08 158.91 32.15 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 126.705 2.002 . . . . 0.0 109.842 169.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.05 156.13 66.14 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.129 2.553 . . . . 0.0 113.117 177.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -138.03 142.61 40.35 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.199 1.4 . . . . 0.0 111.103 177.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 88.5 m -138.73 137.2 36.54 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 126.148 1.779 . . . . 0.0 109.814 -175.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -64.99 -44.66 88.55 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -171.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 59.88 85.38 0.04 OUTLIER Glycine 0 CA--C 1.538 1.479 0 C-N-CA 124.565 1.079 . . . . 0.0 114.224 177.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 17.8 m 61.25 32.69 19.33 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 125.207 1.403 . . . . 0.0 114.024 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 51.9 m-80 -137.39 160.88 37.83 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.913 1.685 . . . . 0.0 111.767 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 36.1 mtmm -125.88 -4.77 6.93 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 125.49 1.516 . . . . 0.0 114.632 -177.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 32.8 p -110.14 11.57 23.7 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.886 1.675 . . . . 0.0 112.836 -176.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 66.8 mt -112.21 127.04 55.84 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.318 1.447 . . . . 0.0 111.312 -176.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 28.8 tp -78.74 124.79 28.56 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.936 0.894 . . . . 0.0 110.668 176.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 54.2 p -99.61 152.16 20.36 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.237 1.415 . . . . 0.0 112.434 177.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -167.45 177.32 6.06 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.052 1.341 . . . . 0.0 112.992 -172.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -115.32 177.13 4.77 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.857 2.063 . . . . 0.0 111.161 173.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -67.22 140.46 57.42 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.093 0.957 . . . . 0.0 111.818 170.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 74.66 4.68 71.37 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 125.007 1.289 . . . . 0.0 115.797 177.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -68.42 164.23 21.48 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 118.115 0.958 . . . . 0.0 111.461 167.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 95.7 t -118.16 136.17 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.642 1.177 . . . . 0.0 109.251 -177.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 29.7 mt -133.45 141.18 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.349 1.06 . . . . 0.0 108.795 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 23.5 m -102.21 136.34 42.21 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.817 1.247 . . . . 0.0 109.528 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 21.0 mt -79.18 138.71 37.97 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 118.544 0.611 . . . . 0.0 111.446 -177.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 44.7 mt -112.83 -10.15 13.6 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.993 0.917 . . . . 0.0 113.277 -177.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 371' ' ' ILE . . . . . 0.408 ' CG2' ' HD2' ' A' ' 372' ' ' PRO . 9.0 mt -124.58 140.1 34.64 Favored Pre-proline 0 N--CA 1.478 0.938 0 C-N-CA 126.363 1.865 . . . . 0.0 109.682 176.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 372' ' ' PRO . . . . . 0.408 ' HD2' ' CG2' ' A' ' 371' ' ' ILE . 58.1 Cg_endo -70.83 -8.36 23.45 Favored 'Trans proline' 0 CA--C 1.547 1.156 0 C-N-CA 123.834 3.022 . . . . 0.0 114.322 176.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -152.18 149.1 28.38 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.922 1.689 . . . . 0.0 111.893 173.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -74.08 171.35 13.68 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.443 1.097 . . . . 0.0 113.744 175.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -128.24 103.42 7.17 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.217 1.807 . . . . 0.0 110.448 -179.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 52.05 30.55 7.6 Favored 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 99.69 -15.57 59.59 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 125.654 1.597 . . . . 0.0 114.287 -178.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -85.07 128.8 34.79 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.221 1.011 . . . . 0.0 110.955 175.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 12.1 mt -99.4 161.41 13.63 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.212 1.005 . . . . 0.0 110.213 165.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -123.82 122.21 37.44 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 125.157 1.383 . . . . 0.0 107.519 173.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -145.5 167.24 27.56 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-N 115.82 -0.627 . . . . 0.0 113.927 -172.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -113.45 118.47 34.6 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.006 1.322 . . . . 0.0 109.019 173.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 33.9 t-80 -63.69 141.66 58.69 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.321 1.049 . . . . 0.0 111.789 178.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -75.2 -46.19 35.55 Favored 'General case' 0 CA--C 1.547 0.827 0 O-C-N 120.573 -1.329 . . . . 0.0 113.037 -178.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 57.4 t -70.31 -54.26 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 178.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 93.4 p -90.25 -17.27 27.76 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 119.583 1.083 . . . . 0.0 113.785 -173.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm 56.41 20.0 4.45 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 126.651 1.98 . . . . 0.0 114.023 -175.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -76.38 158.81 31.07 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.276 0.63 . . . . 0.0 112.051 171.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 82.2 mtt85 -125.18 158.91 32.81 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.148 1.779 . . . . 0.0 110.645 176.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 159.38 169.72 23.05 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.951 1.262 . . . . 0.0 112.278 176.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -68.36 148.73 50.29 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.994 0.426 . . . . 0.0 110.627 169.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -155.82 156.32 30.46 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 124.084 0.954 . . . . 0.0 110.747 172.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -66.72 120.61 7.73 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 122.433 2.088 . . . . 0.0 111.724 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 36.2 t -59.92 -25.38 65.1 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 175.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 75.2 m -69.44 -18.81 63.76 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 174.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -81.1 -0.34 39.58 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.635 1.174 . . . . 0.0 113.987 177.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 81.3 p -127.44 161.01 29.72 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.055 1.342 . . . . 0.0 111.599 174.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 32.3 mmtm -124.6 169.04 12.32 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.514 1.926 . . . . 0.0 109.248 170.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.72 128.23 35.53 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 171.027 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.54 -62.09 1.84 Allowed 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 123.94 1.829 . . . . 0.0 113.354 -177.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -60.2 119.76 8.49 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 128.945 2.898 . . . . 0.0 112.109 -178.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 . . . . . 0 C--O 1.259 1.576 0 C-N-CA 124.982 1.313 . . . . 0.0 113.865 -179.788 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 526' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.991 0.424 . . . . 0.0 111.013 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 52.7 mt -72.23 133.27 83.54 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 125.034 1.334 . . . . 0.0 109.438 176.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -69.03 160.95 47.86 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 123.42 2.747 . . . . 0.0 112.124 178.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.59 144.68 85.38 Favored 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 122.267 1.978 . . . . 0.0 112.352 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -70.59 153.66 94.84 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 123.095 0.558 . . . . 0.0 111.872 171.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -69.7 174.67 9.12 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 123.509 2.806 . . . . 0.0 113.2 179.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -86.05 1.33 50.73 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.353 1.061 . . . . 0.0 113.037 -178.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 38.1 p90 -133.46 154.37 80.83 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 124.823 1.249 . . . . 0.0 113.033 -174.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.56 153.11 60.24 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 123.66 2.907 . . . . 0.0 112.875 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -68.48 141.13 92.93 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 123.914 0.885 . . . . 0.0 113.096 -177.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.59 177.54 7.87 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 124.059 3.173 . . . . 0.0 113.239 177.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 32.8 p -134.25 153.94 79.72 Favored Pre-proline 0 N--CA 1.478 0.963 0 C-N-CA 125.401 1.48 . . . . 0.0 112.998 -172.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -68.29 163.22 37.18 Favored 'Trans proline' 0 CA--C 1.548 1.202 0 C-N-CA 123.772 2.981 . . . . 0.0 111.854 176.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -65.1 148.41 89.23 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.242 2.628 . . . . 0.0 112.885 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 540' ' ' VAL . . . . . . . . . . . . . 7.5 p -82.77 -10.45 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 125.05 1.34 . . . . 0.0 113.367 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 541' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -114.06 176.09 5.19 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.155 1.782 . . . . 0.0 112.081 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 542' ' ' ASN . . . . . . . . . . . . . 14.0 m120 . . . . . 0 C--O 1.253 1.259 0 C-N-CA 126.468 1.907 . . . . 0.0 111.639 -177.185 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.529 0 CA-C-O 121.241 0.356 . . . . 0.0 112.287 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 52.1 m -141.83 110.22 6.0 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.612 1.565 . . . . 0.0 109.899 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 338' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -67.71 -53.72 25.26 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.407 0.683 . . . . 0.0 111.872 -174.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 339' ' ' MET . . . . . . . . . . . . . 15.6 ptp -170.51 150.03 3.37 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.59 1.956 . . . . 0.0 111.348 174.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -88.72 -15.6 34.37 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.647 1.179 . . . . 0.0 114.087 178.036 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 341' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -137.39 134.72 36.25 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 126.894 2.078 . . . . 0.0 109.097 -178.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 342' ' ' GLN . . . . . . . . . . . . . 71.3 tp60 -65.08 137.12 57.47 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 118.837 0.744 . . . . 0.0 111.155 177.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 3.2 mptm? -123.74 164.4 19.22 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 125.708 1.603 . . . . 0.0 111.349 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 16.7 m -133.88 155.36 39.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 126.937 2.095 . . . . 0.0 109.54 171.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.45 134.27 54.75 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.385 1.074 . . . . 0.0 110.343 175.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 62.1 p -76.63 158.64 30.93 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.186 1.394 . . . . 0.0 111.774 179.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 2.0 pp -122.91 -9.79 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -155.35 159.22 31.9 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 125.836 1.654 . . . . 0.0 111.26 170.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.91 155.61 65.0 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.534 2.823 . . . . 0.0 113.443 177.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 -139.37 140.73 37.54 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.411 1.485 . . . . 0.0 111.899 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 28.3 m -136.91 128.72 29.03 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.673 1.589 . . . . 0.0 110.774 -172.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -67.42 -37.38 82.96 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -177.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 74.95 -55.06 2.64 Favored Glycine 0 CA--C 1.539 1.532 0 C-N-CA 126.538 2.018 . . . . 0.0 116.095 170.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 3.0 t -148.44 23.1 1.03 Allowed 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.75 1.62 . . . . 0.0 112.104 -176.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -131.5 165.5 23.44 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.087 1.755 . . . . 0.0 110.802 -166.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -121.32 -29.08 4.55 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 178.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 48.3 p -88.88 12.81 14.2 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.117 1.367 . . . . 0.0 113.987 -175.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 62.0 mt -107.84 131.01 54.94 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.841 1.256 . . . . 0.0 111.487 -178.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 24.0 tp -82.86 132.97 35.14 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.682 0.793 . . . . 0.0 110.534 174.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 45.3 m -114.86 147.73 39.5 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.226 1.411 . . . . 0.0 112.379 -178.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -166.42 178.95 5.83 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.412 1.485 . . . . 0.0 112.397 -166.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -118.18 174.79 6.01 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.974 2.11 . . . . 0.0 111.724 176.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 66.3 tt0 -64.25 140.94 58.92 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.317 -0.864 . . . . 0.0 111.002 168.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 70.36 19.48 76.06 Favored Glycine 0 CA--C 1.537 1.433 0 N-CA-C 114.37 0.508 . . . . 0.0 114.37 177.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -86.23 170.09 12.43 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.732 1.213 . . . . 0.0 111.522 169.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 89.7 t -125.82 128.09 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 125.658 1.583 . . . . 0.0 109.038 -168.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 22.7 mt -133.18 143.13 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 124.358 1.063 . . . . 0.0 110.056 -176.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 2.6 m -100.77 144.03 30.22 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.641 1.576 . . . . 0.0 110.398 -177.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 23.5 mt -84.67 141.11 30.83 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 118.333 0.515 . . . . 0.0 112.085 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 43.8 mt -120.05 -11.69 9.23 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.758 1.223 . . . . 0.0 113.298 179.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 371' ' ' ILE . . . . . 0.413 HG22 ' H ' ' A' ' 373' ' ' GLU . 7.1 mt -130.25 141.1 40.71 Favored Pre-proline 0 N--CA 1.476 0.853 0 C-N-CA 126.703 2.001 . . . . 0.0 109.224 175.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.69 -6.02 18.28 Favored 'Trans proline' 0 CA--C 1.548 1.208 0 C-N-CA 124.113 3.209 . . . . 0.0 114.835 175.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 373' ' ' GLU . . . . . 0.413 ' H ' HG22 ' A' ' 371' ' ' ILE . 12.6 pt-20 -151.67 162.78 40.42 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.162 1.785 . . . . 0.0 112.169 175.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.57 170.91 9.78 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.485 1.114 . . . . 0.0 113.202 176.007 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -128.63 106.39 8.92 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.403 1.881 . . . . 0.0 110.54 -178.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 51.32 31.09 6.62 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 124.943 1.297 . . . . 0.0 114.468 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 98.32 -8.32 62.45 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 125.293 1.425 . . . . 0.0 114.515 -177.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -95.42 122.46 38.17 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.729 1.265 . . . . 0.0 110.979 177.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 14.2 mt -88.39 160.49 17.56 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.751 0.82 . . . . 0.0 110.625 162.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 79.4 t80 -123.28 124.46 43.02 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.169 1.388 . . . . 0.0 107.924 170.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -149.95 173.84 29.56 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 123.864 0.745 . . . . 0.0 113.289 -170.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -126.29 115.18 19.3 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.959 1.304 . . . . 0.0 110.271 178.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 23.4 t-80 -61.59 144.72 53.95 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.43 1.092 . . . . 0.0 112.151 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -79.2 -48.26 14.53 Favored 'General case' 0 CA--C 1.548 0.882 0 O-C-N 120.926 -1.109 . . . . 0.0 112.565 178.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 58.5 t -68.3 -53.6 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 124.325 1.05 . . . . 0.0 113.73 176.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 40.2 m -89.77 -16.51 30.11 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 119.277 0.944 . . . . 0.0 113.188 -171.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 11.1 mmmm 54.49 19.92 2.58 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 127.358 2.263 . . . . 0.0 114.647 -176.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -82.14 152.7 26.39 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.938 0.895 . . . . 0.0 111.496 174.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 56.4 mtm-85 -117.58 158.97 23.66 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 126.172 1.789 . . . . 0.0 110.931 173.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 159.8 171.76 26.09 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.512 1.053 . . . . 0.0 112.453 175.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -68.46 145.22 54.27 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 120.961 0.41 . . . . 0.0 110.456 168.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -153.91 154.55 30.21 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 124.246 1.019 . . . . 0.0 111.015 173.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -63.4 122.94 11.28 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.529 2.153 . . . . 0.0 112.046 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 82.6 p -61.27 -25.98 67.46 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 176.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.83 -13.34 61.65 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.969 2.107 . . . . 0.0 114.86 174.355 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -85.01 -0.57 54.85 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.5 1.12 . . . . 0.0 113.133 174.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 71.3 p -131.69 169.76 15.73 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.653 1.981 . . . . 0.0 110.475 173.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -133.32 -73.49 0.49 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.322 1.049 . . . . 0.0 110.114 178.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 399' ' ' LEU . . . . . 0.545 HD13 ' H ' ' A' ' 400' ' ' LEU . 0.2 OUTLIER -165.78 158.39 15.12 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.92 2.488 . . . . 0.0 106.91 170.637 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 400' ' ' LEU . . . . . 0.545 ' H ' HD13 ' A' ' 399' ' ' LEU . 0.2 OUTLIER -59.79 -71.59 0.12 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 123.482 1.61 . . . . 0.0 111.806 172.512 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -108.15 129.99 55.15 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 111.168 -2.742 . . . . 0.0 110.355 -170.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 . . . . . 0 C--O 1.254 1.29 0 C-N-CA 124.712 1.205 . . . . 0.0 112.735 -177.062 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 526' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 121.127 0.489 . . . . 0.0 109.976 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 55.1 mt -75.69 133.15 73.8 Favored Pre-proline 0 N--CA 1.477 0.899 0 C-N-CA 124.847 1.259 . . . . 0.0 109.371 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -68.82 160.07 51.2 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 123.483 2.789 . . . . 0.0 112.007 178.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -63.77 144.47 89.03 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.428 2.086 . . . . 0.0 112.271 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -70.01 153.34 95.47 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 122.99 0.516 . . . . 0.0 111.629 171.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -69.28 174.75 8.64 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.459 2.773 . . . . 0.0 113.151 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -85.62 1.39 49.42 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.318 1.047 . . . . 0.0 112.976 -178.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 33.8 p90 -134.55 154.33 79.6 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 124.775 1.23 . . . . 0.0 112.94 -175.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.34 151.97 60.49 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.645 2.897 . . . . 0.0 112.681 178.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -66.83 145.23 98.89 Favored Pre-proline 0 CA--C 1.549 0.913 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -177.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.32 175.22 10.89 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.752 2.968 . . . . 0.0 112.781 178.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 23.0 p -129.73 153.96 80.91 Favored Pre-proline 0 N--CA 1.477 0.922 0 C-N-CA 124.732 1.213 . . . . 0.0 112.363 -173.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -66.56 163.08 34.08 Favored 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 122.999 2.466 . . . . 0.0 111.651 175.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -64.57 163.31 27.69 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 123.102 2.534 . . . . 0.0 112.257 174.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 540' ' ' VAL . . . . . . . . . . . . . 23.2 t -122.22 107.31 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.05 1.34 . . . . 0.0 108.275 -178.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 541' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -139.68 143.96 37.36 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.47 1.908 . . . . 0.0 110.417 -176.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 542' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 . . . . . 0 C--O 1.255 1.367 0 C-N-CA 124.791 1.236 . . . . 0.0 112.56 -179.346 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.532 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 1.6 t 56.45 27.75 12.64 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 126.04 1.736 . . . . 0.0 114.803 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 338' ' ' HIS . . . . . . . . . . . . . 42.0 t60 -82.86 64.76 7.65 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.503 1.521 . . . . 0.0 112.234 -176.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 339' ' ' MET . . . . . . . . . . . . . 14.7 mmt -139.28 165.12 28.02 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.934 1.694 . . . . 0.0 112.615 -176.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 34.9 tttm -131.69 33.18 4.03 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.338 1.855 . . . . 0.0 111.977 -179.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 341' ' ' LYS . . . . . . . . . . . . . 64.6 mtpt -133.62 157.22 46.28 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 126.964 2.106 . . . . 0.0 109.786 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 342' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -118.65 138.72 52.41 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.929 0.871 . . . . 0.0 111.395 -178.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -123.7 163.53 20.93 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 126.047 1.739 . . . . 0.0 111.952 -178.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 16.0 m -137.5 157.59 34.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 127.028 2.131 . . . . 0.0 109.159 169.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -121.02 131.71 54.45 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.197 0.999 . . . . 0.0 109.664 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 74.8 p -74.9 152.6 38.86 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.962 0.905 . . . . 0.0 111.177 -177.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.8 pp -123.49 -6.71 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -178.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -154.04 158.23 32.47 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 126.249 1.82 . . . . 0.0 110.121 169.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -68.96 154.5 70.72 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.792 2.328 . . . . 0.0 112.413 176.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 -140.32 145.06 36.72 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.499 1.52 . . . . 0.0 110.7 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 95.8 m -142.35 126.53 17.48 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.022 1.329 . . . . 0.0 110.192 -171.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -58.05 116.45 3.53 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.791 0.836 . . . . 0.0 111.413 168.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . -136.33 136.35 8.34 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 125.011 1.291 . . . . 0.0 110.986 177.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 83.5 p 52.06 20.03 1.17 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 126.02 1.728 . . . . 0.0 115.366 -166.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -149.38 174.81 12.05 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.811 1.244 . . . . 0.0 113.599 -172.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -126.75 -31.57 2.67 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 126.161 1.784 . . . . 0.0 114.318 177.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 38.0 p -90.85 19.16 5.76 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 126.009 1.724 . . . . 0.0 114.336 -174.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 56.8 mt -98.15 128.8 44.84 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.87 1.268 . . . . 0.0 110.485 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 31.4 tp -80.22 114.12 18.89 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.377 0.671 . . . . 0.0 110.844 175.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 50.3 m -83.88 150.03 25.98 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.043 0.937 . . . . 0.0 112.559 175.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -164.8 178.17 7.4 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.598 1.559 . . . . 0.0 113.217 -177.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -117.15 173.96 6.38 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.431 1.892 . . . . 0.0 111.258 173.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -64.98 142.32 58.48 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 121.301 -0.874 . . . . 0.0 111.648 170.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 77.05 5.79 85.34 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 124.071 0.843 . . . . 0.0 114.98 175.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -77.83 166.33 23.05 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.97 1.308 . . . . 0.0 111.96 172.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 67.9 t -121.07 131.24 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.105 1.362 . . . . 0.0 109.325 -172.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 25.2 mt -134.76 137.6 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.527 1.131 . . . . 0.0 109.245 -177.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 12.0 m -98.09 140.22 32.73 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.931 1.292 . . . . 0.0 110.236 -178.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 23.7 mt -80.03 137.94 36.91 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 118.235 0.47 . . . . 0.0 111.928 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 37.1 mt -114.62 -9.8 12.57 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.527 1.131 . . . . 0.0 113.122 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 9.4 mt -127.75 141.17 40.22 Favored Pre-proline 0 N--CA 1.479 1.01 0 C-N-CA 126.893 2.077 . . . . 0.0 109.632 176.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.28 -7.1 20.35 Favored 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 124.088 3.192 . . . . 0.0 114.817 177.036 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -151.24 160.22 43.94 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.288 1.835 . . . . 0.0 111.428 174.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.34 168.0 17.99 Favored 'General case' 0 CA--C 1.547 0.86 0 O-C-N 120.993 -1.067 . . . . 0.0 113.027 173.032 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -122.89 103.49 8.66 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 126.954 2.101 . . . . 0.0 109.105 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 51.96 30.54 7.41 Favored 'General case' 0 CA--C 1.555 1.17 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 102.45 -17.95 52.2 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 125.894 1.711 . . . . 0.0 114.276 -178.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -84.86 128.31 34.56 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.511 1.124 . . . . 0.0 111.463 178.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 16.9 mt -98.17 161.32 13.77 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.121 0.968 . . . . 0.0 110.51 164.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -125.9 121.72 33.98 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 125.37 1.468 . . . . 0.0 107.552 174.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -145.38 171.72 26.36 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-N 115.555 -0.748 . . . . 0.0 113.872 -172.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -119.63 117.26 27.84 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.006 1.323 . . . . 0.0 109.872 176.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 24.4 t-80 -63.77 145.16 56.29 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.854 1.262 . . . . 0.0 112.035 178.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -80.23 -44.66 19.34 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 120.914 -1.116 . . . . 0.0 113.706 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 57.7 t -69.18 -51.05 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 123.926 0.891 . . . . 0.0 113.306 176.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 13.2 t -91.03 -21.32 21.31 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -171.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt 56.32 16.71 2.5 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 126.446 1.898 . . . . 0.0 114.597 -171.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -74.11 156.16 37.69 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.362 0.665 . . . . 0.0 111.852 172.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -124.79 155.27 39.66 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.203 1.801 . . . . 0.0 110.08 176.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 162.62 168.76 25.01 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 124.911 1.243 . . . . 0.0 112.021 177.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -68.86 147.74 51.26 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.111 0.565 . . . . 0.0 110.721 171.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -155.21 155.27 29.83 Favored Pre-proline 0 CA--C 1.541 0.597 0 C-N-CA 124.315 1.046 . . . . 0.0 110.676 172.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -66.11 121.42 8.74 Favored 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 122.353 2.036 . . . . 0.0 110.975 177.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 29.7 t -55.01 -39.13 68.75 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.687 -0.633 . . . . 0.0 112.364 178.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 15.5 m -59.47 -21.85 60.68 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -74.24 -0.27 16.4 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.552 1.141 . . . . 0.0 113.514 172.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 48.1 p -133.27 162.81 30.8 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.86 1.664 . . . . 0.0 111.792 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -135.16 155.52 50.55 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.311 1.444 . . . . 0.0 110.036 176.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.31 124.34 20.32 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.742 0.817 . . . . 0.0 109.575 175.504 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 14.1 tp -60.12 -42.65 95.2 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 115.389 1.625 . . . . 0.0 115.389 -171.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -111.09 72.6 0.78 Allowed 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 126.824 2.05 . . . . 0.0 111.907 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 . . . . . 0 C--O 1.252 1.22 0 C-N-CA 126.665 1.986 . . . . 0.0 114.412 176.751 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 526' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.444 0.164 . . . . 0.0 110.835 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 35.7 mt -68.66 131.74 91.24 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 124.399 1.08 . . . . 0.0 110.329 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.19 159.13 52.97 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 123.498 2.799 . . . . 0.0 112.063 178.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.82 147.08 89.36 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.402 2.068 . . . . 0.0 112.561 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -73.98 157.11 87.46 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 123.692 0.797 . . . . 0.0 112.465 174.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.19 174.77 8.53 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.449 2.766 . . . . 0.0 113.381 176.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -88.39 3.06 51.27 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.997 1.319 . . . . 0.0 112.623 -178.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 32.6 p90 -134.85 154.62 79.43 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 124.557 1.143 . . . . 0.0 112.823 -175.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.51 152.49 60.07 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 123.788 2.992 . . . . 0.0 112.868 179.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -68.17 142.97 95.48 Favored Pre-proline 0 CA--C 1.551 0.981 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -176.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.32 179.94 5.01 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 124.114 3.209 . . . . 0.0 112.709 176.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 26.6 p -135.21 154.3 78.74 Favored Pre-proline 0 N--CA 1.479 0.983 0 C-N-CA 125.036 1.334 . . . . 0.0 112.657 -173.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -66.56 161.92 39.21 Favored 'Trans proline' 0 CA--C 1.547 1.165 0 C-N-CA 123.336 2.691 . . . . 0.0 111.484 175.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -64.94 154.61 72.33 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 123.052 2.501 . . . . 0.0 112.417 176.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 540' ' ' VAL . . . . . . . . . . . . . 6.9 m -70.33 -13.5 17.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 126.933 2.093 . . . . 0.0 114.695 -177.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 541' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.69 170.61 18.78 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 125.892 1.677 . . . . 0.0 111.716 174.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 542' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 . . . . . 0 C--O 1.253 1.262 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 -175.215 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.493 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 21.1 t -149.76 155.17 39.68 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.132 1.373 . . . . 0.0 111.595 177.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 338' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -135.92 9.99 3.32 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.261 1.424 . . . . 0.0 113.57 -172.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 339' ' ' MET . . . . . . . . . . . . . 79.8 mtp -131.34 158.29 41.1 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.996 1.318 . . . . 0.0 111.654 -176.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -109.94 47.47 0.95 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.853 1.661 . . . . 0.0 111.412 -173.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 341' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -66.47 75.48 0.1 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 126.926 2.09 . . . . 0.0 112.6 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 342' ' ' GLN . . . . . . . . . . . . . 70.7 tp60 -61.25 136.21 57.98 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.742 0.782 . . . . 0.0 111.057 175.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 3.4 mptm? -124.47 164.16 20.32 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.615 1.566 . . . . 0.0 110.747 177.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 17.3 m -133.26 154.91 40.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 126.471 1.909 . . . . 0.0 109.555 169.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 15.5 ttpt -119.53 136.39 54.36 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.138 0.975 . . . . 0.0 110.667 175.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 77.8 p -78.7 155.95 29.17 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.765 1.626 . . . . 0.0 111.783 -176.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.8 pp -122.24 -9.16 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 -176.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -155.29 159.22 31.91 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 126.346 1.858 . . . . 0.0 110.472 169.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.91 155.94 64.2 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.315 2.677 . . . . 0.0 113.348 178.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 44.7 t-80 -139.36 150.33 45.2 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.583 1.553 . . . . 0.0 111.98 -178.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 11.3 t -147.34 150.29 34.44 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.452 1.501 . . . . 0.0 112.12 -178.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -78.59 -26.46 45.44 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -178.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 66.75 -57.66 0.21 Allowed Glycine 0 CA--C 1.54 1.646 0 C-N-CA 127.378 2.418 . . . . 0.0 115.969 178.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 9.7 t -143.61 -13.26 0.67 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 126.868 2.067 . . . . 0.0 112.811 178.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -77.0 175.93 9.12 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 125.362 1.465 . . . . 0.0 112.592 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -125.13 -30.73 3.17 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.899 1.68 . . . . 0.0 113.229 176.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 58.0 p -91.07 17.17 8.37 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 125.136 1.374 . . . . 0.0 114.193 -175.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 58.4 mt -108.31 130.34 55.19 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.759 1.224 . . . . 0.0 111.358 -178.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 36.4 tp -82.49 120.1 25.05 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.877 0.871 . . . . 0.0 110.862 176.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 55.6 p -89.76 152.7 21.18 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.665 1.186 . . . . 0.0 112.523 173.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -167.75 178.93 5.02 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.434 1.494 . . . . 0.0 112.483 -175.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -117.94 174.06 6.41 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.405 1.882 . . . . 0.0 111.525 174.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -64.92 141.97 58.6 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.747 0.819 . . . . 0.0 111.368 170.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 73.66 10.67 80.11 Favored Glycine 0 CA--C 1.537 1.452 0 N-CA-C 114.525 0.57 . . . . 0.0 114.525 177.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -82.79 164.01 20.87 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.415 1.086 . . . . 0.0 111.342 171.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 93.6 t -119.46 136.99 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.559 1.144 . . . . 0.0 109.881 -171.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 17.1 mt -137.35 137.94 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.997 1.319 . . . . 0.0 109.272 -176.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 10.2 m -95.52 140.56 30.19 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.869 1.268 . . . . 0.0 110.56 176.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 23.3 mt -79.23 139.08 38.01 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.347 0.659 . . . . 0.0 111.803 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 32.4 mt -116.44 -6.78 11.72 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 124.253 1.021 . . . . 0.0 113.347 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 4.9 mt -134.49 140.52 35.92 Favored Pre-proline 0 N--CA 1.48 1.073 0 C-N-CA 126.517 1.927 . . . . 0.0 109.344 176.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.6 -8.53 23.81 Favored 'Trans proline' 0 CA--C 1.546 1.109 0 C-N-CA 123.963 3.109 . . . . 0.0 114.74 178.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -152.05 157.31 41.48 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.882 1.673 . . . . 0.0 111.92 175.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -80.35 168.73 18.66 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.481 1.112 . . . . 0.0 113.841 177.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -125.65 105.18 8.81 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.685 1.994 . . . . 0.0 110.287 178.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 50.96 32.14 7.09 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 125.084 1.354 . . . . 0.0 114.535 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 99.04 -16.67 59.11 Favored Glycine 0 CA--C 1.536 1.393 0 C-N-CA 125.743 1.64 . . . . 0.0 114.305 -178.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 83.0 m95 -85.33 129.74 34.74 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.479 1.112 . . . . 0.0 111.12 175.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 12.6 mt -99.15 162.99 12.75 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.227 1.011 . . . . 0.0 110.316 164.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -127.22 119.06 25.52 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.962 1.305 . . . . 0.0 107.935 176.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -146.63 175.47 26.04 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.064 0.84 . . . . 0.0 113.871 -170.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -127.42 121.63 31.41 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.376 1.47 . . . . 0.0 110.524 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 -66.84 133.58 50.37 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.317 1.047 . . . . 0.0 112.135 -176.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -70.25 -31.04 68.24 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 120.304 -1.497 . . . . 0.0 113.349 -178.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 58.1 t -81.42 -33.97 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 124.408 1.083 . . . . 0.0 113.522 -176.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 13.2 t -125.31 -15.2 6.28 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.887 1.275 . . . . 0.0 113.37 -167.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 54.84 20.8 3.25 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 126.78 2.032 . . . . 0.0 114.202 -177.236 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -69.22 147.99 50.48 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.573 1.149 . . . . 0.0 111.147 166.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 81.7 mtm180 -122.43 156.78 33.32 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.95 1.7 . . . . 0.0 111.473 179.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 162.83 171.45 29.07 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 124.817 1.198 . . . . 0.0 112.296 174.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -67.66 147.78 52.23 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.148 0.499 . . . . 0.0 110.347 169.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -154.42 155.75 31.04 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 124.321 1.048 . . . . 0.0 110.863 173.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -65.71 121.63 9.06 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.158 1.905 . . . . 0.0 111.627 178.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 33.8 t -61.86 -16.91 54.21 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 121.417 -0.802 . . . . 0.0 113.053 172.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 16.6 m -73.23 -17.65 61.32 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.888 1.275 . . . . 0.0 113.785 173.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -88.56 1.62 54.59 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.286 1.434 . . . . 0.0 113.072 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 58.3 p -128.42 167.38 17.1 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 127.084 2.154 . . . . 0.0 109.826 172.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -128.99 -71.27 0.64 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.997 0.919 . . . . 0.0 109.6 175.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 399' ' ' LEU . . . . . 0.513 HD13 ' H ' ' A' ' 400' ' ' LEU . 0.1 OUTLIER -167.51 158.34 11.34 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.508 2.323 . . . . 0.0 107.656 170.114 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 400' ' ' LEU . . . . . 0.513 ' H ' HD13 ' A' ' 399' ' ' LEU . 0.7 OUTLIER -60.81 -68.4 0.31 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 124.064 1.888 . . . . 0.0 111.32 170.345 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -63.07 155.3 28.2 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 110.197 -3.183 . . . . 0.0 112.957 -171.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 . . . . . 0 C--O 1.253 1.287 0 C-N-CA 125.907 1.683 . . . . 0.0 112.401 -177.815 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 526' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.883 0.373 . . . . 0.0 110.512 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 60.7 mt -73.85 131.54 81.55 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 124.884 1.273 . . . . 0.0 109.488 -178.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.88 159.37 53.56 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 123.433 2.755 . . . . 0.0 112.147 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.44 146.14 89.05 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 122.42 2.08 . . . . 0.0 112.438 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -72.28 156.44 90.52 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 123.48 0.712 . . . . 0.0 112.14 172.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -68.96 174.77 8.34 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.43 2.754 . . . . 0.0 113.054 175.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -86.9 2.02 50.63 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.556 1.142 . . . . 0.0 112.844 -178.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 37.3 p90 -133.94 154.62 80.42 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 124.666 1.187 . . . . 0.0 112.79 -174.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.43 153.17 60.97 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 123.652 2.901 . . . . 0.0 112.758 178.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -65.92 143.22 98.4 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 123.821 0.848 . . . . 0.0 113.084 -177.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.8 177.81 7.17 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 124.001 3.134 . . . . 0.0 112.945 178.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 25.5 p -130.48 154.76 81.68 Favored Pre-proline 0 N--CA 1.478 0.944 0 C-N-CA 125.288 1.435 . . . . 0.0 112.775 -175.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.79 165.44 29.69 Favored 'Trans proline' 0 CA--C 1.547 1.15 0 C-N-CA 123.439 2.76 . . . . 0.0 111.885 174.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -65.92 165.96 22.06 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.406 2.737 . . . . 0.0 112.821 174.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 540' ' ' VAL . . . . . . . . . . . . . 17.6 t -120.26 76.42 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-O 123.29 1.519 . . . . 0.0 109.556 -173.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 541' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -146.8 160.7 41.94 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.919 2.088 . . . . 0.0 111.78 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 542' ' ' ASN . . . . . . . . . . . . . 8.9 t30 . . . . . 0 C--O 1.252 1.218 0 C-N-CA 125.19 1.396 . . . . 0.0 112.182 179.234 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.434 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 61.1 m -140.27 160.28 40.32 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.7 1.6 . . . . 0.0 111.362 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 338' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -135.18 24.74 3.54 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.833 1.253 . . . . 0.0 113.647 -171.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 339' ' ' MET . . . . . . . . . . . . . 28.1 ptm -95.44 -6.39 40.9 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -176.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -79.38 -44.51 21.34 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.139 0.976 . . . . 0.0 113.598 -173.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 341' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -81.65 71.18 8.66 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.843 1.257 . . . . 0.0 110.455 169.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 342' ' ' GLN . . . . . . . . . . . . . 71.1 tp60 -61.38 136.51 58.06 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.392 0.615 . . . . 0.0 110.172 170.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 3.3 mptm? -124.14 163.99 20.38 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.235 1.414 . . . . 0.0 110.834 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 15.6 m -132.89 157.13 42.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 126.73 2.012 . . . . 0.0 109.436 171.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -120.48 136.42 54.76 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.143 0.977 . . . . 0.0 109.946 177.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 45.9 p -80.44 148.57 30.47 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.383 1.473 . . . . 0.0 110.877 -175.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.7 pp -112.87 -10.25 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -176.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -155.55 159.31 31.75 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 126.666 1.987 . . . . 0.0 110.528 170.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.86 156.06 61.15 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 123.536 2.824 . . . . 0.0 113.129 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 32.0 t-80 -136.71 141.01 43.05 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.385 1.474 . . . . 0.0 111.79 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 92.8 m -128.97 122.56 30.4 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.55 1.54 . . . . 0.0 110.387 -172.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -71.73 -30.35 65.52 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -176.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 60.82 -134.77 49.41 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 123.818 0.723 . . . . 0.0 112.985 -177.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 12.6 t -66.8 -26.68 67.07 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 74.4 m-80 -69.25 156.05 39.39 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.825 0.85 . . . . 0.0 112.63 178.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 14.3 tptt -113.28 -24.58 9.29 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.877 1.271 . . . . 0.0 113.935 -177.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 35.8 p -91.59 12.14 21.95 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.004 1.322 . . . . 0.0 113.891 -175.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 68.7 mt -103.57 130.75 51.04 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.935 1.294 . . . . 0.0 110.97 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 30.2 tp -82.8 128.97 34.9 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.247 0.619 . . . . 0.0 110.401 174.033 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 34.4 t -107.87 147.32 31.11 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.591 1.556 . . . . 0.0 111.474 -179.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -164.58 177.94 7.72 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.626 1.57 . . . . 0.0 112.354 -170.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -121.82 168.83 11.4 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.944 2.098 . . . . 0.0 111.069 175.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -61.94 136.58 58.03 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.175 -0.953 . . . . 0.0 111.312 173.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 83.71 -1.92 88.09 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 123.749 0.69 . . . . 0.0 114.793 178.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -70.88 167.02 19.89 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.382 1.091 . . . . 0.0 112.203 170.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 84.6 t -125.86 133.41 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 125.018 1.327 . . . . 0.0 109.545 -169.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 24.9 mt -136.48 141.35 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.733 1.213 . . . . 0.0 109.462 -176.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 3.3 m -100.78 140.34 35.2 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.319 1.448 . . . . 0.0 110.599 -177.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 21.7 mt -80.21 136.98 36.59 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 118.423 0.556 . . . . 0.0 111.963 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 38.3 mt -117.52 -11.77 10.45 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.589 1.156 . . . . 0.0 113.341 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 371' ' ' ILE . . . . . 0.439 ' CG2' ' HD2' ' A' ' 372' ' ' PRO . 5.6 mt -128.09 140.04 37.13 Favored Pre-proline 0 N--CA 1.474 0.746 0 C-N-CA 126.154 1.782 . . . . 0.0 109.68 176.292 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 372' ' ' PRO . . . . . 0.439 ' HD2' ' CG2' ' A' ' 371' ' ' ILE . 60.6 Cg_endo -72.97 -7.22 20.35 Favored 'Trans proline' 0 CA--C 1.546 1.076 0 C-N-CA 123.434 2.756 . . . . 0.0 114.001 177.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -150.62 157.41 42.95 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.799 1.639 . . . . 0.0 112.088 173.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -84.91 171.54 12.09 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.222 1.009 . . . . 0.0 112.786 175.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -133.36 110.21 9.88 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.97 1.708 . . . . 0.0 110.819 -176.138 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 50.74 31.02 5.46 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 125.336 1.454 . . . . 0.0 114.448 -179.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 99.18 -8.41 60.78 Favored Glycine 0 CA--C 1.536 1.396 0 C-N-CA 125.379 1.466 . . . . 0.0 114.467 -177.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 75.3 m95 -99.44 128.43 45.56 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 118.438 1.119 . . . . 0.0 111.55 -178.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 14.1 mt -96.07 161.21 14.07 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.915 0.886 . . . . 0.0 110.544 165.227 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -124.92 122.36 37.12 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 125.167 1.387 . . . . 0.0 107.646 173.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -145.84 169.67 27.23 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 115.627 -0.715 . . . . 0.0 113.159 -173.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -117.55 114.67 23.78 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.811 1.244 . . . . 0.0 109.516 177.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 26.7 t-80 -60.69 146.35 46.02 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.861 1.264 . . . . 0.0 111.87 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -81.25 -46.2 15.14 Favored 'General case' 0 CA--C 1.548 0.866 0 O-C-N 120.768 -1.208 . . . . 0.0 112.866 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 60.1 t -68.92 -53.85 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 124.051 0.94 . . . . 0.0 113.31 175.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 16.3 t -86.11 -22.43 27.11 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -171.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm 54.93 17.2 1.73 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 126.575 1.95 . . . . 0.0 114.579 -168.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -74.33 156.03 37.55 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.476 0.655 . . . . 0.0 111.986 172.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 54.5 mtp180 -127.31 148.43 50.24 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.636 1.974 . . . . 0.0 109.758 177.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 167.98 168.79 30.61 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 124.501 1.048 . . . . 0.0 111.859 178.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -68.05 145.85 54.06 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.098 0.475 . . . . 0.0 110.556 170.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -152.76 154.45 31.42 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 124.103 0.961 . . . . 0.0 110.776 173.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.57 122.29 10.36 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.333 2.022 . . . . 0.0 110.864 178.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 98.1 p -56.4 -37.31 69.98 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.687 -0.633 . . . . 0.0 112.079 176.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 17.2 m -58.2 -20.95 45.47 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 127.273 2.229 . . . . 0.0 115.003 177.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -79.91 1.32 27.69 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.788 1.235 . . . . 0.0 112.961 175.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 60.3 p -131.15 164.43 25.51 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 126.574 1.95 . . . . 0.0 110.673 174.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 12.1 mmmm -128.26 -74.71 0.57 Allowed 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.161 0.984 . . . . 0.0 109.519 177.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 399' ' ' LEU . . . . . 0.439 HD13 ' H ' ' A' ' 400' ' ' LEU . 0.1 OUTLIER -169.73 155.84 6.1 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 128.079 2.552 . . . . 0.0 107.729 169.912 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 400' ' ' LEU . . . . . 0.439 ' H ' HD13 ' A' ' 399' ' ' LEU . 0.2 OUTLIER -63.27 -59.71 4.37 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 123.474 1.607 . . . . 0.0 112.711 173.103 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -135.25 146.18 48.33 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 112.216 -2.265 . . . . 0.0 111.915 -172.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 . . . . . 0 C--O 1.255 1.369 0 C-N-CA 125.477 1.511 . . . . 0.0 112.353 -165.613 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 526' ' ' HIS . . . . . . . . . . . . . 32.4 m170 . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 121.004 0.43 . . . . 0.0 111.268 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 52.4 mt -65.34 133.02 95.34 Favored Pre-proline 0 N--CA 1.479 1.019 0 C-N-CA 124.982 1.313 . . . . 0.0 109.878 177.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -69.39 160.31 50.3 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 123.702 2.935 . . . . 0.0 112.163 178.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.96 144.22 87.31 Favored 'Trans proline' 0 CA--C 1.534 0.522 0 C-N-CA 122.376 2.051 . . . . 0.0 112.191 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -69.6 153.56 95.58 Favored Pre-proline 0 CA--C 1.551 1.01 0 C-N-CA 122.972 0.509 . . . . 0.0 111.733 171.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -69.23 174.26 9.31 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.322 2.681 . . . . 0.0 113.19 178.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -86.67 2.48 48.34 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.523 1.129 . . . . 0.0 112.948 -178.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 34.0 p90 -133.52 153.39 80.31 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 124.748 1.219 . . . . 0.0 113.104 -176.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -71.62 152.12 59.05 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 123.623 2.882 . . . . 0.0 112.607 178.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -68.56 146.33 97.64 Favored Pre-proline 0 CA--C 1.55 0.971 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -176.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.7 178.72 5.97 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 124.034 3.156 . . . . 0.0 113.086 177.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 19.3 p -133.12 155.0 81.48 Favored Pre-proline 0 N--CA 1.48 1.027 0 C-N-CA 125.18 1.392 . . . . 0.0 112.658 -175.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.02 161.0 47.65 Favored 'Trans proline' 0 CA--C 1.547 1.151 0 C-N-CA 123.375 2.717 . . . . 0.0 111.986 176.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -66.85 150.82 83.16 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.232 2.621 . . . . 0.0 112.74 178.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 540' ' ' VAL . . . . . . . . . . . . . 49.9 t -71.96 -28.94 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 124.722 1.209 . . . . 0.0 112.241 -178.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 541' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -149.65 168.13 24.44 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.553 1.541 . . . . 0.0 112.501 -177.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 542' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 . . . . . 0 C--O 1.252 1.211 0 C-N-CA 125.351 1.461 . . . . 0.0 113.832 174.384 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.462 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 36.9 m -61.98 160.51 12.27 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.157 1.383 . . . . 0.0 113.323 176.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 338' ' ' HIS . . . . . . . . . . . . . 31.5 p80 -128.21 -23.81 3.22 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 -176.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 339' ' ' MET . . . . . . . . . . . . . 81.7 mtp -71.1 135.44 47.68 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 119.132 0.878 . . . . 0.0 110.84 175.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.11 -26.8 64.13 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.182 0.993 . . . . 0.0 113.598 -175.297 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 341' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -119.83 165.43 14.6 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.639 1.976 . . . . 0.0 110.012 176.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 342' ' ' GLN . . . . . . . . . . . . . 72.3 tp60 -124.25 138.15 54.43 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.856 0.836 . . . . 0.0 110.625 175.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 3.1 mptm? -120.93 163.9 17.53 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 125.642 1.577 . . . . 0.0 111.091 177.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 15.9 m -133.91 155.57 39.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 C-N-CA 126.569 1.948 . . . . 0.0 108.926 168.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 5.7 tptt -119.37 130.53 55.38 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 124.183 0.993 . . . . 0.0 109.372 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 76.3 p -74.46 151.57 39.56 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.457 0.703 . . . . 0.0 111.127 -176.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.9 pp -122.69 -8.36 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -178.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -155.63 159.35 31.71 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 126.919 2.088 . . . . 0.0 110.024 169.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.1 159.62 53.17 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.275 2.65 . . . . 0.0 112.97 176.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -140.35 152.0 45.45 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.051 1.34 . . . . 0.0 111.993 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 15.2 t -146.31 154.65 41.93 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.598 1.559 . . . . 0.0 112.183 -174.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -92.06 -34.43 14.39 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -176.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 69.48 -61.87 0.63 Allowed Glycine 0 CA--C 1.54 1.645 0 C-N-CA 126.58 2.038 . . . . 0.0 115.995 177.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 49.2 m -142.27 19.98 2.08 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 126.351 1.86 . . . . 0.0 112.415 -172.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -128.66 164.52 22.73 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.984 1.714 . . . . 0.0 111.281 -165.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.44 -11.68 9.46 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -178.046 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 52.2 p -116.57 15.82 15.55 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.363 1.465 . . . . 0.0 112.727 -171.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 47.1 mt -106.71 116.72 32.42 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.045 1.338 . . . . 0.0 110.972 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 25.5 tp -72.05 124.31 24.67 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.644 0.778 . . . . 0.0 110.669 176.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 58.0 p -97.76 152.65 18.92 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.988 1.315 . . . . 0.0 112.401 175.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -167.4 178.43 5.5 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.513 1.525 . . . . 0.0 112.195 -173.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -118.83 173.74 6.7 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.787 2.035 . . . . 0.0 110.941 173.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -65.19 141.16 58.76 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.746 0.818 . . . . 0.0 111.624 171.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 80.29 3.21 89.76 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 124.173 0.892 . . . . 0.0 115.213 175.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -76.2 168.79 19.41 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.231 1.412 . . . . 0.0 112.238 173.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 80.5 t -123.49 130.01 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 125.642 1.577 . . . . 0.0 109.153 -171.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 30.8 mt -134.72 137.29 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.136 0.974 . . . . 0.0 109.525 -178.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 20.0 m -97.76 139.31 33.83 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.033 1.333 . . . . 0.0 110.491 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 20.3 mt -79.34 144.33 34.3 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.235 0.47 . . . . 0.0 111.972 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 47.4 mt -118.58 -1.15 11.22 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.731 1.212 . . . . 0.0 112.93 -178.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 371' ' ' ILE . . . . . 0.488 ' CG2' ' HD2' ' A' ' 372' ' ' PRO . 3.8 mt -134.36 142.57 43.42 Favored Pre-proline 0 N--CA 1.478 0.937 0 C-N-CA 126.848 2.059 . . . . 0.0 109.947 177.409 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 372' ' ' PRO . . . . . 0.488 ' HD2' ' CG2' ' A' ' 371' ' ' ILE . 57.0 Cg_endo -71.87 -9.08 24.21 Favored 'Trans proline' 0 CA--C 1.547 1.151 0 C-N-CA 123.463 2.775 . . . . 0.0 114.021 176.07 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -152.65 150.22 29.25 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.027 1.731 . . . . 0.0 111.857 173.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -71.49 168.69 16.99 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.202 1.001 . . . . 0.0 113.554 173.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -123.72 103.4 8.36 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 126.324 1.85 . . . . 0.0 109.911 178.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 51.65 32.73 9.65 Favored 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 177.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 99.29 -12.72 61.83 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 125.415 1.484 . . . . 0.0 114.298 -178.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -89.18 121.41 31.45 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.451 1.1 . . . . 0.0 110.709 175.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 13.1 mt -88.8 158.86 18.0 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.366 0.667 . . . . 0.0 110.372 162.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 380' ' ' TYR . . . . . 0.417 ' HB3' HD11 ' A' ' 371' ' ' ILE . 58.7 t80 -120.65 125.18 47.06 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 125.001 1.32 . . . . 0.0 107.789 170.338 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -149.41 171.64 29.54 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 115.873 -0.603 . . . . 0.0 113.871 -172.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -123.08 120.93 34.73 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.452 1.501 . . . . 0.0 109.623 177.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 29.4 t-80 -65.68 150.68 48.08 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.717 1.207 . . . . 0.0 112.159 178.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -81.15 -49.31 10.99 Favored 'General case' 0 CA--C 1.548 0.883 0 O-C-N 120.941 -1.099 . . . . 0.0 113.649 178.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 82.8 t -71.05 -52.15 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 178.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 23.2 t -83.96 -23.33 31.12 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.595 0.758 . . . . 0.0 112.852 -174.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp 55.72 15.83 1.75 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 126.681 1.992 . . . . 0.0 114.532 -168.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -73.14 153.72 40.64 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.409 0.623 . . . . 0.0 111.944 173.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -123.68 153.61 40.58 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 126.553 1.941 . . . . 0.0 110.682 178.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 165.45 169.59 29.27 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 124.344 0.973 . . . . 0.0 112.24 175.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -66.92 148.09 52.4 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.066 0.46 . . . . 0.0 110.148 166.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -155.67 154.39 27.95 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 124.3 1.04 . . . . 0.0 110.359 172.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -63.82 123.19 11.56 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.525 2.15 . . . . 0.0 110.926 177.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 99.2 p -56.75 -38.55 72.58 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.655 -0.653 . . . . 0.0 112.136 178.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 14.7 m -61.32 -22.4 64.87 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.044 1.738 . . . . 0.0 114.825 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -73.66 -1.89 20.82 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.829 1.251 . . . . 0.0 113.215 172.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 62.3 p -129.14 160.54 32.53 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.675 1.59 . . . . 0.0 110.987 175.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 30.5 mmtm -123.34 161.5 24.56 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 125.349 1.46 . . . . 0.0 109.563 171.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.3 124.63 23.23 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 174.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.51 -53.15 55.62 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 124.159 1.933 . . . . 0.0 113.911 -175.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -78.69 77.25 5.17 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 128.381 2.672 . . . . 0.0 112.547 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 . . . . . 0 C--O 1.254 1.314 0 C-N-CA 127.06 2.144 . . . . 0.0 114.315 176.624 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 526' ' ' HIS . . . . . . . . . . . . . 37.2 p-80 . . . . . 0 N--CA 1.485 1.289 0 CA-C-O 120.909 0.385 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 53.8 mt -69.78 133.22 88.5 Favored Pre-proline 0 N--CA 1.477 0.891 0 C-N-CA 124.546 1.138 . . . . 0.0 109.552 177.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -69.31 158.87 55.92 Favored 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 123.569 2.846 . . . . 0.0 112.049 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -64.46 145.56 87.99 Favored 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 122.37 2.047 . . . . 0.0 112.17 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -73.07 156.41 89.56 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 123.193 0.597 . . . . 0.0 112.215 173.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -68.78 174.32 8.8 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 123.42 2.747 . . . . 0.0 113.023 175.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -89.5 3.98 50.67 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.509 1.124 . . . . 0.0 113.087 -178.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 34.7 p90 -134.09 154.38 80.14 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 124.722 1.209 . . . . 0.0 112.701 -177.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.49 152.6 60.25 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 123.687 2.924 . . . . 0.0 112.641 179.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -67.87 143.9 96.82 Favored Pre-proline 0 CA--C 1.55 0.969 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -177.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.13 179.08 5.76 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 123.858 3.039 . . . . 0.0 112.716 177.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 24.7 p -131.31 154.91 82.07 Favored Pre-proline 0 N--CA 1.479 0.997 0 C-N-CA 125.194 1.398 . . . . 0.0 112.458 -174.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -67.03 164.57 29.49 Favored 'Trans proline' 0 CA--C 1.546 1.123 0 C-N-CA 123.397 2.732 . . . . 0.0 111.17 174.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -64.12 159.18 44.17 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.835 2.357 . . . . 0.0 112.352 175.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 540' ' ' VAL . . . . . . . . . . . . . 32.7 m -66.11 -13.41 15.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 126.821 2.048 . . . . 0.0 114.697 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 541' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -97.46 126.26 42.62 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.777 1.631 . . . . 0.0 110.579 177.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 542' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 . . . . . 0 C--O 1.253 1.254 0 C-N-CA 124.663 1.185 . . . . 0.0 112.975 174.495 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.454 0 N-CA-C 111.574 -0.61 . . . . 0.0 111.574 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 44.6 m -127.21 -44.05 1.61 Allowed 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.022 0.929 . . . . 0.0 113.227 -174.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 338' ' ' HIS . . . . . . . . . . . . . 24.4 p-80 -90.06 -9.04 49.98 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.236 1.014 . . . . 0.0 113.261 170.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 339' ' ' MET . . . . . . . . . . . . . 8.7 tpt -123.26 85.45 2.42 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.194 1.798 . . . . 0.0 109.486 -175.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -119.84 0.14 10.8 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.519 1.528 . . . . 0.0 114.478 -173.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 341' ' ' LYS . . . . . . . . . . . . . 2.3 tmmm? -89.71 57.52 3.92 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 127.154 2.182 . . . . 0.0 110.139 176.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 342' ' ' GLN . . . . . . . . . . . . . 70.1 tp60 -68.2 148.4 50.9 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.706 0.765 . . . . 0.0 110.775 174.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 9.7 tptt -124.5 155.62 38.66 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 125.211 1.405 . . . . 0.0 111.347 -175.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 17.9 m -138.03 157.2 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 125.609 1.564 . . . . 0.0 110.052 175.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt -121.76 134.3 54.93 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.249 1.02 . . . . 0.0 110.221 175.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 82.7 p -76.4 156.34 33.27 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.622 1.569 . . . . 0.0 111.75 -179.085 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.9 pp -123.24 -6.91 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -153.73 157.69 32.62 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 125.758 1.623 . . . . 0.0 110.577 169.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.67 155.54 62.73 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.194 2.596 . . . . 0.0 112.994 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 32.6 t-80 -143.9 137.75 28.08 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.934 1.694 . . . . 0.0 110.43 -178.219 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 48.7 m -142.0 125.24 16.44 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.508 1.123 . . . . 0.0 110.292 -177.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -61.4 -50.89 71.03 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.101 0.96 . . . . 0.0 112.887 177.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 50.44 -109.71 0.75 Allowed Glycine 0 CA--C 1.54 1.642 0 O-C-N 121.143 -0.973 . . . . 0.0 113.365 -176.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 27.8 m -70.8 -15.81 62.69 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 176.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -70.98 176.73 4.13 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.503 1.121 . . . . 0.0 112.414 174.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? -133.83 154.7 50.84 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.864 1.666 . . . . 0.0 110.275 171.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 17.5 p 57.27 17.97 3.99 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 127.22 2.208 . . . . 0.0 115.949 175.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 15.3 mt -99.51 137.65 37.7 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.664 1.186 . . . . 0.0 110.653 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 30.6 tp -82.91 124.81 30.7 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 122.995 0.518 . . . . 0.0 110.818 175.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 47.4 m -91.74 147.55 22.91 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.775 1.23 . . . . 0.0 111.985 175.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -166.2 177.99 6.56 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.676 1.59 . . . . 0.0 112.755 -175.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -115.53 175.01 5.71 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.318 1.847 . . . . 0.0 111.617 173.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -62.46 141.1 58.55 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 121.349 -0.845 . . . . 0.0 111.106 168.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 71.53 18.63 77.23 Favored Glycine 0 CA--C 1.537 1.45 0 N-CA-C 114.651 0.62 . . . . 0.0 114.651 176.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -88.25 159.52 18.08 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.688 1.195 . . . . 0.0 111.645 173.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 88.0 t -111.28 130.33 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.011 1.324 . . . . 0.0 109.765 -173.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 23.1 mt -136.01 136.53 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.865 1.266 . . . . 0.0 109.035 -177.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 9.9 m -97.89 139.45 33.73 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.87 1.268 . . . . 0.0 110.004 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 20.6 mt -78.99 140.79 37.91 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 118.864 0.756 . . . . 0.0 111.953 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 37.4 mt -119.53 -5.38 10.29 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.891 1.276 . . . . 0.0 113.569 -177.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 371' ' ' ILE . . . . . 0.872 HG22 ' HD2' ' A' ' 372' ' ' PRO . 0.2 OUTLIER -127.9 146.76 60.26 Favored Pre-proline 0 N--CA 1.477 0.888 0 C-N-CA 126.722 2.009 . . . . 0.0 108.213 173.73 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 372' ' ' PRO . . . . . 0.872 ' HD2' HG22 ' A' ' 371' ' ' ILE . 82.9 Cg_endo -75.01 -17.09 19.81 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.461 2.774 . . . . 0.0 112.402 177.439 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -148.25 142.48 26.13 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.172 1.789 . . . . 0.0 111.202 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -72.29 172.95 9.36 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 125.658 1.583 . . . . 0.0 113.592 176.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -132.97 108.43 8.9 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.377 1.871 . . . . 0.0 110.833 -177.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 50.18 32.44 6.02 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 125.323 1.449 . . . . 0.0 114.707 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 98.94 -7.44 60.69 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 125.236 1.398 . . . . 0.0 114.462 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 78.8 m95 -99.77 128.97 45.84 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.485 1.143 . . . . 0.0 111.505 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 16.2 mt -98.42 161.36 13.73 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.622 1.169 . . . . 0.0 110.92 167.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 380' ' ' TYR . . . . . 0.453 ' HB3' ' CG1' ' A' ' 371' ' ' ILE . 60.2 t80 -121.33 122.2 39.33 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 173.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -145.58 170.75 26.8 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 115.749 -0.66 . . . . 0.0 114.46 -174.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -120.62 119.05 31.74 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.385 1.474 . . . . 0.0 109.717 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 -61.93 146.53 49.66 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.068 1.347 . . . . 0.0 111.68 177.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -80.55 -47.82 13.64 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 120.801 -1.187 . . . . 0.0 113.512 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 89.7 t -69.93 -51.93 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 124.287 1.035 . . . . 0.0 113.241 177.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 13.5 t -86.93 -21.69 26.1 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -173.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp 54.62 19.45 2.45 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 126.439 1.896 . . . . 0.0 114.303 -169.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -75.98 153.8 36.3 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.376 0.67 . . . . 0.0 111.896 172.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 70.9 mtm180 -127.93 148.04 50.49 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.463 1.905 . . . . 0.0 110.458 -179.133 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 169.86 170.93 34.87 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.83 1.205 . . . . 0.0 111.881 177.158 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -67.69 145.56 54.65 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.61 0.764 . . . . 0.0 110.902 171.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -152.78 153.2 29.8 Favored Pre-proline 0 CA--C 1.541 0.631 0 O-C-N 120.826 -1.171 . . . . 0.0 111.849 174.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -63.76 124.26 13.35 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 122.902 2.401 . . . . 0.0 112.14 178.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 97.5 p -62.97 -21.0 65.79 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 174.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 19.3 m -74.23 -17.54 60.87 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.826 1.25 . . . . 0.0 114.23 174.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -81.84 -2.72 52.0 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.567 1.147 . . . . 0.0 113.439 177.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 72.2 p -128.18 169.66 13.88 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.563 1.945 . . . . 0.0 110.061 173.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -130.12 -77.79 0.54 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.786 0.834 . . . . 0.0 109.984 177.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 399' ' ' LEU . . . . . 0.417 HD13 ' H ' ' A' ' 400' ' ' LEU . 0.2 OUTLIER -166.86 145.79 5.31 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.378 2.271 . . . . 0.0 107.41 172.271 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 400' ' ' LEU . . . . . 0.417 ' H ' HD13 ' A' ' 399' ' ' LEU . 0.1 OUTLIER -64.79 -68.44 0.36 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 123.115 1.436 . . . . 0.0 112.79 176.523 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -129.61 126.96 39.65 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 112.553 -2.112 . . . . 0.0 112.019 -169.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 . . . . . 0 C--O 1.254 1.33 0 C-N-CA 125.567 1.547 . . . . 0.0 112.355 -171.934 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 526' ' ' HIS . . . . . . . . . . . . . 40.3 m80 . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.49 0.186 . . . . 0.0 110.726 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 36.0 mt -70.05 130.89 89.33 Favored Pre-proline 0 N--CA 1.477 0.902 0 C-N-CA 124.02 0.928 . . . . 0.0 109.272 176.202 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -68.7 162.48 40.98 Favored 'Trans proline' 0 CA--C 1.545 1.049 0 C-N-CA 123.492 2.794 . . . . 0.0 111.776 177.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.26 143.32 83.04 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.09 1.86 . . . . 0.0 112.365 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -70.0 152.91 95.75 Favored Pre-proline 0 CA--C 1.553 1.065 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.528 170.205 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -69.77 174.86 8.89 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.402 2.735 . . . . 0.0 113.309 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -90.69 8.35 34.86 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.756 1.222 . . . . 0.0 112.568 -178.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 37.0 p90 -135.82 153.01 76.93 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 124.828 1.251 . . . . 0.0 112.874 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.07 152.09 62.18 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.662 2.908 . . . . 0.0 112.276 178.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -67.53 144.13 97.52 Favored Pre-proline 0 CA--C 1.551 0.99 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -175.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.36 177.07 8.37 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 124.03 3.153 . . . . 0.0 113.106 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 27.3 p -132.23 153.66 81.36 Favored Pre-proline 0 N--CA 1.478 0.968 0 C-N-CA 125.076 1.35 . . . . 0.0 112.827 -172.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -67.84 165.07 29.13 Favored 'Trans proline' 0 CA--C 1.55 1.284 0 C-N-CA 123.55 2.833 . . . . 0.0 112.054 175.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -65.49 163.73 28.78 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 123.664 2.909 . . . . 0.0 113.173 176.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 540' ' ' VAL . . . . . . . . . . . . . 4.7 t -133.88 53.06 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 125.635 1.574 . . . . 0.0 110.065 -169.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 541' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -70.25 59.72 0.19 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 127.139 2.176 . . . . 0.0 113.428 178.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 542' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 . . . . . 0 C--O 1.254 1.323 0 C-N-CA 125.396 1.478 . . . . 0.0 112.385 173.65 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.693 0 N-CA-C 111.518 -0.633 . . . . 0.0 111.518 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 81.4 p -152.14 140.75 20.78 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.256 1.022 . . . . 0.0 112.524 174.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 338' ' ' HIS . . . . . . . . . . . . . 25.4 p-80 -73.48 -24.02 60.14 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -178.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 339' ' ' MET . . . . . . . . . . . . . 5.4 ppp? -75.72 -21.19 57.75 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -178.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -101.6 -37.2 8.48 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.627 1.171 . . . . 0.0 112.817 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 341' ' ' LYS . . . . . . . . . . . . . 34.9 tptt -112.39 44.04 1.51 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 126.288 1.835 . . . . 0.0 110.107 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 342' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -50.39 131.52 24.5 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.398 1.079 . . . . 0.0 110.238 -179.2 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -120.72 146.97 45.91 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.93 1.292 . . . . 0.0 111.726 178.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 16.7 m -127.67 143.26 41.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 113.998 -1.455 . . . . 0.0 108.729 173.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -111.28 131.82 54.85 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.771 0.796 . . . . 0.0 109.944 175.06 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 70.6 p -76.34 151.67 36.6 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.955 1.702 . . . . 0.0 111.61 -175.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.7 pp -122.56 -6.1 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 N-CA-C 114.684 1.364 . . . . 0.0 114.684 -175.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -154.58 158.96 32.32 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 126.446 1.898 . . . . 0.0 110.199 169.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -69.46 159.3 54.16 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 123.085 2.523 . . . . 0.0 112.923 177.362 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -136.85 150.21 48.16 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.918 1.287 . . . . 0.0 112.039 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 35.5 m -140.85 144.07 35.12 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.429 1.492 . . . . 0.0 111.004 -162.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -110.81 -28.86 8.21 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -175.175 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 55.21 -116.72 7.23 Favored Glycine 0 CA--C 1.538 1.524 0 CA-C-N 119.159 0.89 . . . . 0.0 112.73 -175.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 80.6 p -75.24 -15.42 60.53 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 177.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -72.8 159.76 33.26 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.4 1.08 . . . . 0.0 112.325 -178.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 34.1 mtmm -127.98 -1.71 5.88 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 -179.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 39.6 p -117.89 11.67 13.56 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 125.44 1.496 . . . . 0.0 113.015 -176.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 63.0 mt -106.83 125.46 51.04 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.028 1.331 . . . . 0.0 110.653 179.536 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 26.0 tp -77.3 127.58 32.84 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.338 0.655 . . . . 0.0 110.596 176.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 37.3 p -100.96 147.08 26.58 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.136 1.374 . . . . 0.0 112.217 177.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -163.48 178.99 7.59 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.556 1.542 . . . . 0.0 112.054 -174.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -130.27 157.32 42.83 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 127.282 2.233 . . . . 0.0 111.358 177.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -50.98 129.51 23.81 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.494 0.717 . . . . 0.0 112.311 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 91.45 -9.01 78.33 Favored Glycine 0 CA--C 1.538 1.476 0 C-N-CA 124.261 0.934 . . . . 0.0 114.633 -179.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -68.05 153.02 44.6 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 118.903 1.351 . . . . 0.0 111.891 172.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 74.3 t -115.51 140.26 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 125.389 1.476 . . . . 0.0 109.989 -173.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 36.2 mt -136.07 136.57 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 125.668 1.587 . . . . 0.0 108.559 -177.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 31.8 m -99.46 137.23 38.25 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.649 1.18 . . . . 0.0 109.7 177.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 15.7 mt -69.45 147.34 51.06 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -177.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 77.4 mt -120.87 -2.21 9.81 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 125.079 1.351 . . . . 0.0 113.435 178.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 371' ' ' ILE . . . . . 0.62 HG22 ' HD2' ' A' ' 372' ' ' PRO . 2.0 mt -137.04 142.7 39.29 Favored Pre-proline 0 N--CA 1.477 0.906 0 C-N-CA 126.623 1.969 . . . . 0.0 109.14 177.343 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 372' ' ' PRO . . . . . 0.62 ' HD2' HG22 ' A' ' 371' ' ' ILE . 42.3 Cg_endo -70.42 -15.83 34.67 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 123.056 2.504 . . . . 0.0 113.308 177.5 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -145.15 150.13 36.23 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.492 1.917 . . . . 0.0 111.028 177.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -75.23 172.28 12.69 Favored 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 176.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -124.7 101.87 7.31 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.255 1.822 . . . . 0.0 110.293 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 51.95 31.78 9.07 Favored 'General case' 0 CA--C 1.554 1.135 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 175.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 100.01 -4.36 57.43 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 125.099 1.333 . . . . 0.0 114.64 -178.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 82.5 m95 -103.28 121.29 42.41 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.639 1.576 . . . . 0.0 110.521 176.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 12.1 mt -85.07 160.42 19.99 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.364 0.666 . . . . 0.0 110.578 163.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 380' ' ' TYR . . . . . 0.429 ' HB3' HD11 ' A' ' 371' ' ' ILE . 57.5 t80 -122.98 126.49 47.27 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.208 1.403 . . . . 0.0 107.56 170.246 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -150.48 170.38 30.38 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-N 115.857 -0.611 . . . . 0.0 113.643 -173.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -118.83 119.64 34.99 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.226 1.41 . . . . 0.0 109.325 176.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -61.59 146.32 49.25 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.361 1.464 . . . . 0.0 111.745 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -79.55 -47.67 15.13 Favored 'General case' 0 CA--C 1.548 0.897 0 O-C-N 120.774 -1.203 . . . . 0.0 113.734 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 81.9 t -73.93 -49.47 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.988 0.915 . . . . 0.0 112.968 178.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 15.5 t -86.91 -21.74 26.12 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -173.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp 54.27 17.47 1.52 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 126.712 2.005 . . . . 0.0 114.771 -169.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -75.21 159.58 31.41 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.506 0.723 . . . . 0.0 112.16 173.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -126.58 159.0 34.78 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.336 1.854 . . . . 0.0 110.468 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 157.72 169.67 21.67 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 124.454 1.025 . . . . 0.0 112.538 175.133 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -67.85 145.58 54.49 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.002 0.521 . . . . 0.0 110.416 169.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -153.2 153.63 29.74 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 124.003 0.921 . . . . 0.0 111.162 173.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -62.86 121.06 8.81 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.748 2.299 . . . . 0.0 111.381 178.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.0 -17.53 63.4 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 121.303 -0.873 . . . . 0.0 113.096 177.31 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 79.6 p -73.43 -22.12 60.29 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.712 2.005 . . . . 0.0 114.282 174.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -79.09 2.89 19.15 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.507 1.523 . . . . 0.0 113.325 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 30.8 p -133.97 171.01 14.78 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.966 2.106 . . . . 0.0 109.93 175.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -125.43 -80.81 0.62 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.717 0.807 . . . . 0.0 109.521 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 399' ' ' LEU . . . . . 0.455 HD13 ' N ' ' A' ' 400' ' ' LEU . 0.7 OUTLIER -165.25 150.48 9.28 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 127.629 2.372 . . . . 0.0 106.77 167.642 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 400' ' ' LEU . . . . . 0.455 ' N ' HD13 ' A' ' 399' ' ' LEU . 0.6 OUTLIER -58.96 -70.4 0.15 Allowed 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 123.836 1.779 . . . . 0.0 112.443 176.025 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -61.14 122.0 13.92 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 110.799 -2.909 . . . . 0.0 111.655 -170.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 . . . . . 0 C--O 1.252 1.234 0 C-N-CA 125.024 1.329 . . . . 0.0 114.032 -177.121 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 526' ' ' HIS . . . . . . . . . . . . . 47.3 p-80 . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 121.095 0.474 . . . . 0.0 111.289 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 61.9 mt -68.4 131.32 91.79 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 124.478 1.111 . . . . 0.0 109.491 176.172 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -69.37 160.57 49.28 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 123.611 2.874 . . . . 0.0 112.357 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.37 145.47 88.24 Favored 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 122.579 2.186 . . . . 0.0 112.368 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -77.24 158.2 79.84 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 123.691 0.796 . . . . 0.0 112.448 174.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -68.56 174.97 7.63 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 123.527 2.818 . . . . 0.0 113.176 176.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -93.56 9.87 34.96 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.908 1.283 . . . . 0.0 112.408 -178.241 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 38.6 p90 -138.46 153.93 73.07 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 124.67 1.188 . . . . 0.0 112.622 -178.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -71.18 152.28 61.76 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.444 2.763 . . . . 0.0 112.069 176.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -66.81 148.86 98.68 Favored Pre-proline 0 CA--C 1.549 0.926 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -176.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.78 -175.9 1.83 Allowed 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 124.069 3.179 . . . . 0.0 112.638 176.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 23.4 p -135.41 153.4 77.85 Favored Pre-proline 0 N--CA 1.475 0.8 0 C-N-CA 125.196 1.399 . . . . 0.0 112.465 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -65.42 164.38 26.18 Favored 'Trans proline' 0 CA--C 1.549 1.241 0 C-N-CA 123.225 2.617 . . . . 0.0 111.273 173.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -65.65 169.97 12.0 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 123.379 2.719 . . . . 0.0 113.248 177.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 540' ' ' VAL . . . . . . . . . . . . . 22.6 m -67.64 2.15 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 128.428 2.691 . . . . 0.0 115.713 177.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 541' ' ' GLN . . . . . . . . . . . . . 28.9 pt20 -129.86 166.66 19.52 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.899 2.079 . . . . 0.0 111.763 179.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 542' ' ' ASN . . . . . . . . . . . . . 1.5 t30 . . . . . 0 C--O 1.254 1.304 0 C-N-CA 125.339 1.456 . . . . 0.0 111.454 -177.953 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.61 0 N-CA-C 111.694 -0.562 . . . . 0.0 111.694 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 28.5 m -71.42 75.1 0.76 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 126.436 1.895 . . . . 0.0 113.954 -174.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 338' ' ' HIS . . . . . . . . . . . . . 13.7 t-160 -61.38 -39.6 91.27 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.068 1.347 . . . . 0.0 113.536 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 339' ' ' MET . . . . . . . . . . . . . 20.7 ptp -159.32 173.7 15.89 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.126 1.77 . . . . 0.0 112.126 177.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 11.7 mmmm -115.81 -64.15 1.35 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.772 1.229 . . . . 0.0 112.666 -173.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 341' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -73.72 144.87 45.55 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 118.936 0.789 . . . . 0.0 111.032 170.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 342' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.67 152.26 41.81 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.784 1.234 . . . . 0.0 112.155 177.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -120.08 163.12 18.15 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 114.132 -1.394 . . . . 0.0 112.847 166.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 12.9 m -134.32 153.54 35.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 127.573 2.349 . . . . 0.0 108.5 171.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -118.92 130.82 55.92 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.709 0.804 . . . . 0.0 110.203 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 76.5 p -73.61 151.17 40.94 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.792 0.837 . . . . 0.0 111.138 -178.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.8 pp -123.45 -7.93 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 -177.08 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -154.35 156.78 32.04 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 126.255 1.822 . . . . 0.0 110.233 169.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -69.78 156.74 62.52 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 123.316 2.677 . . . . 0.0 112.856 178.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 350' ' ' HIS . . . . . 0.416 ' HE1' HD12 ' A' ' 358' ' ' LEU . 55.5 t-80 -138.26 145.38 41.25 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.024 1.329 . . . . 0.0 111.855 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 28.7 m -145.37 135.04 23.41 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.396 1.478 . . . . 0.0 110.962 -174.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -75.63 33.58 0.11 Allowed 'General case' 0 CA--C 1.56 1.344 0 C-N-CA 126.929 2.092 . . . . 0.0 114.595 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . -48.28 -24.48 3.6 Favored Glycine 0 CA--C 1.54 1.608 0 C-N-CA 127.407 2.432 . . . . 0.0 118.847 -163.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 5.7 t -150.31 39.09 0.73 Allowed 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 118.951 1.375 . . . . 0.0 111.172 175.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -139.85 179.01 6.84 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.626 1.17 . . . . 0.0 112.668 -162.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 15.2 ttmt -142.82 147.16 34.98 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.859 1.664 . . . . 0.0 111.346 176.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . 0.26 24.9 p 59.62 19.92 8.51 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 128.005 2.522 . . . . 0.0 116.334 -177.254 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 358' ' ' LEU . . . . . 0.416 HD12 ' HE1' ' A' ' 350' ' ' HIS . 4.4 mm? -77.71 141.99 39.01 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.084 1.354 . . . . 0.0 110.554 172.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 22.9 tp -85.41 136.83 33.29 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 161.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 65.8 m -117.23 143.81 45.47 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.443 1.497 . . . . 0.0 111.428 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -162.55 178.98 8.09 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.091 1.357 . . . . 0.0 112.892 -167.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -116.93 173.53 6.6 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.226 1.811 . . . . 0.0 111.443 174.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -65.63 142.74 57.96 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.16 0.984 . . . . 0.0 111.559 171.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 75.67 8.28 84.13 Favored Glycine 0 CA--C 1.534 1.258 0 CA-C-O 119.298 -0.723 . . . . 0.0 114.819 176.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -79.07 163.41 25.15 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.556 1.142 . . . . 0.0 111.733 171.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 99.8 t -114.84 134.65 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.124 1.37 . . . . 0.0 109.163 -176.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 35.9 mt -132.45 141.48 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.275 1.03 . . . . 0.0 109.043 178.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 16.9 m -105.34 137.27 43.41 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.074 1.35 . . . . 0.0 109.467 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 9.9 mt -73.44 145.1 46.0 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -176.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 72.2 mt -119.53 -12.65 9.29 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 124.83 1.252 . . . . 0.0 113.311 178.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 371' ' ' ILE . . . . . 0.415 ' CG2' ' HD2' ' A' ' 372' ' ' PRO . 9.8 mt -127.79 141.22 40.41 Favored Pre-proline 0 N--CA 1.478 0.932 0 C-N-CA 126.096 1.759 . . . . 0.0 110.255 175.098 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 372' ' ' PRO . . . . . 0.415 ' HD2' ' CG2' ' A' ' 371' ' ' ILE . 56.5 Cg_endo -71.7 -7.58 21.45 Favored 'Trans proline' 0 CA--C 1.547 1.144 0 C-N-CA 123.948 3.098 . . . . 0.0 114.48 176.163 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -152.55 153.71 33.96 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.663 1.585 . . . . 0.0 112.262 172.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -75.32 169.78 17.39 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.491 1.116 . . . . 0.0 113.647 174.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -128.6 105.92 8.61 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 126.669 1.988 . . . . 0.0 109.957 179.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 50.37 32.17 6.1 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 124.954 1.302 . . . . 0.0 114.373 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 99.55 -17.38 57.7 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 125.863 1.697 . . . . 0.0 114.377 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -82.59 125.29 31.0 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.542 1.137 . . . . 0.0 111.138 176.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 14.4 mt -94.42 162.94 13.62 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.636 0.774 . . . . 0.0 110.364 162.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -126.45 125.38 42.03 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 170.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -147.53 169.96 28.35 Favored Glycine 0 CA--C 1.527 0.781 0 C-N-CA 124.085 0.85 . . . . 0.0 112.671 -173.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -117.24 121.2 40.54 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 124.492 1.117 . . . . 0.0 109.275 175.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -63.54 152.35 38.87 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.762 1.225 . . . . 0.0 112.382 178.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -86.85 -45.89 10.44 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 120.991 -1.068 . . . . 0.0 113.45 177.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 53.1 t -67.32 -54.49 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 123.799 0.84 . . . . 0.0 113.008 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 22.2 m -96.07 -12.86 24.21 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -172.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt 55.47 19.82 3.36 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 126.674 1.99 . . . . 0.0 114.77 -174.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -75.35 158.31 32.97 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.54 0.736 . . . . 0.0 112.153 175.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 53.7 mtt180 -128.83 153.13 47.73 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 127.022 2.129 . . . . 0.0 109.579 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 162.68 166.09 20.86 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 125.198 1.38 . . . . 0.0 111.421 176.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -65.82 144.5 56.8 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.388 0.675 . . . . 0.0 110.177 170.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -153.31 155.1 31.51 Favored Pre-proline 0 CA--C 1.539 0.527 0 O-C-N 120.507 -1.371 . . . . 0.0 110.978 175.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -65.38 118.63 5.62 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.23 1.953 . . . . 0.0 110.831 177.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 29.4 t -54.15 -38.77 65.85 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.75 -0.593 . . . . 0.0 112.109 177.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 14.7 m -60.08 -21.66 61.75 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 178.224 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -75.43 -3.47 34.0 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.561 1.145 . . . . 0.0 113.157 173.047 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 80.8 p -123.05 160.17 26.92 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.712 1.605 . . . . 0.0 110.747 172.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 398' ' ' LYS . . . . . 0.412 ' HE2' ' HA ' ' A' ' 398' ' ' LYS . 10.1 mmpt? -121.5 163.95 17.98 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.708 1.203 . . . . 0.0 108.61 167.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.2 129.86 42.72 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.142 169.47 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -50.98 -62.23 1.74 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 123.96 1.838 . . . . 0.0 112.315 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -66.7 146.66 54.23 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 111.35 -2.659 . . . . 0.0 112.06 177.389 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 . . . . . 0 N--CA 1.487 1.404 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -175.737 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 526' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 120.76 0.314 . . . . 0.0 110.768 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 49.8 mt -66.65 132.75 94.12 Favored Pre-proline 0 N--CA 1.479 1.001 0 C-N-CA 124.652 1.181 . . . . 0.0 109.8 178.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -68.69 160.93 47.44 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 123.624 2.883 . . . . 0.0 112.036 177.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.77 144.85 89.98 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.31 2.006 . . . . 0.0 112.493 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -68.29 152.54 96.47 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 123.041 0.536 . . . . 0.0 111.875 172.047 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -70.07 174.41 9.81 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.608 2.872 . . . . 0.0 113.543 -178.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -89.37 5.27 45.89 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.208 1.403 . . . . 0.0 112.378 -178.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 29.3 p90 -137.08 155.06 76.29 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 124.353 1.061 . . . . 0.0 112.642 -177.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.75 153.13 53.65 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 123.806 3.004 . . . . 0.0 112.965 178.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -67.81 140.03 93.84 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 123.788 0.835 . . . . 0.0 112.968 -177.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -73.45 179.05 5.9 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 123.979 3.119 . . . . 0.0 112.789 176.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 25.8 p -132.79 154.79 81.58 Favored Pre-proline 0 N--CA 1.48 1.058 0 C-N-CA 125.122 1.369 . . . . 0.0 112.479 -175.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -66.94 165.15 27.1 Favored 'Trans proline' 0 CA--C 1.549 1.243 0 C-N-CA 123.437 2.758 . . . . 0.0 111.621 175.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -64.54 160.72 38.4 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.337 2.692 . . . . 0.0 113.147 178.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 540' ' ' VAL . . . . . . . . . . . . . 18.8 t -129.76 83.42 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 125.471 1.508 . . . . 0.0 109.235 -174.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 541' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -135.38 4.63 3.17 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.372 1.869 . . . . 0.0 113.955 -174.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 542' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 . . . . . 0 C--O 1.254 1.313 0 C-N-CA 125.426 1.491 . . . . 0.0 112.958 177.117 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.557 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 85.5 p -149.26 167.19 26.7 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.257 1.423 . . . . 0.0 112.172 178.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 338' ' ' HIS . . . . . . . . . . . . . 16.5 t60 -68.53 172.38 6.24 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.876 0.87 . . . . 0.0 112.143 171.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 339' ' ' MET . . . . . . . . . . . . . 25.1 ptp -139.75 160.29 40.24 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.782 1.233 . . . . 0.0 112.899 177.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -101.18 -1.14 34.64 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 125.088 1.355 . . . . 0.0 113.929 -175.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 341' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -76.33 111.86 12.22 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.509 1.524 . . . . 0.0 111.381 178.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 342' ' ' GLN . . . . . . . . . . . . . 72.6 tp60 -64.85 138.45 58.38 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.579 0.704 . . . . 0.0 111.107 172.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 3.2 mptm? -124.59 164.31 20.1 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 125.858 1.663 . . . . 0.0 111.179 176.106 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 16.7 m -131.82 159.53 43.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 126.219 1.808 . . . . 0.0 109.212 168.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -122.99 132.23 54.05 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 124.268 1.027 . . . . 0.0 109.352 -177.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 74.4 p -78.35 152.47 32.32 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.416 0.686 . . . . 0.0 110.824 -177.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.8 pp -125.7 -5.68 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 N-CA-C 114.441 1.275 . . . . 0.0 114.441 -178.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -153.86 160.67 30.68 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 126.117 1.767 . . . . 0.0 110.431 168.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -69.77 156.59 62.91 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 123.117 2.545 . . . . 0.0 113.139 174.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -141.51 152.05 43.82 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.224 1.41 . . . . 0.0 111.451 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 7.7 t -148.27 157.92 43.78 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.954 1.301 . . . . 0.0 113.018 -174.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -87.31 82.75 7.5 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.809 1.643 . . . . 0.0 112.866 -175.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . -66.07 105.31 1.23 Allowed Glycine 0 CA--C 1.537 1.424 0 C-N-CA 124.24 0.924 . . . . 0.0 112.704 174.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 33.5 m 52.13 44.07 29.96 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 126.04 1.736 . . . . 0.0 114.44 179.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -147.15 174.13 11.87 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -169.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.64 -16.12 3.86 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 126.135 1.774 . . . . 0.0 115.082 174.438 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 65.7 p -102.96 13.61 33.92 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 125.098 1.359 . . . . 0.0 113.511 -176.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 45.3 mt -101.49 116.09 31.99 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.728 1.211 . . . . 0.0 111.027 -176.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 27.6 tp -74.04 118.25 16.78 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.502 0.721 . . . . 0.0 110.962 178.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 59.9 p -87.91 154.34 20.6 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.282 1.033 . . . . 0.0 112.978 174.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -167.39 179.41 5.01 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.917 1.687 . . . . 0.0 112.014 -177.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -119.49 176.7 5.23 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.577 1.951 . . . . 0.0 110.942 172.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 66.5 tt0 -65.92 139.47 58.26 Favored 'General case' 0 CA--C 1.546 0.814 0 O-C-N 121.349 -0.844 . . . . 0.0 111.548 171.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 82.19 4.29 90.27 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.298 0.951 . . . . 0.0 115.376 175.121 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -77.07 170.25 16.86 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.946 1.298 . . . . 0.0 112.616 173.197 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 94.6 t -125.24 129.35 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.786 1.634 . . . . 0.0 109.09 -169.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 29.6 mt -134.81 137.8 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.94 0.896 . . . . 0.0 109.968 -177.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 10.1 m -96.9 140.06 32.01 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.993 1.317 . . . . 0.0 110.834 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 20.7 mt -78.91 136.67 37.34 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 122.943 0.497 . . . . 0.0 111.55 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 50.1 mt -114.63 -2.0 13.2 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.7 1.2 . . . . 0.0 113.045 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 371' ' ' ILE . . . . . 0.584 HG22 ' HD2' ' A' ' 372' ' ' PRO . 2.1 mt -134.82 143.28 45.64 Favored Pre-proline 0 N--CA 1.478 0.972 0 C-N-CA 126.623 1.969 . . . . 0.0 109.568 178.118 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 372' ' ' PRO . . . . . 0.584 ' HD2' HG22 ' A' ' 371' ' ' ILE . 56.1 Cg_endo -72.46 -9.73 24.5 Favored 'Trans proline' 0 CA--C 1.548 1.18 0 C-N-CA 123.203 2.602 . . . . 0.0 113.639 176.532 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -153.32 152.43 31.11 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.862 1.665 . . . . 0.0 112.302 174.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -71.83 169.91 14.76 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.769 1.228 . . . . 0.0 113.855 173.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -129.36 106.96 9.14 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.466 1.907 . . . . 0.0 110.047 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 51.05 31.69 6.73 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.097 1.359 . . . . 0.0 114.567 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 97.35 -11.79 65.19 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 125.465 1.507 . . . . 0.0 114.439 -178.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 77.8 m95 -89.28 123.94 33.95 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.49 1.116 . . . . 0.0 110.809 175.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 15.1 mt -90.14 156.76 18.12 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.536 0.735 . . . . 0.0 110.228 162.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 380' ' ' TYR . . . . . 0.482 ' HB3' HD11 ' A' ' 371' ' ' ILE . 58.7 t80 -116.77 124.55 49.88 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.904 1.282 . . . . 0.0 107.616 169.433 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -148.74 171.95 28.99 Favored Glycine 0 CA--C 1.524 0.594 0 CA-C-N 115.659 -0.701 . . . . 0.0 113.376 -173.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -122.81 120.42 33.49 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.774 1.23 . . . . 0.0 109.859 177.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 25.2 t-80 -64.86 145.61 56.04 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.429 1.092 . . . . 0.0 111.66 178.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -80.19 -45.37 18.19 Favored 'General case' 0 CA--C 1.547 0.861 0 O-C-N 120.927 -1.108 . . . . 0.0 113.448 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 87.7 t -72.53 -53.78 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 177.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 35.2 m -86.41 -17.32 34.64 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.288 0.949 . . . . 0.0 113.142 -172.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp 53.96 21.31 2.8 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 126.69 1.996 . . . . 0.0 114.505 -173.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -80.55 152.46 28.62 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.189 0.596 . . . . 0.0 111.527 173.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 46.7 mtm-85 -119.44 155.6 31.73 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.252 1.821 . . . . 0.0 110.65 175.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 164.01 169.68 27.87 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.372 0.987 . . . . 0.0 112.217 174.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -66.53 145.75 55.28 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.351 0.661 . . . . 0.0 110.485 166.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -155.23 154.43 28.57 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 124.482 1.113 . . . . 0.0 110.391 172.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 393' ' ' PRO . . . . . 0.438 ' HB3' ' HB1' ' B' ' 535' ' ' ALA . 24.3 Cg_endo -65.37 124.14 12.48 Favored 'Trans proline' 0 CA--C 1.532 0.4 0 C-N-CA 122.581 2.188 . . . . 0.0 111.497 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 96.3 p -56.88 -37.21 71.06 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 8.7 p -67.66 -14.24 62.78 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.094 1.758 . . . . 0.0 115.503 179.214 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -79.86 -2.08 41.92 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 119.524 1.056 . . . . 0.0 113.106 168.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 77.0 p -126.86 166.07 18.15 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.446 1.498 . . . . 0.0 111.186 172.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -144.51 163.49 33.7 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.975 1.31 . . . . 0.0 110.346 171.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.52 124.58 19.5 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.809 0.844 . . . . 0.0 109.433 178.364 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 400' ' ' LEU . . . . . 0.415 ' O ' HD12 ' A' ' 400' ' ' LEU . 3.6 tp -49.74 -43.31 47.84 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 -172.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -77.67 -19.93 54.56 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 113.058 -1.883 . . . . 0.0 115.116 -175.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 . . . . . 0 N--CA 1.485 1.311 0 C-N-CA 125.939 1.696 . . . . 0.0 112.988 -171.518 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 526' ' ' HIS . . . . . . . . . . . . . 64.6 m80 . . . . . 0 N--CA 1.485 1.32 0 CA-C-O 120.869 0.366 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 63.6 mt -71.38 133.29 85.29 Favored Pre-proline 0 N--CA 1.477 0.885 0 C-N-CA 124.857 1.263 . . . . 0.0 109.429 176.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -69.41 159.85 52.07 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 123.561 2.841 . . . . 0.0 112.238 178.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.13 144.74 87.9 Favored 'Trans proline' 0 CA--C 1.535 0.529 0 C-N-CA 122.424 2.083 . . . . 0.0 112.148 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -73.89 156.7 87.93 Favored Pre-proline 0 CA--C 1.551 0.994 0 C-N-CA 123.243 0.617 . . . . 0.0 112.207 173.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -68.87 175.21 7.65 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.346 2.697 . . . . 0.0 113.128 176.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -92.2 9.03 35.42 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.853 1.261 . . . . 0.0 112.514 -178.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 34.9 p90 -138.31 154.16 73.53 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 124.846 1.259 . . . . 0.0 112.759 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.6 153.04 60.05 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 123.621 2.881 . . . . 0.0 112.547 178.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 535' ' ' ALA . . . . . 0.438 ' HB1' ' HB3' ' A' ' 393' ' ' PRO . . . -67.52 144.16 97.56 Favored Pre-proline 0 CA--C 1.55 0.964 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -176.467 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.86 176.26 9.24 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.949 3.099 . . . . 0.0 112.555 178.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 22.5 p -129.39 154.24 80.67 Favored Pre-proline 0 N--CA 1.479 0.993 0 C-N-CA 124.759 1.224 . . . . 0.0 112.779 -171.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -67.85 162.09 41.13 Favored 'Trans proline' 0 CA--C 1.546 1.118 0 C-N-CA 123.28 2.653 . . . . 0.0 111.352 176.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -65.5 154.18 74.86 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.982 2.454 . . . . 0.0 112.482 177.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 540' ' ' VAL . . . . . . . . . . . . . 12.6 m -68.42 -10.91 13.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 127.316 2.246 . . . . 0.0 114.897 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 541' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -150.45 165.39 33.32 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.043 1.737 . . . . 0.0 111.963 177.005 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 542' ' ' ASN . . . . . . . . . . . . . 9.5 p30 . . . . . 0 C--O 1.253 1.249 0 C-N-CA 124.671 1.188 . . . . 0.0 113.684 174.797 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.495 0 N-CA-C 111.727 -0.549 . . . . 0.0 111.727 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 18.6 m -87.97 12.36 13.52 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.426 1.49 . . . . 0.0 114.902 -172.017 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 338' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 -142.71 144.13 32.57 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.283 1.433 . . . . 0.0 111.582 -174.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 339' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -152.26 174.84 13.29 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 126.131 1.773 . . . . 0.0 112.358 -177.008 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -131.25 48.22 2.45 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.409 1.483 . . . . 0.0 112.679 -172.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 341' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -123.78 99.55 6.34 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 126.248 1.819 . . . . 0.0 110.389 175.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 342' ' ' GLN . . . . . . . . . . . . . 70.5 tp60 -66.35 137.13 56.68 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.353 0.597 . . . . 0.0 111.352 174.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 3.1 mptm? -127.57 165.82 19.19 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.825 1.65 . . . . 0.0 111.868 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 16.2 m -135.25 157.15 39.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 126.725 2.01 . . . . 0.0 109.399 169.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -120.53 131.24 54.6 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.914 0.886 . . . . 0.0 110.364 178.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 71.3 p -73.49 151.75 40.94 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.06 0.944 . . . . 0.0 111.379 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.7 pp -124.3 -8.28 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -177.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -154.35 157.23 32.26 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 126.474 1.91 . . . . 0.0 109.906 169.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.3 157.4 61.97 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.093 2.529 . . . . 0.0 113.025 177.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -139.17 144.45 38.59 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.064 1.345 . . . . 0.0 111.259 178.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 55.0 m -142.26 134.21 27.25 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.803 1.641 . . . . 0.0 109.869 -171.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -67.01 -46.05 75.68 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -170.007 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 57.07 89.9 0.01 OUTLIER Glycine 0 CA--C 1.538 1.517 0 C-N-CA 125.153 1.358 . . . . 0.0 114.925 176.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 77.8 p 60.95 29.01 18.75 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 126.271 1.828 . . . . 0.0 115.127 -176.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -135.97 160.34 38.9 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.915 1.686 . . . . 0.0 111.895 -179.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 33.7 mtmm -125.13 -7.65 7.11 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -178.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 29.6 p -106.76 9.77 31.0 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.584 1.554 . . . . 0.0 113.096 -176.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 70.7 mt -108.0 128.97 55.13 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.997 1.319 . . . . 0.0 111.195 -177.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 31.1 tp -80.68 121.11 25.46 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.477 0.711 . . . . 0.0 110.642 176.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 47.4 p -90.19 152.62 21.01 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.564 1.145 . . . . 0.0 112.487 173.096 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -165.94 179.21 5.98 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.581 1.553 . . . . 0.0 112.34 -177.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -119.08 174.51 6.28 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.338 1.855 . . . . 0.0 111.205 174.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -68.62 137.99 54.68 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.044 0.938 . . . . 0.0 111.693 172.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 84.21 12.96 75.17 Favored Glycine 0 CA--C 1.536 1.39 0 N-CA-C 114.881 0.712 . . . . 0.0 114.881 174.105 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -95.48 160.91 14.29 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.96 1.704 . . . . 0.0 111.669 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 72.7 t -108.91 133.73 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.632 1.173 . . . . 0.0 109.74 -171.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 16.5 mt -133.88 139.23 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.446 1.098 . . . . 0.0 109.349 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 6.8 m -101.2 141.84 33.49 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.593 1.157 . . . . 0.0 110.134 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 23.7 mt -79.36 141.72 36.68 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.008 0.523 . . . . 0.0 111.943 -177.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 61.6 mt -116.46 -7.78 11.64 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.596 1.158 . . . . 0.0 113.003 178.096 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 7.5 mt -132.77 142.01 43.18 Favored Pre-proline 0 N--CA 1.478 0.969 0 C-N-CA 126.857 2.063 . . . . 0.0 109.807 175.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.08 -8.81 24.35 Favored 'Trans proline' 0 CA--C 1.548 1.177 0 C-N-CA 123.828 3.019 . . . . 0.0 114.788 175.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 26.8 pt-20 -152.69 155.4 37.18 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.811 1.645 . . . . 0.0 112.404 174.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -75.87 170.72 15.69 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.613 1.165 . . . . 0.0 113.853 174.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -132.51 107.86 8.74 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.533 1.933 . . . . 0.0 110.268 -178.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 50.65 30.53 4.96 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 124.993 1.317 . . . . 0.0 114.331 -178.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 100.14 -16.42 58.24 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 125.674 1.606 . . . . 0.0 114.425 -178.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -87.07 129.61 34.84 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.55 1.175 . . . . 0.0 111.198 178.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 12.5 mt -96.62 161.68 13.78 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.955 0.902 . . . . 0.0 110.311 163.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -124.83 123.75 40.62 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.201 1.4 . . . . 0.0 107.771 173.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -148.65 175.16 28.05 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-N 115.731 -0.668 . . . . 0.0 113.682 -172.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -126.07 120.62 30.7 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.254 1.422 . . . . 0.0 110.027 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -61.85 155.93 22.01 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.716 1.206 . . . . 0.0 111.887 179.068 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -98.46 -21.96 16.28 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 120.661 -1.274 . . . . 0.0 114.363 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 58.5 t -82.63 -33.81 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 C-N-CA 123.466 0.706 . . . . 0.0 112.718 178.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 5.5 t -127.33 -11.49 5.74 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.683 1.193 . . . . 0.0 113.694 -170.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? 54.68 23.02 4.42 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 125.753 1.621 . . . . 0.0 113.762 -177.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -69.25 154.47 41.99 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.688 1.195 . . . . 0.0 111.355 169.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 80.3 mtt180 -127.05 161.19 28.99 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.922 1.689 . . . . 0.0 110.947 -177.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 156.87 169.39 20.74 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 124.521 1.058 . . . . 0.0 112.449 174.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -67.1 147.87 52.6 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.144 0.497 . . . . 0.0 110.361 168.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -154.36 155.71 31.05 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 124.112 0.965 . . . . 0.0 110.75 172.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -65.15 120.39 7.6 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.314 2.009 . . . . 0.0 111.707 178.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 81.7 p -57.99 -22.77 51.04 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 114.225 1.195 . . . . 0.0 114.225 177.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 16.3 m -77.09 -17.69 58.52 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 176.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -79.36 -2.49 41.81 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.476 1.11 . . . . 0.0 113.687 177.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 67.2 p -123.36 163.68 20.31 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.623 1.569 . . . . 0.0 110.771 171.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -126.74 151.91 47.55 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 125.193 1.397 . . . . 0.0 108.886 169.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.69 128.2 35.41 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 176.263 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 60.0 tp -56.05 -36.52 68.12 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 115.699 1.74 . . . . 0.0 115.699 -169.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -149.97 125.04 9.99 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 127.627 2.371 . . . . 0.0 113.009 176.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 . . . . . 0 C--O 1.254 1.328 0 C-N-CA 125.209 1.404 . . . . 0.0 113.639 176.38 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 526' ' ' HIS . . . . . . . . . . . . . 53.6 m80 . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.65 0.262 . . . . 0.0 110.817 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 61.0 mt -65.56 132.01 94.93 Favored Pre-proline 0 N--CA 1.478 0.93 0 C-N-CA 124.785 1.234 . . . . 0.0 109.773 179.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -69.31 160.57 49.3 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 123.568 2.845 . . . . 0.0 112.074 178.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -63.99 143.45 85.03 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 122.281 1.987 . . . . 0.0 112.103 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -71.94 155.05 92.39 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 123.083 0.553 . . . . 0.0 112.053 172.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -68.8 174.87 8.02 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.419 2.746 . . . . 0.0 113.095 176.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -91.14 8.95 33.08 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.913 1.285 . . . . 0.0 112.407 -178.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 38.2 p90 -138.02 154.36 74.22 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 124.9 1.28 . . . . 0.0 112.827 -178.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -72.03 153.82 57.69 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.726 2.951 . . . . 0.0 112.58 178.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -68.97 142.9 93.88 Favored Pre-proline 0 CA--C 1.552 1.043 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -176.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -73.92 179.65 5.49 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 124.173 3.249 . . . . 0.0 113.071 176.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 26.9 p -132.89 155.29 81.32 Favored Pre-proline 0 N--CA 1.48 1.058 0 C-N-CA 125.25 1.42 . . . . 0.0 112.842 -174.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -67.46 164.64 30.04 Favored 'Trans proline' 0 CA--C 1.549 1.266 0 C-N-CA 123.504 2.803 . . . . 0.0 111.57 174.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -66.21 162.53 35.52 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 123.46 2.773 . . . . 0.0 113.085 176.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 540' ' ' VAL . . . . . . . . . . . . . 35.2 t -115.98 -7.47 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 125.752 1.621 . . . . 0.0 111.583 -177.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 541' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.58 84.98 2.11 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.679 1.992 . . . . 0.0 110.791 -175.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 542' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 . . . . . 0 C--O 1.254 1.294 0 C-N-CA 125.622 1.569 . . . . 0.0 113.426 -179.431 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 15.9 m . . . . . 0 C--O 1.237 0.434 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 19.0 ttmt -118.2 131.34 56.39 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.991 0.916 . . . . 0.0 109.728 177.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 27.8 p -73.47 156.93 37.71 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.265 0.626 . . . . 0.0 111.315 -177.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 2.1 pp -127.32 -5.84 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 N-CA-C 114.722 1.378 . . . . 0.0 114.722 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -156.58 158.58 31.46 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 125.852 1.661 . . . . 0.0 110.415 171.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.21 156.68 64.04 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.216 2.611 . . . . 0.0 112.918 176.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 52.1 t-80 . . . . . 0 N--CA 1.474 0.735 0 C-N-CA 125.093 1.357 . . . . 0.0 111.735 179.164 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 53.7 p . . . . . 0 N--CA 1.48 1.029 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 67.7 mt -104.39 124.52 49.36 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.763 1.225 . . . . 0.0 111.45 -177.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 23.7 tp -77.26 124.47 27.89 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.637 0.775 . . . . 0.0 110.828 176.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 58.5 p -94.97 153.38 17.68 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.876 1.27 . . . . 0.0 112.632 174.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -167.42 178.85 5.26 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.759 1.624 . . . . 0.0 112.132 -175.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -117.28 178.51 4.34 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.663 1.985 . . . . 0.0 110.93 173.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -66.96 141.3 57.66 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.304 -0.873 . . . . 0.0 111.47 170.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 79.29 5.44 89.14 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 124.232 0.92 . . . . 0.0 115.345 174.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -74.34 166.62 23.17 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.757 1.223 . . . . 0.0 112.822 176.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 90.8 t -119.36 126.33 75.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 125.666 1.586 . . . . 0.0 108.884 -174.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 26.4 mt -133.62 135.46 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.56 1.144 . . . . 0.0 109.059 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 59.3 m -102.72 136.73 42.01 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.757 1.223 . . . . 0.0 110.058 -177.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 19.5 mt -75.34 148.0 39.64 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -175.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 49.5 mt -121.25 0.93 10.2 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 124.782 1.233 . . . . 0.0 112.908 178.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 371' ' ' ILE . . . . . 0.531 HG22 ' HD2' ' A' ' 372' ' ' PRO . 2.2 mt -137.13 142.67 38.96 Favored Pre-proline 0 N--CA 1.48 1.05 0 C-N-CA 126.716 2.006 . . . . 0.0 109.794 177.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 372' ' ' PRO . . . . . 0.531 ' HD2' HG22 ' A' ' 371' ' ' ILE . 55.6 Cg_endo -72.27 -8.87 23.5 Favored 'Trans proline' 0 CA--C 1.546 1.085 0 C-N-CA 123.423 2.749 . . . . 0.0 113.959 176.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -153.63 152.82 31.29 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.855 1.662 . . . . 0.0 112.139 174.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -72.88 169.68 16.31 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.23 1.012 . . . . 0.0 113.63 174.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 18.2 tppt? -126.39 102.36 7.12 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.776 2.03 . . . . 0.0 109.801 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 52.67 30.36 8.64 Favored 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 178.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 102.09 -18.44 51.93 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.803 1.668 . . . . 0.0 114.199 -178.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 82.0 m95 -84.4 129.47 34.86 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.524 1.13 . . . . 0.0 111.119 175.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 11.4 mt -99.23 158.56 15.61 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.925 0.89 . . . . 0.0 110.285 165.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 380' ' ' TYR . . . . . 0.416 ' HB3' HD11 ' A' ' 371' ' ' ILE . 50.2 t80 -118.57 123.78 45.87 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.867 1.267 . . . . 0.0 107.721 171.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -148.62 172.43 28.81 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-N 115.854 -0.612 . . . . 0.0 113.602 -173.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -123.83 119.32 29.34 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.547 1.539 . . . . 0.0 109.402 176.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 25.0 t-80 -62.92 147.86 49.11 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.905 1.282 . . . . 0.0 111.546 177.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -80.39 -50.4 10.17 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 120.91 -1.119 . . . . 0.0 113.46 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 68.0 t -69.38 -49.0 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 O-C-N 121.37 -0.831 . . . . 0.0 113.111 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 20.3 t -86.11 -23.26 26.71 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.406 0.682 . . . . 0.0 112.646 -175.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 34.7 mmtm 53.46 20.51 2.06 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 126.187 1.795 . . . . 0.0 114.265 -169.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -76.41 152.78 36.12 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.458 0.703 . . . . 0.0 111.799 171.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 74.4 mtm180 -122.15 157.14 32.18 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.443 1.897 . . . . 0.0 111.195 177.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 161.02 170.57 25.81 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.529 1.061 . . . . 0.0 112.505 174.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -66.74 147.36 53.37 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.133 0.492 . . . . 0.0 110.313 166.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -154.73 155.73 30.76 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 124.304 1.042 . . . . 0.0 110.427 172.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -64.6 119.42 6.46 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.347 2.032 . . . . 0.0 110.822 176.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 28.9 t -55.79 -38.79 70.4 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.56 -0.712 . . . . 0.0 111.936 177.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 1.6 p -61.15 -17.39 52.61 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.306 1.842 . . . . 0.0 115.859 177.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -76.55 -0.34 22.85 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 119.705 1.139 . . . . 0.0 113.086 169.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 32.4 p . . . . . 0 N--CA 1.466 0.37 0 C-N-CA 126.081 1.752 . . . . 0.0 111.008 179.646 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 62.8 mt . . . . . 0 N--CA 1.478 0.935 0 CA-C-O 119.106 -0.473 . . . . 0.0 109.829 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -69.44 159.75 52.42 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 123.601 2.867 . . . . 0.0 112.264 178.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.23 144.95 87.98 Favored 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 122.374 2.05 . . . . 0.0 112.241 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -73.58 156.11 88.85 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 123.265 0.626 . . . . 0.0 112.224 173.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -69.14 174.73 8.55 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.48 2.787 . . . . 0.0 113.155 177.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -88.6 4.77 45.78 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.797 1.239 . . . . 0.0 112.62 -178.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 36.3 p90 -136.32 154.62 77.23 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 124.677 1.191 . . . . 0.0 112.829 -176.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.95 153.17 58.1 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 123.753 2.969 . . . . 0.0 112.779 178.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -68.7 143.15 94.67 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 123.732 0.813 . . . . 0.0 113.028 -177.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.73 176.86 8.82 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.992 3.128 . . . . 0.0 113.023 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 27.8 p -130.32 153.0 81.18 Favored Pre-proline 0 N--CA 1.478 0.959 0 C-N-CA 124.983 1.313 . . . . 0.0 112.82 -173.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -67.07 163.26 34.7 Favored 'Trans proline' 0 CA--C 1.548 1.183 0 C-N-CA 123.485 2.79 . . . . 0.0 111.338 176.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo . . . . . 0 CA--C 1.54 0.803 0 C-N-CA 123.007 2.471 . . . . 0.0 112.516 178.787 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 16.2 m . . . . . 0 C--O 1.236 0.387 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -113.45 133.4 55.22 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.675 0.79 . . . . 0.0 110.092 174.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 68.3 p -72.84 154.75 40.47 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.279 1.032 . . . . 0.0 111.175 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.9 pp -125.59 -6.41 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 -179.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -155.92 159.76 31.31 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 126.273 1.829 . . . . 0.0 109.889 169.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -68.75 155.96 67.02 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.041 2.494 . . . . 0.0 113.203 177.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 . . . . . 0 CA--C 1.541 0.605 0 C-N-CA 125.466 1.507 . . . . 0.0 111.409 178.711 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 75.8 p . . . . . 0 N--CA 1.483 1.177 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 69.0 mt -112.17 133.41 54.32 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.818 1.247 . . . . 0.0 111.762 -176.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 27.9 tp -87.72 121.27 29.94 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.096 0.958 . . . . 0.0 111.01 177.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 59.8 p -86.7 153.48 21.7 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.454 1.102 . . . . 0.0 112.866 172.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -167.53 178.34 5.47 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.901 1.68 . . . . 0.0 112.147 -178.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -118.54 175.96 5.48 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.877 2.071 . . . . 0.0 111.067 173.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -64.06 141.19 58.86 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.817 0.847 . . . . 0.0 111.404 169.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 75.47 11.49 84.28 Favored Glycine 0 CA--C 1.539 1.556 0 N-CA-C 114.975 0.75 . . . . 0.0 114.975 175.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -81.98 162.9 22.49 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.989 1.316 . . . . 0.0 112.036 173.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 86.9 t -117.35 129.2 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.96 1.304 . . . . 0.0 109.41 -172.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 30.5 mt -134.72 136.13 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.383 1.073 . . . . 0.0 109.474 -177.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 33.6 m -99.97 138.81 36.53 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.149 1.379 . . . . 0.0 110.31 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 20.8 mt -76.62 146.7 38.05 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 122.853 0.461 . . . . 0.0 112.219 -177.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 39.5 mt -120.07 -3.31 10.12 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 124.799 1.24 . . . . 0.0 112.773 177.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 371' ' ' ILE . . . . . 0.45 HG22 ' H ' ' A' ' 373' ' ' GLU . 6.2 mt -135.87 142.0 38.85 Favored Pre-proline 0 N--CA 1.481 1.101 0 C-N-CA 127.186 2.194 . . . . 0.0 109.917 177.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.13 -7.05 20.3 Favored 'Trans proline' 0 CA--C 1.546 1.121 0 C-N-CA 124.446 3.431 . . . . 0.0 115.248 175.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . 0.45 ' H ' HG22 ' A' ' 371' ' ' ILE . 18.1 pt-20 -151.48 167.34 28.33 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 126.091 1.756 . . . . 0.0 112.228 176.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -92.11 170.08 10.12 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.542 1.137 . . . . 0.0 113.036 175.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 10.5 tptp -133.51 111.09 10.41 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 126.366 1.866 . . . . 0.0 110.272 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 52.35 27.52 4.92 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 124.87 1.268 . . . . 0.0 114.257 -177.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 98.12 -14.31 62.63 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 125.727 1.632 . . . . 0.0 114.595 -176.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 75.7 m95 -87.04 133.31 33.61 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.412 1.106 . . . . 0.0 111.518 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 18.1 mt -102.01 162.59 12.79 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 124.342 1.057 . . . . 0.0 110.198 164.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -125.08 121.79 35.34 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.957 1.303 . . . . 0.0 107.733 175.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -145.44 174.12 25.57 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 115.542 -0.754 . . . . 0.0 114.139 -173.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -124.55 120.57 32.33 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.773 1.629 . . . . 0.0 109.798 177.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 15.8 t-80 -65.6 144.62 56.85 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.792 1.237 . . . . 0.0 111.952 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -77.71 -48.61 16.29 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 120.877 -1.139 . . . . 0.0 113.538 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 83.3 t -69.96 -48.99 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 124.03 0.932 . . . . 0.0 113.296 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 7.2 t -93.59 -16.05 24.77 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -171.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp 53.36 18.82 1.4 Allowed 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 127.024 2.13 . . . . 0.0 114.986 -173.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -78.01 156.11 30.33 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.411 0.684 . . . . 0.0 111.581 174.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -123.78 157.98 32.79 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.112 1.765 . . . . 0.0 110.652 177.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 159.68 168.86 22.26 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 124.252 0.93 . . . . 0.0 112.67 175.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -67.2 148.44 51.77 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.313 0.578 . . . . 0.0 110.258 168.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -154.36 154.39 29.5 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 124.526 1.13 . . . . 0.0 110.463 173.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -65.46 121.65 9.12 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.558 2.172 . . . . 0.0 110.883 177.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 30.4 t -56.44 -38.01 71.02 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.464 -0.772 . . . . 0.0 112.397 178.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 75.3 m -63.27 -19.6 64.71 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -73.08 -1.88 19.1 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.271 1.029 . . . . 0.0 113.192 171.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 53.8 p . . . . . 0 N--CA 1.467 0.412 0 C-N-CA 125.962 1.705 . . . . 0.0 111.441 178.071 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 64.1 mt . . . . . 0 CA--C 1.549 0.923 0 CA-C-O 119.009 -0.52 . . . . 0.0 109.759 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -69.76 158.73 55.95 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 123.459 2.772 . . . . 0.0 111.862 177.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.0 144.8 88.7 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 122.245 1.964 . . . . 0.0 112.256 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -69.74 154.77 94.47 Favored Pre-proline 0 CA--C 1.55 0.981 0 C-N-CA 122.962 0.505 . . . . 0.0 111.905 171.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -68.52 174.09 8.87 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.283 2.655 . . . . 0.0 113.009 177.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -86.65 1.95 50.13 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.463 1.105 . . . . 0.0 113.044 -178.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -132.74 153.57 81.12 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 124.736 1.215 . . . . 0.0 112.943 -176.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.4 152.97 61.16 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 123.694 2.929 . . . . 0.0 112.757 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -68.63 143.89 95.58 Favored Pre-proline 0 CA--C 1.551 1.013 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -73.54 -179.28 4.34 Favored 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 124.028 3.152 . . . . 0.0 112.791 176.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 22.2 p -134.28 155.07 80.21 Favored Pre-proline 0 N--CA 1.479 1.024 0 C-N-CA 125.247 1.419 . . . . 0.0 112.632 -175.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.59 163.13 36.22 Favored 'Trans proline' 0 CA--C 1.548 1.189 0 C-N-CA 123.512 2.808 . . . . 0.0 111.742 176.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo . . . . . 0 CA--C 1.54 0.786 0 C-N-CA 122.935 2.423 . . . . 0.0 112.576 177.764 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 15.7 m . . . . . 0 C--O 1.235 0.335 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -121.02 128.17 52.43 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.227 1.011 . . . . 0.0 109.901 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 59.0 p -71.79 154.04 41.56 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.01 0.924 . . . . 0.0 111.415 -177.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.8 pp -124.65 -8.36 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -156.01 159.54 31.45 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 126.731 2.012 . . . . 0.0 110.116 169.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.63 158.35 58.09 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.208 2.605 . . . . 0.0 113.331 177.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 . . . . . 0 N--CA 1.474 0.748 0 C-N-CA 124.98 1.312 . . . . 0.0 111.866 179.043 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 74.3 p . . . . . 0 N--CA 1.485 1.287 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 47.7 mt -97.37 120.43 37.71 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.714 1.206 . . . . 0.0 110.473 175.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 25.4 tp -73.18 131.95 42.63 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.494 0.718 . . . . 0.0 110.502 175.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 31.9 p -110.75 149.58 30.31 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.072 1.749 . . . . 0.0 112.395 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -167.11 179.08 5.33 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.149 1.379 . . . . 0.0 112.667 -169.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -116.49 177.0 4.85 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.712 2.005 . . . . 0.0 111.155 173.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -67.04 142.83 57.05 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.177 0.991 . . . . 0.0 111.888 170.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 75.61 5.39 78.32 Favored Glycine 0 CA--C 1.538 1.502 0 C-N-CA 124.376 0.988 . . . . 0.0 115.248 174.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -73.75 161.48 30.19 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.704 1.202 . . . . 0.0 111.723 171.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 59.3 t -112.51 138.32 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.485 1.114 . . . . 0.0 109.407 178.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 36.5 mt -136.26 140.77 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 124.717 1.207 . . . . 0.0 108.835 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 23.5 m -98.27 140.18 32.95 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.765 1.226 . . . . 0.0 110.853 178.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 22.7 mt -79.11 141.16 37.55 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 122.804 0.442 . . . . 0.0 111.554 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 63.1 mt -113.03 -4.45 13.86 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 124.673 1.189 . . . . 0.0 112.744 178.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 7.9 mt -132.92 141.76 42.21 Favored Pre-proline 0 N--CA 1.478 0.928 0 C-N-CA 127.001 2.12 . . . . 0.0 109.851 177.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.35 -7.98 22.42 Favored 'Trans proline' 0 CA--C 1.547 1.133 0 C-N-CA 123.974 3.116 . . . . 0.0 114.575 175.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -153.5 151.96 30.42 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.05 1.74 . . . . 0.0 112.062 175.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -74.62 171.33 14.05 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.417 1.087 . . . . 0.0 113.731 175.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -132.95 107.14 8.1 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.205 1.802 . . . . 0.0 110.249 -178.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 51.28 30.91 6.33 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 125.004 1.322 . . . . 0.0 114.343 -179.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 98.95 -16.75 59.1 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.772 1.653 . . . . 0.0 114.3 -177.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -85.75 132.06 34.21 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.308 1.043 . . . . 0.0 111.146 177.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 13.2 mt -100.7 159.94 14.76 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.939 0.896 . . . . 0.0 110.114 164.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -121.66 123.25 41.45 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 173.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -146.0 172.89 26.51 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-N 115.743 -0.662 . . . . 0.0 114.376 -172.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -124.68 116.46 22.41 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.88 1.672 . . . . 0.0 109.126 176.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 21.5 t-80 -61.88 144.29 55.14 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.818 1.247 . . . . 0.0 111.982 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -80.29 -45.32 18.07 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 121.217 -0.927 . . . . 0.0 112.705 -178.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 97.2 t -70.87 -52.73 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 124.256 1.022 . . . . 0.0 113.469 175.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 7.6 t -91.56 -15.61 28.41 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -171.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt 54.41 19.08 2.15 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 126.767 2.027 . . . . 0.0 114.777 -174.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -77.87 157.51 29.82 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.522 0.729 . . . . 0.0 111.822 174.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 54.1 mtt85 -128.52 155.9 44.14 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.007 1.723 . . . . 0.0 110.801 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 160.15 169.67 23.75 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 124.69 1.138 . . . . 0.0 112.03 176.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -66.8 147.17 53.6 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.114 0.566 . . . . 0.0 110.234 166.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -154.47 155.4 30.67 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 124.32 1.048 . . . . 0.0 110.17 172.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -65.64 120.1 7.23 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.167 1.911 . . . . 0.0 110.749 176.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 29.8 t -54.46 -38.45 66.37 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 121.897 -0.502 . . . . 0.0 111.958 176.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 17.9 m -58.58 -21.37 52.9 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.836 1.654 . . . . 0.0 115.255 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -77.41 0.27 23.17 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.606 1.163 . . . . 0.0 113.468 173.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 68.9 p . . . . . 0 N--CA 1.466 0.371 0 C-N-CA 125.945 1.698 . . . . 0.0 111.328 176.34 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 58.9 mt . . . . . 0 CA--C 1.55 0.946 0 CA-C-O 118.954 -0.546 . . . . 0.0 109.821 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.36 160.37 49.75 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 123.532 2.821 . . . . 0.0 112.079 178.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.99 144.16 86.99 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.331 2.02 . . . . 0.0 112.357 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -72.41 156.14 90.63 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 123.361 0.664 . . . . 0.0 112.138 172.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -68.75 175.02 7.76 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.443 2.762 . . . . 0.0 113.219 176.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -91.8 8.93 34.86 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.856 1.262 . . . . 0.0 112.35 -178.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 36.3 p90 -137.73 154.56 74.86 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 124.617 1.167 . . . . 0.0 112.786 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -72.07 153.54 57.46 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 123.763 2.975 . . . . 0.0 112.74 178.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -69.26 142.42 92.52 Favored Pre-proline 0 CA--C 1.551 1.008 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -175.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -73.86 179.75 5.38 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 124.173 3.249 . . . . 0.0 113.266 178.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 28.1 p -132.59 155.45 81.21 Favored Pre-proline 0 N--CA 1.479 0.988 0 C-N-CA 125.392 1.477 . . . . 0.0 113.024 -172.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.13 163.0 39.43 Favored 'Trans proline' 0 CA--C 1.548 1.197 0 C-N-CA 123.545 2.83 . . . . 0.0 111.936 175.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo . . . . . 0 CA--C 1.54 0.818 0 C-N-CA 123.376 2.717 . . . . 0.0 112.925 178.016 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 16.3 m . . . . . 0 C--O 1.237 0.409 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -115.95 132.13 56.74 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 124.396 1.079 . . . . 0.0 109.885 177.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 72.3 p -75.04 153.94 38.2 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.526 0.73 . . . . 0.0 111.366 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.9 pp -123.97 -7.92 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -156.38 158.77 31.62 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 126.102 1.761 . . . . 0.0 110.117 170.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.02 155.78 68.34 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 122.947 2.431 . . . . 0.0 112.968 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 . . . . . 0 N--CA 1.471 0.616 0 C-N-CA 124.931 1.292 . . . . 0.0 111.621 178.772 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 36.7 p . . . . . 0 N--CA 1.482 1.168 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 81.8 mt -106.23 126.22 51.96 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.961 1.305 . . . . 0.0 110.963 -176.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 31.5 tp -73.86 141.8 46.09 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 122.987 0.515 . . . . 0.0 110.205 171.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 58.0 p -121.65 148.86 44.02 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.192 1.397 . . . . 0.0 111.721 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -165.54 178.5 6.68 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.97 1.308 . . . . 0.0 112.447 -167.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -117.7 177.63 4.69 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 127.117 2.167 . . . . 0.0 110.802 174.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -67.54 141.5 56.84 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 121.215 -0.928 . . . . 0.0 111.595 170.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 77.48 6.7 86.84 Favored Glycine 0 CA--C 1.538 1.485 0 N-CA-C 115.274 0.87 . . . . 0.0 115.274 176.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -74.02 164.67 26.32 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 118.437 1.119 . . . . 0.0 112.02 170.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 77.2 t -120.61 128.07 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.337 1.455 . . . . 0.0 109.125 -174.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 31.0 mt -132.55 137.06 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 123.399 0.68 . . . . 0.0 109.506 -175.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 20.5 m -98.02 140.27 32.61 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.334 1.054 . . . . 0.0 110.649 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 23.8 mt -81.17 142.94 32.74 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 122.975 0.51 . . . . 0.0 111.718 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 39.2 mt -116.04 -4.54 12.0 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.42 1.088 . . . . 0.0 113.003 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 6.9 mt -134.13 141.53 39.83 Favored Pre-proline 0 N--CA 1.477 0.88 0 C-N-CA 127.007 2.123 . . . . 0.0 109.57 177.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.81 -7.36 20.98 Favored 'Trans proline' 0 CA--C 1.549 1.255 0 C-N-CA 123.98 3.12 . . . . 0.0 114.561 176.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -150.3 154.49 37.96 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.073 1.749 . . . . 0.0 111.478 173.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -78.47 168.82 19.22 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 121.006 -1.059 . . . . 0.0 113.156 173.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -121.89 103.01 8.54 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 126.253 1.821 . . . . 0.0 110.253 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 52.14 31.47 9.05 Favored 'General case' 0 CA--C 1.555 1.136 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 177.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 99.84 -4.33 57.67 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 125.317 1.437 . . . . 0.0 114.675 -178.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -101.69 118.47 37.01 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.199 1.4 . . . . 0.0 110.67 176.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 12.6 mt -82.93 161.49 21.81 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.393 0.616 . . . . 0.0 110.546 162.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -126.04 123.5 38.56 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.152 1.381 . . . . 0.0 107.975 171.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -150.67 173.88 30.13 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-N 115.933 -0.576 . . . . 0.0 114.509 -169.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -126.21 120.29 29.67 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.653 1.581 . . . . 0.0 110.11 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 25.0 t-80 -66.4 156.07 35.66 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.256 1.422 . . . . 0.0 112.554 178.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -83.05 -48.18 10.88 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 178.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 71.2 t -75.66 -49.07 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 125.206 1.402 . . . . 0.0 113.393 -178.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 23.2 t -87.77 -23.34 24.12 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 118.786 0.721 . . . . 0.0 112.561 -176.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 7.0 mmmm 54.91 19.49 2.67 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 126.529 1.932 . . . . 0.0 114.006 -171.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -75.09 155.26 37.33 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.896 0.878 . . . . 0.0 111.817 172.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 -121.49 156.37 32.93 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 126.111 1.764 . . . . 0.0 111.429 176.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 165.57 169.63 29.44 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.898 1.237 . . . . 0.0 112.042 175.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -66.99 149.92 49.96 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.06 0.457 . . . . 0.0 110.126 166.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -155.87 154.37 27.66 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 124.263 1.025 . . . . 0.0 110.162 171.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 393' ' ' PRO . . . . . 0.4 ' HB3' ' HB1' ' B' ' 535' ' ' ALA . 20.4 Cg_endo -63.78 119.84 7.03 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.181 1.921 . . . . 0.0 110.406 177.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.1 -36.41 70.59 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 121.391 -0.818 . . . . 0.0 111.564 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 18.2 m -59.43 -22.11 60.99 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 126.748 2.019 . . . . 0.0 114.944 178.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -74.88 0.72 14.66 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.763 1.225 . . . . 0.0 113.217 172.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 36.6 p . . . . . 0 N--CA 1.468 0.461 0 C-N-CA 125.735 1.614 . . . . 0.0 111.803 179.859 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 57.9 mt . . . . . 0 N--CA 1.479 0.997 0 CA-C-O 119.033 -0.508 . . . . 0.0 109.663 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -69.93 160.49 49.48 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 123.574 2.849 . . . . 0.0 112.138 177.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.07 144.49 87.52 Favored 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 122.294 1.996 . . . . 0.0 112.136 178.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -73.14 155.49 90.12 Favored Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 123.118 0.567 . . . . 0.0 112.027 173.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -69.07 174.7 8.52 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 123.537 2.824 . . . . 0.0 113.128 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -92.34 9.02 35.82 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.913 1.285 . . . . 0.0 112.472 -178.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 34.9 p90 -137.85 153.86 74.11 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 124.621 1.168 . . . . 0.0 112.842 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -71.92 151.91 57.08 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.579 2.853 . . . . 0.0 112.364 177.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 535' ' ' ALA . . . . . 0.4 ' HB1' ' HB3' ' A' ' 393' ' ' PRO . . . -69.91 146.3 95.16 Favored Pre-proline 0 CA--C 1.549 0.923 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -175.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.95 178.12 6.87 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 123.979 3.119 . . . . 0.0 112.833 176.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 25.3 p -132.36 154.02 81.43 Favored Pre-proline 0 N--CA 1.478 0.941 0 C-N-CA 125.316 1.447 . . . . 0.0 112.449 -175.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -66.5 162.24 37.6 Favored 'Trans proline' 0 CA--C 1.548 1.186 0 C-N-CA 123.353 2.702 . . . . 0.0 111.48 175.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 CA--C 1.541 0.827 0 C-N-CA 123.167 2.578 . . . . 0.0 112.713 179.085 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 17.4 m . . . . . 0 C--O 1.234 0.288 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -118.19 134.99 54.52 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.292 1.037 . . . . 0.0 110.362 176.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 81.3 p -77.44 154.21 32.83 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.065 1.346 . . . . 0.0 111.674 -176.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.9 pp -119.7 -9.62 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -178.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -154.69 159.04 32.25 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 126.427 1.891 . . . . 0.0 110.538 170.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -69.88 158.01 58.25 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.225 2.617 . . . . 0.0 112.987 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 35.9 t-80 . . . . . 0 CA--C 1.539 0.539 0 C-N-CA 125.835 1.654 . . . . 0.0 111.193 -179.242 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 41.2 p . . . . . 0 N--CA 1.479 1.006 0 N-CA-C 114.004 1.112 . . . . 0.0 114.004 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -102.68 118.52 37.02 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.096 1.358 . . . . 0.0 110.773 -171.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 28.5 tp -72.25 120.64 18.14 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 122.999 0.52 . . . . 0.0 110.736 176.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 50.1 m -95.54 147.97 23.0 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.315 1.046 . . . . 0.0 111.982 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -164.5 178.02 7.71 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.131 1.372 . . . . 0.0 113.215 -171.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -116.71 175.12 5.72 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.373 1.869 . . . . 0.0 111.681 174.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -64.31 140.72 58.9 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.01 0.924 . . . . 0.0 111.563 170.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 75.12 6.31 79.06 Favored Glycine 0 CA--C 1.539 1.532 0 C-N-CA 123.985 0.803 . . . . 0.0 115.076 176.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -77.02 161.62 28.18 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.731 1.212 . . . . 0.0 111.983 174.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 91.9 t -114.64 131.53 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 124.952 1.301 . . . . 0.0 109.841 -172.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 23.8 mt -135.23 139.73 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.204 1.402 . . . . 0.0 108.839 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 25.0 m -100.88 138.66 37.62 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.16 1.384 . . . . 0.0 110.302 -178.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 23.0 mt -79.15 136.37 37.09 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 118.138 0.426 . . . . 0.0 111.768 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 24.9 mt -114.36 -10.13 12.69 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.308 1.043 . . . . 0.0 113.089 -179.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 10.0 mt -126.69 141.16 39.47 Favored Pre-proline 0 N--CA 1.475 0.822 0 C-N-CA 126.565 1.946 . . . . 0.0 109.588 175.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.12 -7.71 21.51 Favored 'Trans proline' 0 CA--C 1.548 1.203 0 C-N-CA 123.8 3.0 . . . . 0.0 114.615 176.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -152.52 153.27 33.12 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.686 1.595 . . . . 0.0 112.368 176.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 19.2 pm0 -75.56 169.06 18.83 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.652 1.181 . . . . 0.0 113.619 173.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -130.63 106.67 8.65 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 126.75 2.02 . . . . 0.0 109.992 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 51.12 30.48 5.62 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 124.926 1.29 . . . . 0.0 114.41 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 100.94 -14.06 58.81 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 125.807 1.67 . . . . 0.0 114.475 -178.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 82.0 m95 -89.42 135.47 33.57 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.281 1.032 . . . . 0.0 111.633 178.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 18.9 mt -107.17 161.02 15.14 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.833 1.253 . . . . 0.0 109.973 166.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -123.16 120.05 32.05 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.671 1.188 . . . . 0.0 107.884 175.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -143.7 170.96 25.52 Favored Glycine 0 CA--C 1.527 0.844 0 CA-C-N 115.611 -0.722 . . . . 0.0 114.199 -173.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -120.37 118.43 30.34 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.424 1.489 . . . . 0.0 110.114 178.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 19.8 t-80 -63.4 147.43 51.24 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.903 1.281 . . . . 0.0 112.059 178.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -79.87 -49.46 11.9 Favored 'General case' 0 CA--C 1.547 0.865 0 O-C-N 120.868 -1.145 . . . . 0.0 113.411 177.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 63.7 t -68.8 -50.78 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.993 0.917 . . . . 0.0 113.234 178.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 23.0 t -86.15 -23.56 26.53 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.439 0.695 . . . . 0.0 112.868 -173.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp 54.71 16.42 1.38 Allowed 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 126.655 1.982 . . . . 0.0 114.66 -168.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -75.17 153.35 38.21 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.387 0.675 . . . . 0.0 111.794 172.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 82.4 mtm180 -124.06 151.1 44.22 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 126.42 1.888 . . . . 0.0 110.76 177.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 170.26 168.31 31.92 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 124.521 1.057 . . . . 0.0 112.146 175.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -65.5 145.68 55.81 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.136 0.493 . . . . 0.0 110.237 167.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -153.33 155.23 31.59 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 124.432 1.093 . . . . 0.0 111.037 175.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -65.65 121.7 9.15 Favored 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 122.496 2.131 . . . . 0.0 111.715 178.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 41.0 t -59.55 -27.75 66.49 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 121.644 -0.66 . . . . 0.0 112.649 174.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 17.8 m -66.96 -17.94 65.15 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 174.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -83.38 -2.24 55.3 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.717 1.207 . . . . 0.0 113.543 178.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 67.1 p . . . . . 0 N--CA 1.472 0.635 0 C-N-CA 126.29 1.836 . . . . 0.0 109.897 172.017 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 45.2 mt . . . . . 0 N--CA 1.476 0.862 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -69.16 160.64 49.09 Favored 'Trans proline' 0 CA--C 1.545 1.047 0 C-N-CA 123.321 2.681 . . . . 0.0 111.963 177.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -64.52 145.86 88.26 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 122.286 1.99 . . . . 0.0 112.321 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -68.63 153.24 96.06 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 122.975 0.51 . . . . 0.0 111.85 171.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -69.56 174.48 9.27 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 123.487 2.791 . . . . 0.0 113.165 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -87.94 2.9 50.5 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.608 1.163 . . . . 0.0 112.957 -178.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 37.5 p90 -133.86 154.48 80.44 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 124.744 1.217 . . . . 0.0 112.778 -176.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.47 152.62 60.4 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 123.625 2.883 . . . . 0.0 112.688 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -66.96 142.0 97.07 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 123.703 0.801 . . . . 0.0 113.033 -177.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.19 176.94 8.46 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 123.852 3.035 . . . . 0.0 112.836 177.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 31.9 p -131.56 154.5 81.87 Favored Pre-proline 0 N--CA 1.478 0.951 0 C-N-CA 125.254 1.422 . . . . 0.0 112.659 -173.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.28 162.89 40.03 Favored 'Trans proline' 0 CA--C 1.548 1.18 0 C-N-CA 123.562 2.842 . . . . 0.0 111.94 176.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo . . . . . 0 CA--C 1.54 0.8 0 C-N-CA 123.236 2.624 . . . . 0.0 112.562 178.733 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 15.3 m . . . . . 0 C--O 1.234 0.281 0 CA-C-O 121.292 0.568 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -122.78 132.55 54.27 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.45 1.1 . . . . 0.0 109.699 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 74.2 p -78.67 152.42 31.66 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.502 1.121 . . . . 0.0 111.172 -177.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.8 pp -120.95 -9.33 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 -178.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -153.38 158.62 32.72 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 126.286 1.834 . . . . 0.0 110.308 168.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -69.09 156.93 63.59 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.407 2.738 . . . . 0.0 113.271 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 44.0 t-80 . . . . . 0 N--CA 1.473 0.676 0 C-N-CA 125.516 1.526 . . . . 0.0 111.4 178.602 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 56.3 p . . . . . 0 N--CA 1.479 1.017 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 56.2 mt -102.08 132.32 48.01 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.606 1.162 . . . . 0.0 111.13 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 28.2 tp -83.66 120.11 25.58 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.06 0.544 . . . . 0.0 110.872 175.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 54.7 p -88.54 152.46 21.84 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.566 1.147 . . . . 0.0 112.637 172.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -167.88 177.57 5.63 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.532 1.533 . . . . 0.0 112.304 -176.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -117.07 174.46 6.09 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.452 1.901 . . . . 0.0 111.452 174.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -64.27 140.49 58.87 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.442 -0.786 . . . . 0.0 111.608 170.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 77.57 3.76 83.63 Favored Glycine 0 CA--C 1.537 1.406 0 C-N-CA 124.349 0.976 . . . . 0.0 115.117 175.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -72.1 168.36 18.3 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.527 1.131 . . . . 0.0 112.344 173.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 91.2 t -118.91 130.42 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.603 1.561 . . . . 0.0 108.935 -174.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 17.2 mt -134.35 138.32 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.401 1.08 . . . . 0.0 109.57 -178.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 11.8 m -104.31 139.22 39.61 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.144 1.378 . . . . 0.0 110.72 -176.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 25.9 mt -79.17 142.81 36.0 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -173.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 29.8 mt -119.18 -8.8 10.09 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.514 1.125 . . . . 0.0 113.07 178.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 371' ' ' ILE . . . . . 0.441 HG22 ' H ' ' A' ' 373' ' ' GLU . 5.7 mt -134.73 141.25 37.94 Favored Pre-proline 0 N--CA 1.478 0.957 0 C-N-CA 126.833 2.053 . . . . 0.0 109.397 176.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.64 -0.6 10.01 Favored 'Trans proline' 0 CA--C 1.548 1.219 0 C-N-CA 124.62 3.546 . . . . 0.0 114.601 175.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . 0.441 ' H ' HG22 ' A' ' 371' ' ' ILE . 12.6 pt-20 -151.05 175.84 11.71 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.779 2.032 . . . . 0.0 111.535 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -116.16 164.96 13.71 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.148 1.379 . . . . 0.0 112.928 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -123.21 106.52 10.81 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 126.121 1.768 . . . . 0.0 110.323 -176.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 49.96 33.1 6.25 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.314 1.446 . . . . 0.0 114.789 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 96.82 -2.49 62.07 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.113 1.34 . . . . 0.0 114.628 -178.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 78.8 m95 -101.47 121.89 42.79 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.158 1.383 . . . . 0.0 110.763 177.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 13.1 mt -88.42 164.45 15.49 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.424 0.689 . . . . 0.0 110.151 162.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -127.29 121.03 30.01 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 124.953 1.301 . . . . 0.0 108.088 173.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -147.84 177.22 26.24 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.137 0.875 . . . . 0.0 113.865 -170.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -129.63 124.16 33.03 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.541 1.536 . . . . 0.0 110.555 -177.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -66.63 140.88 57.95 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.33 1.052 . . . . 0.0 112.164 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -73.05 -36.75 66.95 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 120.939 -1.1 . . . . 0.0 113.511 177.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 59.1 t -77.31 -34.43 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -173.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 8.5 t -124.62 -12.29 7.19 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.704 1.201 . . . . 0.0 113.442 -168.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? 56.37 16.91 2.62 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 125.995 1.718 . . . . 0.0 114.739 -175.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -66.99 147.24 53.48 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.204 1.002 . . . . 0.0 111.186 170.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -121.76 156.52 32.98 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.845 1.658 . . . . 0.0 111.516 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 164.52 170.17 29.09 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 124.162 0.886 . . . . 0.0 113.027 173.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -65.85 145.18 56.26 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.184 0.594 . . . . 0.0 110.346 168.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -153.48 153.46 29.18 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 124.125 0.97 . . . . 0.0 111.314 174.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -63.49 121.46 9.25 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.546 2.164 . . . . 0.0 111.345 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.66 -17.38 64.0 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 121.296 -0.877 . . . . 0.0 113.036 178.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 77.6 p -73.98 -22.19 59.71 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.777 2.031 . . . . 0.0 114.159 174.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -79.8 -1.11 37.36 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.254 1.421 . . . . 0.0 113.425 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 69.9 p . . . . . 0 N--CA 1.471 0.599 0 C-N-CA 126.584 1.954 . . . . 0.0 110.873 174.658 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 69.3 mt . . . . . 0 N--CA 1.477 0.923 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.28 160.34 49.91 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 123.57 2.847 . . . . 0.0 112.16 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.07 144.87 88.55 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.378 2.052 . . . . 0.0 112.238 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -73.42 157.13 88.35 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 123.387 0.675 . . . . 0.0 112.192 173.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -68.34 174.13 8.64 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.289 2.659 . . . . 0.0 113.157 176.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -86.26 0.28 54.17 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.651 1.18 . . . . 0.0 113.02 -178.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 38.4 p90 -133.28 153.57 80.69 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 124.792 1.237 . . . . 0.0 113.003 -174.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -71.45 152.54 60.46 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.542 2.828 . . . . 0.0 112.317 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -68.12 149.03 98.3 Favored Pre-proline 0 CA--C 1.55 0.952 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -176.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -72.27 -176.83 2.35 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 124.122 3.215 . . . . 0.0 112.801 176.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 24.3 p -137.04 153.89 75.58 Favored Pre-proline 0 N--CA 1.476 0.855 0 C-N-CA 125.341 1.457 . . . . 0.0 112.649 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -67.61 165.24 28.11 Favored 'Trans proline' 0 CA--C 1.548 1.176 0 C-N-CA 123.504 2.803 . . . . 0.0 111.948 175.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo . . . . . 0 CA--C 1.541 0.86 0 C-N-CA 123.453 2.769 . . . . 0.0 113.351 177.194 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 16.0 m . . . . . 0 C--O 1.236 0.343 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -119.26 132.01 55.85 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.954 0.901 . . . . 0.0 109.904 178.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 66.8 p -74.74 149.89 39.63 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 124.852 1.261 . . . . 0.0 111.483 -178.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.7 pp -124.63 -7.82 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -176.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -154.95 157.19 31.89 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 126.67 1.988 . . . . 0.0 109.652 169.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -69.05 158.34 58.28 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.883 2.388 . . . . 0.0 112.439 177.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 36.3 t-80 . . . . . 0 N--CA 1.475 0.794 0 C-N-CA 125.048 1.339 . . . . 0.0 112.018 -179.166 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 32.6 p . . . . . 0 N--CA 1.485 1.3 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 49.3 mt -110.49 134.68 52.13 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.308 1.443 . . . . 0.0 110.921 -177.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 31.8 tp -83.21 126.05 32.22 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.871 0.868 . . . . 0.0 110.953 177.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 69.8 m -91.38 147.49 22.99 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.405 1.082 . . . . 0.0 111.957 173.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -163.21 177.56 8.94 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.708 1.603 . . . . 0.0 112.19 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -131.98 154.03 49.74 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.743 2.017 . . . . 0.0 111.5 178.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -50.89 130.59 25.51 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.716 0.806 . . . . 0.0 112.748 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 94.93 -14.27 65.63 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 124.342 0.973 . . . . 0.0 114.362 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -68.75 155.44 40.12 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.378 1.089 . . . . 0.0 112.165 174.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 69.3 t -111.74 142.52 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 125.823 1.649 . . . . 0.0 109.893 -175.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 16.9 mt -136.59 138.61 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.107 1.363 . . . . 0.0 109.024 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 18.5 m -102.55 137.24 41.04 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.705 1.202 . . . . 0.0 110.2 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 27.0 mt -77.04 143.51 39.26 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 122.935 0.494 . . . . 0.0 111.966 -175.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 42.5 mt -116.77 -7.18 11.52 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 124.73 1.212 . . . . 0.0 113.084 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 7.1 mt -130.83 140.41 38.59 Favored Pre-proline 0 N--CA 1.477 0.892 0 C-N-CA 126.617 1.967 . . . . 0.0 109.391 176.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.01 -7.29 20.77 Favored 'Trans proline' 0 CA--C 1.547 1.14 0 C-N-CA 123.582 2.854 . . . . 0.0 114.849 176.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -152.67 152.24 31.51 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.85 1.66 . . . . 0.0 111.937 174.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -76.45 170.45 16.36 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.626 1.17 . . . . 0.0 113.68 176.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -129.7 106.25 8.58 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.337 1.855 . . . . 0.0 110.142 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 49.92 32.51 5.61 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 125.328 1.451 . . . . 0.0 114.559 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 99.65 -14.37 60.56 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 125.506 1.527 . . . . 0.0 114.388 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -89.01 134.03 34.13 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.662 1.231 . . . . 0.0 111.457 176.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 13.1 mt -102.1 162.09 13.18 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.533 1.133 . . . . 0.0 110.277 165.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -124.07 123.04 39.46 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.981 1.312 . . . . 0.0 107.924 172.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -149.27 175.01 28.68 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 115.644 -0.707 . . . . 0.0 113.704 -170.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -126.47 122.72 36.02 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.272 1.429 . . . . 0.0 110.73 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -63.13 149.0 46.35 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.834 1.254 . . . . 0.0 112.353 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -88.34 -24.98 22.99 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 120.859 -1.151 . . . . 0.0 113.903 178.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 59.1 t -80.33 -35.01 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 O-C-N 121.352 -0.843 . . . . 0.0 112.658 -179.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 6.6 t -128.62 -10.79 5.02 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.59 1.156 . . . . 0.0 113.707 -169.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 4.8 mptt 53.82 24.65 4.6 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 125.432 1.493 . . . . 0.0 113.512 -175.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -68.79 147.45 51.75 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.6 1.16 . . . . 0.0 110.92 168.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 74.0 mtm-85 -120.2 157.28 29.4 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.556 1.542 . . . . 0.0 111.821 178.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 164.86 169.42 28.45 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.643 1.116 . . . . 0.0 112.584 175.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -69.61 148.01 49.94 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 122.802 0.441 . . . . 0.0 110.54 169.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -155.47 155.97 30.36 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 123.98 0.912 . . . . 0.0 111.685 175.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -65.02 121.1 8.48 Favored 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 122.81 2.34 . . . . 0.0 111.883 177.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 89.8 p -60.23 -22.4 62.98 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 176.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 18.1 m -74.59 -18.37 60.58 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 175.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -80.65 -0.86 39.97 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.712 1.205 . . . . 0.0 113.133 178.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 62.2 p . . . . . 0 N--CA 1.467 0.382 0 C-N-CA 125.871 1.668 . . . . 0.0 111.516 175.52 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 63.6 mt . . . . . 0 CA--C 1.55 0.943 0 CA-C-O 119.004 -0.522 . . . . 0.0 109.682 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.92 161.33 46.36 Favored 'Trans proline' 0 CA--C 1.545 1.05 0 C-N-CA 123.573 2.849 . . . . 0.0 112.091 177.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.16 144.46 86.92 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.271 1.981 . . . . 0.0 112.707 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -72.15 156.5 90.62 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 123.47 0.708 . . . . 0.0 112.194 171.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.42 174.37 9.32 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.435 2.757 . . . . 0.0 113.222 176.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -89.24 3.16 52.92 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.886 1.274 . . . . 0.0 113.016 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 40.8 p90 -134.15 154.42 80.09 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 124.764 1.226 . . . . 0.0 112.91 -175.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -71.54 153.37 60.31 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 123.689 2.926 . . . . 0.0 112.721 178.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -68.21 142.64 95.07 Favored Pre-proline 0 CA--C 1.553 1.081 0 C-N-CA 124.078 0.951 . . . . 0.0 113.215 -176.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.38 177.2 8.21 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 124.125 3.217 . . . . 0.0 113.002 176.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 35.6 p -132.43 153.35 81.17 Favored Pre-proline 0 N--CA 1.479 0.986 0 C-N-CA 125.289 1.436 . . . . 0.0 112.848 -175.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -69.17 162.94 39.73 Favored 'Trans proline' 0 CA--C 1.549 1.271 0 C-N-CA 123.699 2.933 . . . . 0.0 112.103 177.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo . . . . . 0 CA--C 1.541 0.83 0 C-N-CA 123.409 2.74 . . . . 0.0 113.223 179.159 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 16.8 m . . . . . 0 N--CA 1.467 0.376 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -115.07 132.96 56.43 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.752 0.821 . . . . 0.0 110.61 174.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 81.7 p -72.06 152.29 42.51 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.411 1.084 . . . . 0.0 111.185 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.8 pp -121.97 -8.86 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -178.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -155.06 158.18 32.02 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 127.04 2.136 . . . . 0.0 109.897 169.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -68.85 158.01 59.57 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.116 2.544 . . . . 0.0 112.691 177.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 . . . . . 0 CA--C 1.542 0.648 0 C-N-CA 125.117 1.367 . . . . 0.0 111.696 -179.533 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 39.8 p . . . . . 0 N--CA 1.482 1.132 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 66.6 mt -101.66 128.15 48.09 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.968 1.307 . . . . 0.0 110.86 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 33.1 tp -78.32 121.35 24.33 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.208 0.603 . . . . 0.0 110.171 173.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 71.0 m -94.97 146.72 24.05 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.384 1.074 . . . . 0.0 111.438 175.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -162.58 178.14 8.82 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.252 1.421 . . . . 0.0 112.455 -175.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -116.47 173.52 6.56 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.145 1.778 . . . . 0.0 111.456 174.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -65.33 142.03 58.38 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.041 0.936 . . . . 0.0 111.565 171.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 75.41 9.36 84.45 Favored Glycine 0 CA--C 1.538 1.517 0 N-CA-C 114.808 0.683 . . . . 0.0 114.808 177.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -81.6 161.93 23.31 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.597 1.159 . . . . 0.0 111.705 172.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 31.2 t -115.42 135.35 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.735 1.214 . . . . 0.0 109.35 -174.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 18.4 mt -138.16 135.82 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.496 1.118 . . . . 0.0 109.342 -176.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 12.5 m -92.64 141.85 28.02 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.246 1.018 . . . . 0.0 110.476 174.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 23.0 mt -82.25 143.2 31.51 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 122.968 0.507 . . . . 0.0 111.64 178.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 47.2 mt -114.37 -4.65 12.95 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 124.591 1.156 . . . . 0.0 112.841 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 371' ' ' ILE . . . . . 0.4 HG22 ' H ' ' A' ' 373' ' ' GLU . 6.9 mt -134.65 141.71 39.8 Favored Pre-proline 0 N--CA 1.48 1.045 0 C-N-CA 127.048 2.139 . . . . 0.0 109.66 177.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.2 -8.07 22.11 Favored 'Trans proline' 0 CA--C 1.547 1.171 0 C-N-CA 124.025 3.15 . . . . 0.0 114.706 176.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . 0.4 ' H ' HG22 ' A' ' 371' ' ' ILE . 26.2 pt-20 -151.26 160.21 43.94 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.823 1.649 . . . . 0.0 111.94 173.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -85.42 169.9 13.22 Favored 'General case' 0 CA--C 1.55 0.96 0 O-C-N 121.048 -1.032 . . . . 0.0 113.026 177.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -126.63 105.82 8.97 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.731 2.012 . . . . 0.0 109.826 -177.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 50.85 31.42 6.07 Favored 'General case' 0 CA--C 1.555 1.145 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 100.79 -11.09 59.16 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 125.482 1.515 . . . . 0.0 114.408 -178.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -95.22 126.9 40.86 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.543 1.137 . . . . 0.0 111.248 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 13.0 mt -95.59 161.5 14.02 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.523 0.678 . . . . 0.0 110.495 163.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -124.01 122.16 37.17 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 125.159 1.383 . . . . 0.0 107.779 175.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -146.97 176.51 25.81 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-N 115.632 -0.713 . . . . 0.0 114.201 -171.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -129.55 120.82 25.96 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.493 1.517 . . . . 0.0 110.464 -178.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -65.51 141.15 58.57 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.643 1.177 . . . . 0.0 112.219 -177.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -75.69 -29.83 59.14 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 120.619 -1.301 . . . . 0.0 113.526 -178.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 51.2 t -81.49 -37.33 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 124.207 1.003 . . . . 0.0 113.419 -175.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 6.9 t -124.81 -8.84 7.27 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.484 1.113 . . . . 0.0 113.699 -171.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.58 23.76 3.74 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 126.181 1.792 . . . . 0.0 113.822 -177.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -68.97 150.83 47.26 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.436 1.094 . . . . 0.0 110.938 169.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -125.63 157.35 37.44 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.632 1.573 . . . . 0.0 110.757 -177.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 161.04 169.58 24.49 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 124.496 1.046 . . . . 0.0 112.237 174.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -66.77 148.38 52.0 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.151 0.501 . . . . 0.0 110.399 168.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -155.04 154.87 29.52 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 124.321 1.048 . . . . 0.0 110.223 171.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -63.72 122.2 10.2 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.434 2.089 . . . . 0.0 110.774 177.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 95.8 p -55.13 -40.24 70.32 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.8 -0.562 . . . . 0.0 112.135 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 5.3 t -62.15 -23.05 66.35 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.244 1.818 . . . . 0.0 114.464 -178.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -72.16 -3.43 23.3 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.615 1.166 . . . . 0.0 113.58 172.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 68.2 p . . . . . 0 N--CA 1.465 0.292 0 C-N-CA 125.5 1.52 . . . . 0.0 111.083 176.404 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 61.2 mt . . . . . 0 CA--C 1.549 0.941 0 CA-C-O 119.035 -0.507 . . . . 0.0 109.806 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.76 160.25 50.39 Favored 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 123.571 2.848 . . . . 0.0 112.003 177.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.97 142.91 83.56 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.455 2.103 . . . . 0.0 112.36 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -72.19 154.4 92.19 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 123.282 0.633 . . . . 0.0 111.883 172.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -69.24 174.4 9.11 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.463 2.775 . . . . 0.0 113.039 178.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -87.64 1.76 52.81 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.636 1.174 . . . . 0.0 112.843 -178.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 34.7 p90 -133.54 154.35 80.73 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.712 1.205 . . . . 0.0 112.873 -175.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.95 152.72 57.77 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.667 2.912 . . . . 0.0 112.684 178.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -69.94 144.67 93.37 Favored Pre-proline 0 CA--C 1.55 0.98 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -176.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -73.8 179.32 5.77 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 124.103 3.202 . . . . 0.0 113.069 176.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 29.0 p -133.48 154.77 81.0 Favored Pre-proline 0 N--CA 1.479 1.015 0 C-N-CA 125.424 1.49 . . . . 0.0 112.64 -174.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.59 162.19 42.0 Favored 'Trans proline' 0 CA--C 1.548 1.222 0 C-N-CA 123.863 3.042 . . . . 0.0 111.995 176.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo . . . . . 0 CA--C 1.54 0.785 0 C-N-CA 123.447 2.765 . . . . 0.0 112.772 178.326 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 15.5 m . . . . . 0 C--O 1.235 0.319 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.89 125.98 44.81 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.264 1.026 . . . . 0.0 109.383 -175.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 73.1 p -72.31 153.23 41.63 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.585 0.754 . . . . 0.0 110.793 -175.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.9 pp -122.91 -6.94 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -177.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -158.73 160.3 29.34 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 126.684 1.993 . . . . 0.0 110.158 170.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -69.75 157.5 60.2 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 123.286 2.657 . . . . 0.0 113.263 176.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 . . . . . 0 N--CA 1.473 0.709 0 C-N-CA 125.218 1.407 . . . . 0.0 111.957 -179.973 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 44.8 p . . . . . 0 N--CA 1.483 1.194 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 55.9 mt -102.35 127.68 49.24 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.706 1.203 . . . . 0.0 111.121 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 23.3 tp -77.68 129.54 35.67 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.498 0.719 . . . . 0.0 110.955 177.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 43.9 t -101.81 146.52 27.68 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.884 1.273 . . . . 0.0 111.827 176.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -163.9 178.32 7.87 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.919 1.688 . . . . 0.0 112.246 -174.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -117.3 177.13 4.84 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.898 2.079 . . . . 0.0 111.15 174.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -64.65 140.43 58.87 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.966 0.906 . . . . 0.0 111.597 169.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 75.34 5.62 77.77 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 124.594 1.093 . . . . 0.0 115.707 175.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -71.87 169.3 16.1 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.674 1.19 . . . . 0.0 112.12 171.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 95.7 t -126.42 127.52 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 125.519 1.528 . . . . 0.0 108.84 -169.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 35.3 mt -133.62 138.26 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 124.352 1.061 . . . . 0.0 108.969 -176.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 52.2 m -102.88 136.65 42.31 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.972 1.309 . . . . 0.0 110.045 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 15.9 mt -73.37 147.09 44.67 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -175.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 58.3 mt -120.78 -8.52 9.44 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.582 1.153 . . . . 0.0 113.396 177.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 6.5 mt -133.73 140.99 38.35 Favored Pre-proline 0 N--CA 1.48 1.047 0 C-N-CA 126.311 1.844 . . . . 0.0 109.666 176.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.73 -7.68 21.63 Favored 'Trans proline' 0 CA--C 1.546 1.104 0 C-N-CA 124.047 3.165 . . . . 0.0 114.722 176.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -152.22 153.8 34.5 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.76 1.624 . . . . 0.0 112.146 174.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -77.44 170.83 15.87 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 124.46 1.104 . . . . 0.0 113.894 175.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -129.26 105.62 8.26 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.563 1.945 . . . . 0.0 109.897 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 50.68 32.62 7.15 Favored 'General case' 0 CA--C 1.553 1.09 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 98.37 -12.63 63.33 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 125.411 1.481 . . . . 0.0 114.411 -178.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 77.6 m95 -89.38 123.19 33.31 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.315 1.058 . . . . 0.0 110.807 176.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 13.5 mt -90.23 161.37 15.73 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.367 0.667 . . . . 0.0 110.225 161.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -124.43 124.84 43.19 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.123 1.369 . . . . 0.0 107.934 171.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -148.8 172.09 29.01 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 124.154 0.883 . . . . 0.0 113.287 -171.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -124.88 121.05 33.42 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.233 1.413 . . . . 0.0 109.699 177.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -64.05 147.45 52.09 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.523 1.129 . . . . 0.0 111.93 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -81.15 -46.71 14.5 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 120.876 -1.14 . . . . 0.0 113.175 178.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 57.8 t -70.98 -51.78 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 98.9 p -91.51 -17.12 26.19 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -174.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp 55.96 17.57 2.65 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 126.809 2.044 . . . . 0.0 114.725 -172.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -72.06 151.72 42.91 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 121.455 0.645 . . . . 0.0 111.732 171.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 72.5 mtm180 -120.67 157.0 30.54 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.347 1.859 . . . . 0.0 110.551 176.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 163.21 169.38 26.57 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 124.095 0.855 . . . . 0.0 112.368 173.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -65.71 148.35 51.91 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.074 0.464 . . . . 0.0 110.077 166.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -154.96 153.95 28.17 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 124.111 0.964 . . . . 0.0 110.457 172.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -63.98 122.11 10.02 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.492 2.128 . . . . 0.0 110.752 176.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 95.2 p -55.16 -38.06 67.8 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 74.7 m -64.88 -19.44 65.91 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -74.13 -2.51 24.89 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.36 1.064 . . . . 0.0 113.125 171.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 64.2 p . . . . . 0 N--CA 1.466 0.372 0 C-N-CA 125.703 1.601 . . . . 0.0 110.823 173.849 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 71.9 mt . . . . . 0 N--CA 1.477 0.906 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.11 159.56 52.72 Favored 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 123.636 2.891 . . . . 0.0 112.29 178.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.57 146.07 88.44 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 122.473 2.115 . . . . 0.0 112.445 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -74.24 157.21 86.92 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 123.616 0.766 . . . . 0.0 112.3 173.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -68.84 174.84 8.12 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.453 2.769 . . . . 0.0 113.19 175.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -86.2 0.6 53.31 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.735 1.214 . . . . 0.0 112.965 -178.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 36.6 p90 -134.73 155.18 79.65 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 124.796 1.239 . . . . 0.0 112.96 -174.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.86 152.72 58.29 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.726 2.951 . . . . 0.0 112.821 178.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -68.06 144.34 96.91 Favored Pre-proline 0 CA--C 1.552 1.032 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -175.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.4 -179.59 4.59 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 124.141 3.228 . . . . 0.0 112.857 176.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 22.8 p -135.17 155.29 79.03 Favored Pre-proline 0 N--CA 1.481 1.08 0 C-N-CA 125.051 1.341 . . . . 0.0 112.814 -175.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.87 163.47 35.41 Favored 'Trans proline' 0 CA--C 1.548 1.21 0 C-N-CA 123.628 2.885 . . . . 0.0 111.88 175.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo . . . . . 0 CA--C 1.541 0.847 0 C-N-CA 123.312 2.675 . . . . 0.0 113.092 178.043 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 17.7 m . . . . . 0 N--CA 1.467 0.403 0 CA-C-O 121.206 0.527 . . . . 0.0 110.62 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -123.27 126.95 47.85 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.081 1.352 . . . . 0.0 110.599 -178.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 81.6 p -71.7 152.09 43.09 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.586 0.754 . . . . 0.0 111.427 -178.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.9 pp -122.93 -8.98 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 -177.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -155.08 158.91 32.15 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 126.705 2.002 . . . . 0.0 109.842 169.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.05 156.13 66.14 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.129 2.553 . . . . 0.0 113.117 177.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 . . . . . 0 N--CA 1.474 0.731 0 C-N-CA 125.199 1.4 . . . . 0.0 111.103 177.753 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 32.8 p . . . . . 0 N--CA 1.481 1.082 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 66.8 mt -112.21 127.04 55.84 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.318 1.447 . . . . 0.0 111.312 -176.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 28.8 tp -78.74 124.79 28.56 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.936 0.894 . . . . 0.0 110.668 176.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 54.2 p -99.61 152.16 20.36 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.237 1.415 . . . . 0.0 112.434 177.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -167.45 177.32 6.06 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.052 1.341 . . . . 0.0 112.992 -172.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -115.32 177.13 4.77 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.857 2.063 . . . . 0.0 111.161 173.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -67.22 140.46 57.42 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.093 0.957 . . . . 0.0 111.818 170.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 74.66 4.68 71.37 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 125.007 1.289 . . . . 0.0 115.797 177.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -68.42 164.23 21.48 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 118.115 0.958 . . . . 0.0 111.461 167.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 95.7 t -118.16 136.17 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.642 1.177 . . . . 0.0 109.251 -177.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 29.7 mt -133.45 141.18 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.349 1.06 . . . . 0.0 108.795 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 23.5 m -102.21 136.34 42.21 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.817 1.247 . . . . 0.0 109.528 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 21.0 mt -79.18 138.71 37.97 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 118.544 0.611 . . . . 0.0 111.446 -177.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 44.7 mt -112.83 -10.15 13.6 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.993 0.917 . . . . 0.0 113.277 -177.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 371' ' ' ILE . . . . . 0.408 ' CG2' ' HD2' ' A' ' 372' ' ' PRO . 9.0 mt -124.58 140.1 34.64 Favored Pre-proline 0 N--CA 1.478 0.938 0 C-N-CA 126.363 1.865 . . . . 0.0 109.682 176.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 372' ' ' PRO . . . . . 0.408 ' HD2' ' CG2' ' A' ' 371' ' ' ILE . 58.1 Cg_endo -70.83 -8.36 23.45 Favored 'Trans proline' 0 CA--C 1.547 1.156 0 C-N-CA 123.834 3.022 . . . . 0.0 114.322 176.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -152.18 149.1 28.38 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.922 1.689 . . . . 0.0 111.893 173.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -74.08 171.35 13.68 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.443 1.097 . . . . 0.0 113.744 175.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -128.24 103.42 7.17 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.217 1.807 . . . . 0.0 110.448 -179.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 52.05 30.55 7.6 Favored 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 99.69 -15.57 59.59 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 125.654 1.597 . . . . 0.0 114.287 -178.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -85.07 128.8 34.79 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.221 1.011 . . . . 0.0 110.955 175.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 12.1 mt -99.4 161.41 13.63 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.212 1.005 . . . . 0.0 110.213 165.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -123.82 122.21 37.44 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 125.157 1.383 . . . . 0.0 107.519 173.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -145.5 167.24 27.56 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-N 115.82 -0.627 . . . . 0.0 113.927 -172.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -113.45 118.47 34.6 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.006 1.322 . . . . 0.0 109.019 173.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 33.9 t-80 -63.69 141.66 58.69 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.321 1.049 . . . . 0.0 111.789 178.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -75.2 -46.19 35.55 Favored 'General case' 0 CA--C 1.547 0.827 0 O-C-N 120.573 -1.329 . . . . 0.0 113.037 -178.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 57.4 t -70.31 -54.26 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 178.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 93.4 p -90.25 -17.27 27.76 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 119.583 1.083 . . . . 0.0 113.785 -173.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm 56.41 20.0 4.45 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 126.651 1.98 . . . . 0.0 114.023 -175.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -76.38 158.81 31.07 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.276 0.63 . . . . 0.0 112.051 171.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 82.2 mtt85 -125.18 158.91 32.81 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.148 1.779 . . . . 0.0 110.645 176.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 159.38 169.72 23.05 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.951 1.262 . . . . 0.0 112.278 176.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -68.36 148.73 50.29 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.994 0.426 . . . . 0.0 110.627 169.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -155.82 156.32 30.46 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 124.084 0.954 . . . . 0.0 110.747 172.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -66.72 120.61 7.73 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 122.433 2.088 . . . . 0.0 111.724 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 36.2 t -59.92 -25.38 65.1 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 175.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 75.2 m -69.44 -18.81 63.76 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 174.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -81.1 -0.34 39.58 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.635 1.174 . . . . 0.0 113.987 177.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 81.3 p . . . . . 0 N--CA 1.467 0.424 0 C-N-CA 125.055 1.342 . . . . 0.0 111.599 174.332 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 52.7 mt . . . . . 0 CA--C 1.549 0.905 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -69.03 160.95 47.86 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 123.42 2.747 . . . . 0.0 112.124 178.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.59 144.68 85.38 Favored 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 122.267 1.978 . . . . 0.0 112.352 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -70.59 153.66 94.84 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 123.095 0.558 . . . . 0.0 111.872 171.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -69.7 174.67 9.12 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 123.509 2.806 . . . . 0.0 113.2 179.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -86.05 1.33 50.73 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.353 1.061 . . . . 0.0 113.037 -178.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 38.1 p90 -133.46 154.37 80.83 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 124.823 1.249 . . . . 0.0 113.033 -174.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.56 153.11 60.24 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 123.66 2.907 . . . . 0.0 112.875 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -68.48 141.13 92.93 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 123.914 0.885 . . . . 0.0 113.096 -177.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.59 177.54 7.87 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 124.059 3.173 . . . . 0.0 113.239 177.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 32.8 p -134.25 153.94 79.72 Favored Pre-proline 0 N--CA 1.478 0.963 0 C-N-CA 125.401 1.48 . . . . 0.0 112.998 -172.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -68.29 163.22 37.18 Favored 'Trans proline' 0 CA--C 1.548 1.202 0 C-N-CA 123.772 2.981 . . . . 0.0 111.854 176.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo . . . . . 0 CA--C 1.541 0.833 0 C-N-CA 123.242 2.628 . . . . 0.0 112.885 178.945 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 16.7 m . . . . . 0 C--O 1.234 0.283 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.45 134.27 54.75 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.385 1.074 . . . . 0.0 110.343 175.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 62.1 p -76.63 158.64 30.93 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.186 1.394 . . . . 0.0 111.774 179.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 2.0 pp -122.91 -9.79 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -155.35 159.22 31.9 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 125.836 1.654 . . . . 0.0 111.26 170.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.91 155.61 65.0 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.534 2.823 . . . . 0.0 113.443 177.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 . . . . . 0 N--CA 1.474 0.741 0 C-N-CA 125.411 1.485 . . . . 0.0 111.899 -179.384 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 48.3 p . . . . . 0 N--CA 1.479 0.995 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 62.0 mt -107.84 131.01 54.94 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.841 1.256 . . . . 0.0 111.487 -178.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 24.0 tp -82.86 132.97 35.14 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.682 0.793 . . . . 0.0 110.534 174.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 45.3 m -114.86 147.73 39.5 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.226 1.411 . . . . 0.0 112.379 -178.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -166.42 178.95 5.83 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.412 1.485 . . . . 0.0 112.397 -166.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -118.18 174.79 6.01 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.974 2.11 . . . . 0.0 111.724 176.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 66.3 tt0 -64.25 140.94 58.92 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.317 -0.864 . . . . 0.0 111.002 168.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 70.36 19.48 76.06 Favored Glycine 0 CA--C 1.537 1.433 0 N-CA-C 114.37 0.508 . . . . 0.0 114.37 177.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -86.23 170.09 12.43 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.732 1.213 . . . . 0.0 111.522 169.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 89.7 t -125.82 128.09 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 125.658 1.583 . . . . 0.0 109.038 -168.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 22.7 mt -133.18 143.13 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 124.358 1.063 . . . . 0.0 110.056 -176.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 2.6 m -100.77 144.03 30.22 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.641 1.576 . . . . 0.0 110.398 -177.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 23.5 mt -84.67 141.11 30.83 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 118.333 0.515 . . . . 0.0 112.085 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 43.8 mt -120.05 -11.69 9.23 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.758 1.223 . . . . 0.0 113.298 179.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 371' ' ' ILE . . . . . 0.413 HG22 ' H ' ' A' ' 373' ' ' GLU . 7.1 mt -130.25 141.1 40.71 Favored Pre-proline 0 N--CA 1.476 0.853 0 C-N-CA 126.703 2.001 . . . . 0.0 109.224 175.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.69 -6.02 18.28 Favored 'Trans proline' 0 CA--C 1.548 1.208 0 C-N-CA 124.113 3.209 . . . . 0.0 114.835 175.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . 0.413 ' H ' HG22 ' A' ' 371' ' ' ILE . 12.6 pt-20 -151.67 162.78 40.42 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.162 1.785 . . . . 0.0 112.169 175.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.57 170.91 9.78 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.485 1.114 . . . . 0.0 113.202 176.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -128.63 106.39 8.92 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.403 1.881 . . . . 0.0 110.54 -178.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 51.32 31.09 6.62 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 124.943 1.297 . . . . 0.0 114.468 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 98.32 -8.32 62.45 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 125.293 1.425 . . . . 0.0 114.515 -177.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -95.42 122.46 38.17 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.729 1.265 . . . . 0.0 110.979 177.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 14.2 mt -88.39 160.49 17.56 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.751 0.82 . . . . 0.0 110.625 162.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 79.4 t80 -123.28 124.46 43.02 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.169 1.388 . . . . 0.0 107.924 170.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -149.95 173.84 29.56 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 123.864 0.745 . . . . 0.0 113.289 -170.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -126.29 115.18 19.3 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.959 1.304 . . . . 0.0 110.271 178.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 23.4 t-80 -61.59 144.72 53.95 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.43 1.092 . . . . 0.0 112.151 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -79.2 -48.26 14.53 Favored 'General case' 0 CA--C 1.548 0.882 0 O-C-N 120.926 -1.109 . . . . 0.0 112.565 178.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 58.5 t -68.3 -53.6 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 124.325 1.05 . . . . 0.0 113.73 176.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 40.2 m -89.77 -16.51 30.11 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 119.277 0.944 . . . . 0.0 113.188 -171.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 11.1 mmmm 54.49 19.92 2.58 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 127.358 2.263 . . . . 0.0 114.647 -176.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -82.14 152.7 26.39 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.938 0.895 . . . . 0.0 111.496 174.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 56.4 mtm-85 -117.58 158.97 23.66 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 126.172 1.789 . . . . 0.0 110.931 173.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 159.8 171.76 26.09 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.512 1.053 . . . . 0.0 112.453 175.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -68.46 145.22 54.27 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 120.961 0.41 . . . . 0.0 110.456 168.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -153.91 154.55 30.21 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 124.246 1.019 . . . . 0.0 111.015 173.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -63.4 122.94 11.28 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.529 2.153 . . . . 0.0 112.046 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 82.6 p -61.27 -25.98 67.46 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 176.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.83 -13.34 61.65 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.969 2.107 . . . . 0.0 114.86 174.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -85.01 -0.57 54.85 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.5 1.12 . . . . 0.0 113.133 174.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 71.3 p . . . . . 0 N--CA 1.475 0.802 0 C-N-CA 126.653 1.981 . . . . 0.0 110.475 173.873 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 55.1 mt . . . . . 0 N--CA 1.477 0.899 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -68.82 160.07 51.2 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 123.483 2.789 . . . . 0.0 112.007 178.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -63.77 144.47 89.03 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.428 2.086 . . . . 0.0 112.271 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -70.01 153.34 95.47 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 122.99 0.516 . . . . 0.0 111.629 171.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -69.28 174.75 8.64 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.459 2.773 . . . . 0.0 113.151 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -85.62 1.39 49.42 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.318 1.047 . . . . 0.0 112.976 -178.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 33.8 p90 -134.55 154.33 79.6 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 124.775 1.23 . . . . 0.0 112.94 -175.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.34 151.97 60.49 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.645 2.897 . . . . 0.0 112.681 178.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -66.83 145.23 98.89 Favored Pre-proline 0 CA--C 1.549 0.913 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -177.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.32 175.22 10.89 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.752 2.968 . . . . 0.0 112.781 178.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 23.0 p -129.73 153.96 80.91 Favored Pre-proline 0 N--CA 1.477 0.922 0 C-N-CA 124.732 1.213 . . . . 0.0 112.363 -173.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -66.56 163.08 34.08 Favored 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 122.999 2.466 . . . . 0.0 111.651 175.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo . . . . . 0 CA--C 1.539 0.736 0 C-N-CA 123.102 2.534 . . . . 0.0 112.257 174.955 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 16.0 m . . . . . 0 C--O 1.236 0.355 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -121.02 131.71 54.45 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.197 0.999 . . . . 0.0 109.664 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 74.8 p -74.9 152.6 38.86 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.962 0.905 . . . . 0.0 111.177 -177.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.8 pp -123.49 -6.71 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -178.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -154.04 158.23 32.47 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 126.249 1.82 . . . . 0.0 110.121 169.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -68.96 154.5 70.72 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.792 2.328 . . . . 0.0 112.413 176.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 . . . . . 0 CA--C 1.537 0.466 0 C-N-CA 125.499 1.52 . . . . 0.0 110.7 179.846 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 38.0 p . . . . . 0 N--CA 1.485 1.277 0 N-CA-C 114.336 1.235 . . . . 0.0 114.336 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 56.8 mt -98.15 128.8 44.84 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.87 1.268 . . . . 0.0 110.485 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 31.4 tp -80.22 114.12 18.89 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.377 0.671 . . . . 0.0 110.844 175.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 50.3 m -83.88 150.03 25.98 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.043 0.937 . . . . 0.0 112.559 175.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -164.8 178.17 7.4 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.598 1.559 . . . . 0.0 113.217 -177.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -117.15 173.96 6.38 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.431 1.892 . . . . 0.0 111.258 173.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -64.98 142.32 58.48 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 121.301 -0.874 . . . . 0.0 111.648 170.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 77.05 5.79 85.34 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 124.071 0.843 . . . . 0.0 114.98 175.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -77.83 166.33 23.05 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.97 1.308 . . . . 0.0 111.96 172.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 67.9 t -121.07 131.24 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.105 1.362 . . . . 0.0 109.325 -172.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 25.2 mt -134.76 137.6 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.527 1.131 . . . . 0.0 109.245 -177.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 12.0 m -98.09 140.22 32.73 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.931 1.292 . . . . 0.0 110.236 -178.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 23.7 mt -80.03 137.94 36.91 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 118.235 0.47 . . . . 0.0 111.928 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 37.1 mt -114.62 -9.8 12.57 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.527 1.131 . . . . 0.0 113.122 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 9.4 mt -127.75 141.17 40.22 Favored Pre-proline 0 N--CA 1.479 1.01 0 C-N-CA 126.893 2.077 . . . . 0.0 109.632 176.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.28 -7.1 20.35 Favored 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 124.088 3.192 . . . . 0.0 114.817 177.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -151.24 160.22 43.94 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.288 1.835 . . . . 0.0 111.428 174.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.34 168.0 17.99 Favored 'General case' 0 CA--C 1.547 0.86 0 O-C-N 120.993 -1.067 . . . . 0.0 113.027 173.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -122.89 103.49 8.66 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 126.954 2.101 . . . . 0.0 109.105 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 51.96 30.54 7.41 Favored 'General case' 0 CA--C 1.555 1.17 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 102.45 -17.95 52.2 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 125.894 1.711 . . . . 0.0 114.276 -178.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -84.86 128.31 34.56 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.511 1.124 . . . . 0.0 111.463 178.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 16.9 mt -98.17 161.32 13.77 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.121 0.968 . . . . 0.0 110.51 164.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -125.9 121.72 33.98 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 125.37 1.468 . . . . 0.0 107.552 174.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -145.38 171.72 26.36 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-N 115.555 -0.748 . . . . 0.0 113.872 -172.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -119.63 117.26 27.84 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.006 1.323 . . . . 0.0 109.872 176.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 24.4 t-80 -63.77 145.16 56.29 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.854 1.262 . . . . 0.0 112.035 178.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -80.23 -44.66 19.34 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 120.914 -1.116 . . . . 0.0 113.706 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 57.7 t -69.18 -51.05 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 123.926 0.891 . . . . 0.0 113.306 176.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 13.2 t -91.03 -21.32 21.31 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -171.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt 56.32 16.71 2.5 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 126.446 1.898 . . . . 0.0 114.597 -171.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -74.11 156.16 37.69 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.362 0.665 . . . . 0.0 111.852 172.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -124.79 155.27 39.66 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.203 1.801 . . . . 0.0 110.08 176.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 162.62 168.76 25.01 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 124.911 1.243 . . . . 0.0 112.021 177.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -68.86 147.74 51.26 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.111 0.565 . . . . 0.0 110.721 171.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -155.21 155.27 29.83 Favored Pre-proline 0 CA--C 1.541 0.597 0 C-N-CA 124.315 1.046 . . . . 0.0 110.676 172.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -66.11 121.42 8.74 Favored 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 122.353 2.036 . . . . 0.0 110.975 177.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 29.7 t -55.01 -39.13 68.75 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.687 -0.633 . . . . 0.0 112.364 178.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 15.5 m -59.47 -21.85 60.68 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -74.24 -0.27 16.4 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.552 1.141 . . . . 0.0 113.514 172.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 48.1 p . . . . . 0 N--CA 1.468 0.468 0 C-N-CA 125.86 1.664 . . . . 0.0 111.792 179.11 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 35.7 mt . . . . . 0 CA--C 1.548 0.901 0 CA-C-O 119.295 -0.383 . . . . 0.0 110.329 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.19 159.13 52.97 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 123.498 2.799 . . . . 0.0 112.063 178.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.82 147.08 89.36 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.402 2.068 . . . . 0.0 112.561 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -73.98 157.11 87.46 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 123.692 0.797 . . . . 0.0 112.465 174.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.19 174.77 8.53 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.449 2.766 . . . . 0.0 113.381 176.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -88.39 3.06 51.27 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.997 1.319 . . . . 0.0 112.623 -178.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 32.6 p90 -134.85 154.62 79.43 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 124.557 1.143 . . . . 0.0 112.823 -175.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.51 152.49 60.07 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 123.788 2.992 . . . . 0.0 112.868 179.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -68.17 142.97 95.48 Favored Pre-proline 0 CA--C 1.551 0.981 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -176.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.32 179.94 5.01 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 124.114 3.209 . . . . 0.0 112.709 176.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 26.6 p -135.21 154.3 78.74 Favored Pre-proline 0 N--CA 1.479 0.983 0 C-N-CA 125.036 1.334 . . . . 0.0 112.657 -173.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -66.56 161.92 39.21 Favored 'Trans proline' 0 CA--C 1.547 1.165 0 C-N-CA 123.336 2.691 . . . . 0.0 111.484 175.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo . . . . . 0 CA--C 1.541 0.856 0 C-N-CA 123.052 2.501 . . . . 0.0 112.417 176.68 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 17.3 m . . . . . 0 N--CA 1.466 0.34 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 15.5 ttpt -119.53 136.39 54.36 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.138 0.975 . . . . 0.0 110.667 175.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 77.8 p -78.7 155.95 29.17 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.765 1.626 . . . . 0.0 111.783 -176.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.8 pp -122.24 -9.16 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 -176.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -155.29 159.22 31.91 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 126.346 1.858 . . . . 0.0 110.472 169.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.91 155.94 64.2 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.315 2.677 . . . . 0.0 113.348 178.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 44.7 t-80 . . . . . 0 N--CA 1.473 0.715 0 C-N-CA 125.583 1.553 . . . . 0.0 111.98 -178.838 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 58.0 p . . . . . 0 N--CA 1.482 1.16 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 58.4 mt -108.31 130.34 55.19 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.759 1.224 . . . . 0.0 111.358 -178.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 36.4 tp -82.49 120.1 25.05 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.877 0.871 . . . . 0.0 110.862 176.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 55.6 p -89.76 152.7 21.18 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.665 1.186 . . . . 0.0 112.523 173.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -167.75 178.93 5.02 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.434 1.494 . . . . 0.0 112.483 -175.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -117.94 174.06 6.41 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.405 1.882 . . . . 0.0 111.525 174.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -64.92 141.97 58.6 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.747 0.819 . . . . 0.0 111.368 170.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 73.66 10.67 80.11 Favored Glycine 0 CA--C 1.537 1.452 0 N-CA-C 114.525 0.57 . . . . 0.0 114.525 177.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -82.79 164.01 20.87 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.415 1.086 . . . . 0.0 111.342 171.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 93.6 t -119.46 136.99 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.559 1.144 . . . . 0.0 109.881 -171.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 17.1 mt -137.35 137.94 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.997 1.319 . . . . 0.0 109.272 -176.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 10.2 m -95.52 140.56 30.19 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.869 1.268 . . . . 0.0 110.56 176.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 23.3 mt -79.23 139.08 38.01 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.347 0.659 . . . . 0.0 111.803 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 32.4 mt -116.44 -6.78 11.72 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 124.253 1.021 . . . . 0.0 113.347 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 4.9 mt -134.49 140.52 35.92 Favored Pre-proline 0 N--CA 1.48 1.073 0 C-N-CA 126.517 1.927 . . . . 0.0 109.344 176.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.6 -8.53 23.81 Favored 'Trans proline' 0 CA--C 1.546 1.109 0 C-N-CA 123.963 3.109 . . . . 0.0 114.74 178.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -152.05 157.31 41.48 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.882 1.673 . . . . 0.0 111.92 175.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -80.35 168.73 18.66 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.481 1.112 . . . . 0.0 113.841 177.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -125.65 105.18 8.81 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.685 1.994 . . . . 0.0 110.287 178.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 50.96 32.14 7.09 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 125.084 1.354 . . . . 0.0 114.535 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 99.04 -16.67 59.11 Favored Glycine 0 CA--C 1.536 1.393 0 C-N-CA 125.743 1.64 . . . . 0.0 114.305 -178.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 83.0 m95 -85.33 129.74 34.74 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.479 1.112 . . . . 0.0 111.12 175.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 12.6 mt -99.15 162.99 12.75 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.227 1.011 . . . . 0.0 110.316 164.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -127.22 119.06 25.52 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.962 1.305 . . . . 0.0 107.935 176.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -146.63 175.47 26.04 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.064 0.84 . . . . 0.0 113.871 -170.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -127.42 121.63 31.41 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.376 1.47 . . . . 0.0 110.524 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 -66.84 133.58 50.37 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.317 1.047 . . . . 0.0 112.135 -176.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -70.25 -31.04 68.24 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 120.304 -1.497 . . . . 0.0 113.349 -178.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 58.1 t -81.42 -33.97 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 124.408 1.083 . . . . 0.0 113.522 -176.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 13.2 t -125.31 -15.2 6.28 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.887 1.275 . . . . 0.0 113.37 -167.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 54.84 20.8 3.25 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 126.78 2.032 . . . . 0.0 114.202 -177.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -69.22 147.99 50.48 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.573 1.149 . . . . 0.0 111.147 166.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 81.7 mtm180 -122.43 156.78 33.32 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.95 1.7 . . . . 0.0 111.473 179.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 162.83 171.45 29.07 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 124.817 1.198 . . . . 0.0 112.296 174.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -67.66 147.78 52.23 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.148 0.499 . . . . 0.0 110.347 169.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -154.42 155.75 31.04 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 124.321 1.048 . . . . 0.0 110.863 173.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -65.71 121.63 9.06 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.158 1.905 . . . . 0.0 111.627 178.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 33.8 t -61.86 -16.91 54.21 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 121.417 -0.802 . . . . 0.0 113.053 172.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 16.6 m -73.23 -17.65 61.32 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.888 1.275 . . . . 0.0 113.785 173.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -88.56 1.62 54.59 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.286 1.434 . . . . 0.0 113.072 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 58.3 p . . . . . 0 N--CA 1.472 0.661 0 C-N-CA 127.084 2.154 . . . . 0.0 109.826 172.098 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 60.7 mt . . . . . 0 CA--C 1.547 0.861 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.88 159.37 53.56 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 123.433 2.755 . . . . 0.0 112.147 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.44 146.14 89.05 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 122.42 2.08 . . . . 0.0 112.438 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -72.28 156.44 90.52 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 123.48 0.712 . . . . 0.0 112.14 172.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -68.96 174.77 8.34 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.43 2.754 . . . . 0.0 113.054 175.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -86.9 2.02 50.63 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.556 1.142 . . . . 0.0 112.844 -178.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 37.3 p90 -133.94 154.62 80.42 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 124.666 1.187 . . . . 0.0 112.79 -174.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.43 153.17 60.97 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 123.652 2.901 . . . . 0.0 112.758 178.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -65.92 143.22 98.4 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 123.821 0.848 . . . . 0.0 113.084 -177.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.8 177.81 7.17 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 124.001 3.134 . . . . 0.0 112.945 178.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 25.5 p -130.48 154.76 81.68 Favored Pre-proline 0 N--CA 1.478 0.944 0 C-N-CA 125.288 1.435 . . . . 0.0 112.775 -175.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.79 165.44 29.69 Favored 'Trans proline' 0 CA--C 1.547 1.15 0 C-N-CA 123.439 2.76 . . . . 0.0 111.885 174.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo . . . . . 0 CA--C 1.541 0.867 0 C-N-CA 123.406 2.737 . . . . 0.0 112.821 174.594 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 15.6 m . . . . . 0 N--CA 1.467 0.384 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -120.48 136.42 54.76 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.143 0.977 . . . . 0.0 109.946 177.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 45.9 p -80.44 148.57 30.47 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.383 1.473 . . . . 0.0 110.877 -175.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.7 pp -112.87 -10.25 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -176.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -155.55 159.31 31.75 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 126.666 1.987 . . . . 0.0 110.528 170.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.86 156.06 61.15 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 123.536 2.824 . . . . 0.0 113.129 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 32.0 t-80 . . . . . 0 N--CA 1.474 0.727 0 C-N-CA 125.385 1.474 . . . . 0.0 111.79 -179.78 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 35.8 p . . . . . 0 N--CA 1.479 0.984 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 68.7 mt -103.57 130.75 51.04 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.935 1.294 . . . . 0.0 110.97 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 30.2 tp -82.8 128.97 34.9 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.247 0.619 . . . . 0.0 110.401 174.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 34.4 t -107.87 147.32 31.11 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.591 1.556 . . . . 0.0 111.474 -179.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -164.58 177.94 7.72 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.626 1.57 . . . . 0.0 112.354 -170.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -121.82 168.83 11.4 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.944 2.098 . . . . 0.0 111.069 175.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -61.94 136.58 58.03 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.175 -0.953 . . . . 0.0 111.312 173.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 83.71 -1.92 88.09 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 123.749 0.69 . . . . 0.0 114.793 178.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -70.88 167.02 19.89 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.382 1.091 . . . . 0.0 112.203 170.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 84.6 t -125.86 133.41 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 125.018 1.327 . . . . 0.0 109.545 -169.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 24.9 mt -136.48 141.35 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.733 1.213 . . . . 0.0 109.462 -176.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 3.3 m -100.78 140.34 35.2 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.319 1.448 . . . . 0.0 110.599 -177.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 21.7 mt -80.21 136.98 36.59 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 118.423 0.556 . . . . 0.0 111.963 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 38.3 mt -117.52 -11.77 10.45 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.589 1.156 . . . . 0.0 113.341 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 371' ' ' ILE . . . . . 0.439 ' CG2' ' HD2' ' A' ' 372' ' ' PRO . 5.6 mt -128.09 140.04 37.13 Favored Pre-proline 0 N--CA 1.474 0.746 0 C-N-CA 126.154 1.782 . . . . 0.0 109.68 176.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 372' ' ' PRO . . . . . 0.439 ' HD2' ' CG2' ' A' ' 371' ' ' ILE . 60.6 Cg_endo -72.97 -7.22 20.35 Favored 'Trans proline' 0 CA--C 1.546 1.076 0 C-N-CA 123.434 2.756 . . . . 0.0 114.001 177.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -150.62 157.41 42.95 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.799 1.639 . . . . 0.0 112.088 173.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -84.91 171.54 12.09 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.222 1.009 . . . . 0.0 112.786 175.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -133.36 110.21 9.88 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.97 1.708 . . . . 0.0 110.819 -176.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 50.74 31.02 5.46 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 125.336 1.454 . . . . 0.0 114.448 -179.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 99.18 -8.41 60.78 Favored Glycine 0 CA--C 1.536 1.396 0 C-N-CA 125.379 1.466 . . . . 0.0 114.467 -177.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 75.3 m95 -99.44 128.43 45.56 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 118.438 1.119 . . . . 0.0 111.55 -178.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 14.1 mt -96.07 161.21 14.07 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.915 0.886 . . . . 0.0 110.544 165.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -124.92 122.36 37.12 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 125.167 1.387 . . . . 0.0 107.646 173.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -145.84 169.67 27.23 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 115.627 -0.715 . . . . 0.0 113.159 -173.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -117.55 114.67 23.78 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.811 1.244 . . . . 0.0 109.516 177.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 26.7 t-80 -60.69 146.35 46.02 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.861 1.264 . . . . 0.0 111.87 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -81.25 -46.2 15.14 Favored 'General case' 0 CA--C 1.548 0.866 0 O-C-N 120.768 -1.208 . . . . 0.0 112.866 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 60.1 t -68.92 -53.85 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 124.051 0.94 . . . . 0.0 113.31 175.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 16.3 t -86.11 -22.43 27.11 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -171.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm 54.93 17.2 1.73 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 126.575 1.95 . . . . 0.0 114.579 -168.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -74.33 156.03 37.55 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.476 0.655 . . . . 0.0 111.986 172.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 54.5 mtp180 -127.31 148.43 50.24 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.636 1.974 . . . . 0.0 109.758 177.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 167.98 168.79 30.61 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 124.501 1.048 . . . . 0.0 111.859 178.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -68.05 145.85 54.06 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.098 0.475 . . . . 0.0 110.556 170.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -152.76 154.45 31.42 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 124.103 0.961 . . . . 0.0 110.776 173.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.57 122.29 10.36 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.333 2.022 . . . . 0.0 110.864 178.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 98.1 p -56.4 -37.31 69.98 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.687 -0.633 . . . . 0.0 112.079 176.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 17.2 m -58.2 -20.95 45.47 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 127.273 2.229 . . . . 0.0 115.003 177.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -79.91 1.32 27.69 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.788 1.235 . . . . 0.0 112.961 175.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 60.3 p . . . . . 0 N--CA 1.472 0.671 0 C-N-CA 126.574 1.95 . . . . 0.0 110.673 174.516 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 52.4 mt . . . . . 0 N--CA 1.479 1.019 0 CA-C-O 119.117 -0.468 . . . . 0.0 109.878 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -69.39 160.31 50.3 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 123.702 2.935 . . . . 0.0 112.163 178.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.96 144.22 87.31 Favored 'Trans proline' 0 CA--C 1.534 0.522 0 C-N-CA 122.376 2.051 . . . . 0.0 112.191 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -69.6 153.56 95.58 Favored Pre-proline 0 CA--C 1.551 1.01 0 C-N-CA 122.972 0.509 . . . . 0.0 111.733 171.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -69.23 174.26 9.31 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.322 2.681 . . . . 0.0 113.19 178.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -86.67 2.48 48.34 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.523 1.129 . . . . 0.0 112.948 -178.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 34.0 p90 -133.52 153.39 80.31 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 124.748 1.219 . . . . 0.0 113.104 -176.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -71.62 152.12 59.05 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 123.623 2.882 . . . . 0.0 112.607 178.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -68.56 146.33 97.64 Favored Pre-proline 0 CA--C 1.55 0.971 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -176.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.7 178.72 5.97 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 124.034 3.156 . . . . 0.0 113.086 177.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 19.3 p -133.12 155.0 81.48 Favored Pre-proline 0 N--CA 1.48 1.027 0 C-N-CA 125.18 1.392 . . . . 0.0 112.658 -175.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.02 161.0 47.65 Favored 'Trans proline' 0 CA--C 1.547 1.151 0 C-N-CA 123.375 2.717 . . . . 0.0 111.986 176.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo . . . . . 0 CA--C 1.54 0.817 0 C-N-CA 123.232 2.621 . . . . 0.0 112.74 178.451 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 15.9 m . . . . . 0 C--O 1.236 0.377 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 5.7 tptt -119.37 130.53 55.38 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 124.183 0.993 . . . . 0.0 109.372 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 76.3 p -74.46 151.57 39.56 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.457 0.703 . . . . 0.0 111.127 -176.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.9 pp -122.69 -8.36 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -178.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -155.63 159.35 31.71 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 126.919 2.088 . . . . 0.0 110.024 169.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.1 159.62 53.17 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.275 2.65 . . . . 0.0 112.97 176.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 . . . . . 0 N--CA 1.474 0.771 0 C-N-CA 125.051 1.34 . . . . 0.0 111.993 179.494 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 52.2 p . . . . . 0 N--CA 1.481 1.119 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 47.1 mt -106.71 116.72 32.42 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.045 1.338 . . . . 0.0 110.972 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 25.5 tp -72.05 124.31 24.67 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.644 0.778 . . . . 0.0 110.669 176.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 58.0 p -97.76 152.65 18.92 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.988 1.315 . . . . 0.0 112.401 175.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -167.4 178.43 5.5 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.513 1.525 . . . . 0.0 112.195 -173.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -118.83 173.74 6.7 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.787 2.035 . . . . 0.0 110.941 173.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -65.19 141.16 58.76 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.746 0.818 . . . . 0.0 111.624 171.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 80.29 3.21 89.76 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 124.173 0.892 . . . . 0.0 115.213 175.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -76.2 168.79 19.41 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.231 1.412 . . . . 0.0 112.238 173.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 80.5 t -123.49 130.01 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 125.642 1.577 . . . . 0.0 109.153 -171.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 30.8 mt -134.72 137.29 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.136 0.974 . . . . 0.0 109.525 -178.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 20.0 m -97.76 139.31 33.83 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.033 1.333 . . . . 0.0 110.491 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 20.3 mt -79.34 144.33 34.3 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.235 0.47 . . . . 0.0 111.972 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 47.4 mt -118.58 -1.15 11.22 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.731 1.212 . . . . 0.0 112.93 -178.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 371' ' ' ILE . . . . . 0.488 ' CG2' ' HD2' ' A' ' 372' ' ' PRO . 3.8 mt -134.36 142.57 43.42 Favored Pre-proline 0 N--CA 1.478 0.937 0 C-N-CA 126.848 2.059 . . . . 0.0 109.947 177.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 372' ' ' PRO . . . . . 0.488 ' HD2' ' CG2' ' A' ' 371' ' ' ILE . 57.0 Cg_endo -71.87 -9.08 24.21 Favored 'Trans proline' 0 CA--C 1.547 1.151 0 C-N-CA 123.463 2.775 . . . . 0.0 114.021 176.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -152.65 150.22 29.25 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.027 1.731 . . . . 0.0 111.857 173.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -71.49 168.69 16.99 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.202 1.001 . . . . 0.0 113.554 173.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -123.72 103.4 8.36 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 126.324 1.85 . . . . 0.0 109.911 178.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 51.65 32.73 9.65 Favored 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 177.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 99.29 -12.72 61.83 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 125.415 1.484 . . . . 0.0 114.298 -178.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -89.18 121.41 31.45 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.451 1.1 . . . . 0.0 110.709 175.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 13.1 mt -88.8 158.86 18.0 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.366 0.667 . . . . 0.0 110.372 162.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 380' ' ' TYR . . . . . 0.417 ' HB3' HD11 ' A' ' 371' ' ' ILE . 58.7 t80 -120.65 125.18 47.06 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 125.001 1.32 . . . . 0.0 107.789 170.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -149.41 171.64 29.54 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 115.873 -0.603 . . . . 0.0 113.871 -172.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -123.08 120.93 34.73 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.452 1.501 . . . . 0.0 109.623 177.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 29.4 t-80 -65.68 150.68 48.08 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.717 1.207 . . . . 0.0 112.159 178.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -81.15 -49.31 10.99 Favored 'General case' 0 CA--C 1.548 0.883 0 O-C-N 120.941 -1.099 . . . . 0.0 113.649 178.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 82.8 t -71.05 -52.15 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 178.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 23.2 t -83.96 -23.33 31.12 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.595 0.758 . . . . 0.0 112.852 -174.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp 55.72 15.83 1.75 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 126.681 1.992 . . . . 0.0 114.532 -168.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -73.14 153.72 40.64 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.409 0.623 . . . . 0.0 111.944 173.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -123.68 153.61 40.58 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 126.553 1.941 . . . . 0.0 110.682 178.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 165.45 169.59 29.27 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 124.344 0.973 . . . . 0.0 112.24 175.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -66.92 148.09 52.4 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.066 0.46 . . . . 0.0 110.148 166.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -155.67 154.39 27.95 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 124.3 1.04 . . . . 0.0 110.359 172.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -63.82 123.19 11.56 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.525 2.15 . . . . 0.0 110.926 177.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 99.2 p -56.75 -38.55 72.58 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.655 -0.653 . . . . 0.0 112.136 178.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 14.7 m -61.32 -22.4 64.87 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.044 1.738 . . . . 0.0 114.825 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -73.66 -1.89 20.82 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.829 1.251 . . . . 0.0 113.215 172.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 62.3 p . . . . . 0 N--CA 1.465 0.315 0 C-N-CA 125.675 1.59 . . . . 0.0 110.987 175.244 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 53.8 mt . . . . . 0 N--CA 1.477 0.891 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -69.31 158.87 55.92 Favored 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 123.569 2.846 . . . . 0.0 112.049 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -64.46 145.56 87.99 Favored 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 122.37 2.047 . . . . 0.0 112.17 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -73.07 156.41 89.56 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 123.193 0.597 . . . . 0.0 112.215 173.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -68.78 174.32 8.8 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 123.42 2.747 . . . . 0.0 113.023 175.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -89.5 3.98 50.67 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.509 1.124 . . . . 0.0 113.087 -178.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 34.7 p90 -134.09 154.38 80.14 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 124.722 1.209 . . . . 0.0 112.701 -177.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.49 152.6 60.25 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 123.687 2.924 . . . . 0.0 112.641 179.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -67.87 143.9 96.82 Favored Pre-proline 0 CA--C 1.55 0.969 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -177.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.13 179.08 5.76 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 123.858 3.039 . . . . 0.0 112.716 177.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 24.7 p -131.31 154.91 82.07 Favored Pre-proline 0 N--CA 1.479 0.997 0 C-N-CA 125.194 1.398 . . . . 0.0 112.458 -174.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -67.03 164.57 29.49 Favored 'Trans proline' 0 CA--C 1.546 1.123 0 C-N-CA 123.397 2.732 . . . . 0.0 111.17 174.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo . . . . . 0 CA--C 1.54 0.791 0 C-N-CA 122.835 2.357 . . . . 0.0 112.352 175.662 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 17.9 m . . . . . 0 N--CA 1.468 0.468 0 CA-C-O 120.983 0.421 . . . . 0.0 110.052 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt -121.76 134.3 54.93 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.249 1.02 . . . . 0.0 110.221 175.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 82.7 p -76.4 156.34 33.27 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.622 1.569 . . . . 0.0 111.75 -179.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.9 pp -123.24 -6.91 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -153.73 157.69 32.62 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 125.758 1.623 . . . . 0.0 110.577 169.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.67 155.54 62.73 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.194 2.596 . . . . 0.0 112.994 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 32.6 t-80 . . . . . 0 CA--C 1.539 0.525 0 C-N-CA 125.934 1.694 . . . . 0.0 110.43 -178.219 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 17.5 p . . . . . 0 N--CA 1.483 1.19 0 N-CA-C 115.949 1.833 . . . . 0.0 115.949 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 15.3 mt -99.51 137.65 37.7 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.664 1.186 . . . . 0.0 110.653 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 30.6 tp -82.91 124.81 30.7 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 122.995 0.518 . . . . 0.0 110.818 175.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 47.4 m -91.74 147.55 22.91 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.775 1.23 . . . . 0.0 111.985 175.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -166.2 177.99 6.56 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.676 1.59 . . . . 0.0 112.755 -175.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -115.53 175.01 5.71 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.318 1.847 . . . . 0.0 111.617 173.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -62.46 141.1 58.55 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 121.349 -0.845 . . . . 0.0 111.106 168.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 71.53 18.63 77.23 Favored Glycine 0 CA--C 1.537 1.45 0 N-CA-C 114.651 0.62 . . . . 0.0 114.651 176.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -88.25 159.52 18.08 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.688 1.195 . . . . 0.0 111.645 173.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 88.0 t -111.28 130.33 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.011 1.324 . . . . 0.0 109.765 -173.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 23.1 mt -136.01 136.53 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.865 1.266 . . . . 0.0 109.035 -177.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 9.9 m -97.89 139.45 33.73 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.87 1.268 . . . . 0.0 110.004 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 20.6 mt -78.99 140.79 37.91 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 118.864 0.756 . . . . 0.0 111.953 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 37.4 mt -119.53 -5.38 10.29 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.891 1.276 . . . . 0.0 113.569 -177.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 371' ' ' ILE . . . . . 0.872 HG22 ' HD2' ' A' ' 372' ' ' PRO . 0.2 OUTLIER -127.9 146.76 60.26 Favored Pre-proline 0 N--CA 1.477 0.888 0 C-N-CA 126.722 2.009 . . . . 0.0 108.213 173.73 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 372' ' ' PRO . . . . . 0.872 ' HD2' HG22 ' A' ' 371' ' ' ILE . 82.9 Cg_endo -75.01 -17.09 19.81 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.461 2.774 . . . . 0.0 112.402 177.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -148.25 142.48 26.13 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.172 1.789 . . . . 0.0 111.202 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -72.29 172.95 9.36 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 125.658 1.583 . . . . 0.0 113.592 176.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -132.97 108.43 8.9 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.377 1.871 . . . . 0.0 110.833 -177.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 50.18 32.44 6.02 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 125.323 1.449 . . . . 0.0 114.707 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 98.94 -7.44 60.69 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 125.236 1.398 . . . . 0.0 114.462 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 78.8 m95 -99.77 128.97 45.84 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.485 1.143 . . . . 0.0 111.505 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 16.2 mt -98.42 161.36 13.73 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.622 1.169 . . . . 0.0 110.92 167.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 380' ' ' TYR . . . . . 0.453 ' HB3' ' CG1' ' A' ' 371' ' ' ILE . 60.2 t80 -121.33 122.2 39.33 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 173.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -145.58 170.75 26.8 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 115.749 -0.66 . . . . 0.0 114.46 -174.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -120.62 119.05 31.74 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.385 1.474 . . . . 0.0 109.717 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 -61.93 146.53 49.66 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.068 1.347 . . . . 0.0 111.68 177.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -80.55 -47.82 13.64 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 120.801 -1.187 . . . . 0.0 113.512 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 89.7 t -69.93 -51.93 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 124.287 1.035 . . . . 0.0 113.241 177.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 13.5 t -86.93 -21.69 26.1 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -173.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp 54.62 19.45 2.45 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 126.439 1.896 . . . . 0.0 114.303 -169.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -75.98 153.8 36.3 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.376 0.67 . . . . 0.0 111.896 172.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 70.9 mtm180 -127.93 148.04 50.49 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.463 1.905 . . . . 0.0 110.458 -179.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 169.86 170.93 34.87 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.83 1.205 . . . . 0.0 111.881 177.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -67.69 145.56 54.65 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.61 0.764 . . . . 0.0 110.902 171.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -152.78 153.2 29.8 Favored Pre-proline 0 CA--C 1.541 0.631 0 O-C-N 120.826 -1.171 . . . . 0.0 111.849 174.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -63.76 124.26 13.35 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 122.902 2.401 . . . . 0.0 112.14 178.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 97.5 p -62.97 -21.0 65.79 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 174.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 19.3 m -74.23 -17.54 60.87 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.826 1.25 . . . . 0.0 114.23 174.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -81.84 -2.72 52.0 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.567 1.147 . . . . 0.0 113.439 177.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 72.2 p . . . . . 0 N--CA 1.47 0.563 0 C-N-CA 126.563 1.945 . . . . 0.0 110.061 173.994 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 36.0 mt . . . . . 0 N--CA 1.477 0.902 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -68.7 162.48 40.98 Favored 'Trans proline' 0 CA--C 1.545 1.049 0 C-N-CA 123.492 2.794 . . . . 0.0 111.776 177.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.26 143.32 83.04 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.09 1.86 . . . . 0.0 112.365 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -70.0 152.91 95.75 Favored Pre-proline 0 CA--C 1.553 1.065 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.528 170.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -69.77 174.86 8.89 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.402 2.735 . . . . 0.0 113.309 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -90.69 8.35 34.86 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.756 1.222 . . . . 0.0 112.568 -178.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 37.0 p90 -135.82 153.01 76.93 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 124.828 1.251 . . . . 0.0 112.874 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.07 152.09 62.18 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.662 2.908 . . . . 0.0 112.276 178.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -67.53 144.13 97.52 Favored Pre-proline 0 CA--C 1.551 0.99 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -175.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.36 177.07 8.37 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 124.03 3.153 . . . . 0.0 113.106 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 27.3 p -132.23 153.66 81.36 Favored Pre-proline 0 N--CA 1.478 0.968 0 C-N-CA 125.076 1.35 . . . . 0.0 112.827 -172.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -67.84 165.07 29.13 Favored 'Trans proline' 0 CA--C 1.55 1.284 0 C-N-CA 123.55 2.833 . . . . 0.0 112.054 175.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo . . . . . 0 CA--C 1.543 0.939 0 C-N-CA 123.664 2.909 . . . . 0.0 113.173 176.468 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 16.7 m . . . . . 0 C--O 1.234 0.253 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -111.28 131.82 54.85 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.771 0.796 . . . . 0.0 109.944 175.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 70.6 p -76.34 151.67 36.6 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.955 1.702 . . . . 0.0 111.61 -175.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.7 pp -122.56 -6.1 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 N-CA-C 114.684 1.364 . . . . 0.0 114.684 -175.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -154.58 158.96 32.32 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 126.446 1.898 . . . . 0.0 110.199 169.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -69.46 159.3 54.16 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 123.085 2.523 . . . . 0.0 112.923 177.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 . . . . . 0 N--CA 1.473 0.723 0 C-N-CA 124.918 1.287 . . . . 0.0 112.039 179.601 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 39.6 p . . . . . 0 N--CA 1.483 1.185 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 63.0 mt -106.83 125.46 51.04 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.028 1.331 . . . . 0.0 110.653 179.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 26.0 tp -77.3 127.58 32.84 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.338 0.655 . . . . 0.0 110.596 176.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 37.3 p -100.96 147.08 26.58 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.136 1.374 . . . . 0.0 112.217 177.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -163.48 178.99 7.59 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.556 1.542 . . . . 0.0 112.054 -174.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -130.27 157.32 42.83 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 127.282 2.233 . . . . 0.0 111.358 177.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -50.98 129.51 23.81 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.494 0.717 . . . . 0.0 112.311 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 91.45 -9.01 78.33 Favored Glycine 0 CA--C 1.538 1.476 0 C-N-CA 124.261 0.934 . . . . 0.0 114.633 -179.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -68.05 153.02 44.6 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 118.903 1.351 . . . . 0.0 111.891 172.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 74.3 t -115.51 140.26 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 125.389 1.476 . . . . 0.0 109.989 -173.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 36.2 mt -136.07 136.57 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 125.668 1.587 . . . . 0.0 108.559 -177.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 31.8 m -99.46 137.23 38.25 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.649 1.18 . . . . 0.0 109.7 177.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 15.7 mt -69.45 147.34 51.06 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -177.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 77.4 mt -120.87 -2.21 9.81 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 125.079 1.351 . . . . 0.0 113.435 178.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 371' ' ' ILE . . . . . 0.62 HG22 ' HD2' ' A' ' 372' ' ' PRO . 2.0 mt -137.04 142.7 39.29 Favored Pre-proline 0 N--CA 1.477 0.906 0 C-N-CA 126.623 1.969 . . . . 0.0 109.14 177.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 372' ' ' PRO . . . . . 0.62 ' HD2' HG22 ' A' ' 371' ' ' ILE . 42.3 Cg_endo -70.42 -15.83 34.67 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 123.056 2.504 . . . . 0.0 113.308 177.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -145.15 150.13 36.23 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.492 1.917 . . . . 0.0 111.028 177.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -75.23 172.28 12.69 Favored 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 176.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -124.7 101.87 7.31 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.255 1.822 . . . . 0.0 110.293 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 51.95 31.78 9.07 Favored 'General case' 0 CA--C 1.554 1.135 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 175.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 100.01 -4.36 57.43 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 125.099 1.333 . . . . 0.0 114.64 -178.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 82.5 m95 -103.28 121.29 42.41 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.639 1.576 . . . . 0.0 110.521 176.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 12.1 mt -85.07 160.42 19.99 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.364 0.666 . . . . 0.0 110.578 163.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 380' ' ' TYR . . . . . 0.429 ' HB3' HD11 ' A' ' 371' ' ' ILE . 57.5 t80 -122.98 126.49 47.27 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.208 1.403 . . . . 0.0 107.56 170.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -150.48 170.38 30.38 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-N 115.857 -0.611 . . . . 0.0 113.643 -173.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -118.83 119.64 34.99 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.226 1.41 . . . . 0.0 109.325 176.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -61.59 146.32 49.25 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.361 1.464 . . . . 0.0 111.745 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -79.55 -47.67 15.13 Favored 'General case' 0 CA--C 1.548 0.897 0 O-C-N 120.774 -1.203 . . . . 0.0 113.734 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 81.9 t -73.93 -49.47 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.988 0.915 . . . . 0.0 112.968 178.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 15.5 t -86.91 -21.74 26.12 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -173.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp 54.27 17.47 1.52 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 126.712 2.005 . . . . 0.0 114.771 -169.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -75.21 159.58 31.41 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.506 0.723 . . . . 0.0 112.16 173.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -126.58 159.0 34.78 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.336 1.854 . . . . 0.0 110.468 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 157.72 169.67 21.67 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 124.454 1.025 . . . . 0.0 112.538 175.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -67.85 145.58 54.49 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.002 0.521 . . . . 0.0 110.416 169.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -153.2 153.63 29.74 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 124.003 0.921 . . . . 0.0 111.162 173.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -62.86 121.06 8.81 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.748 2.299 . . . . 0.0 111.381 178.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.0 -17.53 63.4 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 121.303 -0.873 . . . . 0.0 113.096 177.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 79.6 p -73.43 -22.12 60.29 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.712 2.005 . . . . 0.0 114.282 174.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -79.09 2.89 19.15 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.507 1.523 . . . . 0.0 113.325 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 30.8 p . . . . . 0 CA--C 1.539 0.521 0 C-N-CA 126.966 2.106 . . . . 0.0 109.93 175.557 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 61.9 mt . . . . . 0 CA--C 1.549 0.919 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -69.37 160.57 49.28 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 123.611 2.874 . . . . 0.0 112.357 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.37 145.47 88.24 Favored 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 122.579 2.186 . . . . 0.0 112.368 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -77.24 158.2 79.84 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 123.691 0.796 . . . . 0.0 112.448 174.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -68.56 174.97 7.63 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 123.527 2.818 . . . . 0.0 113.176 176.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -93.56 9.87 34.96 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.908 1.283 . . . . 0.0 112.408 -178.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 38.6 p90 -138.46 153.93 73.07 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 124.67 1.188 . . . . 0.0 112.622 -178.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -71.18 152.28 61.76 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.444 2.763 . . . . 0.0 112.069 176.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -66.81 148.86 98.68 Favored Pre-proline 0 CA--C 1.549 0.926 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -176.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.78 -175.9 1.83 Allowed 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 124.069 3.179 . . . . 0.0 112.638 176.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 23.4 p -135.41 153.4 77.85 Favored Pre-proline 0 N--CA 1.475 0.8 0 C-N-CA 125.196 1.399 . . . . 0.0 112.465 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -65.42 164.38 26.18 Favored 'Trans proline' 0 CA--C 1.549 1.241 0 C-N-CA 123.225 2.617 . . . . 0.0 111.273 173.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo . . . . . 0 CA--C 1.542 0.915 0 C-N-CA 123.379 2.719 . . . . 0.0 113.248 177.761 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 12.9 m . . . . . 0 C--O 1.236 0.385 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -118.92 130.82 55.92 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.709 0.804 . . . . 0.0 110.203 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 76.5 p -73.61 151.17 40.94 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.792 0.837 . . . . 0.0 111.138 -178.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.8 pp -123.45 -7.93 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 -177.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -154.35 156.78 32.04 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 126.255 1.822 . . . . 0.0 110.233 169.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -69.78 156.74 62.52 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 123.316 2.677 . . . . 0.0 112.856 178.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 350' ' ' HIS . . . . . 0.416 ' HE1' HD12 ' A' ' 358' ' ' LEU . 55.5 t-80 . . . . . 0 CA--C 1.543 0.687 0 C-N-CA 125.024 1.329 . . . . 0.0 111.855 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . 0.26 24.9 p . . . . . 0 N--CA 1.488 1.461 0 N-CA-C 116.334 1.976 . . . . 0.0 116.334 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 358' ' ' LEU . . . . . 0.416 HD12 ' HE1' ' A' ' 350' ' ' HIS . 4.4 mm? -77.71 141.99 39.01 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.084 1.354 . . . . 0.0 110.554 172.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 22.9 tp -85.41 136.83 33.29 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 161.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 65.8 m -117.23 143.81 45.47 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.443 1.497 . . . . 0.0 111.428 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -162.55 178.98 8.09 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.091 1.357 . . . . 0.0 112.892 -167.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -116.93 173.53 6.6 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.226 1.811 . . . . 0.0 111.443 174.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -65.63 142.74 57.96 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.16 0.984 . . . . 0.0 111.559 171.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 75.67 8.28 84.13 Favored Glycine 0 CA--C 1.534 1.258 0 CA-C-O 119.298 -0.723 . . . . 0.0 114.819 176.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -79.07 163.41 25.15 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.556 1.142 . . . . 0.0 111.733 171.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 99.8 t -114.84 134.65 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.124 1.37 . . . . 0.0 109.163 -176.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 35.9 mt -132.45 141.48 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.275 1.03 . . . . 0.0 109.043 178.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 16.9 m -105.34 137.27 43.41 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.074 1.35 . . . . 0.0 109.467 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 9.9 mt -73.44 145.1 46.0 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -176.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 72.2 mt -119.53 -12.65 9.29 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 124.83 1.252 . . . . 0.0 113.311 178.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 371' ' ' ILE . . . . . 0.415 ' CG2' ' HD2' ' A' ' 372' ' ' PRO . 9.8 mt -127.79 141.22 40.41 Favored Pre-proline 0 N--CA 1.478 0.932 0 C-N-CA 126.096 1.759 . . . . 0.0 110.255 175.098 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 372' ' ' PRO . . . . . 0.415 ' HD2' ' CG2' ' A' ' 371' ' ' ILE . 56.5 Cg_endo -71.7 -7.58 21.45 Favored 'Trans proline' 0 CA--C 1.547 1.144 0 C-N-CA 123.948 3.098 . . . . 0.0 114.48 176.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -152.55 153.71 33.96 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.663 1.585 . . . . 0.0 112.262 172.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -75.32 169.78 17.39 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.491 1.116 . . . . 0.0 113.647 174.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -128.6 105.92 8.61 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 126.669 1.988 . . . . 0.0 109.957 179.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 50.37 32.17 6.1 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 124.954 1.302 . . . . 0.0 114.373 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 99.55 -17.38 57.7 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 125.863 1.697 . . . . 0.0 114.377 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -82.59 125.29 31.0 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.542 1.137 . . . . 0.0 111.138 176.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 14.4 mt -94.42 162.94 13.62 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.636 0.774 . . . . 0.0 110.364 162.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -126.45 125.38 42.03 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 170.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -147.53 169.96 28.35 Favored Glycine 0 CA--C 1.527 0.781 0 C-N-CA 124.085 0.85 . . . . 0.0 112.671 -173.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -117.24 121.2 40.54 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 124.492 1.117 . . . . 0.0 109.275 175.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -63.54 152.35 38.87 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.762 1.225 . . . . 0.0 112.382 178.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -86.85 -45.89 10.44 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 120.991 -1.068 . . . . 0.0 113.45 177.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 53.1 t -67.32 -54.49 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 123.799 0.84 . . . . 0.0 113.008 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 22.2 m -96.07 -12.86 24.21 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -172.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt 55.47 19.82 3.36 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 126.674 1.99 . . . . 0.0 114.77 -174.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -75.35 158.31 32.97 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.54 0.736 . . . . 0.0 112.153 175.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 53.7 mtt180 -128.83 153.13 47.73 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 127.022 2.129 . . . . 0.0 109.579 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 162.68 166.09 20.86 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 125.198 1.38 . . . . 0.0 111.421 176.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -65.82 144.5 56.8 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.388 0.675 . . . . 0.0 110.177 170.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -153.31 155.1 31.51 Favored Pre-proline 0 CA--C 1.539 0.527 0 O-C-N 120.507 -1.371 . . . . 0.0 110.978 175.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -65.38 118.63 5.62 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.23 1.953 . . . . 0.0 110.831 177.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 29.4 t -54.15 -38.77 65.85 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.75 -0.593 . . . . 0.0 112.109 177.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 14.7 m -60.08 -21.66 61.75 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 178.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -75.43 -3.47 34.0 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.561 1.145 . . . . 0.0 113.157 173.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 80.8 p . . . . . 0 N--CA 1.465 0.324 0 C-N-CA 125.712 1.605 . . . . 0.0 110.747 172.167 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 49.8 mt . . . . . 0 N--CA 1.479 1.001 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -68.69 160.93 47.44 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 123.624 2.883 . . . . 0.0 112.036 177.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.77 144.85 89.98 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.31 2.006 . . . . 0.0 112.493 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -68.29 152.54 96.47 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 123.041 0.536 . . . . 0.0 111.875 172.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -70.07 174.41 9.81 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.608 2.872 . . . . 0.0 113.543 -178.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -89.37 5.27 45.89 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.208 1.403 . . . . 0.0 112.378 -178.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 29.3 p90 -137.08 155.06 76.29 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 124.353 1.061 . . . . 0.0 112.642 -177.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.75 153.13 53.65 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 123.806 3.004 . . . . 0.0 112.965 178.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -67.81 140.03 93.84 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 123.788 0.835 . . . . 0.0 112.968 -177.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -73.45 179.05 5.9 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 123.979 3.119 . . . . 0.0 112.789 176.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 25.8 p -132.79 154.79 81.58 Favored Pre-proline 0 N--CA 1.48 1.058 0 C-N-CA 125.122 1.369 . . . . 0.0 112.479 -175.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -66.94 165.15 27.1 Favored 'Trans proline' 0 CA--C 1.549 1.243 0 C-N-CA 123.437 2.758 . . . . 0.0 111.621 175.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo . . . . . 0 CA--C 1.539 0.764 0 C-N-CA 123.337 2.692 . . . . 0.0 113.147 178.564 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 16.7 m . . . . . 0 C--O 1.235 0.342 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -122.99 132.23 54.05 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 124.268 1.027 . . . . 0.0 109.352 -177.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 74.4 p -78.35 152.47 32.32 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.416 0.686 . . . . 0.0 110.824 -177.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.8 pp -125.7 -5.68 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 N-CA-C 114.441 1.275 . . . . 0.0 114.441 -178.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -153.86 160.67 30.68 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 126.117 1.767 . . . . 0.0 110.431 168.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -69.77 156.59 62.91 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 123.117 2.545 . . . . 0.0 113.139 174.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 . . . . . 0 N--CA 1.473 0.694 0 C-N-CA 125.224 1.41 . . . . 0.0 111.451 179.127 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 65.7 p . . . . . 0 N--CA 1.483 1.211 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 45.3 mt -101.49 116.09 31.99 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.728 1.211 . . . . 0.0 111.027 -176.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 27.6 tp -74.04 118.25 16.78 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.502 0.721 . . . . 0.0 110.962 178.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 59.9 p -87.91 154.34 20.6 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.282 1.033 . . . . 0.0 112.978 174.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -167.39 179.41 5.01 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.917 1.687 . . . . 0.0 112.014 -177.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -119.49 176.7 5.23 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.577 1.951 . . . . 0.0 110.942 172.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 66.5 tt0 -65.92 139.47 58.26 Favored 'General case' 0 CA--C 1.546 0.814 0 O-C-N 121.349 -0.844 . . . . 0.0 111.548 171.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 82.19 4.29 90.27 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.298 0.951 . . . . 0.0 115.376 175.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -77.07 170.25 16.86 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.946 1.298 . . . . 0.0 112.616 173.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 94.6 t -125.24 129.35 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.786 1.634 . . . . 0.0 109.09 -169.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 29.6 mt -134.81 137.8 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.94 0.896 . . . . 0.0 109.968 -177.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 10.1 m -96.9 140.06 32.01 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.993 1.317 . . . . 0.0 110.834 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 20.7 mt -78.91 136.67 37.34 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 122.943 0.497 . . . . 0.0 111.55 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 50.1 mt -114.63 -2.0 13.2 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.7 1.2 . . . . 0.0 113.045 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 371' ' ' ILE . . . . . 0.584 HG22 ' HD2' ' A' ' 372' ' ' PRO . 2.1 mt -134.82 143.28 45.64 Favored Pre-proline 0 N--CA 1.478 0.972 0 C-N-CA 126.623 1.969 . . . . 0.0 109.568 178.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 372' ' ' PRO . . . . . 0.584 ' HD2' HG22 ' A' ' 371' ' ' ILE . 56.1 Cg_endo -72.46 -9.73 24.5 Favored 'Trans proline' 0 CA--C 1.548 1.18 0 C-N-CA 123.203 2.602 . . . . 0.0 113.639 176.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -153.32 152.43 31.11 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.862 1.665 . . . . 0.0 112.302 174.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -71.83 169.91 14.76 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.769 1.228 . . . . 0.0 113.855 173.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -129.36 106.96 9.14 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.466 1.907 . . . . 0.0 110.047 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 51.05 31.69 6.73 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.097 1.359 . . . . 0.0 114.567 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 97.35 -11.79 65.19 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 125.465 1.507 . . . . 0.0 114.439 -178.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 77.8 m95 -89.28 123.94 33.95 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.49 1.116 . . . . 0.0 110.809 175.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 15.1 mt -90.14 156.76 18.12 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.536 0.735 . . . . 0.0 110.228 162.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 380' ' ' TYR . . . . . 0.482 ' HB3' HD11 ' A' ' 371' ' ' ILE . 58.7 t80 -116.77 124.55 49.88 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.904 1.282 . . . . 0.0 107.616 169.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -148.74 171.95 28.99 Favored Glycine 0 CA--C 1.524 0.594 0 CA-C-N 115.659 -0.701 . . . . 0.0 113.376 -173.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -122.81 120.42 33.49 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.774 1.23 . . . . 0.0 109.859 177.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 25.2 t-80 -64.86 145.61 56.04 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.429 1.092 . . . . 0.0 111.66 178.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -80.19 -45.37 18.19 Favored 'General case' 0 CA--C 1.547 0.861 0 O-C-N 120.927 -1.108 . . . . 0.0 113.448 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 87.7 t -72.53 -53.78 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 177.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 35.2 m -86.41 -17.32 34.64 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.288 0.949 . . . . 0.0 113.142 -172.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp 53.96 21.31 2.8 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 126.69 1.996 . . . . 0.0 114.505 -173.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -80.55 152.46 28.62 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.189 0.596 . . . . 0.0 111.527 173.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 46.7 mtm-85 -119.44 155.6 31.73 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.252 1.821 . . . . 0.0 110.65 175.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 164.01 169.68 27.87 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.372 0.987 . . . . 0.0 112.217 174.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -66.53 145.75 55.28 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.351 0.661 . . . . 0.0 110.485 166.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -155.23 154.43 28.57 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 124.482 1.113 . . . . 0.0 110.391 172.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 393' ' ' PRO . . . . . 0.438 ' HB3' ' HB1' ' B' ' 535' ' ' ALA . 24.3 Cg_endo -65.37 124.14 12.48 Favored 'Trans proline' 0 CA--C 1.532 0.4 0 C-N-CA 122.581 2.188 . . . . 0.0 111.497 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 96.3 p -56.88 -37.21 71.06 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 8.7 p -67.66 -14.24 62.78 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.094 1.758 . . . . 0.0 115.503 179.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -79.86 -2.08 41.92 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 119.524 1.056 . . . . 0.0 113.106 168.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 77.0 p . . . . . 0 C--O 1.234 0.287 0 C-N-CA 125.446 1.498 . . . . 0.0 111.186 172.285 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 63.6 mt . . . . . 0 N--CA 1.477 0.885 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -69.41 159.85 52.07 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 123.561 2.841 . . . . 0.0 112.238 178.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.13 144.74 87.9 Favored 'Trans proline' 0 CA--C 1.535 0.529 0 C-N-CA 122.424 2.083 . . . . 0.0 112.148 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -73.89 156.7 87.93 Favored Pre-proline 0 CA--C 1.551 0.994 0 C-N-CA 123.243 0.617 . . . . 0.0 112.207 173.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -68.87 175.21 7.65 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.346 2.697 . . . . 0.0 113.128 176.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -92.2 9.03 35.42 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.853 1.261 . . . . 0.0 112.514 -178.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 34.9 p90 -138.31 154.16 73.53 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 124.846 1.259 . . . . 0.0 112.759 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.6 153.04 60.05 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 123.621 2.881 . . . . 0.0 112.547 178.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 535' ' ' ALA . . . . . 0.438 ' HB1' ' HB3' ' A' ' 393' ' ' PRO . . . -67.52 144.16 97.56 Favored Pre-proline 0 CA--C 1.55 0.964 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -176.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.86 176.26 9.24 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.949 3.099 . . . . 0.0 112.555 178.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 22.5 p -129.39 154.24 80.67 Favored Pre-proline 0 N--CA 1.479 0.993 0 C-N-CA 124.759 1.224 . . . . 0.0 112.779 -171.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -67.85 162.09 41.13 Favored 'Trans proline' 0 CA--C 1.546 1.118 0 C-N-CA 123.28 2.653 . . . . 0.0 111.352 176.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo . . . . . 0 CA--C 1.54 0.811 0 C-N-CA 122.982 2.454 . . . . 0.0 112.482 177.146 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 16.2 m . . . . . 0 C--O 1.237 0.413 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -120.53 131.24 54.6 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.914 0.886 . . . . 0.0 110.364 178.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 71.3 p -73.49 151.75 40.94 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.06 0.944 . . . . 0.0 111.379 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.7 pp -124.3 -8.28 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -177.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -154.35 157.23 32.26 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 126.474 1.91 . . . . 0.0 109.906 169.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.3 157.4 61.97 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.093 2.529 . . . . 0.0 113.025 177.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 . . . . . 0 N--CA 1.472 0.666 0 C-N-CA 125.064 1.345 . . . . 0.0 111.259 178.231 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 29.6 p . . . . . 0 N--CA 1.479 1.014 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 70.7 mt -108.0 128.97 55.13 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.997 1.319 . . . . 0.0 111.195 -177.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 31.1 tp -80.68 121.11 25.46 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.477 0.711 . . . . 0.0 110.642 176.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 47.4 p -90.19 152.62 21.01 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.564 1.145 . . . . 0.0 112.487 173.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -165.94 179.21 5.98 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.581 1.553 . . . . 0.0 112.34 -177.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -119.08 174.51 6.28 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.338 1.855 . . . . 0.0 111.205 174.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -68.62 137.99 54.68 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.044 0.938 . . . . 0.0 111.693 172.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 84.21 12.96 75.17 Favored Glycine 0 CA--C 1.536 1.39 0 N-CA-C 114.881 0.712 . . . . 0.0 114.881 174.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -95.48 160.91 14.29 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.96 1.704 . . . . 0.0 111.669 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 72.7 t -108.91 133.73 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.632 1.173 . . . . 0.0 109.74 -171.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 16.5 mt -133.88 139.23 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.446 1.098 . . . . 0.0 109.349 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 6.8 m -101.2 141.84 33.49 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.593 1.157 . . . . 0.0 110.134 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 23.7 mt -79.36 141.72 36.68 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.008 0.523 . . . . 0.0 111.943 -177.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 61.6 mt -116.46 -7.78 11.64 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.596 1.158 . . . . 0.0 113.003 178.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 7.5 mt -132.77 142.01 43.18 Favored Pre-proline 0 N--CA 1.478 0.969 0 C-N-CA 126.857 2.063 . . . . 0.0 109.807 175.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.08 -8.81 24.35 Favored 'Trans proline' 0 CA--C 1.548 1.177 0 C-N-CA 123.828 3.019 . . . . 0.0 114.788 175.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 26.8 pt-20 -152.69 155.4 37.18 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.811 1.645 . . . . 0.0 112.404 174.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -75.87 170.72 15.69 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.613 1.165 . . . . 0.0 113.853 174.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -132.51 107.86 8.74 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.533 1.933 . . . . 0.0 110.268 -178.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 50.65 30.53 4.96 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 124.993 1.317 . . . . 0.0 114.331 -178.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 100.14 -16.42 58.24 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 125.674 1.606 . . . . 0.0 114.425 -178.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -87.07 129.61 34.84 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.55 1.175 . . . . 0.0 111.198 178.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 12.5 mt -96.62 161.68 13.78 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.955 0.902 . . . . 0.0 110.311 163.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -124.83 123.75 40.62 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.201 1.4 . . . . 0.0 107.771 173.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -148.65 175.16 28.05 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-N 115.731 -0.668 . . . . 0.0 113.682 -172.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -126.07 120.62 30.7 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.254 1.422 . . . . 0.0 110.027 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -61.85 155.93 22.01 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.716 1.206 . . . . 0.0 111.887 179.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -98.46 -21.96 16.28 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 120.661 -1.274 . . . . 0.0 114.363 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 58.5 t -82.63 -33.81 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 C-N-CA 123.466 0.706 . . . . 0.0 112.718 178.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 5.5 t -127.33 -11.49 5.74 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.683 1.193 . . . . 0.0 113.694 -170.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? 54.68 23.02 4.42 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 125.753 1.621 . . . . 0.0 113.762 -177.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -69.25 154.47 41.99 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.688 1.195 . . . . 0.0 111.355 169.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 80.3 mtt180 -127.05 161.19 28.99 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.922 1.689 . . . . 0.0 110.947 -177.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 156.87 169.39 20.74 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 124.521 1.058 . . . . 0.0 112.449 174.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -67.1 147.87 52.6 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.144 0.497 . . . . 0.0 110.361 168.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -154.36 155.71 31.05 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 124.112 0.965 . . . . 0.0 110.75 172.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -65.15 120.39 7.6 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.314 2.009 . . . . 0.0 111.707 178.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 81.7 p -57.99 -22.77 51.04 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 114.225 1.195 . . . . 0.0 114.225 177.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 16.3 m -77.09 -17.69 58.52 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 176.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -79.36 -2.49 41.81 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.476 1.11 . . . . 0.0 113.687 177.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 67.2 p . . . . . 0 C--O 1.236 0.383 0 C-N-CA 125.623 1.569 . . . . 0.0 110.771 171.343 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 61.0 mt . . . . . 0 N--CA 1.478 0.93 0 CA-C-O 119.067 -0.492 . . . . 0.0 109.773 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -69.31 160.57 49.3 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 123.568 2.845 . . . . 0.0 112.074 178.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -63.99 143.45 85.03 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 122.281 1.987 . . . . 0.0 112.103 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -71.94 155.05 92.39 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 123.083 0.553 . . . . 0.0 112.053 172.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -68.8 174.87 8.02 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.419 2.746 . . . . 0.0 113.095 176.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -91.14 8.95 33.08 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.913 1.285 . . . . 0.0 112.407 -178.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 38.2 p90 -138.02 154.36 74.22 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 124.9 1.28 . . . . 0.0 112.827 -178.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -72.03 153.82 57.69 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.726 2.951 . . . . 0.0 112.58 178.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -68.97 142.9 93.88 Favored Pre-proline 0 CA--C 1.552 1.043 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -176.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -73.92 179.65 5.49 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 124.173 3.249 . . . . 0.0 113.071 176.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 26.9 p -132.89 155.29 81.32 Favored Pre-proline 0 N--CA 1.48 1.058 0 C-N-CA 125.25 1.42 . . . . 0.0 112.842 -174.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -67.46 164.64 30.04 Favored 'Trans proline' 0 CA--C 1.549 1.266 0 C-N-CA 123.504 2.803 . . . . 0.0 111.57 174.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo . . . . . 0 CA--C 1.542 0.88 0 C-N-CA 123.46 2.773 . . . . 0.0 113.085 176.574 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.688 0 N-CA-C 111.281 -0.727 . . . . 0.0 111.281 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 15.4 t -139.09 -30.3 0.74 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.338 1.055 . . . . 0.0 113.712 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' HIS . . . . . . . . . . . . . 14.2 p-80 -119.14 14.34 13.06 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.753 1.621 . . . . 0.0 112.531 173.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' MET . . . . . . . . . . . . . 14.7 ptm -148.01 154.17 39.93 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.204 1.802 . . . . 0.0 111.882 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.6 37.25 1.2 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 125.173 1.389 . . . . 0.0 114.044 -171.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.75 121.59 43.79 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.7 1.6 . . . . 0.0 110.751 178.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -70.39 142.54 52.07 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.369 0.667 . . . . 0.0 111.029 171.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 4.7 mptt -136.19 169.01 18.33 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.144 1.377 . . . . 0.0 112.313 174.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 15.9 m -132.44 154.52 40.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 126.704 2.002 . . . . 0.0 109.033 165.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 19.0 ttmt -118.2 131.34 56.39 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.991 0.916 . . . . 0.0 109.728 177.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 27.8 p -73.47 156.93 37.71 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.265 0.626 . . . . 0.0 111.315 -177.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 2.1 pp -127.32 -5.84 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 N-CA-C 114.722 1.378 . . . . 0.0 114.722 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -156.58 158.58 31.46 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 125.852 1.661 . . . . 0.0 110.415 171.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.21 156.68 64.04 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.216 2.611 . . . . 0.0 112.918 176.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 52.1 t-80 -140.28 151.03 44.77 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.093 1.357 . . . . 0.0 111.735 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 15.2 t -147.62 150.69 34.9 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.545 1.538 . . . . 0.0 112.005 -176.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -77.45 -35.22 54.15 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -177.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 67.86 -62.58 0.34 Allowed Glycine 0 CA--C 1.54 1.647 0 C-N-CA 126.738 2.113 . . . . 0.0 115.753 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 50.1 m -143.2 27.84 1.56 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 126.541 1.936 . . . . 0.0 112.118 -173.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -138.21 173.63 11.41 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.875 1.67 . . . . 0.0 111.445 -174.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 2.6 tmmm? -120.53 -31.88 4.2 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.207 1.403 . . . . 0.0 113.143 177.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 53.7 p -86.05 13.34 7.84 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.111 1.364 . . . . 0.0 114.601 -174.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 67.7 mt -104.39 124.52 49.36 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.763 1.225 . . . . 0.0 111.45 -177.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 23.7 tp -77.26 124.47 27.89 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.637 0.775 . . . . 0.0 110.828 176.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 58.5 p -94.97 153.38 17.68 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.876 1.27 . . . . 0.0 112.632 174.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -167.42 178.85 5.26 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.759 1.624 . . . . 0.0 112.132 -175.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -117.28 178.51 4.34 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.663 1.985 . . . . 0.0 110.93 173.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -66.96 141.3 57.66 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.304 -0.873 . . . . 0.0 111.47 170.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 79.29 5.44 89.14 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 124.232 0.92 . . . . 0.0 115.345 174.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -74.34 166.62 23.17 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.757 1.223 . . . . 0.0 112.822 176.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 90.8 t -119.36 126.33 75.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 125.666 1.586 . . . . 0.0 108.884 -174.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 26.4 mt -133.62 135.46 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.56 1.144 . . . . 0.0 109.059 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 59.3 m -102.72 136.73 42.01 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.757 1.223 . . . . 0.0 110.058 -177.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 19.5 mt -75.34 148.0 39.64 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -175.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 49.5 mt -121.25 0.93 10.2 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 124.782 1.233 . . . . 0.0 112.908 178.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 371' ' ' ILE . . . . . 0.531 HG22 ' HD2' ' A' ' 372' ' ' PRO . 2.2 mt -137.13 142.67 38.96 Favored Pre-proline 0 N--CA 1.48 1.05 0 C-N-CA 126.716 2.006 . . . . 0.0 109.794 177.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 372' ' ' PRO . . . . . 0.531 ' HD2' HG22 ' A' ' 371' ' ' ILE . 55.6 Cg_endo -72.27 -8.87 23.5 Favored 'Trans proline' 0 CA--C 1.546 1.085 0 C-N-CA 123.423 2.749 . . . . 0.0 113.959 176.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -153.63 152.82 31.29 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.855 1.662 . . . . 0.0 112.139 174.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -72.88 169.68 16.31 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.23 1.012 . . . . 0.0 113.63 174.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 18.2 tppt? -126.39 102.36 7.12 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.776 2.03 . . . . 0.0 109.801 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 52.67 30.36 8.64 Favored 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 178.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 102.09 -18.44 51.93 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.803 1.668 . . . . 0.0 114.199 -178.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 82.0 m95 -84.4 129.47 34.86 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.524 1.13 . . . . 0.0 111.119 175.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 11.4 mt -99.23 158.56 15.61 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.925 0.89 . . . . 0.0 110.285 165.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 380' ' ' TYR . . . . . 0.416 ' HB3' HD11 ' A' ' 371' ' ' ILE . 50.2 t80 -118.57 123.78 45.87 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.867 1.267 . . . . 0.0 107.721 171.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -148.62 172.43 28.81 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-N 115.854 -0.612 . . . . 0.0 113.602 -173.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -123.83 119.32 29.34 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.547 1.539 . . . . 0.0 109.402 176.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 25.0 t-80 -62.92 147.86 49.11 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.905 1.282 . . . . 0.0 111.546 177.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -80.39 -50.4 10.17 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 120.91 -1.119 . . . . 0.0 113.46 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 68.0 t -69.38 -49.0 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 O-C-N 121.37 -0.831 . . . . 0.0 113.111 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 20.3 t -86.11 -23.26 26.71 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.406 0.682 . . . . 0.0 112.646 -175.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 34.7 mmtm 53.46 20.51 2.06 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 126.187 1.795 . . . . 0.0 114.265 -169.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -76.41 152.78 36.12 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.458 0.703 . . . . 0.0 111.799 171.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 74.4 mtm180 -122.15 157.14 32.18 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.443 1.897 . . . . 0.0 111.195 177.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 161.02 170.57 25.81 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.529 1.061 . . . . 0.0 112.505 174.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -66.74 147.36 53.37 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.133 0.492 . . . . 0.0 110.313 166.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -154.73 155.73 30.76 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 124.304 1.042 . . . . 0.0 110.427 172.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -64.6 119.42 6.46 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.347 2.032 . . . . 0.0 110.822 176.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 28.9 t -55.79 -38.79 70.4 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.56 -0.712 . . . . 0.0 111.936 177.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 1.6 p -61.15 -17.39 52.61 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.306 1.842 . . . . 0.0 115.859 177.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -76.55 -0.34 22.85 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 119.705 1.139 . . . . 0.0 113.086 169.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 32.4 p -134.1 161.88 33.64 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 126.081 1.752 . . . . 0.0 111.008 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 51.6 mttm -134.62 155.41 50.53 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.12 1.368 . . . . 0.0 109.814 175.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.45 124.78 21.16 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 175.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 3.6 tp -52.36 -46.22 66.08 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 123.347 1.546 . . . . 0.0 114.962 -173.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -98.46 63.59 1.51 Allowed 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 127.063 2.145 . . . . 0.0 112.499 -178.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 . . . . . 0 C--O 1.255 1.373 0 N-CA-C 114.973 1.472 . . . . 0.0 114.973 171.95 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 526' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.82 0.343 . . . . 0.0 110.985 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 62.8 mt -66.89 132.99 93.9 Favored Pre-proline 0 N--CA 1.478 0.935 0 C-N-CA 125.01 1.324 . . . . 0.0 109.829 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -69.44 159.75 52.42 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 123.601 2.867 . . . . 0.0 112.264 178.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.23 144.95 87.98 Favored 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 122.374 2.05 . . . . 0.0 112.241 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -73.58 156.11 88.85 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 123.265 0.626 . . . . 0.0 112.224 173.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -69.14 174.73 8.55 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.48 2.787 . . . . 0.0 113.155 177.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -88.6 4.77 45.78 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.797 1.239 . . . . 0.0 112.62 -178.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 36.3 p90 -136.32 154.62 77.23 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 124.677 1.191 . . . . 0.0 112.829 -176.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.95 153.17 58.1 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 123.753 2.969 . . . . 0.0 112.779 178.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -68.7 143.15 94.67 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 123.732 0.813 . . . . 0.0 113.028 -177.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.73 176.86 8.82 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.992 3.128 . . . . 0.0 113.023 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 27.8 p -130.32 153.0 81.18 Favored Pre-proline 0 N--CA 1.478 0.959 0 C-N-CA 124.983 1.313 . . . . 0.0 112.82 -173.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -67.07 163.26 34.7 Favored 'Trans proline' 0 CA--C 1.548 1.183 0 C-N-CA 123.485 2.79 . . . . 0.0 111.338 176.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -63.76 150.74 87.74 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.007 2.471 . . . . 0.0 112.516 178.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 540' ' ' VAL . . . . . . . . . . . . . 40.9 t -97.65 103.96 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.181 1.392 . . . . 0.0 108.514 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 541' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -139.11 158.14 44.72 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.748 2.019 . . . . 0.0 111.463 -173.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 542' ' ' ASN . . . . . . . . . . . . . 50.9 t30 . . . . . 0 C--O 1.254 1.315 0 C-N-CA 125.267 1.427 . . . . 0.0 113.258 177.72 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.566 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 22.4 t -62.23 117.27 5.84 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.011 0.924 . . . . 0.0 111.486 176.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -153.44 137.73 16.61 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.232 1.413 . . . . 0.0 110.535 -177.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -153.46 167.3 29.93 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.407 1.483 . . . . 0.0 112.384 -177.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -139.75 129.5 24.6 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.963 1.705 . . . . 0.0 109.568 176.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -151.47 80.24 1.29 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.769 1.228 . . . . 0.0 112.325 -166.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -59.32 136.77 58.07 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.692 0.758 . . . . 0.0 112.037 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 10.5 mptt -131.6 167.8 18.8 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 126.028 1.731 . . . . 0.0 111.506 176.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 16.2 m -133.55 152.89 35.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 126.454 1.901 . . . . 0.0 109.161 166.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -113.45 133.4 55.22 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.675 0.79 . . . . 0.0 110.092 174.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 68.3 p -72.84 154.75 40.47 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.279 1.032 . . . . 0.0 111.175 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.9 pp -125.59 -6.41 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 -179.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -155.92 159.76 31.31 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 126.273 1.829 . . . . 0.0 109.889 169.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -68.75 155.96 67.02 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.041 2.494 . . . . 0.0 113.203 177.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -140.47 152.4 45.61 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.466 1.507 . . . . 0.0 111.409 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 14.5 t -146.85 152.48 38.8 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.389 1.475 . . . . 0.0 111.749 -177.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -73.05 100.59 3.04 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.387 1.075 . . . . 0.0 111.353 176.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . -74.21 80.19 0.86 Allowed Glycine 0 CA--C 1.534 1.219 0 C-N-CA 125.465 1.507 . . . . 0.0 113.083 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 4.3 t 54.77 52.1 12.65 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.831 1.652 . . . . 0.0 112.849 -175.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -143.75 171.36 14.31 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 125.274 1.43 . . . . 0.0 112.214 -174.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 43.0 mtmt -121.74 -9.71 8.83 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 125.647 1.579 . . . . 0.0 114.817 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 75.8 p -115.26 20.47 14.87 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.938 1.295 . . . . 0.0 112.973 -172.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 69.0 mt -112.17 133.41 54.32 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.818 1.247 . . . . 0.0 111.762 -176.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 27.9 tp -87.72 121.27 29.94 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.096 0.958 . . . . 0.0 111.01 177.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 59.8 p -86.7 153.48 21.7 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.454 1.102 . . . . 0.0 112.866 172.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -167.53 178.34 5.47 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.901 1.68 . . . . 0.0 112.147 -178.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -118.54 175.96 5.48 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.877 2.071 . . . . 0.0 111.067 173.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -64.06 141.19 58.86 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.817 0.847 . . . . 0.0 111.404 169.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 75.47 11.49 84.28 Favored Glycine 0 CA--C 1.539 1.556 0 N-CA-C 114.975 0.75 . . . . 0.0 114.975 175.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -81.98 162.9 22.49 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.989 1.316 . . . . 0.0 112.036 173.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 86.9 t -117.35 129.2 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.96 1.304 . . . . 0.0 109.41 -172.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 30.5 mt -134.72 136.13 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.383 1.073 . . . . 0.0 109.474 -177.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 33.6 m -99.97 138.81 36.53 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.149 1.379 . . . . 0.0 110.31 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 20.8 mt -76.62 146.7 38.05 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 122.853 0.461 . . . . 0.0 112.219 -177.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 39.5 mt -120.07 -3.31 10.12 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 124.799 1.24 . . . . 0.0 112.773 177.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 371' ' ' ILE . . . . . 0.45 HG22 ' H ' ' A' ' 373' ' ' GLU . 6.2 mt -135.87 142.0 38.85 Favored Pre-proline 0 N--CA 1.481 1.101 0 C-N-CA 127.186 2.194 . . . . 0.0 109.917 177.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.13 -7.05 20.3 Favored 'Trans proline' 0 CA--C 1.546 1.121 0 C-N-CA 124.446 3.431 . . . . 0.0 115.248 175.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . 0.45 ' H ' HG22 ' A' ' 371' ' ' ILE . 18.1 pt-20 -151.48 167.34 28.33 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 126.091 1.756 . . . . 0.0 112.228 176.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -92.11 170.08 10.12 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.542 1.137 . . . . 0.0 113.036 175.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 10.5 tptp -133.51 111.09 10.41 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 126.366 1.866 . . . . 0.0 110.272 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 52.35 27.52 4.92 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 124.87 1.268 . . . . 0.0 114.257 -177.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 98.12 -14.31 62.63 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 125.727 1.632 . . . . 0.0 114.595 -176.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 75.7 m95 -87.04 133.31 33.61 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.412 1.106 . . . . 0.0 111.518 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 18.1 mt -102.01 162.59 12.79 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 124.342 1.057 . . . . 0.0 110.198 164.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -125.08 121.79 35.34 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.957 1.303 . . . . 0.0 107.733 175.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -145.44 174.12 25.57 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 115.542 -0.754 . . . . 0.0 114.139 -173.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -124.55 120.57 32.33 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.773 1.629 . . . . 0.0 109.798 177.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 15.8 t-80 -65.6 144.62 56.85 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.792 1.237 . . . . 0.0 111.952 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -77.71 -48.61 16.29 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 120.877 -1.139 . . . . 0.0 113.538 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 83.3 t -69.96 -48.99 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 124.03 0.932 . . . . 0.0 113.296 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 7.2 t -93.59 -16.05 24.77 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -171.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp 53.36 18.82 1.4 Allowed 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 127.024 2.13 . . . . 0.0 114.986 -173.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -78.01 156.11 30.33 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.411 0.684 . . . . 0.0 111.581 174.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -123.78 157.98 32.79 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.112 1.765 . . . . 0.0 110.652 177.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 159.68 168.86 22.26 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 124.252 0.93 . . . . 0.0 112.67 175.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -67.2 148.44 51.77 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.313 0.578 . . . . 0.0 110.258 168.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -154.36 154.39 29.5 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 124.526 1.13 . . . . 0.0 110.463 173.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -65.46 121.65 9.12 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.558 2.172 . . . . 0.0 110.883 177.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 30.4 t -56.44 -38.01 71.02 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.464 -0.772 . . . . 0.0 112.397 178.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 75.3 m -63.27 -19.6 64.71 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -73.08 -1.88 19.1 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.271 1.029 . . . . 0.0 113.192 171.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 53.8 p -131.77 164.06 26.84 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.962 1.705 . . . . 0.0 111.441 178.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -134.88 158.23 44.8 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.508 1.523 . . . . 0.0 109.27 174.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.5 127.26 30.32 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 171.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.77 -53.59 24.17 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 123.56 1.647 . . . . 0.0 114.132 -175.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -80.6 31.85 0.3 Allowed 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 128.301 2.64 . . . . 0.0 113.809 -176.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 . . . . . 0 C--O 1.255 1.388 0 C-N-CA 126.852 2.061 . . . . 0.0 113.975 174.261 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 526' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.832 0.348 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 64.1 mt -68.69 132.7 90.8 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 125.173 1.389 . . . . 0.0 109.759 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -69.76 158.73 55.95 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 123.459 2.772 . . . . 0.0 111.862 177.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.0 144.8 88.7 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 122.245 1.964 . . . . 0.0 112.256 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -69.74 154.77 94.47 Favored Pre-proline 0 CA--C 1.55 0.981 0 C-N-CA 122.962 0.505 . . . . 0.0 111.905 171.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -68.52 174.09 8.87 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.283 2.655 . . . . 0.0 113.009 177.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -86.65 1.95 50.13 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.463 1.105 . . . . 0.0 113.044 -178.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -132.74 153.57 81.12 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 124.736 1.215 . . . . 0.0 112.943 -176.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.4 152.97 61.16 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 123.694 2.929 . . . . 0.0 112.757 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -68.63 143.89 95.58 Favored Pre-proline 0 CA--C 1.551 1.013 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -73.54 -179.28 4.34 Favored 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 124.028 3.152 . . . . 0.0 112.791 176.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 22.2 p -134.28 155.07 80.21 Favored Pre-proline 0 N--CA 1.479 1.024 0 C-N-CA 125.247 1.419 . . . . 0.0 112.632 -175.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.59 163.13 36.22 Favored 'Trans proline' 0 CA--C 1.548 1.189 0 C-N-CA 123.512 2.808 . . . . 0.0 111.742 176.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -64.52 149.79 89.34 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 122.935 2.423 . . . . 0.0 112.576 177.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 540' ' ' VAL . . . . . . . . . . . . . 9.8 p -146.45 148.31 17.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 127.29 2.236 . . . . 0.0 109.347 -177.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 541' ' ' GLN . . . . . . . . . . . . . 41.0 mm-40 -136.97 144.53 43.4 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 126.27 1.828 . . . . 0.0 110.612 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 542' ' ' ASN . . . . . . . . . . . . . 55.8 t-20 . . . . . 0 C--O 1.255 1.358 0 C-N-CA 125.361 1.464 . . . . 0.0 111.433 -176.943 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.591 0 N-CA-C 111.759 -0.536 . . . . 0.0 111.759 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 82.0 p 42.92 39.04 1.59 Allowed 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 127.345 2.258 . . . . 0.0 116.116 177.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' HIS . . . . . . . . . . . . . 32.1 t60 -142.2 114.12 8.07 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.1 1.36 . . . . 0.0 110.721 -175.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' MET . . . . . . . . . . . . . 20.2 ptm -63.01 154.82 29.44 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.47 1.108 . . . . 0.0 113.233 178.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -118.81 -46.71 2.54 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.54 1.136 . . . . 0.0 112.747 -177.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -142.78 136.83 29.25 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 126.578 1.951 . . . . 0.0 110.323 -176.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' GLN . . . . . . . . . . . . . 72.6 tp60 -77.35 140.61 39.99 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.68 0.752 . . . . 0.0 111.804 177.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 3.1 mptm? -121.35 163.41 18.7 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.801 1.64 . . . . 0.0 111.3 173.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 15.7 m -134.6 157.72 41.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 126.643 1.977 . . . . 0.0 109.362 171.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -121.02 128.17 52.43 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.227 1.011 . . . . 0.0 109.901 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 59.0 p -71.79 154.04 41.56 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.01 0.924 . . . . 0.0 111.415 -177.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.8 pp -124.65 -8.36 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -156.01 159.54 31.45 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 126.731 2.012 . . . . 0.0 110.116 169.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.63 158.35 58.09 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.208 2.605 . . . . 0.0 113.331 177.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -142.62 154.99 44.89 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.98 1.312 . . . . 0.0 111.866 179.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 9.6 t -148.59 166.71 27.47 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.368 1.467 . . . . 0.0 113.065 -172.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -107.06 82.87 1.74 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.5 1.92 . . . . 0.0 110.546 -176.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . -62.91 -39.9 98.61 Favored Glycine 0 CA--C 1.537 1.43 0 N-CA-C 115.76 1.064 . . . . 0.0 115.76 -169.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 21.8 m -147.77 28.23 0.96 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.93 1.292 . . . . 0.0 112.417 -177.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 355' ' ' ASN . . . . . 0.593 HD22 ' HG ' ' A' ' 358' ' ' LEU . 54.4 t30 -142.49 172.07 13.19 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.524 1.13 . . . . 0.0 113.268 -169.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -127.7 8.52 6.36 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 125.982 1.713 . . . . 0.0 114.979 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 74.3 p -127.22 16.83 7.19 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 125.606 1.563 . . . . 0.0 113.409 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 358' ' ' LEU . . . . . 0.593 ' HG ' HD22 ' A' ' 355' ' ' ASN . 47.7 mt -97.37 120.43 37.71 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.714 1.206 . . . . 0.0 110.473 175.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 25.4 tp -73.18 131.95 42.63 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.494 0.718 . . . . 0.0 110.502 175.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 31.9 p -110.75 149.58 30.31 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.072 1.749 . . . . 0.0 112.395 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -167.11 179.08 5.33 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.149 1.379 . . . . 0.0 112.667 -169.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -116.49 177.0 4.85 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.712 2.005 . . . . 0.0 111.155 173.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -67.04 142.83 57.05 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.177 0.991 . . . . 0.0 111.888 170.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 75.61 5.39 78.32 Favored Glycine 0 CA--C 1.538 1.502 0 C-N-CA 124.376 0.988 . . . . 0.0 115.248 174.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -73.75 161.48 30.19 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.704 1.202 . . . . 0.0 111.723 171.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 59.3 t -112.51 138.32 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.485 1.114 . . . . 0.0 109.407 178.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 36.5 mt -136.26 140.77 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 124.717 1.207 . . . . 0.0 108.835 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 23.5 m -98.27 140.18 32.95 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.765 1.226 . . . . 0.0 110.853 178.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 22.7 mt -79.11 141.16 37.55 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 122.804 0.442 . . . . 0.0 111.554 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 63.1 mt -113.03 -4.45 13.86 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 124.673 1.189 . . . . 0.0 112.744 178.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 7.9 mt -132.92 141.76 42.21 Favored Pre-proline 0 N--CA 1.478 0.928 0 C-N-CA 127.001 2.12 . . . . 0.0 109.851 177.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.35 -7.98 22.42 Favored 'Trans proline' 0 CA--C 1.547 1.133 0 C-N-CA 123.974 3.116 . . . . 0.0 114.575 175.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -153.5 151.96 30.42 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.05 1.74 . . . . 0.0 112.062 175.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -74.62 171.33 14.05 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.417 1.087 . . . . 0.0 113.731 175.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -132.95 107.14 8.1 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.205 1.802 . . . . 0.0 110.249 -178.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 51.28 30.91 6.33 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 125.004 1.322 . . . . 0.0 114.343 -179.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 98.95 -16.75 59.1 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.772 1.653 . . . . 0.0 114.3 -177.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -85.75 132.06 34.21 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.308 1.043 . . . . 0.0 111.146 177.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 13.2 mt -100.7 159.94 14.76 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.939 0.896 . . . . 0.0 110.114 164.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -121.66 123.25 41.45 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 173.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -146.0 172.89 26.51 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-N 115.743 -0.662 . . . . 0.0 114.376 -172.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -124.68 116.46 22.41 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.88 1.672 . . . . 0.0 109.126 176.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 21.5 t-80 -61.88 144.29 55.14 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.818 1.247 . . . . 0.0 111.982 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -80.29 -45.32 18.07 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 121.217 -0.927 . . . . 0.0 112.705 -178.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 97.2 t -70.87 -52.73 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 124.256 1.022 . . . . 0.0 113.469 175.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 7.6 t -91.56 -15.61 28.41 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -171.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt 54.41 19.08 2.15 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 126.767 2.027 . . . . 0.0 114.777 -174.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -77.87 157.51 29.82 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.522 0.729 . . . . 0.0 111.822 174.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 54.1 mtt85 -128.52 155.9 44.14 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.007 1.723 . . . . 0.0 110.801 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 160.15 169.67 23.75 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 124.69 1.138 . . . . 0.0 112.03 176.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -66.8 147.17 53.6 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.114 0.566 . . . . 0.0 110.234 166.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -154.47 155.4 30.67 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 124.32 1.048 . . . . 0.0 110.17 172.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -65.64 120.1 7.23 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.167 1.911 . . . . 0.0 110.749 176.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 29.8 t -54.46 -38.45 66.37 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 121.897 -0.502 . . . . 0.0 111.958 176.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 17.9 m -58.58 -21.37 52.9 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.836 1.654 . . . . 0.0 115.255 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -77.41 0.27 23.17 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.606 1.163 . . . . 0.0 113.468 173.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 68.9 p -130.9 159.72 36.6 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.945 1.698 . . . . 0.0 111.328 176.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -124.73 164.28 20.29 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 125.307 1.443 . . . . 0.0 109.738 171.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.11 126.52 27.99 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.078 -0.964 . . . . 0.0 108.726 173.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . 0.4 HD12 ' O ' ' A' ' 400' ' ' LEU . 0.7 OUTLIER -53.35 -50.74 64.4 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 123.877 1.799 . . . . 0.0 114.459 -174.305 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -66.52 100.8 0.7 Allowed 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 128.303 2.641 . . . . 0.0 111.393 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 . . . . . 0 C--O 1.254 1.313 0 C-N-CA 126.329 1.851 . . . . 0.0 114.52 -173.998 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 526' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 . . . . . 0 N--CA 1.486 1.348 0 N-CA-C 110.578 -0.156 . . . . 0.0 110.578 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 58.9 mt -69.68 130.98 89.9 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 124.202 1.001 . . . . 0.0 109.821 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.36 160.37 49.75 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 123.532 2.821 . . . . 0.0 112.079 178.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.99 144.16 86.99 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.331 2.02 . . . . 0.0 112.357 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -72.41 156.14 90.63 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 123.361 0.664 . . . . 0.0 112.138 172.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -68.75 175.02 7.76 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.443 2.762 . . . . 0.0 113.219 176.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -91.8 8.93 34.86 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.856 1.262 . . . . 0.0 112.35 -178.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 36.3 p90 -137.73 154.56 74.86 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 124.617 1.167 . . . . 0.0 112.786 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -72.07 153.54 57.46 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 123.763 2.975 . . . . 0.0 112.74 178.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -69.26 142.42 92.52 Favored Pre-proline 0 CA--C 1.551 1.008 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -175.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -73.86 179.75 5.38 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 124.173 3.249 . . . . 0.0 113.266 178.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 28.1 p -132.59 155.45 81.21 Favored Pre-proline 0 N--CA 1.479 0.988 0 C-N-CA 125.392 1.477 . . . . 0.0 113.024 -172.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.13 163.0 39.43 Favored 'Trans proline' 0 CA--C 1.548 1.197 0 C-N-CA 123.545 2.83 . . . . 0.0 111.936 175.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -66.22 152.06 82.04 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.376 2.717 . . . . 0.0 112.925 178.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 540' ' ' VAL . . . . . . . . . . . . . 46.1 t -90.21 -27.89 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 124.627 1.171 . . . . 0.0 111.998 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 541' ' ' GLN . . . . . . . . . . . . . 23.0 mm100 -66.46 164.03 17.21 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.702 1.201 . . . . 0.0 113.086 175.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 542' ' ' ASN . . . . . . . . . . . . . 38.6 p30 . . . . . 0 C--O 1.255 1.343 0 C-N-CA 126.479 1.912 . . . . 0.0 113.398 -177.362 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.485 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 78.3 p -148.36 163.46 37.03 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.466 1.506 . . . . 0.0 112.098 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -84.2 -28.08 27.57 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -177.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' MET . . . . . . . . . . . . . 75.7 mtp -141.45 152.88 44.61 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.931 1.292 . . . . 0.0 112.87 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -77.26 -46.75 22.11 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.1 1.36 . . . . 0.0 113.373 -174.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -74.52 124.63 26.97 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.944 1.298 . . . . 0.0 110.388 176.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' GLN . . . . . . . . . . . . . 71.6 tp60 -67.98 136.83 54.53 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.868 0.842 . . . . 0.0 111.062 174.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -124.78 165.41 18.04 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.964 1.706 . . . . 0.0 111.002 177.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 16.3 m -134.45 156.2 40.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 126.717 2.007 . . . . 0.0 109.233 169.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -115.95 132.13 56.74 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 124.396 1.079 . . . . 0.0 109.885 177.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 72.3 p -75.04 153.94 38.2 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.526 0.73 . . . . 0.0 111.366 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.9 pp -123.97 -7.92 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -156.38 158.77 31.62 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 126.102 1.761 . . . . 0.0 110.117 170.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.02 155.78 68.34 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 122.947 2.431 . . . . 0.0 112.968 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -138.25 149.79 46.08 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.931 1.292 . . . . 0.0 111.621 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 10.4 m -142.9 131.72 22.76 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.098 1.359 . . . . 0.0 110.894 -167.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -73.06 -22.96 60.52 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 -178.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 57.81 -120.78 23.22 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.3 0.952 . . . . 0.0 112.118 -176.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 66.1 p -80.05 -10.67 59.79 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 176.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -84.46 170.35 13.6 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.253 1.021 . . . . 0.0 112.993 -176.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 20.8 ttpp -125.73 -16.92 5.59 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -178.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 36.7 p -99.94 13.15 34.9 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.315 1.446 . . . . 0.0 113.549 -176.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 81.8 mt -106.23 126.22 51.96 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.961 1.305 . . . . 0.0 110.963 -176.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 31.5 tp -73.86 141.8 46.09 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 122.987 0.515 . . . . 0.0 110.205 171.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 58.0 p -121.65 148.86 44.02 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.192 1.397 . . . . 0.0 111.721 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -165.54 178.5 6.68 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.97 1.308 . . . . 0.0 112.447 -167.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -117.7 177.63 4.69 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 127.117 2.167 . . . . 0.0 110.802 174.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -67.54 141.5 56.84 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 121.215 -0.928 . . . . 0.0 111.595 170.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 77.48 6.7 86.84 Favored Glycine 0 CA--C 1.538 1.485 0 N-CA-C 115.274 0.87 . . . . 0.0 115.274 176.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -74.02 164.67 26.32 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 118.437 1.119 . . . . 0.0 112.02 170.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 77.2 t -120.61 128.07 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.337 1.455 . . . . 0.0 109.125 -174.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 31.0 mt -132.55 137.06 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 123.399 0.68 . . . . 0.0 109.506 -175.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 20.5 m -98.02 140.27 32.61 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.334 1.054 . . . . 0.0 110.649 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 23.8 mt -81.17 142.94 32.74 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 122.975 0.51 . . . . 0.0 111.718 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 39.2 mt -116.04 -4.54 12.0 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.42 1.088 . . . . 0.0 113.003 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 6.9 mt -134.13 141.53 39.83 Favored Pre-proline 0 N--CA 1.477 0.88 0 C-N-CA 127.007 2.123 . . . . 0.0 109.57 177.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.81 -7.36 20.98 Favored 'Trans proline' 0 CA--C 1.549 1.255 0 C-N-CA 123.98 3.12 . . . . 0.0 114.561 176.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -150.3 154.49 37.96 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.073 1.749 . . . . 0.0 111.478 173.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -78.47 168.82 19.22 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 121.006 -1.059 . . . . 0.0 113.156 173.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -121.89 103.01 8.54 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 126.253 1.821 . . . . 0.0 110.253 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 52.14 31.47 9.05 Favored 'General case' 0 CA--C 1.555 1.136 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 177.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 99.84 -4.33 57.67 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 125.317 1.437 . . . . 0.0 114.675 -178.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -101.69 118.47 37.01 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.199 1.4 . . . . 0.0 110.67 176.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 12.6 mt -82.93 161.49 21.81 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.393 0.616 . . . . 0.0 110.546 162.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -126.04 123.5 38.56 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.152 1.381 . . . . 0.0 107.975 171.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -150.67 173.88 30.13 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-N 115.933 -0.576 . . . . 0.0 114.509 -169.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -126.21 120.29 29.67 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.653 1.581 . . . . 0.0 110.11 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 25.0 t-80 -66.4 156.07 35.66 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.256 1.422 . . . . 0.0 112.554 178.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -83.05 -48.18 10.88 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 178.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 71.2 t -75.66 -49.07 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 125.206 1.402 . . . . 0.0 113.393 -178.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 23.2 t -87.77 -23.34 24.12 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 118.786 0.721 . . . . 0.0 112.561 -176.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 7.0 mmmm 54.91 19.49 2.67 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 126.529 1.932 . . . . 0.0 114.006 -171.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -75.09 155.26 37.33 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.896 0.878 . . . . 0.0 111.817 172.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 -121.49 156.37 32.93 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 126.111 1.764 . . . . 0.0 111.429 176.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 165.57 169.63 29.44 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.898 1.237 . . . . 0.0 112.042 175.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -66.99 149.92 49.96 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.06 0.457 . . . . 0.0 110.126 166.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -155.87 154.37 27.66 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 124.263 1.025 . . . . 0.0 110.162 171.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 393' ' ' PRO . . . . . 0.4 ' HB3' ' HB1' ' B' ' 535' ' ' ALA . 20.4 Cg_endo -63.78 119.84 7.03 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.181 1.921 . . . . 0.0 110.406 177.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.1 -36.41 70.59 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 121.391 -0.818 . . . . 0.0 111.564 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 18.2 m -59.43 -22.11 60.99 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 126.748 2.019 . . . . 0.0 114.944 178.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -74.88 0.72 14.66 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.763 1.225 . . . . 0.0 113.217 172.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 36.6 p -134.81 162.79 31.39 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.735 1.614 . . . . 0.0 111.803 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -134.28 156.42 48.46 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.499 1.52 . . . . 0.0 109.988 176.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.1 124.28 20.07 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.41 1.084 . . . . 0.0 110.337 -177.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 23.9 tp -61.37 -44.62 96.86 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 123.216 1.484 . . . . 0.0 114.838 -175.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -93.61 56.65 2.42 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 127.932 2.493 . . . . 0.0 111.881 -176.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? . . . . . 0 C--O 1.253 1.286 0 C-N-CA 126.792 2.037 . . . . 0.0 115.884 178.855 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 526' ' ' HIS . . . . . . . . . . . . . 32.4 m80 . . . . . 0 N--CA 1.485 1.306 0 CA-C-O 120.462 0.172 . . . . 0.0 110.629 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 57.9 mt -72.28 131.79 84.71 Favored Pre-proline 0 N--CA 1.479 0.997 0 C-N-CA 124.455 1.102 . . . . 0.0 109.663 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -69.93 160.49 49.48 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 123.574 2.849 . . . . 0.0 112.138 177.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.07 144.49 87.52 Favored 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 122.294 1.996 . . . . 0.0 112.136 178.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -73.14 155.49 90.12 Favored Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 123.118 0.567 . . . . 0.0 112.027 173.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -69.07 174.7 8.52 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 123.537 2.824 . . . . 0.0 113.128 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -92.34 9.02 35.82 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.913 1.285 . . . . 0.0 112.472 -178.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 34.9 p90 -137.85 153.86 74.11 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 124.621 1.168 . . . . 0.0 112.842 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -71.92 151.91 57.08 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.579 2.853 . . . . 0.0 112.364 177.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 535' ' ' ALA . . . . . 0.4 ' HB1' ' HB3' ' A' ' 393' ' ' PRO . . . -69.91 146.3 95.16 Favored Pre-proline 0 CA--C 1.549 0.923 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -175.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.95 178.12 6.87 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 123.979 3.119 . . . . 0.0 112.833 176.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 25.3 p -132.36 154.02 81.43 Favored Pre-proline 0 N--CA 1.478 0.941 0 C-N-CA 125.316 1.447 . . . . 0.0 112.449 -175.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -66.5 162.24 37.6 Favored 'Trans proline' 0 CA--C 1.548 1.186 0 C-N-CA 123.353 2.702 . . . . 0.0 111.48 175.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -64.11 154.02 72.92 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.167 2.578 . . . . 0.0 112.713 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 540' ' ' VAL . . . . . . . . . . . . . 38.3 t -100.93 106.38 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.348 1.459 . . . . 0.0 108.219 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 541' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -138.46 175.42 9.58 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 127.337 2.255 . . . . 0.0 111.315 -173.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 542' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 . . . . . 0 C--O 1.253 1.273 0 C-N-CA 126.096 1.758 . . . . 0.0 111.865 -176.17 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.62 0 N-CA-C 112.424 -0.27 . . . . 0.0 112.424 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 11.7 t -145.82 71.98 1.29 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.982 1.313 . . . . 0.0 111.477 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -66.31 -9.7 35.53 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 176.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' MET . . . . . . . . . . . . . 3.1 tpt -85.62 -25.88 26.38 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -175.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 25.5 tptp -61.98 -33.15 73.78 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.37 1.068 . . . . 0.0 113.465 -175.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -108.16 109.21 20.55 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 126.157 1.783 . . . . 0.0 108.316 174.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' GLN . . . . . . . . . . . . . 71.0 tp60 -62.22 136.32 57.88 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.736 0.779 . . . . 0.0 111.081 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -119.67 160.76 21.9 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.363 1.465 . . . . 0.0 111.498 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 17.4 m -136.07 154.06 32.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 126.312 1.845 . . . . 0.0 109.543 171.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -118.19 134.99 54.52 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.292 1.037 . . . . 0.0 110.362 176.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 81.3 p -77.44 154.21 32.83 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.065 1.346 . . . . 0.0 111.674 -176.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.9 pp -119.7 -9.62 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -178.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -154.69 159.04 32.25 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 126.427 1.891 . . . . 0.0 110.538 170.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -69.88 158.01 58.25 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.225 2.617 . . . . 0.0 112.987 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 35.9 t-80 -142.42 144.35 33.06 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.835 1.654 . . . . 0.0 111.193 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 62.2 m -147.58 124.67 11.4 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.619 1.168 . . . . 0.0 111.055 -171.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -65.09 123.29 19.11 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.768 0.827 . . . . 0.0 110.764 167.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . -122.46 -30.23 1.2 Allowed Glycine 0 N--CA 1.478 1.474 0 C-N-CA 124.256 0.932 . . . . 0.0 115.288 -171.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 5.7 t -144.72 39.1 1.24 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.809 1.644 . . . . 0.0 109.796 173.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -141.05 176.13 9.07 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.802 1.641 . . . . 0.0 111.603 -162.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -138.5 -41.25 0.5 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.682 1.193 . . . . 0.0 114.037 177.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 41.2 p -88.05 14.85 8.25 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.143 1.377 . . . . 0.0 114.004 -174.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -102.68 118.52 37.02 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.096 1.358 . . . . 0.0 110.773 -171.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 28.5 tp -72.25 120.64 18.14 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 122.999 0.52 . . . . 0.0 110.736 176.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 50.1 m -95.54 147.97 23.0 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.315 1.046 . . . . 0.0 111.982 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -164.5 178.02 7.71 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.131 1.372 . . . . 0.0 113.215 -171.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -116.71 175.12 5.72 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.373 1.869 . . . . 0.0 111.681 174.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -64.31 140.72 58.9 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.01 0.924 . . . . 0.0 111.563 170.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 75.12 6.31 79.06 Favored Glycine 0 CA--C 1.539 1.532 0 C-N-CA 123.985 0.803 . . . . 0.0 115.076 176.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -77.02 161.62 28.18 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.731 1.212 . . . . 0.0 111.983 174.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 91.9 t -114.64 131.53 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 124.952 1.301 . . . . 0.0 109.841 -172.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 23.8 mt -135.23 139.73 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.204 1.402 . . . . 0.0 108.839 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 25.0 m -100.88 138.66 37.62 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.16 1.384 . . . . 0.0 110.302 -178.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 23.0 mt -79.15 136.37 37.09 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 118.138 0.426 . . . . 0.0 111.768 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 24.9 mt -114.36 -10.13 12.69 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.308 1.043 . . . . 0.0 113.089 -179.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 10.0 mt -126.69 141.16 39.47 Favored Pre-proline 0 N--CA 1.475 0.822 0 C-N-CA 126.565 1.946 . . . . 0.0 109.588 175.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.12 -7.71 21.51 Favored 'Trans proline' 0 CA--C 1.548 1.203 0 C-N-CA 123.8 3.0 . . . . 0.0 114.615 176.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -152.52 153.27 33.12 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.686 1.595 . . . . 0.0 112.368 176.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 19.2 pm0 -75.56 169.06 18.83 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.652 1.181 . . . . 0.0 113.619 173.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -130.63 106.67 8.65 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 126.75 2.02 . . . . 0.0 109.992 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 51.12 30.48 5.62 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 124.926 1.29 . . . . 0.0 114.41 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 100.94 -14.06 58.81 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 125.807 1.67 . . . . 0.0 114.475 -178.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 82.0 m95 -89.42 135.47 33.57 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.281 1.032 . . . . 0.0 111.633 178.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 18.9 mt -107.17 161.02 15.14 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.833 1.253 . . . . 0.0 109.973 166.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -123.16 120.05 32.05 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.671 1.188 . . . . 0.0 107.884 175.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -143.7 170.96 25.52 Favored Glycine 0 CA--C 1.527 0.844 0 CA-C-N 115.611 -0.722 . . . . 0.0 114.199 -173.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -120.37 118.43 30.34 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.424 1.489 . . . . 0.0 110.114 178.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 19.8 t-80 -63.4 147.43 51.24 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.903 1.281 . . . . 0.0 112.059 178.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -79.87 -49.46 11.9 Favored 'General case' 0 CA--C 1.547 0.865 0 O-C-N 120.868 -1.145 . . . . 0.0 113.411 177.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 63.7 t -68.8 -50.78 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.993 0.917 . . . . 0.0 113.234 178.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 23.0 t -86.15 -23.56 26.53 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.439 0.695 . . . . 0.0 112.868 -173.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp 54.71 16.42 1.38 Allowed 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 126.655 1.982 . . . . 0.0 114.66 -168.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -75.17 153.35 38.21 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.387 0.675 . . . . 0.0 111.794 172.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 82.4 mtm180 -124.06 151.1 44.22 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 126.42 1.888 . . . . 0.0 110.76 177.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 170.26 168.31 31.92 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 124.521 1.057 . . . . 0.0 112.146 175.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -65.5 145.68 55.81 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.136 0.493 . . . . 0.0 110.237 167.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -153.33 155.23 31.59 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 124.432 1.093 . . . . 0.0 111.037 175.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -65.65 121.7 9.15 Favored 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 122.496 2.131 . . . . 0.0 111.715 178.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 41.0 t -59.55 -27.75 66.49 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 121.644 -0.66 . . . . 0.0 112.649 174.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 17.8 m -66.96 -17.94 65.15 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 174.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -83.38 -2.24 55.3 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.717 1.207 . . . . 0.0 113.543 178.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 67.1 p -127.38 168.06 15.35 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.29 1.836 . . . . 0.0 109.897 172.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? -126.49 -75.11 0.58 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.769 0.828 . . . . 0.0 109.717 175.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 399' ' ' LEU . . . . . 0.467 HD13 ' H ' ' A' ' 400' ' ' LEU . 0.2 OUTLIER -166.84 151.45 7.34 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 127.252 2.221 . . . . 0.0 107.49 171.762 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . 0.467 ' H ' HD13 ' A' ' 399' ' ' LEU . 0.2 OUTLIER -61.96 -69.2 0.26 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 124.106 1.907 . . . . 0.0 111.825 172.906 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -60.66 155.51 18.8 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 110.449 -3.069 . . . . 0.0 112.87 -175.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 . . . . . 0 C--O 1.253 1.282 0 C-N-CA 125.988 1.715 . . . . 0.0 112.72 -172.557 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 526' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.923 0.392 . . . . 0.0 110.987 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 45.2 mt -70.0 133.27 88.05 Favored Pre-proline 0 N--CA 1.476 0.862 0 C-N-CA 125.012 1.325 . . . . 0.0 109.625 178.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -69.16 160.64 49.09 Favored 'Trans proline' 0 CA--C 1.545 1.047 0 C-N-CA 123.321 2.681 . . . . 0.0 111.963 177.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -64.52 145.86 88.26 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 122.286 1.99 . . . . 0.0 112.321 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -68.63 153.24 96.06 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 122.975 0.51 . . . . 0.0 111.85 171.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -69.56 174.48 9.27 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 123.487 2.791 . . . . 0.0 113.165 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -87.94 2.9 50.5 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.608 1.163 . . . . 0.0 112.957 -178.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 37.5 p90 -133.86 154.48 80.44 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 124.744 1.217 . . . . 0.0 112.778 -176.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.47 152.62 60.4 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 123.625 2.883 . . . . 0.0 112.688 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -66.96 142.0 97.07 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 123.703 0.801 . . . . 0.0 113.033 -177.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.19 176.94 8.46 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 123.852 3.035 . . . . 0.0 112.836 177.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 31.9 p -131.56 154.5 81.87 Favored Pre-proline 0 N--CA 1.478 0.951 0 C-N-CA 125.254 1.422 . . . . 0.0 112.659 -173.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.28 162.89 40.03 Favored 'Trans proline' 0 CA--C 1.548 1.18 0 C-N-CA 123.562 2.842 . . . . 0.0 111.94 176.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -64.42 144.89 86.89 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 123.236 2.624 . . . . 0.0 112.562 178.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 540' ' ' VAL . . . . . . . . . . . . . 48.9 t -75.95 -37.39 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 124.209 1.004 . . . . 0.0 111.389 178.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 541' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -68.13 151.77 46.5 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.715 1.206 . . . . 0.0 113.13 176.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 542' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 . . . . . 0 C--O 1.252 1.22 0 C-N-CA 124.778 1.231 . . . . 0.0 112.223 173.405 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.443 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.4 p -152.65 165.98 33.57 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.828 1.251 . . . . 0.0 112.698 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 338' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -138.16 162.49 34.09 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.022 1.729 . . . . 0.0 111.245 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 339' ' ' MET . . . . . . . . . . . . . 45.2 mtm 53.74 34.28 18.68 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.877 1.671 . . . . 0.0 113.753 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 17.3 ttpt -112.48 25.87 11.09 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.849 1.66 . . . . 0.0 113.465 -170.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 341' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.66 102.04 10.38 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.427 1.491 . . . . 0.0 109.418 178.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 342' ' ' GLN . . . . . . . . . . . . . 71.3 tp60 -65.35 136.03 56.04 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.599 0.714 . . . . 0.0 111.214 176.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -132.36 167.8 19.24 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.984 1.314 . . . . 0.0 111.326 175.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 15.3 m -130.58 160.27 41.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 126.636 1.975 . . . . 0.0 109.576 171.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -122.78 132.55 54.27 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.45 1.1 . . . . 0.0 109.699 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 74.2 p -78.67 152.42 31.66 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.502 1.121 . . . . 0.0 111.172 -177.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.8 pp -120.95 -9.33 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 -178.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -153.38 158.62 32.72 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 126.286 1.834 . . . . 0.0 110.308 168.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -69.09 156.93 63.59 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.407 2.738 . . . . 0.0 113.271 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 44.0 t-80 -138.97 144.02 38.78 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.516 1.526 . . . . 0.0 111.4 178.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 86.1 m -140.87 137.76 33.45 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 126.018 1.727 . . . . 0.0 110.352 -174.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -67.06 -33.08 74.73 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -173.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 52.47 62.35 5.86 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 124.748 1.166 . . . . 0.0 115.115 170.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 2.8 t 74.93 47.43 0.11 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 126.045 1.738 . . . . 0.0 112.611 -174.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -144.41 170.3 16.29 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 125.359 1.463 . . . . 0.0 111.232 173.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -128.01 -21.41 3.65 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.728 1.611 . . . . 0.0 113.84 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 56.3 p -96.37 8.24 44.47 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.831 1.252 . . . . 0.0 113.757 -178.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 56.2 mt -102.08 132.32 48.01 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.606 1.162 . . . . 0.0 111.13 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 28.2 tp -83.66 120.11 25.58 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.06 0.544 . . . . 0.0 110.872 175.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 54.7 p -88.54 152.46 21.84 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.566 1.147 . . . . 0.0 112.637 172.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -167.88 177.57 5.63 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.532 1.533 . . . . 0.0 112.304 -176.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -117.07 174.46 6.09 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.452 1.901 . . . . 0.0 111.452 174.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -64.27 140.49 58.87 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.442 -0.786 . . . . 0.0 111.608 170.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 77.57 3.76 83.63 Favored Glycine 0 CA--C 1.537 1.406 0 C-N-CA 124.349 0.976 . . . . 0.0 115.117 175.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -72.1 168.36 18.3 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.527 1.131 . . . . 0.0 112.344 173.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 91.2 t -118.91 130.42 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.603 1.561 . . . . 0.0 108.935 -174.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 17.2 mt -134.35 138.32 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.401 1.08 . . . . 0.0 109.57 -178.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 11.8 m -104.31 139.22 39.61 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.144 1.378 . . . . 0.0 110.72 -176.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 25.9 mt -79.17 142.81 36.0 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -173.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 29.8 mt -119.18 -8.8 10.09 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.514 1.125 . . . . 0.0 113.07 178.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 371' ' ' ILE . . . . . 0.441 HG22 ' H ' ' A' ' 373' ' ' GLU . 5.7 mt -134.73 141.25 37.94 Favored Pre-proline 0 N--CA 1.478 0.957 0 C-N-CA 126.833 2.053 . . . . 0.0 109.397 176.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.64 -0.6 10.01 Favored 'Trans proline' 0 CA--C 1.548 1.219 0 C-N-CA 124.62 3.546 . . . . 0.0 114.601 175.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . 0.441 ' H ' HG22 ' A' ' 371' ' ' ILE . 12.6 pt-20 -151.05 175.84 11.71 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.779 2.032 . . . . 0.0 111.535 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -116.16 164.96 13.71 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.148 1.379 . . . . 0.0 112.928 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -123.21 106.52 10.81 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 126.121 1.768 . . . . 0.0 110.323 -176.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 49.96 33.1 6.25 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.314 1.446 . . . . 0.0 114.789 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 96.82 -2.49 62.07 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.113 1.34 . . . . 0.0 114.628 -178.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 78.8 m95 -101.47 121.89 42.79 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.158 1.383 . . . . 0.0 110.763 177.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 13.1 mt -88.42 164.45 15.49 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.424 0.689 . . . . 0.0 110.151 162.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -127.29 121.03 30.01 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 124.953 1.301 . . . . 0.0 108.088 173.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -147.84 177.22 26.24 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.137 0.875 . . . . 0.0 113.865 -170.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -129.63 124.16 33.03 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.541 1.536 . . . . 0.0 110.555 -177.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -66.63 140.88 57.95 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.33 1.052 . . . . 0.0 112.164 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -73.05 -36.75 66.95 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 120.939 -1.1 . . . . 0.0 113.511 177.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 59.1 t -77.31 -34.43 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -173.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 8.5 t -124.62 -12.29 7.19 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.704 1.201 . . . . 0.0 113.442 -168.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? 56.37 16.91 2.62 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 125.995 1.718 . . . . 0.0 114.739 -175.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -66.99 147.24 53.48 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.204 1.002 . . . . 0.0 111.186 170.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -121.76 156.52 32.98 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.845 1.658 . . . . 0.0 111.516 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 164.52 170.17 29.09 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 124.162 0.886 . . . . 0.0 113.027 173.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -65.85 145.18 56.26 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.184 0.594 . . . . 0.0 110.346 168.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -153.48 153.46 29.18 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 124.125 0.97 . . . . 0.0 111.314 174.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -63.49 121.46 9.25 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.546 2.164 . . . . 0.0 111.345 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.66 -17.38 64.0 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 121.296 -0.877 . . . . 0.0 113.036 178.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 77.6 p -73.98 -22.19 59.71 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.777 2.031 . . . . 0.0 114.159 174.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -79.8 -1.11 37.36 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.254 1.421 . . . . 0.0 113.425 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 69.9 p -129.98 166.67 19.6 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.584 1.954 . . . . 0.0 110.873 174.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -127.06 -90.91 0.52 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.963 0.905 . . . . 0.0 110.2 176.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 399' ' ' LEU . . . . . 0.415 HD13 ' N ' ' A' ' 400' ' ' LEU . 0.6 OUTLIER -162.04 135.16 6.12 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.688 1.595 . . . . 0.0 109.131 173.783 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . 0.415 ' N ' HD13 ' A' ' 399' ' ' LEU . 17.6 tp -65.6 -53.37 42.62 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -177.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -149.3 111.84 4.75 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 125.738 1.615 . . . . 0.0 112.965 -174.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 . . . . . 0 C--O 1.253 1.258 0 C-N-CA 125.566 1.546 . . . . 0.0 113.794 179.529 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 526' ' ' HIS . . . . . . . . . . . . . 52.2 m80 . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.659 0.266 . . . . 0.0 110.577 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 69.3 mt -68.65 131.47 91.35 Favored Pre-proline 0 N--CA 1.477 0.923 0 C-N-CA 124.513 1.125 . . . . 0.0 109.517 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.28 160.34 49.91 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 123.57 2.847 . . . . 0.0 112.16 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.07 144.87 88.55 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.378 2.052 . . . . 0.0 112.238 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -73.42 157.13 88.35 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 123.387 0.675 . . . . 0.0 112.192 173.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -68.34 174.13 8.64 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.289 2.659 . . . . 0.0 113.157 176.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -86.26 0.28 54.17 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.651 1.18 . . . . 0.0 113.02 -178.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 38.4 p90 -133.28 153.57 80.69 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 124.792 1.237 . . . . 0.0 113.003 -174.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -71.45 152.54 60.46 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.542 2.828 . . . . 0.0 112.317 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -68.12 149.03 98.3 Favored Pre-proline 0 CA--C 1.55 0.952 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -176.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -72.27 -176.83 2.35 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 124.122 3.215 . . . . 0.0 112.801 176.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 24.3 p -137.04 153.89 75.58 Favored Pre-proline 0 N--CA 1.476 0.855 0 C-N-CA 125.341 1.457 . . . . 0.0 112.649 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -67.61 165.24 28.11 Favored 'Trans proline' 0 CA--C 1.548 1.176 0 C-N-CA 123.504 2.803 . . . . 0.0 111.948 175.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -62.41 159.27 36.57 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.453 2.769 . . . . 0.0 113.351 177.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 540' ' ' VAL . . . . . . . . . . . . . 3.6 t -137.23 49.79 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 126.554 1.942 . . . . 0.0 109.61 -171.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 541' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -126.45 169.82 12.61 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.921 2.088 . . . . 0.0 111.316 -178.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 542' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 . . . . . 0 C--O 1.254 1.306 0 C-N-CA 126.384 1.874 . . . . 0.0 113.053 -175.256 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.49 0 N-CA-C 111.054 -0.819 . . . . 0.0 111.054 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 23.0 t -145.66 129.27 17.07 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.035 1.334 . . . . 0.0 110.599 175.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 338' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -71.82 -38.1 70.25 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.531 0.938 . . . . 0.0 113.531 -173.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 339' ' ' MET . . . . . . . . . . . . . 84.9 mtp -98.23 143.26 28.92 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.088 0.955 . . . . 0.0 111.618 -177.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -74.44 95.77 2.78 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.645 1.178 . . . . 0.0 110.957 173.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 341' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.38 165.06 33.18 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.984 2.114 . . . . 0.0 109.693 172.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 342' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -138.76 140.16 38.54 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.039 0.935 . . . . 0.0 110.788 172.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -120.4 162.23 19.86 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.031 1.333 . . . . 0.0 111.717 174.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 16.0 m -134.77 156.23 39.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 126.909 2.084 . . . . 0.0 108.973 172.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -119.26 132.01 55.85 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.954 0.901 . . . . 0.0 109.904 178.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 66.8 p -74.74 149.89 39.63 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 124.852 1.261 . . . . 0.0 111.483 -178.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.7 pp -124.63 -7.82 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -176.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -154.95 157.19 31.89 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 126.67 1.988 . . . . 0.0 109.652 169.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -69.05 158.34 58.28 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.883 2.388 . . . . 0.0 112.439 177.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 36.3 t-80 -128.52 161.38 29.68 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.048 1.339 . . . . 0.0 112.018 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 86.9 m -132.14 141.28 49.07 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.581 1.552 . . . . 0.0 111.291 -166.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -140.0 31.23 2.0 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 125.512 1.525 . . . . 0.0 111.993 -176.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . -75.34 -29.71 59.7 Favored Glycine 0 CA--C 1.537 1.43 0 O-C-N 120.875 -1.141 . . . . 0.0 115.135 -173.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 46.3 m -102.09 5.68 40.58 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.078 1.351 . . . . 0.0 113.415 -178.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -142.56 173.14 11.8 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.143 1.777 . . . . 0.0 111.799 -173.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 2.4 mmmm -134.14 8.88 3.76 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 -171.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 32.6 p -134.3 18.42 3.69 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 125.767 1.627 . . . . 0.0 113.047 -177.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 49.3 mt -110.49 134.68 52.13 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.308 1.443 . . . . 0.0 110.921 -177.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 31.8 tp -83.21 126.05 32.22 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.871 0.868 . . . . 0.0 110.953 177.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 69.8 m -91.38 147.49 22.99 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.405 1.082 . . . . 0.0 111.957 173.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -163.21 177.56 8.94 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.708 1.603 . . . . 0.0 112.19 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -131.98 154.03 49.74 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.743 2.017 . . . . 0.0 111.5 178.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -50.89 130.59 25.51 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.716 0.806 . . . . 0.0 112.748 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 94.93 -14.27 65.63 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 124.342 0.973 . . . . 0.0 114.362 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -68.75 155.44 40.12 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.378 1.089 . . . . 0.0 112.165 174.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 69.3 t -111.74 142.52 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 125.823 1.649 . . . . 0.0 109.893 -175.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 16.9 mt -136.59 138.61 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.107 1.363 . . . . 0.0 109.024 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 18.5 m -102.55 137.24 41.04 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.705 1.202 . . . . 0.0 110.2 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 27.0 mt -77.04 143.51 39.26 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 122.935 0.494 . . . . 0.0 111.966 -175.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 42.5 mt -116.77 -7.18 11.52 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 124.73 1.212 . . . . 0.0 113.084 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 7.1 mt -130.83 140.41 38.59 Favored Pre-proline 0 N--CA 1.477 0.892 0 C-N-CA 126.617 1.967 . . . . 0.0 109.391 176.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.01 -7.29 20.77 Favored 'Trans proline' 0 CA--C 1.547 1.14 0 C-N-CA 123.582 2.854 . . . . 0.0 114.849 176.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -152.67 152.24 31.51 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.85 1.66 . . . . 0.0 111.937 174.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -76.45 170.45 16.36 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.626 1.17 . . . . 0.0 113.68 176.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -129.7 106.25 8.58 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.337 1.855 . . . . 0.0 110.142 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 49.92 32.51 5.61 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 125.328 1.451 . . . . 0.0 114.559 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 99.65 -14.37 60.56 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 125.506 1.527 . . . . 0.0 114.388 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -89.01 134.03 34.13 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.662 1.231 . . . . 0.0 111.457 176.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 13.1 mt -102.1 162.09 13.18 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.533 1.133 . . . . 0.0 110.277 165.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -124.07 123.04 39.46 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.981 1.312 . . . . 0.0 107.924 172.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -149.27 175.01 28.68 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 115.644 -0.707 . . . . 0.0 113.704 -170.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -126.47 122.72 36.02 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.272 1.429 . . . . 0.0 110.73 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -63.13 149.0 46.35 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.834 1.254 . . . . 0.0 112.353 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -88.34 -24.98 22.99 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 120.859 -1.151 . . . . 0.0 113.903 178.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 59.1 t -80.33 -35.01 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 O-C-N 121.352 -0.843 . . . . 0.0 112.658 -179.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 6.6 t -128.62 -10.79 5.02 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.59 1.156 . . . . 0.0 113.707 -169.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 4.8 mptt 53.82 24.65 4.6 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 125.432 1.493 . . . . 0.0 113.512 -175.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -68.79 147.45 51.75 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.6 1.16 . . . . 0.0 110.92 168.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 74.0 mtm-85 -120.2 157.28 29.4 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.556 1.542 . . . . 0.0 111.821 178.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 164.86 169.42 28.45 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.643 1.116 . . . . 0.0 112.584 175.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -69.61 148.01 49.94 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 122.802 0.441 . . . . 0.0 110.54 169.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -155.47 155.97 30.36 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 123.98 0.912 . . . . 0.0 111.685 175.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -65.02 121.1 8.48 Favored 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 122.81 2.34 . . . . 0.0 111.883 177.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 89.8 p -60.23 -22.4 62.98 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 176.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 18.1 m -74.59 -18.37 60.58 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 175.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -80.65 -0.86 39.97 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.712 1.205 . . . . 0.0 113.133 178.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 62.2 p -131.07 165.61 22.86 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.871 1.668 . . . . 0.0 111.516 175.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -135.49 159.87 40.24 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.863 1.665 . . . . 0.0 109.674 174.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.74 124.68 20.59 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.381 0.672 . . . . 0.0 109.49 174.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.5 tp -54.87 -45.16 74.57 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 123.692 1.71 . . . . 0.0 114.9 -172.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -73.83 99.89 3.32 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 127.165 2.186 . . . . 0.0 111.798 -177.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 . . . . . 0 C--O 1.253 1.239 0 C-N-CA 125.557 1.543 . . . . 0.0 113.719 177.803 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 526' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.809 0.338 . . . . 0.0 110.807 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 63.6 mt -69.14 132.16 90.24 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 124.838 1.255 . . . . 0.0 109.682 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.92 161.33 46.36 Favored 'Trans proline' 0 CA--C 1.545 1.05 0 C-N-CA 123.573 2.849 . . . . 0.0 112.091 177.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.16 144.46 86.92 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.271 1.981 . . . . 0.0 112.707 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -72.15 156.5 90.62 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 123.47 0.708 . . . . 0.0 112.194 171.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.42 174.37 9.32 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.435 2.757 . . . . 0.0 113.222 176.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -89.24 3.16 52.92 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.886 1.274 . . . . 0.0 113.016 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 40.8 p90 -134.15 154.42 80.09 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 124.764 1.226 . . . . 0.0 112.91 -175.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -71.54 153.37 60.31 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 123.689 2.926 . . . . 0.0 112.721 178.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -68.21 142.64 95.07 Favored Pre-proline 0 CA--C 1.553 1.081 0 C-N-CA 124.078 0.951 . . . . 0.0 113.215 -176.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.38 177.2 8.21 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 124.125 3.217 . . . . 0.0 113.002 176.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 35.6 p -132.43 153.35 81.17 Favored Pre-proline 0 N--CA 1.479 0.986 0 C-N-CA 125.289 1.436 . . . . 0.0 112.848 -175.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -69.17 162.94 39.73 Favored 'Trans proline' 0 CA--C 1.549 1.271 0 C-N-CA 123.699 2.933 . . . . 0.0 112.103 177.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -65.87 153.46 78.02 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.409 2.74 . . . . 0.0 113.223 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 540' ' ' VAL . . . . . . . . . . . . . 46.8 t -89.92 -16.99 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 125.241 1.417 . . . . 0.0 112.23 -178.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 541' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -61.79 162.07 9.3 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.275 1.43 . . . . 0.0 113.265 177.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 542' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 . . . . . 0 C--O 1.248 1.001 0 C-N-CA 126.027 1.731 . . . . 0.0 112.095 -174.36 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.6 0 CA-C-O 121.298 0.388 . . . . 0.0 112.212 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 36.6 p -66.02 147.0 54.02 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.276 1.03 . . . . 0.0 112.625 173.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 338' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -157.0 170.83 21.63 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.204 1.402 . . . . 0.0 112.165 176.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 339' ' ' MET . . . . . . . . . . . . . 22.7 mmt 55.94 23.12 6.31 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 126.36 1.864 . . . . 0.0 115.035 178.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm -69.93 -24.4 63.36 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -173.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 341' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -132.75 138.38 47.17 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.919 1.688 . . . . 0.0 109.868 176.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 342' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -75.42 137.84 41.27 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.856 0.836 . . . . 0.0 110.877 172.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -122.46 162.61 21.37 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 126.076 1.75 . . . . 0.0 110.681 175.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 16.8 m -136.67 154.12 31.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 125.93 1.692 . . . . 0.0 109.618 171.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -115.07 132.96 56.43 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.752 0.821 . . . . 0.0 110.61 174.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 81.7 p -72.06 152.29 42.51 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.411 1.084 . . . . 0.0 111.185 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.8 pp -121.97 -8.86 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -178.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -155.06 158.18 32.02 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 127.04 2.136 . . . . 0.0 109.897 169.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -68.85 158.01 59.57 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.116 2.544 . . . . 0.0 112.691 177.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 -139.18 146.13 40.19 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.117 1.367 . . . . 0.0 111.696 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 86.9 m -142.58 123.7 14.54 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.384 1.473 . . . . 0.0 111.436 -172.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -59.38 114.56 2.73 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 125.464 1.506 . . . . 0.0 111.179 165.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . -111.34 -41.07 1.18 Allowed Glycine 0 CA--C 1.54 1.6 0 N-CA-C 115.668 1.027 . . . . 0.0 115.668 -168.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 16.1 t -137.38 33.65 2.53 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.569 1.548 . . . . 0.0 110.746 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -149.89 -179.48 7.17 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.722 1.609 . . . . 0.0 112.045 -165.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 46.8 tptt -132.25 -30.45 1.52 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.291 1.436 . . . . 0.0 113.763 172.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 39.8 p -89.29 23.51 2.48 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.618 1.167 . . . . 0.0 113.918 -174.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 66.6 mt -101.66 128.15 48.09 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.968 1.307 . . . . 0.0 110.86 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 33.1 tp -78.32 121.35 24.33 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.208 0.603 . . . . 0.0 110.171 173.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 71.0 m -94.97 146.72 24.05 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.384 1.074 . . . . 0.0 111.438 175.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -162.58 178.14 8.82 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.252 1.421 . . . . 0.0 112.455 -175.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -116.47 173.52 6.56 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.145 1.778 . . . . 0.0 111.456 174.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -65.33 142.03 58.38 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.041 0.936 . . . . 0.0 111.565 171.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 75.41 9.36 84.45 Favored Glycine 0 CA--C 1.538 1.517 0 N-CA-C 114.808 0.683 . . . . 0.0 114.808 177.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -81.6 161.93 23.31 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.597 1.159 . . . . 0.0 111.705 172.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 31.2 t -115.42 135.35 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.735 1.214 . . . . 0.0 109.35 -174.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 18.4 mt -138.16 135.82 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.496 1.118 . . . . 0.0 109.342 -176.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 12.5 m -92.64 141.85 28.02 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.246 1.018 . . . . 0.0 110.476 174.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 23.0 mt -82.25 143.2 31.51 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 122.968 0.507 . . . . 0.0 111.64 178.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 47.2 mt -114.37 -4.65 12.95 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 124.591 1.156 . . . . 0.0 112.841 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 371' ' ' ILE . . . . . 0.4 HG22 ' H ' ' A' ' 373' ' ' GLU . 6.9 mt -134.65 141.71 39.8 Favored Pre-proline 0 N--CA 1.48 1.045 0 C-N-CA 127.048 2.139 . . . . 0.0 109.66 177.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.2 -8.07 22.11 Favored 'Trans proline' 0 CA--C 1.547 1.171 0 C-N-CA 124.025 3.15 . . . . 0.0 114.706 176.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . 0.4 ' H ' HG22 ' A' ' 371' ' ' ILE . 26.2 pt-20 -151.26 160.21 43.94 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.823 1.649 . . . . 0.0 111.94 173.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -85.42 169.9 13.22 Favored 'General case' 0 CA--C 1.55 0.96 0 O-C-N 121.048 -1.032 . . . . 0.0 113.026 177.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -126.63 105.82 8.97 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.731 2.012 . . . . 0.0 109.826 -177.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 50.85 31.42 6.07 Favored 'General case' 0 CA--C 1.555 1.145 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 100.79 -11.09 59.16 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 125.482 1.515 . . . . 0.0 114.408 -178.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -95.22 126.9 40.86 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.543 1.137 . . . . 0.0 111.248 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 13.0 mt -95.59 161.5 14.02 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.523 0.678 . . . . 0.0 110.495 163.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -124.01 122.16 37.17 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 125.159 1.383 . . . . 0.0 107.779 175.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -146.97 176.51 25.81 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-N 115.632 -0.713 . . . . 0.0 114.201 -171.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -129.55 120.82 25.96 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.493 1.517 . . . . 0.0 110.464 -178.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -65.51 141.15 58.57 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.643 1.177 . . . . 0.0 112.219 -177.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -75.69 -29.83 59.14 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 120.619 -1.301 . . . . 0.0 113.526 -178.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 51.2 t -81.49 -37.33 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 124.207 1.003 . . . . 0.0 113.419 -175.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 6.9 t -124.81 -8.84 7.27 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.484 1.113 . . . . 0.0 113.699 -171.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.58 23.76 3.74 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 126.181 1.792 . . . . 0.0 113.822 -177.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -68.97 150.83 47.26 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.436 1.094 . . . . 0.0 110.938 169.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -125.63 157.35 37.44 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.632 1.573 . . . . 0.0 110.757 -177.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 161.04 169.58 24.49 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 124.496 1.046 . . . . 0.0 112.237 174.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -66.77 148.38 52.0 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.151 0.501 . . . . 0.0 110.399 168.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -155.04 154.87 29.52 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 124.321 1.048 . . . . 0.0 110.223 171.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -63.72 122.2 10.2 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.434 2.089 . . . . 0.0 110.774 177.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 95.8 p -55.13 -40.24 70.32 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.8 -0.562 . . . . 0.0 112.135 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 5.3 t -62.15 -23.05 66.35 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.244 1.818 . . . . 0.0 114.464 -178.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -72.16 -3.43 23.3 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.615 1.166 . . . . 0.0 113.58 172.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 68.2 p -130.47 158.21 40.54 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.5 1.52 . . . . 0.0 111.083 176.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -128.36 161.55 29.17 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.772 1.229 . . . . 0.0 110.055 174.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.32 124.12 20.04 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 114.784 -1.098 . . . . 0.0 108.514 174.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -49.1 -58.46 4.92 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 123.929 1.823 . . . . 0.0 113.427 -176.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -70.3 76.97 0.54 Allowed 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 129.1 2.96 . . . . 0.0 112.871 -177.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 . . . . . 0 N--CA 1.486 1.33 0 C-N-CA 129.046 2.938 . . . . 0.0 115.308 -175.677 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 526' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.942 0.401 . . . . 0.0 111.23 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 61.2 mt -67.32 132.41 93.26 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 125.126 1.37 . . . . 0.0 109.806 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.76 160.25 50.39 Favored 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 123.571 2.848 . . . . 0.0 112.003 177.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.97 142.91 83.56 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.455 2.103 . . . . 0.0 112.36 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -72.19 154.4 92.19 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 123.282 0.633 . . . . 0.0 111.883 172.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -69.24 174.4 9.11 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.463 2.775 . . . . 0.0 113.039 178.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -87.64 1.76 52.81 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.636 1.174 . . . . 0.0 112.843 -178.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 34.7 p90 -133.54 154.35 80.73 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.712 1.205 . . . . 0.0 112.873 -175.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.95 152.72 57.77 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.667 2.912 . . . . 0.0 112.684 178.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -69.94 144.67 93.37 Favored Pre-proline 0 CA--C 1.55 0.98 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -176.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -73.8 179.32 5.77 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 124.103 3.202 . . . . 0.0 113.069 176.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 29.0 p -133.48 154.77 81.0 Favored Pre-proline 0 N--CA 1.479 1.015 0 C-N-CA 125.424 1.49 . . . . 0.0 112.64 -174.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.59 162.19 42.0 Favored 'Trans proline' 0 CA--C 1.548 1.222 0 C-N-CA 123.863 3.042 . . . . 0.0 111.995 176.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.49 149.87 84.33 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.447 2.765 . . . . 0.0 112.772 178.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 540' ' ' VAL . . . . . . . . . . . . . 47.3 t -76.19 -34.35 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 124.461 1.105 . . . . 0.0 111.805 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 541' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.55 169.8 22.33 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.831 1.652 . . . . 0.0 112.155 -177.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 542' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 . . . . . 0 C--O 1.254 1.299 0 C-N-CA 125.425 1.49 . . . . 0.0 113.601 -176.286 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.641 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 87.4 p -151.62 170.16 20.37 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.757 1.223 . . . . 0.0 112.434 176.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 338' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -98.19 -1.13 42.83 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.386 1.474 . . . . 0.0 114.031 -178.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 339' ' ' MET . . . . . . . . . . . . . 93.8 mtp -72.15 -42.47 65.93 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -174.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -74.44 -33.12 62.85 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.129 0.972 . . . . 0.0 113.113 -178.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 341' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.1 76.3 1.37 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 126.011 1.724 . . . . 0.0 111.678 -173.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 342' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -42.82 145.79 0.43 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 127.811 2.444 . . . . 0.0 113.548 171.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.36 163.98 20.59 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.738 1.615 . . . . 0.0 111.336 166.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 15.5 m -128.4 158.61 40.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 126.43 1.892 . . . . 0.0 109.032 168.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.89 125.98 44.81 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.264 1.026 . . . . 0.0 109.383 -175.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 73.1 p -72.31 153.23 41.63 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.585 0.754 . . . . 0.0 110.793 -175.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.9 pp -122.91 -6.94 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -177.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -158.73 160.3 29.34 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 126.684 1.993 . . . . 0.0 110.158 170.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -69.75 157.5 60.2 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 123.286 2.657 . . . . 0.0 113.263 176.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -144.63 152.66 40.81 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.218 1.407 . . . . 0.0 111.957 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 13.7 t -151.71 156.43 40.31 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.75 1.22 . . . . 0.0 112.972 -178.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -84.65 69.5 10.65 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.532 1.933 . . . . 0.0 111.89 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . -53.75 -31.06 45.36 Favored Glycine 0 CA--C 1.54 1.651 0 C-N-CA 125.35 1.452 . . . . 0.0 116.57 -171.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 5.1 t -154.0 42.74 0.54 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.844 1.257 . . . . 0.0 111.643 178.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -147.36 175.88 10.44 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -165.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.16 -9.27 4.28 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 127.306 2.243 . . . . 0.0 115.217 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 44.8 p -126.28 17.98 7.67 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 125.269 1.427 . . . . 0.0 113.155 -172.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 55.9 mt -102.35 127.68 49.24 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.706 1.203 . . . . 0.0 111.121 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 23.3 tp -77.68 129.54 35.67 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.498 0.719 . . . . 0.0 110.955 177.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 43.9 t -101.81 146.52 27.68 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.884 1.273 . . . . 0.0 111.827 176.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -163.9 178.32 7.87 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.919 1.688 . . . . 0.0 112.246 -174.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -117.3 177.13 4.84 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.898 2.079 . . . . 0.0 111.15 174.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -64.65 140.43 58.87 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.966 0.906 . . . . 0.0 111.597 169.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 75.34 5.62 77.77 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 124.594 1.093 . . . . 0.0 115.707 175.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -71.87 169.3 16.1 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.674 1.19 . . . . 0.0 112.12 171.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 95.7 t -126.42 127.52 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 125.519 1.528 . . . . 0.0 108.84 -169.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 35.3 mt -133.62 138.26 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 124.352 1.061 . . . . 0.0 108.969 -176.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 52.2 m -102.88 136.65 42.31 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.972 1.309 . . . . 0.0 110.045 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 15.9 mt -73.37 147.09 44.67 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -175.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 58.3 mt -120.78 -8.52 9.44 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.582 1.153 . . . . 0.0 113.396 177.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 6.5 mt -133.73 140.99 38.35 Favored Pre-proline 0 N--CA 1.48 1.047 0 C-N-CA 126.311 1.844 . . . . 0.0 109.666 176.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.73 -7.68 21.63 Favored 'Trans proline' 0 CA--C 1.546 1.104 0 C-N-CA 124.047 3.165 . . . . 0.0 114.722 176.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -152.22 153.8 34.5 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.76 1.624 . . . . 0.0 112.146 174.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -77.44 170.83 15.87 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 124.46 1.104 . . . . 0.0 113.894 175.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -129.26 105.62 8.26 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.563 1.945 . . . . 0.0 109.897 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 50.68 32.62 7.15 Favored 'General case' 0 CA--C 1.553 1.09 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 98.37 -12.63 63.33 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 125.411 1.481 . . . . 0.0 114.411 -178.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 77.6 m95 -89.38 123.19 33.31 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.315 1.058 . . . . 0.0 110.807 176.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 13.5 mt -90.23 161.37 15.73 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.367 0.667 . . . . 0.0 110.225 161.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -124.43 124.84 43.19 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.123 1.369 . . . . 0.0 107.934 171.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -148.8 172.09 29.01 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 124.154 0.883 . . . . 0.0 113.287 -171.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -124.88 121.05 33.42 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.233 1.413 . . . . 0.0 109.699 177.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -64.05 147.45 52.09 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.523 1.129 . . . . 0.0 111.93 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -81.15 -46.71 14.5 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 120.876 -1.14 . . . . 0.0 113.175 178.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 57.8 t -70.98 -51.78 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 98.9 p -91.51 -17.12 26.19 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -174.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp 55.96 17.57 2.65 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 126.809 2.044 . . . . 0.0 114.725 -172.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -72.06 151.72 42.91 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 121.455 0.645 . . . . 0.0 111.732 171.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 72.5 mtm180 -120.67 157.0 30.54 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.347 1.859 . . . . 0.0 110.551 176.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 163.21 169.38 26.57 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 124.095 0.855 . . . . 0.0 112.368 173.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -65.71 148.35 51.91 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.074 0.464 . . . . 0.0 110.077 166.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -154.96 153.95 28.17 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 124.111 0.964 . . . . 0.0 110.457 172.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -63.98 122.11 10.02 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.492 2.128 . . . . 0.0 110.752 176.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 95.2 p -55.16 -38.06 67.8 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 74.7 m -64.88 -19.44 65.91 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -74.13 -2.51 24.89 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.36 1.064 . . . . 0.0 113.125 171.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 64.2 p -128.22 156.73 42.5 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.703 1.601 . . . . 0.0 110.823 173.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 32.1 mmtm -120.86 165.02 15.76 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.386 1.074 . . . . 0.0 109.249 167.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.29 126.35 27.32 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 169.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.1 tt -54.48 -59.17 5.06 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 124.858 2.266 . . . . 0.0 113.847 -168.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -80.33 143.6 33.45 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 109.403 -3.544 . . . . 0.0 112.047 -173.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 . . . . . 0 C--O 1.252 1.232 0 C-N-CA 125.065 1.346 . . . . 0.0 113.565 -177.365 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 526' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.851 0.358 . . . . 0.0 110.654 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 71.9 mt -72.16 132.87 83.97 Favored Pre-proline 0 N--CA 1.477 0.906 0 C-N-CA 124.611 1.164 . . . . 0.0 109.429 178.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.11 159.56 52.72 Favored 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 123.636 2.891 . . . . 0.0 112.29 178.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.57 146.07 88.44 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 122.473 2.115 . . . . 0.0 112.445 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -74.24 157.21 86.92 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 123.616 0.766 . . . . 0.0 112.3 173.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -68.84 174.84 8.12 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.453 2.769 . . . . 0.0 113.19 175.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -86.2 0.6 53.31 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.735 1.214 . . . . 0.0 112.965 -178.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 36.6 p90 -134.73 155.18 79.65 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 124.796 1.239 . . . . 0.0 112.96 -174.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.86 152.72 58.29 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.726 2.951 . . . . 0.0 112.821 178.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -68.06 144.34 96.91 Favored Pre-proline 0 CA--C 1.552 1.032 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -175.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.4 -179.59 4.59 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 124.141 3.228 . . . . 0.0 112.857 176.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 22.8 p -135.17 155.29 79.03 Favored Pre-proline 0 N--CA 1.481 1.08 0 C-N-CA 125.051 1.341 . . . . 0.0 112.814 -175.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.87 163.47 35.41 Favored 'Trans proline' 0 CA--C 1.548 1.21 0 C-N-CA 123.628 2.885 . . . . 0.0 111.88 175.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -65.48 156.91 60.99 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.312 2.675 . . . . 0.0 113.092 178.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 540' ' ' VAL . . . . . . . . . . . . . 8.3 p -145.14 140.43 22.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 127.116 2.166 . . . . 0.0 109.75 -176.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 541' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -131.36 7.59 4.57 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.477 1.511 . . . . 0.0 113.784 -171.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 542' ' ' ASN . . . . . . . . . . . . . 26.9 m120 . . . . . 0 C--O 1.252 1.236 0 C-N-CA 125.28 1.432 . . . . 0.0 112.983 173.74 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.973 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 33.5 p -144.02 135.73 26.1 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.124 1.37 . . . . 0.0 111.962 -177.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 338' ' ' HIS . . . . . . . . . . . . . 15.0 p-80 -83.64 -2.26 55.74 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 339' ' ' MET . . . . . . . . . . . . . 15.0 ttp 48.79 64.98 1.49 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 126.67 1.988 . . . . 0.0 113.929 177.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -52.56 -31.3 35.29 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 126.04 1.736 . . . . 0.0 115.001 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 341' ' ' LYS . . . . . . . . . . . . . 1.2 tpmt? -157.47 149.75 22.67 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.334 1.854 . . . . 0.0 110.806 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 342' ' ' GLN . . . . . . . . . . . . . 71.2 tp60 -67.2 147.84 52.54 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.01 0.924 . . . . 0.0 112.425 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 9.3 tptt -121.76 159.6 26.33 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.712 1.605 . . . . 0.0 111.637 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 17.7 m -139.38 158.95 28.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 126.166 1.787 . . . . 0.0 110.62 174.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -123.27 126.95 47.85 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.081 1.352 . . . . 0.0 110.599 -178.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 81.6 p -71.7 152.09 43.09 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.586 0.754 . . . . 0.0 111.427 -178.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.9 pp -122.93 -8.98 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 -177.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -155.08 158.91 32.15 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 126.705 2.002 . . . . 0.0 109.842 169.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.05 156.13 66.14 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.129 2.553 . . . . 0.0 113.117 177.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -138.03 142.61 40.35 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.199 1.4 . . . . 0.0 111.103 177.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 88.5 m -138.73 137.2 36.54 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 126.148 1.779 . . . . 0.0 109.814 -175.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -64.99 -44.66 88.55 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -171.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 59.88 85.38 0.04 OUTLIER Glycine 0 CA--C 1.538 1.479 0 C-N-CA 124.565 1.079 . . . . 0.0 114.224 177.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 17.8 m 61.25 32.69 19.33 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 125.207 1.403 . . . . 0.0 114.024 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 51.9 m-80 -137.39 160.88 37.83 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.913 1.685 . . . . 0.0 111.767 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 36.1 mtmm -125.88 -4.77 6.93 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 125.49 1.516 . . . . 0.0 114.632 -177.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 32.8 p -110.14 11.57 23.7 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.886 1.675 . . . . 0.0 112.836 -176.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 66.8 mt -112.21 127.04 55.84 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.318 1.447 . . . . 0.0 111.312 -176.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 28.8 tp -78.74 124.79 28.56 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.936 0.894 . . . . 0.0 110.668 176.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 54.2 p -99.61 152.16 20.36 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.237 1.415 . . . . 0.0 112.434 177.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -167.45 177.32 6.06 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.052 1.341 . . . . 0.0 112.992 -172.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -115.32 177.13 4.77 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.857 2.063 . . . . 0.0 111.161 173.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -67.22 140.46 57.42 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.093 0.957 . . . . 0.0 111.818 170.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 74.66 4.68 71.37 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 125.007 1.289 . . . . 0.0 115.797 177.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -68.42 164.23 21.48 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 118.115 0.958 . . . . 0.0 111.461 167.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 95.7 t -118.16 136.17 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.642 1.177 . . . . 0.0 109.251 -177.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 29.7 mt -133.45 141.18 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.349 1.06 . . . . 0.0 108.795 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 23.5 m -102.21 136.34 42.21 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.817 1.247 . . . . 0.0 109.528 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 21.0 mt -79.18 138.71 37.97 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 118.544 0.611 . . . . 0.0 111.446 -177.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 44.7 mt -112.83 -10.15 13.6 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.993 0.917 . . . . 0.0 113.277 -177.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 371' ' ' ILE . . . . . 0.408 ' CG2' ' HD2' ' A' ' 372' ' ' PRO . 9.0 mt -124.58 140.1 34.64 Favored Pre-proline 0 N--CA 1.478 0.938 0 C-N-CA 126.363 1.865 . . . . 0.0 109.682 176.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 372' ' ' PRO . . . . . 0.408 ' HD2' ' CG2' ' A' ' 371' ' ' ILE . 58.1 Cg_endo -70.83 -8.36 23.45 Favored 'Trans proline' 0 CA--C 1.547 1.156 0 C-N-CA 123.834 3.022 . . . . 0.0 114.322 176.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -152.18 149.1 28.38 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.922 1.689 . . . . 0.0 111.893 173.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -74.08 171.35 13.68 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.443 1.097 . . . . 0.0 113.744 175.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -128.24 103.42 7.17 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.217 1.807 . . . . 0.0 110.448 -179.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 52.05 30.55 7.6 Favored 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 99.69 -15.57 59.59 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 125.654 1.597 . . . . 0.0 114.287 -178.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -85.07 128.8 34.79 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.221 1.011 . . . . 0.0 110.955 175.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 12.1 mt -99.4 161.41 13.63 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.212 1.005 . . . . 0.0 110.213 165.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -123.82 122.21 37.44 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 125.157 1.383 . . . . 0.0 107.519 173.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -145.5 167.24 27.56 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-N 115.82 -0.627 . . . . 0.0 113.927 -172.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -113.45 118.47 34.6 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.006 1.322 . . . . 0.0 109.019 173.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 33.9 t-80 -63.69 141.66 58.69 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.321 1.049 . . . . 0.0 111.789 178.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -75.2 -46.19 35.55 Favored 'General case' 0 CA--C 1.547 0.827 0 O-C-N 120.573 -1.329 . . . . 0.0 113.037 -178.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 57.4 t -70.31 -54.26 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 178.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 93.4 p -90.25 -17.27 27.76 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 119.583 1.083 . . . . 0.0 113.785 -173.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm 56.41 20.0 4.45 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 126.651 1.98 . . . . 0.0 114.023 -175.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -76.38 158.81 31.07 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.276 0.63 . . . . 0.0 112.051 171.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 82.2 mtt85 -125.18 158.91 32.81 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.148 1.779 . . . . 0.0 110.645 176.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 159.38 169.72 23.05 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.951 1.262 . . . . 0.0 112.278 176.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -68.36 148.73 50.29 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.994 0.426 . . . . 0.0 110.627 169.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -155.82 156.32 30.46 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 124.084 0.954 . . . . 0.0 110.747 172.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -66.72 120.61 7.73 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 122.433 2.088 . . . . 0.0 111.724 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 36.2 t -59.92 -25.38 65.1 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 175.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 75.2 m -69.44 -18.81 63.76 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 174.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -81.1 -0.34 39.58 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.635 1.174 . . . . 0.0 113.987 177.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 81.3 p -127.44 161.01 29.72 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.055 1.342 . . . . 0.0 111.599 174.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 32.3 mmtm -124.6 169.04 12.32 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.514 1.926 . . . . 0.0 109.248 170.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.72 128.23 35.53 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 171.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.54 -62.09 1.84 Allowed 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 123.94 1.829 . . . . 0.0 113.354 -177.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -60.2 119.76 8.49 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 128.945 2.898 . . . . 0.0 112.109 -178.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 . . . . . 0 C--O 1.259 1.576 0 C-N-CA 124.982 1.313 . . . . 0.0 113.865 -179.788 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 526' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.991 0.424 . . . . 0.0 111.013 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 52.7 mt -72.23 133.27 83.54 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 125.034 1.334 . . . . 0.0 109.438 176.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -69.03 160.95 47.86 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 123.42 2.747 . . . . 0.0 112.124 178.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.59 144.68 85.38 Favored 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 122.267 1.978 . . . . 0.0 112.352 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -70.59 153.66 94.84 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 123.095 0.558 . . . . 0.0 111.872 171.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -69.7 174.67 9.12 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 123.509 2.806 . . . . 0.0 113.2 179.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -86.05 1.33 50.73 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.353 1.061 . . . . 0.0 113.037 -178.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 38.1 p90 -133.46 154.37 80.83 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 124.823 1.249 . . . . 0.0 113.033 -174.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.56 153.11 60.24 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 123.66 2.907 . . . . 0.0 112.875 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -68.48 141.13 92.93 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 123.914 0.885 . . . . 0.0 113.096 -177.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.59 177.54 7.87 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 124.059 3.173 . . . . 0.0 113.239 177.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 32.8 p -134.25 153.94 79.72 Favored Pre-proline 0 N--CA 1.478 0.963 0 C-N-CA 125.401 1.48 . . . . 0.0 112.998 -172.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -68.29 163.22 37.18 Favored 'Trans proline' 0 CA--C 1.548 1.202 0 C-N-CA 123.772 2.981 . . . . 0.0 111.854 176.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -65.1 148.41 89.23 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.242 2.628 . . . . 0.0 112.885 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 540' ' ' VAL . . . . . . . . . . . . . 7.5 p -82.77 -10.45 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 125.05 1.34 . . . . 0.0 113.367 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 541' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -114.06 176.09 5.19 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.155 1.782 . . . . 0.0 112.081 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 542' ' ' ASN . . . . . . . . . . . . . 14.0 m120 . . . . . 0 C--O 1.253 1.259 0 C-N-CA 126.468 1.907 . . . . 0.0 111.639 -177.185 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.529 0 CA-C-O 121.241 0.356 . . . . 0.0 112.287 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 52.1 m -141.83 110.22 6.0 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.612 1.565 . . . . 0.0 109.899 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 338' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -67.71 -53.72 25.26 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.407 0.683 . . . . 0.0 111.872 -174.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 339' ' ' MET . . . . . . . . . . . . . 15.6 ptp -170.51 150.03 3.37 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.59 1.956 . . . . 0.0 111.348 174.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -88.72 -15.6 34.37 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.647 1.179 . . . . 0.0 114.087 178.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 341' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -137.39 134.72 36.25 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 126.894 2.078 . . . . 0.0 109.097 -178.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 342' ' ' GLN . . . . . . . . . . . . . 71.3 tp60 -65.08 137.12 57.47 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 118.837 0.744 . . . . 0.0 111.155 177.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 3.2 mptm? -123.74 164.4 19.22 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 125.708 1.603 . . . . 0.0 111.349 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 16.7 m -133.88 155.36 39.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 126.937 2.095 . . . . 0.0 109.54 171.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.45 134.27 54.75 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.385 1.074 . . . . 0.0 110.343 175.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 62.1 p -76.63 158.64 30.93 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.186 1.394 . . . . 0.0 111.774 179.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 2.0 pp -122.91 -9.79 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -155.35 159.22 31.9 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 125.836 1.654 . . . . 0.0 111.26 170.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.91 155.61 65.0 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.534 2.823 . . . . 0.0 113.443 177.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 -139.37 140.73 37.54 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.411 1.485 . . . . 0.0 111.899 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 28.3 m -136.91 128.72 29.03 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.673 1.589 . . . . 0.0 110.774 -172.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -67.42 -37.38 82.96 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -177.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 74.95 -55.06 2.64 Favored Glycine 0 CA--C 1.539 1.532 0 C-N-CA 126.538 2.018 . . . . 0.0 116.095 170.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 3.0 t -148.44 23.1 1.03 Allowed 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.75 1.62 . . . . 0.0 112.104 -176.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -131.5 165.5 23.44 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.087 1.755 . . . . 0.0 110.802 -166.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -121.32 -29.08 4.55 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 178.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 48.3 p -88.88 12.81 14.2 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.117 1.367 . . . . 0.0 113.987 -175.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 62.0 mt -107.84 131.01 54.94 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.841 1.256 . . . . 0.0 111.487 -178.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 24.0 tp -82.86 132.97 35.14 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.682 0.793 . . . . 0.0 110.534 174.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 45.3 m -114.86 147.73 39.5 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.226 1.411 . . . . 0.0 112.379 -178.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -166.42 178.95 5.83 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.412 1.485 . . . . 0.0 112.397 -166.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -118.18 174.79 6.01 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.974 2.11 . . . . 0.0 111.724 176.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 66.3 tt0 -64.25 140.94 58.92 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.317 -0.864 . . . . 0.0 111.002 168.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 70.36 19.48 76.06 Favored Glycine 0 CA--C 1.537 1.433 0 N-CA-C 114.37 0.508 . . . . 0.0 114.37 177.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -86.23 170.09 12.43 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.732 1.213 . . . . 0.0 111.522 169.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 89.7 t -125.82 128.09 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 125.658 1.583 . . . . 0.0 109.038 -168.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 22.7 mt -133.18 143.13 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 124.358 1.063 . . . . 0.0 110.056 -176.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 2.6 m -100.77 144.03 30.22 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.641 1.576 . . . . 0.0 110.398 -177.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 23.5 mt -84.67 141.11 30.83 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 118.333 0.515 . . . . 0.0 112.085 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 43.8 mt -120.05 -11.69 9.23 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.758 1.223 . . . . 0.0 113.298 179.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 371' ' ' ILE . . . . . 0.413 HG22 ' H ' ' A' ' 373' ' ' GLU . 7.1 mt -130.25 141.1 40.71 Favored Pre-proline 0 N--CA 1.476 0.853 0 C-N-CA 126.703 2.001 . . . . 0.0 109.224 175.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.69 -6.02 18.28 Favored 'Trans proline' 0 CA--C 1.548 1.208 0 C-N-CA 124.113 3.209 . . . . 0.0 114.835 175.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . 0.413 ' H ' HG22 ' A' ' 371' ' ' ILE . 12.6 pt-20 -151.67 162.78 40.42 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.162 1.785 . . . . 0.0 112.169 175.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.57 170.91 9.78 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.485 1.114 . . . . 0.0 113.202 176.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -128.63 106.39 8.92 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.403 1.881 . . . . 0.0 110.54 -178.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 51.32 31.09 6.62 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 124.943 1.297 . . . . 0.0 114.468 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 98.32 -8.32 62.45 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 125.293 1.425 . . . . 0.0 114.515 -177.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -95.42 122.46 38.17 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.729 1.265 . . . . 0.0 110.979 177.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 14.2 mt -88.39 160.49 17.56 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.751 0.82 . . . . 0.0 110.625 162.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 79.4 t80 -123.28 124.46 43.02 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.169 1.388 . . . . 0.0 107.924 170.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -149.95 173.84 29.56 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 123.864 0.745 . . . . 0.0 113.289 -170.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -126.29 115.18 19.3 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.959 1.304 . . . . 0.0 110.271 178.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 23.4 t-80 -61.59 144.72 53.95 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.43 1.092 . . . . 0.0 112.151 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -79.2 -48.26 14.53 Favored 'General case' 0 CA--C 1.548 0.882 0 O-C-N 120.926 -1.109 . . . . 0.0 112.565 178.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 58.5 t -68.3 -53.6 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 124.325 1.05 . . . . 0.0 113.73 176.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 40.2 m -89.77 -16.51 30.11 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 119.277 0.944 . . . . 0.0 113.188 -171.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 11.1 mmmm 54.49 19.92 2.58 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 127.358 2.263 . . . . 0.0 114.647 -176.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -82.14 152.7 26.39 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.938 0.895 . . . . 0.0 111.496 174.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 56.4 mtm-85 -117.58 158.97 23.66 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 126.172 1.789 . . . . 0.0 110.931 173.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 159.8 171.76 26.09 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.512 1.053 . . . . 0.0 112.453 175.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -68.46 145.22 54.27 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 120.961 0.41 . . . . 0.0 110.456 168.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -153.91 154.55 30.21 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 124.246 1.019 . . . . 0.0 111.015 173.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -63.4 122.94 11.28 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.529 2.153 . . . . 0.0 112.046 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 82.6 p -61.27 -25.98 67.46 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 176.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.83 -13.34 61.65 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.969 2.107 . . . . 0.0 114.86 174.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -85.01 -0.57 54.85 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.5 1.12 . . . . 0.0 113.133 174.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 71.3 p -131.69 169.76 15.73 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.653 1.981 . . . . 0.0 110.475 173.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -133.32 -73.49 0.49 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.322 1.049 . . . . 0.0 110.114 178.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 399' ' ' LEU . . . . . 0.545 HD13 ' H ' ' A' ' 400' ' ' LEU . 0.2 OUTLIER -165.78 158.39 15.12 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.92 2.488 . . . . 0.0 106.91 170.637 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . 0.545 ' H ' HD13 ' A' ' 399' ' ' LEU . 0.2 OUTLIER -59.79 -71.59 0.12 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 123.482 1.61 . . . . 0.0 111.806 172.512 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -108.15 129.99 55.15 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 111.168 -2.742 . . . . 0.0 110.355 -170.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 . . . . . 0 C--O 1.254 1.29 0 C-N-CA 124.712 1.205 . . . . 0.0 112.735 -177.062 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 526' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 121.127 0.489 . . . . 0.0 109.976 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 55.1 mt -75.69 133.15 73.8 Favored Pre-proline 0 N--CA 1.477 0.899 0 C-N-CA 124.847 1.259 . . . . 0.0 109.371 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -68.82 160.07 51.2 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 123.483 2.789 . . . . 0.0 112.007 178.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -63.77 144.47 89.03 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.428 2.086 . . . . 0.0 112.271 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -70.01 153.34 95.47 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 122.99 0.516 . . . . 0.0 111.629 171.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -69.28 174.75 8.64 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.459 2.773 . . . . 0.0 113.151 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -85.62 1.39 49.42 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.318 1.047 . . . . 0.0 112.976 -178.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 33.8 p90 -134.55 154.33 79.6 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 124.775 1.23 . . . . 0.0 112.94 -175.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.34 151.97 60.49 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.645 2.897 . . . . 0.0 112.681 178.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -66.83 145.23 98.89 Favored Pre-proline 0 CA--C 1.549 0.913 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -177.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.32 175.22 10.89 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.752 2.968 . . . . 0.0 112.781 178.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 23.0 p -129.73 153.96 80.91 Favored Pre-proline 0 N--CA 1.477 0.922 0 C-N-CA 124.732 1.213 . . . . 0.0 112.363 -173.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -66.56 163.08 34.08 Favored 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 122.999 2.466 . . . . 0.0 111.651 175.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -64.57 163.31 27.69 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 123.102 2.534 . . . . 0.0 112.257 174.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 540' ' ' VAL . . . . . . . . . . . . . 23.2 t -122.22 107.31 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.05 1.34 . . . . 0.0 108.275 -178.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 541' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -139.68 143.96 37.36 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.47 1.908 . . . . 0.0 110.417 -176.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 542' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 . . . . . 0 C--O 1.255 1.367 0 C-N-CA 124.791 1.236 . . . . 0.0 112.56 -179.346 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.532 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 1.6 t 56.45 27.75 12.64 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 126.04 1.736 . . . . 0.0 114.803 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 338' ' ' HIS . . . . . . . . . . . . . 42.0 t60 -82.86 64.76 7.65 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.503 1.521 . . . . 0.0 112.234 -176.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 339' ' ' MET . . . . . . . . . . . . . 14.7 mmt -139.28 165.12 28.02 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.934 1.694 . . . . 0.0 112.615 -176.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 34.9 tttm -131.69 33.18 4.03 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.338 1.855 . . . . 0.0 111.977 -179.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 341' ' ' LYS . . . . . . . . . . . . . 64.6 mtpt -133.62 157.22 46.28 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 126.964 2.106 . . . . 0.0 109.786 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 342' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -118.65 138.72 52.41 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.929 0.871 . . . . 0.0 111.395 -178.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -123.7 163.53 20.93 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 126.047 1.739 . . . . 0.0 111.952 -178.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 16.0 m -137.5 157.59 34.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 127.028 2.131 . . . . 0.0 109.159 169.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -121.02 131.71 54.45 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.197 0.999 . . . . 0.0 109.664 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 74.8 p -74.9 152.6 38.86 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.962 0.905 . . . . 0.0 111.177 -177.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.8 pp -123.49 -6.71 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -178.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -154.04 158.23 32.47 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 126.249 1.82 . . . . 0.0 110.121 169.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -68.96 154.5 70.72 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.792 2.328 . . . . 0.0 112.413 176.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 -140.32 145.06 36.72 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.499 1.52 . . . . 0.0 110.7 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 95.8 m -142.35 126.53 17.48 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.022 1.329 . . . . 0.0 110.192 -171.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -58.05 116.45 3.53 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.791 0.836 . . . . 0.0 111.413 168.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . -136.33 136.35 8.34 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 125.011 1.291 . . . . 0.0 110.986 177.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 83.5 p 52.06 20.03 1.17 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 126.02 1.728 . . . . 0.0 115.366 -166.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -149.38 174.81 12.05 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.811 1.244 . . . . 0.0 113.599 -172.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -126.75 -31.57 2.67 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 126.161 1.784 . . . . 0.0 114.318 177.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 38.0 p -90.85 19.16 5.76 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 126.009 1.724 . . . . 0.0 114.336 -174.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 56.8 mt -98.15 128.8 44.84 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.87 1.268 . . . . 0.0 110.485 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 31.4 tp -80.22 114.12 18.89 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.377 0.671 . . . . 0.0 110.844 175.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 50.3 m -83.88 150.03 25.98 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.043 0.937 . . . . 0.0 112.559 175.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -164.8 178.17 7.4 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.598 1.559 . . . . 0.0 113.217 -177.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -117.15 173.96 6.38 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.431 1.892 . . . . 0.0 111.258 173.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -64.98 142.32 58.48 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 121.301 -0.874 . . . . 0.0 111.648 170.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 77.05 5.79 85.34 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 124.071 0.843 . . . . 0.0 114.98 175.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -77.83 166.33 23.05 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.97 1.308 . . . . 0.0 111.96 172.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 67.9 t -121.07 131.24 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.105 1.362 . . . . 0.0 109.325 -172.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 25.2 mt -134.76 137.6 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.527 1.131 . . . . 0.0 109.245 -177.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 12.0 m -98.09 140.22 32.73 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.931 1.292 . . . . 0.0 110.236 -178.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 23.7 mt -80.03 137.94 36.91 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 118.235 0.47 . . . . 0.0 111.928 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 37.1 mt -114.62 -9.8 12.57 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.527 1.131 . . . . 0.0 113.122 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 9.4 mt -127.75 141.17 40.22 Favored Pre-proline 0 N--CA 1.479 1.01 0 C-N-CA 126.893 2.077 . . . . 0.0 109.632 176.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.28 -7.1 20.35 Favored 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 124.088 3.192 . . . . 0.0 114.817 177.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -151.24 160.22 43.94 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.288 1.835 . . . . 0.0 111.428 174.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.34 168.0 17.99 Favored 'General case' 0 CA--C 1.547 0.86 0 O-C-N 120.993 -1.067 . . . . 0.0 113.027 173.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -122.89 103.49 8.66 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 126.954 2.101 . . . . 0.0 109.105 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 51.96 30.54 7.41 Favored 'General case' 0 CA--C 1.555 1.17 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 102.45 -17.95 52.2 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 125.894 1.711 . . . . 0.0 114.276 -178.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -84.86 128.31 34.56 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.511 1.124 . . . . 0.0 111.463 178.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 16.9 mt -98.17 161.32 13.77 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.121 0.968 . . . . 0.0 110.51 164.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -125.9 121.72 33.98 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 125.37 1.468 . . . . 0.0 107.552 174.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -145.38 171.72 26.36 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-N 115.555 -0.748 . . . . 0.0 113.872 -172.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -119.63 117.26 27.84 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.006 1.323 . . . . 0.0 109.872 176.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 24.4 t-80 -63.77 145.16 56.29 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.854 1.262 . . . . 0.0 112.035 178.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -80.23 -44.66 19.34 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 120.914 -1.116 . . . . 0.0 113.706 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 57.7 t -69.18 -51.05 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 123.926 0.891 . . . . 0.0 113.306 176.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 13.2 t -91.03 -21.32 21.31 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -171.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt 56.32 16.71 2.5 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 126.446 1.898 . . . . 0.0 114.597 -171.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -74.11 156.16 37.69 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.362 0.665 . . . . 0.0 111.852 172.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -124.79 155.27 39.66 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.203 1.801 . . . . 0.0 110.08 176.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 162.62 168.76 25.01 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 124.911 1.243 . . . . 0.0 112.021 177.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -68.86 147.74 51.26 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.111 0.565 . . . . 0.0 110.721 171.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -155.21 155.27 29.83 Favored Pre-proline 0 CA--C 1.541 0.597 0 C-N-CA 124.315 1.046 . . . . 0.0 110.676 172.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -66.11 121.42 8.74 Favored 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 122.353 2.036 . . . . 0.0 110.975 177.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 29.7 t -55.01 -39.13 68.75 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.687 -0.633 . . . . 0.0 112.364 178.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 15.5 m -59.47 -21.85 60.68 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -74.24 -0.27 16.4 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.552 1.141 . . . . 0.0 113.514 172.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 48.1 p -133.27 162.81 30.8 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.86 1.664 . . . . 0.0 111.792 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -135.16 155.52 50.55 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.311 1.444 . . . . 0.0 110.036 176.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.31 124.34 20.32 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.742 0.817 . . . . 0.0 109.575 175.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 14.1 tp -60.12 -42.65 95.2 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 115.389 1.625 . . . . 0.0 115.389 -171.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -111.09 72.6 0.78 Allowed 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 126.824 2.05 . . . . 0.0 111.907 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 . . . . . 0 C--O 1.252 1.22 0 C-N-CA 126.665 1.986 . . . . 0.0 114.412 176.751 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 526' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.444 0.164 . . . . 0.0 110.835 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 35.7 mt -68.66 131.74 91.24 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 124.399 1.08 . . . . 0.0 110.329 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.19 159.13 52.97 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 123.498 2.799 . . . . 0.0 112.063 178.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.82 147.08 89.36 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.402 2.068 . . . . 0.0 112.561 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -73.98 157.11 87.46 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 123.692 0.797 . . . . 0.0 112.465 174.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.19 174.77 8.53 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.449 2.766 . . . . 0.0 113.381 176.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -88.39 3.06 51.27 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.997 1.319 . . . . 0.0 112.623 -178.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 32.6 p90 -134.85 154.62 79.43 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 124.557 1.143 . . . . 0.0 112.823 -175.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.51 152.49 60.07 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 123.788 2.992 . . . . 0.0 112.868 179.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -68.17 142.97 95.48 Favored Pre-proline 0 CA--C 1.551 0.981 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -176.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.32 179.94 5.01 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 124.114 3.209 . . . . 0.0 112.709 176.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 26.6 p -135.21 154.3 78.74 Favored Pre-proline 0 N--CA 1.479 0.983 0 C-N-CA 125.036 1.334 . . . . 0.0 112.657 -173.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -66.56 161.92 39.21 Favored 'Trans proline' 0 CA--C 1.547 1.165 0 C-N-CA 123.336 2.691 . . . . 0.0 111.484 175.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -64.94 154.61 72.33 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 123.052 2.501 . . . . 0.0 112.417 176.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 540' ' ' VAL . . . . . . . . . . . . . 6.9 m -70.33 -13.5 17.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 126.933 2.093 . . . . 0.0 114.695 -177.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 541' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.69 170.61 18.78 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 125.892 1.677 . . . . 0.0 111.716 174.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 542' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 . . . . . 0 C--O 1.253 1.262 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 -175.215 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.493 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 21.1 t -149.76 155.17 39.68 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.132 1.373 . . . . 0.0 111.595 177.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 338' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -135.92 9.99 3.32 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.261 1.424 . . . . 0.0 113.57 -172.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 339' ' ' MET . . . . . . . . . . . . . 79.8 mtp -131.34 158.29 41.1 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.996 1.318 . . . . 0.0 111.654 -176.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -109.94 47.47 0.95 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.853 1.661 . . . . 0.0 111.412 -173.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 341' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -66.47 75.48 0.1 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 126.926 2.09 . . . . 0.0 112.6 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 342' ' ' GLN . . . . . . . . . . . . . 70.7 tp60 -61.25 136.21 57.98 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.742 0.782 . . . . 0.0 111.057 175.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 3.4 mptm? -124.47 164.16 20.32 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.615 1.566 . . . . 0.0 110.747 177.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 17.3 m -133.26 154.91 40.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 126.471 1.909 . . . . 0.0 109.555 169.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 15.5 ttpt -119.53 136.39 54.36 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.138 0.975 . . . . 0.0 110.667 175.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 77.8 p -78.7 155.95 29.17 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.765 1.626 . . . . 0.0 111.783 -176.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.8 pp -122.24 -9.16 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 -176.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -155.29 159.22 31.91 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 126.346 1.858 . . . . 0.0 110.472 169.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.91 155.94 64.2 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.315 2.677 . . . . 0.0 113.348 178.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 44.7 t-80 -139.36 150.33 45.2 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.583 1.553 . . . . 0.0 111.98 -178.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 11.3 t -147.34 150.29 34.44 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.452 1.501 . . . . 0.0 112.12 -178.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -78.59 -26.46 45.44 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -178.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 66.75 -57.66 0.21 Allowed Glycine 0 CA--C 1.54 1.646 0 C-N-CA 127.378 2.418 . . . . 0.0 115.969 178.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 9.7 t -143.61 -13.26 0.67 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 126.868 2.067 . . . . 0.0 112.811 178.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -77.0 175.93 9.12 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 125.362 1.465 . . . . 0.0 112.592 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -125.13 -30.73 3.17 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.899 1.68 . . . . 0.0 113.229 176.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 58.0 p -91.07 17.17 8.37 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 125.136 1.374 . . . . 0.0 114.193 -175.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 58.4 mt -108.31 130.34 55.19 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.759 1.224 . . . . 0.0 111.358 -178.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 36.4 tp -82.49 120.1 25.05 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.877 0.871 . . . . 0.0 110.862 176.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 55.6 p -89.76 152.7 21.18 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.665 1.186 . . . . 0.0 112.523 173.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -167.75 178.93 5.02 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.434 1.494 . . . . 0.0 112.483 -175.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -117.94 174.06 6.41 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.405 1.882 . . . . 0.0 111.525 174.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -64.92 141.97 58.6 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.747 0.819 . . . . 0.0 111.368 170.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 73.66 10.67 80.11 Favored Glycine 0 CA--C 1.537 1.452 0 N-CA-C 114.525 0.57 . . . . 0.0 114.525 177.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -82.79 164.01 20.87 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.415 1.086 . . . . 0.0 111.342 171.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 93.6 t -119.46 136.99 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.559 1.144 . . . . 0.0 109.881 -171.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 17.1 mt -137.35 137.94 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.997 1.319 . . . . 0.0 109.272 -176.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 10.2 m -95.52 140.56 30.19 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.869 1.268 . . . . 0.0 110.56 176.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 23.3 mt -79.23 139.08 38.01 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.347 0.659 . . . . 0.0 111.803 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 32.4 mt -116.44 -6.78 11.72 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 124.253 1.021 . . . . 0.0 113.347 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 4.9 mt -134.49 140.52 35.92 Favored Pre-proline 0 N--CA 1.48 1.073 0 C-N-CA 126.517 1.927 . . . . 0.0 109.344 176.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.6 -8.53 23.81 Favored 'Trans proline' 0 CA--C 1.546 1.109 0 C-N-CA 123.963 3.109 . . . . 0.0 114.74 178.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -152.05 157.31 41.48 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.882 1.673 . . . . 0.0 111.92 175.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -80.35 168.73 18.66 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.481 1.112 . . . . 0.0 113.841 177.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -125.65 105.18 8.81 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.685 1.994 . . . . 0.0 110.287 178.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 50.96 32.14 7.09 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 125.084 1.354 . . . . 0.0 114.535 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 99.04 -16.67 59.11 Favored Glycine 0 CA--C 1.536 1.393 0 C-N-CA 125.743 1.64 . . . . 0.0 114.305 -178.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 83.0 m95 -85.33 129.74 34.74 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.479 1.112 . . . . 0.0 111.12 175.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 12.6 mt -99.15 162.99 12.75 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.227 1.011 . . . . 0.0 110.316 164.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -127.22 119.06 25.52 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.962 1.305 . . . . 0.0 107.935 176.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -146.63 175.47 26.04 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.064 0.84 . . . . 0.0 113.871 -170.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -127.42 121.63 31.41 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.376 1.47 . . . . 0.0 110.524 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 -66.84 133.58 50.37 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.317 1.047 . . . . 0.0 112.135 -176.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -70.25 -31.04 68.24 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 120.304 -1.497 . . . . 0.0 113.349 -178.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 58.1 t -81.42 -33.97 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 124.408 1.083 . . . . 0.0 113.522 -176.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 13.2 t -125.31 -15.2 6.28 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.887 1.275 . . . . 0.0 113.37 -167.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 54.84 20.8 3.25 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 126.78 2.032 . . . . 0.0 114.202 -177.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -69.22 147.99 50.48 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.573 1.149 . . . . 0.0 111.147 166.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 81.7 mtm180 -122.43 156.78 33.32 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.95 1.7 . . . . 0.0 111.473 179.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 162.83 171.45 29.07 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 124.817 1.198 . . . . 0.0 112.296 174.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -67.66 147.78 52.23 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.148 0.499 . . . . 0.0 110.347 169.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -154.42 155.75 31.04 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 124.321 1.048 . . . . 0.0 110.863 173.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -65.71 121.63 9.06 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.158 1.905 . . . . 0.0 111.627 178.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 33.8 t -61.86 -16.91 54.21 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 121.417 -0.802 . . . . 0.0 113.053 172.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 16.6 m -73.23 -17.65 61.32 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.888 1.275 . . . . 0.0 113.785 173.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -88.56 1.62 54.59 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.286 1.434 . . . . 0.0 113.072 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 58.3 p -128.42 167.38 17.1 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 127.084 2.154 . . . . 0.0 109.826 172.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -128.99 -71.27 0.64 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.997 0.919 . . . . 0.0 109.6 175.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 399' ' ' LEU . . . . . 0.513 HD13 ' H ' ' A' ' 400' ' ' LEU . 0.1 OUTLIER -167.51 158.34 11.34 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.508 2.323 . . . . 0.0 107.656 170.114 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . 0.513 ' H ' HD13 ' A' ' 399' ' ' LEU . 0.7 OUTLIER -60.81 -68.4 0.31 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 124.064 1.888 . . . . 0.0 111.32 170.345 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -63.07 155.3 28.2 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 110.197 -3.183 . . . . 0.0 112.957 -171.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 . . . . . 0 C--O 1.253 1.287 0 C-N-CA 125.907 1.683 . . . . 0.0 112.401 -177.815 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 526' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.883 0.373 . . . . 0.0 110.512 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 60.7 mt -73.85 131.54 81.55 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 124.884 1.273 . . . . 0.0 109.488 -178.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.88 159.37 53.56 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 123.433 2.755 . . . . 0.0 112.147 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.44 146.14 89.05 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 122.42 2.08 . . . . 0.0 112.438 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -72.28 156.44 90.52 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 123.48 0.712 . . . . 0.0 112.14 172.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -68.96 174.77 8.34 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.43 2.754 . . . . 0.0 113.054 175.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -86.9 2.02 50.63 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.556 1.142 . . . . 0.0 112.844 -178.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 37.3 p90 -133.94 154.62 80.42 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 124.666 1.187 . . . . 0.0 112.79 -174.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.43 153.17 60.97 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 123.652 2.901 . . . . 0.0 112.758 178.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -65.92 143.22 98.4 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 123.821 0.848 . . . . 0.0 113.084 -177.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.8 177.81 7.17 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 124.001 3.134 . . . . 0.0 112.945 178.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 25.5 p -130.48 154.76 81.68 Favored Pre-proline 0 N--CA 1.478 0.944 0 C-N-CA 125.288 1.435 . . . . 0.0 112.775 -175.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.79 165.44 29.69 Favored 'Trans proline' 0 CA--C 1.547 1.15 0 C-N-CA 123.439 2.76 . . . . 0.0 111.885 174.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -65.92 165.96 22.06 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.406 2.737 . . . . 0.0 112.821 174.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 540' ' ' VAL . . . . . . . . . . . . . 17.6 t -120.26 76.42 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-O 123.29 1.519 . . . . 0.0 109.556 -173.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 541' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -146.8 160.7 41.94 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.919 2.088 . . . . 0.0 111.78 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 542' ' ' ASN . . . . . . . . . . . . . 8.9 t30 . . . . . 0 C--O 1.252 1.218 0 C-N-CA 125.19 1.396 . . . . 0.0 112.182 179.234 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.434 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 61.1 m -140.27 160.28 40.32 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.7 1.6 . . . . 0.0 111.362 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 338' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -135.18 24.74 3.54 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.833 1.253 . . . . 0.0 113.647 -171.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 339' ' ' MET . . . . . . . . . . . . . 28.1 ptm -95.44 -6.39 40.9 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -176.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -79.38 -44.51 21.34 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.139 0.976 . . . . 0.0 113.598 -173.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 341' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -81.65 71.18 8.66 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.843 1.257 . . . . 0.0 110.455 169.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 342' ' ' GLN . . . . . . . . . . . . . 71.1 tp60 -61.38 136.51 58.06 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.392 0.615 . . . . 0.0 110.172 170.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 3.3 mptm? -124.14 163.99 20.38 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.235 1.414 . . . . 0.0 110.834 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 15.6 m -132.89 157.13 42.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 126.73 2.012 . . . . 0.0 109.436 171.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -120.48 136.42 54.76 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.143 0.977 . . . . 0.0 109.946 177.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 45.9 p -80.44 148.57 30.47 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.383 1.473 . . . . 0.0 110.877 -175.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.7 pp -112.87 -10.25 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -176.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -155.55 159.31 31.75 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 126.666 1.987 . . . . 0.0 110.528 170.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.86 156.06 61.15 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 123.536 2.824 . . . . 0.0 113.129 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 32.0 t-80 -136.71 141.01 43.05 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.385 1.474 . . . . 0.0 111.79 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 92.8 m -128.97 122.56 30.4 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.55 1.54 . . . . 0.0 110.387 -172.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -71.73 -30.35 65.52 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -176.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 60.82 -134.77 49.41 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 123.818 0.723 . . . . 0.0 112.985 -177.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 12.6 t -66.8 -26.68 67.07 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 74.4 m-80 -69.25 156.05 39.39 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.825 0.85 . . . . 0.0 112.63 178.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 14.3 tptt -113.28 -24.58 9.29 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.877 1.271 . . . . 0.0 113.935 -177.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 35.8 p -91.59 12.14 21.95 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.004 1.322 . . . . 0.0 113.891 -175.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 68.7 mt -103.57 130.75 51.04 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.935 1.294 . . . . 0.0 110.97 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 30.2 tp -82.8 128.97 34.9 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.247 0.619 . . . . 0.0 110.401 174.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 34.4 t -107.87 147.32 31.11 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.591 1.556 . . . . 0.0 111.474 -179.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -164.58 177.94 7.72 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.626 1.57 . . . . 0.0 112.354 -170.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -121.82 168.83 11.4 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.944 2.098 . . . . 0.0 111.069 175.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -61.94 136.58 58.03 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.175 -0.953 . . . . 0.0 111.312 173.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 83.71 -1.92 88.09 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 123.749 0.69 . . . . 0.0 114.793 178.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -70.88 167.02 19.89 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.382 1.091 . . . . 0.0 112.203 170.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 84.6 t -125.86 133.41 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 125.018 1.327 . . . . 0.0 109.545 -169.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 24.9 mt -136.48 141.35 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.733 1.213 . . . . 0.0 109.462 -176.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 3.3 m -100.78 140.34 35.2 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.319 1.448 . . . . 0.0 110.599 -177.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 21.7 mt -80.21 136.98 36.59 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 118.423 0.556 . . . . 0.0 111.963 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 38.3 mt -117.52 -11.77 10.45 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.589 1.156 . . . . 0.0 113.341 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 371' ' ' ILE . . . . . 0.439 ' CG2' ' HD2' ' A' ' 372' ' ' PRO . 5.6 mt -128.09 140.04 37.13 Favored Pre-proline 0 N--CA 1.474 0.746 0 C-N-CA 126.154 1.782 . . . . 0.0 109.68 176.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 372' ' ' PRO . . . . . 0.439 ' HD2' ' CG2' ' A' ' 371' ' ' ILE . 60.6 Cg_endo -72.97 -7.22 20.35 Favored 'Trans proline' 0 CA--C 1.546 1.076 0 C-N-CA 123.434 2.756 . . . . 0.0 114.001 177.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -150.62 157.41 42.95 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.799 1.639 . . . . 0.0 112.088 173.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -84.91 171.54 12.09 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.222 1.009 . . . . 0.0 112.786 175.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -133.36 110.21 9.88 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.97 1.708 . . . . 0.0 110.819 -176.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 50.74 31.02 5.46 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 125.336 1.454 . . . . 0.0 114.448 -179.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 99.18 -8.41 60.78 Favored Glycine 0 CA--C 1.536 1.396 0 C-N-CA 125.379 1.466 . . . . 0.0 114.467 -177.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 75.3 m95 -99.44 128.43 45.56 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 118.438 1.119 . . . . 0.0 111.55 -178.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 14.1 mt -96.07 161.21 14.07 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.915 0.886 . . . . 0.0 110.544 165.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -124.92 122.36 37.12 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 125.167 1.387 . . . . 0.0 107.646 173.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -145.84 169.67 27.23 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 115.627 -0.715 . . . . 0.0 113.159 -173.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -117.55 114.67 23.78 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.811 1.244 . . . . 0.0 109.516 177.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 26.7 t-80 -60.69 146.35 46.02 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.861 1.264 . . . . 0.0 111.87 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -81.25 -46.2 15.14 Favored 'General case' 0 CA--C 1.548 0.866 0 O-C-N 120.768 -1.208 . . . . 0.0 112.866 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 60.1 t -68.92 -53.85 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 124.051 0.94 . . . . 0.0 113.31 175.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 16.3 t -86.11 -22.43 27.11 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -171.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm 54.93 17.2 1.73 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 126.575 1.95 . . . . 0.0 114.579 -168.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -74.33 156.03 37.55 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.476 0.655 . . . . 0.0 111.986 172.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 54.5 mtp180 -127.31 148.43 50.24 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.636 1.974 . . . . 0.0 109.758 177.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 167.98 168.79 30.61 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 124.501 1.048 . . . . 0.0 111.859 178.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -68.05 145.85 54.06 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.098 0.475 . . . . 0.0 110.556 170.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -152.76 154.45 31.42 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 124.103 0.961 . . . . 0.0 110.776 173.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.57 122.29 10.36 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.333 2.022 . . . . 0.0 110.864 178.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 98.1 p -56.4 -37.31 69.98 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.687 -0.633 . . . . 0.0 112.079 176.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 17.2 m -58.2 -20.95 45.47 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 127.273 2.229 . . . . 0.0 115.003 177.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -79.91 1.32 27.69 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.788 1.235 . . . . 0.0 112.961 175.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 60.3 p -131.15 164.43 25.51 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 126.574 1.95 . . . . 0.0 110.673 174.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 12.1 mmmm -128.26 -74.71 0.57 Allowed 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.161 0.984 . . . . 0.0 109.519 177.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 399' ' ' LEU . . . . . 0.439 HD13 ' H ' ' A' ' 400' ' ' LEU . 0.1 OUTLIER -169.73 155.84 6.1 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 128.079 2.552 . . . . 0.0 107.729 169.912 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . 0.439 ' H ' HD13 ' A' ' 399' ' ' LEU . 0.2 OUTLIER -63.27 -59.71 4.37 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 123.474 1.607 . . . . 0.0 112.711 173.103 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -135.25 146.18 48.33 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 112.216 -2.265 . . . . 0.0 111.915 -172.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 . . . . . 0 C--O 1.255 1.369 0 C-N-CA 125.477 1.511 . . . . 0.0 112.353 -165.613 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 526' ' ' HIS . . . . . . . . . . . . . 32.4 m170 . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 121.004 0.43 . . . . 0.0 111.268 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 52.4 mt -65.34 133.02 95.34 Favored Pre-proline 0 N--CA 1.479 1.019 0 C-N-CA 124.982 1.313 . . . . 0.0 109.878 177.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -69.39 160.31 50.3 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 123.702 2.935 . . . . 0.0 112.163 178.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.96 144.22 87.31 Favored 'Trans proline' 0 CA--C 1.534 0.522 0 C-N-CA 122.376 2.051 . . . . 0.0 112.191 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -69.6 153.56 95.58 Favored Pre-proline 0 CA--C 1.551 1.01 0 C-N-CA 122.972 0.509 . . . . 0.0 111.733 171.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -69.23 174.26 9.31 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.322 2.681 . . . . 0.0 113.19 178.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -86.67 2.48 48.34 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.523 1.129 . . . . 0.0 112.948 -178.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 34.0 p90 -133.52 153.39 80.31 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 124.748 1.219 . . . . 0.0 113.104 -176.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -71.62 152.12 59.05 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 123.623 2.882 . . . . 0.0 112.607 178.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -68.56 146.33 97.64 Favored Pre-proline 0 CA--C 1.55 0.971 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -176.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.7 178.72 5.97 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 124.034 3.156 . . . . 0.0 113.086 177.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 19.3 p -133.12 155.0 81.48 Favored Pre-proline 0 N--CA 1.48 1.027 0 C-N-CA 125.18 1.392 . . . . 0.0 112.658 -175.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.02 161.0 47.65 Favored 'Trans proline' 0 CA--C 1.547 1.151 0 C-N-CA 123.375 2.717 . . . . 0.0 111.986 176.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -66.85 150.82 83.16 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.232 2.621 . . . . 0.0 112.74 178.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 540' ' ' VAL . . . . . . . . . . . . . 49.9 t -71.96 -28.94 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 124.722 1.209 . . . . 0.0 112.241 -178.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 541' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -149.65 168.13 24.44 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.553 1.541 . . . . 0.0 112.501 -177.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 542' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 . . . . . 0 C--O 1.252 1.211 0 C-N-CA 125.351 1.461 . . . . 0.0 113.832 174.384 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.462 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 36.9 m -61.98 160.51 12.27 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.157 1.383 . . . . 0.0 113.323 176.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 338' ' ' HIS . . . . . . . . . . . . . 31.5 p80 -128.21 -23.81 3.22 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 -176.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 339' ' ' MET . . . . . . . . . . . . . 81.7 mtp -71.1 135.44 47.68 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 119.132 0.878 . . . . 0.0 110.84 175.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.11 -26.8 64.13 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.182 0.993 . . . . 0.0 113.598 -175.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 341' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -119.83 165.43 14.6 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.639 1.976 . . . . 0.0 110.012 176.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 342' ' ' GLN . . . . . . . . . . . . . 72.3 tp60 -124.25 138.15 54.43 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.856 0.836 . . . . 0.0 110.625 175.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 3.1 mptm? -120.93 163.9 17.53 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 125.642 1.577 . . . . 0.0 111.091 177.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 15.9 m -133.91 155.57 39.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 C-N-CA 126.569 1.948 . . . . 0.0 108.926 168.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 5.7 tptt -119.37 130.53 55.38 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 124.183 0.993 . . . . 0.0 109.372 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 76.3 p -74.46 151.57 39.56 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.457 0.703 . . . . 0.0 111.127 -176.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.9 pp -122.69 -8.36 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -178.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -155.63 159.35 31.71 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 126.919 2.088 . . . . 0.0 110.024 169.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.1 159.62 53.17 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.275 2.65 . . . . 0.0 112.97 176.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -140.35 152.0 45.45 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.051 1.34 . . . . 0.0 111.993 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 15.2 t -146.31 154.65 41.93 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.598 1.559 . . . . 0.0 112.183 -174.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -92.06 -34.43 14.39 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -176.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 69.48 -61.87 0.63 Allowed Glycine 0 CA--C 1.54 1.645 0 C-N-CA 126.58 2.038 . . . . 0.0 115.995 177.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 49.2 m -142.27 19.98 2.08 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 126.351 1.86 . . . . 0.0 112.415 -172.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -128.66 164.52 22.73 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.984 1.714 . . . . 0.0 111.281 -165.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.44 -11.68 9.46 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -178.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 52.2 p -116.57 15.82 15.55 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.363 1.465 . . . . 0.0 112.727 -171.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 47.1 mt -106.71 116.72 32.42 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.045 1.338 . . . . 0.0 110.972 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 25.5 tp -72.05 124.31 24.67 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.644 0.778 . . . . 0.0 110.669 176.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 58.0 p -97.76 152.65 18.92 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.988 1.315 . . . . 0.0 112.401 175.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -167.4 178.43 5.5 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.513 1.525 . . . . 0.0 112.195 -173.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -118.83 173.74 6.7 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.787 2.035 . . . . 0.0 110.941 173.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -65.19 141.16 58.76 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.746 0.818 . . . . 0.0 111.624 171.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 80.29 3.21 89.76 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 124.173 0.892 . . . . 0.0 115.213 175.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -76.2 168.79 19.41 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.231 1.412 . . . . 0.0 112.238 173.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 80.5 t -123.49 130.01 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 125.642 1.577 . . . . 0.0 109.153 -171.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 30.8 mt -134.72 137.29 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.136 0.974 . . . . 0.0 109.525 -178.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 20.0 m -97.76 139.31 33.83 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.033 1.333 . . . . 0.0 110.491 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 20.3 mt -79.34 144.33 34.3 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.235 0.47 . . . . 0.0 111.972 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 47.4 mt -118.58 -1.15 11.22 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.731 1.212 . . . . 0.0 112.93 -178.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 371' ' ' ILE . . . . . 0.488 ' CG2' ' HD2' ' A' ' 372' ' ' PRO . 3.8 mt -134.36 142.57 43.42 Favored Pre-proline 0 N--CA 1.478 0.937 0 C-N-CA 126.848 2.059 . . . . 0.0 109.947 177.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 372' ' ' PRO . . . . . 0.488 ' HD2' ' CG2' ' A' ' 371' ' ' ILE . 57.0 Cg_endo -71.87 -9.08 24.21 Favored 'Trans proline' 0 CA--C 1.547 1.151 0 C-N-CA 123.463 2.775 . . . . 0.0 114.021 176.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -152.65 150.22 29.25 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.027 1.731 . . . . 0.0 111.857 173.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -71.49 168.69 16.99 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.202 1.001 . . . . 0.0 113.554 173.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -123.72 103.4 8.36 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 126.324 1.85 . . . . 0.0 109.911 178.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 51.65 32.73 9.65 Favored 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 177.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 99.29 -12.72 61.83 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 125.415 1.484 . . . . 0.0 114.298 -178.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -89.18 121.41 31.45 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.451 1.1 . . . . 0.0 110.709 175.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 13.1 mt -88.8 158.86 18.0 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.366 0.667 . . . . 0.0 110.372 162.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 380' ' ' TYR . . . . . 0.417 ' HB3' HD11 ' A' ' 371' ' ' ILE . 58.7 t80 -120.65 125.18 47.06 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 125.001 1.32 . . . . 0.0 107.789 170.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -149.41 171.64 29.54 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 115.873 -0.603 . . . . 0.0 113.871 -172.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -123.08 120.93 34.73 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.452 1.501 . . . . 0.0 109.623 177.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 29.4 t-80 -65.68 150.68 48.08 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.717 1.207 . . . . 0.0 112.159 178.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -81.15 -49.31 10.99 Favored 'General case' 0 CA--C 1.548 0.883 0 O-C-N 120.941 -1.099 . . . . 0.0 113.649 178.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 82.8 t -71.05 -52.15 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 178.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 23.2 t -83.96 -23.33 31.12 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.595 0.758 . . . . 0.0 112.852 -174.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp 55.72 15.83 1.75 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 126.681 1.992 . . . . 0.0 114.532 -168.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -73.14 153.72 40.64 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.409 0.623 . . . . 0.0 111.944 173.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -123.68 153.61 40.58 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 126.553 1.941 . . . . 0.0 110.682 178.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 165.45 169.59 29.27 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 124.344 0.973 . . . . 0.0 112.24 175.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -66.92 148.09 52.4 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.066 0.46 . . . . 0.0 110.148 166.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -155.67 154.39 27.95 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 124.3 1.04 . . . . 0.0 110.359 172.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -63.82 123.19 11.56 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.525 2.15 . . . . 0.0 110.926 177.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 99.2 p -56.75 -38.55 72.58 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.655 -0.653 . . . . 0.0 112.136 178.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 14.7 m -61.32 -22.4 64.87 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.044 1.738 . . . . 0.0 114.825 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -73.66 -1.89 20.82 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.829 1.251 . . . . 0.0 113.215 172.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 62.3 p -129.14 160.54 32.53 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.675 1.59 . . . . 0.0 110.987 175.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 30.5 mmtm -123.34 161.5 24.56 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 125.349 1.46 . . . . 0.0 109.563 171.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.3 124.63 23.23 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 174.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.51 -53.15 55.62 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 124.159 1.933 . . . . 0.0 113.911 -175.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -78.69 77.25 5.17 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 128.381 2.672 . . . . 0.0 112.547 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 . . . . . 0 C--O 1.254 1.314 0 C-N-CA 127.06 2.144 . . . . 0.0 114.315 176.624 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 526' ' ' HIS . . . . . . . . . . . . . 37.2 p-80 . . . . . 0 N--CA 1.485 1.289 0 CA-C-O 120.909 0.385 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 53.8 mt -69.78 133.22 88.5 Favored Pre-proline 0 N--CA 1.477 0.891 0 C-N-CA 124.546 1.138 . . . . 0.0 109.552 177.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -69.31 158.87 55.92 Favored 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 123.569 2.846 . . . . 0.0 112.049 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -64.46 145.56 87.99 Favored 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 122.37 2.047 . . . . 0.0 112.17 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -73.07 156.41 89.56 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 123.193 0.597 . . . . 0.0 112.215 173.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -68.78 174.32 8.8 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 123.42 2.747 . . . . 0.0 113.023 175.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -89.5 3.98 50.67 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.509 1.124 . . . . 0.0 113.087 -178.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 34.7 p90 -134.09 154.38 80.14 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 124.722 1.209 . . . . 0.0 112.701 -177.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.49 152.6 60.25 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 123.687 2.924 . . . . 0.0 112.641 179.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -67.87 143.9 96.82 Favored Pre-proline 0 CA--C 1.55 0.969 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -177.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.13 179.08 5.76 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 123.858 3.039 . . . . 0.0 112.716 177.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 24.7 p -131.31 154.91 82.07 Favored Pre-proline 0 N--CA 1.479 0.997 0 C-N-CA 125.194 1.398 . . . . 0.0 112.458 -174.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -67.03 164.57 29.49 Favored 'Trans proline' 0 CA--C 1.546 1.123 0 C-N-CA 123.397 2.732 . . . . 0.0 111.17 174.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -64.12 159.18 44.17 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.835 2.357 . . . . 0.0 112.352 175.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 540' ' ' VAL . . . . . . . . . . . . . 32.7 m -66.11 -13.41 15.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 126.821 2.048 . . . . 0.0 114.697 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 541' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -97.46 126.26 42.62 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.777 1.631 . . . . 0.0 110.579 177.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 542' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 . . . . . 0 C--O 1.253 1.254 0 C-N-CA 124.663 1.185 . . . . 0.0 112.975 174.495 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.454 0 N-CA-C 111.574 -0.61 . . . . 0.0 111.574 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 44.6 m -127.21 -44.05 1.61 Allowed 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.022 0.929 . . . . 0.0 113.227 -174.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 338' ' ' HIS . . . . . . . . . . . . . 24.4 p-80 -90.06 -9.04 49.98 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.236 1.014 . . . . 0.0 113.261 170.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 339' ' ' MET . . . . . . . . . . . . . 8.7 tpt -123.26 85.45 2.42 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.194 1.798 . . . . 0.0 109.486 -175.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -119.84 0.14 10.8 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.519 1.528 . . . . 0.0 114.478 -173.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 341' ' ' LYS . . . . . . . . . . . . . 2.3 tmmm? -89.71 57.52 3.92 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 127.154 2.182 . . . . 0.0 110.139 176.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 342' ' ' GLN . . . . . . . . . . . . . 70.1 tp60 -68.2 148.4 50.9 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.706 0.765 . . . . 0.0 110.775 174.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 9.7 tptt -124.5 155.62 38.66 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 125.211 1.405 . . . . 0.0 111.347 -175.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 17.9 m -138.03 157.2 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 125.609 1.564 . . . . 0.0 110.052 175.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt -121.76 134.3 54.93 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.249 1.02 . . . . 0.0 110.221 175.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 82.7 p -76.4 156.34 33.27 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.622 1.569 . . . . 0.0 111.75 -179.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.9 pp -123.24 -6.91 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -153.73 157.69 32.62 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 125.758 1.623 . . . . 0.0 110.577 169.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.67 155.54 62.73 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.194 2.596 . . . . 0.0 112.994 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 32.6 t-80 -143.9 137.75 28.08 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.934 1.694 . . . . 0.0 110.43 -178.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 48.7 m -142.0 125.24 16.44 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.508 1.123 . . . . 0.0 110.292 -177.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -61.4 -50.89 71.03 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.101 0.96 . . . . 0.0 112.887 177.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 50.44 -109.71 0.75 Allowed Glycine 0 CA--C 1.54 1.642 0 O-C-N 121.143 -0.973 . . . . 0.0 113.365 -176.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 27.8 m -70.8 -15.81 62.69 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 176.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -70.98 176.73 4.13 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.503 1.121 . . . . 0.0 112.414 174.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? -133.83 154.7 50.84 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.864 1.666 . . . . 0.0 110.275 171.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 17.5 p 57.27 17.97 3.99 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 127.22 2.208 . . . . 0.0 115.949 175.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 15.3 mt -99.51 137.65 37.7 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.664 1.186 . . . . 0.0 110.653 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 30.6 tp -82.91 124.81 30.7 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 122.995 0.518 . . . . 0.0 110.818 175.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 47.4 m -91.74 147.55 22.91 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.775 1.23 . . . . 0.0 111.985 175.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -166.2 177.99 6.56 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.676 1.59 . . . . 0.0 112.755 -175.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -115.53 175.01 5.71 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.318 1.847 . . . . 0.0 111.617 173.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -62.46 141.1 58.55 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 121.349 -0.845 . . . . 0.0 111.106 168.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 71.53 18.63 77.23 Favored Glycine 0 CA--C 1.537 1.45 0 N-CA-C 114.651 0.62 . . . . 0.0 114.651 176.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -88.25 159.52 18.08 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.688 1.195 . . . . 0.0 111.645 173.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 88.0 t -111.28 130.33 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.011 1.324 . . . . 0.0 109.765 -173.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 23.1 mt -136.01 136.53 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.865 1.266 . . . . 0.0 109.035 -177.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 9.9 m -97.89 139.45 33.73 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.87 1.268 . . . . 0.0 110.004 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 20.6 mt -78.99 140.79 37.91 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 118.864 0.756 . . . . 0.0 111.953 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 37.4 mt -119.53 -5.38 10.29 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.891 1.276 . . . . 0.0 113.569 -177.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 371' ' ' ILE . . . . . 0.872 HG22 ' HD2' ' A' ' 372' ' ' PRO . 0.2 OUTLIER -127.9 146.76 60.26 Favored Pre-proline 0 N--CA 1.477 0.888 0 C-N-CA 126.722 2.009 . . . . 0.0 108.213 173.73 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 372' ' ' PRO . . . . . 0.872 ' HD2' HG22 ' A' ' 371' ' ' ILE . 82.9 Cg_endo -75.01 -17.09 19.81 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.461 2.774 . . . . 0.0 112.402 177.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -148.25 142.48 26.13 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.172 1.789 . . . . 0.0 111.202 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -72.29 172.95 9.36 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 125.658 1.583 . . . . 0.0 113.592 176.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -132.97 108.43 8.9 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.377 1.871 . . . . 0.0 110.833 -177.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 50.18 32.44 6.02 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 125.323 1.449 . . . . 0.0 114.707 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 98.94 -7.44 60.69 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 125.236 1.398 . . . . 0.0 114.462 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 78.8 m95 -99.77 128.97 45.84 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.485 1.143 . . . . 0.0 111.505 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 16.2 mt -98.42 161.36 13.73 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.622 1.169 . . . . 0.0 110.92 167.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 380' ' ' TYR . . . . . 0.453 ' HB3' ' CG1' ' A' ' 371' ' ' ILE . 60.2 t80 -121.33 122.2 39.33 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 173.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -145.58 170.75 26.8 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 115.749 -0.66 . . . . 0.0 114.46 -174.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -120.62 119.05 31.74 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.385 1.474 . . . . 0.0 109.717 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 -61.93 146.53 49.66 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.068 1.347 . . . . 0.0 111.68 177.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -80.55 -47.82 13.64 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 120.801 -1.187 . . . . 0.0 113.512 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 89.7 t -69.93 -51.93 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 124.287 1.035 . . . . 0.0 113.241 177.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 13.5 t -86.93 -21.69 26.1 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -173.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp 54.62 19.45 2.45 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 126.439 1.896 . . . . 0.0 114.303 -169.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -75.98 153.8 36.3 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.376 0.67 . . . . 0.0 111.896 172.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 70.9 mtm180 -127.93 148.04 50.49 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.463 1.905 . . . . 0.0 110.458 -179.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 169.86 170.93 34.87 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.83 1.205 . . . . 0.0 111.881 177.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -67.69 145.56 54.65 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.61 0.764 . . . . 0.0 110.902 171.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -152.78 153.2 29.8 Favored Pre-proline 0 CA--C 1.541 0.631 0 O-C-N 120.826 -1.171 . . . . 0.0 111.849 174.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -63.76 124.26 13.35 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 122.902 2.401 . . . . 0.0 112.14 178.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 97.5 p -62.97 -21.0 65.79 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 174.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 19.3 m -74.23 -17.54 60.87 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.826 1.25 . . . . 0.0 114.23 174.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -81.84 -2.72 52.0 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.567 1.147 . . . . 0.0 113.439 177.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 72.2 p -128.18 169.66 13.88 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.563 1.945 . . . . 0.0 110.061 173.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -130.12 -77.79 0.54 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.786 0.834 . . . . 0.0 109.984 177.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 399' ' ' LEU . . . . . 0.417 HD13 ' H ' ' A' ' 400' ' ' LEU . 0.2 OUTLIER -166.86 145.79 5.31 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.378 2.271 . . . . 0.0 107.41 172.271 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . 0.417 ' H ' HD13 ' A' ' 399' ' ' LEU . 0.1 OUTLIER -64.79 -68.44 0.36 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 123.115 1.436 . . . . 0.0 112.79 176.523 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -129.61 126.96 39.65 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 112.553 -2.112 . . . . 0.0 112.019 -169.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 . . . . . 0 C--O 1.254 1.33 0 C-N-CA 125.567 1.547 . . . . 0.0 112.355 -171.934 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 526' ' ' HIS . . . . . . . . . . . . . 40.3 m80 . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.49 0.186 . . . . 0.0 110.726 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 36.0 mt -70.05 130.89 89.33 Favored Pre-proline 0 N--CA 1.477 0.902 0 C-N-CA 124.02 0.928 . . . . 0.0 109.272 176.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -68.7 162.48 40.98 Favored 'Trans proline' 0 CA--C 1.545 1.049 0 C-N-CA 123.492 2.794 . . . . 0.0 111.776 177.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.26 143.32 83.04 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.09 1.86 . . . . 0.0 112.365 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -70.0 152.91 95.75 Favored Pre-proline 0 CA--C 1.553 1.065 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.528 170.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -69.77 174.86 8.89 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.402 2.735 . . . . 0.0 113.309 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -90.69 8.35 34.86 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.756 1.222 . . . . 0.0 112.568 -178.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 37.0 p90 -135.82 153.01 76.93 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 124.828 1.251 . . . . 0.0 112.874 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.07 152.09 62.18 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.662 2.908 . . . . 0.0 112.276 178.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -67.53 144.13 97.52 Favored Pre-proline 0 CA--C 1.551 0.99 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -175.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.36 177.07 8.37 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 124.03 3.153 . . . . 0.0 113.106 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 27.3 p -132.23 153.66 81.36 Favored Pre-proline 0 N--CA 1.478 0.968 0 C-N-CA 125.076 1.35 . . . . 0.0 112.827 -172.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -67.84 165.07 29.13 Favored 'Trans proline' 0 CA--C 1.55 1.284 0 C-N-CA 123.55 2.833 . . . . 0.0 112.054 175.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -65.49 163.73 28.78 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 123.664 2.909 . . . . 0.0 113.173 176.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 540' ' ' VAL . . . . . . . . . . . . . 4.7 t -133.88 53.06 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 125.635 1.574 . . . . 0.0 110.065 -169.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 541' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -70.25 59.72 0.19 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 127.139 2.176 . . . . 0.0 113.428 178.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 542' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 . . . . . 0 C--O 1.254 1.323 0 C-N-CA 125.396 1.478 . . . . 0.0 112.385 173.65 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.693 0 N-CA-C 111.518 -0.633 . . . . 0.0 111.518 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 81.4 p -152.14 140.75 20.78 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.256 1.022 . . . . 0.0 112.524 174.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 338' ' ' HIS . . . . . . . . . . . . . 25.4 p-80 -73.48 -24.02 60.14 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -178.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 339' ' ' MET . . . . . . . . . . . . . 5.4 ppp? -75.72 -21.19 57.75 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -178.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -101.6 -37.2 8.48 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.627 1.171 . . . . 0.0 112.817 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 341' ' ' LYS . . . . . . . . . . . . . 34.9 tptt -112.39 44.04 1.51 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 126.288 1.835 . . . . 0.0 110.107 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 342' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -50.39 131.52 24.5 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.398 1.079 . . . . 0.0 110.238 -179.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -120.72 146.97 45.91 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.93 1.292 . . . . 0.0 111.726 178.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 16.7 m -127.67 143.26 41.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 113.998 -1.455 . . . . 0.0 108.729 173.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -111.28 131.82 54.85 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.771 0.796 . . . . 0.0 109.944 175.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 70.6 p -76.34 151.67 36.6 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.955 1.702 . . . . 0.0 111.61 -175.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.7 pp -122.56 -6.1 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 N-CA-C 114.684 1.364 . . . . 0.0 114.684 -175.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -154.58 158.96 32.32 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 126.446 1.898 . . . . 0.0 110.199 169.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -69.46 159.3 54.16 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 123.085 2.523 . . . . 0.0 112.923 177.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -136.85 150.21 48.16 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.918 1.287 . . . . 0.0 112.039 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 35.5 m -140.85 144.07 35.12 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.429 1.492 . . . . 0.0 111.004 -162.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -110.81 -28.86 8.21 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -175.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 55.21 -116.72 7.23 Favored Glycine 0 CA--C 1.538 1.524 0 CA-C-N 119.159 0.89 . . . . 0.0 112.73 -175.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 80.6 p -75.24 -15.42 60.53 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 177.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -72.8 159.76 33.26 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.4 1.08 . . . . 0.0 112.325 -178.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 34.1 mtmm -127.98 -1.71 5.88 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 -179.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 39.6 p -117.89 11.67 13.56 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 125.44 1.496 . . . . 0.0 113.015 -176.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 63.0 mt -106.83 125.46 51.04 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.028 1.331 . . . . 0.0 110.653 179.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 26.0 tp -77.3 127.58 32.84 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.338 0.655 . . . . 0.0 110.596 176.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 37.3 p -100.96 147.08 26.58 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.136 1.374 . . . . 0.0 112.217 177.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -163.48 178.99 7.59 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.556 1.542 . . . . 0.0 112.054 -174.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -130.27 157.32 42.83 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 127.282 2.233 . . . . 0.0 111.358 177.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -50.98 129.51 23.81 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.494 0.717 . . . . 0.0 112.311 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 91.45 -9.01 78.33 Favored Glycine 0 CA--C 1.538 1.476 0 C-N-CA 124.261 0.934 . . . . 0.0 114.633 -179.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -68.05 153.02 44.6 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 118.903 1.351 . . . . 0.0 111.891 172.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 74.3 t -115.51 140.26 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 125.389 1.476 . . . . 0.0 109.989 -173.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 36.2 mt -136.07 136.57 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 125.668 1.587 . . . . 0.0 108.559 -177.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 31.8 m -99.46 137.23 38.25 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.649 1.18 . . . . 0.0 109.7 177.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 15.7 mt -69.45 147.34 51.06 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -177.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 77.4 mt -120.87 -2.21 9.81 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 125.079 1.351 . . . . 0.0 113.435 178.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 371' ' ' ILE . . . . . 0.62 HG22 ' HD2' ' A' ' 372' ' ' PRO . 2.0 mt -137.04 142.7 39.29 Favored Pre-proline 0 N--CA 1.477 0.906 0 C-N-CA 126.623 1.969 . . . . 0.0 109.14 177.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 372' ' ' PRO . . . . . 0.62 ' HD2' HG22 ' A' ' 371' ' ' ILE . 42.3 Cg_endo -70.42 -15.83 34.67 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 123.056 2.504 . . . . 0.0 113.308 177.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -145.15 150.13 36.23 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.492 1.917 . . . . 0.0 111.028 177.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -75.23 172.28 12.69 Favored 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 176.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -124.7 101.87 7.31 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.255 1.822 . . . . 0.0 110.293 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 51.95 31.78 9.07 Favored 'General case' 0 CA--C 1.554 1.135 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 175.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 100.01 -4.36 57.43 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 125.099 1.333 . . . . 0.0 114.64 -178.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 82.5 m95 -103.28 121.29 42.41 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.639 1.576 . . . . 0.0 110.521 176.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 12.1 mt -85.07 160.42 19.99 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.364 0.666 . . . . 0.0 110.578 163.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 380' ' ' TYR . . . . . 0.429 ' HB3' HD11 ' A' ' 371' ' ' ILE . 57.5 t80 -122.98 126.49 47.27 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.208 1.403 . . . . 0.0 107.56 170.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -150.48 170.38 30.38 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-N 115.857 -0.611 . . . . 0.0 113.643 -173.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -118.83 119.64 34.99 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.226 1.41 . . . . 0.0 109.325 176.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -61.59 146.32 49.25 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.361 1.464 . . . . 0.0 111.745 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -79.55 -47.67 15.13 Favored 'General case' 0 CA--C 1.548 0.897 0 O-C-N 120.774 -1.203 . . . . 0.0 113.734 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 81.9 t -73.93 -49.47 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.988 0.915 . . . . 0.0 112.968 178.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 15.5 t -86.91 -21.74 26.12 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -173.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp 54.27 17.47 1.52 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 126.712 2.005 . . . . 0.0 114.771 -169.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -75.21 159.58 31.41 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.506 0.723 . . . . 0.0 112.16 173.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -126.58 159.0 34.78 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.336 1.854 . . . . 0.0 110.468 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 157.72 169.67 21.67 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 124.454 1.025 . . . . 0.0 112.538 175.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -67.85 145.58 54.49 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.002 0.521 . . . . 0.0 110.416 169.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -153.2 153.63 29.74 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 124.003 0.921 . . . . 0.0 111.162 173.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -62.86 121.06 8.81 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.748 2.299 . . . . 0.0 111.381 178.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.0 -17.53 63.4 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 121.303 -0.873 . . . . 0.0 113.096 177.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 79.6 p -73.43 -22.12 60.29 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.712 2.005 . . . . 0.0 114.282 174.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -79.09 2.89 19.15 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.507 1.523 . . . . 0.0 113.325 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 30.8 p -133.97 171.01 14.78 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.966 2.106 . . . . 0.0 109.93 175.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -125.43 -80.81 0.62 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.717 0.807 . . . . 0.0 109.521 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 399' ' ' LEU . . . . . 0.455 HD13 ' N ' ' A' ' 400' ' ' LEU . 0.7 OUTLIER -165.25 150.48 9.28 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 127.629 2.372 . . . . 0.0 106.77 167.642 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . 0.455 ' N ' HD13 ' A' ' 399' ' ' LEU . 0.6 OUTLIER -58.96 -70.4 0.15 Allowed 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 123.836 1.779 . . . . 0.0 112.443 176.025 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -61.14 122.0 13.92 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 110.799 -2.909 . . . . 0.0 111.655 -170.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 . . . . . 0 C--O 1.252 1.234 0 C-N-CA 125.024 1.329 . . . . 0.0 114.032 -177.121 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 526' ' ' HIS . . . . . . . . . . . . . 47.3 p-80 . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 121.095 0.474 . . . . 0.0 111.289 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 61.9 mt -68.4 131.32 91.79 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 124.478 1.111 . . . . 0.0 109.491 176.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -69.37 160.57 49.28 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 123.611 2.874 . . . . 0.0 112.357 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.37 145.47 88.24 Favored 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 122.579 2.186 . . . . 0.0 112.368 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -77.24 158.2 79.84 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 123.691 0.796 . . . . 0.0 112.448 174.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -68.56 174.97 7.63 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 123.527 2.818 . . . . 0.0 113.176 176.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -93.56 9.87 34.96 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.908 1.283 . . . . 0.0 112.408 -178.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 38.6 p90 -138.46 153.93 73.07 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 124.67 1.188 . . . . 0.0 112.622 -178.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -71.18 152.28 61.76 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.444 2.763 . . . . 0.0 112.069 176.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -66.81 148.86 98.68 Favored Pre-proline 0 CA--C 1.549 0.926 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -176.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.78 -175.9 1.83 Allowed 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 124.069 3.179 . . . . 0.0 112.638 176.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 23.4 p -135.41 153.4 77.85 Favored Pre-proline 0 N--CA 1.475 0.8 0 C-N-CA 125.196 1.399 . . . . 0.0 112.465 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -65.42 164.38 26.18 Favored 'Trans proline' 0 CA--C 1.549 1.241 0 C-N-CA 123.225 2.617 . . . . 0.0 111.273 173.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -65.65 169.97 12.0 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 123.379 2.719 . . . . 0.0 113.248 177.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 540' ' ' VAL . . . . . . . . . . . . . 22.6 m -67.64 2.15 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 128.428 2.691 . . . . 0.0 115.713 177.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 541' ' ' GLN . . . . . . . . . . . . . 28.9 pt20 -129.86 166.66 19.52 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.899 2.079 . . . . 0.0 111.763 179.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 542' ' ' ASN . . . . . . . . . . . . . 1.5 t30 . . . . . 0 C--O 1.254 1.304 0 C-N-CA 125.339 1.456 . . . . 0.0 111.454 -177.953 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.61 0 N-CA-C 111.694 -0.562 . . . . 0.0 111.694 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 28.5 m -71.42 75.1 0.76 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 126.436 1.895 . . . . 0.0 113.954 -174.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 338' ' ' HIS . . . . . . . . . . . . . 13.7 t-160 -61.38 -39.6 91.27 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.068 1.347 . . . . 0.0 113.536 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 339' ' ' MET . . . . . . . . . . . . . 20.7 ptp -159.32 173.7 15.89 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.126 1.77 . . . . 0.0 112.126 177.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 11.7 mmmm -115.81 -64.15 1.35 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.772 1.229 . . . . 0.0 112.666 -173.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 341' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -73.72 144.87 45.55 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 118.936 0.789 . . . . 0.0 111.032 170.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 342' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.67 152.26 41.81 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.784 1.234 . . . . 0.0 112.155 177.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -120.08 163.12 18.15 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 114.132 -1.394 . . . . 0.0 112.847 166.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 12.9 m -134.32 153.54 35.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 127.573 2.349 . . . . 0.0 108.5 171.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -118.92 130.82 55.92 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.709 0.804 . . . . 0.0 110.203 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 76.5 p -73.61 151.17 40.94 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.792 0.837 . . . . 0.0 111.138 -178.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.8 pp -123.45 -7.93 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 -177.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -154.35 156.78 32.04 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 126.255 1.822 . . . . 0.0 110.233 169.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -69.78 156.74 62.52 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 123.316 2.677 . . . . 0.0 112.856 178.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 350' ' ' HIS . . . . . 0.416 ' HE1' HD12 ' A' ' 358' ' ' LEU . 55.5 t-80 -138.26 145.38 41.25 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.024 1.329 . . . . 0.0 111.855 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 28.7 m -145.37 135.04 23.41 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.396 1.478 . . . . 0.0 110.962 -174.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -75.63 33.58 0.11 Allowed 'General case' 0 CA--C 1.56 1.344 0 C-N-CA 126.929 2.092 . . . . 0.0 114.595 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . -48.28 -24.48 3.6 Favored Glycine 0 CA--C 1.54 1.608 0 C-N-CA 127.407 2.432 . . . . 0.0 118.847 -163.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 5.7 t -150.31 39.09 0.73 Allowed 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 118.951 1.375 . . . . 0.0 111.172 175.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -139.85 179.01 6.84 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.626 1.17 . . . . 0.0 112.668 -162.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 15.2 ttmt -142.82 147.16 34.98 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.859 1.664 . . . . 0.0 111.346 176.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . 0.26 24.9 p 59.62 19.92 8.51 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 128.005 2.522 . . . . 0.0 116.334 -177.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 358' ' ' LEU . . . . . 0.416 HD12 ' HE1' ' A' ' 350' ' ' HIS . 4.4 mm? -77.71 141.99 39.01 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.084 1.354 . . . . 0.0 110.554 172.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 22.9 tp -85.41 136.83 33.29 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 161.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 65.8 m -117.23 143.81 45.47 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.443 1.497 . . . . 0.0 111.428 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -162.55 178.98 8.09 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.091 1.357 . . . . 0.0 112.892 -167.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -116.93 173.53 6.6 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.226 1.811 . . . . 0.0 111.443 174.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -65.63 142.74 57.96 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.16 0.984 . . . . 0.0 111.559 171.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 75.67 8.28 84.13 Favored Glycine 0 CA--C 1.534 1.258 0 CA-C-O 119.298 -0.723 . . . . 0.0 114.819 176.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -79.07 163.41 25.15 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.556 1.142 . . . . 0.0 111.733 171.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 99.8 t -114.84 134.65 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.124 1.37 . . . . 0.0 109.163 -176.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 35.9 mt -132.45 141.48 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.275 1.03 . . . . 0.0 109.043 178.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 16.9 m -105.34 137.27 43.41 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.074 1.35 . . . . 0.0 109.467 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 9.9 mt -73.44 145.1 46.0 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -176.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 72.2 mt -119.53 -12.65 9.29 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 124.83 1.252 . . . . 0.0 113.311 178.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 371' ' ' ILE . . . . . 0.415 ' CG2' ' HD2' ' A' ' 372' ' ' PRO . 9.8 mt -127.79 141.22 40.41 Favored Pre-proline 0 N--CA 1.478 0.932 0 C-N-CA 126.096 1.759 . . . . 0.0 110.255 175.098 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 372' ' ' PRO . . . . . 0.415 ' HD2' ' CG2' ' A' ' 371' ' ' ILE . 56.5 Cg_endo -71.7 -7.58 21.45 Favored 'Trans proline' 0 CA--C 1.547 1.144 0 C-N-CA 123.948 3.098 . . . . 0.0 114.48 176.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -152.55 153.71 33.96 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.663 1.585 . . . . 0.0 112.262 172.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -75.32 169.78 17.39 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.491 1.116 . . . . 0.0 113.647 174.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -128.6 105.92 8.61 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 126.669 1.988 . . . . 0.0 109.957 179.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 50.37 32.17 6.1 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 124.954 1.302 . . . . 0.0 114.373 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 99.55 -17.38 57.7 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 125.863 1.697 . . . . 0.0 114.377 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -82.59 125.29 31.0 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.542 1.137 . . . . 0.0 111.138 176.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 14.4 mt -94.42 162.94 13.62 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.636 0.774 . . . . 0.0 110.364 162.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -126.45 125.38 42.03 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 170.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -147.53 169.96 28.35 Favored Glycine 0 CA--C 1.527 0.781 0 C-N-CA 124.085 0.85 . . . . 0.0 112.671 -173.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -117.24 121.2 40.54 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 124.492 1.117 . . . . 0.0 109.275 175.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -63.54 152.35 38.87 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.762 1.225 . . . . 0.0 112.382 178.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -86.85 -45.89 10.44 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 120.991 -1.068 . . . . 0.0 113.45 177.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 53.1 t -67.32 -54.49 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 123.799 0.84 . . . . 0.0 113.008 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 22.2 m -96.07 -12.86 24.21 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -172.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt 55.47 19.82 3.36 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 126.674 1.99 . . . . 0.0 114.77 -174.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -75.35 158.31 32.97 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.54 0.736 . . . . 0.0 112.153 175.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 53.7 mtt180 -128.83 153.13 47.73 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 127.022 2.129 . . . . 0.0 109.579 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 162.68 166.09 20.86 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 125.198 1.38 . . . . 0.0 111.421 176.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -65.82 144.5 56.8 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.388 0.675 . . . . 0.0 110.177 170.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -153.31 155.1 31.51 Favored Pre-proline 0 CA--C 1.539 0.527 0 O-C-N 120.507 -1.371 . . . . 0.0 110.978 175.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -65.38 118.63 5.62 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.23 1.953 . . . . 0.0 110.831 177.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 29.4 t -54.15 -38.77 65.85 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.75 -0.593 . . . . 0.0 112.109 177.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 14.7 m -60.08 -21.66 61.75 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 178.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -75.43 -3.47 34.0 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.561 1.145 . . . . 0.0 113.157 173.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 80.8 p -123.05 160.17 26.92 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.712 1.605 . . . . 0.0 110.747 172.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . 0.412 ' HE2' ' HA ' ' A' ' 398' ' ' LYS . 10.1 mmpt? -121.5 163.95 17.98 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.708 1.203 . . . . 0.0 108.61 167.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.2 129.86 42.72 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.142 169.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -50.98 -62.23 1.74 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 123.96 1.838 . . . . 0.0 112.315 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -66.7 146.66 54.23 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 111.35 -2.659 . . . . 0.0 112.06 177.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 . . . . . 0 N--CA 1.487 1.404 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -175.737 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 526' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 120.76 0.314 . . . . 0.0 110.768 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 49.8 mt -66.65 132.75 94.12 Favored Pre-proline 0 N--CA 1.479 1.001 0 C-N-CA 124.652 1.181 . . . . 0.0 109.8 178.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -68.69 160.93 47.44 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 123.624 2.883 . . . . 0.0 112.036 177.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.77 144.85 89.98 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.31 2.006 . . . . 0.0 112.493 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -68.29 152.54 96.47 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 123.041 0.536 . . . . 0.0 111.875 172.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -70.07 174.41 9.81 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.608 2.872 . . . . 0.0 113.543 -178.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -89.37 5.27 45.89 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.208 1.403 . . . . 0.0 112.378 -178.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 29.3 p90 -137.08 155.06 76.29 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 124.353 1.061 . . . . 0.0 112.642 -177.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.75 153.13 53.65 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 123.806 3.004 . . . . 0.0 112.965 178.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -67.81 140.03 93.84 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 123.788 0.835 . . . . 0.0 112.968 -177.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -73.45 179.05 5.9 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 123.979 3.119 . . . . 0.0 112.789 176.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 25.8 p -132.79 154.79 81.58 Favored Pre-proline 0 N--CA 1.48 1.058 0 C-N-CA 125.122 1.369 . . . . 0.0 112.479 -175.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -66.94 165.15 27.1 Favored 'Trans proline' 0 CA--C 1.549 1.243 0 C-N-CA 123.437 2.758 . . . . 0.0 111.621 175.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -64.54 160.72 38.4 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.337 2.692 . . . . 0.0 113.147 178.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 540' ' ' VAL . . . . . . . . . . . . . 18.8 t -129.76 83.42 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 125.471 1.508 . . . . 0.0 109.235 -174.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 541' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -135.38 4.63 3.17 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.372 1.869 . . . . 0.0 113.955 -174.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 542' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 . . . . . 0 C--O 1.254 1.313 0 C-N-CA 125.426 1.491 . . . . 0.0 112.958 177.117 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.557 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 85.5 p -149.26 167.19 26.7 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.257 1.423 . . . . 0.0 112.172 178.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 338' ' ' HIS . . . . . . . . . . . . . 16.5 t60 -68.53 172.38 6.24 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.876 0.87 . . . . 0.0 112.143 171.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 339' ' ' MET . . . . . . . . . . . . . 25.1 ptp -139.75 160.29 40.24 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.782 1.233 . . . . 0.0 112.899 177.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -101.18 -1.14 34.64 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 125.088 1.355 . . . . 0.0 113.929 -175.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 341' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -76.33 111.86 12.22 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.509 1.524 . . . . 0.0 111.381 178.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 342' ' ' GLN . . . . . . . . . . . . . 72.6 tp60 -64.85 138.45 58.38 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.579 0.704 . . . . 0.0 111.107 172.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 3.2 mptm? -124.59 164.31 20.1 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 125.858 1.663 . . . . 0.0 111.179 176.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 16.7 m -131.82 159.53 43.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 126.219 1.808 . . . . 0.0 109.212 168.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -122.99 132.23 54.05 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 124.268 1.027 . . . . 0.0 109.352 -177.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 74.4 p -78.35 152.47 32.32 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.416 0.686 . . . . 0.0 110.824 -177.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.8 pp -125.7 -5.68 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 N-CA-C 114.441 1.275 . . . . 0.0 114.441 -178.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -153.86 160.67 30.68 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 126.117 1.767 . . . . 0.0 110.431 168.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -69.77 156.59 62.91 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 123.117 2.545 . . . . 0.0 113.139 174.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -141.51 152.05 43.82 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.224 1.41 . . . . 0.0 111.451 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 7.7 t -148.27 157.92 43.78 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.954 1.301 . . . . 0.0 113.018 -174.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -87.31 82.75 7.5 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.809 1.643 . . . . 0.0 112.866 -175.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . -66.07 105.31 1.23 Allowed Glycine 0 CA--C 1.537 1.424 0 C-N-CA 124.24 0.924 . . . . 0.0 112.704 174.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 33.5 m 52.13 44.07 29.96 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 126.04 1.736 . . . . 0.0 114.44 179.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -147.15 174.13 11.87 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -169.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.64 -16.12 3.86 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 126.135 1.774 . . . . 0.0 115.082 174.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 65.7 p -102.96 13.61 33.92 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 125.098 1.359 . . . . 0.0 113.511 -176.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 45.3 mt -101.49 116.09 31.99 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.728 1.211 . . . . 0.0 111.027 -176.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 27.6 tp -74.04 118.25 16.78 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.502 0.721 . . . . 0.0 110.962 178.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 59.9 p -87.91 154.34 20.6 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.282 1.033 . . . . 0.0 112.978 174.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -167.39 179.41 5.01 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.917 1.687 . . . . 0.0 112.014 -177.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -119.49 176.7 5.23 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.577 1.951 . . . . 0.0 110.942 172.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 66.5 tt0 -65.92 139.47 58.26 Favored 'General case' 0 CA--C 1.546 0.814 0 O-C-N 121.349 -0.844 . . . . 0.0 111.548 171.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 82.19 4.29 90.27 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.298 0.951 . . . . 0.0 115.376 175.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -77.07 170.25 16.86 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.946 1.298 . . . . 0.0 112.616 173.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 94.6 t -125.24 129.35 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.786 1.634 . . . . 0.0 109.09 -169.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 29.6 mt -134.81 137.8 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.94 0.896 . . . . 0.0 109.968 -177.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 10.1 m -96.9 140.06 32.01 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.993 1.317 . . . . 0.0 110.834 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 20.7 mt -78.91 136.67 37.34 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 122.943 0.497 . . . . 0.0 111.55 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 50.1 mt -114.63 -2.0 13.2 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.7 1.2 . . . . 0.0 113.045 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 371' ' ' ILE . . . . . 0.584 HG22 ' HD2' ' A' ' 372' ' ' PRO . 2.1 mt -134.82 143.28 45.64 Favored Pre-proline 0 N--CA 1.478 0.972 0 C-N-CA 126.623 1.969 . . . . 0.0 109.568 178.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 372' ' ' PRO . . . . . 0.584 ' HD2' HG22 ' A' ' 371' ' ' ILE . 56.1 Cg_endo -72.46 -9.73 24.5 Favored 'Trans proline' 0 CA--C 1.548 1.18 0 C-N-CA 123.203 2.602 . . . . 0.0 113.639 176.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -153.32 152.43 31.11 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.862 1.665 . . . . 0.0 112.302 174.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -71.83 169.91 14.76 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.769 1.228 . . . . 0.0 113.855 173.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -129.36 106.96 9.14 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.466 1.907 . . . . 0.0 110.047 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 51.05 31.69 6.73 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.097 1.359 . . . . 0.0 114.567 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 97.35 -11.79 65.19 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 125.465 1.507 . . . . 0.0 114.439 -178.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 77.8 m95 -89.28 123.94 33.95 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.49 1.116 . . . . 0.0 110.809 175.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 15.1 mt -90.14 156.76 18.12 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.536 0.735 . . . . 0.0 110.228 162.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 380' ' ' TYR . . . . . 0.482 ' HB3' HD11 ' A' ' 371' ' ' ILE . 58.7 t80 -116.77 124.55 49.88 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.904 1.282 . . . . 0.0 107.616 169.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -148.74 171.95 28.99 Favored Glycine 0 CA--C 1.524 0.594 0 CA-C-N 115.659 -0.701 . . . . 0.0 113.376 -173.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -122.81 120.42 33.49 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.774 1.23 . . . . 0.0 109.859 177.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 25.2 t-80 -64.86 145.61 56.04 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.429 1.092 . . . . 0.0 111.66 178.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -80.19 -45.37 18.19 Favored 'General case' 0 CA--C 1.547 0.861 0 O-C-N 120.927 -1.108 . . . . 0.0 113.448 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 87.7 t -72.53 -53.78 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 177.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 35.2 m -86.41 -17.32 34.64 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.288 0.949 . . . . 0.0 113.142 -172.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp 53.96 21.31 2.8 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 126.69 1.996 . . . . 0.0 114.505 -173.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -80.55 152.46 28.62 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.189 0.596 . . . . 0.0 111.527 173.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 46.7 mtm-85 -119.44 155.6 31.73 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.252 1.821 . . . . 0.0 110.65 175.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 164.01 169.68 27.87 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.372 0.987 . . . . 0.0 112.217 174.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -66.53 145.75 55.28 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.351 0.661 . . . . 0.0 110.485 166.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -155.23 154.43 28.57 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 124.482 1.113 . . . . 0.0 110.391 172.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 393' ' ' PRO . . . . . 0.438 ' HB3' ' HB1' ' B' ' 535' ' ' ALA . 24.3 Cg_endo -65.37 124.14 12.48 Favored 'Trans proline' 0 CA--C 1.532 0.4 0 C-N-CA 122.581 2.188 . . . . 0.0 111.497 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 96.3 p -56.88 -37.21 71.06 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 8.7 p -67.66 -14.24 62.78 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.094 1.758 . . . . 0.0 115.503 179.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -79.86 -2.08 41.92 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 119.524 1.056 . . . . 0.0 113.106 168.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 77.0 p -126.86 166.07 18.15 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.446 1.498 . . . . 0.0 111.186 172.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -144.51 163.49 33.7 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.975 1.31 . . . . 0.0 110.346 171.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.52 124.58 19.5 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.809 0.844 . . . . 0.0 109.433 178.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . 0.415 ' O ' HD12 ' A' ' 400' ' ' LEU . 3.6 tp -49.74 -43.31 47.84 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 -172.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -77.67 -19.93 54.56 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 113.058 -1.883 . . . . 0.0 115.116 -175.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 . . . . . 0 N--CA 1.485 1.311 0 C-N-CA 125.939 1.696 . . . . 0.0 112.988 -171.518 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 526' ' ' HIS . . . . . . . . . . . . . 64.6 m80 . . . . . 0 N--CA 1.485 1.32 0 CA-C-O 120.869 0.366 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 63.6 mt -71.38 133.29 85.29 Favored Pre-proline 0 N--CA 1.477 0.885 0 C-N-CA 124.857 1.263 . . . . 0.0 109.429 176.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -69.41 159.85 52.07 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 123.561 2.841 . . . . 0.0 112.238 178.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.13 144.74 87.9 Favored 'Trans proline' 0 CA--C 1.535 0.529 0 C-N-CA 122.424 2.083 . . . . 0.0 112.148 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -73.89 156.7 87.93 Favored Pre-proline 0 CA--C 1.551 0.994 0 C-N-CA 123.243 0.617 . . . . 0.0 112.207 173.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -68.87 175.21 7.65 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.346 2.697 . . . . 0.0 113.128 176.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -92.2 9.03 35.42 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.853 1.261 . . . . 0.0 112.514 -178.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 34.9 p90 -138.31 154.16 73.53 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 124.846 1.259 . . . . 0.0 112.759 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.6 153.04 60.05 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 123.621 2.881 . . . . 0.0 112.547 178.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 535' ' ' ALA . . . . . 0.438 ' HB1' ' HB3' ' A' ' 393' ' ' PRO . . . -67.52 144.16 97.56 Favored Pre-proline 0 CA--C 1.55 0.964 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -176.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.86 176.26 9.24 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.949 3.099 . . . . 0.0 112.555 178.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 22.5 p -129.39 154.24 80.67 Favored Pre-proline 0 N--CA 1.479 0.993 0 C-N-CA 124.759 1.224 . . . . 0.0 112.779 -171.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -67.85 162.09 41.13 Favored 'Trans proline' 0 CA--C 1.546 1.118 0 C-N-CA 123.28 2.653 . . . . 0.0 111.352 176.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -65.5 154.18 74.86 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.982 2.454 . . . . 0.0 112.482 177.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 540' ' ' VAL . . . . . . . . . . . . . 12.6 m -68.42 -10.91 13.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 127.316 2.246 . . . . 0.0 114.897 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 541' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -150.45 165.39 33.32 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.043 1.737 . . . . 0.0 111.963 177.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 542' ' ' ASN . . . . . . . . . . . . . 9.5 p30 . . . . . 0 C--O 1.253 1.249 0 C-N-CA 124.671 1.188 . . . . 0.0 113.684 174.797 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.495 0 N-CA-C 111.727 -0.549 . . . . 0.0 111.727 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 18.6 m -87.97 12.36 13.52 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.426 1.49 . . . . 0.0 114.902 -172.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 338' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 -142.71 144.13 32.57 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.283 1.433 . . . . 0.0 111.582 -174.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 339' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -152.26 174.84 13.29 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 126.131 1.773 . . . . 0.0 112.358 -177.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 340' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -131.25 48.22 2.45 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.409 1.483 . . . . 0.0 112.679 -172.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 341' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -123.78 99.55 6.34 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 126.248 1.819 . . . . 0.0 110.389 175.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 342' ' ' GLN . . . . . . . . . . . . . 70.5 tp60 -66.35 137.13 56.68 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.353 0.597 . . . . 0.0 111.352 174.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 3.1 mptm? -127.57 165.82 19.19 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.825 1.65 . . . . 0.0 111.868 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 16.2 m -135.25 157.15 39.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 126.725 2.01 . . . . 0.0 109.399 169.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -120.53 131.24 54.6 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.914 0.886 . . . . 0.0 110.364 178.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 71.3 p -73.49 151.75 40.94 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.06 0.944 . . . . 0.0 111.379 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 347' ' ' ILE . . . . . . . . . . . . . 1.7 pp -124.3 -8.28 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -177.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 348' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -154.35 157.23 32.26 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 126.474 1.91 . . . . 0.0 109.906 169.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.3 157.4 61.97 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.093 2.529 . . . . 0.0 113.025 177.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -139.17 144.45 38.59 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.064 1.345 . . . . 0.0 111.259 178.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 55.0 m -142.26 134.21 27.25 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.803 1.641 . . . . 0.0 109.869 -171.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -67.01 -46.05 75.68 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -170.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 57.07 89.9 0.01 OUTLIER Glycine 0 CA--C 1.538 1.517 0 C-N-CA 125.153 1.358 . . . . 0.0 114.925 176.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 354' ' ' SER . . . . . . . . . . . . . 77.8 p 60.95 29.01 18.75 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 126.271 1.828 . . . . 0.0 115.127 -176.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -135.97 160.34 38.9 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.915 1.686 . . . . 0.0 111.895 -179.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 33.7 mtmm -125.13 -7.65 7.11 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -178.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 29.6 p -106.76 9.77 31.0 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.584 1.554 . . . . 0.0 113.096 -176.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 70.7 mt -108.0 128.97 55.13 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.997 1.319 . . . . 0.0 111.195 -177.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 359' ' ' LEU . . . . . . . . . . . . . 31.1 tp -80.68 121.11 25.46 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.477 0.711 . . . . 0.0 110.642 176.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 360' ' ' SER . . . . . . . . . . . . . 47.4 p -90.19 152.62 21.01 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.564 1.145 . . . . 0.0 112.487 173.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 361' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -165.94 179.21 5.98 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.581 1.553 . . . . 0.0 112.34 -177.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -119.08 174.51 6.28 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.338 1.855 . . . . 0.0 111.205 174.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -68.62 137.99 54.68 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.044 0.938 . . . . 0.0 111.693 172.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 84.21 12.96 75.17 Favored Glycine 0 CA--C 1.536 1.39 0 N-CA-C 114.881 0.712 . . . . 0.0 114.881 174.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 365' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -95.48 160.91 14.29 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.96 1.704 . . . . 0.0 111.669 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 366' ' ' VAL . . . . . . . . . . . . . 72.7 t -108.91 133.73 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.632 1.173 . . . . 0.0 109.74 -171.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 16.5 mt -133.88 139.23 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.446 1.098 . . . . 0.0 109.349 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 368' ' ' THR . . . . . . . . . . . . . 6.8 m -101.2 141.84 33.49 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.593 1.157 . . . . 0.0 110.134 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 369' ' ' LEU . . . . . . . . . . . . . 23.7 mt -79.36 141.72 36.68 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.008 0.523 . . . . 0.0 111.943 -177.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 61.6 mt -116.46 -7.78 11.64 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.596 1.158 . . . . 0.0 113.003 178.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 7.5 mt -132.77 142.01 43.18 Favored Pre-proline 0 N--CA 1.478 0.969 0 C-N-CA 126.857 2.063 . . . . 0.0 109.807 175.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 372' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.08 -8.81 24.35 Favored 'Trans proline' 0 CA--C 1.548 1.177 0 C-N-CA 123.828 3.019 . . . . 0.0 114.788 175.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 26.8 pt-20 -152.69 155.4 37.18 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.811 1.645 . . . . 0.0 112.404 174.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 374' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -75.87 170.72 15.69 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.613 1.165 . . . . 0.0 113.853 174.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -132.51 107.86 8.74 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.533 1.933 . . . . 0.0 110.268 -178.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 376' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 50.65 30.53 4.96 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 124.993 1.317 . . . . 0.0 114.331 -178.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 100.14 -16.42 58.24 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 125.674 1.606 . . . . 0.0 114.425 -178.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 378' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -87.07 129.61 34.84 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.55 1.175 . . . . 0.0 111.198 178.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 12.5 mt -96.62 161.68 13.78 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.955 0.902 . . . . 0.0 110.311 163.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 380' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -124.83 123.75 40.62 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.201 1.4 . . . . 0.0 107.771 173.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . -148.65 175.16 28.05 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-N 115.731 -0.668 . . . . 0.0 113.682 -172.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -126.07 120.62 30.7 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.254 1.422 . . . . 0.0 110.027 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 383' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -61.85 155.93 22.01 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.716 1.206 . . . . 0.0 111.887 179.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -98.46 -21.96 16.28 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 120.661 -1.274 . . . . 0.0 114.363 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 58.5 t -82.63 -33.81 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 C-N-CA 123.466 0.706 . . . . 0.0 112.718 178.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 5.5 t -127.33 -11.49 5.74 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.683 1.193 . . . . 0.0 113.694 -170.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? 54.68 23.02 4.42 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 125.753 1.621 . . . . 0.0 113.762 -177.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -69.25 154.47 41.99 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.688 1.195 . . . . 0.0 111.355 169.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 80.3 mtt180 -127.05 161.19 28.99 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.922 1.689 . . . . 0.0 110.947 -177.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . 156.87 169.39 20.74 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 124.521 1.058 . . . . 0.0 112.449 174.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 391' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -67.1 147.87 52.6 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.144 0.497 . . . . 0.0 110.361 168.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -154.36 155.71 31.05 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 124.112 0.965 . . . . 0.0 110.75 172.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 393' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -65.15 120.39 7.6 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.314 2.009 . . . . 0.0 111.707 178.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 81.7 p -57.99 -22.77 51.04 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 114.225 1.195 . . . . 0.0 114.225 177.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 16.3 m -77.09 -17.69 58.52 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 176.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 396' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -79.36 -2.49 41.81 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.476 1.11 . . . . 0.0 113.687 177.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 397' ' ' THR . . . . . . . . . . . . . 67.2 p -123.36 163.68 20.31 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.623 1.569 . . . . 0.0 110.771 171.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -126.74 151.91 47.55 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 125.193 1.397 . . . . 0.0 108.886 169.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.69 128.2 35.41 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 176.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 60.0 tp -56.05 -36.52 68.12 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 115.699 1.74 . . . . 0.0 115.699 -169.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -149.97 125.04 9.99 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 127.627 2.371 . . . . 0.0 113.009 176.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 . . . . . 0 C--O 1.254 1.328 0 C-N-CA 125.209 1.404 . . . . 0.0 113.639 176.38 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 526' ' ' HIS . . . . . . . . . . . . . 53.6 m80 . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.65 0.262 . . . . 0.0 110.817 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 527' ' ' ILE . . . . . . . . . . . . . 61.0 mt -65.56 132.01 94.93 Favored Pre-proline 0 N--CA 1.478 0.93 0 C-N-CA 124.785 1.234 . . . . 0.0 109.773 179.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -69.31 160.57 49.3 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 123.568 2.845 . . . . 0.0 112.074 178.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 529' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -63.99 143.45 85.03 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 122.281 1.987 . . . . 0.0 112.103 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 530' ' ' ALA . . . . . . . . . . . . . . . -71.94 155.05 92.39 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 123.083 0.553 . . . . 0.0 112.053 172.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 531' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -68.8 174.87 8.02 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.419 2.746 . . . . 0.0 113.095 176.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 532' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -91.14 8.95 33.08 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.913 1.285 . . . . 0.0 112.407 -178.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 533' ' ' TRP . . . . . . . . . . . . . 38.2 p90 -138.02 154.36 74.22 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 124.9 1.28 . . . . 0.0 112.827 -178.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 534' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -72.03 153.82 57.69 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.726 2.951 . . . . 0.0 112.58 178.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 535' ' ' ALA . . . . . . . . . . . . . . . -68.97 142.9 93.88 Favored Pre-proline 0 CA--C 1.552 1.043 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -176.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 536' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -73.92 179.65 5.49 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 124.173 3.249 . . . . 0.0 113.071 176.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 537' ' ' THR . . . . . . . . . . . . . 26.9 p -132.89 155.29 81.32 Favored Pre-proline 0 N--CA 1.48 1.058 0 C-N-CA 125.25 1.42 . . . . 0.0 112.842 -174.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 538' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -67.46 164.64 30.04 Favored 'Trans proline' 0 CA--C 1.549 1.266 0 C-N-CA 123.504 2.803 . . . . 0.0 111.57 174.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 539' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -66.21 162.53 35.52 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 123.46 2.773 . . . . 0.0 113.085 176.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 540' ' ' VAL . . . . . . . . . . . . . 35.2 t -115.98 -7.47 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 125.752 1.621 . . . . 0.0 111.583 -177.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 541' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.58 84.98 2.11 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.679 1.992 . . . . 0.0 110.791 -175.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 542' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 . . . . . 0 C--O 1.254 1.294 0 C-N-CA 125.622 1.569 . . . . 0.0 113.426 -179.431 . . . . . . . . 0 0 . 1 stop_ save_